"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,US,A,US 733001 A,140-175-137-169-060,1903-07-07,1903,US 1903/0146015 A,1903-03-03,US 1903/0146015 A,1903-03-03,SHOE-FASTENING.,,PLEASANT H SANDLIN;;BRYANT GEORGE,BRYANT GEORGE,,https://lens.org/140-175-137-169-060,Granted Patent,no,0,2,1,1,0,A43C7/00;;A43C7/00;;Y10T24/3724;;Y10T24/3724,,,0,0,,,,EXPIRED
2,GB,A,GB 189311439 A,168-726-268-203-438,1894-06-09,1894,GB 189311439D A,1893-06-10,GB 189311439T A,1893-06-10,An Improved Machine for Giving Electric Shocks Automatically by the Insertion of a Coin.,,BRYANT GEORGE,BRYANT GEORGE,,https://lens.org/168-726-268-203-438,Patent Application,no,0,0,1,1,0,,,,0,0,,,,DISCONTINUED
3,US,A,US 1071506 A,119-285-382-102-122,1913-08-26,1913,US 1911/0635089 A,1911-06-24,US 1911/0635089 A,1911-06-24,RAILWAY-CROSSING SIGNAL SYSTEM.,,BRYANT GEORGE,BRYANT GEORGE,,https://lens.org/119-285-382-102-122,Granted Patent,no,0,1,1,1,0,B61L29/222;;B61L29/222,,,0,0,,,,EXPIRED
4,US,A,US 1545393 A,161-953-826-840-788,1925-07-07,1925,US 64769723 A,1923-06-25,US 64769723 A,1923-06-25,Lunch box,,GEORGE BRYANT,GEORGE BRYANT,,https://lens.org/161-953-826-840-788,Granted Patent,no,0,4,1,1,0,A47J27/10;;A47J27/10,A47J27/10,,0,0,,,,EXPIRED
5,US,A,US 1002133 A,108-195-047-627-150,1911-08-29,1911,US 1909/0512000 A,1909-08-09,US 1909/0512000 A,1909-08-09,PROCESS FOR THE TREATMENT OF METALS AND ALLOYS.,,CHARLES HORACE IVINSON,BRYANT GEORGE,,https://lens.org/108-195-047-627-150,Granted Patent,no,0,2,1,1,0,C22B7/02;;C22B7/02,,,0,0,,,,EXPIRED
6,CA,A,CA 40062 A,008-955-450-601-851,1892-08-26,1892,CA 40062D A,,CA 40062T A,,CONSTRUCTION OF BOOTS AND SHOES,,BRYANT GEORGE,BRYANT GEORGE,,https://lens.org/008-955-450-601-851,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
7,GB,A,GB 189713842 A,190-847-721-593-680,1898-06-04,1898,GB 189713842D A,1897-06-05,GB 189713842T A,1897-06-05,Improved Lock for Securely Fastening of Doors.,"13,842. Bryant, G. June 5. Locks, key.-The bolt B, which may be operated by a handle C or by a key, has an aperture b which engages with a button or striking-plate D, the bolt moving outwards and being returned by a spring when the door is closed. A blocking-catch E locks the bolt in the inner position, and also moves a shutter over the keyhole. To prevent the catch from being disengaged by forcing back the shutter, the catch has a pin engaging a hole in the lock case, from which it must be disengaged before the catch can be moved.",BRYANT GEORGE,BRYANT GEORGE,,https://lens.org/190-847-721-593-680,Patent Application,no,0,0,1,1,0,,,,0,0,,,,DISCONTINUED
8,CA,A,CA 178431 A,103-327-246-341-788,1917-07-31,1917,CA 178431D A,1917-03-16,CA 178431T A,1917-03-16,LATHE,,BRYANT GEORGE FORRESTER,BRYANT GEORGE FORRESTER,,https://lens.org/103-327-246-341-788,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
9,US,A,US 3934356 A,100-526-884-233-653,1976-01-27,1976,US 29600172 A,1972-10-10,US 29600172 A,1972-10-10,Teaching aid for air conditioning apparatus,"For use in teaching a skill for service and repair of heating and air conditioning equipment, a teaching aid which incorporates a closed chamber, preferably insulated, which receives therein the air distribution portion of a heating and air conditioning system. The apparatus utilizes a complete miniaturized refrigerant system which has a sealed compressor unit, an evaporator, a condensor, and the appropriate lines connecting the various components. In the preferred embodiment, a removable skid mounted base supports the condensor and compressor.",G M BROOKS IND INC,BRYANT GEORGE W,,https://lens.org/100-526-884-233-653,Granted Patent,yes,3,9,1,1,0,G09B25/02;;G09B25/02,G09B25/02,35/13,0,0,,,,EXPIRED
10,US,A,US 2068032 A,166-021-772-953-403,1937-01-19,1937,US 1320035 A,1935-03-27,US 1320035 A,1935-03-27,Process and apparatus for the manufacture of rayon,,SKENANDOA RAYON CORP,WILLARD BRYANT GEORGE,,https://lens.org/166-021-772-953-403,Granted Patent,no,0,1,1,1,0,D01D10/0418;;D01D10/0418,D01D10/04,,0,0,,,,EXPIRED
11,CA,A,CA 701842 A,065-112-436-860-111,1965-01-12,1965,CA 701842D A,,CA 701842T A,,DYEABLE GRAFT POLYOLEFIN RESINS,,UNION CARBIDE CORP,BRYANT GEORGE M,,https://lens.org/065-112-436-860-111,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
12,US,A,US 1050076 A,139-796-373-607-604,1913-01-07,1913,US 1910/0572844 A,1910-07-20,US 1910/0572844 A,1910-07-20,FERTILIZER-DISTRIBUTER.,,BRYANT GEORGE J,BRYANT GEORGE J,,https://lens.org/139-796-373-607-604,Granted Patent,no,0,0,1,1,0,A01C15/12;;A01C15/12,,,0,0,,,,EXPIRED
13,US,A,US 1105960 A,096-670-066-208-097,1914-08-04,1914,US 1913/0771764 A,1913-06-04,US 1913/0771764 A,1913-06-04,WASHSTAND.,,BRYANT GEORGE H,BRYANT GEORGE H,,https://lens.org/096-670-066-208-097,Granted Patent,no,0,1,1,1,0,F16M11/24;;F16M11/24,,,0,0,,,,EXPIRED
14,CA,A,CA 1191320 A,116-658-551-786-212,1985-08-06,1985,CA 407191 A,1982-07-13,US 36407982 A,1982-03-31,STUD FASTENERS AND WALL STRUCTURES EMPLOYING SAME,"The present invention is directed to improved fasteners for securing insulation to a supporting structure, to a method of using the fasteners, and to combination wall structures obtained by such use. The fasteners arc adapted to facilitate the securement of relatively thick insulation to a supporting structure, particularly where the supporting structure consists of a relatively hard material, such as aged concrete of high compressive strength.",GRACE W R & CO,BRYANT GEORGE E,,https://lens.org/116-658-551-786-212,Granted Patent,no,0,1,2,3,0,E04D3/3602;;E04F13/0805;;E04F13/0837;;E04F19/06;;E04D3/3602;;E04F13/0805;;E04F13/0837;;E04F19/06,E04F13/08;;E04F19/06,20-29,0,0,,,,EXPIRED
15,US,A,US 1093825 A,111-706-235-912-880,1914-04-21,1914,US 1912/0715561 A,1912-08-17,US 1912/0715561 A,1912-08-17,TIRE-TOOL.,,BRYANT GEORGE W,BRYANT GEORGE W,,https://lens.org/111-706-235-912-880,Granted Patent,no,0,4,1,1,0,B60C25/02;;B60C25/02,,,0,0,,,,EXPIRED
16,US,A,US 924314 A,190-058-187-324-47X,1909-06-08,1909,US 1908/0413595 A,1908-01-31,US 1908/0413595 A,1908-01-31,CAR-WHEEL AND METHOD OF MANUFACTURE.,,BRYANT GEORGE H,BRYANT GEORGE H,,https://lens.org/190-058-187-324-47X,Granted Patent,no,0,0,1,1,0,B60B17/0006;;B60B17/0006,,,0,0,,,,EXPIRED
17,CA,A,CA 211733 A,080-229-239-309-876,1921-05-24,1921,CA 211733D A,,CA 211733T A,,BREAK HOOK,,BRYANT GEORGE WESLEY,BRYANT GEORGE WESLEY,,https://lens.org/080-229-239-309-876,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
18,GB,A,GB 126894 A,133-940-685-420-561,1919-05-22,1919,GB 1634618 A,1918-10-08,GB 1634618 A,1918-10-08,Improvements in Road Tractor and other Wheels and Pulleys.,"126,894. Bryant, G. C. Oct. 8, 1918. Pulleys and driving-drums.-In a built-up pulley &c. the spokes are formed by bars &c. extending across the wheel, diametrically-opposed spokes being integral with an eye or collar adapted to fit over the hub. In the construction shown, two sets of spokes, each. comprising dished plates C<1>, C<2>, C<3>, are fitted over the hub bosses J and riveted or bolted to flanges H, E on the hub and rim respectively.",BRYANT GEORGE CANNINGS,BRYANT GEORGE CANNINGS,,https://lens.org/133-940-685-420-561,Granted Patent,no,0,0,1,1,0,B60B1/10,B60B1/10,,0,0,,,,EXPIRED
19,CA,A,CA 132767 A,176-966-991-559-591,1911-05-02,1911,CA 132767D A,1911-02-20,CA 132767T A,1911-02-20,SPRING CONTRACTING AND REMOVING DEVICE,,BRYANT GEORGE WALTER,BRYANT GEORGE WALTER,,https://lens.org/176-966-991-559-591,Granted Patent,no,0,1,1,1,0,,,,0,0,,,,EXPIRED
20,GB,A,GB 190216464 A,075-711-395-068-853,1903-05-28,1903,GB 190216464D A,1902-07-24,GB 190216464T A,1902-07-24,Improvements in Rotary Engines.,"16,464. Bryant, G. W. July 24. Annular-chamber type.-The casing a is divided by a partition d into two annular chambers, each containing a piston vane g carried by a disc e<2> on the main shaft e. The rotary abutments h are shaped like cut-away tubes, and are formed on a central boss h<1> driven by a toothed wheel e', or other gearing, on the shaft. The supply and exhaust pipes, not shown, are connected to the sleeve j of the casing, containing a tubular valve i with supply and exhaust ports i', i<2> connected by duplicate passages e<5>, e<6> to ports e', e<8> in the sleeves in the working chambers. The valve is used for reversing and for varying the cut-off. The engine may have only one working chamber.",BRYANT GEORGE WALLACE,BRYANT GEORGE WALLACE,,https://lens.org/075-711-395-068-853,Patent Application,no,0,2,1,1,0,,,,0,0,,,,DISCONTINUED
21,GB,A,GB 875921 A,190-807-377-074-884,1961-08-23,1961,GB 3651957 A,1957-11-22,GB 3651957 A,1957-11-22,Portable radio receivers,"875,921. Knobs &c. BURNDEPT Ltd. Feb. 23, 1959 [Nov. 22, 1957], No. 36519/57. Class 52(1) [Also in Groups XXV and XL(c)] A portable radio receiver has a T-shaped handle, the crossbar of which includes a wound ferrite aerial, the stem of the handle being retractable within a socket against the bias of a spring and can be locked in the retracted position by partial rotation. As shown, the handle 2 contains a ferrite rod 3 carrying coils 4 for different wavebands. The socket is moulded from plastic material and comprises a fixing plate 5 and a shell 7. The handle 2 is biased into its upward position by means of a spring 18 acting on a collar 8. When the handle 2 is in its upward position a pin 9 projecting from the collar 8 can engage a slot 14 to prevent rotation. The handle is locked in its retracted position by engagement of the pin 9 in a recess 17 formed in the wall of the shell 7. Specification 811,826 is referred to.",BURNDEPT LTD,BRYANT MATTHEW GEORGE,,https://lens.org/190-807-377-074-884,Granted Patent,no,0,2,1,1,0,H04B1/086;;H01Q7/00,H01Q7/00;;H04B1/08,E2A ACSA          ACSA;;H1Q QKC           KC;;H3Q QAA           QAA,0,0,,,,EXPIRED
22,US,A,US 1836954 A,051-395-630-983-857,1931-12-15,1931,US 15127826 A,1926-11-29,US 15127826 A,1926-11-29,Metal working machine,,MARYE SAFETY NUT CORP,BRYANT GEORGE F,,https://lens.org/051-395-630-983-857,Granted Patent,no,0,5,1,1,0,B23G9/005;;Y10T409/300504;;Y10T408/368;;Y10T29/5128;;Y10T409/300448;;Y10T409/300504;;Y10T408/368;;Y10T29/5128;;Y10T409/300448;;B23G9/005,B23G9/00,,0,0,,,,EXPIRED
23,DE,A1,DE 2314840 A1,096-529-229-881-006,1973-10-11,1973,DE 2314840 A,1973-03-24,US 23851572 A,1972-03-27,"EINRICHTUNG UND VERFAHREN ZUM INDUKTIONSHAERTEN VON VENTILSITZEN, INSBESONDERE AN BRENNKRAFTMASCHINEN",,PARK OHIO INDUSTRIES INC,BRYANT WILLIAM GEORGE,,https://lens.org/096-529-229-881-006,Patent Application,no,0,3,13,13,0,H05B6/06;;H05B6/06;;H05B6/101;;H05B6/101,H05B6/40;;C21D1/10;;H05B6/02;;H05B6/06,,0,0,,,,DISCONTINUED
24,US,A,US 1628109 A,099-112-993-577-056,1927-05-10,1927,US 67343423 A,1923-11-08,US 67343423 A,1923-11-08,Printing press,,ELECTROGRAPH ADVERTISING SERVI,BRYANT GEORGE F,,https://lens.org/099-112-993-577-056,Granted Patent,no,0,0,1,1,0,B41L15/02;;B41L15/02,B41L15/02,,0,0,,,,EXPIRED
25,US,A,US 1378619 A,113-680-974-488-593,1921-05-17,1921,US 43074220 A,1920-12-14,US 43074220 A,1920-12-14,Shackle,,BRYANT ROBERTSON GEORGE,BRYANT ROBERTSON GEORGE,,https://lens.org/113-680-974-488-593,Granted Patent,no,0,3,1,1,0,B60D1/26;;B60D1/26,B60D1/26,,0,0,,,,EXPIRED
26,US,A,US 1887798 A,110-709-701-732-869,1932-11-15,1932,US 47267130 A,1930-08-02,US 47267130 A,1930-08-02,Rotary filter press,,HENRY VOGT MACHINE COMPANY,ROCK BRYANT GEORGE,,https://lens.org/110-709-701-732-869,Granted Patent,no,0,4,1,1,0,B01D33/466;;B01D33/466;;B01D33/21;;B01D33/21;;B01D33/23;;B01D33/23,B01D33/00;;B01D35/16,,0,0,,,,EXPIRED
27,US,A,US 1008694 A,141-163-009-254-699,1911-11-14,1911,US 1911/0607028 A,1911-02-07,US 1911/0607028 A,1911-02-07,SPRING CONTRACTING AND REMOVING DEVICE.,,BRYANT GEORGE W,BRYANT GEORGE W,,https://lens.org/141-163-009-254-699,Granted Patent,no,0,6,1,1,0,B25B27/26;;B25B27/26;;Y10T29/53561;;Y10T29/53561,,,0,0,,,,EXPIRED
28,GB,A,GB 1267406 A,108-455-214-814-278,1972-03-22,1972,GB 2460269 A,1969-05-14,GB 2460269 A,1969-05-14,IMPROVEMENTS IN END FITTINGS FOR HOSES AND TUBES,"1,267,406. Pipe couplings. COMPOFLEX CO. Ltd. 15 April, 1970 [14 May, 1969], No. 24602/69. Heading F2G. A connector 1 for two hoses or pipes, preferably formed with internal corrugations, consists of a tubular member formed externally at each end with gripping means, e.g. studs or sawtooth serrations 2 which may be continuous as shown, to provide a drive fit with the hoses or pipes, and with one or more slots 3. The connector 1 may be formed from rigid polyvinyl chloride or other non-corrosive plastics, thermoplastics or thermosetting materials. The connector 1 may be used between pipes in land drainage systems. One end of the connector may be of greater diameter than the other, for use between pipes of different sizes.",COMPOFLEX CO LTD,BRYANT FREDERICK GEORGE,,https://lens.org/108-455-214-814-278,Granted Patent,no,0,4,3,3,0,F16L31/00,F16L31/00,F2G G24A2         G24A;;F2G G24A2         24A2;;F2G G28           G24A;;F2G G28           24A2,0,0,,,,EXPIRED
29,US,A,US 1072081 A,116-279-466-633-211,1913-09-02,1913,US 1912/0716899 A,1912-08-24,US 1912/0716899 A,1912-08-24,SAFETY DEVICE FOR RAILROAD-LOCOMOTIVE TENDERS.,,BRYANT GEORGE E,BRYANT GEORGE E,,https://lens.org/116-279-466-633-211,Granted Patent,no,0,0,1,1,0,B61C17/04;;B61C17/04,,,0,0,,,,EXPIRED
30,US,A,US 1536656 A,168-756-003-811-398,1925-05-05,1925,US 73499824 A,1924-08-29,US 73499824 A,1924-08-29,Draft break hook,,WESLEY BRYANT GEORGE,WESLEY BRYANT GEORGE,,https://lens.org/168-756-003-811-398,Granted Patent,no,0,2,1,1,0,B60D1/04;;B60D1/04,B60D1/04,,0,0,,,,EXPIRED
31,GB,A,GB 190520815 A,179-099-005-396-273,1906-08-23,1906,GB 190520815D A,1905-10-14,GB 190520815T A,1905-10-14,Improvements in Rotary Pumps and the like,"20,815. Bryant, G. W. Oct. 14. Annular-chamber type of rotary pumps or motors with rotary abutments. To a central shaft i, Figs. 1 and 2, are secured two hollow sleeves h<1>, each of which carries a hollow piston h, rotating in an annular chamber e. Two crescent-shaped abutments j' are made integral with a central cylindrical part j<3>. The outer curved surfaces of the abutments are provided with teethjl, which mesh with teeth h<3> partially encircling the piston sleeve. The construction shown allows the piston to extend beyond the axis of the abutment chamber. The action as a pump is as follows :-The piston h, Fig. 2, is rotated counter-clockwise. The fluid in front of the piston is driven through the port d' into the discharge pipe d. The suction behind the piston causes fluid to flow up the suction pipe c, through the port h<4> in the sleeve h<1> into the interior of the piston, and through the port h<5> into the chamber e, ready to be discharged through the port d<1> when the piston passes the abutment. When the teeth on one pair of abutments and piston pass out of mesh, the teeth of the other pair pass into mesh, so that continuous rotation of the abutments is secured. The pistons proper never actually touch the abutments. When the apparatus is used as a motor, the pipe c is the inlet and the pipe d is the exhaust. A single-cylinder modification is described, the construction being similar to the above except that the second piston and abutment are omitted and the casing modified accordingly.",BRYANT GEORGE WALLACE,BRYANT GEORGE WALLACE,,https://lens.org/179-099-005-396-273,Patent Application,no,0,0,1,1,0,,,,0,0,,,,DISCONTINUED
32,US,A,US 2530150 A,185-673-137-417-786,1950-11-14,1950,US 71691346 A,1946-12-18,AU 2530150X A,1945-12-21,Dragline excavating apparatus,,LETOURNEAU INC,BRYANT GEORGE E,,https://lens.org/185-673-137-417-786,Granted Patent,no,4,1,1,1,0,E02F3/58;;E02F3/58,E02F3/58,,0,0,,,,EXPIRED
33,FI,A,FI 28179 A,061-477-879-258-054,1956-02-10,1956,FI 28179D A,,FI 28179T A,,"Stol, soffa eller dylikt",,CHARLES NEWTH & SONS LTD,GEORGE BRYANT STANLEY,,https://lens.org/061-477-879-258-054,Granted Patent,no,0,0,1,1,0,,A47C1/031,,0,0,,,,EXPIRED
34,GB,A,GB 695254 A,063-676-537-408-432,1953-08-05,1953,GB 2179351 A,1951-09-17,GB 2179351 A,1951-09-17,Improvements in or relating to bed settees,"695,254. Bed-settees. NEWTH & SONS, Ltd., C. July 9, 1952 [Sept. 17, 1951]. No. 21793/51. Addition to 623,975. Class 52(ii) The bed-settee claimed in the parent Specification is modified in that, when the bed section frames are constructed of wood, the pivots connecting said sections are arranged on the upper surface and the front section is supported in extended position, from the seat by members which are jointed intermediately of their ends. As shown, the bedsection frames are connected by pivots 20, 21, 22 and the front bed section 13 is supported, in extended position, at each side by a strut 16 pivoted at 17 to the bed section 13 and at the other end to an arm 16A which it itself pivoted at 18A to a member 19 secured to the seat 23. The arm 16A is provided with a projection 16B to service as a stop.",CHARLES NEWTH & SONS LTD,BRYANT STANLEY GEORGE,,https://lens.org/063-676-537-408-432,Granted Patent,no,0,0,1,1,0,A47C17/225,A47C17/22,A4J J11B2B1       -5;;A4J J11B2B4       -5;;A4J J11B3B1       -5;;A4J J11B3B2       -5;;A4J J11B6FY       -5;;A4J J11B6F1       -5;;A4J J11B7A        -5;;A4J J11B8A2       -5;;A4J J11B8B1       -5;;A4J J11B9A        -5;;A4J J11B9C1       -5;;A4J J11B9EY       -5;;A4J J11B9E4       -5,0,0,,,,EXPIRED
35,CA,A,CA 155714 A,125-524-764-985-736,1914-05-19,1914,CA 155714D A,1914-01-19,CA 155714T A,1914-01-19,TIRE TOOL,,BRYANT GEORGE WALTER,BRYANT GEORGE WALTER,,https://lens.org/125-524-764-985-736,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
36,GB,A,GB 1235616 A,146-351-696-154-218,1971-06-16,1971,GB 4189569 A,1969-08-22,GB 4189569 A,1969-08-22,IMPROVEMENTS RELATING TO COAT-HANGERS,"1,235,616. Garment hangers. G. W. BRYANT. 18 Nov., 1969 [22 Aug., 1969], No. 41895/69. Heading A4U. In a coat &c. hanger the suspensory member 2 has a stem 3, which forms with an intermediate part 3a a V-shaped recess for wedging engagement with a clothes line 6, and a hook part 4. The member is preferably resilient and is moulded, bent, pressed or stamped from metal or plastics and may be integral with the bar or passed through a hole therein and retained by a 'stop 7 which is integral with the stem or secured thereto. In modifications, the bar is of wood, a trouser bar joins the ends of the bar, or teeth or serrations, pointing away from the bar, are provided in the V-shaped recess.",BRYANT GEORGE WILLIAM,BRYANT GEORGE WILLIAM,,https://lens.org/146-351-696-154-218,Granted Patent,no,0,3,1,1,0,A47G25/325,A47G25/32,A4L LAL           L121;;A4L L121          L121;;A4U U4B2          U4BZ;;A4U U4B4          U4BZ;;A4U U4B9A         U4BZ,0,0,,,,EXPIRED
37,US,A,US 1461648 A,161-855-953-035-889,1923-07-10,1923,US 48221121 A,1921-07-02,US 48221121 A,1921-07-02,Window-cleaner's life net,,BRYANT GEORGE W,BRYANT GEORGE W,,https://lens.org/161-855-953-035-889,Granted Patent,no,0,4,1,1,0,A47L3/00;;A47L3/00,A47L3/00,,0,0,,,,EXPIRED
38,US,A,US 1123088 A,181-899-279-821-473,1914-12-29,1914,US 1914/0811085 A,1914-01-08,US 1914/0811085 A,1914-01-08,SASH-HOLDER.,,BRYANT GEORGE H,BRYANT GEORGE H,,https://lens.org/181-899-279-821-473,Granted Patent,no,0,2,1,1,0,E06B3/44;;E06B3/44,,,0,0,,,,EXPIRED
39,US,A,US 2479467 A,198-313-350-010-275,1949-08-16,1949,US 78943547 A,1947-12-03,US 78943547 A,1947-12-03,Folding hand truck,,BRYANT GEORGE A,BRYANT GEORGE A,,https://lens.org/198-313-350-010-275,Granted Patent,no,2,9,1,1,0,B62B1/12;;B62B1/12,B62B1/12,,0,0,,,,EXPIRED
40,DK,B,DK 137770 B,108-222-053-629-612,1978-05-01,1978,DK 53570 A,1970-02-03,GB 651369 A,1969-02-06,Forbindelsesstykke til at forbinde et hus med en slange.,,COMPOFLEX CO LTD,BRYANT FREDERICK GEORGE,,https://lens.org/108-222-053-629-612,Patent Application,no,0,0,5,5,0,F16L33/01;;F16L33/24,F16L33/01;;F16L33/24,,0,0,,,,EXPIRED
41,GB,A,GB 1240562 A,152-775-984-992-984,1971-07-28,1971,GB 651369 A,1969-02-06,GB 651369 A,1969-02-06,IMPROVEMENTS IN END FITTINGS FOR HOSES AND TUBES,"1,240,562. Pipe couplings. COMPOFLEX CO. Ltd. 26 Jan., 1970 [6 Feb., 1969], No. 6513/69. Heading F2G. A hose connector 1 has external gripping protrusions 2 at one end for drive fit insertion into a hose bore, and a smooth outer surface 3 and threaded bore 4 at the other end. The protrusions 2 have a saw-tooth profile and may be discontinuous. Alternatively the protrusions 2 are studs. The ends of the connector may be of different diameter. The gripping end of the connector 1 is pushed into a corrugated plastics hose 5, the braid 6 of which is extended over the smooth surface 3. A rotary joint assembly comprising sleeves 9, 8, 12 and a ferrule 7 is coupled to the connector 1 and hose 5, the sleeve 4 being screwed into the connector, forcing the tapered metal ferrule 7 over the braid 6, gripping the braid on the smooth surface 3 of the connector. The connector 1 may be of rigid polyvinyl chloride, polypropylene, nylon, polystyrene, steel, stainless steel, aluminium, copper, or bronze. The hose 5 may be of polypropylene with the braid 6 of polyethylene. The joint may be used in association with a vacuum cleaner.",COMPOFLEX CO LTD,BRYANT FREDERICK GEORGE,,https://lens.org/152-775-984-992-984,Granted Patent,no,0,5,5,5,0,F16L33/01;;F16L33/24,F16L33/01;;F16L33/24,F2G G22C          G22C;;F2G G24A2         G24A;;F2G G24A2         24A2;;F2G G25B          G25B;;F2G G28           G22C;;F2G G28           G25B;;F2G G28           G6C2;;F2G G28           24A2;;F2G G36           G22C;;F2G G36           G25B;;F2G G36           G6C2;;F2G G36           24A2;;F2G G6C2          G6C;;F2G G6C2          G6C2,0,0,,,,EXPIRED
42,US,A,US 1381746 A,070-076-959-302-181,1921-06-14,1921,US 43074120 A,1920-12-14,US 43074120 A,1920-12-14,Stake,,BRYANT ROBERTSON GEORGE,BRYANT ROBERTSON GEORGE,,https://lens.org/070-076-959-302-181,Granted Patent,no,0,0,1,1,0,B62D33/0207;;B62D33/0207,B62D33/02,,0,0,,,,EXPIRED
43,US,A,US 4545103 A,117-085-379-804-685,1985-10-08,1985,US 57055984 A,1984-01-13,US 57055984 A;;US 36407982 A,1982-03-31,Method of securing an insulation member to a wall or wall-stud assembly,"The present invention is directed to improved fasteners for securing insulation to a supporting structure, to a method of using the fasteners, and to combination wall structures obtained by such use. The fasteners are adapted to facilitate the securement of relatively thick insulation to a supporting structure, particularly where the supporting structure consists of a relatively hard material, such as aged concrete of high compressive strength.",GRACE W R & CO,BRYANT GEORGE E,W. R. GRACE & CO.-CONN (1988-05-25),https://lens.org/117-085-379-804-685,Granted Patent,yes,22,9,1,3,0,E04D3/3602;;E04D3/3602;;E04F13/0805;;E04F13/0805;;E04F13/0837;;E04F13/0837;;E04F19/06;;E04F19/06;;Y10T29/49632;;Y10T29/49632;;Y10T29/49833;;Y10T29/49833;;Y10T29/4995;;Y10T29/4995;;Y10T29/49952;;Y10T29/49952,E04F13/08;;E04F19/06,29/432;;X 29155R;;X 29526R,0,0,,,,EXPIRED
44,GB,A,GB 189904378 A,150-243-082-366-677,1899-04-01,1899,GB 189904378D A,1899-02-28,GB 189904378T A,1899-02-28,Improvements in Shoes for Horses and other Animals.,,BRYANT ARTHUR GEORGE,BRYANT ARTHUR GEORGE,,https://lens.org/150-243-082-366-677,Patent Application,no,0,0,1,1,0,,,,0,0,,,,DISCONTINUED
45,US,A,US 941756 A,003-521-490-010-167,1909-11-30,1909,US 1909/0480118 A,1909-02-26,US 1909/0480118 A,1909-02-26,AIR-HEATER.,,BRYANT GEORGE LINCOLN,BRYANT GEORGE LINCOLN,,https://lens.org/003-521-490-010-167,Granted Patent,no,0,0,1,1,0,F28D1/03;;F28D1/03;;Y10S165/341;;Y10S165/341,,,0,0,,,,EXPIRED
46,US,A,US 4438611 A,037-690-159-506-876,1984-03-27,1984,US 36407982 A,1982-03-31,US 36407982 A,1982-03-31,Stud fasteners and wall structures employing same,"The present invention is directed to improved fasteners for securing insulation to a supporting structure, to a method of using the fasteners, and to combination wall structures obtained by such use. The fasteners are adapted to facilitate the securement of relatively thick insulation to a supporting structure, particularly where the supporting structure consists of a relatively hard material, such as aged concrete of high compressive strength.",GRACE W R & CO,BRYANT GEORGE E,W. R. GRACE & CO.-CONN (1988-05-25);;W.R. GRACE & CO. A CORP. OF CT (1982-04-12),https://lens.org/037-690-159-506-876,Granted Patent,yes,16,85,2,3,0,E04D3/3602;;E04F13/0805;;E04F13/0837;;E04F19/06;;E04D3/3602;;E04F13/0805;;E04F13/0837;;E04F19/06,E04F13/08;;E04F19/06,52/309.2;;52/359;;52/410,0,0,,,,EXPIRED
47,CA,A,CA 202326 A,059-830-554-656-807,1920-07-27,1920,CA 202326D A,,CA 202326T A,,ROAD TRACTOR,,UNIVERSAL WHEEL COMPANY,BRYANT GEORGE CANNINGS,,https://lens.org/059-830-554-656-807,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
48,AU,A,AU 1973/051419 A,065-763-899-552-712,1974-07-25,1974,AU 1973/051419 A,1973-01-24,US 23851572 A,1972-03-27,INDUCTION HEATER,,PARK OHIO INDUSTRIES INC,BRYANT WILLIAM GEORGE,,https://lens.org/065-763-899-552-712,Patent Application,no,0,0,13,13,0,H05B6/06;;H05B6/06;;H05B6/101;;H05B6/101,H05B6/40;;C21D1/10;;H05B6/02;;H05B6/06,,0,0,,,,EXPIRED
49,US,A,US 1722892 A,169-916-733-723-425,1929-07-30,1929,US 19148027 A,1927-05-14,US 19148027 A,1927-05-14,Spray gun and spray head therefor,,BRUNNER MFG COMPANY,WILLARD BRYANT GEORGE,,https://lens.org/169-916-733-723-425,Granted Patent,no,0,3,1,1,0,B05B7/083;;B05B7/083;;B05B7/0815;;B05B7/0815,B05B7/08,,0,0,,,,EXPIRED
50,US,A,US 2711181 A,176-435-413-469-401,1955-06-21,1955,US 22401551 A,1951-05-01,US 22401551 A,1951-05-01,Spherical structure,,SPHERIC STRUCTURES INC,BRYANT WOODS GEORGE,,https://lens.org/176-435-413-469-401,Granted Patent,no,6,21,1,1,0,E04B1/3441;;Y10S135/906;;E04B1/3441;;Y10S135/906,E04B1/344,,0,0,,,,EXPIRED
51,US,A,US 2251034 A,183-778-637-467-956,1941-07-29,1941,US 34247940 A,1940-06-26,US 34247940 A,1940-06-26,Machine tool,,LUCIEN I YEOMANS,BRYANT GEORGE F,,https://lens.org/183-778-637-467-956,Granted Patent,no,0,1,1,1,0,B23B41/12;;B23B41/12;;Y10T29/5134;;Y10T29/5134,B23B41/12,,0,0,,,,EXPIRED
52,CA,A,CA 598801 A,139-257-804-648-481,1960-05-31,1960,CA 598801D A,,CA 598801T A,,MANDREL,,BRYANT GEORGE F;;BRYANT RAYMOND C,BRYANT GEORGE F;;BRYANT RAYMOND C,,https://lens.org/139-257-804-648-481,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
53,US,A,US 2548096 A,019-468-009-132-450,1951-04-10,1951,US 8836849 A,1949-04-19,US 8836849 A,1949-04-19,Expanding mandrel,,BRYANT GEORGE F;;BRYANT RAYMOND C,BRYANT GEORGE F;;BRYANT RAYMOND C,,https://lens.org/019-468-009-132-450,Granted Patent,no,7,8,1,1,0,B23B31/185;;Y10T279/3487;;Y10T279/1041;;Y10T279/17264;;Y10T279/1095;;Y10T279/3487;;Y10T279/1041;;Y10T279/17264;;Y10T279/1095;;B23B31/185,B23B31/18,,0,0,,,,EXPIRED
54,US,A,US 2690914 A,199-504-413-925-201,1954-10-05,1954,US 21114551 A,1951-02-15,US 21114551 A,1951-02-15,Mandrel,,BRYANT GEORGE F;;BRYANT RAYMOND C,BRYANT GEORGE F;;BRYANT RAYMOND C,,https://lens.org/199-504-413-925-201,Granted Patent,no,12,7,1,1,0,B23B31/4046;;Y10T279/1083;;Y10T279/1058;;Y10T279/1083;;Y10T279/1058;;B23B31/4046,B23B31/40,,0,0,,,,EXPIRED
55,FI,A,FI 773716 A,106-312-763-410-902,1978-06-15,1978,FI 773716 A,1977-12-09,GB 5214876 A,1976-12-14,FOERBAETTRINGAR VID FRAMSTAELLNING AV FILTERSTAVAR,,BRITISH AMERICAN TOBACCO CO,BRYANT ROBERT GEORGE WILLIAM,,https://lens.org/106-312-763-410-902,Patent Application,no,0,0,14,14,0,A24C5/3412;;G01N21/952;;Y10T83/739;;Y10T83/2024;;Y10T83/2085;;Y10T83/543;;Y10T83/533;;Y10T83/739;;Y10T83/2024;;Y10T83/2085;;Y10T83/543;;Y10T83/533;;A24C5/3412;;G01N21/952,A24C5/34;;G01N21/952,,0,0,,,,EXPIRED
56,MY,A,MY 8500771 A,023-942-946-640-599,1985-12-31,1985,MY 8500771 A,1985-12-30,GB 8106653 A,1981-03-03,IMPROVEMENTS RELATING TO APPARATUS FOR MONITORING PARTICULATE MATERIALS,,BRITISH AMERICAN TOBACCO CO,BRYANT ROBERT GEORGE WILLIAM,,https://lens.org/023-942-946-640-599,Granted Patent,no,0,0,7,9,0,G01F1/005;;G01F23/32;;G01F1/005;;G01F23/32,G01F1/00;;G01F23/32,,0,0,,,,EXPIRED
57,FI,C,FI 63166 C,140-986-686-225-204,1983-05-10,1983,FI 773716 A,1977-12-09,GB 5214876 A,1976-12-14,FOERFARANDE FOER UPPMAERKANDE AV FEL I EN OEVERDRAGEN FILTERSTAV,,BRITISH AMERICAN TOBACCO CO,BRYANT ROBERT GEORGE WILLIAM,,https://lens.org/140-986-686-225-204,Granted Patent,no,0,0,14,14,0,A24C5/3412;;G01N21/952;;Y10T83/739;;Y10T83/2024;;Y10T83/2085;;Y10T83/543;;Y10T83/533;;Y10T83/739;;Y10T83/2024;;Y10T83/2085;;Y10T83/543;;Y10T83/533;;A24C5/3412;;G01N21/952,A24C5/34;;G01N21/952,,0,0,,,,EXPIRED
58,DE,C2,DE 3207684 C2,059-803-267-777-266,1994-02-10,1994,DE 3207684 A,1982-03-03,GB 8106653 A,1981-03-03,Vorrichtung zum Erfassung und Steuern der Menge von Überschuß-Tabakmaterial in einer Zigarettenherstellmaschine,,MOLINS PLC MILTON KEYNES,BRYANT ROBERT GEORGE WILLIAM,"MOLINS PLC, MILTON KEYNES, BUCKINGHAMSHIRE, GB (1992-05-27)",https://lens.org/059-803-267-777-266,Granted Patent,no,0,0,7,9,0,G01F1/005;;G01F23/32;;G01F1/005;;G01F23/32,G01F1/00;;G01F23/32,,0,0,,,,EXPIRED
59,AT,T1,AT E367639 T1,037-842-864-762-410,2007-08-15,2007,AT 00930281 T,2000-05-01,US 35020099 A,1999-07-08,SEISMISCHES LEITERSEIL-EINFÜHRKABEL,A conductive rope-like lead-in cable connects a seismic streamer to a towing vessel. The lead-in cable comprises a first electrical conductor at the center core of the cable for carrying a first polarity of power to the streamer for providing tensile strength to the load-in cable. A first layer of insulation surrounds the first electrical conductor. A second electrical conductor for a second polarity of power to the streamer surrounds the first layer of insulation. A second layer of insulation surrounds the second electrical conductor. A layer of seismic data conductors surrounds the second layer of insulation. A third layer of insulation surrounds the layer of seismic data conductors. A metallic protective layer surrounds the third layer of insulation. Steel is effectively and efficiently used both to provide tensile strength and for electrical power conduction.,PGS EXPLORATION US INC,BRYANT MICHAEL;;GEORGE NICK,,https://lens.org/037-842-864-762-410,Granted Patent,no,0,0,14,14,0,H01B7/045;;H01B9/003;;H01B9/04;;G01V1/201;;H01B9/003;;H01B7/045;;H01B9/04;;G01V1/201,H01B7/04;;H01B9/00;;H01B9/04,,0,0,,,,EXPIRED
60,US,A,US 999203 A,088-946-945-773-02X,1911-08-01,1911,US 1910/0593243 A,1910-11-19,US 1910/0593243 A,1910-11-19,MACHINE FOR INSERTING FASTENINGS.,,UNITED SHOE MACHINERY AB,BRYANT GEORGE;;UNDERWOOD WILLIAM,,https://lens.org/088-946-945-773-02X,Granted Patent,no,0,0,1,1,0,B25B5/06;;B25B5/06,,,0,0,,,,EXPIRED
61,DE,T2,DE 69013678 T2,181-213-026-274-097,1995-05-24,1995,DE 69013678 T,1990-02-16,US 32484789 A;;US 9000924 W,1989-03-17,MULTISCHICHTIGER HARTMETALL-SCHNEIDEINSATZ.,,KENNAMETAL INC,BRYANT WILLIAM;;GRAB GEORGE,,https://lens.org/181-213-026-274-097,Granted Patent,no,0,0,17,19,0,B23B27/14;;B23B27/145;;B23B2228/36;;C23C30/005,B22F7/00;;B22F7/04;;B23B27/14;;C23C16/30;;C23C30/00,,0,0,,,,EXPIRED
62,AU,A,AU 1977/031295 A,121-940-798-811-66X,1979-06-14,1979,AU 1977/031295 A,1977-12-07,GB 5214876 A,1976-12-14,FILTER ROD MANUFACTURE,,BRITISH AMERICAN TOBACCO CO,BRYANT ROBERT GEORGE WILLIAM,,https://lens.org/121-940-798-811-66X,Patent Application,no,0,0,14,14,0,A24C5/3412;;G01N21/952;;Y10T83/739;;Y10T83/2024;;Y10T83/2085;;Y10T83/543;;Y10T83/533;;Y10T83/739;;Y10T83/2024;;Y10T83/2085;;Y10T83/543;;Y10T83/533;;A24C5/3412;;G01N21/952,A24C5/34;;G01N21/952,,0,0,,,,DISCONTINUED
63,AU,A,AU 1982/080928 A,122-758-545-251-022,1982-09-09,1982,AU 1982/080928 A,1982-02-26,GB 8106653 A,1981-03-03,MONITORING AMOUNT OF PARTICLES BEING CONVEYED IN A STREAM THEREOF,,BRITISH AMERICAN TOBACCO CO,BRYANT ROBERT GEORGE WILLIAM,,https://lens.org/122-758-545-251-022,Patent Application,no,0,1,7,9,0,G01F1/005;;G01F23/32;;G01F1/005;;G01F23/32,G01F1/00;;G01F23/32,,0,0,,,,EXPIRED
64,AU,B2,AU 550525 B2,000-661-524-354-335,1986-03-27,1986,AU 1982/080928 A,1982-02-26,GB 8106653 A,1981-03-03,MONITORING AMOUNT OF PARTICLES BEING CONVEYED IN A STREAM THEREOF,,BRITISH AMERICAN TOBACCO CO,BRYANT ROBERT GEORGE WILLIAM,,https://lens.org/000-661-524-354-335,Granted Patent,no,0,0,7,9,0,G01F1/005;;G01F23/32;;G01F1/005;;G01F23/32,G01F1/00;;G01F23/32,,0,0,,,,EXPIRED
65,DE,A1,DE 3207684 A1,037-378-657-490-030,1982-10-07,1982,DE 3207684 A,1982-03-03,GB 8106653 A,1981-03-03,"APPARAT ZUM ANZEIGEN DER MENGE VON PARTIKULIERTEM MATERIAL, INSBESONDERE VON TABAK",,BRITISH AMERICAN TOBACCO CO,BRYANT ROBERT GEORGE WILLIAM,"MOLINS PLC, MILTON KEYNES, BUCKINGHAMSHIRE, GB (1992-05-27)",https://lens.org/037-378-657-490-030,Patent Application,no,16,1,7,9,0,G01F1/005;;G01F23/32;;G01F1/005;;G01F23/32,G01F1/00;;G01F23/32,,0,0,,,,EXPIRED
66,DE,D1,DE 69013678 D1,099-783-061-205-647,1994-12-01,1994,DE 69013678 T,1990-02-16,US 32484789 A;;US 9000924 W,1989-03-17,MULTISCHICHTIGER HARTMETALL-SCHNEIDEINSATZ.,,KENNAMETAL INC,BRYANT WILLIAM;;GRAB GEORGE,,https://lens.org/099-783-061-205-647,Granted Patent,no,0,0,17,19,0,B23B27/14;;B23B27/145;;B23B2228/36;;C23C30/005,B22F7/00;;B22F7/04;;B23B27/14;;C23C16/30;;C23C30/00,,0,0,,,,EXPIRED
67,FI,B,FI 63166 B,101-719-396-367-326,1983-01-31,1983,FI 773716 A,1977-12-09,GB 5214876 A,1976-12-14,FOERFARANDE FOER UPPMAERKANDE AV FEL I EN OEVERDRAGEN FILTERSTAV,,BRITISH AMERICAN TOBACCO CO,BRYANT ROBERT GEORGE WILLIAM,,https://lens.org/101-719-396-367-326,Patent Application,no,0,0,14,14,0,A24C5/3412;;G01N21/952;;Y10T83/739;;Y10T83/2024;;Y10T83/2085;;Y10T83/543;;Y10T83/533;;Y10T83/739;;Y10T83/2024;;Y10T83/2085;;Y10T83/543;;Y10T83/533;;A24C5/3412;;G01N21/952,A24C5/34;;G01N21/952,,0,0,,,,EXPIRED
68,DE,A1,DE 2346808 A1,024-897-053-070-062,1974-04-11,1974,DE 2346808 A,1973-09-18,GB 4341272 A,1972-09-19,GEDRUCKTE LEITERPLATTE,,BRITISH AMERICAN TOBACCO CO,BRYANT ROBERT GEORGE WILLIAM,,https://lens.org/024-897-053-070-062,Patent Application,no,0,0,4,4,0,H05K1/0287;;H05K2201/10689,H05K1/02;;H01L23/32;;H05K1/00,,0,0,,,,PENDING
69,DE,A1,DE 2755776 A1,055-561-817-361-720,1978-06-15,1978,DE 2755776 A,1977-12-14,GB 5214876 A,1976-12-14,DETEKTVORRICHTUNG FUER EINEN FEHLER IN TABAKRAUCHFILTERN,,BRITISH AMERICAN TOBACCO CO,BRYANT ROBERT GEORGE WILLIAM,,https://lens.org/055-561-817-361-720,Patent Application,no,0,2,14,14,0,A24C5/3412;;G01N21/952;;Y10T83/739;;Y10T83/2024;;Y10T83/2085;;Y10T83/543;;Y10T83/533;;Y10T83/739;;Y10T83/2024;;Y10T83/2085;;Y10T83/543;;Y10T83/533;;A24C5/3412;;G01N21/952,A24C5/34;;G01N21/952,,0,0,,,,DISCONTINUED
70,CH,A5,CH 620579 A5,057-126-537-095-102,1980-12-15,1980,CH 1531777 A,1977-12-13,GB 5214876 A,1976-12-14,CH 620579 A5,,BRITISH AMERICAN TOBACCO CO,BRYANT ROBERT GEORGE WILLIAM,,https://lens.org/057-126-537-095-102,Granted Patent,no,0,0,14,14,0,A24C5/3412;;G01N21/952;;Y10T83/739;;Y10T83/2024;;Y10T83/2085;;Y10T83/543;;Y10T83/533;;Y10T83/739;;Y10T83/2024;;Y10T83/2085;;Y10T83/543;;Y10T83/533;;A24C5/3412;;G01N21/952,A24C5/34;;G01N21/952,,0,0,,,,EXPIRED
71,US,A,US 3417765 A,008-915-909-934-232,1968-12-24,1968,US 66773367 A,1967-09-14,US 66773367 A,1967-09-14,Telescoping and longitudinally adjustable crutch,,RAYMOND WILLIAM SLATER;;GEORGE R. BRYANT;;LEWIS BRYANT,WILLIAM SLATER RAYMOND;;BRYANT GEORGE R;;LEWIS BRYANT,,https://lens.org/008-915-909-934-232,Granted Patent,no,5,37,1,1,0,A61H3/02;;A61H3/02,A61H3/02,135/50,0,0,,,,EXPIRED
72,ZA,B,ZA 895346 B,143-558-505-680-717,1990-10-31,1990,ZA 895346 A,1989-07-13,US 21889588 A,1988-07-14,PROCESS FOR PRODUCING ALCOHOLS AND ALDEHYDES,,UNION CARBIDE CHEM PLASTIC,ABATJOGLOU ANTHONY GEORGE;;ANTHONY GEORGE ABATJOGLOU;;BRYANT DAVID ROBERT;;DAVID ROBERT BRYANT,,https://lens.org/143-558-505-680-717,Granted Patent,no,0,0,11,11,0,C07C45/50;;C07C47/02;;C07C29/16,B01J31/24;;C07B61/00;;C07C27/00;;C07C27/22;;C07C29/16;;C07C31/02;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00,,0,0,,,,EXPIRED
73,ZA,B,ZA 875058 B,114-210-744-425-335,1988-03-30,1988,ZA 875058 A,1987-07-10,US 88419786 A,1986-07-10,HYDROFORMYLATION USING LOW VOLATILE/ORGANIC SOLUBLE PHOSPHINE LIGANDS,,UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;ANTHONY GEORGE ABATJOGLOU;;BRYANT DAVID ROBERT;;DAVID ROBERT BRYANT,,https://lens.org/114-210-744-425-335,Granted Patent,no,0,0,52,52,0,C07C45/50;;C07F9/5004;;Y02P20/582;;C07B41/00;;C07C47/02;;C07C45/50;;C07F9/5004;;Y02P20/582,B01J31/00;;C07B61/00;;B01J31/24;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00;;C07F9/50,,0,0,,,,EXPIRED
74,CA,A,CA 5214 A,015-467-463-320-064,1875-09-28,1875,CA 5214D A,,CA 5214T A,,MITRING MACHINE,,WILLIAMS SAMUEL;;BRYANT GEORGE S,WILLIAMS SAMUEL;;BRYANT GEORGE S,,https://lens.org/015-467-463-320-064,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
75,GB,A,GB 117053 A,067-669-320-766-925,1918-07-04,1918,GB 451818 A,1918-03-14,GB 451818 A,1918-03-14,Improvements in Screens for Cinematograph Pictures and the like.,"117,053. Heale, F., and Bryant, G. W. March 14, 1918. Optical - projection apparatus. - A screen for kinematograph pictures &c. said to give a stereoscopic effect consists of a plaster or fabric screen silvered on the face and arrayed behind two separate veiling screens of fine mesh netting or the like silvened on the front and blackened at the back, all three screens being spaced apart.",HEALE FRANK;;BRYANT GEORGE WALLACE,HEALE FRANK;;BRYANT GEORGE WALLACE,,https://lens.org/067-669-320-766-925,Granted Patent,no,0,1,1,1,0,G03B21/606,G03B21/60,,0,0,,,,EXPIRED
76,FR,A,FR 492401 A,082-305-715-754-992,1919-07-08,1919,FR 492401D A,1918-10-19,GB 492401X A,1918-03-14,Perfectionnements apportés aux écrans pour projections cinématographiques ou autres,,FRANK HEALE;;GEORGE WALLACE BRYANT,HEALE FRANK;;BRYANT GEORGE WALLACE,,https://lens.org/082-305-715-754-992,Granted Patent,no,0,0,1,1,0,G03B21/606,G03B21/606,"XII, 2",0,0,,,,EXPIRED
77,BR,A2,BR 112012016325 A2,021-249-442-705-063,2016-08-23,2016,BR 112012016325 A,2011-01-03,US 2011/0020052 W;;US 29173209 P;;US 29180409 P;;US 29177909 P,2009-12-31,"""dispositivo de acoplamento aparelho e kit de ultrassom, e, métodos para realizar fisioterapia, para aplicar energia ultrassônica e para administrar topicamente uma droga a um indivíduo""","""dispositivo de acoplamento utrassônico, aparelho ultrassônico, kit de ultrassom terapêutico, e, métodos para realizar fisioterapia em um sujeito, para aplicar energia utrassônica em um sujeito e para administrar topicamente um medicamento a um sujeito"" a presente invenção diz respeito a um dispositivo de acoplamento ultrassônico para uso com vários transdutores, sistemas e aplicações de ultrassom. o dispositivo de acoplamento inclui um compartimento de acoplamento compreendendo uma câmara com uma parede lateral contínua e uma abertura em uma primeira extremidade. a parede lateral contínua é configurada para manter um transdutor ultrassônico de baixo perfil dentro da câmara de forma que uma superfície emissora de ultrassom dianteira do transdutor ultrassônico de baixo perfil fique voltada para fora em direção à abertura da cãmara. a superfície emissora de ultrassom dianteira é configurada apara controlar a direção e o padrão de onda da energia ultrassônica emitida pelo transdutor. a parede lateral contínua é também configurada para manter uma quantidade de um meio condutor de ultrassom dentro da câmara e é operacional para manter o meio condutor de ultrassom em contato simultâneo com uma superfície de um sujeito e com pelo menos uma porção da superfície emissora de ultrassom dianteira do transdutor. a presente invenção também diz respeito a u aparelho ultrassônico, estojo e método de usar o dispositivo de acoplamento utrassônico, aparelho e estojo.",ZETROZ LLC,GUFFEY BRYANT;;LEWIS GEORGE K,"ZETROZ, INC. (US) (2016-09-20);;ZETROZ LLC (US) (2016-09-06)",https://lens.org/021-249-442-705-063,Patent Application,no,0,0,32,32,0,A61B8/4281;;A61B17/2251;;A61B2017/2253;;A61N2007/0078;;A61B8/4227;;A61B8/4236;;A61B8/4427;;A61B2017/00734;;A61N2007/006;;A61N2007/0091;;A61N2007/0095;;A61B8/44;;A61N7/00;;Y10T29/49005;;A61B2034/301;;A61B34/30;;A61B2034/303;;A61B2034/107;;A61B34/10;;A61N2007/0034;;Y10T29/49005;;A61B8/4281;;A61B17/2251;;A61B2017/2253;;A61N2007/0078;;A61B8/4227;;A61B8/4236;;A61B2017/00734;;A61N2007/0091;;A61N2007/0095;;A61B8/4427;;A61B8/44;;A61N2007/006;;A61N7/00,A61B8/00;;A61N7/00,,0,0,,,,DISCONTINUED
78,CA,A,CA 198399 A,048-700-220-825-514,1920-03-23,1920,CA 198399D A,,CA 198399T A,,SCREEN FOR CINEMATOGRAPH PICTURES,,HEALE FRANK;;BRYANT GEORGE WALLACE,HEALE FRANK;;BRYANT GEORGE WALLACE,,https://lens.org/048-700-220-825-514,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
79,ZA,B,ZA 895973 B,002-862-538-767-003,1990-05-30,1990,ZA 895973 A,1989-08-04,US 22850788 A,1988-08-05,PREPARATION OF IONIC PHOSPHITES AND THEIR USE IN HOMOGENEOUS TRANSITION METAL CATALYZED PROCESS,,UNION CARBIDE CHEM PLASTIC,ABATJOGLOU ANTHONY GEORGE;;ANTHONY GEORGE ABATJOGLOU;;BRYANT DAVID ROBERT;;DAVID ROBERT BRYANT,,https://lens.org/002-862-538-767-003,Granted Patent,no,0,0,22,23,0,B01J31/185;;B01J31/185;;B01J2231/321;;B01J2231/321;;B01J2531/0266;;B01J2531/0266;;B01J2531/80;;B01J2531/80;;B01J2531/822;;B01J2531/822;;C07F9/165;;C07F9/65746;;C07F9/65746;;C07C45/50;;C07C45/50;;C07F9/65744;;C07F9/65744;;Y02P20/582;;Y02P20/582,B01J31/22;;B01J31/18;;C07B61/00;;C07C45/49;;C07C45/50;;C07C47/02;;C07F9/6574;;C07F9/6578;;C07F9/6584;;C07F9/6596,,0,0,,,,EXPIRED
80,CA,A,CA 367057 A,194-049-906-735-883,1937-06-29,1937,CA 367057D A,,CA 367057T A,,TELEPHONE EXCHANGE SYSTEM,,WESTERN ELECTRIC CO,HATTON WILLIAM;;BRYANT GEORGE HENRY,,https://lens.org/194-049-906-735-883,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
81,GB,A,GB 190518057 A,016-170-024-974-225,1906-09-06,1906,GB 190518057D A,1905-09-06,GB 190518057T A,1905-09-06,Improvements in or relating to the Silencing or Treatment of the Exhaust from Internal Combustion Engines.,"18,057. Bryant, C. H., and CandelÞt, G. Sept. 6. Exhaust - silencers. - The exhaust gases of an internal-combustion engine are purified by mixing them with air and passing them across a pointed igniter contained within the silencer. The exhaust enters the inlet B, mixes with air entering the holes E in front of the non- return plate F, and passes the nozzle C and igniter D to the outlet G. The igniter is partly covered with asbestos, and may be a cone, spiked plate, or knob which becomes highly heated and produces the combustion of any combustible impurities.",BRYANT CHARLES HENRY;;CANDELET GEORGE,BRYANT CHARLES HENRY;;CANDELET GEORGE,,https://lens.org/016-170-024-974-225,Patent Application,no,0,0,1,1,0,,,,0,0,,,,DISCONTINUED
82,ZA,B,ZA 878638 B,012-744-267-622-974,1988-07-27,1988,ZA 878638 A,1987-11-18,US 93200286 A,1986-11-18,HYDROFORMYLATION USING LOW VOLATILE PHOSPHINE LIGANDS,,UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;ANTHONY GEORGE ABATJOGLOU;;BRYANT DAVID ROBERT;;DAVID ROBERT BRYANT,,https://lens.org/012-744-267-622-974,Granted Patent,no,0,0,53,53,0,C07C45/50;;Y02P20/582;;C07C47/55;;C07C47/02;;C07C45/50;;Y02P20/582,B01J31/00;;B01J31/24;;B01J31/28;;C07B61/00;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00,,0,0,,,,EXPIRED
83,EP,A1,EP 0832883 A1,000-495-103-570-506,1998-04-01,1998,EP 97307498 A,1997-09-25,US 2675296 P,1996-09-26,Tetrahydrobenzo(a)fluorene compounds and methods of use,"The invention provides tetrahydrobenzo[a]fluorene compounds, formulations, and methods of inhibiting bone loss or bone resorption, particularly osteoporosis, and cardiovascular-related pathological conditions, including hyperlipidemia.",LILLY CO ELI,BRYANT HENRY;;CULLINAN GEORGE JOSEPH,,https://lens.org/000-495-103-570-506,Patent Application,yes,6,1,11,11,0,A61K31/565;;A61K31/57;;C07C217/18;;C07D295/088;;C07C2603/40;;A61P19/10;;A61P3/06;;A61P43/00;;A61P9/00;;C07D295/088;;A61K31/565;;C07C217/18;;A61K31/57;;C07C2603/40,C07D295/08;;A61K31/135;;A61K31/40;;A61K31/445;;A61K31/55;;A61K31/565;;A61K31/57;;A61P3/06;;A61P9/00;;A61P19/10;;A61P43/00;;C07C217/18;;C07C309/65;;C07D207/06;;C07D295/092;;C07J69/00,,0,0,,,,EXPIRED
84,US,A,US 2233724 A,008-331-393-346-528,1941-03-04,1941,US 29614639 A,1939-09-22,US 29614639 A,1939-09-22,Cutting tool,,NAT TUBE CO,BRYANT BANNISTER;;GREENWOOD GEORGE C,,https://lens.org/008-331-393-346-528,Granted Patent,no,0,27,1,1,0,B23B27/12;;B23B27/12;;Y10T407/12;;Y10T407/12;;Y10T407/2274;;Y10T407/2274,B23B27/12,,0,0,,,,EXPIRED
85,CA,A,CA 410753 A,090-102-828-496-168,1943-02-23,1943,CA 410753D A,,CA 410753T A,,CUTTING TOOL,,NAT TUBE CO,BANNISTER BRYANT;;GREENWOOD GEORGE C,,https://lens.org/090-102-828-496-168,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
86,FR,A,FR 365712 A,076-918-356-707-995,1906-09-15,1906,FR 365712D A,1906-04-27,FR 365712T A,1906-04-27,Procédé et dispositif pour le traitement des gaz d'échappement des moteurs à combustion interne,,CHARLES HENRY BRYANT;;GEORGE CANDELET,BRYANT CHARLES HENRY;;CANDELET GEORGE,,https://lens.org/076-918-356-707-995,Granted Patent,no,0,0,1,1,0,F01N3/26,F01N3/26,"V, 8",0,0,,,,EXPIRED
87,GB,A,GB 190907193 A,021-770-502-778-131,1910-03-17,1910,GB 190907193D A,1909-03-25,GB 190907193T A,1909-03-25,Improvements in Electrical Apparatus for Medical and other Purposes and in Articles to which such Apparatus may be Applied.,"7193. Bryant, G., and Ivinson, C. H. March 25. Resistances, powder. In electrical apparatus for medical purposes, an adjustable resistance is used which consists of powdered plumbago between screws m, s in a cavity in a block n. A nut h upon the screw m makes contact with metal foil h, and the screw s works in a metal plate r. A dial and a pin 5 and a stop 6 may be provided. The screw s may carry a pin which in one position engages a spring tongue and breaks the circuit.",BRYANT GEORGE;;IVINSON CHARLES HORACE,BRYANT GEORGE;;IVINSON CHARLES HORACE,,https://lens.org/021-770-502-778-131,Patent Application,no,0,0,1,1,0,,,,0,0,,,,DISCONTINUED
88,US,A,US 2289167 A,053-130-018-151-682,1942-07-07,1942,US 30945039 A,1939-12-15,US 30945039 A,1939-12-15,Cutting tool,,NAT TUBE CO,BRYANT BANNISTER;;GREENWOOD GEORGE C,,https://lens.org/053-130-018-151-682,Granted Patent,no,0,11,1,1,0,B23B5/12;;B23B5/12;;B23B27/12;;B23B27/12;;Y10T29/5126;;Y10T29/5126;;Y10T82/2527;;Y10T82/2527;;Y10T82/30;;Y10T82/30;;Y10T407/12;;Y10T407/12;;Y10T407/193;;Y10T407/193,B23B5/12;;B23B27/12,,0,0,,,,EXPIRED
89,US,A,US 2274579 A,050-790-527-924-561,1942-02-24,1942,US 39200041 A,1941-05-05,US 39200041 A,1941-05-05,Method of producing seamless tubes,,NAT TUBE CO,BRYANT BANNISTER;;KIRCHNER GEORGE J,,https://lens.org/050-790-527-924-561,Granted Patent,no,0,2,1,1,0,B21B19/02;;B21B19/02,B21B19/02,,0,0,,,,EXPIRED
90,GB,A,GB 191212757 A,081-606-110-393-517,1913-03-20,1913,GB 191212757D A,1912-05-30,GB 191212757T A,1912-05-30,Improvements in Electrical Apparatus for Medical and other Purposes.,"12,757. Ivinson, C. H., and Bryant, G. May 30. Resistances, powder. In medical electric apparatus of the kind described in Specification 7193/09, the adjustable resistance consists of powdered graphite, or graphite and titanium oxide, or other suitable material r, in a ring q of rubber or other compressible material, between two screws n, s. The resistance is regulated by turning the milled head t of the screws s, the motion being limited by stops u, v.",IVINSON CHARLES HORACE;;BRYANT GEORGE,IVINSON CHARLES HORACE;;BRYANT GEORGE,,https://lens.org/081-606-110-393-517,Patent Application,no,0,0,1,1,0,A61N1/26,A61N1/26,,0,0,,,,DISCONTINUED
91,US,A,US 2274581 A,102-668-715-026-49X,1942-02-24,1942,US 31025239 A,1939-12-20,US 31025239 A,1939-12-20,Method of producing seamless tubes,,NAT TUBE CO,BRYANT BANNISTER;;KIRCHNER GEORGE J,,https://lens.org/102-668-715-026-49X,Granted Patent,no,0,2,1,1,0,B21B19/04;;B21B19/04,B21B19/04,,0,0,,,,EXPIRED
92,GB,A,GB 190901403 A,179-713-268-427-972,1910-01-20,1910,GB 190901403D A,1909-01-20,GB 190901403T A,1909-01-20,Improvements in solders for Metals and Alloys.,"1403. Bryant, G., and Ivinson, C. H. Jan. 20. Alloys.-Solders are purified or refined by dropping the solder, or its constituent metals, when in a molten and finely-divided condition into one or more solutions containing materials having a physical, chemical, or fluxing action on the solder, the flux in some cases being dissolved by the solder. The molten solder is dropped from a sieve placed at about 12 inches above the surface of the liquid, which, for example, may consist of phosphorated oil floating on a solution of zinc chloride. The resulting product is then collected and re-melted for use. The materials used in solution in water also include potassium ferrocyanide, permanganate, or bichromate, or other salt, acid, or alkali ; and, for solution in oil, sulphur, selenium, and iodine. Tin, zinc, lead, cadmium, bismuth, antimony, copper, aluminium, and silver, are mentioned as the constituent metals of the solders.",BRYANT GEORGE;;IVINSON CHARLES HORACE,BRYANT GEORGE;;IVINSON CHARLES HORACE,,https://lens.org/179-713-268-427-972,Patent Application,no,0,1,1,1,0,B23K35/0244,B23K35/02,,0,0,,,,DISCONTINUED
93,CA,A,CA 410536 A,064-757-702-445-01X,1943-02-09,1943,CA 410536D A,,CA 410536T A,,CUTTING TOOL,,NAT TUBE CO,BANNISTER BRYANT;;GREENWOOD GEORGE C,,https://lens.org/064-757-702-445-01X,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
94,US,A,US 974549 A,097-441-577-631-644,1910-11-01,1910,US 1909/0521527 A,1909-10-07,US 1909/0521527 A,1909-10-07,CAR-WHEEL.,,BRYANT GEORGE H;;ZIESING AUGUST,BRYANT GEORGE H;;ZIESING AUGUST,,https://lens.org/097-441-577-631-644,Granted Patent,no,0,7,1,1,0,B60B17/0017;;B60B17/0017;;Y10T74/19907;;Y10T74/19907,,,0,0,,,,EXPIRED
95,US,A,US 1349064 A,149-641-769-555-114,1920-08-10,1920,US 27414019 A,1919-01-30,US 27414019 A,1919-01-30,Screen for cinematograph-pictures and the like,,FRANK HEALE;;WALLACE BRYANT GEORGE,FRANK HEALE;;WALLACE BRYANT GEORGE,,https://lens.org/149-641-769-555-114,Granted Patent,no,0,1,1,1,0,G03B21/606;;G03B21/606,G03B21/60,,0,0,,,,EXPIRED
96,GB,A,GB 190901404 A,036-641-440-907-148,1910-01-20,1910,GB 190901404D A,1909-01-20,GB 190901404T A,1909-01-20,A Process for the Treatment of Metals and Alloys for various Useful Purposes.,"1404. Bryant, G., and Ivinson, C. H. Jan. 20. Annealing and modifying physical characters of metals.-Metals and alloys are toughened, or, in some cases, made more brittle, by dropping the metal &c., when in a molten and finelydivided condition, into one or more solvents containing chemical reagents in solution. The metal for instance zinc, is dropped from a sieve placed about twelve inches above the surface of the liquid, which may consist of a solution of phosphorus or sulphur in oil. The particles are collected and re-melted for use.",BRYANT GEORGE;;IVINSON CHARLES HORACE,BRYANT GEORGE;;IVINSON CHARLES HORACE,,https://lens.org/036-641-440-907-148,Patent Application,no,0,0,1,1,0,C22B9/106,C22B9/10,,0,0,,,,DISCONTINUED
97,CA,A,CA 409360 A,093-718-204-266-561,1942-12-15,1942,CA 409360D A,,CA 409360T A,,SEAMLESS TUBE PRODUCING METHOD,,NAT TUBE CO,KIRCHNER GEORGE J;;BANNISTER BRYANT,,https://lens.org/093-718-204-266-561,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
98,US,B2,US 7041909 B2,118-972-023-285-260,2006-05-09,2006,US 69083903 A,2003-10-22,US 69083903 A;;US 0312520 W;;US 37487902 P,2002-04-23,Methods of installing and apparatuses to install an aluminum conductor composite core reinforced cable,"This invention relates to splice and dead end fittings and methods for splicing together two aluminum conductor composite core reinforced cable (ACCC) or terminating one composite core reinforced cable. The compression fitting uses a compressible body inside a rigid enclosure to hold the composite cores. First, the composite cores can be stripped of the aluminum conductor to provide the best bond between the compressible body and the composite core, the load-bearing member of the cable. After inserting the composite core into the compressible body, a compression implement may be used to compress the compressible body. Without the ability to expand because the rigid enclosure forces the compressible body to maintain its shape, the compressible body places compressive forces on the composite core. The compressible body holds the composite core with frictional or mechanical forces.",COMPSITE TECHNOLOGY CORP,BRYANT DAVID C;;KORZENIOWSKI GEORGE,CTC GLOBAL CORPORATION (2012-07-03);;COMPOSITE TECHNOLOGY CORPORATION (2004-02-26);;CTC CABLE CORPORATION (2006-05-23),https://lens.org/118-972-023-285-260,Granted Patent,yes,9,36,51,99,0,B32B15/04;;B32B27/04;;H01B5/105;;H01B7/1825;;H01B9/006;;H01B13/0016;;H02G7/04;;H02G7/056;;H02G15/06;;H02G15/18;;Y10T428/2938;;Y10T428/2913;;Y10T428/2933;;Y10T442/172;;Y10T428/24994;;Y10T428/249945;;Y10T428/24995;;Y10T428/249942;;Y10T428/249949;;Y10T428/249924;;Y10T428/249946;;B32B15/04;;B32B5/02;;B29D22/00;;B32B27/12;;Y10T428/2938;;Y10T428/2913;;Y10T428/2933;;Y10T442/172;;Y10T428/24994;;Y10T428/249945;;Y10T428/24995;;Y10T428/249942;;Y10T428/249949;;Y10T428/249924;;Y10T428/249946;;H02G7/04;;H01B9/006;;H01B13/0016;;B32B27/04;;H02G15/18;;B32B15/04;;H02G15/06;;H02G7/056;;H01B5/105;;H01B7/1825,H01B5/10;;B32B5/02;;H02G3/06;;B32B15/04;;B32B27/04;;B32B27/12;;D02G3/00;;D04H1/00;;H01B1/02;;H01B7/18;;H01B9/00;;H01B13/00,174 88R,2,0,,,"Fargo Mfg. Company, ""XL' Dead Ends and Splices"", New Product Bulletin, Apr., 1997, Sect. 8, pp. 5, 9, 11, 46, 47, & 81.;;International Search Report and written opinion corresponding to related PCT application (PCT/US04/35199).",EXPIRED
99,CA,A,CA 133811 A,197-849-110-185-323,1911-06-20,1911,CA 133811D A,1910-02-28,CA 133811T A,1910-02-28,SOLDER MANUFACTURE,,STANDARD ALLOYS LTD;;IVINSON CHARLES HORACE;;BRYANT GEORGE,IVINSON CHARLES HORACE;;BRYANT GEORGE,,https://lens.org/197-849-110-185-323,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
100,GB,A,GB 2367327 A,171-225-376-844-059,2002-04-03,2002,GB 0023797 A,2000-09-28,GB 0023797 A,2000-09-28,Adaptor for door lock cam follower,An adaptor (4) for a door lock cam follower (2) has a main body (5) having a square outer profile substantially to match that of a door lock spindle of one size in cross-section and thus being sized to be received in a spindle-receiving aperture (3) of the door lock cam follower (2). The adaptor itself also has a square spindle-receiving aperture (6) extending through the body that is profiled and sized to receive a door lock spindle of a cross-sectional size smaller than the size of the door lock aperture (3).,INGERSOLL RAND ARCHITECTURAL HARDWARE LTD,WHITTLE CLEMENT GEORGE;;BRYANT DAVID;;WILCOX GEOFFREY GEORGE,,https://lens.org/171-225-376-844-059,Patent Application,no,2,0,3,3,0,E05B3/00;;E05B15/0013,E05B3/00;;E05B15/00,E2A AEM           AEM;;E2A AEQ           AEQ;;E2A A420          AEM;;E2A A420          AEQ;;F2U U226          U2TAN;;F2U U354          U2TAN;;F2U U388          U2TAN,0,0,,,,EXPIRED
101,GB,B,GB 2367327 B,133-481-050-702-282,2004-01-07,2004,GB 0023797 A,2000-09-28,GB 0023797 A,2000-09-28,Adaptor for door lock cam follower,,INGERSOLL RAND ARCHITECTURAL HARDWARE LTD;;IR SECURITY & SAFETY LTD,WHITTLE CLEMENT GEORGE;;BRYANT DAVID;;WILCOX GEOFFREY GEORGE,,https://lens.org/133-481-050-702-282,Granted Patent,no,2,0,3,3,0,E05B3/00;;E05B15/0013,E05B3/00;;E05B15/00,E2A AEM           AEM;;E2A AEQ           AEQ;;E2A A420          AEM;;E2A A420          AEQ;;F2U U226          U2TAN;;F2U U354          U2TAN;;F2U U388          U2TAN,0,0,,,,EXPIRED
102,MX,B,MX 166784 B,016-359-395-335-958,1993-02-04,1993,MX 938387 A,1987-11-17,US 93200286 A,1986-11-18,HIDROFORMILACION USANDO GRUPOS COORDINADORES DE FOSFINA DE BAJA VOLATILIDAD,"La presente invención se refiere a un procedimiento de hidroformilación no acuoso para producir aldehídos, el cual comprende hacer reaccionar un compuesto orgánico olefínicamente insaturado que contiene de 2 a 20 átomos de carbono, con monóxido de carbono e hidrógeno, en un medio de reacción de hidroformilación no acuoso que contiene un compuesto orgánico olefínicamente insaturado, un producto de aldehído, un catalizador complejo de rodio solubilizado y un grupo coordinador de fósforo y un grupo coordinador de fósforo libre solubilizado y en donde las condiciones de reacción de hidroformilación comprenden una temperatura de reacción de aproximadamente 45 grados C a aproximadamente 200 grados C, una presión de gas total de hidrógeno, monóxido de carbono y el compuesto olefínicamente insaturado de menos de aproximadamente 35.15 kilogramos por centímetro cuadrado absoluta, una presión parcial de monóxido de carbono de desde aproximadamente 0.0703 a 8.44 kilogramos por centímetro cuadrado absoluta, una presión parcial de hidrógeno de aproximadamente 0.703 a 11.25 kilogramos por centímetro cuadrado absoluta y en donde el medio de reacción contiene por lo menos aproximadamente 2 moles del grupo coordinador de fósforo libre total por mol de rodio en el medio.",UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/016-359-395-335-958,Granted Patent,no,0,0,53,53,0,C07C45/50;;Y02P20/582;;C07C47/55;;C07C47/02;;C07C45/50;;Y02P20/582,B01J31/00;;B01J31/24;;B01J31/28;;C07B61/00;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00,,0,0,,,,EXPIRED
103,KR,B1,KR 0121790 B1,018-947-197-175-90X,1997-11-12,1997,KR 900702468 A,1990-11-17,US 32484789 A;;US 9000924 W,1989-03-17,MULTILAYER COATED CEMENTED CARBIDE CUTTING INSERT,"인덱시블 금속절삭 인서트가 코발트 시멘티드 텅스텐 카바이드 기재를 지니며, 그 기재상에는 다층의 내화성 코팅이 제공되 있다. 그 기재는 6.1 내지 6.5중량 퍼센트(w/o)의 코발트 함유량을 지니며, 90.8 내지 91.6록크웰 A경도 및 110 내지 180에르스텟의 마그네틱 보자력을 특징으로 한다. 상기 코팅은, 티타늄 나이트리드와 같은 조합 IVB금속 나이트리드에 의해 상호간 이격되고 상호간 접합되며, 티타늄, 지르코늄 그리고/또는 하프늄의 카보나이트리드 그리고/또는 카바이드로 구성된 5 내지 8μ두께의 지지층에 의해 기재에 접합된 적어도 다수의 알루미나 층들을 포함한다.",KENNAMETAL INC,BRYANT WILLIAM A;;GRAB GEORGE P,,https://lens.org/018-947-197-175-90X,Granted Patent,no,0,0,17,19,0,B23B27/14;;B23B27/145;;B23B2228/36;;C23C30/005,B22F7/00;;B22F7/04;;B23B27/14;;C23C16/30;;C23C30/00,,0,0,,,,EXPIRED
104,US,A1,US 2023/0229873 A1,034-239-684-246-894,2023-07-20,2023,US 202318125273 A,2023-03-23,US 202318125273 A;;US 202117342969 A;;US 202016990300 A,2020-08-11,AUGMENTED REALITY INFORMATION DISPLAY AND INTERACTION VIA NFC BASED AUTHENTICATION,"Various embodiments are generally directed to improving card security by providing a user a contactless card with no sensitive card information, such as card number, card verification value, and expiration date, printed thereon, and displaying the sensitive card information relative to the card in augmented reality (AR) based on successful NFC-based user authentication. According to examples, the NFC-based user authentication may be performed by one-tapping or single tapping the contactless card to user mobile device. One or more portions of the sensitive card information may be obfuscated to further enhance card security. Moreover, the user can interact with AR elements including the sensitive card information to perform various actions.",CAPITAL ONE SERVICES LLC,BERGERON GEORGE;;YEE BRYANT;;BULGAKOV MYKHAYLO,CAPITAL ONE SERVICES LLC (2020-08-10),https://lens.org/034-239-684-246-894,Patent Application,yes,5,0,11,11,0,G06Q40/02;;H04L9/0861;;H04L2209/805;;H04L9/3242;;G06K7/10297;;H04W12/47;;H04W12/069;;H04W12/02;;H04L63/08;;H04L63/0421;;H04W12/61;;G06F21/35;;H04W12/47;;H04W12/047;;H04W12/65;;G06F3/14;;G06Q20/34;;G06K7/10297;;H04L9/3226;;G06F21/6245;;G06F3/0484;;G06Q40/02;;G06F3/14;;H04L9/0861,G06K7/10;;G06F3/0484;;G06F3/14;;G06F21/62;;G06Q40/02;;H04L9/08;;H04L9/32,,0,0,,,,PENDING
105,US,A,US 2738329 A,038-737-273-538-128,1956-03-13,1956,US 31941852 A,1952-11-07,GB 2738329X A,1952-01-30,Production of greases having elevated dropping points,,SHELL DEV,ALWYN PARRY GEORGE;;BRYANT MATTHEWS JOHN,,https://lens.org/038-737-273-538-128,Granted Patent,no,8,5,1,1,0,C10M5/00;;C10M5/00;;C10M2201/083;;C10M2201/083;;C10M2203/108;;C10M2203/108;;C10M2207/125;;C10M2207/125;;C10M2207/129;;C10M2207/129;;C10M2207/282;;C10M2207/282;;C10M2207/34;;C10M2207/34;;C10M2209/103;;C10M2209/103;;C10M2209/105;;C10M2209/105;;C10M2209/107;;C10M2209/107;;C10M2209/108;;C10M2209/108;;C10M2209/109;;C10M2209/109;;C10M2215/02;;C10M2215/02;;C10M2215/04;;C10M2215/04;;C10M2215/044;;C10M2215/044;;C10M2215/06;;C10M2215/06;;C10M2215/26;;C10M2215/26;;C10M2223/04;;C10M2223/04;;C10M2223/042;;C10M2223/042;;C10M2223/06;;C10M2223/06;;C10M2223/061;;C10M2223/061;;C10M2223/065;;C10M2223/065;;C10M2227/02;;C10M2227/02;;C10N2010/00;;C10N2010/00;;C10N2010/02;;C10N2010/02;;C10N2010/04;;C10N2010/04;;C10N2010/06;;C10N2010/06;;C10N2050/10;;C10N2050/10,,C5F F415          -;;C5F F50X          -;;C5F F504          -;;C5F F505          -;;C5F F506          -;;C5F F508          -;;C5F F509          -;;C5F F510          -;;C5F F511          -;;C5F F512          -;;C5F F514          -;;C5F F516          -;;C5F F517          -;;C5F F537          -;;C5F F590          -;;C5F F591          -;;C5F F592          -;;C5F F593          -;;C5F F660          -;;C5F F661          -;;C5F F672          -;;C5F F691          -,0,0,,,,EXPIRED
106,IL,A,IL 175077 A,043-480-593-418-176,2011-07-31,2011,IL 17507706 A,2006-04-20,US 69144703 A;;US 69230403 A;;US 2004/0035201 W,2003-10-22,ALUMINUM CONDUCTOR COMPOSITE CORE REINFORCED CABLE AND METHOD OF MANUFACTURE,,HIEL CLEMENT;;KORZENIOWSKI GEORGE;;BRYANT DAVID;;CTC CABLE CORP;;COMPOSITE TECH CORP,HIEL CLEMENT;;KORZENIOWSKI GEORGE;;BRYANT DAVID,,https://lens.org/043-480-593-418-176,Patent Application,no,0,0,34,35,0,B29C70/52;;B29L2031/3462;;B32B1/00;;B32B15/02;;B32B15/08;;B32B15/20;;B32B27/04;;H01B5/105;;B29C70/528;;Y10T428/2918;;Y10T428/2933;;Y10T428/2936;;Y10T442/30;;B32B27/04;;B82Y30/00;;Y10T428/2918;;Y10T428/2933;;Y10T428/2936;;Y10T442/30;;B32B2305/08;;B32B2307/54;;B32B27/08;;B32B2457/00;;B29L2031/3462;;B32B1/00;;B29C70/52;;B32B15/02;;B32B15/20;;B32B27/04;;B32B15/08;;H01B5/105;;B29C70/528,B05D1/18;;B05D3/02;;B32B27/04;;B65H/;;D04H3/08,,0,0,,,,ACTIVE
107,US,A1,US 2022/0109299 A1,054-877-488-017-033,2022-04-07,2022,US 202117644104 A,2021-12-14,US 202117644104 A;;US 202016991347 A,2020-08-12,METHODS AND SYSTEMS FOR PROVIDING ESTIMATED TRANSACTIONAL DATA,"A computer-implemented method for providing an estimated utility expenditure to a user may include: obtaining, via one or more processors, historical transactional data of one or more customers other than the user from one or more transactional entities, wherein the historical transactional data includes: at least one address of a given customer of the one or more customers; and a historical utility expenditure associated with the at least one address; generating, via the one or more processors, a heatmap based on the historical transactional data of the one or more customers via one or more algorithms, wherein the heatmap is indicative of at least the estimated utility expenditure associated with the at least one address during a predetermined period; and causing a display of a user device associated with the user to demonstrate the heatmap.",CAPITAL ONE SERVICES LLC,YEE BRYANT;;BERGERON GEORGE;;BULGAKOV MYKHAYLO,CAPITAL ONE SERVICES LLC (2020-08-12),https://lens.org/054-877-488-017-033,Patent Application,yes,6,0,6,6,0,G06Q50/06;;H02J13/00001;;H02J3/003;;Y04S10/40;;Y04S10/50;;H02J3/003;;H02J13/00001;;G06Q50/06;;H02J2203/20;;H02J13/00034;;G06Q30/0283,H02J3/00;;G06Q50/06;;H02J13/00,,0,0,,,,ACTIVE
108,MX,B,MX 172507 B,081-497-641-600-474,1993-12-17,1993,MX 1984090 A,1990-03-12,US 32484789 A,1989-03-17,"PIEZA DE INSERCION CORTADORA DE CARBURO CEMENTADA, REVESTIDA DE CAPAS MULTIPLES","La presente invención se refiere a una pieza de inserción cortadora que comprende: un cuerpo que tiene una cara de inclinación y una cara de flanco; un filo cortante en una junta o unión de la cara de inclinación y la cara de flanco; el cuerpo está compuesto de: un substrato de carburo cementado que consiste esencialmente de granos de carburo de tungsteno, los granos de carburo de la solución sólida contienen tungsteno y un elemento que se selecciona del grupo que consiste de titanio, tántalo, niobio, zirconio y hafnio, solos o juntos, y de 6.1 a 6.5 por ciento en peso de cobalto; el substrato tiene una dureza por lo menos de 90.8 a 91.6 rockwell a. y una fuerza coercitiva magnética de 110 a 180 oerstads; un revestimiento unido al substrato; el revestimiento incluye una capa de respaldo o soporte unida mal substrato, que tiene un espesor de por lo menos 5 micrómetros, y que se selecciona del grupo que consiste de los carburos, carbonitruros de titanio, hafnio y zirconio solo o en combinación; una capa activa compuesta de subcapas alternativas que incluyen por lo menos una pluralidad de subcapas de alúmina separadas una de la otra mediante una subcapa intermedia que se selecciona del grupo que consiste de los nitruros de titanio, zirconio y hafnio, solo o en combinación, y la primera subcapa de alúmina está unida a la segunda capa; una capa de acabado unida a la capa de alúmina externa; la capa de acabado se selecciona del grupo que consiste de los carbonitruros y nitruros de titanio, hafnio y zirconio solos o en combinación; en donde la alúmina en la subcapa tiene un tamaño de gramo promedio de entre aproximadamente 0.15 a 0.5 micrómetros.",KENNAMETAL INC,BRYANT WILLIAM A;;GRAB GEORGE P,,https://lens.org/081-497-641-600-474,Granted Patent,no,0,0,17,19,0,B23B27/14;;B23B27/145;;B23B2228/36;;C23C30/005,B22F7/00;;B22F7/04;;B23B27/14;;C23C16/30;;C23C30/00,,0,0,,,,EXPIRED
109,DE,D1,DE 69711529 D1,089-015-671-604-835,2002-05-08,2002,DE 69711529 T,1997-09-25,US 2675296 P,1996-09-26,Tetra-Hydrobenzo(a)fluorenverbindungen und ihre Anwendungen,"The invention provides tetrahydrobenzoÄaÜfluorene compounds, formulations, and methods of inhibiting bone loss or bone resorption, particularly osteoporosis, and cardiovascular-related pathological conditions, including hyperlipidemia.",LILLY CO ELI,BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH,,https://lens.org/089-015-671-604-835,Granted Patent,no,0,0,11,11,0,A61K31/565;;A61K31/57;;C07C217/18;;C07D295/088;;C07C2603/40;;A61P19/10;;A61P3/06;;A61P43/00;;A61P9/00;;C07D295/088;;A61K31/565;;C07C217/18;;A61K31/57;;C07C2603/40,C07D295/08;;A61K31/135;;A61K31/40;;A61K31/445;;A61K31/55;;A61K31/565;;A61K31/57;;A61P3/06;;A61P9/00;;A61P19/10;;A61P43/00;;C07C217/18;;C07C309/65;;C07D207/06;;C07D295/092;;C07J69/00,,0,0,,,,EXPIRED
110,ES,A6,ES 2007367 A6,103-935-140-508-964,1989-06-16,1989,ES 8702037 A,1987-07-10,US 88419786 A,1986-07-10,Hydroformylation using low volatile/organic soluble phosphine ligands.,"A nonaqueous hydroformylation process for producing aldehydes using low volatile, organic soluble monosulfonated tertiary phosphine salt ligands.",UNION CARBIDE CORP,ABATJOBLU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/103-935-140-508-964,Granted Patent,no,0,0,52,52,0,C07C45/50;;C07F9/5004;;Y02P20/582;;C07B41/00;;C07C47/02;;C07C45/50;;C07F9/5004;;Y02P20/582,B01J31/00;;B01J31/24;;C07C45/00;;C07C45/50;;C07B61/00;;C07C47/02;;C07C67/00;;C07F9/50,,0,0,,,,EXPIRED
111,US,A,US 1108533 A,129-353-271-589-104,1914-08-25,1914,US 1912/0698539 A,1912-05-20,US 1912/0698539 A,1912-05-20,WAGON-BRAKE.,,WATT GEORGE M;;BRYANT JOHN E,WATT GEORGE M;;BRYANT JOHN E,,https://lens.org/129-353-271-589-104,Granted Patent,no,0,0,1,1,0,F16D49/16;;F16D49/16,,,0,0,,,,EXPIRED
112,DE,A1,DE 2536732 A1,142-763-510-225-459,1976-03-04,1976,DE 2536732 A,1975-08-18,US 49851374 A,1974-08-19,PLATTENSPIELER-TONABNEHMER-SYSTEM,,EMPIRE SCIENT CORP,SHAPER HARRY BRYANT;;LITCHER DONALD GEORGE,,https://lens.org/142-763-510-225-459,Patent Application,no,1,2,7,7,0,H04R11/08;;H04R11/12;;H04R11/08;;H04R11/12,G11B3/50;;H04R11/08;;H04R11/12,,0,0,,,,EXPIRED
113,AU,B2,AU 2004/284079 B2,153-244-164-935-62X,2011-08-18,2011,AU 2004/284079 A,2004-10-22,US 69230403 A;;US 69144703 A;;US 2004/0035201 W,2003-10-22,Aluminum conductor composite core reinforced cable and method of manufacture,"This invention relates to an aluminum conductor composite core reinforced cable (ACCC) and method of manufacture. An ACCC cable (300) has a composite core surrounded by an outer film (305) and at least one layer of aluminum conductor (306). The composite core (303) comprises a plurality of fibers from at least one fiber type in one or more matrix materials. According to the invention, unique processing techniques such a B-Staging and / or film-coating techniques can be used to increase production rates from a few feet per minute to sixty or more feet per minute.",CTC CABLE CORP,GEORGE KORZENIOWSKI;;DAVID BRYANT;;CLEMENT HIEL,CTC CABLE CORPORATION (2006-06-08),https://lens.org/153-244-164-935-62X,Granted Patent,no,10,0,34,35,0,B29C70/52;;B29L2031/3462;;B32B1/00;;B32B15/02;;B32B15/08;;B32B15/20;;B32B27/04;;H01B5/105;;B29C70/528;;Y10T428/2918;;Y10T428/2933;;Y10T428/2936;;Y10T442/30;;B32B27/04;;B82Y30/00;;Y10T428/2918;;Y10T428/2933;;Y10T428/2936;;Y10T442/30;;B32B2305/08;;B32B2307/54;;B32B27/08;;B32B2457/00;;B29L2031/3462;;B32B1/00;;B29C70/52;;B32B15/02;;B32B15/20;;B32B27/04;;B32B15/08;;H01B5/105;;B29C70/528,B05D1/18;;B05D3/02;;B32B27/04;;B65H/;;D04H3/08,,0,0,,,,INACTIVE
114,CN,A,CN 87105466 A,156-932-991-393-439,1988-02-03,1988,CN 87105466 A,1987-07-10,US 88419786 A,1986-07-10,HYDROFORMYLATION USING LOW VOLATILE ORGANIC SOLUBLE PHOSPHINE LIGANDS,,UNION CARBIDE CORP.,ANTHONY GEORGE ABATJOGLOU;;DAVID ROBERT BRYANT,,https://lens.org/156-932-991-393-439,Patent Application,no,0,4,52,52,0,C07C45/50;;C07F9/5004;;Y02P20/582;;C07B41/00;;C07C47/02;;C07C45/50;;C07F9/5004;;Y02P20/582,C07B61/00;;B01J31/00;;B01J31/24;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00;;C07F9/50,,0,0,,,,EXPIRED
115,CA,A,CA 681540 A,167-377-311-704-686,1964-03-03,1964,CA 681540D A,,CA 681540T A,,POLYPROPYLENE COMPOSITIONS,,UNION CARBIDE CORP,BRYANT GEORGE M;;ZUTTY NATHAN L,,https://lens.org/167-377-311-704-686,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
116,NO,D0,NO 874810 D0,188-147-963-876-246,1987-11-18,1987,NO 874810 A,1987-11-18,US 93200286 A,1986-11-18,HYDROFORMYLERING VED ANVENDELSE AV FOSFIN-LIGANDER MED LAV FLYKTIGHET.,,UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/188-147-963-876-246,Patent Application,no,0,0,53,53,0,C07C45/50;;Y02P20/582;;C07C47/55;;C07C47/02;;C07C45/50;;Y02P20/582,B01J31/00;;B01J31/24;;B01J31/28;;C07B61/00;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00,,0,0,,,,EXPIRED
117,ZA,B,ZA 887549 B,102-612-111-760-690,1990-06-27,1990,ZA 887549 A,1988-10-07,US 10533087 A,1987-10-07,"PROCESS FOR PREPARING 3,3-DISUBSTITUTED INDOLINES",,DU PONT,BRYANT WALTER MARVIN III;;WALTER MARVIN BRYANT III;;HUHN GEORGE FREDERICK;;GEORGE FREDERICK HUHN,,https://lens.org/102-612-111-760-690,Granted Patent,no,0,0,22,22,0,C07D401/14;;C07D403/14;;C07D403/06;;C07D401/14;;C07D403/14,C07D401/06;;C07D401/14;;C07D209/34;;C07D403/06;;C07D403/14,,0,0,,,,EXPIRED
118,DE,D1,DE 3261623 D1,000-726-342-648-409,1985-01-31,1985,DE 3261623 T,1982-08-16,US 29318981 A,1981-08-17,HYDROFORMYLATION PROCESS USING A RHODIUM COMPLEX CATALYST WITH TRIARYLPHOSPHINE AND BIPHOSPHINE MONOXIDE LIGANDS,,UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/000-726-342-648-409,Granted Patent,no,0,0,9,10,0,B01J31/2495;;B01J31/2495;;B01J31/0267;;B01J31/0267;;B01J31/1875;;B01J31/1875;;B01J31/2404;;B01J31/2404;;B01J31/28;;B01J2231/321;;B01J2231/321;;B01J2531/822;;B01J2531/822;;C07C45/50;;C07C45/50;;C07C45/50,B01J31/00;;B01J31/24;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00,,0,0,,,,EXPIRED
119,US,A,US 4984940 A,003-754-065-693-03X,1991-01-15,1991,US 46171290 A,1990-01-08,US 46171290 A;;US 32484789 A,1989-03-17,Multilayer coated cemented carbide cutting insert,"An indexable metalcutting insert is provided having a cobalt cemented tungsten carbide substrate wit a multilayer refractory coating thereon. The substrate has a cobalt content of 6.1 to 6.5 weight percent and is characterized by a hardness of 90.8 to 91.6 Rockwell A and a magnetic coercive force of 110 to 180 oerstads. The coating contains at least a plurality of alumina layers which are separated from and bonded to each other by a group IVB metal nitride, such as titanium nitride, and which are bonded to the substrate by a backing layer of 5 to 8 .mu. in thickness, composed of a carbide and/or carbonitride of titanium, zirconium and/or hafnium.",KENNAMETAL INC,BRYANT WILLIAM A;;GRAB GEORGE P,KENNAMETAL INC (2008-09-10);;KENNAMETAL PC INC (2000-10-23),https://lens.org/003-754-065-693-03X,Granted Patent,yes,9,135,1,19,0,B23B27/145;;B23B27/145;;B23B2228/36;;B23B2228/36;;C23C30/005;;C23C30/005;;Y10T407/27;;Y10T407/27,B23B27/14;;C23C30/00,407/119;;51/295;;51/309;;427/249;;428/698,2,1,073-361-477-427-792,10.1016/0043-1648(84)90011-5,"Schintlmeister et al., Cutting Tool Materials Coated by Vapour Deposition, Wear 100 (1984), pp. 153 169.;;Dreyer et al., Development and Tool Life Behavior of Super Wear Resistant Multilayer Coatings on Harometals, Metals Society (Book 278), London, England (1982), pp. 112 117.",EXPIRED
120,KR,A,KR 20230049645 A,006-377-238-902-265,2023-04-13,2023,KR 20237005466 A,2021-08-10,US 202016990300 A;;US 2021/0045386 W,2020-08-11,NFC 기반 인증을 통한 증강현실 정보 표시 및 상호작용,"다양한 실시형태는 일반적으로 카드 번호, 카드 검증 값 및 유효기한과 같은 민감한 카드 정보가 인쇄되지 않은 비접촉식 카드를 사용자에게 제공하고 성공적인 NFC-기반 사용자 인증을 기반으로 카드에 대한 민감한 카드 정보를 증강 현실(AR)로 표시함으로써 카드 보안을 향상시키는 것에 관한 것이다. 실시예에 따르면 NFC-기반의 사용자 인증은 비접촉식 카드를 사용자 모바일 디바이스에 원 탭 또는 단일 탭 함으로써 수행될 수 있다. 카드 보안을 더욱 강화하기 위해 민감한 카드 정보 중 하나 이상의 부분은 난독화 될 수 있다. 또한 사용자는 민감한 카드 정보를 포함하는 AR 엘레멘트와 상호 작용하여 다양한 동작을 수행할 수 있다.",CAPITAL ONE SERVICES LLC,BERGERON GEORGE;;YEE BRYANT;;BULGAKOV MYKHAYLO,,https://lens.org/006-377-238-902-265,Patent Application,no,0,0,11,11,0,G06Q40/02;;H04L9/0861;;H04L2209/805;;H04L9/3242;;G06K7/10297;;H04W12/47;;H04W12/069;;H04W12/02;;H04L63/08;;H04L63/0421;;H04W12/61;;G06F21/35;;H04W12/47;;H04W12/047;;H04W12/65;;G06F3/14;;G06Q20/34;;G06K7/10297;;H04L9/3226;;G06F21/6245;;G06F3/0484;;G06Q40/02;;G06F3/14;;H04L9/0861,H04W12/47;;G06F3/14;;G06Q20/34;;H04W12/047;;H04W12/65,,0,0,,,,PENDING
121,DE,T2,DE 69225063 T2,023-194-053-303-981,1998-09-10,1998,DE 69225063 T,1992-12-01,US 85775792 A,1992-03-26,Differentialdruck-Gegenschwerkraftgiessen,,GEN MOTORS CORP,CHANDLEY GEORGE D;;CROCKER BRYANT W,,https://lens.org/023-194-053-303-981,Granted Patent,no,0,1,9,9,0,B22D18/06;;B22D27/20;;B22D18/06;;B22D27/20,B22D1/00;;B22D18/06;;B22D27/20,,0,0,,,,EXPIRED
122,HU,A,HU T49344 A,057-231-520-720-017,1989-09-28,1989,HU 518088 A,1988-10-06,US 10533087 A,1987-10-07,"PROCESS FOR PRODUCTION OF DERIVATIVES OF 3,3-DISUBSTITUATED INDOLINE",,WILMINGTON,BRYANT WALTER M;;HUHN GEORGE F,"THE DU PONT MERCK PHARMACEUTICAL CO., US (1992-05-28)",https://lens.org/057-231-520-720-017,Unknown,no,0,0,22,22,0,C07D401/14;;C07D403/14;;C07D403/06;;C07D401/14;;C07D403/14,C07D401/06;;C07D209/34;;C07D401/14;;C07D403/06;;C07D403/14,,0,0,,,,EXPIRED
123,BR,A,BR 8706223 A,048-363-074-440-178,1988-06-21,1988,BR 8706223 A,1987-11-18,US 93200286 A,1986-11-18,PROCESSO DE HIDROFORMILACAO NAO AQUOSA PARA PRODUZIR ALDEIDOS,,UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/048-363-074-440-178,Patent Application,no,0,0,53,53,0,C07C45/50;;Y02P20/582;;C07C47/55;;C07C47/02;;C07C45/50;;Y02P20/582,B01J31/24;;B01J31/00;;B01J31/28;;C07B61/00;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00,,0,0,,,,DISCONTINUED
124,DK,D0,DK 359987 D0,063-754-936-168-035,1987-07-10,1987,DK 359987 A,1987-07-10,US 88419786 A,1986-07-10,IKKE-VANDIG HYDROFORMYLERING VED ANVENDELSE AF TUNGTFLYGTIGE ORGANISK OPLOESELIGE PHOSPHIN-LIGANDER,,UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/063-754-936-168-035,Patent Application,no,0,0,52,52,0,C07C45/50;;C07F9/5004;;Y02P20/582;;C07B41/00;;C07C47/02;;C07C45/50;;C07F9/5004;;Y02P20/582,B01J31/00;;B01J31/24;;C07B61/00;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00;;C07F9/50,,0,0,,,,DISCONTINUED
125,ES,T3,ES 2078228 T3,073-667-608-804-28X,1995-12-16,1995,ES 89114453 T,1989-08-04,US 22850788 A,1988-08-05,FOSFITOS IONICOS Y SU USO EN PROCEDIMIENTOS CATALIZADOS POR METALES DE TRANSICION HOMOGENEOS.,"ESTA INVENCION SE REFIERE A FOSFITOS IONICOS NUEVOS Y SU USO COMO LIGANDOS EN PROCESOS CATALIZADOS POR METALES DE TRANSICION HOMOGENEOS, ESPECIALMENTE HIDROFORMILACION.",UNION CARBIDE CHEM PLASTIC,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/073-667-608-804-28X,Granted Patent,no,0,0,22,23,0,B01J31/185;;B01J31/185;;B01J2231/321;;B01J2231/321;;B01J2531/0266;;B01J2531/0266;;B01J2531/80;;B01J2531/80;;B01J2531/822;;B01J2531/822;;C07F9/165;;C07F9/65746;;C07F9/65746;;C07C45/50;;C07C45/50;;C07F9/65744;;C07F9/65744;;Y02P20/582;;Y02P20/582,B01J31/22;;B01J31/18;;C07B61/00;;C07C45/49;;C07C45/50;;C07C47/02;;C07F9/6574;;C07F9/6578;;C07F9/6584;;C07F9/6596,,0,0,,,,EXPIRED
126,CN,A,CN 102869409 A,086-971-900-554-423,2013-01-09,2013,CN 201180010665 A,2011-01-03,US 2011/0020052 W;;US 29180409 P;;US 29177909 P;;US 29173209 P,2009-12-31,Ultrasound coupling device,"The present invention relates to an ultrasound coupling device for use with various ultrasound transducers, systems, and applications. The coupling device includes a coupling compartment comprising a chamber having a continuous side wall and an opening on a first end. The continuous side wall is configured to hold a low-profile ultrasound transducer within the chamber so that a front ultrasound emitting surface of the low-profile ultrasound transducer faces outward toward the chamber opening. The front ultrasound emitting surface is configured to control the direction and wave pattern of ultrasonic energy emitted from the transducer.; The continuous side wall is also configured to hold a quantity of an ultrasound conductive medium within the chamber and is operative to keep the ultrasound conductive medium in simultaneous contact with a surface of a subject and with at least a portion of the front ultrasound emitting surface of the transducer. The present invention also relates to an ultrasound apparatus, kit, and methods of using the ultrasound coupling device, apparatus, and kit.",ZETROZ LLC,LEWIS JR GEORGE K;;GUFFEY BRYANT,,https://lens.org/086-971-900-554-423,Patent Application,no,2,5,32,32,0,A61B8/4281;;A61B17/2251;;A61B2017/2253;;A61N2007/0078;;A61B8/4227;;A61B8/4236;;A61B8/4427;;A61B2017/00734;;A61N2007/006;;A61N2007/0091;;A61N2007/0095;;A61B8/44;;A61N7/00;;Y10T29/49005;;A61B2034/301;;A61B34/30;;A61B2034/303;;A61B2034/107;;A61B34/10;;A61N2007/0034;;Y10T29/49005;;A61B8/4281;;A61B17/2251;;A61B2017/2253;;A61N2007/0078;;A61B8/4227;;A61B8/4236;;A61B2017/00734;;A61N2007/0091;;A61N2007/0095;;A61B8/4427;;A61B8/44;;A61N2007/006;;A61N7/00,A61N7/00;;A61B8/00,,0,0,,,,DISCONTINUED
127,EP,B1,EP 0195458 B1,102-060-839-144-142,1988-09-28,1988,EP 86103923 A,1986-03-21,US 71472285 A,1985-03-22,PROCESS FOR TREATING WET PAPER WITH FOAM,"Specifically structured foamed compositions of paper treating agents applied to wet paper, such as wet-end paper web produced during high speed paper manufacture, provide uniform treating agent distribution and treated paper having properties comparable to dry-processed paper.",UNION CARBIDE CORPORATION,"BRYANT, GEORGE MACON;;BROWN, RUSSELL LEE",,https://lens.org/102-060-839-144-142,Granted Patent,yes,4,3,10,10,0,D21H21/56;;D21H23/26,D21H17/35;;D21H17/03;;D21H19/00;;D21H21/56;;D21H23/26,,2,0,,,"TAPPI, vol. 51, no. 4, April 1968, pages 83A-86A, Atlanta, GA, US; W.P. HAMILL: ""Coating paper with foam"";;H. HENTSCHEL: ""Chemische Technologie der Zellstoff- und Papierherstellung"", 1967, 3rd edition, pages 546-552, VEB Fachverlag, Leipzig, DD; ""Trockung und Fertigstellung des Papiers""",EXPIRED
128,ZA,B,ZA 200603663 B,131-204-937-572-935,2012-04-25,2012,ZA 200603663 A,2006-05-09,US 69144703 A;;US 69230403 A;;US 2004/0035201 W,2003-10-22,ALUMINIUM CONDUCTOR COMPOSITE CORE REINFORCED CABLE AND METHOD OF MANUFACTURE,,COMPOSITE TECH CORP,HIEL CLEMENT;;KORZENIOWSKI GEORGE;;BRYANT DAVID,,https://lens.org/131-204-937-572-935,Granted Patent,no,0,0,1,35,0,,B32B/;;B05D/;;D04H/,,0,0,,,,ACTIVE
129,CA,A,CA 837182 A,138-007-958-370-859,1970-03-17,1970,CA 837182D A,,CA 837182T A,,DYEABLE POLYPROPYLENE,,UNION CARBIDE CORP,ZUTTY NATHAN L;;BRYANT GEORGE M,,https://lens.org/138-007-958-370-859,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
130,AP,A0,AP 2006003610 A0,180-468-748-440-825,2006-06-30,2006,AP 2006003610 A,2004-10-22,US 69144703 A;;US 69230403 A;;US 2004/0035201 W,2003-10-22,Aluminium conductor composite core reinforced cable and method of manufacture,,CTC CABLE CORP,BRYANT DAVID;;HIEL CLEMENT;;KORZENIOWSKI GEORGE,,https://lens.org/180-468-748-440-825,Patent Application,no,0,0,34,35,0,B29C70/52;;B29L2031/3462;;B32B1/00;;B32B15/02;;B32B15/08;;B32B15/20;;B32B27/04;;H01B5/105;;B29C70/528;;Y10T428/2918;;Y10T428/2933;;Y10T428/2936;;Y10T442/30;;B32B27/04;;B82Y30/00;;Y10T428/2918;;Y10T428/2933;;Y10T428/2936;;Y10T442/30;;B32B2305/08;;B32B2307/54;;B32B27/08;;B32B2457/00;;B29L2031/3462;;B32B1/00;;B29C70/52;;B32B15/02;;B32B15/20;;B32B27/04;;B32B15/08;;H01B5/105;;B29C70/528,B05D1/18;;B05D3/02;;B32B27/04;;B65H/;;D04H3/08,,0,0,,,,ACTIVE
131,US,B1,US 11062098 B1,161-325-312-976-592,2021-07-13,2021,US 202016990300 A,2020-08-11,US 202016990300 A,2020-08-11,Augmented reality information display and interaction via NFC based authentication,"Various embodiments are generally directed to improving card security by providing a user a contactless card with no sensitive card information, such as card number, card verification value, and expiration date, printed thereon, and displaying the sensitive card information relative to the card in augmented reality (AR) based on successful NFC-based user authentication. According to examples, the NFC-based user authentication may be performed by one-tapping or single tapping the contactless card to user mobile device. One or more portions of the sensitive card information may be obfuscated to further enhance card security. Moreover, the user can interact with AR elements including the sensitive card information to perform various actions.",CAPITAL ONE SERVICES LLC,BERGERON GEORGE;;YEE BRYANT;;BULGAKOV MYKHAYLO,CAPITAL ONE SERVICES LLC (2020-08-10),https://lens.org/161-325-312-976-592,Granted Patent,yes,588,4,11,11,0,G06Q40/02;;H04L9/0861;;H04L2209/805;;H04L9/3242;;G06K7/10297;;H04W12/47;;H04W12/069;;H04W12/02;;H04L63/08;;H04L63/0421;;H04W12/61;;G06F21/35;;H04W12/47;;H04W12/047;;H04W12/65;;G06F3/14;;G06Q20/34;;G06K7/10297;;H04L9/3226;;G06F21/6245;;G06F3/0484;;G06Q40/02;;G06F3/14;;H04L9/0861,G06K7/10;;G06F3/0484;;G06F3/14;;G06F21/62;;G06Q40/02;;H04L9/08;;H04L9/32,,41,4,135-218-917-563-284;;057-942-955-996-523;;035-291-375-623-97X;;009-833-327-056-035,10.17487/rfc2104;;10.1109/afrcon.2013.6757740;;17431302;;10.1109/tpami.2007.1049;;10.1145/2348543.2348569,"Satina, L. and Poll, E., “SmartCards and RFID”, Course PowerPoint Presentation for IPA Security Course, Digital Security at University of Nijmegen, Netherlands (date unknown) 75 pages.;;Haykin, M. and Warnar, R., “Smart Card Technology: New Methods for Computer Access Control”, Computer Science and Technology NIST Special Publication 500-157:1-60 (1988).;;Lehpamer, H., “Component of the RFID System”, RFID Design Principles, 2nd edition pp. 133-201 (2012).;;Author Unknown, “CardrefresherSM from American Express®”, [online] 2019 [retrieved on Mar. 25, 2019]. Retrieved from Internet URL: https://merchant-channel.americanexpress.com/merchant/en_US/cardrefresher, 2 pages.;;Author Unknown, “Add Account Updater to your recurring payment tool”, [online] 2018-19 [retrieved on Mar. 25, 2019]. Retrieved from Internet URL: https://www.authorize.net/our-features/account-updater/, 5 pages.;;Author Unknown, “Visa® Account Updater for Merchants”, [online] 2019 [retrieved on Mar. 25, 2019]. Retrieved from Internet URL: https://usa.visa.com/dam/VCOM/download/merchants/visa-account-updater-product-information-fact-sheet-for-merchants.pdf, 2 pages.;;Author Unknown, “Manage the cards that you use with Apple Pay”, Apple Support [online] 2019 [retrieved on Mar. 25, 2019]. Retrieved from Internet URL: https://support.apple.com/en-us/HT205583, 5 pages.;;Author Unknown, “Contactless Specifications for Payment Systems”, EMV Book B—Entry Point Specification [online] 2016 [retrieved on Mar. 25, 2019]. Retrieved from Internet URL: https://www.emvco.com/wp-content/uploads/2017/05/BookB_Entry_Point_Specification_v2_6_20160809023257319.pdf, 52 pages.;;Author Unknown, “EMV Integrated Circuit Card Specifcations for Payment Systems, Book 2, Security and Key Management,” Version 3.4, [online] 2011 [retrieved on Mar. 25, 2019]. Retrieved from Internet URL: https://www.emvco.com/wp-content/uploads/2017/05/EMV_v4.3_Book_2_Security_and_Key_Management_20120607061923900.pdf, 174 pages.;;Author Unknown, “NFC Guide: All You Need to Know About Near Field Communication”, Square Guide [online] 2018 [retrieved on Nov. 13, 2018]. Retrieved from Internet URL: https://squareup.com/guides/nfc, 8 pages.;;Profis, S., “Everything you need to know about NFC and mobile payments” CNET Directory [online], 2014 [retrieved on Mar. 25, 2019]. Retrieved from the Internet URL: https://www.cnet.com/how-to/how-nfc-works-and-mobile-payments/, 6 pages.;;Cozma, N., “Copy data from other devices in Android 5.0 Lollipop setup”, CNET Directory [online] 2014 [retrieved on Mar. 25, 2019]. Retrieved from the Internet URL: https://www.cnet.com/how-to/copy-data-from-other-devices-in-android-5-0-lollipop-setup/, 5 pages.;;Kevin, Android Enthusiast, “How to copy text string from nfc tag”, StackExchange [online] 2013 [retrieved on Mar. 25, 2019]. Retrieved from the Internet URL: https://android.stackexchange.com/questions/55689/how-to-copy-text-string-from-nfc-tag, 11 pages.;;Author Unknown, “Tap & Go Device Setup”, Samsung [online] date unknown [retrieved on Mar. 25, 2019]. Retrieved from the Internet URL: https://www.samsung.com/us/switch-me/switch-to-the-galaxy-s-5/app/partial/setup-device/tap-go.html, 1 page.;;Author Unknown, “Multiple encryption”, Wikipedia [online] 2019 [retrieved on Mar. 25, 2019]. Retrieved from Internet URL: https://en.wikipedia.org/wiki/Multiple_encryption, 4 pages.;;Krawczyk, et al., “HMAC: Keyed-Hashing for Message Authentication”, Network Working Group RFC:2104 memo [online] 1997 [retrieved on Mar. 25, 2019]. Retrieved from Internet URL: https://tools.ietf.org/html/rfc2104, 12 pages.;;Song, et al., “The AES-CMAC Algorithm”, Network Working Group RFC: 4493 memo [online] 2006 [retrieved on Mar. 25, 2019]. Retrieved from Internet URL: https://tools.ietf.org/html/rfc4493, 21 pages.;;Katz, J. and Lindell, Y., “Aggregate Message Authentication Codes”, Topics in Cryptology [online] 2008 [retrieved on Mar. 25, 2019]. Retrieved from Internet URL: https://www.cs.umd.edu/˜jkatz/papers/aggregateMAC.pdf, 11 pages.;;Adams, D., and Maier, A-K., “Goldbug BIG SEVEN open source crypto-messengers to be compared—or: comprehensive Confidentiality Review & Audit of GoldBug Encrypting E-Mail-Client & Secure Instant Messenger”, Big Seven Study 2016 [online] [retrieved on Mar. 25, 2018]. Retrieved from Internet URL: https://sf.net/projects/goldbug/files/bigseven-crypto-audit.pdf, 309 pages.;;Author Unknown, “Triple DES”, Wikipedia [online] 2018 [retrieved on Mar. 25, 2019]. Retrieved from Internet URL: https://simple.wikipedia.org/wiki/Triple_DES, 2 pages.;;Song F., and Yun, A.I., “Quantum Security of NMAC and Related Constructions—PRF domain extension against quantum attacks”, IACR Cryptology ePrint Archive [online] 2017 [retrieved on Mar. 25, 2019]. Retrieved from Internet URL: https://eprint.iacr.org/2017/509.pdf, 41 pages.;;Saxena, N., “Lecture 10: NMAC, HMAC and Number Theory”, CS 6903 Modern Cryptography [online] 2008 [retrieved on Mar. 25, 2019]. Retrieved from Internet URL: http://isis.poly.edu/courses/cs6903/Lectures/lecture10.pdf, 8 pages.;;Berg, G., “Fundamentals of EMV”, Smart Card Alliance [online] date unknown [retrieved on Mar. 27, 2019]. Retrieveed from Internet URL: https://www.securetechalliance.org/resources/media/scap13_preconference/02.pdf, 37 pages.;;Pierce, K., “Is the amazon echo nfc compatible?”, Amazon.com Customer Q&A [online] 2016 [retrieved on Mar. 26, 2019]. Retrieved from Internet URL: https://www.amazon.com/ask/questions/Tx1RJXYSPE6XLJD?_encodi . . . , 2 pages.;;Author Unknown, “Multi-Factor Authentication”, idaptive [online] 2019 [retrieved on Mar. 25, 2019]. Retrieved from Internet URL: https://www.centrify.com/products/application-services/adaptive-multi-factor-authentication/risk-based-mfa/, 10 pages.;;Author Unknown, “Adaptive Authentication”, SecureAuth [online] 2019 [retrieved on Mar. 25, 2019}. Retrieved from Internet URL: https://www.secureauth.com/products/access-management/adaptive-authentication, 7 pages.;;Van den Breekel, J., et al., “EMV in a nutshell”, Technical Report, 2016 [retrieved on Mar. 25, 2019]. Retrieved from Internet URL: https://www.cs.ru.nl/E.Poll/papers/EMVtechreport.pdf, 37 pages.;;Author Unknown, “Autofill”, Computer Hope [online] 2018 [retrieved on Mar. 25, 2019]. Retrieved from Internet URL: https://www.computerhope.com/jargon/a/autofill.htm, 2 pages.;;Author Unknown, “Fill out forms automatically”, Google Chrome Help [online] 2019 [retrieved on Mar. 25, 2019]. Retrieved from Internet URL: https://support.google.com/chrome/answer/142893?co=GENIE.Platform%3DDesktop&hl=en, 3 pages.;;Author Unknown, “Autofill credit cards, contacts, and passwords in Safari on Mac”, Apple Safari User Guide [online] 2019 [retrieved on Mar. 25, 2019]. Retrieved from Internet URL: https://support.apple.com/guide/safari/use-autofill-brw1103/mac, 3 pages.;;Menghin, M.J., “Power Optimization Techniques for Near Field Communication Systems”, 2014 Dissertation at Technical University of Graz [online]. Retrieved from Internet URL: https://diglib.tugraz.at/download.php?d=576a7b910d2d6&location=browse, 135 pages.;;Mareli, M., et al., “Experimental evaluation of NFC reliability between an RFID tag and a smartphone”, Conference paper (2013) IEEE AFRICON At Mauritius [online] [retrieved on Mar. 25, 2019]. Retrieved from Internet URL: https://core.ac.uk/download/pdf/54204839.pdf, 5 pages.;;Davison, A., et al., “MonoSLAM: Real-Time Single Camera SLAM”, IEEE Transactions on Pattern Analysis and Machine Intelligence 29(6): 1052-1067 (2007).;;Barba, R., “Sharing your location with your bank sounds creepy, but it's also useful”, Bankrate, LLC [online] 2017 [retrieved on Mar. 25, 2019]. Retrieved from Internet URL: https://www.bankrate.com/banking/banking-app-location-sharing/, 6 pages.;;Author Unknown: “onetappayment™”, [online] Jan. 24, 2019, [retrieved on Mar. 25, 2019]. Retrieved from Internet URL: https://www.payubiz.in/onetap, 4 pages.;;Vu, et al., “Distinguishing users with capacitive touch communication”, Proceedings of the Annual International Conference on Mobile Computing and Networking, 2012, MOBICOM. 10.1145/2348543.2348569.;;Pourghomi, P., et al., “A Proposed NFC Payment Application,” International Journal of Advanced Computer Science and Applications, 4(8):173-181 (2013).;;Author unknown, “EMV Card Personalization Specification”, EMVCo., LLC., specification version 1.0, (2003) 81 pages.;;Ullmann et al., “On-Card” User Authentication for Contactless Smart Cards based on Gesture Recognition, paper presentation LNI proceedings, (2012) 12 pages.;;Faraj, S.T., et al., “Investigation of Java Smart Card Technology for Multi-Task Applications”, J of Al-Anbar University for Pure Science, 2(1):23 pages (2008).;;Dhamdhere, P., “Key Benefits of a Unified Platform for Loyalty, Referral Marketing, and UGC” Annex Cloud [online] May 19, 2017 [retrieved on Jul. 3, 2019]. Retrieved from Internet URL: https://www.annexcloude.com/blog/benefits-unified-platform/, 13 pages.",ACTIVE
132,EP,A4,EP 0463000 A4,011-078-997-403-118,1992-03-11,1992,EP 90904146 A,1990-02-16,US 9000924 W;;US 32484789 A,1989-03-17,MULTILAYER COATED CEMENTED CARBIDE CUTTING INSERT,,KENNAMETAL INC.,"BRYANT, WILLIAM, A.;;GRAB, GEORGE, P.",,https://lens.org/011-078-997-403-118,Search Report,no,0,0,17,19,0,B23B27/14;;B23B27/145;;B23B2228/36;;C23C30/005,B22F7/00;;B22F7/04;;B23B27/14;;C23C16/30;;C23C30/00,,1,0,,,See references of WO 9011156A1,EXPIRED
133,US,A,US 3648079 A,024-644-779-228-695,1972-03-07,1972,US 3648079D A,1970-07-10,US 5378070 A,1970-07-10,HIGH-SPEED SENSE LATCH CIRCUIT,"A sense latch circuit having a short access time. The latch output switches state rapidly due to the incorporation of a minimum number of logic stages between the sense inputs and the output drive stage, thereby introducing a minimum number of delays. Nonsaturable logic circuits are utilized to allow fast switching. At the inputs of the sense latch circuit, the high DC levels of the sense signals are reduced in magnitude for application to an ECL circuit switch with the use of diodes and resistor dividers. This arrangement allows for large temperature variations without saturating any of the logic stages.",COGAR CORP,BRYANT RICHARD W;;TU GEORGE K,,https://lens.org/024-644-779-228-695,Granted Patent,no,5,1,2,2,0,G11C11/416;;G11C11/416;;G11C7/062;;G11C7/062;;G11C7/065;;G11C7/065;;H03K3/286;;H03K3/286,G11C7/06;;G11C11/416;;H03K3/286,307/289;;307/235;;330 30   D,0,0,,,,EXPIRED
134,BR,A,BR 8601246 A,040-812-394-802-879,1986-12-02,1986,BR 8601246 A,1986-03-20,US 71472285 A,1985-03-22,PROCESSO PARA TRATAMENTO DE PAPEL UMIDO E PARA PRODUCAO DE PAPEL TRATADO,"Specifically structured foamed compositions of paper treating agents applied to wet paper, such as wet-end paper web produced during high speed paper manufacture, provide uniform treating agent distribution and treated paper having properties comparable to dry-processed paper.",UNION CARBIDE CORP,BRYANT GEORGE MACON;;BROWN RUSSELL LEE,,https://lens.org/040-812-394-802-879,Patent Application,no,0,0,10,10,0,D21H21/56;;D21H23/26,D21H17/03;;D21H17/35;;D21H19/00;;D21H21/56;;D21H23/26,,0,0,,,,PENDING
135,US,B2,US 7179522 B2,069-226-053-051-625,2007-02-20,2007,US 97162904 A,2004-10-22,US 97162904 A;;US 69144703 A;;US 69230403 A;;US 0312520 W;;US 37487902 P,2002-04-23,Aluminum conductor composite core reinforced cable and method of manufacture,"This invention relates to an aluminum conductor composite core reinforced cable (ACCC) and method of manufacture. An ACCC cable has a composite core surrounded by at least one layer of aluminum conductor. The composite core comprises a plurality of fibers from at least one fiber type in one or more matrix materials. The composite core can have a maximum operating temperature capability above 100° C. or within the range of about −45° C. to about 240° C. or higher, at least 50% fiber to resin volume fraction, a tensile strength in the range of about 160 Ksi to about 370 Ksi, a modulus of elasticity in the range of about 7 Msi to about 37 Msi and a coefficient of thermal expansion in the range of about −0.6×10 −6 per deg. C. to about 1.0×10 −5 per deg. C. According to the invention, unique processing techniques such a B-Staging and/or film-coating techniques can be used to increase production rates from a few feet per minute to sixty or more feet per minute.",CTC CABLE CORP,HIEL CLEMENT;;KORZENIOWSKI GEORGE;;BRYANT DAVID,CTC GLOBAL CORPORATION (2012-07-03);;CTC CABLE CORPORATION (2005-07-29),https://lens.org/069-226-053-051-625,Granted Patent,yes,57,71,2,99,0,H01B5/105;;Y10T428/2933;;Y10T428/2938;;Y10T428/249949;;Y10T428/249945;;Y10T428/24994;;Y10T428/249946;;Y10T428/24995;;Y10T428/249942;;Y10T428/2933;;Y10T428/2938;;Y10T428/249949;;Y10T428/249945;;Y10T428/24994;;Y10T428/249946;;Y10T428/24995;;Y10T428/249942;;H01B5/105,B32B27/04;;G02B6/44;;H02G3/00,428/300.7;;428/297.4;;428/299.4;;428/299.1;;428/298.1;;428/300.4;;428/378;;X174 70 R;;X174102 R;;X174106 R;;X174113 C;;427/379;;427/389.7,4,0,,,"Sucuma P. Elliot, ""HECO puts new composite conductors to the test"", Transmission and Distribution World, Jun. 1, 2003.;;Office of Industrial Technologies, ""Development of a Composite-Reinforced Aluminum Conductor"", Dec. 2001.;;Oak Ridge National Laboratory, ""Power Grid of the Future"", ONRL Review, vol. 35, No. 2, 2002, web-print.;;Alcoa Conductor Products Company, T&D Conductors; Overhead; Underground; Building Wire:, Jul. 1, 1989, p. 33.",EXPIRED
136,FI,A0,FI 873054 A0,067-603-432-253-508,1987-07-10,1987,FI 873054 A,1987-07-10,US 88419786 A,1986-07-10,HYDROFORMYLERING SOM UTNYTTJAR LITET FLYKTIGA FOSFINLIGANDER LOESLIGA I ORGANISKA AEMNEN.,,UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/067-603-432-253-508,Patent Application,no,0,0,52,52,0,C07C45/50;;C07F9/5004;;Y02P20/582;;C07B41/00;;C07C47/02;;C07C45/50;;C07F9/5004;;Y02P20/582,B01J31/00;;C07B61/00;;B01J31/24;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00;;C07F9/50,,0,0,,,,EXPIRED
137,ES,T3,ES 2175279 T3,076-609-473-527-580,2002-11-16,2002,ES 97307498 T,1997-09-25,US 2675296 P,1996-09-26,COMPUESTOS DE TETRAHIDROBENZO(A)FLUORENO Y PROCEDIMIENTOS DE USO.,"The invention provides tetrahydrobenzoÄaÜfluorene compounds, formulations, and methods of inhibiting bone loss or bone resorption, particularly osteoporosis, and cardiovascular-related pathological conditions, including hyperlipidemia.",LILLY CO ELI,BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH,,https://lens.org/076-609-473-527-580,Granted Patent,no,0,0,11,11,0,A61K31/565;;A61K31/57;;C07C217/18;;C07D295/088;;C07C2603/40;;A61P19/10;;A61P3/06;;A61P43/00;;A61P9/00;;C07D295/088;;A61K31/565;;C07C217/18;;A61K31/57;;C07C2603/40,A61K31/135;;A61K31/40;;C07D295/08;;A61K31/445;;A61K31/55;;A61K31/565;;A61K31/57;;A61P3/06;;A61P9/00;;A61P19/10;;A61P43/00;;C07C217/18;;C07C309/65;;C07D207/06;;C07D295/092;;C07J69/00,,0,0,,,,EXPIRED
138,RO,B1,RO 97309 B1,080-353-956-529-634,1989-08-02,1989,RO 12902587 A,1987-07-10,RO 12902587 A,1987-07-10,PROCESS FOR PREPARING ALDEHYDES BY THE HYDROFORMYLATIONS OF OLEFINS,"Instalatia se refera la un procedeu de obtinere a aldehidelor prin hidrogenarea olefinelor ca monoxid de carbon si hidrogen în prezenta unui catalizator complex reprezentat de ligand de fosfor rodiu si de fosfor liber, caracterizat prin aceea ca ligandul este o sare de fosfina tertiara monosulfonata cu formula generala: (vezi formula în text) în care R este individual radicalul alchil ramificat cu 3...9 atomi de carbon, fenil, ciclohexil si M supra + este un radical cuaternar de amoniu cu formula generala II: R sub 1, R sub 2, R sub 3, R sub 4 si N în care R sub 1 este H sau alchil cu 1...20 atomi de G, R sub 2 si R sub 3 sunt alchil cu 1...20 atomi de C; R sub 4 e alchil sau aralchil cu 8...20 atomi de C, în cantitate de minimum 4 mol ligand de fosfor per mol de rodiu, reactia având loc la 60...140 degree C la un raport molar H2/CO al hidrogenului gazos fata de monoxidul de carbon 1 : 1...50 : 1 la o presiune totala de minimum 3,5 kgf/cm supra 2, o presiune partiala de CO de 0,07...8,4 kgf/cm supra 2 si o presiune partiala de H2 de 1,05...11,2 kgf/cm supra 2.",UNION CARBIDE CORP,ANTHONY GEORGE ABATJOGLOU;;DAVID ROBERT BRYANT,,https://lens.org/080-353-956-529-634,Unknown,no,0,0,1,1,0,,C07C45/50,,0,0,,,,DISCONTINUED
139,US,A1,US 2021/0110462 A1,084-748-747-794-847,2021-04-15,2021,US 202016840438 A,2020-04-05,US 202016840438 A;;US 201916597246 A,2019-10-09,COMPUTER-IMPLEMENTED METHODS FOR TECHNOLOGICAL APPLICATIONS INVOLVING PROVISION OF AN ONLINE PORTAL FOR MANAGING A USER ACCOUNT INCLUDING AN INTERACTIVE GUI HAVING FUNCTIONALITY FOR PRE-AUTHORIZING FUTURE TRANSACTIONS,"Systems and methods involving a computer-implemented portal that enables a user to pre-authorize purchase of items not yet available for sale are disclosed. In one embodiment, an exemplary method may comprise: providing an online portal that enables a user to manage a financial account; executing a first routine of the portal including interactive functionality enabling the user to specify and pre-authorize purchase of an item that is not yet available for sale; searching to determine at least one electronic source at which the item can be purchased when it becomes available for purchase; and executing a purchase transaction at the future date/time when the item is released for sale, to purchase the item for the user.",CAPITAL ONE SERVICES LLC,YEE BRYANT;;BERGERON GEORGE;;BULGAKOV MYKHAYLO,,https://lens.org/084-748-747-794-847,Patent Application,yes,0,1,5,5,0,G06Q30/0641;;G06Q30/0635;;G06Q20/40;;G06Q20/28;;G06Q20/405;;G06Q20/385;;G06Q30/0635;;G06Q30/0641,G06Q30/06;;G06Q20/38,,0,0,,,,ACTIVE
140,NZ,A,NZ 546772 A,081-086-226-139-055,2010-01-29,2010,NZ 54677204 A,2004-10-22,US 69144703 A;;US 69230403 A;;US 2004/0035201 W,2003-10-22,A composite core for a reinforced aluminium cable,"A composite core 302 comprised of a matrix material, the matrix material further comprising a chemical formulation comprising at least a resin, at least one hardener and one or more accelerators, said formulation having elongation properties in excess of glass fiber elongation properties, and a plurality of longitudinally extending fibers of one or more fiber types embedded in the matrix material to form a fiber/resin matrix, wherein, the fiber/resin matrix is cured to form the composite core.",CTC CABLE CORP,BRYANT DAVID;;HIEL CLEMENT;;KORZENIOWSKI GEORGE,,https://lens.org/081-086-226-139-055,Patent Application,no,0,0,34,35,0,B29C70/52;;B29L2031/3462;;B32B1/00;;B32B15/02;;B32B15/08;;B32B15/20;;B32B27/04;;H01B5/105;;B29C70/528;;Y10T428/2918;;Y10T428/2933;;Y10T428/2936;;Y10T442/30;;B32B27/04;;B82Y30/00;;Y10T428/2918;;Y10T428/2933;;Y10T428/2936;;Y10T442/30;;B32B2305/08;;B32B2307/54;;B32B27/08;;B32B2457/00;;B29L2031/3462;;B32B1/00;;B29C70/52;;B32B15/02;;B32B15/20;;B32B27/04;;B32B15/08;;H01B5/105;;B29C70/528,B05D1/18;;B05D3/02;;B32B27/04;;B65H/;;D04H3/08,,0,0,,,,DISCONTINUED
141,KR,B1,KR 870000543 B1,086-316-993-048-923,1987-03-18,1987,KR 820001051 A,1982-03-11,US 24308281 A,1981-03-12,PROCESS FOR REMOVING HYDROPEROXIDES AND ALDEHYDES FROM ALLYL-ALKYLETHER,"Hydroperoxides (I) present in allyl alkyl ethers (II) are decomposed to prods. including alpha, beta-unsatd. aldehydes by treatment of CH2=CHCH2-O-C(Z1)(Z2)CHZ3Z4 (II) with a metal hydride (III) (where Z1Z2 are C1-4 alkyl; Z3Z4 are H or C1-3 alkyl; or Z2Z3 are together with C's as 5- or 6-membered cycloaliphatic ring). Prefd. (III) include alkali(ne earth) metal borohydrides, alkali metal trialkylborohydrides, LiAlH4 or Na(MeOCH2CH2O)2AlH2 and amt. used is a 2-100 fold mol. excess based on (I).",UNION CARBIDE CORP,ABATIOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/086-316-993-048-923,Granted Patent,no,0,0,16,17,0,C07C29/175;;C07C31/10;;C07C41/36;;C07C41/44;;C07C45/53;;C07C45/62;;C07C43/00,C07C29/17;;C07C43/18;;C07C31/10;;C07C41/00;;C07C41/34;;C07C41/36;;C07C41/44;;C07C43/00;;C07C43/15;;C07C43/188;;C07C45/53;;C07C45/62;;C07C67/00,,0,0,,,,EXPIRED
142,BR,A,BR 8904259 A,083-147-159-148-638,1990-04-10,1990,BR 8904259 A,1989-08-24,US 23622188 A,1988-08-25,METODO PARA RECUPERAR METAL DE TRANSICAO DO GRUPO VIII DE UM LIQUIDO CONTENDO METAIS DE TRANSICAO;RESINA DE TROCA IONICA;E METODO PARA RECUPERAR RODIO DE UM PRODUTO DE ALDEIDO DE UM PROCESSO DE HIDROFORMILACAO,,UNION CARBIDE CHEM PLASTIC,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/083-147-159-148-638,Patent Application,no,0,0,15,15,0,B01J31/24;;B01J31/24;;B01J31/185;;B01J31/185;;B01J31/20;;B01J31/20;;B01J31/2234;;B01J31/2234;;B01J31/2404;;B01J31/2404;;B01J31/2409;;B01J31/2409;;B01J31/4023;;B01J31/4023;;B01J31/4046;;B01J31/4046;;B01J31/4053;;B01J31/4053;;B01J39/12;;B01J39/12;;B01J2231/321;;B01J2231/321;;B01J2531/02;;B01J2531/0211;;B01J2531/0211;;B01J2531/80;;B01J2531/80;;B01J2531/822;;B01J2531/822;;B01J2531/985;;B01J2531/985;;B01J2540/12;;B01J2540/12;;B01J2540/32;;B01J2540/32;;B01J2540/42;;B01J2540/42;;B01J2540/525;;B01J2540/525;;B01J2540/68;;B01J2540/68;;C01G55/00;;C01G55/001;;C01G55/001;;C07C45/50;;C07C45/50;;C07C45/79;;C07C45/79;;C22B3/42;;C22B3/42;;Y02P10/20;;Y02P10/20;;Y02P20/584;;Y02P20/584,B01D15/04;;B01J31/40;;B01J39/12;;B01J45/00;;C01G55/00;;C02F1/42;;C02F101/10;;C02F103/36;;C07C45/50;;C07C45/79;;C22B3/00,,0,0,,,,DISCONTINUED
143,US,A1,US 2022/0366472 A1,100-534-583-759-619,2022-11-17,2022,US 202117302960 A,2021-05-17,US 202117302960 A,2021-05-17,PROVIDING ENTITY RECOMMENDATIONS FOR ITEMS,"In some implementations, a client device may determine, using a program associated with an application that executes on the client device, a plurality of item identifiers associated with a plurality of items. The client device may identify, using the program, a combination of entities that provide the plurality of items with a reduced aggregate metric as compared to another entity or other combinations of entities from a plurality of entities. The client device may provide, via the program, a recommendation to initiate a transaction for the plurality of items from the combination of entities. The client device may initiate, via the program, the transaction for the plurality of items from the combination of entities using account information associated with each entity in the combination of entities.",CAPITAL ONE SERVICES LLC,YEE BRYANT;;BERGERON GEORGE;;BULGAKOV MYKHAYLO,,https://lens.org/100-534-583-759-619,Patent Application,yes,8,0,1,1,0,G06Q30/0633;;G06Q30/0639;;G06Q30/0623;;G06Q30/0605;;G06Q30/0631;;G06Q30/0631;;G06N5/04;;G06Q30/0639;;G06F3/0482;;G06Q30/0633;;G06Q30/0623;;G06Q30/0605,G06Q30/06;;G06F3/0482;;G06N5/04,,0,0,,,,PENDING
144,ES,T3,ES 2029983 T3,127-734-739-726-087,1995-02-16,1995,ES 90904146 T,1990-02-16,US 32484789 A,1989-03-17,"PIEZA POSTIZA DE CORTE DE CARBURO CEMENTADO Y REVESTIDO, MULTICAPA.","SE PROPORCIONA UN ACCESORIO DE INSERCION GRADUABLE PARA CORTAR METAL CON UN SUSTRATO DE CARBURO DE TUNGSTENO CEMENTADO DE COBALTO (32) CON UN RECUBRIMIENTO REFRACTORIO DE CAPAS MULTIPLES EN EL (34). EL SUSTRATO (32) TIENE UN CONTENIDO DE COBALTO DE 6.1 A 6.5% PESO Y SE CARACTERIZA POR UNA DUREZA DE 90.8 A 91.6 ROCKWELL A Y UNA FUERZA COERCIBLE MAGNETICA DE 110 A 180 OERSTEDIOS. EL RECUBRIMIENTO (34) CONTIENE AL MENOS UNA PLURALIDAD DE CAPAS DE ALUMINIO (42) QUE SON SEPARADOS DE Y UNIDOS UNO A OTRO POR UN GRUPO DE NITRURO DE METAL IVB (44), TAL COMO NITRURO DE TITANIO, Y ESTAN UNIDOS AL SUSTRATO (32) POR UNA CAPA DE SOPORTE DE 5 A 8 (MU) EN GROSOR, COMPUESTA DE UN CARBURO Y/O CARBONITRURO DE ZIRCONIO TITANIO Y/O HAFNIO.",KENNAMETAL INC,BRYANT WILLIAM A;;GRAB GEORGE P,,https://lens.org/127-734-739-726-087,Granted Patent,no,0,0,17,19,0,B23B27/14;;B23B27/145;;B23B2228/36;;C23C30/005,B22F7/00;;B22F7/04;;B23B27/14;;C23C16/30;;C23C30/00,,0,0,,,,EXPIRED
145,US,A,US 2839315 A,146-609-087-924-307,1958-06-17,1958,US 47872954 A,1954-12-30,US 47872954 A,1954-12-30,Safety joint with shear pin release means,,ROY L ARTERBURY,ARTERBURY BRYANT P;;CLARK GEORGE M,,https://lens.org/146-609-087-924-307,Granted Patent,no,7,8,1,1,0,E21B17/06;;Y10S285/922;;E21B17/06;;Y10S285/922,E21B17/06,,0,0,,,,EXPIRED
146,CN,U,CN 218000739 U,142-647-001-187-062,2022-12-09,2022,CN 202221844736 U,2022-07-18,US 202117443530 A,2021-07-27,Compression fitting,"The utility model relates to a compression fitting which comprises a nut which is provided with a threaded end used for containing a threaded pipe and a containing end used for containing a plunger head. And a plunger having an inner bore for receiving a capillary tube and the plunger head for engaging a ferrule positioned within the receiving end between the plunger head and the threaded tube, the plunger slidably engaged with the nut to force the ferrule out of the nut.",THERMO FINNIGAN LLC,GUCKENBERG GEORGE B;;BRYANT ANDREW D,,https://lens.org/142-647-001-187-062,Limited Patent,no,0,0,4,4,0,G01N30/6039;;G01N30/6004;;F16L19/0225;;G01N30/16;;F16L19/025;;G01N30/6026,F16L19/025;;F16L33/00;;G01N30/16,,0,0,,,,ACTIVE
147,CA,A1,CA 3188253 A1,153-441-613-542-091,2022-02-17,2022,CA 3188253 A,2021-08-10,US 202016990300 A;;US 2021/0045386 W,2020-08-11,AUGMENTED REALITY INFORMATION DISPLAY AND INTERACTION VIA NFC BASED AUTHENTICATION,"Various embodiments are generally directed to improving card security by providing a user a contactless card with no sensitive card information, such as card number, card verification value, and expiration date, printed thereon, and displaying the sensitive card information relative to the card in augmented reality (AR) based on successful NFC-based user authentication. According to examples, the NFC-based user authentication may be performed by one-tapping or single tapping the contactless card to user mobile device. One or more portions of the sensitive card information may be obfuscated to further enhance card security. Moreover, the user can interact with AR elements including the sensitive card information to perform various actions.",CAPITAL ONE SERVICES LLC,BERGERON GEORGE;;YEE BRYANT;;BULGAKOV MYKHAYLO,,https://lens.org/153-441-613-542-091,Patent Application,no,0,0,11,11,0,G06Q40/02;;H04L9/0861;;H04L2209/805;;H04L9/3242;;G06K7/10297;;H04W12/47;;H04W12/069;;H04W12/02;;H04L63/08;;H04L63/0421;;H04W12/61;;G06F21/35;;H04W12/47;;H04W12/047;;H04W12/65;;G06F3/14;;G06Q20/34;;G06K7/10297;;H04L9/3226;;G06F21/6245;;G06F3/0484;;G06Q40/02;;G06F3/14;;H04L9/0861,H04W12/61;;G06F21/35;;G06Q40/02;;H04W12/02;;H04W12/069;;H04W12/47,,0,0,,,,PENDING
148,AU,A1,AU 2021/325015 A1,147-878-385-688-420,2023-03-09,2023,AU 2021/325015 A,2021-08-10,US 202016990300 A;;US 2021/0045386 W,2020-08-11,Augmented reality information display and interaction via NFC based authentication,"Various embodiments are generally directed to improving card security by providing a user a contactless card with no sensitive card information, such as card number, card verification value, and expiration date, printed thereon, and displaying the sensitive card information relative to the card in augmented reality (AR) based on successful NFC-based user authentication. According to examples, the NFC-based user authentication may be performed by one-tapping or single tapping the contactless card to user mobile device. One or more portions of the sensitive card information may be obfuscated to further enhance card security. Moreover, the user can interact with AR elements including the sensitive card information to perform various actions.",CAPITAL ONE SERVICES LLC,BERGERON GEORGE;;YEE BRYANT;;BULGAKOV MYKHAYLO,,https://lens.org/147-878-385-688-420,Patent Application,no,0,0,11,11,0,G06Q40/02;;H04L9/0861;;H04L2209/805;;H04L9/3242;;G06K7/10297;;H04W12/47;;H04W12/069;;H04W12/02;;H04L63/08;;H04L63/0421;;H04W12/61;;G06F21/35;;H04W12/47;;H04W12/047;;H04W12/65;;G06F3/14;;G06Q20/34;;G06K7/10297;;H04L9/3226;;G06F21/6245;;G06F3/0484;;G06Q40/02;;G06F3/14;;H04L9/0861,H04W12/61;;G06F21/35;;G06K7/10;;G06Q40/02;;H04L9/08;;H04L9/32;;H04W12/02;;H04W12/069;;H04W12/47,,0,0,,,,PENDING
149,AU,A,AU 1987/081280 A,150-078-477-596-059,1988-05-19,1988,AU 1987/081280 A,1987-11-17,US 93200286 A,1986-11-18,HYDROFORMYLATION USING LOW VOLATILE PHOSPHINE LIGANDS,,UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/150-078-477-596-059,Patent Application,no,0,0,53,53,0,C07C45/50;;Y02P20/582;;C07C47/55;;C07C47/02;;C07C45/50;;Y02P20/582,B01J31/24;;B01J31/00;;B01J31/28;;C07B61/00;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00,,0,0,,,,EXPIRED
150,HU,B,HU 199826 B,150-485-901-142-119,1990-03-28,1990,HU 518088 A,1988-10-06,US 10533087 A,1987-10-07,"PROCESS FOR PRODUCTION OF DERIVATIVES OF 3,3-DISUBSTITUATED INDOLINE",,DU PONT,BRYANT WALTER M;;HUHN GEORGE F,"THE DU PONT MERCK PHARMACEUTICAL CO., US (1992-05-28)",https://lens.org/150-485-901-142-119,Granted Patent,no,0,0,22,22,0,C07D401/14;;C07D403/14;;C07D403/06;;C07D401/14;;C07D403/14,C07D401/06;;C07D401/14;;C07D403/06;;C07D403/14;;C07D209/34,,0,0,,,,EXPIRED
151,DE,D1,DE 69225063 D1,191-607-515-421-953,1998-05-14,1998,DE 69225063 T,1992-12-01,US 85775792 A,1992-03-26,Differentialdruck-Gegenschwerkraftgiessen,,GEN MOTORS CORP,CHANDLEY GEORGE D;;CROCKER BRYANT W,,https://lens.org/191-607-515-421-953,Granted Patent,no,0,0,9,9,0,B22D18/06;;B22D27/20;;B22D18/06;;B22D27/20,B22D1/00;;B22D18/06;;B22D27/20,,0,0,,,,EXPIRED
152,US,A1,US 2021/0035105 A1,193-494-435-332-699,2021-02-04,2021,US 202016914619 A,2020-06-29,US 202016914619 A;;US 201916525242 A,2019-07-29,COMPUTER-BASED SYSTEMS AND PLATFORMS AND COMPUTER-IMPLEMENTED METHODS CONFIGURED FOR ONE OR MORE TECHNOLOGICAL APPLICATIONS INVOLVING REDUCTION OF FALSE-POSITIVE FRAUD DETECTION INCIDENTS,"Systems and methods involving computer-based processing for proactively reducing false-positive fraud detection incidents are disclosed. In one embodiment, an exemplary computer-implemented method may comprise: detecting when a subject online transaction matches criteria indicating it is unusual; operating a browser extension application to obtain UI image data and purchase details of an item purchased by a user during the unusual online transaction; evaluating historical transactions of the user to identify a potentially fraudulent online transaction; and executing a false-positive detection routine to determine if the potentially fraudulent online transaction is valid.",CAPITAL ONE SERVICES LLC,YEE BRYANT;;BERGERON GEORGE;;BULGAKOV MYKHAYLO,,https://lens.org/193-494-435-332-699,Patent Application,yes,0,0,3,3,0,H04W4/14;;H04L67/02;;H04L67/10;;G06F9/44526;;G06Q20/4016;;H04L67/535;;H04L67/55;;G06Q20/4016;;G06Q20/3255;;G06Q20/425;;H04L67/10;;H04L67/02;;H04W4/14;;H04L67/55,G06Q20/40;;G06K9/78;;G06Q20/32;;G06Q20/42;;H04L29/08;;H04W4/14,,0,0,,,,ACTIVE
153,NO,L,NO 872887 L,015-854-195-418-638,1988-01-11,1988,NO 872887 A,1987-07-10,US 88419786 A,1986-07-10,HYDROFORMYLERINGSPROSESS VED BRUK AV FOSFINLIGANDER.,,UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/015-854-195-418-638,Abstract,no,0,0,52,52,0,C07C45/50;;C07F9/5004;;Y02P20/582;;C07B41/00;;C07C47/02;;C07C45/50;;C07F9/5004;;Y02P20/582,B01J31/00;;B01J31/24;;C07B61/00;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00;;C07F9/50,,0,0,,,,EXPIRED
154,BR,B1,BR PI0415724 B1,031-267-069-455-036,2015-06-23,2015,BR PI0415724 A,2004-10-22,US 69144703 A;;US 69230403 A;;US 2004/0035201 W,2003-10-22,Cabo reforçado de núcleo de compósito condutor de alumínio,,COMPOSITE TECH CORP,HIEL CLEMENT;;KORZENIOWSKI GEORGE;;BRYANT DAVID,,https://lens.org/031-267-069-455-036,Granted Patent,no,0,0,34,35,0,B29C70/52;;B29L2031/3462;;B32B1/00;;B32B15/02;;B32B15/08;;B32B15/20;;B32B27/04;;H01B5/105;;B29C70/528;;Y10T428/2918;;Y10T428/2933;;Y10T428/2936;;Y10T442/30;;B32B27/04;;B82Y30/00;;Y10T428/2918;;Y10T428/2933;;Y10T428/2936;;Y10T442/30;;B32B2305/08;;B32B2307/54;;B32B27/08;;B32B2457/00;;B29L2031/3462;;B32B1/00;;B29C70/52;;B32B15/02;;B32B15/20;;B32B27/04;;B32B15/08;;H01B5/105;;B29C70/528,B32B27/04;;B05D1/18;;B05D3/02;;B65H/;;D04H3/08,,0,0,,,,INACTIVE
155,WO,A1,WO 2001/004911 A1,024-378-915-136-877,2001-01-18,2001,US 0011811 W,2000-05-01,US 35020099 A,1999-07-08,SEISMIC CONDUCTIVE ROPE LEAD-IN CABLE,"There is provided a conductive rope-like lead-in cable for connecting a seismic streamer to a towing vessel. The lead-in cable comprises a first electrical conductor at the center core of the cable for carrying a first polarity of power to the streamer. A first layer of insulation surrounds the first electrical conductor. A second electrical conductor for carrying a second polarity of power to the streamer surrounds the first layer of insulation. A second layer of insulation surrounds the second electrical conductor. A layer of seismic data conductors for carrying seismic data signals from the streamer surrounds the second layer of insulation. A third layer of insulation surrounds the layer of seismic data conductors. A metallic protective layer surrounds the third layer of insulation for providing cut resistance to the lead-in cable. The second electrical conductor, the first, second, and third layers of insulation, the layer of seismic data conductors, and the metallic protective layer are all concentrically disposed about the longitudinal axis of the first electrical conductor at the center core of the lead-in cable. Steel is effectively and efficiently used both to provide tensile strength and for electrical power conduction, thus eliminating all or much of the copper from the cable without sacrificing tensile and compressive strength.",PGS EXPLORATION US INC,BRYANT MICHAEL J;;GEORGE NICK C,,https://lens.org/024-378-915-136-877,Patent Application,yes,2,6,14,14,0,H01B7/045;;H01B9/003;;H01B9/04;;G01V1/201;;H01B9/003;;H01B7/045;;H01B9/04;;G01V1/201,H01B7/04;;H01B9/00;;H01B9/04,,0,0,,,,PATENTED
156,BR,A,BR 9300222 A,029-127-570-594-949,1993-09-28,1993,BR 9300222 A,1993-01-19,US 85775792 A,1992-03-26,"PROCESSO,APARELHO E MOLDE DE FUNDICAO PARA A FUNDICAO CONTRA A GRAVIDADE,POR PRESSAO DIFERENCIAL,DE UM BANHO DE METAL LIQUIDO",,GEN MOTORS CORP,CHANDLEY GEORGE D;;CROCKER BRYANT W,,https://lens.org/029-127-570-594-949,Patent Application,no,0,0,9,9,0,B22D18/06;;B22D27/20;;B22D18/06;;B22D27/20,B22D1/00;;B22D18/06;;B22D27/20,,0,0,,,,PENDING
157,AU,A,AU 1990/051945 A,044-123-771-964-286,1990-10-22,1990,AU 1990/051945 A,1990-02-16,US 32484789 A,1989-03-17,MULTILAYER COATED CEMENTED CARBIDE CUTTING INSERT,,KENNAMETAL INC,BRYANT WILLIAM A;;GRAB GEORGE P,,https://lens.org/044-123-771-964-286,Patent Application,no,0,0,17,19,0,B23B27/14;;B23B27/145;;B23B2228/36;;C23C30/005,B22F7/00;;B22F7/04;;B23B27/14;;C23C16/30;;C23C30/00,,0,0,,,,EXPIRED
158,CN,A,CN 116697043 A,048-867-831-440-984,2023-09-05,2023,CN 202310163689 A,2023-02-24,US 202263315621 P,2022-03-02,Ferrule sleeve for preventing leakage and jamming of ferrule due to excessive ferrule deformation,"A ferrule is provided that includes a deformable portion and a rigid sleeve surrounding at least a portion of the deformable portion. The deformable portion includes between about 5% and about 50% graphite. The deformable portion also includes between about 50% and about 95% polyimide. The rigid sleeve may comprise a metal, such as stainless steel.",THERMO FINNIGAN LLC,GUCKENBERGER GEORGE B;;BRYANT ASHLEY D,,https://lens.org/048-867-831-440-984,Patent Application,no,0,0,2,2,0,G01N30/7206;;G01N2030/185;;G01N30/18,F16J15/10;;G01N30/02,,0,0,,,,PENDING
159,EP,A1,EP 0073398 A1,052-841-325-507-858,1983-03-09,1983,EP 82107438 A,1982-08-16,US 29318981 A,1981-08-17,Hydroformylation process using a rhodium complex catalyst with triarylphosphine and biphosphine monoxide ligands.,"A rhodium catalyzed hydroformylation process carried out in the presence of free triarylphosphine ligand and free organic tertiary bisphosphine monooxide ligand, and catalytic precursor solutions for said process.",UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/052-841-325-507-858,Patent Application,yes,2,6,9,10,0,B01J31/2495;;B01J31/2495;;B01J31/0267;;B01J31/0267;;B01J31/1875;;B01J31/1875;;B01J31/2404;;B01J31/2404;;B01J31/28;;B01J2231/321;;B01J2231/321;;B01J2531/822;;B01J2531/822;;C07C45/50;;C07C45/50;;C07C45/50,B01J31/00;;B01J31/24;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00,,0,0,,,,EXPIRED
160,BR,A,BR 9001433 A,071-871-748-798-518,1991-04-09,1991,BR 9001433 A,1990-03-19,US 32484789 A,1989-03-17,ENXERTO DE CORTE INDEXAVEL,,KENNAMETAL INC,BRYANT WILLIAM A;;GRAB GEORGE P,,https://lens.org/071-871-748-798-518,Patent Application,no,0,0,17,19,0,B23B27/14;;B23B27/145;;B23B2228/36;;C23C30/005,B22F7/00;;B22F7/04;;B23B27/14;;C23C16/30;;C23C30/00,,0,0,,,,EXPIRED
161,CA,A1,CA 2363883 A1,073-588-760-354-687,2001-01-18,2001,CA 2363883 A,2000-05-01,US 35020099 A;;US 0011811 W,1999-07-08,SEISMIC CONDUCTIVE ROPE LEAD-IN CABLE,"There is provided a conductive rope-like lead-in cable for connecting a seismic streamer to a towing vessel. The lead-in cable comprises a first electrical conductor at the center core of the cable for carrying a first polarity of power to the streamer. A first layer of insulation surrounds the first electrical conductor. A second electrical conductor for carrying a second polarity of power to the streamer surrounds the first layer of insulation. A second layer of insulation surrounds the second electrical conductor. A layer of seismic data conductors for carrying seismic data signals from the streamer surrounds the second layer of insulation. A third layer of insulation surrounds the layer of seismic data conductors. A metall ic protective layer surrounds the third layer of insulation for providing cut resistance to the lead-in cable. The second electrical conductor, the first, second, and third layers of insulation, the layer of seismic data conductors , and the metallic protective layer are all concentrically disposed about the longitudinal axis of the first electrical conductor at the center core of th e lead-in cable. Steel is effectively and efficiently used both to provide tensile strength and for electrical power conduction, thus eliminating all o r much of the copper from the cable without sacrificing tensile and compressiv e strength.",PGS EXPLORATION US INC,GEORGE NICK C;;BRYANT MICHAEL J,,https://lens.org/073-588-760-354-687,Patent Application,no,0,0,14,14,0,H01B7/045;;H01B9/003;;H01B9/04;;G01V1/201;;H01B9/003;;H01B7/045;;H01B9/04;;G01V1/201,H01B7/04;;H01B9/00;;H01B9/04,,0,0,,,,DISCONTINUED
162,PT,B,PT 91385 B,081-744-420-567-768,1995-05-04,1995,PT 9138589 A,1989-08-04,US 22850788 A,1988-08-05,"PROCESSOS APERFEICOADOS, HOMOGENIOS, CATALISADOS COM UM METAL DE TRANSICAO MEDIANTE UTILIZACAO DE CATALISADORES COMPLEXOS A BASE DE LIGANDOS DE FOSFITOS IONICOS E PREPARACAO DOS REFERIDOS CATALISADORES",,UNION CARBIDE CHEM PLASTIC,BRYANT DAVID ROBERT;;ABATJOGLOU ANTHONY GEORGE,,https://lens.org/081-744-420-567-768,Granted Patent,no,0,0,22,23,0,B01J31/185;;B01J31/185;;B01J2231/321;;B01J2231/321;;B01J2531/0266;;B01J2531/0266;;B01J2531/80;;B01J2531/80;;B01J2531/822;;B01J2531/822;;C07F9/165;;C07F9/65746;;C07F9/65746;;C07C45/50;;C07C45/50;;C07F9/65744;;C07F9/65744;;Y02P20/582;;Y02P20/582,B01J31/22;;B01J31/18;;C07B61/00;;C07C45/49;;C07C45/50;;C07C47/02;;C07F9/6574;;C07F9/6578;;C07F9/6584;;C07F9/6596,,0,0,,,,EXPIRED
163,EP,A4,EP 2519322 A4,105-420-702-580-272,2017-10-11,2017,EP 11728550 A,2011-01-03,US 29180409 P;;US 29177909 P;;US 29173209 P;;US 2011/0020052 W,2009-12-31,ULTRASOUND COUPLING DEVICE,,ZETROZ INC,LEWIS JR GEORGE K;;GUFFEY BRYANT,"ZETROZ, INC. (2013-10-23);;ZETROZ SYSTEMS, LLC (2022-04-20)",https://lens.org/105-420-702-580-272,Search Report,no,5,0,32,32,0,A61B8/4281;;A61B17/2251;;A61B2017/2253;;A61N2007/0078;;A61B8/4227;;A61B8/4236;;A61B8/4427;;A61B2017/00734;;A61N2007/006;;A61N2007/0091;;A61N2007/0095;;A61B8/44;;A61N7/00;;Y10T29/49005;;A61B2034/301;;A61B34/30;;A61B2034/303;;A61B2034/107;;A61B34/10;;A61N2007/0034;;Y10T29/49005;;A61B8/4281;;A61B17/2251;;A61B2017/2253;;A61N2007/0078;;A61B8/4227;;A61B8/4236;;A61B2017/00734;;A61N2007/0091;;A61N2007/0095;;A61B8/4427;;A61B8/44;;A61N2007/006;;A61N7/00,A61N7/00;;A61B8/00,,1,0,,,See also references of WO 2011082402A2,ACTIVE
164,AU,A,AU 1989/040198 A,108-456-871-335-474,1990-03-01,1990,AU 1989/040198 A,1989-08-24,US 23622188 A,1988-08-25,TRANSITION METAL RECOVERY,,UNION CARBIDE CHEM PLASTIC,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/108-456-871-335-474,Patent Application,no,0,0,15,15,0,B01J31/24;;B01J31/24;;B01J31/185;;B01J31/185;;B01J31/20;;B01J31/20;;B01J31/2234;;B01J31/2234;;B01J31/2404;;B01J31/2404;;B01J31/2409;;B01J31/2409;;B01J31/4023;;B01J31/4023;;B01J31/4046;;B01J31/4046;;B01J31/4053;;B01J31/4053;;B01J39/12;;B01J39/12;;B01J2231/321;;B01J2231/321;;B01J2531/02;;B01J2531/0211;;B01J2531/0211;;B01J2531/80;;B01J2531/80;;B01J2531/822;;B01J2531/822;;B01J2531/985;;B01J2531/985;;B01J2540/12;;B01J2540/12;;B01J2540/32;;B01J2540/32;;B01J2540/42;;B01J2540/42;;B01J2540/525;;B01J2540/525;;B01J2540/68;;B01J2540/68;;C01G55/00;;C01G55/001;;C01G55/001;;C07C45/50;;C07C45/50;;C07C45/79;;C07C45/79;;C22B3/42;;C22B3/42;;Y02P10/20;;Y02P10/20;;Y02P20/584;;Y02P20/584,B01D15/04;;B01J31/40;;B01J39/12;;B01J45/00;;C01G55/00;;C02F1/42;;C02F101/10;;C02F103/36;;C07C45/50;;C07C45/79;;C22B3/00,,0,0,,,,EXPIRED
165,EP,A2,EP 0254937 A2,097-296-431-739-259,1988-02-03,1988,EP 87110014 A,1987-07-10,US 88419786 A,1986-07-10,Hydroformylation using low volatile/organic soluble phosphine ligands.,"A nonaqueous hydroformylation process for producing aldehydes using low volatile, organic soluble monosulfonated tertiary phosphine salt ligands.",UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/097-296-431-739-259,Patent Application,yes,0,13,52,52,0,C07C45/50;;C07F9/5004;;Y02P20/582;;C07B41/00;;C07C47/02;;C07C45/50;;C07F9/5004;;Y02P20/582,B01J31/00;;B01J31/24;;C07B61/00;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00;;C07F9/50,,0,0,,,,EXPIRED
166,CA,A1,CA 2543111 A1,100-777-304-599-98X,2005-05-06,2005,CA 2543111 A,2004-10-22,US 69144703 A;;US 69230403 A;;US 2004/0035201 W,2003-10-22,ALUMINUM CONDUCTOR COMPOSITE CORE REINFORCED CABLE AND METHOD OF MANUFACTURE,,COMPOSITE TECH CORP,HIEL CLEMENT;;KORZENIOWSKI GEORGE;;BRYANT DAVID,,https://lens.org/100-777-304-599-98X,Patent Application,no,0,0,34,35,0,B29C70/52;;B29L2031/3462;;B32B1/00;;B32B15/02;;B32B15/08;;B32B15/20;;B32B27/04;;H01B5/105;;B29C70/528;;Y10T428/2918;;Y10T428/2933;;Y10T428/2936;;Y10T442/30;;B32B27/04;;B82Y30/00;;Y10T428/2918;;Y10T428/2933;;Y10T428/2936;;Y10T442/30;;B32B2305/08;;B32B2307/54;;B32B27/08;;B32B2457/00;;B29L2031/3462;;B32B1/00;;B29C70/52;;B32B15/02;;B32B15/20;;B32B27/04;;B32B15/08;;H01B5/105;;B29C70/528,B32B27/04;;B05D1/18;;B05D3/02;;B65H/;;D04H3/08,,0,0,,,,ACTIVE
167,MX,B,MX 164441 B,100-334-078-000-488,1992-08-13,1992,MX 1708589 A,1989-08-04,US 22850788 A,1988-08-05,FOSFITOS IONICOS Y SU USO EN PROCEDIMIENTOS HOMOGENEOS CATALIZADOS CON METAL DE TRANSICION,,UNION CARBIDE CHEM PLASTIC,BRYANT DAVID ROBERT;;ABATJOGLOU ANTHONY GEORGE,,https://lens.org/100-334-078-000-488,Granted Patent,no,0,0,22,23,0,B01J31/185;;B01J31/185;;B01J2231/321;;B01J2231/321;;B01J2531/0266;;B01J2531/0266;;B01J2531/80;;B01J2531/80;;B01J2531/822;;B01J2531/822;;C07F9/165;;C07F9/65746;;C07F9/65746;;C07C45/50;;C07C45/50;;C07F9/65744;;C07F9/65744;;Y02P20/582;;Y02P20/582,B01J31/22;;B01J31/18;;C07B61/00;;C07C45/49;;C07C45/50;;C07C47/02;;C07F9/6574;;C07F9/6578;;C07F9/6584;;C07F9/6596,,0,0,,,,EXPIRED
168,AU,B2,AU 559430 B2,120-838-469-954-398,1987-03-12,1987,AU 1982/081256 A,1982-03-10,US 24308281 A,1981-03-12,PROCESS FOR REMOVING HYDROPEROXIDES AND ALDEHYDES FROM ALLYL ALKYL ETHERS,"Described herein is a process for the conversion of hydroperoxides, present in alkyl-alkyl ethers to products including alpha , beta -unsaturated aldehydes and for reducing such alpha , beta -unsaturated aldehydes to alcohols prior to the use of the ether as a feedstock in a hydroformylation reaction to produce the corresponding ether aldehyde. The process involves contacting the ether with a metal hydride, either in aqueous solution and/or by means of an ion exchange resin. Such treatment decomposes the hydroperoxides and then reduces their alpha , beta -unsaturated aldehyde decomposition products, thereby reducing the catalyst inhibition period present in the hydroformylation reaction which is observed when such alpha , beta -unsaturated aldehyde impurities are present.",UNION CARBIDE CORP,ABATIOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/120-838-469-954-398,Granted Patent,no,0,0,16,17,0,C07C29/175;;C07C31/10;;C07C41/36;;C07C41/44;;C07C45/53;;C07C45/62;;C07C43/00,C07C43/18;;C07C29/17;;C07C31/10;;C07C41/00;;C07C41/34;;C07C41/36;;C07C41/44;;C07C43/00;;C07C43/15;;C07C43/188;;C07C45/53;;C07C45/62;;C07C67/00,,0,0,,,,EXPIRED
169,EP,A1,EP 4197214 A1,133-566-813-546-074,2023-06-21,2023,EP 21763461 A,2021-08-10,US 202016990300 A;;US 2021/0045386 W,2020-08-11,AUGMENTED REALITY INFORMATION DISPLAY AND INTERACTION VIA NFC BASED AUTHENTICATION,,CAPITAL ONE SERVICES LLC,BERGERON GEORGE;;YEE BRYANT;;BULGAKOV MYKHAYLO,,https://lens.org/133-566-813-546-074,Patent Application,yes,0,0,11,11,0,G06Q40/02;;H04L9/0861;;H04L2209/805;;H04L9/3242;;G06K7/10297;;H04W12/47;;H04W12/069;;H04W12/02;;H04L63/08;;H04L63/0421;;H04W12/61;;G06F21/35;;H04W12/47;;H04W12/047;;H04W12/65;;G06F3/14;;G06Q20/34;;G06K7/10297;;H04L9/3226;;G06F21/6245;;G06F3/0484;;G06Q40/02;;G06F3/14;;H04L9/0861,H04W12/61,,0,0,,,,PENDING
170,DE,B,DE 1247642 B,140-593-245-230-836,1967-08-07,1967,DE U0011613 A,1963-04-23,US 18930362 A;;US 18930462 A;;US 18931362 A,1962-04-23,Formmassen aus Polyolefinen,,UNION CARBIDE CORP,BRYANT GEORGE MACON;;ZUTTY NATHAN LEWIS,,https://lens.org/140-593-245-230-836,Patent Application,no,3,0,11,20,0,C08L23/02;;C08L23/10;;C08L23/12;;C08L33/26;;C08L39/04;;D06P3/79;;D06P3/79;;C08L33/26;;C08L23/10;;C08L23/12;;C08L39/04;;C08L23/02;;Y10S8/928;;Y10S8/09,C08L23/02;;C08L23/12;;C08L33/26;;C08L39/04;;D06P3/79,,0,0,,,,DISCONTINUED
171,DK,T3,DK 0832883 T3,156-645-335-631-804,2002-06-17,2002,DK 97307498 T,1997-09-25,US 2675296 P,1996-09-26,Tetrahydrobenzo(a)fluorenforbindelser og fremgangsmåder til anvendelse,"The invention provides tetrahydrobenzoÄaÜfluorene compounds, formulations, and methods of inhibiting bone loss or bone resorption, particularly osteoporosis, and cardiovascular-related pathological conditions, including hyperlipidemia.",LILLY CO ELI,BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH,,https://lens.org/156-645-335-631-804,Granted Patent,no,0,0,11,11,0,A61K31/565;;A61K31/57;;C07C217/18;;C07D295/088;;C07C2603/40;;A61P19/10;;A61P3/06;;A61P43/00;;A61P9/00;;C07D295/088;;A61K31/565;;C07C217/18;;A61K31/57;;C07C2603/40,C07D295/08;;A61K31/135;;A61K31/40;;A61K31/445;;A61K31/55;;A61K31/565;;A61K31/57;;A61P3/06;;A61P9/00;;A61P19/10;;A61P43/00;;C07C217/18;;C07C309/65;;C07D207/06;;C07D295/092;;C07J69/00,,0,0,,,,EXPIRED
172,EP,B1,EP 0562170 B1,167-424-167-125-08X,1998-04-08,1998,EP 92120474 A,1992-12-01,US 85775792 A,1992-03-26,"Differential pressure, countergravity casting",,GEN MOTORS CORP,CHANDLEY GEORGE D;;CROCKER BRYANT W,,https://lens.org/167-424-167-125-08X,Granted Patent,yes,8,0,9,9,0,B22D18/06;;B22D27/20;;B22D18/06;;B22D27/20,B22D1/00;;B22D18/06;;B22D27/20,,0,0,,,,EXPIRED
173,HU,B,HU 202468 B,171-827-628-651-738,1991-03-28,1991,HU 316387 A,1987-07-10,US 88419786 A,1986-07-10,IMPROVED FORHYDROFORMILIZING PROCESS FOR PRODUCING ALDEHYDES IN NONAQUOUS MEDIUM WITH UTILIZING HARDLY VOLATILE PHOSPHOROUS LIGUANDES,,UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/171-827-628-651-738,Granted Patent,no,0,0,52,52,0,C07C45/50;;C07F9/5004;;Y02P20/582;;C07B41/00;;C07C47/02;;C07C45/50;;C07F9/5004;;Y02P20/582,B01J31/00;;B01J31/24;;C07C45/00;;C07B61/00;;C07C45/50;;C07C47/02;;C07C67/00;;C07F9/50,,0,0,,,,EXPIRED
174,US,B2,US 11636276 B2,165-574-496-006-568,2023-04-25,2023,US 202117342969 A,2021-06-09,US 202117342969 A;;US 202016990300 A,2020-08-11,Augmented reality information display and interaction via NFC based authentication,"Various embodiments are generally directed to improving card security by providing a user a contactless card with no sensitive card information, such as card number, card verification value, and expiration date, printed thereon, and displaying the sensitive card information relative to the card in augmented reality (AR) based on successful NFC-based user authentication. According to examples, the NFC-based user authentication may be performed by one-tapping or single tapping the contactless card to user mobile device. One or more portions of the sensitive card information may be obfuscated to further enhance card security. Moreover, the user can interact with AR elements including the sensitive card information to perform various actions.",CAPITAL ONE SERVICES LLC,BERGERON GEORGE;;YEE BRYANT;;BULGAKOV MYKHAYLO,CAPITAL ONE SERVICES LLC (2020-08-10),https://lens.org/165-574-496-006-568,Granted Patent,yes,8,0,11,11,0,G06Q40/02;;H04L9/0861;;H04L2209/805;;H04L9/3242;;G06K7/10297;;H04W12/47;;H04W12/069;;H04W12/02;;H04L63/08;;H04L63/0421;;H04W12/61;;G06F21/35;;H04W12/47;;H04W12/047;;H04W12/65;;G06F3/14;;G06Q20/34;;G06K7/10297;;H04L9/3226;;G06F21/6245;;G06F3/0484;;G06Q40/02;;G06F3/14;;H04L9/0861,G06K7/10;;G06F3/0484;;G06F3/14;;G06F21/62;;G06Q40/02;;H04L9/08;;H04L9/32,,1,0,,,"International Search Report and Written Opinion for International Patent Application No. PCT/US2021/045386 dated Oct. 28, 2021, 12 pages.",ACTIVE
175,US,B2,US 11836769 B2,168-702-236-498-79X,2023-12-05,2023,US 202318188827 A,2023-03-23,US 202318188827 A;;US 202117644104 A;;US 202016991347 A,2020-08-12,Methods and systems for providing estimated transactional data,"A computer-implemented method for providing an estimated utility expenditure to a user may include: obtaining, via one or more processors, historical transactional data of one or more customers other than the user from one or more transactional entities, wherein the historical transactional data includes: at least one address of a given customer of the one or more customers; and a historical utility expenditure associated with the at least one address; generating, via the one or more processors, a heatmap based on the historical transactional data of the one or more customers via one or more algorithms, wherein the heatmap is indicative of at least the estimated utility expenditure associated with the at least one address during a predetermined period; and causing a display of a user device associated with the user to demonstrate the heatmap.",CAPITAL ONE SERVICES LLC,YEE BRYANT;;BERGERON GEORGE;;BULGAKOV MYKHAYLO,CAPITAL ONE SERVICES LLC (2020-08-12),https://lens.org/168-702-236-498-79X,Granted Patent,yes,13,0,6,6,0,G06Q50/06;;H02J13/00001;;H02J3/003;;Y04S10/40;;Y04S10/50;;H02J3/003;;H02J13/00001;;G06Q50/06;;H02J2203/20;;H02J13/00034;;G06Q30/0283,G06Q30/0283;;G06Q50/06,,0,0,,,,ACTIVE
176,EP,A1,EP 0761679 A1,179-891-102-321-803,1997-03-12,1997,EP 96306196 A,1996-08-27,US 295995 P,1995-08-30,N-Butylsulfonate esters of estrogens,"The present invention provides
   wherein
 X is α-CH 2 OR 1  when A is α-hydro, A and B together are ethylene, and C and D together are ethylene, β-CH 2 OR 1 , or -CO-; R is -H or n-butylsulfonoyl; R 1  is R provided that at least one of R and R 1  must be n-butylsulfonoyl; R 2  is -H, α- or β-hydroxy, or α- or β-n-butylsulfonoyl; A is
  B is
  C is -CH 2  or
   and D is -CH 2  or
   methods of inhibiting estrogen deficient patholigies, and pharmaceutical formulations.",LILLY CO ELI,BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH,,https://lens.org/179-891-102-321-803,Patent Application,yes,2,2,3,3,0,C07J31/006,C07J31/00,,2,2,108-601-792-247-79X;;134-378-353-036-10X,1135241;;1135245,"S. SCHWARZ ET AL: ""Steroide. 15. Mitteilung: Sulfonyloxyderivate von Östrogenen"", PHARMAZIE, vol. 30, no. 1, January 1975 (1975-01-01), BERLIN DE, pages 17 - 21, XP002019029;;W. STÖLZNER ET AL: ""Untersuchungen zur Dissoziation zwischen antigonadotrophen und interzeptiven Aktivitäten ausgewählter Östratrienderivate"", PHARMAZIE, vol. 30, no. 1, January 1975 (1975-01-01), BERLIN DE, pages 52 - 53, XP002019030",DISCONTINUED
177,IT,A0,IT 8025625 A0,179-221-051-412-162,1980-10-29,1980,IT 2562580 A,1980-10-29,US 9018479 A,1979-11-01,METODO ED APPARECCHIO DI FUCINATURA.,,UNITED TECHNOLOGIES CORP,MACNITT DONALD GEORGE;;WALKER BRYANT HARDING,,https://lens.org/179-221-051-412-162,Patent Application,no,0,0,30,35,0,B21J5/02;;B21J9/02;;B21J13/02;;B21K1/36;;B21K29/00;;Y10T29/49336;;Y10T29/49336;;B21J5/02;;B21K1/36;;B21J9/02;;B21J13/02;;B21K29/00,B21J5/02;;B21J9/02;;B21J13/02;;B21K1/36;;B21K3/04,,0,0,,,,EXPIRED
178,US,B1,US 11233396 B1,189-010-067-145-954,2022-01-25,2022,US 202016991347 A,2020-08-12,US 202016991347 A,2020-08-12,Methods and systems for providing an estimated utility expenditure,"A computer-implemented method for providing an estimated utility expenditure to a user may include: obtaining, via one or more processors, historical transactional data of one or more customers other than the user from one or more transactional entities, wherein the historical transactional data includes: at least one address of a given customer of the one or more customers; and a historical utility expenditure associated with the at least one address; generating, via the one or more processors, a heatmap based on the historical transactional data of the one or more customers via one or more algorithms, wherein the heatmap is indicative of at least the estimated utility expenditure associated with the at least one address during a predetermined period; and causing a display of a user device associated with the user to demonstrate the heatmap.",CAPITAL ONE SERVICES LLC,YEE BRYANT;;BERGERON GEORGE;;BULGAKOV MYKHAYLO,CAPITAL ONE SERVICES LLC (2020-08-12),https://lens.org/189-010-067-145-954,Granted Patent,yes,10,0,6,6,0,G06Q50/06;;H02J13/00001;;H02J3/003;;Y04S10/40;;Y04S10/50;;H02J3/003;;H02J13/00001;;G06Q50/06;;H02J2203/20;;H02J13/00034;;G06Q30/0283,H02J3/00;;G06Q50/06;;H02J13/00,,0,0,,,,ACTIVE
179,CN,A,CN 1041947 A,198-204-555-117-567,1990-05-09,1990,CN 89107766 A,1989-08-04,US 22850788 A,1988-08-05,PREPARATION OF IONIC PHOSPHITES AND THEIR USE IN HOMOGENEOUS TRANSITION METAL CATALYZED PROCESS,,UNION CARBIDE CHEM PLASTIC,GEORGE ABATJOGLOU ANTHONY;;ROBERT BRYANT DAVID,,https://lens.org/198-204-555-117-567,Patent Application,no,0,2,22,23,0,B01J31/185;;B01J31/185;;B01J2231/321;;B01J2231/321;;B01J2531/0266;;B01J2531/0266;;B01J2531/80;;B01J2531/80;;B01J2531/822;;B01J2531/822;;C07F9/165;;C07F9/65746;;C07F9/65746;;C07C45/50;;C07C45/50;;C07F9/65744;;C07F9/65744;;Y02P20/582;;Y02P20/582,B01J31/22;;B01J31/18;;C07B61/00;;C07C45/49;;C07C45/50;;C07C47/02;;C07F9/6574;;C07F9/6578;;C07F9/6584;;C07F9/6596,,0,0,,,,EXPIRED
180,NO,D0,NO 20024039 D0,007-222-873-664-446,2002-08-23,2002,NO 20024039 A,2002-08-23,US 51442300 A;;US 0103550 W,2000-02-28,Elektrisk kabelinnföring,,PGS EXPLORATION US INC,GEORGE NICK C;;BRYANT MICHAEL JOHN,,https://lens.org/007-222-873-664-446,Patent Application,no,0,0,9,9,0,H01R13/523;;H01R13/523;;H01R13/5208;;H01R13/5208;;H01R31/06;;H01R31/06,H01R13/52;;H01R13/523;;H01R31/06,,0,0,,,,EXPIRED
181,NO,D0,NO 872887 D0,008-250-622-735-726,1987-07-10,1987,NO 872887 A,1987-07-10,US 88419786 A,1986-07-10,HYDROFORMYLERINGSPROSESS VED BRUK AV FOSFINLIGANDER.,,UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/008-250-622-735-726,Patent Application,no,0,0,52,52,0,C07C45/50;;C07F9/5004;;Y02P20/582;;C07B41/00;;C07C47/02;;C07C45/50;;C07F9/5004;;Y02P20/582,B01J31/00;;B01J31/24;;C07B61/00;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00;;C07F9/50,,0,0,,,,EXPIRED
182,EP,A2,EP 0353770 A2,009-044-511-463-27X,1990-02-07,1990,EP 89114453 A,1989-08-04,US 22850788 A,1988-08-05,Ionic phosphites and their use in homogeneous transition metal catalyzed processes.,"This invention relates to novel ionic phosphites and the use thereof as ligands in homogenous transition metal catalyzed pro­cesses, especially hydroformylation.  ",UNION CARBIDE CHEM PLASTIC,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/009-044-511-463-27X,Patent Application,yes,0,18,22,23,0,B01J31/185;;B01J31/185;;B01J2231/321;;B01J2231/321;;B01J2531/0266;;B01J2531/0266;;B01J2531/80;;B01J2531/80;;B01J2531/822;;B01J2531/822;;C07F9/165;;C07F9/65746;;C07F9/65746;;C07C45/50;;C07C45/50;;C07F9/65744;;C07F9/65744;;Y02P20/582;;Y02P20/582,B01J31/22;;B01J31/18;;C07B61/00;;C07C45/49;;C07C45/50;;C07C47/02;;C07F9/6574;;C07F9/6578;;C07F9/6584;;C07F9/6596,,0,0,,,,EXPIRED
183,FI,A0,FI 861218 A0,020-850-778-605-841,1986-03-21,1986,FI 861218 A,1986-03-21,US 71472285 A,1985-03-22,FOERFARANDE FOER BEHANDLING AV VAOTT PAPPER MED SKUM.,"Specifically structured foamed compositions of paper treating agents applied to wet paper, such as wet-end paper web produced during high speed paper manufacture, provide uniform treating agent distribution and treated paper having properties comparable to dry-processed paper.",UNION CARBIDE CORP,BRYANT GEORGE MACON;;BROWN RUSSEL LEE,,https://lens.org/020-850-778-605-841,Patent Application,no,0,0,10,10,0,D21H21/56;;D21H23/26,D21H17/35;;D21H17/03;;D21H19/00;;D21H21/56;;D21H23/26,,0,0,,,,DISCONTINUED
184,EP,B1,EP 0073398 B1,087-567-208-828-215,1984-12-19,1984,EP 82107438 A,1982-08-16,US 29318981 A,1981-08-17,HYDROFORMYLATION PROCESS USING A RHODIUM COMPLEX CATALYST WITH TRIARYLPHOSPHINE AND BIPHOSPHINE MONOXIDE LIGANDS,,UNION CARBIDE CORPORATION,"ABATJOGLOU, ANTHONY GEORGE;;BRYANT, DAVID ROBERT",,https://lens.org/087-567-208-828-215,Granted Patent,yes,2,0,9,10,0,B01J31/2495;;B01J31/2495;;B01J31/0267;;B01J31/0267;;B01J31/1875;;B01J31/1875;;B01J31/2404;;B01J31/2404;;B01J31/28;;B01J2231/321;;B01J2231/321;;B01J2531/822;;B01J2531/822;;C07C45/50;;C07C45/50;;C07C45/50,B01J31/00;;B01J31/24;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00,,0,0,,,,EXPIRED
185,ES,T1,ES 2029983 T1,113-195-435-620-672,1992-10-16,1992,ES 90904146 T,1990-02-16,US 32484789 A,1989-03-17,PIEZA DE CORTE POSTIZA DE CARBURO CEMENTADO Y REVESTIDO MULTICAPA.,"SE PROPORCIONA UN ACCESORIO DE INSERCION GRADUABLE PARA CORTAR METAL CON UN SUSTRATO DE CARBURO DE TUNGSTENO CEMENTADO DE COBALTO (32) CON UN RECUBRIMIENTO REFRACTORIO DE CAPAS MULTIPLES EN EL (34). EL SUSTRATO (32) TIENE UN CONTENIDO DE COBALTO DE 6.1 A 6.5% PESO Y SE CARACTERIZA POR UNA DUREZA DE 90.8 A 91.6 ROCKWELL A Y UNA FUERZA COERCIBLE MAGNETICA DE 110 A 180 OERSTEDIOS. EL RECUBRIMIENTO (34) CONTIENE AL MENOS UNA PLURALIDAD DE CAPAS DE ALUMINIO (42) QUE SON SEPARADOS DE Y UNIDOS UNO A OTRO POR UN GRUPO DE NITRURO DE METAL IVB (44), TAL COMO NITRURO DE TITANIO, Y ESTAN UNIDOS AL SUSTRATO (32) POR UNA CAPA DE SOPORTE DE 5 A 8 (MU) EN GROSOR, COMPUESTA DE UN CARBURO Y/O CARBONITRURO DE ZIRCONIO TITANIO Y/O HAFNIO.",KENNAMETAL INC.,"BRYANT, WILLIAM, A.;;GRAB, GEORGE, P.",,https://lens.org/113-195-435-620-672,Patent Application,no,0,0,17,19,0,B23B27/14;;B23B27/145;;B23B2228/36;;C23C30/005,B22F7/00;;B22F7/04;;B23B27/14;;C23C16/30;;C23C30/00,,0,0,,,,EXPIRED
186,US,A1,US 2002/0193187 A1,126-237-675-939-548,2002-12-19,2002,US 88123701 A,2001-06-15,US 88123701 A,2001-06-15,Snap Bat,"
   The Snap Bat is a light weight, hitting training aid, for both baseball and fastpitch softball. It allows the hitter and the instructor or parent to clearly hear if full extension is developed at the proper point of ball contact in a fundamentally sound swing. Poor swings, such as sweeping or casting will not produce a snap or the snap will clearly too early or too late. In addition, the Snap Bat can also demonstrate advanced hitting techniques, e.g. hitting to the opposite field or pulling the ball. This means that full extension and ball contact takes place either slightly later in the swing (opposite field) or slightly earlier in the swing (pulling the ball). Both the hitter and the instructor or parent can clearly hear the snapping sound and thus accurately analyze each swing. The light weight allows for unlimited repetition, thus developing a muscle memory teaching point for hitters. The device is not designed to make contact with a pitched ball. It is for practice swings only. 
",BICKEL WILLIAM GEORGE;;GOODWILLIE MARK BRYANT,BICKEL WILLIAM GEORGE;;GOODWILLIE MARK BRYANT,,https://lens.org/126-237-675-939-548,Patent Application,yes,9,11,1,1,0,A63B69/0002;;A63B69/0002;;A63B2069/0008;;A63B2069/0008;;A63B2071/0625;;A63B2071/0625,A63B69/00,473/457,0,0,,,,DISCONTINUED
187,AU,B2,AU 605773 B2,160-048-711-194-791,1991-01-24,1991,AU 1987/075531 A,1987-07-10,US 88419786 A,1986-07-10,HYDROFORMYLATION USING LOW VOLATILE/ORGANIC SOLUBLE PHOSPHINE LIGANDS,,UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/160-048-711-194-791,Granted Patent,no,3,0,52,52,0,C07C45/50;;C07F9/5004;;Y02P20/582;;C07B41/00;;C07C47/02;;C07C45/50;;C07F9/5004;;Y02P20/582,C07B61/00;;B01J31/00;;B01J31/24;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00;;C07F9/50,,0,0,,,,EXPIRED
188,AP,A,AP 2251 A,156-578-072-381-593,2011-07-20,2011,AP 2006003610 A,2004-10-22,US 69144703 A;;US 69230403 A;;US 2004/0035201 W,2003-10-22,Aluminium conductor composite core reinforced cable and method of manufacture.,,CTC CABLE CORP,HIEL CLEMENT;;KORZENIOWSKI GEORGE;;BRYANT DAVID,,https://lens.org/156-578-072-381-593,Granted Patent,no,4,0,34,35,0,B29C70/52;;B29L2031/3462;;B32B1/00;;B32B15/02;;B32B15/08;;B32B15/20;;B32B27/04;;H01B5/105;;B29C70/528;;Y10T428/2918;;Y10T428/2933;;Y10T428/2936;;Y10T442/30;;B32B27/04;;B82Y30/00;;Y10T428/2918;;Y10T428/2933;;Y10T428/2936;;Y10T442/30;;B32B2305/08;;B32B2307/54;;B32B27/08;;B32B2457/00;;B29L2031/3462;;B32B1/00;;B29C70/52;;B32B15/02;;B32B15/20;;B32B27/04;;B32B15/08;;H01B5/105;;B29C70/528,B05D1/18;;B05D3/02;;B32B27/04;;B65H/;;D04H3/08,,0,0,,,,ACTIVE
189,RO,B1,RO 99618 B1,168-139-879-663-162,1990-08-30,1990,RO 13049787 A,1987-11-18,RO 13049787 A,1987-11-18,PROCESS FOR PREPARING ALDEHYDES BY HYDROFORMYLATING OLEFINS IN NON-AQUEOUS MEDIUM,"Inventia se refera la un procedeu de preparare a aldehidelor, prin hidroformitarea în mediu neapos a unui compus olefinic cu 3 ... 14 atomi de carbon, cu monoxid de carbon si hidrogen, în prezenta unui catalizator complex ligand al fosforului cu rodiu solubilizat si ligand liber, care foloseste ca ligand al fosforului din complexul catalitic si ligand al fosforului liber o sare metalica a monosulfonat tertiar fosfinei cu formula generala I: (formula generala I) în care fiecare grupare individuala R reprezinta grupul alchil cu 3 la 9 atomi de carbon ramificat, fenil sau ciclohexil, M este un metal, ales dintre Li, Na, K, Pb, Cs, Ca, Ba si n este 1 sau 2, corespunzator valentei, mediul de reactie contine un agent de solubilizare, ales dintre maximum 35% oligomer de oxid de alchilena de M &lt; 150, 60% agent de suprafata neionic, constând din alcooletoxilat, maximum 60% compus organic polar, ales dintre metanol, iropropanol, dimetilsulfoxid, N-metilpirolidona, benzonitril si sulfolan sau maximum 60% amestecurile acestor agenti de solubilizare, reactia are loc la o temperatura de 45 ... 200 degree C si presiune totala a gazelor hidrogen, oxid de carbon si compusul olefinic nesaturat de minimum 35 kg/cm patrat, o presiune partiala a oxidului de carbon de la 0,07 la 8,4 kg/cm patrat si o presiune partiala a hidrogenului de la 0,7 la 11,2 kg/cm patrat si la un continut de minimum 2 moli ligand liber total al fosforului sau mol rodiu.",UNION CARBIDE CORP,ANTHONY GEORGE ABATJOGLOU;;DAVID ROBERT BRYANT,,https://lens.org/168-139-879-663-162,Unknown,no,0,0,1,1,0,,C07C45/50,,0,0,,,,DISCONTINUED
190,US,A1,US 2010/0163275 A1,170-099-117-989-658,2010-07-01,2010,US 71969510 A,2010-03-08,US 71969510 A;;US 59545907 A;;US 2004/0035201 W;;US 69230403 A;;US 69144703 A,2003-10-22,COMPOSITE CORE FOR AN ELECTRICAL CABLE,"This invention relates to an aluminum conductor composite core reinforced cable (ACCC) and method of manufacture. An ACCC cable ( 300 ) has a composite core and at least one layer of aluminum conductor ( 306 ). The composite core (303) comprises a plurality of fibers from at least one fiber type in one or more matrix materials. According to the invention, unique processing techniques such a B-Staging and/or film-coating techniques can be used to increase production rates from a few feet per minute to sixty or more feet per minute.",CTC CABLE CORP,HIEL CLEMENT;;BRYANT DAVID;;KORZENIOWSKI GEORGE,CTC GLOBAL CORPORATION (2012-07-03);;CTC CABLE CORPORATION (2006-07-14),https://lens.org/170-099-117-989-658,Patent Application,yes,28,28,34,35,0,B29C70/52;;B29L2031/3462;;B32B1/00;;B32B15/02;;B32B15/08;;B32B15/20;;B32B27/04;;H01B5/105;;B29C70/528;;Y10T428/2918;;Y10T428/2933;;Y10T428/2936;;Y10T442/30;;B32B27/04;;B82Y30/00;;Y10T428/2918;;Y10T428/2933;;Y10T428/2936;;Y10T442/30;;B32B2305/08;;B32B2307/54;;B32B27/08;;B32B2457/00;;B29L2031/3462;;B32B1/00;;B29C70/52;;B32B15/02;;B32B15/20;;B32B27/04;;B32B15/08;;H01B5/105;;B29C70/528,H01B5/10;;B05D1/18;;B05D3/02;;B32B5/12;;B32B27/04;;B65H/;;D02G3/02;;D02G3/36;;D03D25/00;;D04C1/00;;D04H3/08;;H01B9/00;;H01B17/14,174124 R;;174/68.1;;174/130;;428/375;;428/367;;428/377;;442/181,2,0,,,"Vaughan et al., Characterization of Mechanical and Thermal Properties of Advanced Composite Pultrusions, 1995;;Papineni et al., Study of Static Mechanical Properties of Pultruded Hybrid Graphite/Glass-Epoxy Composites, 1994",DISCONTINUED
191,AU,A1,AU 2022/297539 A1,197-911-846-269-102,2024-01-04,2024,AU 2022/297539 A,2022-06-24,US 202117358473 A;;US 2022/0034863 W,2021-06-25,CRYPTOGRAPHIC AUTHENTICATION TO CONTROL ACCESS TO STORAGE DEVICES,,CAPITAL ONE SERVICES LLC,YEE BRYANT;;BULGAKOV MYKHAYLO;;BERGERON GEORGE,,https://lens.org/197-911-846-269-102,Patent Application,no,0,0,5,5,0,G06F21/44;;G06F21/78;;G06F2221/2105;;H04W12/069;;G06F3/0622;;G06F3/0655;;G06F3/0679;;G06F13/4282;;G06F2213/0042;;H04L9/3226;;H04L9/3234;;H04L2209/805,G06F21/44;;G06F21/78;;H04W12/069,,0,0,,,,PENDING
192,US,A,US 1969201 A,001-643-152-929-122,1934-08-07,1934,US 59958832 A,1932-03-17,US 59958832 A,1932-03-17,Removal of wax from hydrocarbon oils,,INDIAN REFINING CO,BRYANT GEORGE R;;GOVERS FRANCIS X,,https://lens.org/001-643-152-929-122,Granted Patent,no,0,0,1,1,0,C10G73/06;;C10G73/06,C10G73/06,,0,0,,,,EXPIRED
193,US,A1,US 2024/0073215 A1,007-379-716-352-049,2024-02-29,2024,US 202217899081 A,2022-08-30,US 202217899081 A,2022-08-30,COMPUTER-BASED SYSTEMS INVOLVING SHARING SESSION AUTHENTICATION AND/OR ACCOUNT DETAILS WITH A TRUSTED PARTY AND METHODS OF USE THEREOF,"Systems and methods associated with sharing encrypted account details with a trusted party are disclosed. In one embodiment, an exemplary method may comprise hosting an online service accessed by a plurality of user accounts each configured for concurrent access sessions, establishing a first authenticated access session for a first user account between the online service and a first device associated with a first user, receiving a login request associated with the first user account to establish a second authenticated access session between the online service and a second device associated with a second user, transmitting, to the first device, a notification of the login request including a GUI element and a request to authenticate the login request, and establishing the second authenticated access session between the online service and the second device of the second user based on authentication of the second user via the GUI element.",CAPITAL ONE SERVICES LLC,YEE BRYANT;;BERGERON GEORGE;;BULGAKOV MYKHAYLO,,https://lens.org/007-379-716-352-049,Patent Application,yes,0,0,1,1,0,H04L63/102;;H04L63/20;;H04L63/0876,H04L9/40,,0,0,,,,PENDING
194,NO,B1,NO 330430 B1,008-119-188-843-308,2011-04-11,2011,NO 20015191 A,2001-10-24,US 35020099 A;;US 0011811 W,1999-07-08,Seismisk ledende repinnforingskabel,A conductive rope-like lead-in cable connects a seismic streamer to a towing vessel. The lead-in cable comprises a first electrical conductor at the center core of the cable for carrying a first polarity of power to the streamer for providing tensile strength to the load-in cable. A first layer of insulation surrounds the first electrical conductor. A second electrical conductor for a second polarity of power to the streamer surrounds the first layer of insulation. A second layer of insulation surrounds the second electrical conductor. A layer of seismic data conductors surrounds the second layer of insulation. A third layer of insulation surrounds the layer of seismic data conductors. A metallic protective layer surrounds the third layer of insulation. Steel is effectively and efficiently used both to provide tensile strength and for electrical power conduction.,PGS EXPLORATION US INC,BRYANT MICHAEL JOHN;;GEORGE NICK C,,https://lens.org/008-119-188-843-308,Granted Patent,no,0,0,14,14,0,H01B7/045;;H01B9/003;;H01B9/04;;G01V1/201;;H01B9/003;;H01B7/045;;H01B9/04;;G01V1/201,H01B7/04;;H01B7/18;;H01B7/28;;H01B9/00;;H01B9/04,,0,0,,,,EXPIRED
195,WO,A1,WO 2022/272038 A1,020-481-130-755-117,2022-12-29,2022,US 2022/0034863 W,2022-06-24,US 202117358473 A,2021-06-25,CRYPTOGRAPHIC AUTHENTICATION TO CONTROL ACCESS TO STORAGE DEVICES,"Systems, methods, apparatuses, and computer-readable media for cryptographic authentication to control access to storage devices. An applet executing on a processor of a contactless card may receive, via a wireless communications interface of the contactless card, a request to access a storage device of the contactless card, where the storage device is in a locked state. The applet may generate a cryptogram based on the request and transmit the cryptogram to a computing device via the wireless communications interface. The applet may receive, from the computing device, an indication specifying that a server decrypted the cryptogram. The applet may transmit, to a controller of the storage device and based on the indication specifying that the server decrypted the cryptogram, an indication specifying to unlock the storage device. The controller may transition the storage device from the locked state to an unlocked state based on the indication received from the applet.",CAPITAL ONE SERVICES LLC,YEE BRYANT;;BULGAKOV MYKHAYLO;;BERGERON GEORGE,,https://lens.org/020-481-130-755-117,Patent Application,yes,5,0,5,5,0,G06F21/44;;G06F21/78;;G06F2221/2105;;H04W12/069;;G06F3/0622;;G06F3/0655;;G06F3/0679;;G06F13/4282;;G06F2213/0042;;H04L9/3226;;H04L9/3234;;H04L2209/805,G06F21/44;;G06F21/78;;H04W12/069,,0,0,,,,PENDING
196,EP,A2,EP 0355837 A2,025-622-946-632-628,1990-02-28,1990,EP 89115647 A,1989-08-24,US 23622188 A,1988-08-25,Transition metal recovery.,"A method for recovering a transition metal such as rhodium from a polar or non-polar liquid by contacting said transition metal-­containing liquid with an ion-exchange resin having bonded ionically thereto an organophosphorus ligand; the transition metal can be eluted from the bed using a liquid containing a sufficient concentra­tion of organophosphorus ligand.  ",UNION CARBIDE CHEM PLASTIC,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/025-622-946-632-628,Patent Application,yes,0,11,15,15,0,B01J31/24;;B01J31/24;;B01J31/185;;B01J31/185;;B01J31/20;;B01J31/20;;B01J31/2234;;B01J31/2234;;B01J31/2404;;B01J31/2404;;B01J31/2409;;B01J31/2409;;B01J31/4023;;B01J31/4023;;B01J31/4046;;B01J31/4046;;B01J31/4053;;B01J31/4053;;B01J39/12;;B01J39/12;;B01J2231/321;;B01J2231/321;;B01J2531/02;;B01J2531/0211;;B01J2531/0211;;B01J2531/80;;B01J2531/80;;B01J2531/822;;B01J2531/822;;B01J2531/985;;B01J2531/985;;B01J2540/12;;B01J2540/12;;B01J2540/32;;B01J2540/32;;B01J2540/42;;B01J2540/42;;B01J2540/525;;B01J2540/525;;B01J2540/68;;B01J2540/68;;C01G55/00;;C01G55/001;;C01G55/001;;C07C45/50;;C07C45/50;;C07C45/79;;C07C45/79;;C22B3/42;;C22B3/42;;Y02P10/20;;Y02P10/20;;Y02P20/584;;Y02P20/584,B01D15/04;;B01J31/40;;B01J39/12;;B01J45/00;;C01G55/00;;C02F1/42;;C02F101/10;;C02F103/36;;C07C45/50;;C07C45/79;;C22B3/00,,0,0,,,,DISCONTINUED
197,US,B1,US 6716063 B1,045-108-132-366-483,2004-04-06,2004,US 51442300 A,2000-02-28,US 51442300 A,2000-02-28,Electrical cable insert,"
    There is provided an electric cable insert for removably electrically connecting a cable having multiple conductors to a mating receptacle wherein the number and configuration of the cable conductors may be different from those of the sockets of the mating receptacle. The insert includes a housing open on one end to an internal cavity and having a plurality of orifices in the other end. The cable conductors connect to one side of a circuit card within the housing which conductively transitions from the number and configuration of the cable conductors to the number and configuration of the sockets of the mating receptacle. Receptacle pins extend from the opposite side of the circuit card through respective orifices in the housing for connecting to respective sockets in the mating receptacle. A compressed sealing gland disposed within the housing adjacent the circuit card provides the insert with an energized compression seal from the environment. A driver closes the end of the housing and maintains compression in the sealing gland. The cable conductors pass through respective bores in the sealing gland and in the driver. 
",PGS EXPLORATION US INC,BRYANT MICHAEL JOHN;;GEORGE NICK C,PGS EXPLORATION (US) INC (2000-02-23),https://lens.org/045-108-132-366-483,Granted Patent,yes,61,107,9,9,0,H01R13/523;;H01R13/523;;H01R13/5208;;H01R13/5208;;H01R31/06;;H01R31/06,H01R13/52;;H01R13/523;;H01R31/06,439/589,0,0,,,,EXPIRED
198,EP,B1,EP 0060523 B1,060-872-450-017-77X,1984-07-18,1984,EP 82101961 A,1982-03-11,US 24308281 A,1981-03-12,PROCESS FOR REMOVING HYDROPEROXIDES AND ALDEHYDES FROM ALLYL-ALKYL ETHER,"Described herein is a process for the conversion of hydroperoxides, present in alkyl-alkyl ethers to products including alpha , beta -unsaturated aldehydes and for reducing such alpha , beta -unsaturated aldehydes to alcohols prior to the use of the ether as a feedstock in a hydroformylation reaction to produce the corresponding ether aldehyde. The process involves contacting the ether with a metal hydride, either in aqueous solution and/or by means of an ion exchange resin. Such treatment decomposes the hydroperoxides and then reduces their alpha , beta -unsaturated aldehyde decomposition products, thereby reducing the catalyst inhibition period present in the hydroformylation reaction which is observed when such alpha , beta -unsaturated aldehyde impurities are present.",UNION CARBIDE CORPORATION,"ABATIOGLOU, ANTHONY GEORGE;;BRYANT, DAVID ROBERT",,https://lens.org/060-872-450-017-77X,Granted Patent,yes,0,0,16,17,0,C07C29/175;;C07C31/10;;C07C41/36;;C07C41/44;;C07C45/53;;C07C45/62;;C07C43/00,C07C29/17;;C07C31/10;;C07C41/00;;C07C43/18;;C07C41/34;;C07C41/36;;C07C41/44;;C07C43/00;;C07C43/15;;C07C43/188;;C07C45/53;;C07C45/62;;C07C67/00,,0,0,,,,EXPIRED
199,BR,A,BR 0007746 A,064-428-726-707-70X,2001-11-13,2001,BR 0007746 A,2000-05-01,US 35020099 A;;US 0011811 W,1999-07-08,Cabo de baixada para cabo de condução sìsmica,A conductive rope-like lead-in cable connects a seismic streamer to a towing vessel. The lead-in cable comprises a first electrical conductor at the center core of the cable for carrying a first polarity of power to the streamer for providing tensile strength to the load-in cable. A first layer of insulation surrounds the first electrical conductor. A second electrical conductor for a second polarity of power to the streamer surrounds the first layer of insulation. A second layer of insulation surrounds the second electrical conductor. A layer of seismic data conductors surrounds the second layer of insulation. A third layer of insulation surrounds the layer of seismic data conductors. A metallic protective layer surrounds the third layer of insulation. Steel is effectively and efficiently used both to provide tensile strength and for electrical power conduction.,PGS EXPLORATION;;NC,BRYANT MICHAEL J;;GEORGE NICK C,,https://lens.org/064-428-726-707-70X,Patent Application,no,0,0,14,14,0,H01B7/045;;H01B9/003;;H01B9/04;;G01V1/201;;H01B9/003;;H01B7/045;;H01B9/04;;G01V1/201,H01B7/04;;H01B9/00;;H01B9/04,,0,0,,,,DISCONTINUED
200,EG,A,EG 24761 A,071-023-628-630-882,2010-08-01,2010,EG NA2006000384 A,2006-04-23,US 2004/0035201 W;;US 69144703 A;;US 69230403 A,2003-10-22,Aluminium conductor composite core reinforced cable and method of manufacture.,,COMPOSITE TECH CORP,HIEL CLEMENT;;KORZENIOWSKI GEORGE;;BRYANT DAVID,,https://lens.org/071-023-628-630-882,Patent of Addition,no,0,0,34,35,0,B29C70/52;;B29L2031/3462;;B32B1/00;;B32B15/02;;B32B15/08;;B32B15/20;;B32B27/04;;H01B5/105;;B29C70/528;;Y10T428/2918;;Y10T428/2933;;Y10T428/2936;;Y10T442/30;;B32B27/04;;B82Y30/00;;Y10T428/2918;;Y10T428/2933;;Y10T428/2936;;Y10T442/30;;B32B2305/08;;B32B2307/54;;B32B27/08;;B32B2457/00;;B29L2031/3462;;B32B1/00;;B29C70/52;;B32B15/02;;B32B15/20;;B32B27/04;;B32B15/08;;H01B5/105;;B29C70/528,B65H75/04;;B05D1/18;;B05D3/02;;B32B27/04;;B65H/;;D04H3/08,,0,0,,,,PENDING
201,KR,A,KR 20070014109 A,060-330-344-841-152,2007-01-31,2007,KR 20067009890 A,2006-05-22,US 69144703 A;;US 69230403 A,2003-10-22,ALUMINUM CONDUCTOR COMPOSITE CORE REINFORCED CABLE AND METHOD OF MANUFACTURE,"This invention relates to an aluminum conductor composite core reinforced cable (ACCC) and method of manufacture. An ACCC cable (300) has a composite core surrounded by an outer film (305) and at least one layer of aluminum conductor (306). The composite core (303) comprises a plurality of fibers from at least one fiber type in one or more matrix materials. According to the invention, unique processing techniques such a B-Staging and / or film-coating techniques can be used to increase production rates from a few feet per minute to sixty or more feet per minute. ® KIPO & WIPO 2007",CTC CABLE CORP,HIEL CLEMENT;;KORZENIOWSKI GEORGE;;BRYANT DAVID,,https://lens.org/060-330-344-841-152,Patent Application,no,0,2,34,35,0,B29C70/52;;B29L2031/3462;;B32B1/00;;B32B15/02;;B32B15/08;;B32B15/20;;B32B27/04;;H01B5/105;;B29C70/528;;Y10T428/2918;;Y10T428/2933;;Y10T428/2936;;Y10T442/30;;B32B27/04;;B82Y30/00;;Y10T428/2918;;Y10T428/2933;;Y10T428/2936;;Y10T442/30;;B32B2305/08;;B32B2307/54;;B32B27/08;;B32B2457/00;;B29L2031/3462;;B32B1/00;;B29C70/52;;B32B15/02;;B32B15/20;;B32B27/04;;B32B15/08;;H01B5/105;;B29C70/528,B32B27/04;;B05D1/18;;B05D3/02;;B65H/;;D04H3/08,,0,0,,,,DISCONTINUED
202,AU,A1,AU 2004/284079 A1,058-917-925-066-087,2005-05-06,2005,AU 2004/284079 A,2004-10-22,US 69230403 A;;US 69144703 A;;US 2004/0035201 W,2003-10-22,Aluminum conductor composite core reinforced cable and method of manufacture,,COMPOSITE TECH CORP,KORZENIOWSKI GEORGE;;BRYANT DAVID;;HIEL CLEMENT,CTC CABLE CORPORATION (2006-06-08),https://lens.org/058-917-925-066-087,Patent Application,no,0,0,34,35,0,B29C70/52;;B29L2031/3462;;B32B1/00;;B32B15/02;;B32B15/08;;B32B15/20;;B32B27/04;;H01B5/105;;B29C70/528;;Y10T428/2918;;Y10T428/2933;;Y10T428/2936;;Y10T442/30;;B32B27/04;;B82Y30/00;;Y10T428/2918;;Y10T428/2933;;Y10T428/2936;;Y10T442/30;;B32B2305/08;;B32B2307/54;;B32B27/08;;B32B2457/00;;B29L2031/3462;;B32B1/00;;B29C70/52;;B32B15/02;;B32B15/20;;B32B27/04;;B32B15/08;;H01B5/105;;B29C70/528,B32B27/04;;B05D1/18;;B05D3/02;;B65H/;;D04H3/08,,0,0,,,,INACTIVE
203,US,A1,US 2021/0374715 A1,099-737-119-915-434,2021-12-02,2021,US 202016884012 A,2020-05-26,US 202016884012 A,2020-05-26,Transaction Cards and Computer-Based Systems Involving an On-Card Display and Mobile Device for Authenticating Transactions and Methods of Use Thereof,"Transaction cards, systems and methods involving an on-card display and an associated mobile computing device utilized for authenticating transactions are disclosed. In one embodiment, an exemplary transaction card may comprise transaction circuitry configured to conduct purchase transactions involving a mobile computing device coupled to or associated with the transaction card, communication circuitry configured to communicate with a provider of the transaction card, an e-ink display configured to display a QR code on the transaction card for use in authentication, data storage configured to store the QR code, and computer readable media having instructions for initiating a second-factor authentication process and displaying the QR code on the e-ink display to be captured by the mobile computing device and transmitted to a system or server for validating the second-factor authentication process.",CAPITAL ONE SERVICES LLC,BERGERON GEORGE;;YEE BRYANT;;BULGAKOV MYKHAYLO,CAPITAL ONE SERVICES LLC (2020-05-26),https://lens.org/099-737-119-915-434,Patent Application,yes,0,1,3,3,0,G06Q20/341;;G06Q20/3274;;G06Q20/20;;G07F7/0846;;G06K19/07707;;G06K19/07769;;G06Q20/3274;;G06K19/07707;;G06K19/0709;;G06Q20/341,G06Q20/32;;G06K19/07;;G06K19/077;;G06Q20/34,,0,0,,,,ACTIVE
204,US,B2,US 9480863 B2,107-461-270-014-974,2016-11-01,2016,US 201113519953 A,2011-01-03,US 201113519953 A;;US 29180409 P;;US 29177909 P;;US 29173209 P;;US 2011/0020052 W,2009-12-31,Ultrasound coupling device,"The present invention relates to an ultrasound coupling device for use with various ultrasound transducers, systems, and applications. The coupling device includes a coupling compartment comprising a chamber having a continuous side wall and an opening on a first end. The continuous side wall is configured to hold a low-profile ultrasound transducer within the chamber so that a front ultrasound emitting surface of the low-profile ultrasound transducer faces outward toward the chamber opening. The front ultrasound emitting surface is configured to control the direction and wave pattern of ultrasonic energy emitted from the transducer. The continuous side wall is also configured to hold a quantity of an ultrasound conductive medium within the chamber and is operative to keep the ultrasound conductive medium in simultaneous contact with a surface of a subject and with at least a portion of the front ultrasound emitting surface of the transducer. The present invention also relates to an ultrasound apparatus, kit, and methods of using the ultrasound coupling device, apparatus, and kit.",LEWIS JR GEORGE K;;GUFFEY BRYANT;;ZETROZ SYSTEMS LLC,LEWIS JR GEORGE K;;GUFFEY BRYANT,ZETROZ INC (2013-06-12);;ZETROZ SYSTEMS LLC (2016-01-29),https://lens.org/107-461-270-014-974,Granted Patent,yes,31,5,32,32,0,A61B8/4281;;A61B17/2251;;A61B2017/2253;;A61N2007/0078;;A61B8/4227;;A61B8/4236;;A61B8/4427;;A61B2017/00734;;A61N2007/006;;A61N2007/0091;;A61N2007/0095;;A61B8/44;;A61N7/00;;Y10T29/49005;;A61B2034/301;;A61B34/30;;A61B2034/303;;A61B2034/107;;A61B34/10;;A61N2007/0034;;Y10T29/49005;;A61B8/4281;;A61B17/2251;;A61B2017/2253;;A61N2007/0078;;A61B8/4227;;A61B8/4236;;A61B2017/00734;;A61N2007/0091;;A61N2007/0095;;A61B8/4427;;A61B8/44;;A61N2007/006;;A61N7/00,A61N7/00;;A61B8/00;;A61B17/225,,1,0,,,"International Search Report and Written Opinion issued in PCT/US2011/020052, mailed Sep. 27, 2011.",INACTIVE
205,EP,A1,EP 0060523 A1,119-966-704-538-564,1982-09-22,1982,EP 82101961 A,1982-03-11,US 24308281 A,1981-03-12,Process for removing hydroperoxides and aldehydes from allyl-alkyl ether.,"Described herein is a process for the conversion of hydroperoxides, present in allyl-alkyl ethers to products including α,β-unsaturated aldehydes and for reducing such α,β-unsaturated aldehydes to alcohols prior to the use of the ether as a feedstock in a hydroformylation reaction to produce the corresponding ether aldehyde. The process involves contacting the ether with a metal hydride, either in aqueous solution and/or by means of an ion exchange resin. Such treatment decomposes the hydroperoxides and then reduces their α,β-unsaturated aldehyde decomposition products, thereby reducing the catalyst inhibition period present in the hydroformylation reaction which is observed when such α,β-unsaturated aldehyde impurities are present.",UNION CARBIDE CORP,ABATIOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/119-966-704-538-564,Patent Application,yes,3,2,16,17,0,C07C29/175;;C07C31/10;;C07C41/36;;C07C41/44;;C07C45/53;;C07C45/62;;C07C43/00,C07C29/17;;C07C31/10;;C07C41/00;;C07C43/18;;C07C41/34;;C07C41/36;;C07C41/44;;C07C43/00;;C07C43/15;;C07C43/188;;C07C45/53;;C07C45/62;;C07C67/00,,0,0,,,,EXPIRED
206,GB,A,GB 2193494 A,133-021-954-263-430,1988-02-10,1988,GB 8716161 A,1987-07-09,US 88419786 A,1986-07-10,HYDROFORMYLATION PROCESS,,UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/133-021-954-263-430,Patent Application,no,0,0,52,52,0,C07C45/50;;C07F9/5004;;Y02P20/582;;C07B41/00;;C07C47/02;;C07C45/50;;C07F9/5004;;Y02P20/582,B01J31/00;;C07B61/00;;B01J31/24;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00;;C07F9/50,C2C CJE;;C2C CTH;;C2C C20Y;;C2C C228;;C2C C248;;C2C C30Y;;C2C C350;;C2C C40Y;;C2C C408;;C2C C54X;;C2C C568;;C2C C569;;C2C C66Y;;C2C C67Y,0,0,,,,EXPIRED
207,AU,A,AU 2000/048134 A,165-500-627-269-965,2001-01-30,2001,AU 2000/048134 A,2000-05-01,US 35020099 A;;US 0011811 W,1999-07-08,Seismic conductive rope lead-in cable,A conductive rope-like lead-in cable connects a seismic streamer to a towing vessel. The lead-in cable comprises a first electrical conductor at the center core of the cable for carrying a first polarity of power to the streamer for providing tensile strength to the load-in cable. A first layer of insulation surrounds the first electrical conductor. A second electrical conductor for a second polarity of power to the streamer surrounds the first layer of insulation. A second layer of insulation surrounds the second electrical conductor. A layer of seismic data conductors surrounds the second layer of insulation. A third layer of insulation surrounds the layer of seismic data conductors. A metallic protective layer surrounds the third layer of insulation. Steel is effectively and efficiently used both to provide tensile strength and for electrical power conduction.,PGS EXPLORATION US INC,BRYANT MICHAEL J;;GEORGE NICK C,,https://lens.org/165-500-627-269-965,Patent Application,no,0,0,14,14,0,H01B7/045;;H01B9/003;;H01B9/04;;G01V1/201;;H01B9/003;;H01B7/045;;H01B9/04;;G01V1/201,H01B7/04;;H01B9/00;;H01B9/04,,0,0,,,,EXPIRED
208,EP,A3,EP 0268268 A3,175-196-344-648-489,1988-10-26,1988,EP 87116971 A,1987-11-17,US 93200286 A,1986-11-18,HYDROFORMYLATION USING LOW VOLATILE PHOSPHINE LIGANDS,"A non-aqueous hydroformylation process for producing aldehydes which comprises reacting an olefinically unsaturated organic compound with carbon monoxide and hydrogen, in a non-aqueous hydroformylation reaction medium containing the olefinically unsaturated organic compound, aldehyde product, solubilized Group VIII transition metal-phosphorus ligand complex catalyst and solubilized free phosphorus ligand, the improvement comprising employing as the phosphorus ligand of said complex catalyst and as said free phosphorus ligand, a monosulfonated tertiary phosphine metal salt of the general formula
   wherein R represents a radical containing 1 to 30 carbon atoms selected from alkyl, alkaryl, aralkyl and cycloalkyl radicals; M represents an alkali metal or alkaline earth metal cation; and n is 1 or 2 corresponding to the valence of the metal cation.  ",UNION CARBIDE CORPORATION,"ABATJOGLOU, ANTHONY GEORGE;;BRYANT, DAVID ROBERT",,https://lens.org/175-196-344-648-489,Search Report,yes,5,0,53,53,0,C07C45/50;;Y02P20/582;;C07C47/55;;C07C47/02;;C07C45/50;;Y02P20/582,B01J31/00;;B01J31/28;;C07B61/00;;C07C45/00;;B01J31/24;;C07C45/50;;C07C47/02;;C07C67/00,,0,0,,,,EXPIRED
209,CN,A,CN 115681632 A,188-654-549-487-997,2023-02-03,2023,CN 202210843328 A,2022-07-18,US 202117443530 A,2021-07-27,Compression nut or fitting with detachable plunger for easy removal of caught ferrule,"The present invention relates to a compression fitting comprising: a nut having a threaded end for receiving a threaded tube and a receiving end for receiving a plunger head; and a plunger having an inner bore for receiving a capillary tube and the plunger head for engaging a ferrule positioned within the receiving end between the plunger head and the threaded tube, the plunger slidably engaged with the nut to force the ferrule out of the nut.",THERMO FINNIGAN LLC,GUCKENBERG GEORGE B;;BRYANT ANDREW D,,https://lens.org/188-654-549-487-997,Patent Application,no,0,0,4,4,0,G01N30/6039;;G01N30/6004;;F16L19/0225;;G01N30/16;;F16L19/025;;G01N30/6026,F16L19/025;;F16L33/00;;G01N30/16,,0,0,,,,PENDING
210,FR,B1,FR 2606771 B1,192-038-920-657-723,1989-11-03,1989,FR 8715930 A,1987-11-18,US 93200286 A,1986-11-18,PROCEDE D'HYDROFORMYLATION UTILISANT DES LIGANDS PHOSPHINIQUES PEU VOLATILS,,UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/192-038-920-657-723,Granted Patent,no,0,0,53,53,0,C07C45/50;;Y02P20/582;;C07C47/55;;C07C47/02;;C07C45/50;;Y02P20/582,B01J31/00;;B01J31/28;;C07B61/00;;B01J31/24;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00,,0,0,,,,EXPIRED
211,AT,T1,AT E215538 T1,193-403-296-522-823,2002-04-15,2002,AT 97307498 T,1997-09-25,US 2675296 P,1996-09-26,TETRA-HYDROBENZO(A)FLUORENVERBINDUNGEN UND IHRE ANWENDUNGEN,"The invention provides tetrahydrobenzoÄaÜfluorene compounds, formulations, and methods of inhibiting bone loss or bone resorption, particularly osteoporosis, and cardiovascular-related pathological conditions, including hyperlipidemia.",LILLY CO ELI,BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH,,https://lens.org/193-403-296-522-823,Granted Patent,no,0,0,11,11,0,A61K31/565;;A61K31/57;;C07C217/18;;C07D295/088;;C07C2603/40;;A61P19/10;;A61P3/06;;A61P43/00;;A61P9/00;;C07D295/088;;A61K31/565;;C07C217/18;;A61K31/57;;C07C2603/40,C07D295/08;;A61K31/135;;A61K31/40;;A61K31/445;;A61K31/55;;A61K31/565;;A61K31/57;;A61P3/06;;A61P9/00;;A61P19/10;;A61P43/00;;C07C217/18;;C07C309/65;;C07D207/06;;C07D295/092;;C07J69/00,,0,0,,,,DISCONTINUED
212,GB,B,GB 2105230 B,002-565-532-175-460,1984-01-11,1984,GB 8221137 A,1982-07-21,US 9018479 A,1979-11-01,FORGING METHOD AND APPARATUS,,UNITED TECHNOLOGIES CORP,WALKER BRYANT HARDING;;MACNITT DONALD GEORGE,,https://lens.org/002-565-532-175-460,Granted Patent,no,0,0,30,35,0,B21J5/02;;B21J9/02;;B21J13/02;;B21K1/36;;B21K29/00;;Y10T29/49336;;Y10T29/49336;;B21J5/02;;B21K1/36;;B21J9/02;;B21J13/02;;B21K29/00,B21J5/02;;B21J9/02;;B21J13/02;;B21K1/36;;B21K3/04,B3H16N;;B3H2R;;B3H2W,0,0,,,,EXPIRED
213,NO,L,NO 20062079 L,027-147-619-545-263,2006-07-20,2006,NO 20062079 A,2006-05-09,US 69144703 A;;US 69230403 A;;US 2004/0035201 W,2003-10-22,Armert kabel med komposittkjerne med aluminiumsleder og fremgangsmate for fremstilling av en slik kabel,Denne oppfinnelsen vedrører en armert kabel med komposittkjerne med aluminiumsleder (ACCC) og fremgangsmåte for fremstilling av en slik kabel. En ACCC-kabei (300) har en komposittkjernen som er omgitt av et ytre lag (305) og minst et lag aluminiumsleder (306). Komposittkjernen (303) omfatter et flertall fibertyper i et eller flere matrisematerialer. l henhold til oppfinnelsen kan unike prosesseringsteknikker som B-stadie- og I eller filmbeleggingsteknikker benyttes for å øke produksjonshastighetene fra et par fot per minutt til 60 eller fot per minutt.,COMPOSITE TECHNOLOGIES CORP,KORZENIOWSKI GEORGE;;HIEL CLEMENT;;BRYANT DAVID,,https://lens.org/027-147-619-545-263,Abstract,no,0,0,34,35,0,B29C70/52;;B29L2031/3462;;B32B1/00;;B32B15/02;;B32B15/08;;B32B15/20;;B32B27/04;;H01B5/105;;B29C70/528;;Y10T428/2918;;Y10T428/2933;;Y10T428/2936;;Y10T442/30;;B32B27/04;;B82Y30/00;;Y10T428/2918;;Y10T428/2933;;Y10T428/2936;;Y10T442/30;;B32B2305/08;;B32B2307/54;;B32B27/08;;B32B2457/00;;B29L2031/3462;;B32B1/00;;B29C70/52;;B32B15/02;;B32B15/20;;B32B27/04;;B32B15/08;;H01B5/105;;B29C70/528,H01B3/48;;B05D1/18;;B05D3/02;;B32B27/04;;B65H/;;D04H3/08,,0,0,,,,DISCONTINUED
214,EP,A3,EP 0355837 A3,030-357-270-849-136,1990-05-16,1990,EP 89115647 A,1989-08-24,US 23622188 A,1988-08-25,TRANSITION METAL RECOVERY,"A method for recovering a transition metal such as rhodium from a polar or non-polar liquid by contacting said transition metal-­containing liquid with an ion-exchange resin having bonded ionically thereto an organophosphorus ligand; the transition metal can be eluted from the bed using a liquid containing a sufficient concentra­tion of organophosphorus ligand.  ",UNION CARBIDE CHEMICALS AND PLASTICS COMPANY INC. (A NEW YORK CORPORATION),"ABATJOGLOU, ANTHONY GEORGE;;BRYANT, DAVID ROBERT",,https://lens.org/030-357-270-849-136,Search Report,yes,2,0,15,15,0,B01J31/24;;B01J31/24;;B01J31/185;;B01J31/185;;B01J31/20;;B01J31/20;;B01J31/2234;;B01J31/2234;;B01J31/2404;;B01J31/2404;;B01J31/2409;;B01J31/2409;;B01J31/4023;;B01J31/4023;;B01J31/4046;;B01J31/4046;;B01J31/4053;;B01J31/4053;;B01J39/12;;B01J39/12;;B01J2231/321;;B01J2231/321;;B01J2531/02;;B01J2531/0211;;B01J2531/0211;;B01J2531/80;;B01J2531/80;;B01J2531/822;;B01J2531/822;;B01J2531/985;;B01J2531/985;;B01J2540/12;;B01J2540/12;;B01J2540/32;;B01J2540/32;;B01J2540/42;;B01J2540/42;;B01J2540/525;;B01J2540/525;;B01J2540/68;;B01J2540/68;;C01G55/00;;C01G55/001;;C01G55/001;;C07C45/50;;C07C45/50;;C07C45/79;;C07C45/79;;C22B3/42;;C22B3/42;;Y02P10/20;;Y02P10/20;;Y02P20/584;;Y02P20/584,B01D15/04;;B01J31/40;;B01J39/12;;B01J45/00;;C01G55/00;;C02F1/42;;C02F101/10;;C02F103/36;;C07C45/50;;C07C45/79;;C22B3/00,,1,1,002-793-503-737-350,10.1007/bf00618719,"CHEMICAL ABSTRACTS, vol. 98, no. 6, abstract no. 41336f, Columbus, Ohio, US; T.R. SMITH et al.: ""Rhodium complexes of the water-soluble phosphine (2-diphenylphosphinoethyl) trimethylammonium nitrate: Their chemistry in polar solvents, and their use as catalysts in aqueous solution in aqueous/organic two-phase systems and adsorbed on a cation exchange resin"", & TRANSITION MET. CHEM. (WEINHEIM, GER.), 7(5), 288-9",DISCONTINUED
215,CA,A,CA 745974 A,012-571-008-789-590,1966-11-08,1966,CA 745974D A,,CA 745974T A,,ETHYLENE POLYMER EMULSIONS AS TEXTILE SOFTENERS,,UNION CARBIDE CORP,HERSH SOLOMON P;;BRYANT GEORGE M,,https://lens.org/012-571-008-789-590,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
216,DE,B2,DE 2314840 B2,012-562-188-250-095,1976-01-02,1976,DE 2314840 A,1973-03-24,US 23851572 A,1972-03-27,DE 2314840 B2,,"PARK-OHIO INDUSTRIES, INC., CLEVELAND, OHIO (V.ST.A.)","BRYANT, WILLIAM GEORGE, LAKEWOOD, OHIO (V.ST.A.)",,https://lens.org/012-562-188-250-095,Patent Application,no,0,0,13,13,0,H05B6/06;;H05B6/06;;H05B6/101;;H05B6/101,H05B6/40;;C21D1/10;;H05B6/02;;H05B6/06,,0,0,,,,DISCONTINUED
217,US,B1,US 10650440 B1,028-880-113-202-00X,2020-05-12,2020,US 201916597246 A,2019-10-09,US 201916597246 A,2019-10-09,Computer-implemented methods for technological applications involving provision of an online portal for managing a user account including an interactive GUI having functionality for pre-authorizing future transactions,"Systems and methods involving a computer-implemented portal that enables a user to pre-authorize purchase of items not yet available for sale are disclosed. In one embodiment, an exemplary method may comprise: providing an online portal that enables a user to manage a financial account; executing a first routine of the portal including interactive functionality enabling the user to specify and pre-authorize purchase of an item that is not yet available for sale; searching to determine at least one electronic source at which the item can be purchased when it becomes available for purchase; and executing a purchase transaction at the future date/time when the item is released for sale, to purchase the item for the user.",CAPITAL ONE SERVICES LLC,YEE BRYANT;;BERGERON GEORGE;;BULGAKOV MYKHAYLO,CAPITAL ONE SERVICES LLC (2019-10-08),https://lens.org/028-880-113-202-00X,Granted Patent,yes,14,8,5,5,0,G06Q30/0641;;G06Q30/0635;;G06Q20/40;;G06Q20/28;;G06Q20/405;;G06Q20/385;;G06Q30/0635;;G06Q30/0641,G06Q30/00;;G06Q20/38;;G06Q30/06,,1,0,,,"“Rowland's Classic Clothing: Rowland's Classic Clothing Expands Business with Integrated Mail Order and Retail Systems from Options . . . , by Mail Order and from its New Website.” M2 Presswire, Oct. 23, 2008 (Year: 2008).",ACTIVE
218,EP,B1,EP 2687608 B1,034-339-949-407-71X,2017-02-08,2017,EP 13181515 A,2006-06-08,US 68863405 P;;EP 06784710 A,2005-06-08,"Methods for the identification, assessment, and treatment of patients with cancer therapy",,MILLENNIUM PHARM INC,BRYANT BARBARA;;DAMOKOSH ANDREW;;MULLIGAN GEORGE,,https://lens.org/034-339-949-407-71X,Granted Patent,yes,1,0,22,22,0,C12Q2600/106;;C12Q2600/136;;G01N33/57407;;G01N33/57415;;G01N33/57419;;G01N33/57423;;G01N33/57434;;G01N33/57438;;G01N33/57449;;G01N2800/44;;G16B25/00;;G16B40/00;;A61K31/69;;C12Q1/6886;;A61P35/00;;A61P35/02;;G16H10/40;;G16H20/40;;Y02A90/10;;G16B40/10;;G16B25/10;;G16B25/00;;G16B40/00;;C12Q2600/106;;C12Q2600/136;;G01N33/57407;;G01N33/57415;;G01N33/57419;;G01N33/57423;;G01N33/57434;;G01N33/57438;;G01N33/57449;;G01N2800/44;;Y02A90/10;;G16H10/40;;G16H20/40;;G16B40/10;;G16B25/10;;C12Q1/6886;;A61K31/69;;C12Q2600/158;;G01N33/57426;;G06Q20/40,C12Q1/68;;G06Q50/00;;G16B25/10;;G16B40/10,,3,0,,,"BOHEN SEAN P ET AL: ""Variation in gene expression patterns in follicular lymphoma and the response to rituximab"", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES - PNAS, NATIONAL ACADEMY OF SCIENCES, US, vol. 100, no. 4, 18 February 2003 (2003-02-18), pages 1926-1930, XP002595370, ISSN: 0027-8424, DOI: 10.1073/PNAS.0437875100 [retrieved on 2003-02-05];;B. BARLOGIE: ""Treatment of multiple myeloma"", BLOOD, vol. 103, no. 1, 1 January 2004 (2004-01-01), pages 20-32, XP55040377, ISSN: 0006-4971, DOI: 10.1182/blood-2003-04-1045;;BARLOW WILLIAM ET AL: ""Predicting event-free and overall survival after treatment of myeloma with the proteasome inhibitor Bortezomib with pre-treatment and 48-hour post-therapy gene expression patterns"", BLOOD, AMERICAN SOCIETY OF HEMATOLOGY, US, vol. 104, no. 11, Part 1, 1 November 2004 (2004-11-01), page 414A, XP009129472, ISSN: 0006-4971",ACTIVE
219,ES,A6,ES 2012719 A6,060-860-752-115-844,1990-04-01,1990,ES 8901418 A,1989-04-24,US 93200286 A,1986-11-18,Hydroformylation using low volatile phosphine ligands.,"A non-aqueous hydroformylation process for producing aldehydes which comprises reacting an olefinically unsaturated organic compound with carbon monoxide and hydrogen, in a non-aqueous hydroformylation reaction medium containing the olefinically unsaturated organic compound, aldehyde product, solubilized Group VIII transition metal-phosphorus ligand complex catalyst and solubilized free phosphorus ligand, the improvement comprising employing as the phosphorus ligand of said complex catalyst and as said free phosphorus ligand, a monosulfonated tertiary phosphine metal salt of the general formula < CHEM > wherein R represents a radical containing 1 to 30 carbon atoms selected from alkyl, alkaryl, aralkyl and cycloalkyl radicals M represents an alkali metal or alkaline earth metal cation and n is 1 or 2 corresponding to the valence of the metal cation.",UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/060-860-752-115-844,Granted Patent,no,0,0,53,53,0,C07C45/50;;Y02P20/582;;C07C47/55;;C07C47/02;;C07C45/50;;Y02P20/582,B01J31/00;;B01J31/28;;C07B61/00;;B01J31/24;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00,,0,0,,,,EXPIRED
220,EP,B1,EP 0268268 B1,067-007-777-615-737,1992-06-10,1992,EP 87116971 A,1987-11-17,US 93200286 A,1986-11-18,HYDROFORMYLATION USING LOW VOLATILE PHOSPHINE LIGANDS,,UNION CARBIDE CORPORATION,"ABATJOGLOU, ANTHONY GEORGE;;BRYANT, DAVID ROBERT",,https://lens.org/067-007-777-615-737,Granted Patent,yes,5,0,53,53,0,C07C45/50;;Y02P20/582;;C07C47/55;;C07C47/02;;C07C45/50;;Y02P20/582,B01J31/00;;B01J31/28;;C07B61/00;;C07C45/00;;B01J31/24;;C07C45/50;;C07C47/02;;C07C67/00,,0,0,,,,EXPIRED
221,BE,A5,BE 1000619 A5,088-138-757-526-704,1989-02-21,1989,BE 8701298 A,1987-11-17,US 93200286 A,1986-11-18,PROCEDE D'HYDROFORMYLATION UTILISANT DES LIGANDS PHOSPHINIQUES PEU VOLATILS.,L'invention concerne un procédé perfectionné d'hydroformylation consistant à faire réagir un composé organique à non-saturation oléfinique avec un oxyde de carbone et de l'hydrogène en présence d'un catalyseur. Le procédé consiste à utiliser comme ligands pour le catalyseur complexe des ligands organiques solubilisés peu volatils qui sont des sels métalliques de phosphines tertiaires monosulfonées. Application à la production d'aldéhydes,UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/088-138-757-526-704,Granted Patent,no,5,0,53,53,0,C07C45/50;;Y02P20/582;;C07C47/55;;C07C47/02;;C07C45/50;;Y02P20/582,B01J31/24;;B01J31/00;;B01J31/28;;C07B61/00;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00,,0,0,,,,EXPIRED
222,KR,A,KR 20140053398 A,115-119-622-317-466,2014-05-07,2014,KR 20147008499 A,2004-10-22,US 69144703 A;;US 69230403 A;;US 2004/0035201 W,2003-10-22,ALUMINUM CONDUCTOR COMPOSITE CORE REINFORCED CABLE AND METHOD OF MANUFACTURE,,CTC CABLE CORP,HIEL CLEMENT;;KORZENIOWSKI GEORGE;;BRYANT DAVID,,https://lens.org/115-119-622-317-466,Patent Application,no,0,5,34,35,0,B29C70/52;;B29L2031/3462;;B32B1/00;;B32B15/02;;B32B15/08;;B32B15/20;;B32B27/04;;H01B5/105;;B29C70/528;;Y10T428/2918;;Y10T428/2933;;Y10T428/2936;;Y10T442/30;;B32B27/04;;B82Y30/00;;Y10T428/2918;;Y10T428/2933;;Y10T428/2936;;Y10T442/30;;B32B2305/08;;B32B2307/54;;B32B27/08;;B32B2457/00;;B29L2031/3462;;B32B1/00;;B29C70/52;;B32B15/02;;B32B15/20;;B32B27/04;;B32B15/08;;H01B5/105;;B29C70/528,H01B3/48;;B05D1/18;;B05D3/02;;B32B27/04;;B65H/;;D04H3/08;;H01B7/18;;H01B13/00,,0,0,,,,DISCONTINUED
223,DK,A,DK 605887 A,118-910-272-512-889,1988-05-19,1988,DK 605887 A,1987-11-18,US 93200286 A,1986-11-18,FREMGANGSMAADE TIL FREMSTILLING AF ALDEHYDER VED HYDROFORMYLERING I IKKE-VANDIGE REAKTIONSMEDIER,,UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/118-910-272-512-889,Patent Application,no,0,0,53,53,0,C07C45/50;;Y02P20/582;;C07C47/55;;C07C47/02;;C07C45/50;;Y02P20/582,B01J31/00;;B01J31/24;;B01J31/28;;C07B61/00;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00,,0,0,,,,DISCONTINUED
224,CA,A,CA 459746 A,130-628-225-752-885,1949-09-20,1949,CA 459746D A,,CA 459746T A,,FOLDABLE CANOPY FRAME,,WESTMORELAND BASCOM BRYANT;;BARNETT BENJAMIN GEORGE,WESTMORELAND BASCOM BRYANT;;BARNETT BENJAMIN GEORGE,,https://lens.org/130-628-225-752-885,Granted Patent,no,0,1,1,1,0,,,,0,0,,,,EXPIRED
225,US,A,US 3618046 A,128-554-390-148-234,1971-11-02,1971,US 3618046D A,1970-03-09,US 1756770 A,1970-03-09,BILEVEL SEMICONDUCTOR MEMORY CIRCUIT WITH HIGH-SPEED WORD DRIVER,,COGAR CORP,BRYANT RICHARD W;;TU GEORGE K,,https://lens.org/128-554-390-148-234,Granted Patent,no,1,2,3,3,0,G11C11/4116;;H01L27/0611;;H03K3/012;;H03K3/288;;H03K3/35;;G11C11/4116;;H03K3/35;;H03K3/012;;H03K3/288;;H01L27/0611,G11C11/411;;H01L27/06;;H03K3/012;;H03K3/288;;H03K3/35,340173   FF,0,0,,,,EXPIRED
226,ES,T3,ES 2928669 T3,143-645-988-137-617,2022-11-22,2022,ES 11728550 T,2011-01-03,US 29180409 P;;US 29177909 P;;US 29173209 P;;US 2011/0020052 W,2009-12-31,Dispositivo de acoplamiento para ecografía,"La presente invención se refiere a un dispositivo de acoplamiento de ultrasonidos para uso con diversos transductores, sistemas y aplicaciones de ultrasonidos. El dispositivo de acoplamiento incluye un compartimento de acoplamiento que comprende una cámara que tiene una pared lateral continua y una abertura en un primer extremo. La pared lateral continua está configurada para contener un transductor de ultrasonidos de bajo perfil dentro de la cámara de manera que una superficie emisora de ultrasonidos frontal del transductor de ultrasonidos de bajo perfil mire hacia afuera, hacia la abertura de la cámara. La superficie frontal de emisión de ultrasonidos está configurada para controlar la dirección y el patrón de onda de la energía ultrasónica emitida por el transductor. La pared lateral continua también está configurada para contener una cantidad de un medio conductor de ultrasonidos dentro de la cámara y es operativa para mantener el medio conductor de ultrasonidos en contacto simultáneo con una superficie de un sujeto y con al menos una parte de la superficie frontal emisora de ultrasonidos de el transductor La presente invención también se refiere a un aparato, equipo y métodos de ultrasonidos para usar el dispositivo, aparato y equipo de acoplamiento de ultrasonidos. (Traducción automática con Google Translate, sin valor legal)",ZETROZ SYSTEMS LLC,LEWIS JR GEORGE K;;GUFFEY BRYANT,,https://lens.org/143-645-988-137-617,Granted Patent,no,0,0,32,32,0,A61B8/4281;;A61B17/2251;;A61B2017/2253;;A61N2007/0078;;A61B8/4227;;A61B8/4236;;A61B8/4427;;A61B2017/00734;;A61N2007/006;;A61N2007/0091;;A61N2007/0095;;A61B8/44;;A61N7/00;;Y10T29/49005;;A61B2034/301;;A61B34/30;;A61B2034/303;;A61B2034/107;;A61B34/10;;A61N2007/0034;;Y10T29/49005;;A61B8/4281;;A61B17/2251;;A61B2017/2253;;A61N2007/0078;;A61B8/4227;;A61B8/4236;;A61B2017/00734;;A61N2007/0091;;A61N2007/0095;;A61B8/4427;;A61B8/44;;A61N2007/006;;A61N7/00,A61N7/00;;A61B8/00,,0,0,,,,ACTIVE
227,US,A,US 2740481 A,143-739-020-451-011,1956-04-03,1956,US 34459253 A,1953-03-25,US 34459253 A,1953-03-25,Cleaning tool,,ROY L ARTERBURY,ARTERBURY BRYANT P;;CLARK GEORGE M,,https://lens.org/143-739-020-451-011,Granted Patent,no,2,4,1,1,0,E21B37/08;;E21B37/08,E21B37/08,,0,0,,,,EXPIRED
228,WO,A1,WO 2023/154231 A1,157-903-038-744-197,2023-08-17,2023,US 2023/0012335 W,2023-02-03,US 202217667417 A,2022-02-08,SYSTEMS AND METHODS FOR SECURE ACCESS OF STORAGE,"Systems and methods for secure access are provided. The secure access system includes a contactless card, a user device, a processor, and a storage device. The processor receives a first authentication request from the user device. Then, the processor transmits a first authentication credential associated with user login data to the user device. Next, the processor receives a second authentication request from the user device. Upon receipt of the second authentication request, the processor transmits a second authentication credential associated with a contactless card to the user device. Then, the processor receives a first code from the user device, and the storage device performs one or more access actions based on the first code.",CAPITAL ONE SERVICES LLC,YEE BRYANT;;BULGAKOV MYKHAYLO;;BERGERON GEORGE,,https://lens.org/157-903-038-744-197,Patent Application,yes,5,0,2,2,0,G06F21/32;;G06F21/34;;G06F21/40;;G06F21/604;;H04L63/0853;;H04L63/0861;;H04L63/0876;;H04L2463/082;;H04L63/083;;H04L63/102;;H04L63/104;;H04L63/20,G06F21/34;;G06F21/32;;H04L9/40,,0,0,,,,PENDING
229,FR,A1,FR 2606771 A1,154-069-769-746-718,1988-05-20,1988,FR 8715930 A,1987-11-18,US 93200286 A,1986-11-18,PROCEDE D'HYDROFORMYLATION UTILISANT DES LIGANDS PHOSPHINIQUES PEU VOLATILS,<P>L'INVENTION CONCERNE UN PROCEDE PERFECTIONNE D'HYDROFORMYLATION CONSISTANT A FAIRE REAGIR UN COMPOSE ORGANIQUE A NON-SATURATION OLEFINIQUE AVEC UN OXYDE DE CARBONE ET DE L'HYDROGENE EN PRESENCE D'UN CATALYSEUR.</P><P>LE PROCEDE CONSISTE A UTILISER COMME LIGANDS POUR LE CATALYSEUR COMPLEXE DES LIGANDS ORGANIQUES SOLUBILISES PEU VOLATILS QUI SONT DES SELS METALLIQUES DE PHOSPHINES TERTIAIRES MONOSULFONEES.</P><P>APPLICATION A LA PRODUCTION D'ALDEHYDES.</P>,UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/154-069-769-746-718,Patent Application,no,5,0,53,53,0,C07C45/50;;Y02P20/582;;C07C47/55;;C07C47/02;;C07C45/50;;Y02P20/582,B01J31/00;;B01J31/28;;C07B61/00;;C07C45/00;;B01J31/24;;C07C45/50;;C07C47/02;;C07C67/00,,0,0,,,,EXPIRED
230,EP,A1,EP 2687608 A1,144-394-501-065-109,2014-01-22,2014,EP 13181515 A,2006-06-08,US 68863405 P;;EP 06784710 A,2005-06-08,"Methods for the identification, assessment, and treatment of patients with cancer therapy","The present invention is directed to the identification of predictive markers that can be used to determine whether patients with cancer are clinically responsive or non-responsive to a therapeutic regimen prior to treatment. In particular, the present invention is directed to the use of certain individual and/or combinations of predictive markers, wherein the expression of the predictive markers correlates with responsiveness or non-responsiveness to a therapeutic regimen. Thus, by examining the expression levels of individual predictive markers and/or predictive markers comprising a marker set, it is possible to determine whether a therapeutic agent, or combination of agents, will be most likely to reduce the growth rate of tumors in a clinical setting.",MILLENNIUM PHARM INC,BRYANT BARBARA;;DAMOKOSH ANDREW;;MULLIGAN GEORGE,,https://lens.org/144-394-501-065-109,Patent Application,yes,1,0,22,22,0,C12Q2600/106;;C12Q2600/136;;G01N33/57407;;G01N33/57415;;G01N33/57419;;G01N33/57423;;G01N33/57434;;G01N33/57438;;G01N33/57449;;G01N2800/44;;G16B25/00;;G16B40/00;;A61K31/69;;C12Q1/6886;;A61P35/00;;A61P35/02;;G16H10/40;;G16H20/40;;Y02A90/10;;G16B40/10;;G16B25/10;;G16B25/00;;G16B40/00;;C12Q2600/106;;C12Q2600/136;;G01N33/57407;;G01N33/57415;;G01N33/57419;;G01N33/57423;;G01N33/57434;;G01N33/57438;;G01N33/57449;;G01N2800/44;;Y02A90/10;;G16H10/40;;G16H20/40;;G16B40/10;;G16B25/10;;C12Q1/6886;;A61K31/69;;C12Q2600/158;;G01N33/57426;;G06Q20/40,C12Q1/68;;G06Q50/00;;G16B25/10;;G16B40/10,,3,2,033-580-462-919-793;;052-130-043-164-905,12571354;;pmc149935;;10.1073/pnas.0437875100;;12969978;;10.1182/blood-2003-04-1045,"BOHEN SEAN P ET AL: ""Variation in gene expression patterns in follicular lymphoma and the response to rituximab"", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES - PNAS, NATIONAL ACADEMY OF SCIENCES, US, vol. 100, no. 4, 18 February 2003 (2003-02-18), pages 1926 - 1930, XP002595370, ISSN: 0027-8424, [retrieved on 20030205], DOI: 10.1073/PNAS.0437875100;;B. BARLOGIE: ""Treatment of multiple myeloma"", BLOOD, vol. 103, no. 1, 1 January 2004 (2004-01-01), pages 20 - 32, XP055040377, ISSN: 0006-4971, DOI: 10.1182/blood-2003-04-1045;;BARLOW WILLIAM ET AL: ""Predicting event-free and overall survival after treatment of myeloma with the proteasome inhibitor Bortezomib with pre-treatment and 48-hour post-therapy gene expression patterns"", BLOOD, AMERICAN SOCIETY OF HEMATOLOGY, US, vol. 104, no. 11, Part 1, 1 November 2004 (2004-11-01), pages 414A, XP009129472, ISSN: 0006-4971",ACTIVE
231,EP,B1,EP 0353770 B1,147-266-960-242-04X,1995-11-02,1995,EP 89114453 A,1989-08-04,US 22850788 A,1988-08-05,Ionic phosphites and their use in homogeneous transition metal catalyzed processes.,,UNION CARBIDE CHEM PLASTIC,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/147-266-960-242-04X,Granted Patent,yes,2,0,22,23,0,B01J31/185;;B01J31/185;;B01J2231/321;;B01J2231/321;;B01J2531/0266;;B01J2531/0266;;B01J2531/80;;B01J2531/80;;B01J2531/822;;B01J2531/822;;C07F9/165;;C07F9/65746;;C07F9/65746;;C07C45/50;;C07C45/50;;C07F9/65744;;C07F9/65744;;Y02P20/582;;Y02P20/582,B01J31/22;;B01J31/18;;C07B61/00;;C07C45/49;;C07C45/50;;C07C47/02;;C07F9/6574;;C07F9/6578;;C07F9/6584;;C07F9/6596,,0,0,,,,EXPIRED
232,US,B2,US 11637425 B2,177-265-188-805-540,2023-04-25,2023,US 202117644104 A,2021-12-14,US 202117644104 A;;US 202016991347 A,2020-08-12,Methods and systems for providing estimated transactional data,"A computer-implemented method for providing an estimated utility expenditure to a user may include: obtaining, via one or more processors, historical transactional data of one or more customers other than the user from one or more transactional entities, wherein the historical transactional data includes: at least one address of a given customer of the one or more customers; and a historical utility expenditure associated with the at least one address; generating, via the one or more processors, a heatmap based on the historical transactional data of the one or more customers via one or more algorithms, wherein the heatmap is indicative of at least the estimated utility expenditure associated with the at least one address during a predetermined period; and causing a display of a user device associated with the user to demonstrate the heatmap.",CAPITAL ONE SERVICES LLC,YEE BRYANT;;BERGERON GEORGE;;BULGAKOV MYKHAYLO,CAPITAL ONE SERVICES LLC (2020-08-12),https://lens.org/177-265-188-805-540,Granted Patent,yes,13,0,6,6,0,G06Q50/06;;H02J13/00001;;H02J3/003;;Y04S10/40;;Y04S10/50;;H02J3/003;;H02J13/00001;;G06Q50/06;;H02J2203/20;;H02J13/00034;;G06Q30/0283,H02J3/00;;G06Q50/06;;H02J13/00,,0,0,,,,ACTIVE
233,AU,B2,AU 776889 B2,197-235-553-447-656,2004-09-23,2004,AU 2000/048134 A,2000-05-01,US 35020099 A;;US 0011811 W,1999-07-08,Seismic conductive rope lead-in cable,A conductive rope-like lead-in cable connects a seismic streamer to a towing vessel. The lead-in cable comprises a first electrical conductor at the center core of the cable for carrying a first polarity of power to the streamer for providing tensile strength to the load-in cable. A first layer of insulation surrounds the first electrical conductor. A second electrical conductor for a second polarity of power to the streamer surrounds the first layer of insulation. A second layer of insulation surrounds the second electrical conductor. A layer of seismic data conductors surrounds the second layer of insulation. A third layer of insulation surrounds the layer of seismic data conductors. A metallic protective layer surrounds the third layer of insulation. Steel is effectively and efficiently used both to provide tensile strength and for electrical power conduction.,PGS EXPLORATION US INC,BRYANT MICHAEL J;;GEORGE NICK C,,https://lens.org/197-235-553-447-656,Granted Patent,no,3,0,14,14,0,H01B7/045;;H01B9/003;;H01B9/04;;G01V1/201;;H01B9/003;;H01B7/045;;H01B9/04;;G01V1/201,H01B7/04;;H01B9/00;;H01B9/04,,0,0,,,,EXPIRED
234,DE,D1,DE 3777714 D1,194-968-149-842-506,1992-04-30,1992,DE 3777714 T,1987-07-10,US 88419786 A,1986-07-10,HYDROFORMYLIERUNG UNTER VERWENDUNG VON ORGANISCHEN LOESLICHEN PHOSPHINLIGANDEN MIT GERINGER VOLATILITAET.,,UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/194-968-149-842-506,Granted Patent,no,0,0,52,52,0,C07C45/50;;C07F9/5004;;Y02P20/582;;C07B41/00;;C07C47/02;;C07C45/50;;C07F9/5004;;Y02P20/582,C07B61/00;;B01J31/00;;B01J31/24;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00;;C07F9/50,,0,0,,,,EXPIRED
235,EP,B1,EP 0254937 B1,020-172-709-799-697,1992-03-25,1992,EP 87110014 A,1987-07-10,US 88419786 A,1986-07-10,HYDROFORMYLATION USING LOW VOLATILE/ORGANIC SOLUBLE PHOSPHINE LIGANDS,,UNION CARBIDE CORPORATION,"ABATJOGLOU, ANTHONY GEORGE;;BRYANT, DAVID ROBERT",,https://lens.org/020-172-709-799-697,Granted Patent,yes,3,0,52,52,0,C07C45/50;;C07F9/5004;;Y02P20/582;;C07B41/00;;C07C47/02;;C07C45/50;;C07F9/5004;;Y02P20/582,B01J31/00;;B01J31/24;;C07B61/00;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00;;C07F9/50,,0,0,,,,EXPIRED
236,US,B2,US 11767938 B2,041-063-149-808-581,2023-09-26,2023,US 202117443530 A,2021-07-27,US 202117443530 A,2021-07-27,Compression nut or fitting with removable plunger for easily dislodging stuck ferrules,"A compression fitting includes a nut with a threaded end for receiving a threaded tube and a receiving end for holding a plunger head; and a plunger with an inner bore for receiving a capillary tube and the plunger head for engaging a ferrule positioned within the receiving end between the plunger head and the threaded tube, the plunger slidingly engaged with the nut to force the ferrule from the nut.",THERMO FINNIGAN LLC,GUCKENBERGER GEORGE B;;BRYANT ADAM D,THERMO FINNIGAN LLC (2021-07-20),https://lens.org/041-063-149-808-581,Granted Patent,yes,13,0,4,4,0,G01N30/6039;;G01N30/6004;;F16L19/0225;;G01N30/16;;F16L19/025;;G01N30/6026,F16L19/02;;F16L19/025;;G01N30/16;;G01N30/60,,0,0,,,,ACTIVE
237,ES,T3,ES 2624863 T3,038-126-055-064-996,2017-07-17,2017,ES 13181515 T,2006-06-08,US 68863405 P,2005-06-08,"Métodos para identificación, evaluación, y tratamiento de pacientes con terapia de cáncer","Un método para determinar un régimen de terapia contra el cáncer para tratar un tumor en un paciente que comprende: a) determinar el nivel de expresión de un marcador predictivo en una muestra del paciente que comprende células de tumor, b) comparar el nivel de expresión del marcador predictivo a un nivel de control de expresión para determinar si el nivel de expresión del marcador predictivo es un nivel de expresión informativo; y c) determinar un régimen de terapia contra el cáncer para tratar el tumor con base en la expresión del marcador predictivo, en el que dicho régimen de terapia contra el cáncer es un régimen con base en la inhibición del proteasoma, en el que el marcador predictivo se identifica por un grupo de sondas de número de marcador 660 de la Tabla 1B, y en el que un nivel de expresión informativo es un nivel que cae dentro de un rango de expresión que es predictivo de sensibilidad o no sensibilidad y de esta manera también es indicativo de que el paciente es ya sea un paciente que responde o un paciente que no responde, en el que un paciente que responde se podría beneficiar de dicho régimen de terapia contra el cáncer y un paciente que no responde no se beneficiaría de dicho régimen de terapia contra el cáncer.",MILLENNIUM PHARM INC,BRYANT BARBARA;;DAMOKOSH ANDREW;;MULLIGAN GEORGE,,https://lens.org/038-126-055-064-996,Granted Patent,no,0,0,22,22,0,C12Q2600/106;;C12Q2600/136;;G01N33/57407;;G01N33/57415;;G01N33/57419;;G01N33/57423;;G01N33/57434;;G01N33/57438;;G01N33/57449;;G01N2800/44;;G16B25/00;;G16B40/00;;A61K31/69;;C12Q1/6886;;A61P35/00;;A61P35/02;;G16H10/40;;G16H20/40;;Y02A90/10;;G16B40/10;;G16B25/10;;G16B25/00;;G16B40/00;;C12Q2600/106;;C12Q2600/136;;G01N33/57407;;G01N33/57415;;G01N33/57419;;G01N33/57423;;G01N33/57434;;G01N33/57438;;G01N33/57449;;G01N2800/44;;Y02A90/10;;G16H10/40;;G16H20/40;;G16B40/10;;G16B25/10;;C12Q1/6886;;A61K31/69;;C12Q2600/158;;G01N33/57426;;G06Q20/40,C12Q1/68;;G06Q50/00;;G16B25/10;;G16B40/10,,0,0,,,,ACTIVE
238,EP,A3,EP 0353770 A3,061-953-787-877-397,1990-05-16,1990,EP 89114453 A,1989-08-04,US 22850788 A,1988-08-05,IONIC PHOSPHITES AND THEIR USE IN HOMOGENEOUS TRANSITION METAL CATALYZED PROCESSES,"This invention relates to novel ionic phosphites and the use thereof as ligands in homogenous transition metal catalyzed pro­cesses, especially hydroformylation.  ",UNION CARBIDE CHEMICALS AND PLASTICS COMPANY INC. (A NEW YORK CORPORATION),"ABATJOGLOU, ANTHONY GEORGE;;BRYANT, DAVID ROBERT",,https://lens.org/061-953-787-877-397,Search Report,yes,2,0,22,23,0,B01J31/185;;B01J31/185;;B01J2231/321;;B01J2231/321;;B01J2531/0266;;B01J2531/0266;;B01J2531/80;;B01J2531/80;;B01J2531/822;;B01J2531/822;;C07F9/165;;C07F9/65746;;C07F9/65746;;C07C45/50;;C07C45/50;;C07F9/65744;;C07F9/65744;;Y02P20/582;;Y02P20/582,B01J31/22;;B01J31/18;;C07B61/00;;C07C45/49;;C07C45/50;;C07C47/02;;C07F9/6574;;C07F9/6578;;C07F9/6584;;C07F9/6596,,0,0,,,,EXPIRED
239,GB,A,GB 2105230 A,081-063-991-425-727,1983-03-23,1983,GB 8221137 A,1982-07-21,US 9018479 A,1979-11-01,FORGING METHOD AND APPARATUS,,UNITED TECHNOLOGIES CORP,WALKER BRYANT HARDING;;MACNITT DONALD GEORGE,,https://lens.org/081-063-991-425-727,Patent Application,no,0,0,30,35,0,B21J5/02;;B21J9/02;;B21J13/02;;B21K1/36;;B21K29/00;;Y10T29/49336;;Y10T29/49336;;B21J5/02;;B21K1/36;;B21J9/02;;B21J13/02;;B21K29/00,B21J5/02;;B21J9/02;;B21J13/02;;B21K1/36;;B21K3/04,B3H H16N          H16N;;B3H H2R           H16N;;B3H H2W           H16N,0,0,,,,EXPIRED
240,US,A,US 2847073 A,097-829-423-105-781,1958-08-12,1958,US 44828554 A,1954-08-06,US 44828554 A,1954-08-06,Tool for controlling fluid circulation in well bores,,ROY L ARTERBURY,ARTERBURY BRYANT P;;CLARK GEORGE M,,https://lens.org/097-829-423-105-781,Granted Patent,no,5,13,1,1,0,E21B33/124;;E21B33/124,E21B33/124,,0,0,,,,EXPIRED
241,MX,A,MX 158566 A,117-055-194-357-21X,1989-02-15,1989,MX 19175582 A,1982-03-11,US 24308281 A,1981-03-12,PROCEDIMIENTO PARA SEPARAR HIDROPEROXIDOS Y ALDEHIDOS DE ETER DE ALIL-ALQUILO,"Described herein is a process for the conversion of hydroperoxides, present in alkyl-alkyl ethers to products including alpha , beta -unsaturated aldehydes and for reducing such alpha , beta -unsaturated aldehydes to alcohols prior to the use of the ether as a feedstock in a hydroformylation reaction to produce the corresponding ether aldehyde. The process involves contacting the ether with a metal hydride, either in aqueous solution and/or by means of an ion exchange resin. Such treatment decomposes the hydroperoxides and then reduces their alpha , beta -unsaturated aldehyde decomposition products, thereby reducing the catalyst inhibition period present in the hydroformylation reaction which is observed when such alpha , beta -unsaturated aldehyde impurities are present.",UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/117-055-194-357-21X,Granted Patent,no,0,0,16,17,0,C07C29/175;;C07C31/10;;C07C41/36;;C07C41/44;;C07C45/53;;C07C45/62;;C07C43/00,C07C29/17;;C07C43/18;;C07C31/10;;C07C41/00;;C07C41/34;;C07C41/36;;C07C41/44;;C07C43/00;;C07C43/15;;C07C43/188;;C07C45/53;;C07C45/62;;C07C67/00,,0,0,,,,EXPIRED
242,FI,C,FI 89351 C,150-435-620-093-191,1993-09-27,1993,FI 873054 A,1987-07-10,US 88419786 A,1986-07-10,HYDROFORMYLERING SOM UTNYTTJAR SVAGT FLYKTIGA FOSFINLIGANDER SOM AER LOESLIGA I ORGANISKA AEMNEN,,UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/150-435-620-093-191,Granted Patent,no,0,0,52,52,0,C07C45/50;;C07F9/5004;;Y02P20/582;;C07B41/00;;C07C47/02;;C07C45/50;;C07F9/5004;;Y02P20/582,B01J31/00;;B01J31/24;;C07C45/00;;C07B61/00;;C07C45/50;;C07C47/02;;C07C67/00;;C07F9/50,,0,0,,,,EXPIRED
243,CN,A,CN 86101888 A,142-729-768-946-406,1987-09-30,1987,CN 86101888 A,1986-03-22,US 71472285 A,1985-03-22,PROCESS FOR TREATING WET PAPER WITH FOAM,"Specifically structured foamed compositions of paper treating agents applied to wet paper, such as wet-end paper web produced during high speed paper manufacture, provide uniform treating agent distribution and treated paper having properties comparable to dry-processed paper.",UNION CARBIDE CORP.,GEORGE MACON BRYANT;;RUSSELL LEE BROWN,,https://lens.org/142-729-768-946-406,Patent Application,no,0,0,10,10,0,D21H21/56;;D21H23/26,D21H17/03;;D21H17/35;;D21H19/00;;D21H21/56;;D21H23/26,,0,0,,,,PENDING
244,US,B2,US 11431701 B2,144-427-289-247-420,2022-08-30,2022,US 202016996820 A,2020-08-18,US 202016996820 A,2020-08-18,Computer-based systems involving sharing session authentication and/or account details with a trusted party and methods of use thereof,"Systems and methods associated with sharing encrypted account details with a trusted party are disclosed. In one embodiment, an exemplary method may comprise hosting an online service accessed by a plurality of user accounts each configured for concurrent access sessions, establishing a first authenticated access session for a first user account between the online service and a first device associated with a first user, receiving a login request associated with the first user account to establish a second authenticated access session between the online service and a second device associated with a second user, transmitting, to the first device, a notification of the login request including a GUI element and a request to authenticate the login request, and establishing the second authenticated access session between the online service and the second device of the second user based on authentication of the second user via the GUI element.",CAPITAL ONE SERVICES LLC,YEE BRYANT;;BERGERON GEORGE;;BULGAKOV MYKHAYLO,CAPITAL ONE SERVICES LLC (2020-08-17),https://lens.org/144-427-289-247-420,Granted Patent,yes,16,0,2,2,0,H04L67/141;;H04W12/068;;H04L63/105;;H04W12/084;;H04L63/0838;;H04L67/141;;H04L63/105;;H04L63/102,G06F15/16;;G06F7/04;;H04L9/40;;H04L67/141,,0,0,,,,ACTIVE
245,US,A1,US 2022/0417024 A1,149-594-187-361-679,2022-12-29,2022,US 202117358473 A,2021-06-25,US 202117358473 A,2021-06-25,CRYPTOGRAPHIC AUTHENTICATION TO CONTROL ACCESS TO STORAGE DEVICES,"Systems, methods, apparatuses, and computer-readable media for cryptographic authentication to control access to storage devices. An applet executing on a processor of a contactless card may receive, via a wireless communications interface of the contactless card, a request to access a storage device of the contactless card, where the storage device is in a locked state. The applet may generate a cryptogram based on the request and transmit the cryptogram to a computing device via the wireless communications interface. The applet may receive, from the computing device, an indication specifying that a server decrypted the cryptogram. The applet may transmit, to a controller of the storage device and based on the indication specifying that the server decrypted the cryptogram, an indication specifying to unlock the storage device. The controller may transition the storage device from the locked state to an unlocked state based on the indication received from the applet.",CAPITAL ONE SERVICES LLC,YEE BRYANT;;BULGAKOV MYKHAYLO;;BERGERON GEORGE,CAPITAL ONE SERVICES LLC (2021-06-24),https://lens.org/149-594-187-361-679,Patent Application,yes,3,2,5,5,0,G06F21/44;;G06F21/78;;G06F2221/2105;;H04W12/069;;G06F3/0622;;G06F3/0655;;G06F3/0679;;G06F13/4282;;G06F2213/0042;;H04L9/3226;;H04L9/3234;;H04L2209/805,H04L9/32;;G06F3/06;;G06F13/42,,0,0,,,,PENDING
246,US,A1,US 2022/0052522 A1,179-799-959-218-854,2022-02-17,2022,US 202016991347 A,2020-08-12,US 202016991347 A,2020-08-12,METHODS AND SYSTEMS FOR PROVIDING AN ESTIMATED UTILITY EXPENDITURE,"A computer-implemented method for providing an estimated utility expenditure to a user may include: obtaining, via one or more processors, historical transactional data of one or more customers other than the user from one or more transactional entities, wherein the historical transactional data includes: at least one address of a given customer of the one or more customers; and a historical utility expenditure associated with the at least one address; generating, via the one or more processors, a heatmap based on the historical transactional data of the one or more customers via one or more algorithms, wherein the heatmap is indicative of at least the estimated utility expenditure associated with the at least one address during a predetermined period; and causing a display of a user device associated with the user to demonstrate the heatmap.",CAPITAL ONE SERVICES LLC,YEE BRYANT;;BERGERON GEORGE;;BULGAKOV MYKHAYLO,CAPITAL ONE SERVICES LLC (2020-08-12),https://lens.org/179-799-959-218-854,Patent Application,yes,0,0,6,6,0,G06Q50/06;;H02J13/00001;;H02J3/003;;Y04S10/40;;Y04S10/50;;H02J3/003;;H02J13/00001;;G06Q50/06;;H02J2203/20;;H02J13/00034;;G06Q30/0283,H02J3/00;;H02J13/00,,0,0,,,,ACTIVE
247,IN,A,IN 6605DEN2012 A,192-367-083-708-761,2015-10-23,2015,IN 6605DEN2012 A,2012-07-26,US 29180409 P;;US 29177909 P;;US 29173209 P;;US 2011/0020052 W,2009-12-31,ULTRASOUND COUPLING DEVICE,"The present invention relates to an ultrasound coupling device for use with various ultrasound transducers, systems, and applications. The coupling device includes a coupling compartment comprising a chamber having a continuous side wall and an opening on a first end. The continuous side wall is configured to hold a low-profile ultrasound transducer within the chamber so that a front ultrasound emitting surface of the low-profile ultrasound transducer faces outward toward the chamber opening. The front ultrasound emitting surface is configured to control the direction and wave pattern of ultrasonic energy emitted from the transducer. The continuous side wall is also configured to hold a quantity of an ultrasound conductive medium within the chamber and is operative to keep the ultrasound conductive medium in simultaneous contact with a surface of a subject and with at least a portion of the front ultrasound emitting surface of the transducer. The present invention also relates to an ultrasound apparatus, kit, and methods of using the ultrasound coupling device, apparatus, and kit.",ZETROZ LLC,GEORGE K LEWIS JR;;BRYANT GUFFEY,,https://lens.org/192-367-083-708-761,Patent Application,no,0,0,32,32,0,A61B8/4281;;A61B17/2251;;A61B2017/2253;;A61N2007/0078;;A61B8/4227;;A61B8/4236;;A61B8/4427;;A61B2017/00734;;A61N2007/006;;A61N2007/0091;;A61N2007/0095;;A61B8/44;;A61N7/00;;Y10T29/49005;;A61B2034/301;;A61B34/30;;A61B2034/303;;A61B2034/107;;A61B34/10;;A61N2007/0034;;Y10T29/49005;;A61B8/4281;;A61B17/2251;;A61B2017/2253;;A61N2007/0078;;A61B8/4227;;A61B8/4236;;A61B2017/00734;;A61N2007/0091;;A61N2007/0095;;A61B8/4427;;A61B8/44;;A61N2007/006;;A61N7/00,G01N/,,0,0,,,,PENDING
248,WO,A2,WO 2011/082402 A2,198-049-221-208-277,2011-07-07,2011,US 2011/0020052 W,2011-01-03,US 29180409 P;;US 29177909 P;;US 29173209 P,2009-12-31,ULTRASOUND COUPLING DEVICE,"The present invention relates to an ultrasound coupling device for use with various ultrasound transducers, systems, and applications. The coupling device includes a coupling compartment comprising a chamber having a continuous side wall and an opening on a first end. The continuous side wall is configured to hold a low-profile ultrasound transducer within the chamber so that a front ultrasound emitting surface of the low-profile ultrasound transducer faces outward toward the chamber opening. The front ultrasound emitting surface is configured to control the direction and wave pattern of ultrasonic energy emitted from the transducer. The continuous side wall is also configured to hold a quantity of an ultrasound conductive medium within the chamber and is operative to keep the ultrasound conductive medium in simultaneous contact with a surface of a subject and with at least a portion of the front ultrasound emitting surface of the transducer. The present invention also relates to an ultrasound apparatus, kit, and methods of using the ultrasound coupling device, apparatus, and kit.",ZETROZ LLC;;LEWIS JR GEORGE K;;GUFFEY BRYANT,LEWIS JR GEORGE K;;GUFFEY BRYANT,,https://lens.org/198-049-221-208-277,Patent Application,yes,5,14,32,32,0,A61B8/4281;;A61B17/2251;;A61B2017/2253;;A61N2007/0078;;A61B8/4227;;A61B8/4236;;A61B8/4427;;A61B2017/00734;;A61N2007/006;;A61N2007/0091;;A61N2007/0095;;A61B8/44;;A61N7/00;;Y10T29/49005;;A61B2034/301;;A61B34/30;;A61B2034/303;;A61B2034/107;;A61B34/10;;A61N2007/0034;;Y10T29/49005;;A61B8/4281;;A61B17/2251;;A61B2017/2253;;A61N2007/0078;;A61B8/4227;;A61B8/4236;;A61B2017/00734;;A61N2007/0091;;A61N2007/0095;;A61B8/4427;;A61B8/44;;A61N2007/006;;A61N7/00,A61N7/00;;A61B8/00,,1,0,,,See also references of EP 2519322A4,PENDING
249,CA,A1,CA 3221805 A1,029-606-282-975-737,2022-12-29,2022,CA 3221805 A,2022-06-24,US 202117358473 A;;US 2022/0034863 W,2021-06-25,CRYPTOGRAPHIC AUTHENTICATION TO CONTROL ACCESS TO STORAGE DEVICES,"Systems, methods, apparatuses, and computer-readable media for cryptographic authentication to control access to storage devices. An applet executing on a processor of a contactless card may receive, via a wireless communications interface of the contactless card, a request to access a storage device of the contactless card, where the storage device is in a locked state. The applet may generate a cryptogram based on the request and transmit the cryptogram to a computing device via the wireless communications interface. The applet may receive, from the computing device, an indication specifying that a server decrypted the cryptogram. The applet may transmit, to a controller of the storage device and based on the indication specifying that the server decrypted the cryptogram, an indication specifying to unlock the storage device. The controller may transition the storage device from the locked state to an unlocked state based on the indication received from the applet.",CAPITAL ONE SERVICES LLC,YEE BRYANT;;BULGAKOV MYKHAYLO;;BERGERON GEORGE,,https://lens.org/029-606-282-975-737,Patent Application,no,0,0,5,5,0,G06F21/44;;G06F21/78;;G06F2221/2105;;H04W12/069;;G06F3/0622;;G06F3/0655;;G06F3/0679;;G06F13/4282;;G06F2213/0042;;H04L9/3226;;H04L9/3234;;H04L2209/805,G06F21/44;;G06F21/78;;H04W12/069,,0,0,,,,PENDING
250,US,A,US 3685025 A,030-249-531-622-936,1972-08-15,1972,US 3685025D A,1970-06-25,US 4963170 A,1970-06-25,SENSE AMPLIFIER/BIT DRIVER FOR SEMICONDUCTOR MEMORIES,"A combined, differentially operated sense amplifier and bit driver circuit for a semiconductor memory system which requires only a single decoder. The state of a selected cell is sensed depending upon the relative polarities of the signals on a pair of sense/drive conductors extended to a group of cells. A bit is written in a selected cell by energizing a selected one of the same two conductors. The same polarity decoder output signal causes the sense amplifier/bit driver circuit to operate in either the read or write mode depending upon the state of a read/write conductor extended to the circuit.",RICHARD W BRYANT;;GEORGE K TU,BRYANT RICHARD W;;TU GEORGE K,,https://lens.org/030-249-531-622-936,Granted Patent,no,5,3,2,2,0,G11C11/4116;;G11C11/416;;H03K17/6221;;G11C11/416;;H03K17/6221;;G11C11/4116,G11C11/411;;G11C11/416;;H03K17/62,340173   FF;;307/238,0,0,,,,EXPIRED
251,AT,T1,AT E37571 T1,024-314-247-345-274,1988-10-15,1988,AT 86103923 T,1986-03-21,EP 86103923 A;;US 71472285 A,1985-03-22,VERFAHREN ZUR BEHANDLUNG EINES NASSEN PAPIERS MIT SCHAUM.,"Specifically structured foamed compositions of paper treating agents applied to wet paper, such as wet-end paper web produced during high speed paper manufacture, provide uniform treating agent distribution and treated paper having properties comparable to dry-processed paper.",UNION CARBIDE CORP,BRYANT GEORGE MACON;;BROWN RUSSELL LEE,,https://lens.org/024-314-247-345-274,Granted Patent,no,0,0,10,10,0,D21H21/56;;D21H23/26,D21H17/03;;D21H17/35;;D21H19/00;;D21H21/56;;D21H23/26,,0,0,,,,DISCONTINUED
252,EP,A1,EP 0195458 A1,031-159-441-979-963,1986-09-24,1986,EP 86103923 A,1986-03-21,US 71472285 A,1985-03-22,Process for treating wet paper with foam.,"Specifically structured foamed compositions of paper treating agents applied to wet paper, such as wet-end paper web produced during high speed paper manufacture, provide uniform treating agent distribution and treated paper having properties comparable to dry-processed paper.",UNION CARBIDE CORP,BRYANT GEORGE MACON;;BROWN RUSSELL LEE,,https://lens.org/031-159-441-979-963,Patent Application,yes,4,14,10,10,0,D21H21/56;;D21H23/26,D21H17/35;;D21H19/00;;D21H17/03;;D21H21/56;;D21H23/26,,2,0,,,"TAPPI, vol. 51, no. 4, April 1968, pages 83A-86A, Atlanta, GA, US; W.P. HAMILL: ""Coating paper with foam"";;H. HENTSCHEL: ""Chemische Technologie der Zellstoff- und Papierherstellung"", 1967, 3rd edition, pages 546-552, VEB Fachverlag, Leipzig, DD; ""Trockung und Fertigstellung des Papiers""",EXPIRED
253,AT,T1,AT E8494 T1,042-326-478-949-164,1984-08-15,1984,AT 82101961 T,1982-03-11,EP 82101961 A;;US 24308281 A,1981-03-12,VERFAHREN ZUR ENTFERNUNG VON HYDROPEROXIDEN UND ALDEHYDEN AUS ALLYL-ALKYL-AETHERN.,"Described herein is a process for the conversion of hydroperoxides, present in alkyl-alkyl ethers to products including alpha , beta -unsaturated aldehydes and for reducing such alpha , beta -unsaturated aldehydes to alcohols prior to the use of the ether as a feedstock in a hydroformylation reaction to produce the corresponding ether aldehyde. The process involves contacting the ether with a metal hydride, either in aqueous solution and/or by means of an ion exchange resin. Such treatment decomposes the hydroperoxides and then reduces their alpha , beta -unsaturated aldehyde decomposition products, thereby reducing the catalyst inhibition period present in the hydroformylation reaction which is observed when such alpha , beta -unsaturated aldehyde impurities are present.",UNION CARBIDE CORPORATION,"ABATIOGLOU, ANTHONY GEORGE;;BRYANT, DAVID ROBERT",,https://lens.org/042-326-478-949-164,Granted Patent,no,0,0,16,17,0,C07C29/175;;C07C31/10;;C07C41/36;;C07C41/44;;C07C45/53;;C07C45/62;;C07C43/00,C07C43/18;;C07C29/17;;C07C31/10;;C07C41/00;;C07C41/34;;C07C41/36;;C07C41/44;;C07C43/00;;C07C43/15;;C07C43/188;;C07C45/53;;C07C45/62;;C07C67/00,,0,0,,,,DISCONTINUED
254,CA,A1,CA 2214931 A1,091-849-691-215-602,1998-03-26,1998,CA 2214931 A,1997-09-02,US 2675296 P,1996-09-26,TETRAHYDROBENZO-A-FLUORENE COMPOUNDS AND METHOD OF USE,"The invention provides tetrahydrobenzo¢a!fluorene compounds, formulations, and methods of inhibiting bone loss or bone resorption, particularly osteoporosis, and cardiovascular-related pathological conditions, including hyperlipidemia.",LILLY CO ELI,CULLINAN GEORGE JOSEPH;;BRYANT HENRY UHLMAN,,https://lens.org/091-849-691-215-602,Patent Application,no,0,0,11,11,0,A61K31/565;;A61K31/57;;C07C217/18;;C07D295/088;;C07C2603/40;;A61P19/10;;A61P3/06;;A61P43/00;;A61P9/00;;C07D295/088;;A61K31/565;;C07C217/18;;A61K31/57;;C07C2603/40,C07D295/08;;A61K31/135;;A61K31/40;;A61K31/445;;A61K31/55;;A61K31/565;;A61K31/57;;A61P3/06;;A61P9/00;;A61P19/10;;A61P43/00;;C07C217/18;;C07C309/65;;C07D207/06;;C07D295/092;;C07J69/00,,0,0,,,,DISCONTINUED
255,IT,A0,IT 8722675 A0,091-782-308-056-095,1987-11-18,1987,IT 2267587 A,1987-11-18,US 93200286 A,1986-11-18,IDROFORMILAZIONE USANDO LEGANTI FOSFINICI POCO VOLATILI.,,UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/091-782-308-056-095,Patent Application,no,0,0,53,53,0,C07C45/50;;Y02P20/582;;C07C47/55;;C07C47/02;;C07C45/50;;Y02P20/582,B01J31/24;;B01J31/00;;B01J31/28;;C07B61/00;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00,,0,0,,,,EXPIRED
256,US,A,US 3679917 A,099-106-789-080-578,1972-07-25,1972,US 3679917D A,1970-05-01,US 3367170 A,1970-05-01,INTEGRATED CIRCUIT SYSTEM HAVING SINGLE POWER SUPPLY,"An integrated circuit system having a single power supply. Rather than using multiple voltage sources, a single voltage source is used from which multiple reference voltages are derived. Multiple reference voltages can be used due to the incorporation of temperature compensation circuits.",COGAR CORP,BRYANT RICHARD W;;TU GEORGE K,,https://lens.org/099-106-789-080-578,Granted Patent,no,5,14,3,3,0,H03K19/086;;H03K19/086,H03K19/086,307/297;;307/213;;307/215;;307/218;;307/237;;307/310;;330 30   D,2,0,,,"Millman & Taub, Pulse Digital and Switching Waveforms, p. 182 183, McGraw Hill Book Company, 1965;;Cavaliere, Nonlinear Resistor for Collector Clamping, IBM Technical Disclosure Bulletin, P. 328, Vol. 9, No. 3, 8/1966.",EXPIRED
257,FI,B,FI 90858 B,104-330-423-612-926,1993-12-31,1993,FI 875087 A,1987-11-18,US 93200286 A,1986-11-18,Hydroformylointi käyttäen heikosti haihtuvia fosfiiniligandeja,,UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/104-330-423-612-926,Patent Application,no,0,0,53,53,0,C07C45/50;;Y02P20/582;;C07C47/55;;C07C47/02;;C07C45/50;;Y02P20/582,B01J31/00;;B01J31/28;;C07B61/00;;C07C45/00;;B01J31/24;;C07C45/50;;C07C47/02;;C07C67/00,,0,0,,,,EXPIRED
258,AU,B2,AU 611867 B2,115-707-924-366-555,1991-06-27,1991,AU 1987/081280 A,1987-11-17,US 93200286 A,1986-11-18,HYDROFORMYLATION USING LOW VOLATILE PHOSPHINE LIGANDS,,UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/115-707-924-366-555,Granted Patent,no,3,0,53,53,0,C07C45/50;;Y02P20/582;;C07C47/55;;C07C47/02;;C07C45/50;;Y02P20/582,B01J31/24;;B01J31/00;;B01J31/28;;C07B61/00;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00,,0,0,,,,EXPIRED
259,WO,A1,WO 1997/008187 A1,125-365-311-148-198,1997-03-06,1997,US 9614092 W,1996-08-27,US 295995 P,1995-08-30,N-BUTYLSULFONATE ESTERS OF ESTROGENS,"The present invention provides (I) wherein X is α-CH2OR1 when A is α-hydro, A and B together are ethylene, and C and D together are ethylene, β-CH¿2OR?1, or -CO-; R is -H or n-butylsulfonoyl; R1 is R provided that at least one of R and R1 must be n-butylsulfonoyl; R2 is -H, α- or β-hydroxy, or α- or β-n-butylsulfonoyl; A is (a) or (b); B is (c) or (d); C is -CH¿2? or (b); and D is -CH2 or (b), methods of inhibiting estrogen deficient pathologies, and pharmaceutical formulations.",LILLY CO ELI;;BRYANT HENRY U;;CULLINAN GEORGE J,BRYANT HENRY U;;CULLINAN GEORGE J,,https://lens.org/125-365-311-148-198,Patent Application,yes,5,0,3,3,0,C07J31/006,C07J31/00,,0,0,,,,PENDING
260,AU,B2,AU 631199 B2,127-285-399-070-956,1992-11-19,1992,AU 1990/051945 A,1990-02-16,US 32484789 A,1989-03-17,MULTILAYER COATED CEMENTED CARBIDE CUTTING INSERT,,KENNAMETAL INC.,WILLIAM A. BRYANT;;GEORGE P. GRAB,,https://lens.org/127-285-399-070-956,Granted Patent,no,3,0,17,19,0,B23B27/14;;B23B27/145;;B23B2228/36;;C23C30/005,B22F7/00;;B22F7/04;;B23B27/14;;C23C16/30;;C23C30/00,,0,0,,,,EXPIRED
261,DE,D1,DE 3260390 D1,138-163-001-294-735,1984-08-23,1984,DE 3260390 T,1982-03-11,US 24308281 A,1981-03-12,PROCESS FOR REMOVING HYDROPEROXIDES AND ALDEHYDES FROM ALLYL-ALKYL ETHER,"Described herein is a process for the conversion of hydroperoxides, present in alkyl-alkyl ethers to products including alpha , beta -unsaturated aldehydes and for reducing such alpha , beta -unsaturated aldehydes to alcohols prior to the use of the ether as a feedstock in a hydroformylation reaction to produce the corresponding ether aldehyde. The process involves contacting the ether with a metal hydride, either in aqueous solution and/or by means of an ion exchange resin. Such treatment decomposes the hydroperoxides and then reduces their alpha , beta -unsaturated aldehyde decomposition products, thereby reducing the catalyst inhibition period present in the hydroformylation reaction which is observed when such alpha , beta -unsaturated aldehyde impurities are present.",UNION CARBIDE CORP,ABATIOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/138-163-001-294-735,Granted Patent,no,0,0,16,17,0,C07C29/175;;C07C31/10;;C07C41/36;;C07C41/44;;C07C45/53;;C07C45/62;;C07C43/00,C07C43/18;;C07C29/17;;C07C31/10;;C07C41/00;;C07C41/34;;C07C41/36;;C07C41/44;;C07C43/00;;C07C43/15;;C07C43/188;;C07C45/53;;C07C45/62;;C07C67/00,,0,0,,,,EXPIRED
262,US,A1,US 2007/0128435 A1,157-393-904-225-944,2007-06-07,2007,US 59545904 A,2004-10-22,US 59545904 A;;US 69144703 A;;US 69230403 A;;US 0312520 W;;US 37487902 P;;US 2004/0035201 W,2002-04-23,Aluminum conductor composite core reinforced cable and method of manufacture,"This invention relates to an aluminum conductor composite core reinforced cable (ACCC) and method of manufacture. An ACCC 303 cable ( 300 ) has a composite core surrounded by an outer film ( 305 ) and at least one layer of aluminum conductor ( 306 ). The composite core ( 303 ) comprises a plurality of fibers from at least one fiber type in one or more matrix materials. According to the invention, unique processing techniques such a B-Staging and/or film-coating techniques can be used to increase production rates from a few feet per minute to sixty or more feet per minute.",HIEL CLEMENT;;BRYANT DAVID;;KORZENLOWSKI GEORGE,HIEL CLEMENT;;BRYANT DAVID;;KORZENLOWSKI GEORGE,,https://lens.org/157-393-904-225-944,Patent Application,yes,87,40,34,35,0,B29C70/52;;B29L2031/3462;;B32B1/00;;B32B15/02;;B32B15/08;;B32B15/20;;B32B27/04;;H01B5/105;;B29C70/528;;Y10T428/2918;;Y10T428/2933;;Y10T428/2936;;Y10T442/30;;B32B27/04;;B82Y30/00;;Y10T428/2918;;Y10T428/2933;;Y10T428/2936;;Y10T442/30;;B32B2305/08;;B32B2307/54;;B32B27/08;;B32B2457/00;;B29L2031/3462;;B32B1/00;;B29C70/52;;B32B15/02;;B32B15/20;;B32B27/04;;B32B15/08;;H01B5/105;;B29C70/528,D02G3/00;;B05D1/18;;B05D3/02;;B32B27/04;;B65H/;;D04H3/08,428/375,0,0,,,,DISCONTINUED
263,WO,A3,WO 2011/082402 A3,162-615-463-491-973,2011-12-22,2011,US 2011/0020052 W,2011-01-03,US 29180409 P;;US 29177909 P;;US 29173209 P,2009-12-31,ULTRASOUND COUPLING DEVICE,"The present invention relates to an ultrasound coupling device for use with various ultrasound transducers, systems, and applications. The coupling device includes a coupling compartment comprising a chamber having a continuous side wall and an opening on a first end. The continuous side wall is configured to hold a low-profile ultrasound transducer within the chamber so that a front ultrasound emitting surface of the low-profile ultrasound transducer faces outward toward the chamber opening. The front ultrasound emitting surface is configured to control the direction and wave pattern of ultrasonic energy emitted from the transducer. The continuous side wall is also configured to hold a quantity of an ultrasound conductive medium within the chamber and is operative to keep the ultrasound conductive medium in simultaneous contact with a surface of a subject and with at least a portion of the front ultrasound emitting surface of the transducer. The present invention also relates to an ultrasound apparatus, kit, and methods of using the ultrasound coupling device, apparatus, and kit.",ZETROZ LLC;;LEWIS JR GEORGE K;;GUFFEY BRYANT,LEWIS JR GEORGE K;;GUFFEY BRYANT,,https://lens.org/162-615-463-491-973,Search Report,yes,7,0,32,32,0,A61B8/4281;;A61B17/2251;;A61B2017/2253;;A61N2007/0078;;A61B8/4227;;A61B8/4236;;A61B8/4427;;A61B2017/00734;;A61N2007/006;;A61N2007/0091;;A61N2007/0095;;A61B8/44;;A61N7/00;;Y10T29/49005;;A61B2034/301;;A61B34/30;;A61B2034/303;;A61B2034/107;;A61B34/10;;A61N2007/0034;;Y10T29/49005;;A61B8/4281;;A61B17/2251;;A61B2017/2253;;A61N2007/0078;;A61B8/4227;;A61B8/4236;;A61B2017/00734;;A61N2007/0091;;A61N2007/0095;;A61B8/4427;;A61B8/44;;A61N2007/006;;A61N7/00,A61N7/00;;A61B8/00,,0,0,,,,PENDING
264,BE,A5,BE 1001190 A5,162-620-605-167-631,1989-08-16,1989,BE 8700760 A,1987-07-10,US 88419786 A,1986-07-10,HYDROFORMYLATION UTILISANT DES LIGANDS PHOSPHINIQUES FAIBLEMENT VOLATILS/ORGANOSOLUBLES.,"Procédé d'hydroformylation non aqueux destiné à la fabrication d'aldéhydes, suivant lequel on fait réagir un composé organique à insaturation oléfinique, de l'oxyde de carbone et de l'hydrogène dans un milieu réactionnel contenant un catalyseur à complexe de ligand phosphoré et de métal de transition du Groupe VIII organosolubilisé et du ligand phosphoré libre, le ligand étant un sel de phosphine tertiaire monosulfoné organosoluble.",UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/162-620-605-167-631,Granted Patent,no,3,0,52,52,0,C07C45/50;;C07F9/5004;;Y02P20/582;;C07B41/00;;C07C47/02;;C07C45/50;;C07F9/5004;;Y02P20/582,C07B61/00;;B01J31/00;;B01J31/24;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00;;C07F9/50,,0,0,,,,EXPIRED
265,FI,A,FI 875087 A,192-930-054-070-391,1988-05-19,1988,FI 875087 A,1987-11-18,US 93200286 A,1986-11-18,Hydroformylointi käyttäen heikosti haihtuvia fosfiiniligandeja,,UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/192-930-054-070-391,Patent Application,no,0,0,53,53,0,C07C45/50;;Y02P20/582;;C07C47/55;;C07C47/02;;C07C45/50;;Y02P20/582,B01J31/00;;B01J31/24;;B01J31/28;;C07B61/00;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00,,0,0,,,,EXPIRED
266,EP,B1,EP 0463000 B1,007-835-778-198-450,1994-10-26,1994,EP 90904146 A,1990-02-16,US 9000924 W;;US 32484789 A,1989-03-17,MULTILAYER COATED CEMENTED CARBIDE CUTTING INSERT.,,KENNAMETAL INC,BRYANT WILLIAM A;;GRAB GEORGE P,,https://lens.org/007-835-778-198-450,Granted Patent,yes,1,6,17,19,0,B23B27/14;;B23B27/145;;B23B2228/36;;C23C30/005,B22F7/00;;B22F7/04;;B23B27/14;;C23C16/30;;C23C30/00,,0,0,,,,EXPIRED
267,US,A1,US 2023/0029511 A1,013-475-922-554-589,2023-02-02,2023,US 202117443530 A,2021-07-27,US 202117443530 A,2021-07-27,Compression Nut or Fitting with Removable Plunger for Easily Dislodging Stuck Ferrules,"A compression fitting includes a nut with a threaded end for receiving a threaded tube and a receiving end for holding a plunger head; and a plunger with an inner bore for receiving a capillary tube and the plunger head for engaging a ferrule positioned within the receiving end between the plunger head and the threaded tube, the plunger slidingly engaged with the nut to force the ferrule from the nut.",THERMO FINNIGAN LLC,GUCKENBERGER GEORGE B;;BRYANT ADAM D,THERMO FINNIGAN LLC (2021-07-20),https://lens.org/013-475-922-554-589,Patent Application,yes,13,0,4,4,0,G01N30/6039;;G01N30/6004;;F16L19/0225;;G01N30/16;;F16L19/025;;G01N30/6026,F16L19/02;;F16L19/025,,0,0,,,,ACTIVE
268,DE,T2,DE 69711529 T2,012-786-311-941-266,2002-10-31,2002,DE 69711529 T,1997-09-25,US 2675296 P,1996-09-26,Tetra-Hydrobenzo(a)fluorenverbindungen und ihre Anwendungen,"The invention provides tetrahydrobenzoÄaÜfluorene compounds, formulations, and methods of inhibiting bone loss or bone resorption, particularly osteoporosis, and cardiovascular-related pathological conditions, including hyperlipidemia.",LILLY CO ELI,BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH,,https://lens.org/012-786-311-941-266,Granted Patent,no,0,0,11,11,0,A61K31/565;;A61K31/57;;C07C217/18;;C07D295/088;;C07C2603/40;;A61P19/10;;A61P3/06;;A61P43/00;;A61P9/00;;C07D295/088;;A61K31/565;;C07C217/18;;A61K31/57;;C07C2603/40,C07D295/08;;A61K31/135;;A61K31/40;;A61K31/445;;A61K31/55;;A61K31/565;;A61K31/57;;A61P3/06;;A61P9/00;;A61P19/10;;A61P43/00;;C07C217/18;;C07C309/65;;C07D207/06;;C07D295/092;;C07J69/00,,0,0,,,,EXPIRED
269,NO,B,NO 165877 B,020-698-554-932-719,1991-01-14,1991,NO 872887 A,1987-07-10,US 88419786 A,1986-07-10,IKKE-VANDIG HYDROFORMYLERINGSPROSESS FOR FREMSTILLING AV OLEFINER.,,UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/020-698-554-932-719,Unknown,no,0,0,52,52,0,C07C45/50;;C07F9/5004;;Y02P20/582;;C07B41/00;;C07C47/02;;C07C45/50;;C07F9/5004;;Y02P20/582,B01J31/00;;B01J31/24;;C07B61/00;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00;;C07F9/50,,0,0,,,,EXPIRED
270,BR,A,BR 8903474 A,035-116-673-116-011,1990-03-06,1990,BR 8903474 A,1989-07-14,US 21889588 A,1988-07-14,PROCESSO APERFEICOADO PARA A PRODUCAO DE ALCOOIS E ALDEIDOS,,UNION CARBIDE CHEM PLASTIC,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/035-116-673-116-011,Patent Application,no,0,0,11,11,0,C07C45/50;;C07C47/02;;C07C29/16,B01J31/24;;C07B61/00;;C07C27/00;;C07C27/22;;C07C29/16;;C07C31/02;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00,,0,0,,,,DISCONTINUED
271,CN,C,CN 1023798 C,036-589-331-459-547,1994-02-16,1994,CN 89107766 A,1989-08-04,US 22850788 A,1988-08-05,Preparation of ionic phosphites and their use in homogeneous transition metal catalyzed process,,UNION CARBIDE CHEM PLASTIC,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/036-589-331-459-547,Granted Patent,no,0,0,22,23,0,B01J31/185;;B01J31/185;;B01J2231/321;;B01J2231/321;;B01J2531/0266;;B01J2531/0266;;B01J2531/80;;B01J2531/80;;B01J2531/822;;B01J2531/822;;C07F9/165;;C07F9/65746;;C07F9/65746;;C07C45/50;;C07C45/50;;C07F9/65744;;C07F9/65744;;Y02P20/582;;Y02P20/582,B01J31/22;;B01J31/18;;C07B61/00;;C07C45/49;;C07C45/50;;C07C47/02;;C07F9/6574;;C07F9/6578;;C07F9/6584;;C07F9/6596,,0,0,,,,EXPIRED
272,NO,C,NO 165877 C,050-577-734-870-68X,1991-04-24,1991,NO 872887 A,1987-07-10,US 88419786 A,1986-07-10,IKKE-VANDIG HYDROFORMYLERINGSPROSESS FOR FREMSTILLING AV OLEFINER.,,UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/050-577-734-870-68X,Granted Patent,no,0,0,52,52,0,C07C45/50;;C07F9/5004;;Y02P20/582;;C07B41/00;;C07C47/02;;C07C45/50;;C07F9/5004;;Y02P20/582,B01J31/00;;B01J31/24;;C07B61/00;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00;;C07F9/50,,0,0,,,,EXPIRED
273,DE,C,DE 943428 C,072-610-424-153-191,1956-05-17,1956,DE S0034662 A,1953-08-04,DE S0034662 A;;GB 253152 A,1952-01-30,Verfahren zur Herstellung von Schmierfetten,,SHELL REFINING & MARKETING CO,PARRY GEORGE ALWYN;;MATTHEWS JOHN BRYANT,,https://lens.org/072-610-424-153-191,Granted Patent,no,0,3,5,5,0,C10M7/00;;C10M5/00;;C10M2201/02;;C10M2201/083;;C10M2203/10;;C10M2207/022;;C10M2207/10;;C10M2207/125;;C10M2207/129;;C10M2207/24;;C10M2207/282;;C10M2207/34;;C10M2215/06;;C10M2215/064;;C10M2215/065;;C10M2215/067;;C10M2229/02;;C10M2229/05;;C10N2010/00;;C10N2010/02;;C10N2010/04;;C10N2050/10;;C10N2070/00,C10M169/00;;G09B23/24;;G09B23/26,C5F F401          -;;C5F F415          -;;C5F F50X          -;;C5F F504          -;;C5F F505          -;;C5F F506          -;;C5F F508          -;;C5F F509          -;;C5F F510          -;;C5F F511          -;;C5F F512          -;;C5F F516          -;;C5F F517          -;;C5F F593          -;;C5F F595          -;;C5F F597          -;;C5F F803          -,0,0,,,,EXPIRED
274,CA,A1,CA 3194275 A1,083-734-393-812-185,2022-04-07,2022,CA 3194275 A,2021-09-15,US 202017061423 A;;US 2021/0050374 W,2020-10-01,CROWDSOURCED ANNOTATION AND TAGGING SYSTEM FOR DIGITAL TRANSACTIONS AND TRANSACTION PREDICTION SYSTEM,"A system for crowdsourcing annotations for transactions includes a crowdsourcing annotation database and a processor. The database stores crowdsourced annotations associated with merchants. The crowdsourced annotations are shared among, and contributed by, users of a community. The processor receives transaction data for a transaction by a user with a merchant. Relevant crowdsourced annotations associated with the merchant are retrieved from the database and sent to the user to enable to the user to annotate the transaction. The user provides an annotation for the transaction. The system dynamically updates the database based on the annotation provided by the user. In another aspect a transaction prediction system is disclosed. The system receives transaction data and identifies text on a check image associated with the transaction data. The system identifies a recurring expense and associated expense frequency, and may generate an expense warning or suggestion to execute a check to pay the expense.",CAPITAL ONE SERVICES LLC,YEE BRYANT;;BERGERON GEORGE;;BULGAKOV MYKHAYLO,,https://lens.org/083-734-393-812-185,Patent Application,no,0,0,2,6,0,G06V30/19007;;G06V30/242,,,0,0,,,,PENDING
275,US,A,US 1273999 A,097-959-894-376-778,1918-07-30,1918,US 1913/0789227 A,1913-09-11,US 1913/0789227 A,1913-09-11,SPRING SUSPENSION.,,BRYANT ELLSWORTH S;;COULS GEORGE R,BRYANT ELLSWORTH S;;COULS GEORGE R,,https://lens.org/097-959-894-376-778,Granted Patent,no,0,0,1,1,0,B60G11/34;;B60G11/34,,,0,0,,,,EXPIRED
276,EP,A1,EP 1194933 A1,101-902-702-546-628,2002-04-10,2002,EP 00930281 A,2000-05-01,US 0011811 W;;US 35020099 A,1999-07-08,SEISMIC CONDUCTIVE ROPE LEAD-IN CABLE,A conductive rope-like lead-in cable connects a seismic streamer to a towing vessel. The lead-in cable comprises a first electrical conductor at the center core of the cable for carrying a first polarity of power to the streamer for providing tensile strength to the load-in cable. A first layer of insulation surrounds the first electrical conductor. A second electrical conductor for a second polarity of power to the streamer surrounds the first layer of insulation. A second layer of insulation surrounds the second electrical conductor. A layer of seismic data conductors surrounds the second layer of insulation. A third layer of insulation surrounds the layer of seismic data conductors. A metallic protective layer surrounds the third layer of insulation. Steel is effectively and efficiently used both to provide tensile strength and for electrical power conduction.,PGS EXPLORATION US INC,BRYANT MICHAEL J;;GEORGE NICK C,,https://lens.org/101-902-702-546-628,Patent Application,yes,0,0,14,14,0,H01B7/045;;H01B9/003;;H01B9/04;;G01V1/201;;H01B9/003;;H01B7/045;;H01B9/04;;G01V1/201,H01B7/04;;H01B9/00;;H01B9/04,,0,0,,,,EXPIRED
277,AU,A,AU 1989/039251 A,097-375-407-011-968,1990-02-08,1990,AU 1989/039251 A,1989-08-03,US 22850788 A,1988-08-05,PREPARATION OF IONIC PHOSPHITES AND THEIR USE IN HOMOGENEOUS TRANSITION METAL CATALYZED PROCESS,,UNION CARBIDE CHEM PLASTIC,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/097-375-407-011-968,Patent Application,no,0,1,22,23,0,B01J31/185;;B01J31/185;;B01J2231/321;;B01J2231/321;;B01J2531/0266;;B01J2531/0266;;B01J2531/80;;B01J2531/80;;B01J2531/822;;B01J2531/822;;C07F9/165;;C07F9/65746;;C07F9/65746;;C07C45/50;;C07C45/50;;C07F9/65744;;C07F9/65744;;Y02P20/582;;Y02P20/582,B01J31/22;;B01J31/18;;C07B61/00;;C07C45/49;;C07C45/50;;C07C47/02;;C07F9/6574;;C07F9/6578;;C07F9/6584;;C07F9/6596,,0,0,,,,EXPIRED
278,AT,T1,AT E74120 T1,108-971-019-140-635,1992-04-15,1992,AT 87110014 T,1987-07-10,EP 87110014 A;;US 88419786 A,1986-07-10,HYDROFORMYLIERUNG UNTER VERWENDUNG VON ORGANISCHEN LOESLICHEN PHOSPHINLIGANDEN MIT GERINGER VOLATILITAET.,,UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/108-971-019-140-635,Granted Patent,no,0,0,52,52,0,C07C45/50;;C07F9/5004;;Y02P20/582;;C07B41/00;;C07C47/02;;C07C45/50;;C07F9/5004;;Y02P20/582,C07B61/00;;B01J31/00;;B01J31/24;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00;;C07F9/50,,0,0,,,,DISCONTINUED
279,NO,L,NO 861126 L,175-830-265-448-089,1986-09-23,1986,NO 861126 A,1986-03-21,US 71472285 A,1985-03-22,FREMGANGSMAATE FOR BEHANDLING AV VAATT PAPIR MED SKUM.,"Specifically structured foamed compositions of paper treating agents applied to wet paper, such as wet-end paper web produced during high speed paper manufacture, provide uniform treating agent distribution and treated paper having properties comparable to dry-processed paper.",UNION CARBIDE CORP,BRYANT GEORGE MACON;;BROWN RUSSELL LEE,,https://lens.org/175-830-265-448-089,Abstract,no,0,0,10,10,0,D21H21/56;;D21H23/26,D21H17/35;;D21H17/03;;D21H19/00;;D21H21/56;;D21H23/26,,0,0,,,,DISCONTINUED
280,US,A,US 5656079 A,191-067-375-207-781,1997-08-12,1997,US 40308995 A,1995-03-13,US 40308995 A;;US 2520893 A,1993-02-26,Statement of government interest,"The present invention is an apparatus for the synthesis and growth of single crystals of phosphorus compounds starting with the elemental materials in a single furnace without external exposure. The apparatus of the present invention is a crystal growth furnace heated by RF coils. Inside the furnace is a susceptor heated by a lower coil device for holding a crucible. Above the crucible is selectively positioned a phosphorus improved injector. The improved injector is further surrounded by a susceptor which is heated by an upper coil device. The non-phosphorus materials are placed in the crucible and melted to a desired temperature. The phosphorus material previously placed within the injector is heated by the radiant heat from both crucible and the upper susceptor to drive the phosphorus vapor into the melt through a tube. This is closely controlled by noting the temperature within the injector and adjusting the height of the injector above the melt to control the temperature within the phosphorus material. After the formation of the stoichiometric melt, the seed is inserted into the melt for crystal growth if so desired. A further improvement to the above apparatus is the use of an improved injector having a cover and a shield thereabout. The injector and cover have a central hole through which the seed is inserted. The injector is moved vertically within the cover to provide the proper temperature therein.",US ARMY,BLISS DAVID;;BRYANT GEORGE;;GABBE DAVID,UNITED STATES AIR FORCE (1995-03-02);;AIR FORCE UNITED STATES AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (1995-03-09),https://lens.org/191-067-375-207-781,Granted Patent,yes,7,13,1,2,0,C30B15/02;;C30B29/40;;Y10T117/1092;;Y10T117/1092;;C30B15/02;;C30B29/40,C30B15/00;;C30B15/02,117/223;;117/77;;117/81;;117/82;;117/83;;117/935,0,0,,,,EXPIRED
281,DE,D1,DE 68924676 D1,195-316-902-886-510,1995-12-07,1995,DE 68924676 T,1989-08-04,US 22850788 A,1988-08-05,Ionische Phosphite und ihre Verwendung in homogenen übergangsmetallkatalysierten Verfahren.,,UNION CARBIDE CHEM PLASTIC,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/195-316-902-886-510,Granted Patent,no,0,0,22,23,0,B01J31/185;;B01J31/185;;B01J2231/321;;B01J2231/321;;B01J2531/0266;;B01J2531/0266;;B01J2531/80;;B01J2531/80;;B01J2531/822;;B01J2531/822;;C07F9/165;;C07F9/65746;;C07F9/65746;;C07C45/50;;C07C45/50;;C07F9/65744;;C07F9/65744;;Y02P20/582;;Y02P20/582,B01J31/22;;B01J31/18;;C07B61/00;;C07C45/49;;C07C45/50;;C07C47/02;;C07F9/6574;;C07F9/6578;;C07F9/6584;;C07F9/6596,,0,0,,,,EXPIRED
282,CA,A,CA 1032543 A,196-295-695-334-305,1978-06-06,1978,CA 218541 A,1975-01-23,US 44641474 A,1974-07-27,SOLID GLYOXAL-UREAL PRODUCTS,,UNION CARBIDE CORP,GLANCY CHARLES W;;BRYANT GEORGE M,,https://lens.org/196-295-695-334-305,Granted Patent,no,0,0,11,13,0,C08G12/12;;D06M15/423;;D21H19/54;;D21H19/54;;C08G12/12;;D06M15/423,C08G12/00;;C08G12/12;;D06M15/423;;D21H17/50;;D21H19/54,260-315,0,0,,,,EXPIRED
283,GB,B,GB 2193494 B,193-314-634-376-685,1991-01-02,1991,GB 8716161 A,1987-07-09,US 88419786 A,1986-07-10,HYDROFORMYLATION PROCESS,,UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/193-314-634-376-685,Granted Patent,no,0,0,52,52,0,C07C45/50;;C07F9/5004;;Y02P20/582;;C07B41/00;;C07C47/02;;C07C45/50;;C07F9/5004;;Y02P20/582,B01J31/00;;C07B61/00;;B01J31/24;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00;;C07F9/50,C2C CJE;;C2C CTH;;C2C C20Y;;C2C C228;;C2C C248;;C2C C30Y;;C2C C350;;C2C C40Y;;C2C C408;;C2C C54X;;C2C C568;;C2C C569;;C2C C66Y;;C2C C67Y,0,0,,,,EXPIRED
284,JP,A,JP H10109965 A,007-292-726-627-139,1998-04-28,1998,JP 25835197 A,1997-09-24,US 2675296 P,1996-09-26,TETRAHYDROBENZO(A)FLUORENE COMPOUND AND ITS USE,"PROBLEM TO BE SOLVED: To obtain the subject new compound useful for the suppression of pathological states relating to cardiovascular organ including bone loss, bone resorption and especially osteoporosis, hyperlipidemia and other cardiovascular symptoms. SOLUTION: This compound is expressed by formula I R<2> is OH, a 1-4C alkyl, a group of the formula COAr [Ar is a (substituted)phenyl], etc.; R<1> is H or R<2> ; R<3> and R<4> are each a 1-4C alkyl or together form 1-piperidinyl, 1- pyrrolidinyl, etc.; (n) is 2 or 3}, its salt or its solvated product, e.g. 1- 2-[4-(6,6 A,11,11A-tetrahydro-9-methyoxy-5H-benzo[a]fluoren-11-yl) phenoxy]ethyl}pyrrolidine. The compound of the formula I can be produced by treating a corresponding 3,4-dihydronaphthylmethanol precursor such as a compound of the formula II (R2a is OH or a 1-4C alkoxyl) with a trialkylsilane reducing agent in the presence of a strong acid.",LILLY CO ELI,BRYANT HENRY ALMAN;;CULLINAN GEORGE JOSEPH,,https://lens.org/007-292-726-627-139,Patent Application,no,0,0,11,11,0,A61K31/565;;A61K31/57;;C07C217/18;;C07D295/088;;C07C2603/40;;A61P19/10;;A61P3/06;;A61P43/00;;A61P9/00;;C07D295/088;;A61K31/565;;C07C217/18;;A61K31/57;;C07C2603/40,A61K31/135;;A61K31/40;;A61K31/445;;A61K31/55;;A61K31/565;;A61K31/57;;A61P3/06;;A61P9/00;;A61P19/10;;A61P43/00;;C07D295/08;;C07C217/18;;C07C309/65;;C07D207/06;;C07D295/092;;C07J69/00,,0,0,,,,DISCONTINUED
285,EP,A2,EP 1678063 A2,026-788-648-439-594,2006-07-12,2006,EP 04796235 A,2004-10-22,US 2004/0035201 W;;US 69144703 A;;US 69230403 A,2003-10-22,ALUMINUM CONDUCTOR COMPOSITE CORE REINFORCED CABLE AND METHOD OF MANUFACTURE,,CTC CABLE CORP,HIEL CLEMENT;;KORZENIOWSKI GEORGE;;BRYANT DAVID,,https://lens.org/026-788-648-439-594,Patent Application,yes,0,0,34,35,0,B29C70/52;;B29L2031/3462;;B32B1/00;;B32B15/02;;B32B15/08;;B32B15/20;;B32B27/04;;H01B5/105;;B29C70/528;;Y10T428/2918;;Y10T428/2933;;Y10T428/2936;;Y10T442/30;;B32B27/04;;B82Y30/00;;Y10T428/2918;;Y10T428/2933;;Y10T428/2936;;Y10T442/30;;B32B2305/08;;B32B2307/54;;B32B27/08;;B32B2457/00;;B29L2031/3462;;B32B1/00;;B29C70/52;;B32B15/02;;B32B15/20;;B32B27/04;;B32B15/08;;H01B5/105;;B29C70/528,B65H1/00;;B05D1/18;;B05D3/02;;B29C70/08;;B32B15/04;;B32B15/08;;B32B27/04;;B65H/;;D04H3/08;;H01B5/10,,0,0,,,,DISCONTINUED
286,GB,A,GB 189711516 A,038-480-959-173-003,1898-01-29,1898,GB 189711516D A,1897-05-08,GB 189711516T A,1897-05-08,Improvements in Reservoir Pens.,"11,516. Bryant, G. W., and Townsend, T. C. May 8. Pens and penholders.-The nib C, which may be made of celluloid, is held tightly in place in the nib casing B. The split in the nib terminates internally in a hole which is in communication with the interior of the pen. The pen is filled by dipping the writing-end into ink, and withdrawing the glass tube D, by the cap K. When sufficient ink has been sucked in, the pen is inverted to let the ink run into the tube D, which may then be pushed back into place. A protecting-cap F is employed to cover the nib.",BRYANT GEORGE WALLACE;;TOWNSEND THOMAS CHARLES,BRYANT GEORGE WALLACE;;TOWNSEND THOMAS CHARLES,,https://lens.org/038-480-959-173-003,Patent Application,no,0,0,1,1,0,,,,0,0,,,,DISCONTINUED
287,CA,A,CA 787824 A,028-723-167-735-267,1968-06-18,1968,CA 787824D A,,CA 787824T A,,POLYPROPYLENE FIBERS,,UNION CARBIDE CORP,STOFAN RICHARD H;;BRYANT GEORGE M,,https://lens.org/028-723-167-735-267,Granted Patent,no,0,2,1,1,0,,,,0,0,,,,EXPIRED
288,GB,A,GB 189504823 A,046-733-102-496-340,1896-03-07,1896,GB 189504823D A,1895-03-07,GB 189504823T A,1895-03-07,Improvements in and relating to Valves.,,BRYANT GEORGE WALLACE;;MACFARLANE ALEXANDER THOMSON,BRYANT GEORGE WALLACE;;MACFARLANE ALEXANDER THOMSON,,https://lens.org/046-733-102-496-340,Patent Application,no,0,0,1,1,0,,,,0,0,,,,DISCONTINUED
289,IT,A0,IT 8721213 A0,061-110-573-998-358,1987-07-08,1987,IT 2121387 A,1987-07-08,US 88419786 A,1986-07-10,IDROFORMILAZIONE CON L'USO DI LEGANTI COSTITUITI DA FOSFINA ORGANICO SOLUBILE DI BASSA VOLATILITA'.,,UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/061-110-573-998-358,Patent Application,no,0,0,52,52,0,C07C45/50;;C07F9/5004;;Y02P20/582;;C07B41/00;;C07C47/02;;C07C45/50;;C07F9/5004;;Y02P20/582,C07B61/00;;B01J31/00;;B01J31/24;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00;;C07F9/50,,0,0,,,,EXPIRED
290,US,A,US 3656118 A,057-302-705-161-018,1972-04-11,1972,US 3656118D A,1970-05-01,US 3355470 A,1970-05-01,READ/WRITE SYSTEM AND CIRCUIT FOR SEMICONDUCTOR MEMORIES,"This disclosure relates to a system and semiconductor circuit for reading out of and writing into selected storage cells of a semiconductor memory. In particular, the disclosure relates to such a system and circuit wherein a group of cells utilizes a single decoder for both the read and write operations. The use of a single decoder for a group of cells is accomplished by utilizing both the in-phase and out-of-phase outputs of each decoder to minimize the number of logic stages required.",COGAR CORP,BRYANT RICHARD W;;TU GEORGE K,,https://lens.org/057-302-705-161-018,Granted Patent,no,2,0,3,3,0,G11C11/4116;;G11C11/414;;G11C11/416;;H03K3/288;;G11C11/4116;;G11C11/414;;G11C11/416;;H03K3/288,G11C11/411;;G11C11/414;;G11C11/416;;H03K3/288,340173   FF;;340174   DA,0,0,,,,EXPIRED
291,AU,A,AU 1982/081256 A,077-586-903-920-68X,1982-09-16,1982,AU 1982/081256 A,1982-03-10,US 24308281 A,1981-03-12,PROCESS FOR REMOVING HYDROPEROXIDES AND ALDEHYDES FROM ALLYL ALKYL ETHERS,"Described herein is a process for the conversion of hydroperoxides, present in alkyl-alkyl ethers to products including alpha , beta -unsaturated aldehydes and for reducing such alpha , beta -unsaturated aldehydes to alcohols prior to the use of the ether as a feedstock in a hydroformylation reaction to produce the corresponding ether aldehyde. The process involves contacting the ether with a metal hydride, either in aqueous solution and/or by means of an ion exchange resin. Such treatment decomposes the hydroperoxides and then reduces their alpha , beta -unsaturated aldehyde decomposition products, thereby reducing the catalyst inhibition period present in the hydroformylation reaction which is observed when such alpha , beta -unsaturated aldehyde impurities are present.",UNION CARBIDE CORP,ABATIOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/077-586-903-920-68X,Patent Application,no,0,0,16,17,0,C07C29/175;;C07C31/10;;C07C41/36;;C07C41/44;;C07C45/53;;C07C45/62;;C07C43/00,C07C43/18;;C07C29/17;;C07C31/10;;C07C41/00;;C07C41/34;;C07C41/36;;C07C41/44;;C07C43/00;;C07C43/15;;C07C43/188;;C07C45/53;;C07C45/62;;C07C67/00,,0,0,,,,EXPIRED
292,GB,B,GB 2376137 B,089-665-667-888-307,2004-06-23,2004,GB 0220343 A,2001-02-03,US 0103550 W;;US 51442300 A,2000-02-28,Electrical cable insert,,PGS EXPLORATION,GEORGE NICK C;;BRYANT MICHAEL JOHN,,https://lens.org/089-665-667-888-307,Granted Patent,no,4,0,9,9,0,H01R13/523;;H01R13/523;;H01R13/5208;;H01R13/5208;;H01R31/06;;H01R31/06,H01R13/52;;H01R13/523;;H01R31/06,H2E EFBE          EFBE,0,0,,,,EXPIRED
293,CA,A,CA 785745 A,091-877-609-908-038,1968-05-21,1968,CA 785745D A,,CA 785745T A,,POLYETHYLENE FIBERS HAVING IMPROVED STRESS ENDURANCE,,UNION CARBIDE CORP,BRYANT GEORGE M;;POTTS JAMES E,,https://lens.org/091-877-609-908-038,Granted Patent,no,0,1,1,1,0,,,,0,0,,,,EXPIRED
294,FI,A,FI 873054 A,126-297-982-757-167,1988-01-11,1988,FI 873054 A,1987-07-10,US 88419786 A,1986-07-10,HYDROFORMYLERING SOM UTNYTTJAR LITET FLYKTIGA FOSFINLIGANDER LOESLIGA I ORGANISKA AEMNEN.,,UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/126-297-982-757-167,Patent Application,no,0,0,52,52,0,C07C45/50;;C07F9/5004;;Y02P20/582;;C07B41/00;;C07C47/02;;C07C45/50;;C07F9/5004;;Y02P20/582,B01J31/00;;C07B61/00;;B01J31/24;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00;;C07F9/50,,0,0,,,,EXPIRED
295,DE,B,DE 1231431 B,116-049-491-899-376,1966-12-29,1966,DE U0009738 A,1963-04-23,US 18930362 A;;US 18930462 A;;US 18931362 A,1962-04-23,Formmassen aus Polyolefinen,,UNION CARBIDE CORP,BRYANT GEORGE MACON;;ZUTTY NATHAN LEWIS,,https://lens.org/116-049-491-899-376,Patent Application,no,3,0,11,20,0,C08L23/02;;C08L23/10;;C08L23/12;;C08L33/26;;C08L39/04;;D06P3/79;;D06P3/79;;C08L33/26;;C08L23/10;;C08L23/12;;C08L39/04;;C08L23/02;;Y10S8/928;;Y10S8/09,C08L23/02;;C08L23/12;;C08L33/26;;C08L39/04;;D06P3/79,,0,0,,,,DISCONTINUED
296,EP,B1,EP 0832883 B1,142-893-157-819-584,2002-04-03,2002,EP 97307498 A,1997-09-25,US 2675296 P,1996-09-26,Tetrahydrobenzo(a)fluorene compounds and methods of use,"The invention provides tetrahydrobenzoÄaÜfluorene compounds, formulations, and methods of inhibiting bone loss or bone resorption, particularly osteoporosis, and cardiovascular-related pathological conditions, including hyperlipidemia.",LILLY CO ELI,BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH,,https://lens.org/142-893-157-819-584,Granted Patent,yes,1,0,11,11,0,A61K31/565;;A61K31/57;;C07C217/18;;C07D295/088;;C07C2603/40;;A61P19/10;;A61P3/06;;A61P43/00;;A61P9/00;;C07D295/088;;A61K31/565;;C07C217/18;;A61K31/57;;C07C2603/40,C07D295/08;;A61K31/135;;A61K31/40;;A61K31/445;;A61K31/55;;A61K31/565;;A61K31/57;;A61P3/06;;A61P9/00;;A61P19/10;;A61P43/00;;C07C217/18;;C07C309/65;;C07D207/06;;C07D295/092;;C07J69/00,,0,0,,,,EXPIRED
297,JP,A,JP S61258095 A,149-898-246-390-297,1986-11-15,1986,JP 6106986 A,1986-03-20,US 71472285 A,1985-03-22,TREATMENT OF WET PAPER BY FOAM,"Specifically structured foamed compositions of paper treating agents applied to wet paper, such as wet-end paper web produced during high speed paper manufacture, provide uniform treating agent distribution and treated paper having properties comparable to dry-processed paper.",UNION CARBIDE CORP,BRYANT GEORGE MACON;;BROWN RUSSEL LEE,,https://lens.org/149-898-246-390-297,Patent Application,no,5,1,10,10,0,D21H21/56;;D21H23/26,D21H17/35;;D21H19/00;;D21H21/56;;D21H17/03;;D21H23/26,,0,0,,,,DISCONTINUED
298,US,A1,US 2023/0254304 A1,157-829-339-522-691,2023-08-10,2023,US 202217667417 A,2022-02-08,US 202217667417 A,2022-02-08,SYSTEMS AND METHODS FOR SECURE ACCESS OF STORAGE,"Systems and methods for secure access are provided. The secure access system includes a contactless card, a user device, a processor, and a storage device. The processor receives a first authentication request from the user device. Then, the processor transmits a first authentication credential associated with user login data to the user device. Next, the processor receives a second authentication request from the user device. Upon receipt of the second authentication request, the processor transmits a second authentication credential associated with a contactless card to the user device. Then, the processor receives a first code from the user device, and the storage device performs one or more access actions based on the first code.",CAPITAL ONE SERVICES LLC,YEE BRYANT;;BULGAKOV MYKHAYLO;;BERGERON GEORGE,CAPITAL ONE SERVICES LLC (2022-02-08),https://lens.org/157-829-339-522-691,Patent Application,yes,23,0,2,2,0,G06F21/32;;G06F21/34;;G06F21/40;;G06F21/604;;H04L63/0853;;H04L63/0861;;H04L63/0876;;H04L2463/082;;H04L63/083;;H04L63/102;;H04L63/104;;H04L63/20,H04L9/40,,1,1,082-157-376-021-361,10.1109/icirca.2018.8597215,"Dutta et al.; ""Microcontroller Based Bank Locker Security System Using IRIS Scanner and Vein Scanner"", 2018, Proceedings of the International Conference on Inventive Research in Computing Applications, IEEE Xplore, pp. 53-57. (Year: 2018)",PENDING
299,WO,A3,WO 2005/040017 A3,154-230-609-671-604,2005-09-15,2005,US 2004/0035201 W,2004-10-22,US 69144703 A;;US 69230403 A,2003-10-22,ALUMINUM CONDUCTOR COMPOSITE CORE REINFORCED CABLE AND METHOD OF MANUFACTURE,"This invention relates to an aluminum conductor composite core reinforced cable (ACCC) and method of manufacture. An ACCC cable (300) has a composite core surrounded by an outer film (305) and at least one layer of aluminum conductor (306). The composite core (303) comprises a plurality of fibers from at least one fiber type in one or more matrix materials. According to the invention, unique processing techniques such a B-Staging and / or film-coating techniques can be used to increase production rates from a few feet per minute to sixty or more feet per minute.",COMPOSITE TECH CORP;;HIEL CLEMENT;;KORZENIOWSKI GEORGE;;BRYANT DAVID,HIEL CLEMENT;;KORZENIOWSKI GEORGE;;BRYANT DAVID,,https://lens.org/154-230-609-671-604,Search Report,yes,2,0,34,35,0,B29C70/52;;B29L2031/3462;;B32B1/00;;B32B15/02;;B32B15/08;;B32B15/20;;B32B27/04;;H01B5/105;;B29C70/528;;Y10T428/2918;;Y10T428/2933;;Y10T428/2936;;Y10T442/30;;B32B27/04;;B82Y30/00;;Y10T428/2918;;Y10T428/2933;;Y10T428/2936;;Y10T442/30;;B32B2305/08;;B32B2307/54;;B32B27/08;;B32B2457/00;;B29L2031/3462;;B32B1/00;;B29C70/52;;B32B15/02;;B32B15/20;;B32B27/04;;B32B15/08;;H01B5/105;;B29C70/528,B05D1/18;;B05D3/02;;B32B27/04;;B65H/;;D04H3/08,,0,0,,,,PENDING
300,US,B2,US 11449855 B2,166-625-909-398-197,2022-09-20,2022,US 202016884012 A,2020-05-26,US 202016884012 A,2020-05-26,Transaction cards and computer-based systems involving an on-card display and mobile device for authenticating transactions and methods of use thereof,"Transaction cards, systems and methods involving an on-card display and an associated mobile computing device utilized for authenticating transactions are disclosed. In one embodiment, an exemplary transaction card may comprise transaction circuitry configured to conduct purchase transactions involving a mobile computing device coupled to or associated with the transaction card, communication circuitry configured to communicate with a provider of the transaction card, an e-ink display configured to display a QR code on the transaction card for use in authentication, data storage configured to store the QR code, and computer readable media having instructions for initiating a second-factor authentication process and displaying the QR code on the e-ink display to be captured by the mobile computing device and transmitted to a system or server for validating the second-factor authentication process.",CAPITAL ONE SERVICES LLC,BERGERON GEORGE;;YEE BRYANT;;BULGAKOV MYKHAYLO,CAPITAL ONE SERVICES LLC (2020-05-26),https://lens.org/166-625-909-398-197,Granted Patent,yes,9,0,3,3,0,G06Q20/341;;G06Q20/3274;;G06Q20/20;;G07F7/0846;;G06K19/07707;;G06K19/07769;;G06Q20/3274;;G06K19/07707;;G06K19/0709;;G06Q20/341,G06Q20/32;;G06K19/07;;G06K19/077;;G06Q20/34,,0,0,,,,ACTIVE
301,US,A,US 3452385 A,154-080-834-082-338,1969-07-01,1969,US 3452385D A,1966-12-01,US 59834166 A,1966-12-01,AIR FLOW INDICATOR FOR VACUUM CLEANER APPARATUS,,WHIRLPOOL CO,FLECK GEORGE J;;BRYANT EUGENE E,,https://lens.org/154-080-834-082-338,Granted Patent,no,5,7,1,1,0,A47L9/19;;A47L9/19,A47L9/19,15/339,0,0,,,,EXPIRED
302,EP,B1,EP 2519322 B1,176-767-076-455-500,2022-09-21,2022,EP 11728550 A,2011-01-03,US 29180409 P;;US 29177909 P;;US 29173209 P;;US 2011/0020052 W,2009-12-31,ULTRASOUND COUPLING DEVICE,,ZETROZ SYSTEMS LLC,LEWIS JR GEORGE K;;GUFFEY BRYANT,"ZETROZ, INC. (2013-10-23);;ZETROZ SYSTEMS, LLC (2022-04-20)",https://lens.org/176-767-076-455-500,Granted Patent,yes,4,0,32,32,0,A61B8/4281;;A61B17/2251;;A61B2017/2253;;A61N2007/0078;;A61B8/4227;;A61B8/4236;;A61B8/4427;;A61B2017/00734;;A61N2007/006;;A61N2007/0091;;A61N2007/0095;;A61B8/44;;A61N7/00;;Y10T29/49005;;A61B2034/301;;A61B34/30;;A61B2034/303;;A61B2034/107;;A61B34/10;;A61N2007/0034;;Y10T29/49005;;A61B8/4281;;A61B17/2251;;A61B2017/2253;;A61N2007/0078;;A61B8/4227;;A61B8/4236;;A61B2017/00734;;A61N2007/0091;;A61N2007/0095;;A61B8/4427;;A61B8/44;;A61N2007/006;;A61N7/00,A61N7/00;;A61B8/00,,0,0,,,,ACTIVE
303,HU,A,HU T48193 A,169-319-698-953-050,1989-05-29,1989,HU 316387 A,1987-07-10,US 88419786 A,1986-07-10,"IMPROVED HYDROFORMYLATION PROCESS IN NON-AQUEOUS MEDIUM FOR PREPARING ALDEHYDES, BY USING SLIGHTLY VOLATILE PHOSPHINE LIGANDS",,UNION CARBIDE CORP,ABATJOGLOU A GEORGE;;BRYANT D ROBERT,,https://lens.org/169-319-698-953-050,Unknown,no,0,0,52,52,0,C07C45/50;;C07F9/5004;;Y02P20/582;;C07B41/00;;C07C47/02;;C07C45/50;;C07F9/5004;;Y02P20/582,B01J31/00;;C07B61/00;;B01J31/24;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00;;C07F9/50,,0,0,,,,EXPIRED
304,EP,A1,EP 0562170 A1,174-516-880-864-074,1993-09-29,1993,EP 92120474 A,1992-12-01,US 85775792 A,1992-03-26,"Differential pressure, countergravity casting.","A method and apparatus for the differential pressure, countergravity casting of a melt (4) involves a casting mold (10) which includes an ingate (12) for engaging an underlying source of the melt, an upstanding, alloyant-containing reaction chamber (14) having an upper region communicated to the ingate (14a), and an exit gate (15) communicating a lower region (14b) of the reaction chamber to a mold cavity (16). The mold (10) and the source (2) are relatively moved to engage the ingate (14a) and the source (2). A sufficient relative vacuum is applied to the mold cavity (16) to draw the melt from the source upwardly through the ingate (14a) and into the reaction chamber (14) where the melt reacts with alloyant (20) therein. The melt is drawn upwardly to leave at least a portion of the volume of the mold cavity unfilled with melt and to provide a sufficient volume of melt in the reaction chamber (14) to fill the unfilled volume of the mold cavity after disengagement of the mold (10) and the source (2). The mold (10) and the source (2) are then relatively moved by suitable means to disengage the ingate and the source while a relative vacuum is applied to the mold cavity sufficient to draw the volume of melt in the reaction chamber into the mold cavity such that the unfilled volume thereof is filled after the mold and the source are disengaged. The reaction chamber is thereby essentially emptied of melt as required to fill the unfilled volume of the mold cavity. The melt in the ingate (14a) is drained back to the underlying source when the mold and the source are disengaged. The melt is treated with the alloyant (e.g., nodularized) while melt usage for gating to the castings is substantially reduced.",GEN MOTORS CORP,CHANDLEY GEORGE D;;CROCKER BRYANT W,,https://lens.org/174-516-880-864-074,Patent Application,yes,8,1,9,9,0,B22D18/06;;B22D27/20;;B22D18/06;;B22D27/20,B22D1/00;;B22D18/06;;B22D27/20,,0,0,,,,EXPIRED
305,US,A,US 1205588 A,180-743-810-457-585,1916-11-21,1916,US 4738915 A,1915-08-26,US 4738915 A,1915-08-26,MACHINE-TOOL.,,AMALGAMATED MACHINERY CORP,YEOMANS LUCIEN I;;BRYANT GEORGE F,,https://lens.org/180-743-810-457-585,Granted Patent,no,0,0,1,1,0,B23Q5/34;;B23Q5/34;;Y10T82/2531;;Y10T82/2531,,,0,0,,,,EXPIRED
306,IT,B,IT 1223147 B,001-777-428-818-807,1990-09-12,1990,IT 2267587 A,1987-11-18,US 93200286 A,1986-11-18,IDROFORMILAZIONE USANDO LEGANTI FOSFINICI POCO VOLATILI,,UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/001-777-428-818-807,Granted Patent,no,0,0,53,53,0,C07C45/50;;Y02P20/582;;C07C47/55;;C07C47/02;;C07C45/50;;Y02P20/582,B01J31/24;;B01J31/00;;B01J31/28;;C07B61/00;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00,,0,0,,,,EXPIRED
307,US,A,US 5161604 A,012-511-759-037-977,1992-11-10,1992,US 85775792 A,1992-03-26,US 85775792 A,1992-03-26,"Differential pressure, countergravity casting with alloyant reaction chamber","A casting mold includes an ingate for engaging an underlying source of the melt, an upstanding alloyant-containing reaction chamber having an upper region communicated to the ingate, and an exit gate communicating a lower region of the reaction chamber to a mold cavity. The mold and the source of a melt are relatively moved to engage the ingate and the source. A sufficient relative vacuum is applied to the mold cavity to draw the melt from the source upwardly through the ingate and into the reaction chamber where the melt reacts with alloyant therein. The melt is drawn upwardly to leave at least a portion of the volume of the mold cavity unfilled with melt and to provide a sufficient volume of melt in the reaction chamber to fill the unfilled volume of the mold cavity after disengagement of the mold and the source. The mold and the source are then relatively moved to disengage the ingate and the source while a relative vacuum is applied to the mold cavity sufficient to draw the volume of melt in the reaction chamber into the mold cavity such that the unfilled volume thereof is filled after the mold and the source are disengaged. The reaction chamber is thereby essentially emptied of melt as required to fill the unfilled volume of the mold cavity. The melt in the ingate is drained back to the underlying source when the mold and the source are disengaged.",GEN MOTORS CORP,CHANDLEY GEORGE D;;CROCKER BRYANT W,GENERAL MOTORS CORPORATION A CORPORATION OF DELAWARE (1992-03-10),https://lens.org/012-511-759-037-977,Granted Patent,yes,10,9,9,9,0,B22D18/06;;B22D27/20;;B22D18/06;;B22D27/20,B22D18/06;;B22D27/20;;B22D1/00,164/57.1;;164/58.1;;164/63;;164/255;;164/270.1,0,0,,,,EXPIRED
308,CN,A,CN 1040022 A,021-878-146-586-786,1990-02-28,1990,CN 89106565 A,1989-07-13,US 21889588 A,1988-07-14,PROCESS FOR PRODUCING ALCOHOLS AND ALDEHYDES,,UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/021-878-146-586-786,Patent Application,no,0,0,11,11,0,C07C45/50;;C07C47/02;;C07C29/16,B01J31/24;;C07B61/00;;C07C27/00;;C07C27/22;;C07C29/16;;C07C31/02;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00,,0,0,,,,PENDING
309,ES,A6,ES 2012718 A6,012-976-217-603-807,1990-04-01,1990,ES 8901417 A,1989-04-24,US 93200286 A,1986-11-18,Hydroformylation using low volatile phosphine ligands.,"A non-aqueous hydroformylation process for producing aldehydes which comprises reacting an olefinically unsaturated organic compound with carbon monoxide and hydrogen, in a non-aqueous hydroformylation reaction medium containing the olefinically unsaturated organic compound, aldehyde product, solubilized Group VIII transition metal-phosphorus ligand complex catalyst and solubilized free phosphorus ligand, the improvement comprising employing as the phosphorus ligand of said complex catalyst and as said free phosphorus ligand, a monosulfonated tertiary phosphine metal salt of the general formula < CHEM > wherein R represents a radical containing 1 to 30 carbon atoms selected from alkyl, alkaryl, aralkyl and cycloalkyl radicals M represents an alkali metal or alkaline earth metal cation and n is 1 or 2 corresponding to the valence of the metal cation.",UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/012-976-217-603-807,Granted Patent,no,0,0,53,53,0,C07C45/50;;Y02P20/582;;C07C47/55;;C07C47/02;;C07C45/50;;Y02P20/582,B01J31/00;;B01J31/28;;C07B61/00;;B01J31/24;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00,,0,0,,,,EXPIRED
310,US,B2,US 11188972 B2,036-288-272-575-599,2021-11-30,2021,US 202016840438 A,2020-04-05,US 202016840438 A;;US 201916597246 A,2019-10-09,Computer-implemented methods for technological applications involving provision of an online portal for managing a user account including an interactive GUI having functionality for pre-authorizing future transactions,"Systems and methods involving a computer-implemented portal that enables a user to pre-authorize purchase of items not yet available for sale are disclosed. In one embodiment, an exemplary method may comprise: providing an online portal that enables a user to manage a financial account; executing a first routine of the portal including interactive functionality enabling the user to specify and pre-authorize purchase of an item that is not yet available for sale; searching to determine at least one electronic source at which the item can be purchased when it becomes available for purchase; and executing a purchase transaction at the future date/time when the item is released for sale, to purchase the item for the user.",CAPITAL ONE SERVICES LLC,YEE BRYANT;;BERGERON GEORGE;;BULGAKOV MYKHAYLO,,https://lens.org/036-288-272-575-599,Granted Patent,yes,15,0,5,5,0,G06Q30/0641;;G06Q30/0635;;G06Q20/40;;G06Q20/28;;G06Q20/405;;G06Q20/385;;G06Q30/0635;;G06Q30/0641,G06Q30/06;;G06Q20/38,,2,1,145-017-862-029-309,10.36644/mlr.117.5.digital,"Van Loo, Rory. “Digital Market Perfection.” Michigan law review 117.5 (2019): 815-83. ProQuest. Web. Jun. 8, 2021. (Year: 2019).;;“Rowland's Classic Clothing: Rowland's Classic Clothing Expands Business with Integrated Mail Order and Retail Systems from Options . . . , by Mail Order and from its New Website.” M2 Presswire, Oct. 23, 2008 (Year: 2008).",ACTIVE
311,AU,A,AU 1989/038069 A,031-306-650-184-312,1990-01-18,1990,AU 1989/038069 A,1989-07-13,US 21889588 A,1988-07-14,PROCESS FOR PRODUCING ALCOHOLS AND ALDEHYDES,,UNION CARBIDE CHEM PLASTIC,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/031-306-650-184-312,Patent Application,no,0,0,11,11,0,C07C45/50;;C07C47/02;;C07C29/16,B01J31/24;;C07B61/00;;C07C27/00;;C07C27/22;;C07C29/16;;C07C31/02;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00,,0,0,,,,EXPIRED
312,US,A,US 4099931 A,048-042-875-366-193,1978-07-11,1978,US 29406872 A,1972-10-02,US 29406872 A,1972-10-02,High density liquid ramjet fuel,"Blends of Decalin with n-hexane, Tetralin with n-hexane and Tetralin with Decalin are useful as high density rocket ramjet and turbojet fuels under low temperature conditions.",US NAVY,BRYANT JAMES T;;BURDETTE GEORGE W,,https://lens.org/048-042-875-366-193,Granted Patent,yes,8,11,1,1,0,C10L1/04;;C10L1/04,C10L1/04,44/80,3,0,,,"Symposium on Jet Fuels, Amer. Chem. Soc., vol. 5, No. 4, Sep., 1960, p. C. 2;;The Chemical Composition and Properties of Fuels for Jet Propulsion, Paushkin, 1962, pp. 129, 173.;;""Symposium on Jet Fuels"" taken from Preprints of the ACS, Div. of Petroleum Chemistry, pp. C-19 to C-58.",EXPIRED
313,BR,A,BR PI0415724 A,040-915-602-345-337,2007-04-17,2007,BR PI0415724 A,2004-10-22,US 69144703 A;;US 69230403 A;;US 2004/0035201 W,2003-10-22,cabo reforçado de núcleo de compósito condutor de alumìnio e método de produção do mesmo,"""CABO REFORçADO DE NúCLEO DE COMPóSITO CONDUTOR DE ALUMìNIO E MéTODO DE PRODUçãO DO MESMO"". A presente invenção refere-se a um cabo reforçado de núcleo de compósito condutor de alumínio (ACCC) e método de fabricação. o cabo ACCC (300) possui um núcleo de compósito circundado por um revestimento ou filme protetor (305) e é ainda circundado por uma primeira camada de condutor (306). O núcleo de compósito (303) compreende um ou mais reforços do tipo fibra integrados em uma matriz. De acordo com a presente invenção. As resinas usadas de acordo com a invenção podem permitir que o processo atinja velocidades de até e acima de 60 pés/minuto.",COMPOSITE TECH CORP,HIEL CLEMENT;;KORZENIOWSKI GEORGE;;BRYANT DAVID,,https://lens.org/040-915-602-345-337,Patent Application,no,0,0,34,35,0,B29C70/52;;B29L2031/3462;;B32B1/00;;B32B15/02;;B32B15/08;;B32B15/20;;B32B27/04;;H01B5/105;;B29C70/528;;Y10T428/2918;;Y10T428/2933;;Y10T428/2936;;Y10T442/30;;B32B27/04;;B82Y30/00;;Y10T428/2918;;Y10T428/2933;;Y10T428/2936;;Y10T442/30;;B32B2305/08;;B32B2307/54;;B32B27/08;;B32B2457/00;;B29L2031/3462;;B32B1/00;;B29C70/52;;B32B15/02;;B32B15/20;;B32B27/04;;B32B15/08;;H01B5/105;;B29C70/528,B32B27/04;;B05D1/18;;B05D3/02;;B65H/;;D04H3/08,,0,0,,,,INACTIVE
314,WO,A1,WO 2022/035857 A1,047-489-750-528-114,2022-02-17,2022,US 2021/0045386 W,2021-08-10,US 202016990300 A,2020-08-11,AUGMENTED REALITY INFORMATION DISPLAY AND INTERACTION VIA NFC BASED AUTHENTICATION,"Various embodiments are generally directed to improving card security by providing a user a contactless card with no sensitive card information, such as card number, card verification value, and expiration date, printed thereon, and displaying the sensitive card information relative to the card in augmented reality (AR) based on successful NFC-based user authentication. According to examples, the NFC-based user authentication may be performed by one-tapping or single tapping the contactless card to user mobile device. One or more portions of the sensitive card information may be obfuscated to further enhance card security. Moreover, the user can interact with AR elements including the sensitive card information to perform various actions.",CAPITAL ONE SERVICES LLC,BERGERON GEORGE;;YEE BRYANT;;BULGAKOV MYKHAYLO,,https://lens.org/047-489-750-528-114,Patent Application,yes,3,0,11,11,0,G06Q40/02;;H04L9/0861;;H04L2209/805;;H04L9/3242;;G06K7/10297;;H04W12/47;;H04W12/069;;H04W12/02;;H04L63/08;;H04L63/0421;;H04W12/61;;G06F21/35;;H04W12/47;;H04W12/047;;H04W12/65;;G06F3/14;;G06Q20/34;;G06K7/10297;;H04L9/3226;;G06F21/6245;;G06F3/0484;;G06Q40/02;;G06F3/14;;H04L9/0861,H04W12/61;;G06F21/35;;G06K7/10;;G06Q40/02;;H04L9/08;;H04L9/32;;H04W12/02;;H04W12/069;;H04W12/47,,0,0,,,,PENDING
315,NO,L,NO 874810 L,035-386-361-170-991,1988-05-19,1988,NO 874810 A,1987-11-18,US 93200286 A,1986-11-18,HYDROFORMYLERING VED BRUK AV FOSFIN-LIGANDER MED LAV FLYKTIGHET.,,UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/035-386-361-170-991,Abstract,no,0,0,53,53,0,C07C45/50;;Y02P20/582;;C07C47/55;;C07C47/02;;C07C45/50;;Y02P20/582,B01J31/00;;B01J31/24;;B01J31/28;;C07B61/00;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00,,0,0,,,,EXPIRED
316,DE,A1,DE 3739064 A1,053-771-480-578-053,1988-05-26,1988,DE 3739064 A,1987-11-17,US 93200286 A,1986-11-18,HYDROFORMYLIERUNGSVERFAHREN UNTER VERWENDUNG NIEDRIG FLUECHTIGER PHOSPHORLIGANDEN,,UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/053-771-480-578-053,Patent Application,no,5,1,53,53,0,C07C45/50;;Y02P20/582;;C07C47/55;;C07C47/02;;C07C45/50;;Y02P20/582,B01J31/24;;B01J31/00;;B01J31/28;;C07B61/00;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00,,0,0,,,,EXPIRED
317,NO,D0,NO 20015191 D0,055-836-806-893-430,2001-10-24,2001,NO 20015191 A,2001-10-24,US 35020099 A;;US 0011811 W,1999-07-08,Seismisk ledende repinnföringskabel,A conductive rope-like lead-in cable connects a seismic streamer to a towing vessel. The lead-in cable comprises a first electrical conductor at the center core of the cable for carrying a first polarity of power to the streamer for providing tensile strength to the load-in cable. A first layer of insulation surrounds the first electrical conductor. A second electrical conductor for a second polarity of power to the streamer surrounds the first layer of insulation. A second layer of insulation surrounds the second electrical conductor. A layer of seismic data conductors surrounds the second layer of insulation. A third layer of insulation surrounds the layer of seismic data conductors. A metallic protective layer surrounds the third layer of insulation. Steel is effectively and efficiently used both to provide tensile strength and for electrical power conduction.,PGS EXPLORATION US INC,BRYANT MICHAEL J;;GEORGE NICK C,,https://lens.org/055-836-806-893-430,Patent Application,no,0,0,14,14,0,H01B7/045;;H01B9/003;;H01B9/04;;G01V1/201;;H01B9/003;;H01B7/045;;H01B9/04;;G01V1/201,H01B7/04;;H01B9/00;;H01B9/04,,0,0,,,,EXPIRED
318,US,A1,US 2005/0129942 A1,063-342-754-565-16X,2005-06-16,2005,US 97162904 A,2004-10-22,US 97162904 A;;US 69144703 A;;US 69230403 A;;US 0312520 W;;US 37487902 P,2002-04-23,Aluminum conductor composite core reinforced cable and method of manufacture,"This invention relates to an aluminum conductor composite core reinforced cable (ACCC) and method of manufacture. An ACCC cable has a composite core surrounded by at least one layer of aluminum conductor. The composite core comprises a plurality of fibers from at least one fiber type in one or more matrix materials. The composite core can have a maximum operating temperature capability above 100° C. or within the range of about −45° C. to about 240° C. or higher, at least 50% fiber to resin volume fraction, a tensile strength in the range of about 160 Ksi to about 370 Ksi, a modulus of elasticity in the range of about 7 Msi to about 37 Msi and a coefficient of thermal expansion in the range of about −0.6×10 −6 per deg. C. to about 1.0×10 −5 per deg. C. According to the invention, unique processing techniques such a B-Staging and/or film-coating techniques can be used to increase production rates from a few feet per minute to sixty or more feet per minute.",HIEL CLEMENT;;KORZENIOWSKI GEORGE;;BRYANT DAVID,HIEL CLEMENT;;KORZENIOWSKI GEORGE;;BRYANT DAVID,CTC GLOBAL CORPORATION (2012-07-03);;CTC CABLE CORPORATION (2005-07-29),https://lens.org/063-342-754-565-16X,Patent Application,yes,50,38,2,99,0,H01B5/105;;Y10T428/2933;;Y10T428/2938;;Y10T428/249949;;Y10T428/249945;;Y10T428/24994;;Y10T428/249946;;Y10T428/24995;;Y10T428/249942;;Y10T428/2933;;Y10T428/2938;;Y10T428/249949;;Y10T428/249945;;Y10T428/24994;;Y10T428/249946;;Y10T428/24995;;Y10T428/249942;;H01B5/105,G02B6/44,428/375,0,0,,,,EXPIRED
319,PT,A,PT 91385 A,077-074-675-379-350,1990-03-08,1990,PT 9138589 A,1989-08-04,US 22850788 A,1988-08-05,"PROCESSOS APERFEICOADOS, HOMOGENIOS, CATALISADOS COM UM METAL DE TRANSICAO MEDIANTE UTILIZACAO DE CATALISADORES COMPLEXOS A BASE DE LIGANDOS DE FOSFITOS IONICOS E PREPARACAO DOS REFERIDOS CATALISADORES",,UNION CARBIDE CHEM PLASTIC,BRYANT DAVID ROBERT;;ABATJOGLOU ANTHONY GEORGE,,https://lens.org/077-074-675-379-350,Patent Application,no,0,0,22,23,0,B01J31/185;;B01J31/185;;B01J2231/321;;B01J2231/321;;B01J2531/0266;;B01J2531/0266;;B01J2531/80;;B01J2531/80;;B01J2531/822;;B01J2531/822;;C07F9/165;;C07F9/65746;;C07F9/65746;;C07C45/50;;C07C45/50;;C07F9/65744;;C07F9/65744;;Y02P20/582;;Y02P20/582,B01J31/22;;B01J31/18;;C07B61/00;;C07C45/49;;C07C45/50;;C07C47/02;;C07F9/6574;;C07F9/6578;;C07F9/6584;;C07F9/6596,,0,0,,,,EXPIRED
320,FI,A,FI 861218 A,079-616-578-565-385,1986-09-23,1986,FI 861218 A,1986-03-21,US 71472285 A,1985-03-22,FOERFARANDE FOER BEHANDLING AV VAOTT PAPPER MED SKUM.,"Specifically structured foamed compositions of paper treating agents applied to wet paper, such as wet-end paper web produced during high speed paper manufacture, provide uniform treating agent distribution and treated paper having properties comparable to dry-processed paper.",UNION CARBIDE CORP,BRYANT GEORGE MACON;;BROWN RUSSEL LEE,,https://lens.org/079-616-578-565-385,Patent Application,no,0,0,10,10,0,D21H21/56;;D21H23/26,D21H17/35;;D21H17/03;;D21H19/00;;D21H21/56;;D21H23/26,,0,0,,,,DISCONTINUED
321,US,A9,US 2013/0101845 A9,072-197-778-122-740,2013-04-25,2013,US 59545904 A,2004-10-22,US 59545904 A;;US 69144703 A;;US 69230403 A;;US 0312520 W;;US 37487902 P;;US 2004/0035201 W,2002-04-23,Aluminum conductor composite core reinforced cable and method of manufacture,"This invention relates to an aluminum conductor composite core reinforced cable (ACCC) and method of manufacture. An ACCC 303 cable ( 300 ) has a composite core surrounded by an outer film ( 305 ) and at least one layer of aluminum conductor ( 306 ). The composite core ( 303 ) comprises a plurality of fibers from at least one fiber type in one or more matrix materials. According to the invention, unique processing techniques such a B-Staging and/or film-coating techniques can be used to increase production rates from a few feet per minute to sixty or more feet per minute.",HIEL CLEMENT;;BRYANT DAVID;;KORZENLOWSKI GEORGE,HIEL CLEMENT;;BRYANT DAVID;;KORZENLOWSKI GEORGE,CTC GLOBAL CORPORATION (2012-07-03);;CTC CABLE CORPORATION (2006-07-14),https://lens.org/072-197-778-122-740,Amended Application,yes,6,4,34,35,0,B29C70/52;;B29L2031/3462;;B32B1/00;;B32B15/02;;B32B15/08;;B32B15/20;;B32B27/04;;H01B5/105;;B29C70/528;;Y10T428/2918;;Y10T428/2933;;Y10T428/2936;;Y10T442/30;;B32B27/04;;B82Y30/00;;Y10T428/2918;;Y10T428/2933;;Y10T428/2936;;Y10T442/30;;B32B2305/08;;B32B2307/54;;B32B27/08;;B32B2457/00;;B29L2031/3462;;B32B1/00;;B29C70/52;;B32B15/02;;B32B15/20;;B32B27/04;;B32B15/08;;H01B5/105;;B29C70/528,D02G3/00;;B05D1/18;;B05D3/02;;B32B27/04;;B65H/;;D04H3/08,428/375,0,0,,,,DISCONTINUED
322,DE,D1,DE 3779725 D1,115-427-816-354-163,1992-07-16,1992,DE 3779725 T,1987-11-17,US 93200286 A,1986-11-18,HYDROFORMILIERUNG MIT LEICHT-FLUECHTIGEN PHOSPHINLIGANDEN.,,UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/115-427-816-354-163,Granted Patent,no,0,0,53,53,0,C07C45/50;;Y02P20/582;;C07C47/55;;C07C47/02;;C07C45/50;;Y02P20/582,B01J31/24;;B01J31/00;;B01J31/28;;C07B61/00;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00,,0,0,,,,EXPIRED
323,NO,C,NO 166440 C,112-199-022-091-487,1991-07-24,1991,NO 874810 A,1987-11-18,US 93200286 A,1986-11-18,HYDROFORMYLERING VED BRUK AV FOSFIN-LIGANDER MED LAV FLYKTIGHET.,,UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/112-199-022-091-487,Granted Patent,no,0,0,53,53,0,C07C45/50;;Y02P20/582;;C07C47/55;;C07C47/02;;C07C45/50;;Y02P20/582,B01J31/00;;B01J31/28;;C07B61/00;;B01J31/24;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00,,0,0,,,,EXPIRED
324,US,A1,US 2023/0280314 A1,007-025-854-947-886,2023-09-07,2023,US 202318167995 A,2023-02-13,US 202318167995 A;;US 202263315621 P,2022-03-02,FERRULE SLEEVE FOR PREVENTING EXCESSIVE FERRULE DEFORMATION CAUSING LEAKS AND STUCK FERRULES,"A ferrule includes a deformable portion and a rigid sleeve surrounding at least a portion of the deformable portion. The deformable portion includes between about 5% and about 50% graphite. The deformable portion further includes between about 50% and about 95% polyimide. The rigid sleeve can include a metal, such as stainless steel.",THERMO FINNIGAN LLC,GUCKENBERGER GEORGE B;;BRYANT ADAM D,THERMO FINNIGAN LLC (2022-03-02),https://lens.org/007-025-854-947-886,Patent Application,yes,0,0,2,2,0,G01N30/7206;;G01N2030/185;;G01N30/18,G01N30/18,,0,0,,,,PENDING
325,WO,A1,WO 2022/072139 A1,016-677-262-146-25X,2022-04-07,2022,US 2021/0050374 W,2021-09-15,US 202017061423 A,2020-10-01,CROWDSOURCED ANNOTATION AND TAGGING SYSTEM FOR DIGITAL TRANSACTIONS AND TRANSACTION PREDICTION SYSTEM,"A system for crowdsourcing annotations for transactions includes a crowdsourcing annotation database and a processor. The database stores crowdsourced annotations associated with merchants. The crowdsourced annotations are shared among, and contributed by, users of a community. The processor receives transaction data for a transaction by a user with a merchant. Relevant crowdsourced annotations associated with the merchant are retrieved from the database and sent to the user to enable to the user to annotate the transaction. The user provides an annotation for the transaction. The system dynamically updates the database based on the annotation provided by the user. In another aspect a transaction prediction system is disclosed. The system receives transaction data and identifies text on a check image associated with the transaction data. The system identifies a recurring expense and associated expense frequency, and may generate an expense warning or suggestion to execute a check to pay the expense.",CAPITAL ONE SERVICES LLC,YEE BRYANT;;BERGERON GEORGE;;BULGAKOV MYKHAYLO,,https://lens.org/016-677-262-146-25X,Patent Application,yes,3,0,2,6,0,G06V30/19007;;G06V30/242,G06K9/00,,0,0,,,,PENDING
326,US,A,US 3917659 A,036-654-610-338-818,1975-11-04,1975,US 44641474 A,1974-07-27,US 44641474 A,1974-07-27,Solid glyoxal-urea products,"Dry, solid urea-glyoxal products obtained by drying the reaction product of from 0.25 mole to 0.9 mole of urea per mole of glyoxal have been produced for the first time. These products are useful in paper coating compositions and in permanent press application.",UNION CARBIDE CORP,GLANCY CHARLES WILLIAM;;BRYANT GEORGE MACON,,https://lens.org/036-654-610-338-818,Granted Patent,no,0,8,11,13,0,C08G12/12;;D06M15/423;;D21H19/54;;D21H19/54;;C08G12/12;;D06M15/423,C08G12/00;;C08G12/12;;D06M15/423;;D21H17/50;;D21H19/54,260555R,2,0,,,"Behrend et al., Annalen der Chemie, Band 339, pp. 1-8 (1905);;Taral, Chemical Abstracts, Vol. 48, col. 14,222 a-d (1954)",EXPIRED
327,EP,A1,EP 0463000 A1,018-394-319-353-501,1992-01-02,1992,EP 90904146 A,1990-02-16,US 9000924 W;;US 32484789 A,1989-03-17,MULTILAYER COATED CEMENTED CARBIDE CUTTING INSERT.,"L'invention concerne un insert de découpage de métal indexable, comportant un substrat (32) au carbure du tungstène cémenté par du cobalt, sur lequel se trouve un revêtement réfractaire multicouche (34). Ledit substrat a une teneur en cobalt comprise entre 6,1 et 6,5 % en poids, et est caractérisé par une dureté Rockwell d'échelle A comprise entre 90,8 et 91,6, ainsi que par une force coercitive comprise entre 110 et 180 oerstads. Le revêtement (34) contient au moins une pluralité de couches d'oxyde d'aluminium (42) séparées les unes des autres et liées les unes aux autres par un nitrure métallique du groupe IVB (44) tel que le nitrure de titane, lesdites couches étant liées au substrat (32) par une couche de support de 5 à 8 mu d'épaisseur, composée de carbure et/ou de carbonitrure de titane, de zirconium et/ou de hafnium.",KENNAMETAL INC,BRYANT WILLIAM A;;GRAB GEORGE P,,https://lens.org/018-394-319-353-501,Patent Application,yes,0,1,17,19,0,B23B27/14;;B23B27/145;;B23B2228/36;;C23C30/005,B22F7/00;;B22F7/04;;B23B27/14;;C23C16/30;;C23C30/00,,0,0,,,,EXPIRED
328,IT,B,IT 1221979 B,030-467-417-649-575,1990-08-31,1990,IT 2121387 A,1987-07-08,US 88419786 A,1986-07-10,IDROFORMILAZIONE CON L'USO DI LEGANTI COSTITUITI DA FOSFINA ORGANICO SOLUBILE DI BASSA VOLATILITA',,UNION CARBIDE CORP,ANTHONY GEORGE ABATJOGLOU;;DAVID ROBERT BRYANT,,https://lens.org/030-467-417-649-575,Granted Patent,no,0,0,52,52,0,C07C45/50;;C07F9/5004;;Y02P20/582;;C07B41/00;;C07C47/02;;C07C45/50;;C07F9/5004;;Y02P20/582,B01J31/00;;C07B61/00;;B01J31/24;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00;;C07F9/50,,0,0,,,,EXPIRED
329,EP,A2,EP 0268268 A2,025-032-567-221-079,1988-05-25,1988,EP 87116971 A,1987-11-17,US 93200286 A,1986-11-18,Hydroformylation using low volatile phosphine ligands.,"A non-aqueous hydroformylation process for producing aldehydes which comprises reacting an olefinically unsaturated organic compound with carbon monoxide and hydrogen, in a non-aqueous hydroformylation reaction medium containing the olefinically unsaturated organic compound, aldehyde product, solubilized Group VIII transition metal-phosphorus ligand complex catalyst and solubilized free phosphorus ligand, the improvement comprising employing as the phosphorus ligand of said complex catalyst and as said free phosphorus ligand, a monosulfonated tertiary phosphine metal salt of the general formula
   wherein R represents a radical containing 1 to 30 carbon atoms selected from alkyl, alkaryl, aralkyl and cycloalkyl radicals; M represents an alkali metal or alkaline earth metal cation; and n is 1 or 2 corresponding to the valence of the metal cation.  ",UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/025-032-567-221-079,Patent Application,yes,0,8,53,53,0,C07C45/50;;Y02P20/582;;C07C47/55;;C07C47/02;;C07C45/50;;Y02P20/582,B01J31/00;;B01J31/28;;C07B61/00;;B01J31/24;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00,,0,0,,,,EXPIRED
330,AU,A,AU 1987/075531 A,048-985-902-767-536,1988-01-14,1988,AU 1987/075531 A,1987-07-10,US 88419786 A,1986-07-10,ALDEHYDES BY HYDROFORMYLATION OVER RH COMPLEX CAT OF MONOSULPHONATED TERTIARY PHOSPINE,,UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/048-985-902-767-536,Patent Application,no,0,0,52,52,0,C07C45/50;;C07F9/5004;;Y02P20/582;;C07B41/00;;C07C47/02;;C07C45/50;;C07F9/5004;;Y02P20/582,C07B61/00;;B01J31/00;;B01J31/24;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00;;C07F9/50,,0,0,,,,EXPIRED
331,US,A1,US 2023/0083618 A1,056-437-941-166-752,2023-03-16,2023,US 202217947999 A,2022-09-19,US 202217947999 A;;US 202016884012 A,2020-05-26,TRANSACTION CARDS AND COMPUTER-BASED SYSTEMS INVOLVING AN ON-CARD DISPLAY AND MOBILE DEVICE FOR AUTHENTICATING TRANSACTIONS AND METHODS OF USE THEREOF,"Transaction cards, systems and methods involving an on-card display and an associated mobile computing device utilized for authenticating transactions are disclosed. In one embodiment, an exemplary transaction card may comprise transaction circuitry configured to conduct purchase transactions involving a mobile computing device coupled to or associated with the transaction card, communication circuitry configured to communicate with a provider of the transaction card, an e-ink display configured to display a QR code on the transaction card for use in authentication, data storage configured to store the QR code, and computer readable media having instructions for initiating a second-factor authentication process and displaying the QR code on the e-ink display to be captured by the mobile computing device and transmitted to a system or server for validating the second-factor authentication process.",CAPITAL ONE SERVICES LLC,BERGERON GEORGE;;YEE BRYANT;;BULGAKOV MYKHAYLO,CAPITAL ONE SERVICES LLC (2020-05-26),https://lens.org/056-437-941-166-752,Patent Application,yes,4,0,3,3,0,G06Q20/341;;G06Q20/3274;;G06Q20/20;;G07F7/0846;;G06K19/07707;;G06K19/07769;;G06Q20/3274;;G06K19/07707;;G06K19/0709;;G06Q20/341,G06Q20/32;;G06K19/07;;G06K19/077;;G06Q20/34,,0,0,,,,PENDING
332,US,A1,US 2022/0060469 A1,060-869-632-092-773,2022-02-24,2022,US 202016996820 A,2020-08-18,US 202016996820 A,2020-08-18,COMPUTER-BASED SYSTEMS INVOLVING SHARING SESSION AUTHENTICATION AND/OR ACCOUNT DETAILS WITH A TRUSTED PARTY AND METHODS OF USE THEREOF,"Systems and methods associated with sharing encrypted account details with a trusted party are disclosed. In one embodiment, an exemplary method may comprise hosting an online service accessed by a plurality of user accounts each configured for concurrent access sessions, establishing a first authenticated access session for a first user account between the online service and a first device associated with a first user, receiving a login request associated with the first user account to establish a second authenticated access session between the online service and a second device associated with a second user, transmitting, to the first device, a notification of the login request including a GUI element and a request to authenticate the login request, and establishing the second authenticated access session between the online service and the second device of the second user based on authentication of the second user via the GUI element.",CAPITAL ONE SERVICES LLC,YEE BRYANT;;BERGERON GEORGE;;BULGAKOV MYKHAYLO,CAPITAL ONE SERVICES LLC (2020-08-17),https://lens.org/060-869-632-092-773,Patent Application,yes,0,3,2,2,0,H04L67/141;;H04W12/068;;H04L63/105;;H04W12/084;;H04L63/0838;;H04L67/141;;H04L63/105;;H04L63/102,H04L29/06;;H04L29/08,,0,0,,,,ACTIVE
333,US,A,US 1886941 A,066-720-255-866-632,1932-11-08,1932,US 23687627 A,1927-11-30,US 23687627 A,1927-11-30,Method of making crystalline dextrose,,CLINTON CORN SYRUP REFINING CO,CORSON GEORGE E;;BRYANT ARTHUR P,,https://lens.org/066-720-255-866-632,Granted Patent,no,0,1,1,1,0,C13K1/10;;C13K1/10,C13K1/10,,0,0,,,,EXPIRED
334,EP,B1,EP 1194933 B1,124-560-242-358-091,2007-07-18,2007,EP 00930281 A,2000-05-01,US 0011811 W;;US 35020099 A,1999-07-08,SEISMIC CONDUCTIVE ROPE LEAD-IN CABLE,A conductive rope-like lead-in cable connects a seismic streamer to a towing vessel. The lead-in cable comprises a first electrical conductor at the center core of the cable for carrying a first polarity of power to the streamer for providing tensile strength to the load-in cable. A first layer of insulation surrounds the first electrical conductor. A second electrical conductor for a second polarity of power to the streamer surrounds the first layer of insulation. A second layer of insulation surrounds the second electrical conductor. A layer of seismic data conductors surrounds the second layer of insulation. A third layer of insulation surrounds the layer of seismic data conductors. A metallic protective layer surrounds the third layer of insulation. Steel is effectively and efficiently used both to provide tensile strength and for electrical power conduction.,PGS EXPLORATION US INC,BRYANT MICHAEL J;;GEORGE NICK C,,https://lens.org/124-560-242-358-091,Granted Patent,yes,1,0,14,14,0,H01B7/045;;H01B9/003;;H01B9/04;;G01V1/201;;H01B9/003;;H01B7/045;;H01B9/04;;G01V1/201,H01B7/04;;H01B9/00;;H01B9/04,,0,0,,,,EXPIRED
335,DE,D1,DE 3660820 D1,170-444-078-110-771,1988-11-03,1988,DE 3660820 T,1986-03-21,US 71472285 A,1985-03-22,PROCESS FOR TREATING WET PAPER WITH FOAM,"Specifically structured foamed compositions of paper treating agents applied to wet paper, such as wet-end paper web produced during high speed paper manufacture, provide uniform treating agent distribution and treated paper having properties comparable to dry-processed paper.",UNION CARBIDE CORP,BRYANT GEORGE MACON;;BROWN RUSSELL LEE,,https://lens.org/170-444-078-110-771,Granted Patent,no,0,0,10,10,0,D21H21/56;;D21H23/26,D21H17/35;;D21H17/03;;D21H19/00;;D21H21/56;;D21H23/26,,0,0,,,,EXPIRED
336,DE,A1,DE 2060406 A1,167-587-334-404-470,1971-09-30,1971,DE 2060406 A,1970-12-08,US 1756770 A,1970-03-09,Zweipegel-Halbleiterspeicherschaltung mit traegheitsarmem Worttreiber,,COGAR CORP,L BRYANT RICHARD;;K TU GEORGE,,https://lens.org/167-587-334-404-470,Patent Application,no,0,0,3,3,0,G11C11/4116;;H01L27/0611;;H03K3/012;;H03K3/288;;H03K3/35;;G11C11/4116;;H03K3/35;;H03K3/012;;H03K3/288;;H01L27/0611,G11C11/411;;H01L27/06;;H03K3/012;;H03K3/288;;H03K3/35,,0,0,,,,DISCONTINUED
337,AU,A,AU 2001/033283 A,145-303-893-394-103,2001-09-12,2001,AU 2001/033283 A,2001-02-03,US 51442300 A;;US 0103550 W,2000-02-28,Electrical cable insert,,PGS EXPLORATION US INC,GEORGE NICK C;;BRYANT MICHAEL JOHN,,https://lens.org/145-303-893-394-103,Patent Application,no,0,0,9,9,0,H01R13/523;;H01R13/523;;H01R13/5208;;H01R13/5208;;H01R31/06;;H01R31/06,H01R13/52;;H01R13/523;;H01R31/06,,0,0,,,,PENDING
338,CA,A,CA 571217 A,183-445-090-330-44X,1959-02-24,1959,CA 571217D A,,CA 571217T A,,CLEANING TOOL,,RAY L ARTERBURY,ARTERBURY BRYANT P;;CLARK GEORGE M,,https://lens.org/183-445-090-330-44X,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
339,BR,A,BR 8703510 A,169-509-378-691-298,1988-03-22,1988,BR 8703510 A,1987-07-09,US 88419786 A,1986-07-10,PROCESSO E HIDROFORMILACAO NAO AQUOSA PARA PRODUCAO DE ALDEIDOS,,UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/169-509-378-691-298,Patent Application,no,0,0,52,52,0,C07C45/50;;C07F9/5004;;Y02P20/582;;C07B41/00;;C07C47/02;;C07C45/50;;C07F9/5004;;Y02P20/582,C07B61/00;;B01J31/00;;B01J31/24;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00;;C07F9/50,,0,0,,,,DISCONTINUED
340,US,B1,US 10726424 B1,173-767-478-659-048,2020-07-28,2020,US 201916525242 A,2019-07-29,US 201916525242 A,2019-07-29,Computer-based systems and platforms and computer-implemented methods configured for one or more technological applications involving reduction of false-positive fraud detection incidents,"Systems and methods involving computer-based processing for proactively reducing false-positive fraud detection incidents are disclosed. In one embodiment, an exemplary computer-implemented method may comprise: detecting when a subject online transaction matches criteria indicating it is unusual; operating a browser extension application to obtain UI image data and purchase details of an item purchased by a user during the unusual online transaction; evaluating historical transactions of the user to identify a potentially fraudulent online transaction; and executing a false-positive detection routine to determine if the potentially fraudulent online transaction is valid.",CAPITAL ONE SERVICES LLC,YEE BRYANT;;BERGERON GEORGE;;BULGAKOV MYKHAYLO,CAPITAL ONE SERVICES LLC (2019-07-23),https://lens.org/173-767-478-659-048,Granted Patent,yes,10,4,3,3,0,H04W4/14;;H04L67/02;;H04L67/10;;G06F9/44526;;G06Q20/4016;;H04L67/535;;H04L67/55;;G06Q20/4016;;G06Q20/3255;;G06Q20/425;;H04L67/10;;H04L67/02;;H04W4/14;;H04L67/55,G06Q40/00;;G06K9/78;;G06Q20/32;;G06Q20/40;;G06Q20/42;;H04L29/08;;H04W4/14,,0,0,,,,ACTIVE
341,AU,B2,AU 623918 B2,191-816-300-492-384,1992-05-28,1992,AU 1989/039251 A,1989-08-03,US 22850788 A,1988-08-05,PREPARATION OF IONIC PHOSPHITES AND THEIR USE IN HOMOGENEOUS TRANSITION METAL CATALYZED PROCESS,,UNION CARBIDE CHEM PLASTIC,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/191-816-300-492-384,Granted Patent,no,0,0,22,23,0,B01J31/185;;B01J31/185;;B01J2231/321;;B01J2231/321;;B01J2531/0266;;B01J2531/0266;;B01J2531/80;;B01J2531/80;;B01J2531/822;;B01J2531/822;;C07F9/165;;C07F9/65746;;C07F9/65746;;C07C45/50;;C07C45/50;;C07F9/65744;;C07F9/65744;;Y02P20/582;;Y02P20/582,B01J31/22;;B01J31/18;;C07B61/00;;C07C45/49;;C07C45/50;;C07C47/02;;C07F9/6574;;C07F9/6578;;C07F9/6584;;C07F9/6596,,0,0,,,,EXPIRED
342,EA,B1,EA 011625 B1,181-378-719-736-720,2009-04-28,2009,EA 200600813 A,2004-10-22,US 69144703 A;;US 69230403 A;;US 2004/0035201 W,2003-10-22,ALUMINUM CONDUCTOR COMPOSITE CORE REINFORCED CABLE AND METHOD OF MANUFACTURE,"This invention relates to an aluminum conductor composite core reinforced cable (ACCC). A composite core for an electrical cable comprising: a plurality of fibers from at least one fiber type in one or more matrix materials, the resin surrounds and substantially wrapping each of the plurality reinforced fibers oriented substantially parallel to the core longitudinal axis and wt% of fibers in the composite is less 50%. The core comprises resin having extension properties exceeding extension properties of glass fiber. Said ratio fiber/resin is changeable to manufacture the core with changing set of physical properties.",CTC CABLE CORP,HIEL CLEMENT;;KORZENIOWSKI GEORGE;;BRYANT DAVID,,https://lens.org/181-378-719-736-720,Granted Patent,no,6,3,34,35,0,B29C70/52;;B29L2031/3462;;B32B1/00;;B32B15/02;;B32B15/08;;B32B15/20;;B32B27/04;;H01B5/105;;B29C70/528;;Y10T428/2918;;Y10T428/2933;;Y10T428/2936;;Y10T442/30;;B32B27/04;;B82Y30/00;;Y10T428/2918;;Y10T428/2933;;Y10T428/2936;;Y10T442/30;;B32B2305/08;;B32B2307/54;;B32B27/08;;B32B2457/00;;B29L2031/3462;;B32B1/00;;B29C70/52;;B32B15/02;;B32B15/20;;B32B27/04;;B32B15/08;;H01B5/105;;B29C70/528,B32B27/04;;B05D1/18;;B05D3/02;;B65H/;;D04H3/08,,0,0,,,,ACTIVE
343,NO,L,NO 20024039 L,190-392-162-502-894,2002-10-17,2002,NO 20024039 A,2002-08-23,US 51442300 A;;US 0103550 W,2000-02-28,Elektrisk kabelinnföring,,PGS EXPLORATION US INC,GEORGE NICK C;;BRYANT MICHAEL JOHN,,https://lens.org/190-392-162-502-894,Abstract,no,0,0,9,9,0,H01R13/523;;H01R13/523;;H01R13/5208;;H01R13/5208;;H01R31/06;;H01R31/06,H01R13/52;;H01R13/523;;H01R31/06,,0,0,,,,EXPIRED
344,EP,A2,EP 2519322 A2,010-039-702-101-924,2012-11-07,2012,EP 11728550 A,2011-01-03,US 29180409 P;;US 29177909 P;;US 29173209 P;;US 2011/0020052 W,2009-12-31,ULTRASOUND COUPLING DEVICE,,ZETROZ LLC,LEWIS JR GEORGE K;;GUFFEY BRYANT,"ZETROZ, INC. (2013-10-23);;ZETROZ SYSTEMS, LLC (2022-04-20)",https://lens.org/010-039-702-101-924,Patent Application,yes,0,0,32,32,0,A61B8/4281;;A61B17/2251;;A61B2017/2253;;A61N2007/0078;;A61B8/4227;;A61B8/4236;;A61B8/4427;;A61B2017/00734;;A61N2007/006;;A61N2007/0091;;A61N2007/0095;;A61B8/44;;A61N7/00;;Y10T29/49005;;A61B2034/301;;A61B34/30;;A61B2034/303;;A61B2034/107;;A61B34/10;;A61N2007/0034;;Y10T29/49005;;A61B8/4281;;A61B17/2251;;A61B2017/2253;;A61N2007/0078;;A61B8/4227;;A61B8/4236;;A61B2017/00734;;A61N2007/0091;;A61N2007/0095;;A61B8/4427;;A61B8/44;;A61N2007/006;;A61N7/00,A61N7/00;;A61B8/00,,0,0,,,,ACTIVE
345,CA,A1,CA 2079697 A1,010-908-792-385-36X,1993-09-27,1993,CA 2079697 A,1992-10-02,US 85775792 A,1992-03-26,"DIFFERENTIAL PRESSURE, COUNTERGRAVITY CASTING DIFFERENTIAL PRESSURE, COUNTERGRAVITY CASTING","DIFFERENTIAL PRESSURE, COUNTERGRAVITY CASTING A method and apparatus for the differential pressure, countergravity casting of a melt involves a casting mold which includes an ingate for engaging an underlying source of the melt, an upstanding, alloyant-containing reaction chamber having an upper region communicated to the ingate, and an exit gate communicating a lower region of the reaction chamber to a mold cavity. The mold and the source are relatively moved to engage the ingate and the source. A sufficient relative vacuum is applied to the mold cavity to draw the melt from the source upwardly through the ingate and into the reaction chamber where the melt reacts with alloyant therein. The melt is drawn upwardly to leave at least a portion of the volume of the mold cavity unfilled with melt and to provide a sufficient volume of melt in the reaction chamber to fill the unfilled volume of the mold cavity after disengagement of the mold and the source. The mold and the source are then relatively moved by suitable means to disengage the ingate and the source while a relative vacuum is applied to the mold cavity sufficient to draw the volume of melt in the reaction chamber into the mold cavity such that the unfilled volume thereof is filled after the mold and the source are disengaged. The reaction chamber is thereby essentially emptied of melt as required to fill the unfilled volume of the mold cavity. The melt in the ingate is drained back to the underlying source when the mold and the source are disengaged. The melt is treated with the alloyant (e.g., nodularized) while melt usage for gating to the castings is substantially reduced.",GEN MOTORS CORP,CHANDLEY GEORGE D;;CROCKER BRYANT W,,https://lens.org/010-908-792-385-36X,Patent Application,no,0,0,9,9,0,B22D18/06;;B22D27/20;;B22D18/06;;B22D27/20,B22D1/00;;B22D18/06;;B22D27/20,,0,0,,,,DISCONTINUED
346,DE,T2,DE 68924676 T2,026-725-356-558-841,1996-03-28,1996,DE 68924676 T,1989-08-04,US 22850788 A,1988-08-05,Ionische Phosphite und ihre Verwendung in homogenen übergangsmetallkatalysierten Verfahren.,,UNION CARBIDE CHEM PLASTIC,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/026-725-356-558-841,Granted Patent,no,0,0,22,23,0,B01J31/185;;B01J31/185;;B01J2231/321;;B01J2231/321;;B01J2531/0266;;B01J2531/0266;;B01J2531/80;;B01J2531/80;;B01J2531/822;;B01J2531/822;;C07F9/165;;C07F9/65746;;C07F9/65746;;C07C45/50;;C07C45/50;;C07F9/65744;;C07F9/65744;;Y02P20/582;;Y02P20/582,B01J31/22;;B01J31/18;;C07B61/00;;C07C45/49;;C07C45/50;;C07C47/02;;C07F9/6574;;C07F9/6578;;C07F9/6584;;C07F9/6596,,0,0,,,,EXPIRED
347,CN,A,CN 116097692 A,029-272-868-651-062,2023-05-09,2023,CN 202180056159 A,2021-08-10,US 202016990300 A;;US 2021/0045386 W,2020-08-11,Augmented reality information display and interaction via NFC-based authentication,"Various embodiments are generally directed to improving card security by providing a user with a contactless card on which sensitive card information, such as a card number, a card verification value, and an expiration date, is not printed and displaying sensitive card information related to the card in augmented reality (AR) based on successful NFC-based user authentication. According to an example, NFC-based user authentication may be performed by tapping a contactless card once or once to a user mobile device. One or more portions of sensitive card information may be obfuscated to further enhance card security. In addition, the user may interact with AR elements, including sensitive card information, to perform various actions.",CAPITAL ONE SERVICES LLC,BERGERON GEORGE;;YEE BRYANT;;BURGAKOV MIKHAIL,,https://lens.org/029-272-868-651-062,Patent Application,no,0,0,11,11,0,G06Q40/02;;H04L9/0861;;H04L2209/805;;H04L9/3242;;G06K7/10297;;H04W12/47;;H04W12/069;;H04W12/02;;H04L63/08;;H04L63/0421;;H04W12/61;;G06F21/35;;H04W12/47;;H04W12/047;;H04W12/65;;G06F3/14;;G06Q20/34;;G06K7/10297;;H04L9/3226;;G06F21/6245;;G06F3/0484;;G06Q40/02;;G06F3/14;;H04L9/0861,H04W12/47,,0,0,,,,PENDING
348,US,A1,US 2022/0084105 A1,046-572-888-078-583,2022-03-17,2022,US 202117539119 A,2021-11-30,US 202117539119 A;;US 202016840438 A;;US 201916597246 A,2019-10-09,Computer-Implemented Methods for Technological Applications Involving Provision of an Online Portal for Managing a User Account Including an Interactive Gui Having Functionality for Pre-Authorizing Future Transactions,"Systems and methods involving a computer-implemented portal that enables a user to pre-authorize purchase of items not yet available for sale are disclosed. In one embodiment, an exemplary method may comprise: providing an online portal that enables a user to manage a financial account; executing a first routine of the portal including interactive functionality enabling the user to specify and pre-authorize purchase of an item that is not yet available for sale; searching to determine at least one electronic source at which the item can be purchased when it becomes available for purchase; and executing a purchase transaction at the future date/time when the item is released for sale, to purchase the item for the user.",CAPITAL ONE SERVICES LLC,YEE BRYANT;;BERGERON GEORGE;;BULGAKOV MYKHAYLO,,https://lens.org/046-572-888-078-583,Patent Application,yes,3,0,5,5,0,G06Q30/0641;;G06Q30/0635;;G06Q20/40;;G06Q20/28;;G06Q20/405;;G06Q20/385;;G06Q30/0635;;G06Q30/0641,G06Q30/06;;G06Q20/38,,2,0,,,"Gunaratne, Junius. ""Influencing Financial Decision-Making through Human-Computer Interaction Design Interventions."" Order No. 10603102 New York University Tandon School of Engineering, 2017. Ann Arbor: ProQuest. Web. 27 Sep. 2022. (Year: 2017);;""Be Sure to Get what You Want at the Best Price this Holiday."" Business Wire, Dec 01 2004, p. 1. ProQuest. Web. 24 Feb. 2023 . (Year: 2004)",ACTIVE
349,WO,A1,WO 2001/065643 A1,049-788-181-619-149,2001-09-07,2001,US 0103550 W,2001-02-03,US 51442300 A,2000-02-28,ELECTRICAL CABLE INSERT,There is provided an electric cable insert for removably electrically connecting a cable having multiple conductors to a mating receptacle wherein the number and configuration of the cable conductors may be different from those of the sockets of the mating receptacle. The insert includes a housing open on one end to an internal cavity and having a plurality of orifices in the other end. The cable conductors connect to one side of a circuit card within the housing which conductively transitions from the number and configuration of the cable conductors to the number and configuration of the sockets of the mating receptacle. Receptacle pins extend from the opposite side of the circuit card through respective orifices in the housing for connecting to respective sockets in the mating receptacle. A compressed sealing gland disposed within the housing adjacent the circuit card provides the insert with an energized compression seal from the environment. A driver closes the end of the housing and maintains compression in the sealing gland. The cable conductors pass through respective bores in the sealing gland and in the driver.,PGS EXPLORATION US INC,GEORGE NICK C;;BRYANT MICHAEL JOHN,,https://lens.org/049-788-181-619-149,Patent Application,yes,4,5,9,9,0,H01R13/523;;H01R13/523;;H01R13/5208;;H01R13/5208;;H01R31/06;;H01R31/06,H01R13/52;;H01R13/523;;H01R31/06,,0,0,,,,PENDING
350,MX,B,MX 166891 B,064-590-515-670-420,1993-02-11,1993,MX 726387 A,1987-07-09,US 88419786 A,1986-07-10,HIDROFORMULACION USANDO GRUPOS COORDINADORES DE FOSFINA DE BAJA VOLATILIDAD/SOLUBLES ORGANICOS,"La presente invención se refiere a un procedimiento de hidroformilación no acuoso para producir aldehídos, que consiste de: hacer reaccionar un compuesto orgánico olefínicamente insaturado con monóxido de carbono e hidrógeno, en un medio de reacción de hidroformilación no acuoso que contiene un catalizador complejo de un grupo coordinador de fósforo y metal de transición del Grupo VIII orgánico solubilizado y un grupo coordinador de fósforo libre, en donde las condiciones de reacción de hidroformilación comprenden una temperatura de reacción de desde aproximadamente 45 hasta aproximadamente 200 grados C, una presión total de gas de hidrógeno, monóxido de carbono y compuesto olefínicamente insaturado de menos de aproximadamente 105.45 kilogramos por centímetro cuadrado absoluta; en donde la relación molar de H2:CO de hidrógeno gaseoso o monóxido de carbono está dentro de la escala de aproximadamente 1:10 a 100:1; y en donde el medio de reacción contiene cuando menos aproximadamente 4 moles del total del grupo coordinador de fósforo libre por mol del metal de transición del Grupo VIII en el medio; caracterizado en que comprende: emplear como el grupo coordinador de fósforo del catalizador complejo y como el grupo coordinador de fósforo libre, una sal de fosfina terciaria monosulfonada.",UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/064-590-515-670-420,Granted Patent,no,0,0,52,52,0,C07C45/50;;C07F9/5004;;Y02P20/582;;C07B41/00;;C07C47/02;;C07C45/50;;C07F9/5004;;Y02P20/582,B01J31/00;;C07B61/00;;B01J31/24;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00;;C07F9/50,,0,0,,,,EXPIRED
351,CA,A,CA 640367 A,086-799-292-245-106,1962-04-24,1962,CA 640367D A,,CA 640367T A,,TREATMENT OF WET TEXTILE YARN,,UNION CARBIDE CORP,RANKIN WILLIAM W;;BRYANT GEORGE M,,https://lens.org/086-799-292-245-106,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
352,PT,A,PT 91161 A,093-599-523-528-574,1990-02-08,1990,PT 9116189 A,1989-07-13,US 21889588 A,1988-07-14,PROCESSO APERFEICOADO PARA A PRODUCAO DE ALCOOIS E ALDEIDOS,,UNION CARBIDE CHEM PLASTIC,BRYANT DAVID ROBERT;;ABATJOGLOU ANTHONY GEORGE,,https://lens.org/093-599-523-528-574,Patent Application,no,0,0,11,11,0,C07C45/50;;C07C47/02;;C07C29/16,B01J31/24;;C07B61/00;;C07C27/00;;C07C27/22;;C07C29/16;;C07C31/02;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00,,0,0,,,,DISCONTINUED
353,DK,D0,DK 605887 D0,106-467-529-218-433,1987-11-18,1987,DK 605887 A,1987-11-18,US 93200286 A,1986-11-18,FREMGANGSMAADE TIL FREMSTILLING AF ALDEHYDER VED HYDROFORMYLERING I IKKE-VANDIGE REAKTIONSMEDIER,,UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/106-467-529-218-433,Patent Application,no,0,0,53,53,0,C07C45/50;;Y02P20/582;;C07C47/55;;C07C47/02;;C07C45/50;;Y02P20/582,B01J31/00;;B01J31/24;;B01J31/28;;C07B61/00;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00,,0,0,,,,DISCONTINUED
354,DK,A,DK 359987 A,127-823-132-138-961,1988-01-11,1988,DK 359987 A,1987-07-10,US 88419786 A,1986-07-10,IKKE-VANDIG HYDROFORMYLERING VED ANVENDELSE AF TUNGTFLYGTIGE ORGANISK OPLOESELIGE PHOSPHIN-LIGANDER,,UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/127-823-132-138-961,Patent Application,no,0,0,52,52,0,C07C45/50;;C07F9/5004;;Y02P20/582;;C07B41/00;;C07C47/02;;C07C45/50;;C07F9/5004;;Y02P20/582,B01J31/00;;B01J31/24;;C07B61/00;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00;;C07F9/50,,0,0,,,,DISCONTINUED
355,IN,B,IN 170369 B,113-524-673-734-370,1992-03-21,1992,IN 834MA1987 A,1987-11-18,US 93200286 A,1986-11-18,AN IMPROVED PROCESS FOR PRODUCING ALDEHYDES BY NON-AQUEOUS HYDROFORMYLATION,,UNION CARBIDE CORP,ANTHONY GEORGE ABATJOGLOU;;DAVID ROBERT BRYANT,,https://lens.org/113-524-673-734-370,Granted Patent,no,0,0,53,53,0,C07C45/50;;Y02P20/582;;C07C47/55;;C07C47/02;;C07C45/50;;Y02P20/582,B01J31/00;;B01J31/24;;B01J31/28;;C07B61/00;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00,,0,0,,,,EXPIRED
356,NO,L,NO 20015191 L,119-779-771-522-681,2001-10-24,2001,NO 20015191 A,2001-10-24,US 35020099 A;;US 0011811 W,1999-07-08,Seismisk ledende repinnföringskabel,A conductive rope-like lead-in cable connects a seismic streamer to a towing vessel. The lead-in cable comprises a first electrical conductor at the center core of the cable for carrying a first polarity of power to the streamer for providing tensile strength to the load-in cable. A first layer of insulation surrounds the first electrical conductor. A second electrical conductor for a second polarity of power to the streamer surrounds the first layer of insulation. A second layer of insulation surrounds the second electrical conductor. A layer of seismic data conductors surrounds the second layer of insulation. A third layer of insulation surrounds the layer of seismic data conductors. A metallic protective layer surrounds the third layer of insulation. Steel is effectively and efficiently used both to provide tensile strength and for electrical power conduction.,PGS EXPLORATION US INC,BRYANT MICHAEL J;;GEORGE NICK C,,https://lens.org/119-779-771-522-681,Abstract,no,0,0,14,14,0,H01B7/045;;H01B9/003;;H01B9/04;;G01V1/201;;H01B9/003;;H01B7/045;;H01B9/04;;G01V1/201,H01B7/04;;H01B9/00;;H01B9/04,,0,0,,,,EXPIRED
357,US,B2,US 11699180 B2,119-398-286-914-009,2023-07-11,2023,US 202117539119 A,2021-11-30,US 202117539119 A;;US 202016840438 A;;US 201916597246 A,2019-10-09,Computer-implemented methods for technological applications involving provision of an online portal for managing a user account including an interactive GUI having functionality for pre-authorizing future transactions,"Systems and methods involving a computer-implemented portal that enables a user to pre-authorize purchase of items not yet available for sale are disclosed. In one embodiment, an exemplary method may comprise: providing an online portal that enables a user to manage a financial account; executing a first routine of the portal including interactive functionality enabling the user to specify and pre-authorize purchase of an item that is not yet available for sale; searching to determine at least one electronic source at which the item can be purchased when it becomes available for purchase; and executing a purchase transaction at the future date/time when the item is released for sale, to purchase the item for the user.",CAPITAL ONE SERVICES LLC,YEE BRYANT;;BERGERON GEORGE;;BULGAKOV MYKHAYLO,,https://lens.org/119-398-286-914-009,Granted Patent,yes,16,0,5,5,0,G06Q30/0641;;G06Q30/0635;;G06Q20/40;;G06Q20/28;;G06Q20/405;;G06Q20/385;;G06Q30/0635;;G06Q30/0641,G06Q30/00;;G06Q20/38;;G06Q30/0601,,4,1,145-017-862-029-309,10.36644/mlr.117.5.digital,"Gunaratne, Junius. “Influencing Financial Decision-Making through Human-Computer Interaction Design Interventions.” Order No. 10603102 New York University Tandon School of Engineering, 2017. Ann Arbor: ProQuest. Web. Sep. 27, 2022. (Year: 2017).;;“Be Sure to Get what You Want at the Best Price this Holiday.” Business Wire, Dec. 1, 2004, p. 1. ProQuest. Web. Feb. 24, 2023 . (Year: 2004).;;[Author anonymous], “Rowland's Classic Clothing: Rowland's Classic Clothing Expands Business with Integrated Mail Order and Retail Systems from Options . . . by mail order and from its new website,” M2 Presswire [Coventry], Oct. 23, 2008, pp. 1-3.;;Rory Van Loo, “Digital Market Perfection”, Mar. 2019, pp. 815-883 (69 pgs), Michigan Law Review [vol. 117.815].",ACTIVE
358,AU,B2,AU 617836 B2,116-422-687-862-041,1991-12-05,1991,AU 1989/038069 A,1989-07-13,US 21889588 A,1988-07-14,PROCESS FOR PRODUCING ALCOHOLS AND ALDEHYDES,,UNION CARBIDE CHEM PLASTIC,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/116-422-687-862-041,Granted Patent,no,0,0,11,11,0,C07C45/50;;C07C47/02;;C07C29/16,B01J31/24;;C07B61/00;;C07C27/00;;C07C27/22;;C07C29/16;;C07C31/02;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00,,0,0,,,,EXPIRED
359,GB,A,GB 718391 A,177-518-330-500-40X,1954-11-10,1954,GB 253152 A,1952-01-30,GB 253152 A,1952-01-30,Improvements in and relating to lubricating greases,"Lubricating greases of high drop point are prepared by heating a mixture of a lubricating oil, an alkali metal or alkaline earth metal soap and an inorganic nitrite at a temperature above the temperature at which the mixture assumes a grease structure and thereafter cooling the mixture to produce a grease structure. Alternatively, an already-formed grease comprising lubricating oil and alkali metal or alkaline earth metal soap may be heated with the inorganic nitrite until it loses its grease structure and thereafter cooled to reproduce a grease structure. According to another alternative, the inorganic nitrite may be added to a mixture of a lubricating oil and a fat, fatty oil or fatty acid and an alkali metal or alkaline earth metal saponifying agent, heat applied to effect saponification of the fatty material, and the mixture thereafter cooled to produce a grease structure. The lubricating oil may be a mineral lubricating oil or a synthetic lubricating oil such as an ester (e.g. di-(2-ethylhexyl) sebacate) or a silicone (e.g. dimethyl silicone). Nitrites which may be employed are those of Na, K, Li, Ca, Ba, Sr or Mg. They may be added as such or in the form of solution or dispersion in a liquid medium such as water or an organic solvent. Thus, they may be added in the form of a slurry in some of the lubricating oil used in the grease. Fatty materials from which the soap may be derived are saturated or unsaturated fatty acids or substituted fatty acids (e.g. myristic, palmitic, stearic, oleic or 12-hydroxystearic acid) or mixtures thereof, animal oils and fats, vegetable oils, fats and waxes, fish oils, beeswax and degras. The metal radicle of the soap may be Na, K, Li, Ca, Ba or Sr, or the soaps employed may contain more than one metal as in the case of soda-lime greases. Where saponification is carried out in situ, the oxide or hydroxide of the metal may be employed as saponifying agent, and the nitrite may be added before, during or after saponification. The grease compositions may contain additional ingredients such as pour-point depressants, viscosity index improvers, anti-oxidants, anti-corrosion agents and extreme pressure agents. Suitable anti-oxidants are phenyl alpha- or beta-naphthylamine, benzyl phenyl naphthylamine di (p-aminophenyl) phenyl methane, and p, p1- (N, N1-tetramethyl) diamino phenyl methane. In the examples, the preparations are described of greases consisting of the following ingredients:-(a) mineral lubricating oil, sodium stearate, 12-hydroxy stearate, palmitate or myristate, and sodium nitrite, (b) mineral lubricating oil, calcium stearate and calcium nitrite, (c) mineral lubricating oil, lithium 12-hydroxy stearate and lithium nitrite, (d) mineral lubricating oil, lithium soap of hydrogenated castor oil, sodium nitrite and phenyl beta-naphthylamine and (e) dioctyl sebacate, lithium stearate and lithium nitrite. According to the Provisional Specification, the soap employed in the lubricating grease may be an aluminium, zinc or lead soap.",SHELL REFINING & MARKETING CO,PARRY GEORGE ALWYN;;MATTHEWS JOHN BRYANT,,https://lens.org/177-518-330-500-40X,Granted Patent,no,0,2,5,5,0,C10M7/00;;C10M5/00;;C10M2201/02;;C10M2201/083;;C10M2203/10;;C10M2207/022;;C10M2207/10;;C10M2207/125;;C10M2207/129;;C10M2207/24;;C10M2207/282;;C10M2207/34;;C10M2215/06;;C10M2215/064;;C10M2215/065;;C10M2215/067;;C10M2229/02;;C10M2229/05;;C10N2010/00;;C10N2010/02;;C10N2010/04;;C10N2050/10;;C10N2070/00,C10M169/00;;G09B23/24;;G09B23/26,C5F FC            Q;;C5F FD            Q;;C5F F372          Q;;C5F F415          Q;;C5F F50X          Q;;C5F F504          Q;;C5F F505          Q;;C5F F506          Q;;C5F F508          Q;;C5F F509          Q;;C5F F510          Q;;C5F F511          Q;;C5F F512          Q;;C5F F516          Q;;C5F F517          Q;;C5F F537          Q;;C5F F595          Q;;C5F F597          Q;;C5F F792          Q;;C5F F804          Q,0,0,,,,EXPIRED
360,AU,A,AU 1996/070132 A,180-940-094-570-968,1997-03-19,1997,AU 1996/070132 A,1996-08-27,US 295995 P;;US 9614092 W,1995-08-30,N-butylsulfonate esters of estrogens,,LILLY CO ELI,BRYANT HENRY U;;CULLINAN GEORGE J,,https://lens.org/180-940-094-570-968,Patent Application,no,0,0,3,3,0,C07J31/006,C07J31/00,,0,0,,,,PENDING
361,MX,B,MX 166329 B,190-788-220-981-813,1992-12-29,1992,MX 1729889 A,1989-08-24,US 23622188 A,1988-08-25,RECUPERACION DE METAL DE TRANSICION,"La presente invención se refiere a un método para recuperar metal de transición del grupo VIII, a partir de un líquido que contiene el metal de transición, que consiste de (i) poner en contacto el líquido que contiene el metal de transición, con una resina de intercambio de iones, en donde la resina tiene un primer grupo coordinador de organofósforo, ligado iónicamente a la misma, para ocasionar que el metal de transición se separe del líquido y se ligue a la resina y ii) poner en contacto después la resina con un líquido que contiene una cantidad suficiente de un segundo grupo coordinador de organofósforo, para separar el metal de transición de la resina.",UNION CARBIDE CHEM PLASTIC,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/190-788-220-981-813,Granted Patent,no,0,0,15,15,0,B01J31/24;;B01J31/24;;B01J31/185;;B01J31/185;;B01J31/20;;B01J31/20;;B01J31/2234;;B01J31/2234;;B01J31/2404;;B01J31/2404;;B01J31/2409;;B01J31/2409;;B01J31/4023;;B01J31/4023;;B01J31/4046;;B01J31/4046;;B01J31/4053;;B01J31/4053;;B01J39/12;;B01J39/12;;B01J2231/321;;B01J2231/321;;B01J2531/02;;B01J2531/0211;;B01J2531/0211;;B01J2531/80;;B01J2531/80;;B01J2531/822;;B01J2531/822;;B01J2531/985;;B01J2531/985;;B01J2540/12;;B01J2540/12;;B01J2540/32;;B01J2540/32;;B01J2540/42;;B01J2540/42;;B01J2540/525;;B01J2540/525;;B01J2540/68;;B01J2540/68;;C01G55/00;;C01G55/001;;C01G55/001;;C07C45/50;;C07C45/50;;C07C45/79;;C07C45/79;;C22B3/42;;C22B3/42;;Y02P10/20;;Y02P10/20;;Y02P20/584;;Y02P20/584,B01D15/04;;B01J31/40;;B01J39/12;;B01J45/00;;C01G55/00;;C02F1/42;;C02F101/10;;C02F103/36;;C07C45/50;;C07C45/79;;C22B3/00,,0,0,,,,EXPIRED
362,DE,A1,DE 3722928 A1,194-432-284-874-177,1988-01-21,1988,DE 3722928 A,1987-07-10,US 88419786 A,1986-07-10,VERFAHREN ZUR HERSTELLUNG VON ALDEHYDEN DURCH HYDROFORMYLIERUNG,,UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/194-432-284-874-177,Patent Application,no,3,0,52,52,0,C07C45/50;;C07F9/5004;;Y02P20/582;;C07B41/00;;C07C47/02;;C07C45/50;;C07F9/5004;;Y02P20/582,C07B61/00;;B01J31/00;;B01J31/24;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00;;C07F9/50,,0,0,,,,DISCONTINUED
363,AT,T1,AT E77075 T1,017-217-209-899-577,1992-06-15,1992,AT 87116971 T,1987-11-17,EP 87116971 A;;US 93200286 A,1986-11-18,HYDROFORMILIERUNG MIT LEICHT-FLUECHTIGEN PHOSPHINLIGANDEN.,,UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/017-217-209-899-577,Granted Patent,no,0,0,53,53,0,C07C45/50;;Y02P20/582;;C07C47/55;;C07C47/02;;C07C45/50;;Y02P20/582,B01J31/24;;B01J31/00;;B01J31/28;;C07B61/00;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00,,0,0,,,,EXPIRED
364,US,A1,US 2021/0027394 A1,002-377-100-648-254,2021-01-28,2021,US 202017061423 A,2020-10-01,US 202017061423 A;;US 201916519463 A,2019-07-23,CROWDSOURCED ANNOTATION AND TAGGING SYSTEM FOR DIGITAL TRANSACTIONS AND TRANSACTION PREDICTION SYSTEM,"A system for crowdsourcing annotations for transactions includes a crowdsourcing annotation database and a processor. The database stores crowdsourced annotations associated with merchants. The crowdsourced annotations are shared among, and contributed by, users of a community. The processor receives transaction data for a transaction by a user with a merchant. Relevant crowdsourced annotations associated with the merchant are retrieved from the database and sent to the user to enable to the user to annotate the transaction. The user provides an annotation for the transaction. The system dynamically updates the database based on the annotation provided by the user. In another aspect a transaction prediction system is disclosed. The system receives transaction data and identifies text on a check image associated with the transaction data. The system identifies a recurring expense and associated expense frequency, and may generate an expense warning or suggestion to execute a check to pay the expense.",CAPITAL ONE SERVICES LLC,YEE BRYANT;;BERGERON GEORGE;;BULGAKOV MYKHAYLO,CAPITAL ONE SERVICES LLC (2020-09-30),https://lens.org/002-377-100-648-254,Patent Application,yes,1,2,1,6,0,G06F40/169;;G06Q10/101;;G06Q20/0425;;G06Q30/0185;;G06Q30/06;;G06Q40/02;;G06Q40/12;;G06Q20/3221;;G06Q20/4016;;G06Q20/405;;G06Q40/12;;G06F40/30;;G06F40/169,G06Q40/00;;G06F40/30;;G06K9/46,,0,0,,,,PENDING
365,GB,A,GB 2376137 A,026-638-402-061-073,2002-12-04,2002,GB 0220343 A,2001-02-03,US 0103550 W;;US 51442300 A,2000-02-28,Electrical cable insert,There is provided an electric cable insert for removably electrically connecting a cable having multiple conductors to a mating receptacle wherein the number and configuration of the cable conductors may be different from those of the sockets of the mating receptacle. The insert includes a housing open on one end to an internal cavity and having a plurality of orifices in the other end. The cable conductors connect to one side of a circuit card within the housing which conductively transitions from the number and configuration of the cable conductors to the number and configuration of the sockets of the mating receptacle. Receptacle pins extend from the opposite side of the circuit card through respective orifices in the housing for connecting to respective sockets in the mating receptacle. A compressed sealing gland disposed within the housing adjacent the circuit card provides the insert with an energized compression seal from the environment. A driver closes the end of the housing and maintains compression in the sealing gland. The cable conductors pass through respective bores in the sealing gland and in the driver.,PGS EXPLORATION,GEORGE NICK C;;BRYANT MICHAEL JOHN,,https://lens.org/026-638-402-061-073,Patent Application,no,4,0,9,9,0,H01R13/523;;H01R13/523;;H01R13/5208;;H01R13/5208;;H01R31/06;;H01R31/06,H01R13/52;;H01R13/523;;H01R31/06,H2E EFBE          EFBE,0,0,,,,EXPIRED
366,US,A1,US 2022/0050976 A1,031-820-862-896-065,2022-02-17,2022,US 202117342969 A,2021-06-09,US 202117342969 A;;US 202016990300 A,2020-08-11,AUGMENTED REALITY INFORMATION DISPLAY AND INTERACTION VIA NFC BASED AUTHENTICATION,"Various embodiments are generally directed to improving card security by providing a user a contactless card with no sensitive card information, such as card number, card verification value, and expiration date, printed thereon, and displaying the sensitive card information relative to the card in augmented reality (AR) based on successful NFC-based user authentication. According to examples, the NFC-based user authentication may be performed by one-tapping or single tapping the contactless card to user mobile device. One or more portions of the sensitive card information may be obfuscated to further enhance card security. Moreover, the user can interact with AR elements including the sensitive card information to perform various actions.",CAPITAL ONE SERVICES LLC,BERGERON GEORGE;;YEE BRYANT;;BULGAKOV MYKHAYLO,CAPITAL ONE SERVICES LLC (2020-08-10),https://lens.org/031-820-862-896-065,Patent Application,yes,0,1,11,11,0,G06Q40/02;;H04L9/0861;;H04L2209/805;;H04L9/3242;;G06K7/10297;;H04W12/47;;H04W12/069;;H04W12/02;;H04L63/08;;H04L63/0421;;H04W12/61;;G06F21/35;;H04W12/47;;H04W12/047;;H04W12/65;;G06F3/14;;G06Q20/34;;G06K7/10297;;H04L9/3226;;G06F21/6245;;G06F3/0484;;G06Q40/02;;G06F3/14;;H04L9/0861,G06K7/10;;G06F3/14;;G06F21/62;;G06Q40/02;;H04L9/08;;H04L9/32,,0,0,,,,ACTIVE
367,AU,B2,AU 621396 B2,048-035-890-158-493,1992-03-12,1992,AU 1989/040198 A,1989-08-24,US 23622188 A,1988-08-25,TRANSITION METAL RECOVERY,,UNION CARBIDE CHEM PLASTIC,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/048-035-890-158-493,Granted Patent,no,2,0,15,15,0,B01J31/24;;B01J31/24;;B01J31/185;;B01J31/185;;B01J31/20;;B01J31/20;;B01J31/2234;;B01J31/2234;;B01J31/2404;;B01J31/2404;;B01J31/2409;;B01J31/2409;;B01J31/4023;;B01J31/4023;;B01J31/4046;;B01J31/4046;;B01J31/4053;;B01J31/4053;;B01J39/12;;B01J39/12;;B01J2231/321;;B01J2231/321;;B01J2531/02;;B01J2531/0211;;B01J2531/0211;;B01J2531/80;;B01J2531/80;;B01J2531/822;;B01J2531/822;;B01J2531/985;;B01J2531/985;;B01J2540/12;;B01J2540/12;;B01J2540/32;;B01J2540/32;;B01J2540/42;;B01J2540/42;;B01J2540/525;;B01J2540/525;;B01J2540/68;;B01J2540/68;;C01G55/00;;C01G55/001;;C01G55/001;;C07C45/50;;C07C45/50;;C07C45/79;;C07C45/79;;C22B3/42;;C22B3/42;;Y02P10/20;;Y02P10/20;;Y02P20/584;;Y02P20/584,B01D15/04;;B01J31/40;;B01J39/12;;B01J45/00;;C01G55/00;;C02F1/42;;C02F101/10;;C02F103/36;;C07C45/50;;C07C45/79;;C22B3/00,,0,0,,,,EXPIRED
368,ZA,B,ZA 821562 B,027-500-291-886-99X,1983-01-26,1983,ZA 821562 A,1982-03-09,US 24308281 A,1981-03-12,PROCESS FOR REMOVING HYDROPEROXIDES AND ALDEHYDES FROM ALLYLALKYL ETHER,"Described herein is a process for the conversion of hydroperoxides, present in alkyl-alkyl ethers to products including alpha , beta -unsaturated aldehydes and for reducing such alpha , beta -unsaturated aldehydes to alcohols prior to the use of the ether as a feedstock in a hydroformylation reaction to produce the corresponding ether aldehyde. The process involves contacting the ether with a metal hydride, either in aqueous solution and/or by means of an ion exchange resin. Such treatment decomposes the hydroperoxides and then reduces their alpha , beta -unsaturated aldehyde decomposition products, thereby reducing the catalyst inhibition period present in the hydroformylation reaction which is observed when such alpha , beta -unsaturated aldehyde impurities are present.",UNION CARBIDE CORP,ABATIOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/027-500-291-886-99X,Granted Patent,no,0,0,16,17,0,C07C29/175;;C07C31/10;;C07C41/36;;C07C41/44;;C07C45/53;;C07C45/62;;C07C43/00,C07C29/17;;C07C43/18;;C07C31/10;;C07C41/00;;C07C41/34;;C07C41/36;;C07C41/44;;C07C43/00;;C07C43/15;;C07C43/188;;C07C45/53;;C07C45/62;;C07C67/00,,0,0,,,,EXPIRED
369,US,B1,US 6631095 B1,059-644-038-663-77X,2003-10-07,2003,US 35020099 A,1999-07-08,US 35020099 A,1999-07-08,Seismic conductive rope lead-in cable,"
    A conductive rope-like lead-in cable connects a seismic streamer to a towing vessel. The lead-in cable comprises a first electrical conductor at the center core of the cable for carrying a first polarity of power to the streamer for providing tensile strength to the load-in cable. A first layer of insulation surrounds the first electrical conductor. A second electrical conductor for a second polarity of power to the streamer surrounds the first layer of insulation. A second layer of insulation surrounds the second electrical conductor. A layer of seismic data conductors surrounds the second layer of insulation. A third layer of insulation surrounds the layer of seismic data conductors. A metallic protective layer surrounds the third layer of insulation. Steel is effectively and efficiently used both to provide tensile strength and for electrical power conduction. 
",PGS EXPLORATION US INC,BRYANT MICHAEL JOHN;;GEORGE NICK C,PGS EXPLORATION (US) INC (1999-06-29),https://lens.org/059-644-038-663-77X,Granted Patent,yes,14,31,14,14,0,H01B7/045;;H01B9/003;;H01B9/04;;G01V1/201;;H01B9/003;;H01B7/045;;H01B9/04;;G01V1/201,H01B7/04;;H01B9/00;;H01B9/04,367/20;;X174113 R,0,0,,,,EXPIRED
370,US,A,US 3388190 A,061-195-182-504-512,1968-06-11,1968,US 18930362 A,1962-04-23,US 18930362 A;;US 18930462 A;;US 18931362 A,1962-04-23,Dyeable polypropylene,,UNION CARBIDE CORP,BRYANT GEORGE M;;ZUTTY NATHAN L,,https://lens.org/061-195-182-504-512,Granted Patent,no,8,12,11,20,0,C08L23/02;;C08L23/10;;C08L23/12;;C08L33/26;;C08L39/04;;D06P3/79;;D06P3/79;;C08L33/26;;C08L23/10;;C08L23/12;;C08L39/04;;C08L23/02;;Y10S8/928;;Y10S8/09,C08L23/02;;C08L23/12;;C08L33/26;;C08L39/04;;D06P3/79,260/897,0,0,,,,EXPIRED
371,WO,A2,WO 2005/040017 A2,074-666-998-874-145,2005-05-06,2005,US 2004/0035201 W,2004-10-22,US 69144703 A;;US 69230403 A,2003-10-22,ALUMINUM CONDUCTOR COMPOSITE CORE REINFORCED CABLE AND METHOD OF MANUFACTURE,"This invention relates to an aluminum conductor composite core reinforced cable (ACCC) and method of manufacture. An ACCC cable (300) has a composite core surrounded by an outer film (305) and at least one layer of aluminum conductor (306). The composite core (303) comprises a plurality of fibers from at least one fiber type in one or more matrix materials. According to the invention, unique processing techniques such a B-Staging and / or film-coating techniques can be used to increase production rates from a few feet per minute to sixty or more feet per minute.",COMPOSITE TECH CORP;;HIEL CLEMENT;;KORZENIOWSKI GEORGE;;BRYANT DAVID,HIEL CLEMENT;;KORZENIOWSKI GEORGE;;BRYANT DAVID,,https://lens.org/074-666-998-874-145,Patent Application,yes,0,19,34,35,0,B29C70/52;;B29L2031/3462;;B32B1/00;;B32B15/02;;B32B15/08;;B32B15/20;;B32B27/04;;H01B5/105;;B29C70/528;;Y10T428/2918;;Y10T428/2933;;Y10T428/2936;;Y10T442/30;;B32B27/04;;B82Y30/00;;Y10T428/2918;;Y10T428/2933;;Y10T428/2936;;Y10T442/30;;B32B2305/08;;B32B2307/54;;B32B27/08;;B32B2457/00;;B29L2031/3462;;B32B1/00;;B29C70/52;;B32B15/02;;B32B15/20;;B32B27/04;;B32B15/08;;H01B5/105;;B29C70/528,B05D1/18;;B05D3/02;;B32B27/04;;B65H/;;D04H3/08,,0,0,,,,PENDING
372,CN,A,CN 1040826 A,076-645-862-423-740,1990-03-28,1990,CN 89107591 A,1989-08-24,US 23622188 A,1988-08-25,TRANSITION METAL RECOVERY,,UNION CARBIDE CHEM PLASTIC,GEORGE ABATJOGLOU ANTHONY;;ROBERT BRYANT DAVID,,https://lens.org/076-645-862-423-740,Patent Application,no,0,3,15,15,0,B01J31/24;;B01J31/24;;B01J31/185;;B01J31/185;;B01J31/20;;B01J31/20;;B01J31/2234;;B01J31/2234;;B01J31/2404;;B01J31/2404;;B01J31/2409;;B01J31/2409;;B01J31/4023;;B01J31/4023;;B01J31/4046;;B01J31/4046;;B01J31/4053;;B01J31/4053;;B01J39/12;;B01J39/12;;B01J2231/321;;B01J2231/321;;B01J2531/02;;B01J2531/0211;;B01J2531/0211;;B01J2531/80;;B01J2531/80;;B01J2531/822;;B01J2531/822;;B01J2531/985;;B01J2531/985;;B01J2540/12;;B01J2540/12;;B01J2540/32;;B01J2540/32;;B01J2540/42;;B01J2540/42;;B01J2540/525;;B01J2540/525;;B01J2540/68;;B01J2540/68;;C01G55/00;;C01G55/001;;C01G55/001;;C07C45/50;;C07C45/50;;C07C45/79;;C07C45/79;;C22B3/42;;C22B3/42;;Y02P10/20;;Y02P10/20;;Y02P20/584;;Y02P20/584,B01D15/04;;B01J31/40;;B01J39/12;;B01J45/00;;C01G55/00;;C02F1/42;;C02F101/10;;C02F103/36;;C07C45/50;;C07C45/79;;C22B3/00,,0,0,,,,EXPIRED
373,CA,A,CA 169929 A,085-198-703-288-224,1916-06-06,1916,CA 169929D A,1915-12-17,CA 169929T A,1915-12-17,MACHINE TOOL,,AMALGAMATED MACHINERY CORP;;BRYANT GEORGE F;;YEOMANS LUCIEN I,BRYANT GEORGE F;;YEOMANS LUCIEN I,,https://lens.org/085-198-703-288-224,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
374,GB,B,GB 2197867 B,090-360-261-211-45X,1991-05-29,1991,GB 8727013 A,1987-11-18,US 93200286 A,1986-11-18,HYDROFORMYLATION,,UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/090-360-261-211-45X,Granted Patent,no,0,0,53,53,0,C07C45/50;;Y02P20/582;;C07C47/55;;C07C47/02;;C07C45/50;;Y02P20/582,B01J31/00;;B01J31/24;;B01J31/28;;C07B61/00;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00,C2C CJE;;C2C CJE;;C2C CTG;;C2C CTH;;C2C C20Y;;C2C C20Y;;C2C C228;;C2C C228;;C2C C248;;C2C C248;;C2C C30Y;;C2C C30Y;;C2C C304;;C2C C304;;C2C C350;;C2C C350;;C2C C40Y;;C2C C40Y;;C2C C408;;C2C C408;;C2C C54X;;C2C C54X;;C2C C567;;C2C C568;;C2C C569;;C2C C65Y;;C2C C65Y;;C2C C66Y;;C2C C67Y,0,0,,,,EXPIRED
375,FI,B,FI 89351 B,102-967-225-506-773,1993-06-15,1993,FI 873054 A,1987-07-10,US 88419786 A,1986-07-10,Hydroformylering som utnyttjar svagt flyktiga fosfinligander som aer loesliga i organiska aemnen,,UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/102-967-225-506-773,Patent Application,no,0,0,52,52,0,C07C45/50;;C07F9/5004;;Y02P20/582;;C07B41/00;;C07C47/02;;C07C45/50;;C07F9/5004;;Y02P20/582,B01J31/00;;B01J31/24;;C07C45/00;;C07B61/00;;C07C45/50;;C07C47/02;;C07C67/00;;C07F9/50,,0,0,,,,EXPIRED
376,FI,C,FI 90858 C,107-678-985-357-302,1994-04-11,1994,FI 875087 A,1987-11-18,US 93200286 A,1986-11-18,Hydroformylointi käyttäen heikosti haihtuvia fosfiiniligandeja,,UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/107-678-985-357-302,Granted Patent,no,0,0,53,53,0,C07C45/50;;Y02P20/582;;C07C47/55;;C07C47/02;;C07C45/50;;Y02P20/582,B01J31/00;;B01J31/28;;C07B61/00;;C07C45/00;;B01J31/24;;C07C45/50;;C07C47/02;;C07C67/00,,0,0,,,,EXPIRED
377,DE,A1,DE 2508292 A1,122-148-419-436-845,1975-08-28,1975,DE 2508292 A,1975-02-26,US 44641474 A,1974-07-27,"TROCKENE, FESTE HARNSTOFF-GLYOXAL- UEBERZUGSPRAEPARATE",,UNION CARBIDE CORP,GLANCY CHARLES WILLIAM;;BRYANT GEORGE MACON,"UNION CARBIDE CORP., 06817 DANBURY, CONN., US (1982-12-23)",https://lens.org/122-148-419-436-845,Patent Application,no,0,1,11,13,0,C08G12/12;;D06M15/423;;D21H19/54;;D21H19/54;;C08G12/12;;D06M15/423,C08G12/00;;C08G12/12;;D06M15/423;;D21H17/50;;D21H19/54,,0,0,,,,DISCONTINUED
378,DE,A1,DE 2131624 A1,109-743-016-424-837,1971-12-30,1971,DE 2131624 A,1971-06-25,US 4963170 A,1970-06-25,Leseverstaerker und Bittreiber-Schaltung fuer Halbleiter-Speichersystem,,COGAR CORP,W BRYANT RICHARD;;K TU GEORGE,,https://lens.org/109-743-016-424-837,Patent Application,no,0,0,2,2,0,G11C11/4116;;G11C11/416;;H03K17/6221;;G11C11/416;;H03K17/6221;;G11C11/4116,G11C11/411;;G11C11/416;;H03K17/62,,0,0,,,,PENDING
379,GB,A,GB 190104172 A,113-246-057-556-446,1902-01-16,1902,GB 190104172D A,1901-02-27,GB 190104172T A,1901-02-27,Improvements in Planes.,"4172. Bryant, G. E., and Witcombe, E. J. Feb. 27. Planes, hand.-The plane for shouldering-work consists of an angular casting a, b, the blade c projecting through a slot in the side a. One side of this slot is formed by a dovetailed piece j fixed by screws. The blade is held by a plate d pivoted at e and provided with a screw g bearing on the blade.",BRYANT GEORGE EDWIN;;WITCOMBE EDWARD JAMES,BRYANT GEORGE EDWIN;;WITCOMBE EDWARD JAMES,,https://lens.org/113-246-057-556-446,Patent Application,no,0,0,1,1,0,,,,0,0,,,,DISCONTINUED
380,EP,A1,EP 0350921 A1,120-467-210-395-005,1990-01-17,1990,EP 89112856 A,1989-07-13,US 21889588 A,1988-07-14,Process for producing alcohols and aldehydes.,An improved cobalt catalyzed oxo reaction process for producing alcohols and aldehydes which comprises employing a monosulfonated tertiary metal salt ligand and phase separating the alcohol and aldehyde reaction products from the oxo reaction product composition by the use of added water or both added water and an added non-polar hydrocarbon compound.,UNION CARBIDE CHEM PLASTIC,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/120-467-210-395-005,Patent Application,yes,8,11,11,11,0,C07C45/50;;C07C47/02;;C07C29/16,B01J31/24;;C07B61/00;;C07C27/00;;C07C27/22;;C07C29/16;;C07C31/02;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00,,0,0,,,,DISCONTINUED
381,GB,A,GB 190825134 A,132-919-077-010-478,1909-08-12,1909,GB 190825134D A,1908-11-23,GB 190825134T A,1908-11-23,Improvements in or relating to Automatic Switching or Controlling Apparatus for the Distribution of Electricity.,"25,134. Bryant, E. G., and Pearson, R. H. Nov. 23. No Patent granted (Sealing fee not paid). Switches.-For opening and closing supply wires, according to the load on a consumption circuit, especially where transformers are employed, a disk or wheel switch is actuated in turn by two solenoids which are put into action through a two-way switch. The two-way switch is actuated by a solenoid from a battery or auxiliary transformer in a manner depending on the operation of a switch or on the current flowing in the consumption circuit. As shown in Fig. 1, the disk G with conducting faces G<1> completes the supply circuit through contacts H, H<1>, H<2>, H<3> to terminals E<9> E<10>, the connexions being as shown in Fig. 4.. Current flowing through the solenoid L from a battery O<2>, or auxiliary transformer O<3>, keeps the two-way switch arm I up against the carbon contact h connected to the solenoid E. The solenoid L is arranged to become de-energized when there is,no load on the consumer's circuit. The arm I then falls on a contact h<1> connected to the second solenoid E', which attracts its core, and turns the disk G so as to break the supply circuit. The accompanying movement of the coupling lever C thtows a loose contact-lever M<1> away from a contact N' and up to the opposite contact, thus de-energizing the solenoid E<1> when it has completed its stroke, and preparing a circuit for the solenoid E to be subsequentty energized. In a modification, the loose lever M' is replaced by a flexible spring carrying a contact at the end.",BRYANT EDWIN GEORGE;;PEARSON REGINALD HEWITT,BRYANT EDWIN GEORGE;;PEARSON REGINALD HEWITT,,https://lens.org/132-919-077-010-478,Patent Application,no,0,0,1,1,0,,,,0,0,,,,DISCONTINUED
382,CA,C,CA 2543111 C,142-138-881-098-133,2011-09-20,2011,CA 2543111 A,2004-10-22,US 69144703 A;;US 69230403 A;;US 2004/0035201 W,2003-10-22,ALUMINUM CONDUCTOR COMPOSITE CORE REINFORCED CABLE AND METHOD OF MANUFACTURE,"This invention relates to an aluminum conductor composite core reinforced cable (ACCC) and method of manufacture. An ACCC cable (300) has a composite core surrounded by an outer film (305) and at least one layer of aluminum conductor (306). The composite core (303) comprises a plurality of fibers from at least one fiber type in one or more matrix materials. According to the invention, unique processing techniques such a B-Staging and / or film-coating techniques can be used to increase production rates from a few feet per minute to sixty or more feet per minute.",COMPOSITE TECH CORP,HIEL CLEMENT;;KORZIENOWSKI GEORGE;;BRYANT DAVID,,https://lens.org/142-138-881-098-133,Granted Patent,no,0,0,34,35,0,B29C70/52;;B29L2031/3462;;B32B1/00;;B32B15/02;;B32B15/08;;B32B15/20;;B32B27/04;;H01B5/105;;B29C70/528;;Y10T428/2918;;Y10T428/2933;;Y10T428/2936;;Y10T442/30;;B32B27/04;;B82Y30/00;;Y10T428/2918;;Y10T428/2933;;Y10T428/2936;;Y10T442/30;;B32B2305/08;;B32B2307/54;;B32B27/08;;B32B2457/00;;B29L2031/3462;;B32B1/00;;B29C70/52;;B32B15/02;;B32B15/20;;B32B27/04;;B32B15/08;;H01B5/105;;B29C70/528,B32B27/04;;B05D1/18;;B05D3/02;;B65H/;;D04H3/08,,0,0,,,,ACTIVE
383,CN,C,CN 1020720 C,153-222-234-871-127,1993-05-19,1993,CN 87105466 A,1987-07-10,US 88419786 A,1986-07-10,HYDROFORMYLATION USING LOW VOLATILE ORGANIC SOLUBLE PHOSPHINE LIGANDS,,UNION CARBIDE CORP,ABATJOGIOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/153-222-234-871-127,Granted Patent,no,0,0,52,52,0,C07C45/50;;C07F9/5004;;Y02P20/582;;C07B41/00;;C07C47/02;;C07C45/50;;C07F9/5004;;Y02P20/582,C07B61/00;;B01J31/00;;B01J31/24;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00;;C07F9/50,,0,0,,,,EXPIRED
384,CA,A,CA 626337 A,168-693-422-076-660,1961-08-29,1961,CA 626337D A,,CA 626337T A,,TOOL FOR CONTROLLING FLUID CIRCULATION IN WELL BORES,,ROY L ARTERBURY,ARTERBURY BRYANT P;;CLARK GEORGE M,,https://lens.org/168-693-422-076-660,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
385,EP,A4,EP 1678063 A4,197-007-814-327-093,2008-10-08,2008,EP 04796235 A,2004-10-22,US 2004/0035201 W;;US 69144703 A;;US 69230403 A,2003-10-22,ALUMINUM CONDUCTOR COMPOSITE CORE REINFORCED CABLE AND METHOD OF MANUFACTURE,,CTC CABLE CORP,HIEL CLEMENT;;KORZENIOWSKI GEORGE;;BRYANT DAVID,,https://lens.org/197-007-814-327-093,Search Report,no,5,0,34,35,0,B29C70/52;;B29L2031/3462;;B32B1/00;;B32B15/02;;B32B15/08;;B32B15/20;;B32B27/04;;H01B5/105;;B29C70/528;;Y10T428/2918;;Y10T428/2933;;Y10T428/2936;;Y10T442/30;;B32B27/04;;B82Y30/00;;Y10T428/2918;;Y10T428/2933;;Y10T428/2936;;Y10T442/30;;B32B2305/08;;B32B2307/54;;B32B27/08;;B32B2457/00;;B29L2031/3462;;B32B1/00;;B29C70/52;;B32B15/02;;B32B15/20;;B32B27/04;;B32B15/08;;H01B5/105;;B29C70/528,B65H1/00;;B05D1/18;;B05D3/02;;B29C70/08;;B32B15/04;;B32B15/08;;B32B27/04;;B65H/;;D04H3/08;;H01B5/10,,0,0,,,,DISCONTINUED
386,NO,B1,NO 323193 B1,009-985-842-762-631,2007-01-15,2007,NO 20024039 A,2002-08-23,US 51442300 A;;US 0103550 W,2000-02-28,Elektrisk kabelinnforing,,PGS EXPLORATION US INC,BRYANT MICHAEL JOHN;;GEORGE NICK C,,https://lens.org/009-985-842-762-631,Granted Patent,no,0,1,9,9,0,H01R13/523;;H01R13/523;;H01R13/5208;;H01R13/5208;;H01R31/06;;H01R31/06,H01R13/52;;H01R13/523;;H01R31/06,,0,0,,,,EXPIRED
387,GB,A,GB 2197867 A,016-014-919-423-155,1988-06-02,1988,GB 8727013 A,1987-11-18,US 93200286 A,1986-11-18,HYDROFORMYLATION PROCESS,,UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/016-014-919-423-155,Patent Application,no,0,0,53,53,0,C07C45/50;;Y02P20/582;;C07C47/55;;C07C47/02;;C07C45/50;;Y02P20/582,B01J31/00;;B01J31/28;;B01J31/24;;C07B61/00;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00,C2C CJE;;C2C CJE;;C2C CTG;;C2C CTH;;C2C C20Y;;C2C C20Y;;C2C C228;;C2C C228;;C2C C248;;C2C C248;;C2C C30Y;;C2C C30Y;;C2C C304;;C2C C304;;C2C C350;;C2C C350;;C2C C40Y;;C2C C40Y;;C2C C408;;C2C C408;;C2C C54X;;C2C C54X;;C2C C567;;C2C C568;;C2C C569;;C2C C65Y;;C2C C65Y;;C2C C66Y;;C2C C67Y,0,0,,,,EXPIRED
388,FI,A0,FI 875087 A0,035-745-589-177-200,1987-11-18,1987,FI 875087 A,1987-11-18,US 93200286 A,1986-11-18,Hydroformylointi käyttäen heikosti haihtuvia fosfiiniligandeja,,UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/035-745-589-177-200,Patent Application,no,0,0,53,53,0,C07C45/50;;Y02P20/582;;C07C47/55;;C07C47/02;;C07C45/50;;Y02P20/582,B01J31/00;;B01J31/24;;B01J31/28;;C07B61/00;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00,,0,0,,,,EXPIRED
389,US,A,US 3256364 A,051-893-014-528-254,1966-06-14,1966,US 18930462 A,1962-04-23,US 18930462 A;;US 18930362 A;;US 18931362 A,1962-04-23,Dyeable polypropylene compositions containing ethylene-n-vinyl heterocyclic compoundcopolymers,,UNION CARBIDE CORP,BRYANT GEORGE M;;ZUTTY NATHAN L,,https://lens.org/051-893-014-528-254,Granted Patent,no,4,13,11,20,0,C08L23/02;;C08L23/10;;C08L23/12;;C08L33/26;;C08L39/04;;D06P3/79;;D06P3/79;;C08L33/26;;C08L23/10;;C08L23/12;;C08L39/04;;C08L23/02;;Y10S8/928;;Y10S8/09,C08L23/02;;C08L23/12;;C08L33/26;;C08L39/04;;D06P3/79,,0,0,,,,EXPIRED
390,US,A,US 4268641 A,087-400-229-637-907,1981-05-19,1981,US 15452180 A,1980-05-29,US 15452180 A;;US 3277179 A,1979-04-24,Acrylic acid-acrylate copolymer thickening agents,Copolymers of acrylic acid and nonionic surfactant acrylates have been found to be useful thickening agents for both aqueous solutions and water/liquid hydrocarbon emulsions.,UNION CARBIDE CORP,KOENIG HARVEY S;;BRYANT GEORGE M,UNION CARBIDE CORPORATION (1980-10-23),https://lens.org/087-400-229-637-907,Granted Patent,yes,18,93,1,1,0,C08F8/44;;C08F8/44;;Y10S526/932,C08F8/44,C3P PDZ           PDZ,0,0,,,,EXPIRED
391,EP,A3,EP 0254937 A3,082-523-500-890-95X,1989-04-19,1989,EP 87110014 A,1987-07-10,US 88419786 A,1986-07-10,HYDROFORMYLATION USING LOW VOLATILE/ORGANIC SOLUBLE PHOSPHINE LIGANDS,"A nonaqueous hydroformylation process for producing aldehydes using low volatile, organic soluble monosulfonated tertiary phosphine salt ligands.",UNION CARBIDE CORPORATION,"ABATJOGLOU, ANTHONY GEORGE;;BRYANT, DAVID ROBERT",,https://lens.org/082-523-500-890-95X,Search Report,yes,3,0,52,52,0,C07C45/50;;C07F9/5004;;Y02P20/582;;C07B41/00;;C07C47/02;;C07C45/50;;C07F9/5004;;Y02P20/582,B01J31/00;;B01J31/24;;C07B61/00;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00;;C07F9/50,,0,0,,,,EXPIRED
392,US,A1,US 2012/0277640 A1,085-058-893-280-404,2012-11-01,2012,US 201113519953 A,2011-01-03,US 201113519953 A;;US 29180409 P;;US 29177909 P;;US 29173209 P;;US 2011/0020052 W,2009-12-31,ULTRASOUND COUPLING DEVICE,"The present invention relates to an ultrasound coupling device for use with various ultrasound transducers, systems, and applications. The coupling device includes a coupling compartment comprising a chamber having a continuous side wall and an opening on a first end. The continuous side wall is configured to hold a low-profile ultrasound transducer within the chamber so that a front ultrasound emitting surface of the low-profile ultrasound transducer faces outward toward the chamber opening. The front ultrasound emitting surface is configured to control the direction and wave pattern of ultrasonic energy emitted from the transducer. The continuous side wall is also configured to hold a quantity of an ultrasound conductive medium within the chamber and is operative to keep the ultrasound conductive medium in simultaneous contact with a surface of a subject and with at least a portion of the front ultrasound emitting surface of the transducer. The present invention also relates to an ultrasound apparatus, kit, and methods of using the ultrasound coupling device, apparatus, and kit.",LEWIS JR GEORGE K;;GUFFEY BRYANT;;ZETROZ LLC,LEWIS JR GEORGE K;;GUFFEY BRYANT,ZETROZ INC (2013-06-12);;ZETROZ SYSTEMS LLC (2016-01-29),https://lens.org/085-058-893-280-404,Patent Application,yes,5,37,32,32,0,A61B8/4281;;A61B17/2251;;A61B2017/2253;;A61N2007/0078;;A61B8/4227;;A61B8/4236;;A61B8/4427;;A61B2017/00734;;A61N2007/006;;A61N2007/0091;;A61N2007/0095;;A61B8/44;;A61N7/00;;Y10T29/49005;;A61B2034/301;;A61B34/30;;A61B2034/303;;A61B2034/107;;A61B34/10;;A61N2007/0034;;Y10T29/49005;;A61B8/4281;;A61B17/2251;;A61B2017/2253;;A61N2007/0078;;A61B8/4227;;A61B8/4236;;A61B2017/00734;;A61N2007/0091;;A61N2007/0095;;A61B8/4427;;A61B8/44;;A61N2007/006;;A61N7/00,A61N7/00;;A61M37/00,601/2;;604/22,0,0,,,,INACTIVE
393,PT,E,PT 832883 E,111-844-610-950-121,2002-08-30,2002,PT 97307498 T,1997-09-25,US 2675296 P,1996-09-26,COMPOSTOS DE TETRAHIDROBENZO(A)FLUORENO E METODOS DE USO,"The invention provides tetrahydrobenzoÄaÜfluorene compounds, formulations, and methods of inhibiting bone loss or bone resorption, particularly osteoporosis, and cardiovascular-related pathological conditions, including hyperlipidemia.",LILLY CO ELI,CULLINAN GEORGE JOSEPH;;BRYANT HENRY UHLMAN,,https://lens.org/111-844-610-950-121,Granted Patent,no,0,0,11,11,0,A61K31/565;;A61K31/57;;C07C217/18;;C07D295/088;;C07C2603/40;;A61P19/10;;A61P3/06;;A61P43/00;;A61P9/00;;C07D295/088;;A61K31/565;;C07C217/18;;A61K31/57;;C07C2603/40,A61K31/135;;A61K31/40;;C07D295/08;;A61K31/445;;A61K31/55;;A61K31/565;;A61K31/57;;A61P3/06;;A61P9/00;;A61P19/10;;A61P43/00;;C07C217/18;;C07C309/65;;C07D207/06;;C07D295/092;;C07J69/00,,0,0,,,,EXPIRED
394,IT,A0,IT 8025626 A0,089-178-580-150-66X,1980-10-29,1980,IT 2562680 A,1980-10-29,US 9021179 A,1979-11-01,COMPLESSO DI STAMPO DA IMPIEGARE PER OPERAZIONI DI FUCINATURA.,,UNITED TECHNOLOGIES CORP,DONALD GEORGE MACNITT;;BRYANT HARDING WALKER,,https://lens.org/089-178-580-150-66X,Patent Application,no,0,0,27,27,0,B21J5/02;;B21J9/02;;B21J13/02;;B21K1/36;;B21K29/00;;Y10T29/49488;;Y10T29/49488;;B21J5/02;;B21K1/36;;B21J9/02;;B21J13/02;;B21K29/00,B21J5/02;;B21J9/02;;B21J13/02;;B21K1/36;;B21K3/04,,0,0,,,,EXPIRED
395,US,A,US 2935132 A,116-112-144-538-997,1960-05-03,1960,US 54157055 A,1955-10-20,US 54157055 A,1955-10-20,Well screen perforation cleaner,,ROY L ARTERBURY,ARTERBURY BRYANT P;;CLARK GEORGE M,,https://lens.org/116-112-144-538-997,Granted Patent,no,3,15,1,1,0,E21B37/08;;E21B37/08,E21B37/08,,0,0,,,,EXPIRED
396,US,A,US 1752779 A,125-795-363-552-045,1930-04-01,1930,US 26398428 A,1928-03-23,US 26398428 A,1928-03-23,Printing-press bed,,BRYANT GEORGE F;;WARNOCK WALLACE S,BRYANT GEORGE F;;WARNOCK WALLACE S,,https://lens.org/125-795-363-552-045,Granted Patent,no,0,1,1,1,0,B41F27/04;;B41F27/04,B41F27/04,,0,0,,,,EXPIRED
397,US,A1,US 2023/0230134 A1,127-312-369-648-72X,2023-07-20,2023,US 202318188827 A,2023-03-23,US 202318188827 A;;US 202117644104 A;;US 202016991347 A,2020-08-12,METHODS AND SYSTEMS FOR PROVIDING ESTIMATED TRANSACTIONAL DATA,"A computer-implemented method for providing an estimated utility expenditure to a user may include: obtaining, via one or more processors, historical transactional data of one or more customers other than the user from one or more transactional entities, wherein the historical transactional data includes: at least one address of a given customer of the one or more customers; and a historical utility expenditure associated with the at least one address; generating, via the one or more processors, a heatmap based on the historical transactional data of the one or more customers via one or more algorithms, wherein the heatmap is indicative of at least the estimated utility expenditure associated with the at least one address during a predetermined period; and causing a display of a user device associated with the user to demonstrate the heatmap.",CAPITAL ONE SERVICES LLC,YEE BRYANT;;BERGERON GEORGE;;BULGAKOV MYKHAYLO,CAPITAL ONE SERVICES LLC (2020-08-12),https://lens.org/127-312-369-648-72X,Patent Application,yes,6,0,6,6,0,G06Q50/06;;H02J13/00001;;H02J3/003;;Y04S10/40;;Y04S10/50;;H02J3/003;;H02J13/00001;;G06Q50/06;;H02J2203/20;;H02J13/00034;;G06Q30/0283,G06Q30/0283;;G06Q50/06,,0,0,,,,ACTIVE
398,US,A,US 5821253 A,132-991-267-924-672,1998-10-13,1998,US 93764697 A,1997-09-24,US 93764697 A;;US 2675296 P,1996-09-26,Tetrahydrobenzo[a]fluorene compounds and methods of use,"The invention provides tetrahydrobenzo�a!fluorene compounds, formulations, and methods of inhibiting bone loss or bone resorption, particularly osteoporosis, and cardiovascular-related pathological conditions, including hyperlipidemia.",LILLY CO ELI,BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH,ELI LILLY AND COMPANY (1997-09-23),https://lens.org/132-991-267-924-672,Granted Patent,yes,16,2,11,11,0,A61K31/565;;A61K31/57;;C07C217/18;;C07D295/088;;C07C2603/40;;A61P19/10;;A61P3/06;;A61P43/00;;A61P9/00;;C07D295/088;;A61K31/565;;C07C217/18;;A61K31/57;;C07C2603/40,A61K31/135;;A61K31/40;;C07D295/08;;A61K31/445;;A61K31/55;;A61K31/565;;A61K31/57;;A61P3/06;;A61P9/00;;A61P19/10;;A61P43/00;;C07C217/18;;C07C309/65;;C07D207/06;;C07D295/092;;C07J69/00,514/319;;514/212;;514/428;;514/650;;514/239.2;;540/609;;546/195;;548/528;;564/337;;544/154,3,3,008-159-651-906-048;;039-179-689-155-908;;105-610-128-085-169,10.1021/jm00294a011;;5116231;;6431104;;10.1021/jm00374a021;;1473726;;10.1139/g92-143,"Crenshaw, R.R., et al, J. Med. Chem. 14(12):1185 1190 (1971).;;Jones, C.D., et al, J. Med. Chem. 27: 1057 1066) 1984.;;Jones, C.D., et al, J. Med. Chem. 35: 931 938 1992.",EXPIRED
399,DE,D1,DE 60035594 D1,146-458-223-135-092,2007-08-30,2007,DE 60035594 T,2000-05-01,US 35020099 A;;US 0011811 W,1999-07-08,SEISMISCHES LEITERSEIL-EINFÜHRKABEL,A conductive rope-like lead-in cable connects a seismic streamer to a towing vessel. The lead-in cable comprises a first electrical conductor at the center core of the cable for carrying a first polarity of power to the streamer for providing tensile strength to the load-in cable. A first layer of insulation surrounds the first electrical conductor. A second electrical conductor for a second polarity of power to the streamer surrounds the first layer of insulation. A second layer of insulation surrounds the second electrical conductor. A layer of seismic data conductors surrounds the second layer of insulation. A third layer of insulation surrounds the layer of seismic data conductors. A metallic protective layer surrounds the third layer of insulation. Steel is effectively and efficiently used both to provide tensile strength and for electrical power conduction.,PGS EXPLORATION US INC,BRYANT MICHAEL J;;GEORGE NICK C,,https://lens.org/146-458-223-135-092,Granted Patent,no,0,0,14,14,0,H01B7/045;;H01B9/003;;H01B9/04;;G01V1/201;;H01B9/003;;H01B7/045;;H01B9/04;;G01V1/201,H01B7/04;;H01B9/00;;H01B9/04,,0,0,,,,EXPIRED
400,NO,B,NO 166440 B,145-386-786-161-474,1991-04-15,1991,NO 874810 A,1987-11-18,US 93200286 A,1986-11-18,HYDROFORMYLERING VED BRUK AV FOSFIN-LIGANDER MED LAV FLYKTIGHET.,,UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/145-386-786-161-474,Unknown,no,0,0,53,53,0,C07C45/50;;Y02P20/582;;C07C47/55;;C07C47/02;;C07C45/50;;Y02P20/582,B01J31/00;;B01J31/28;;C07B61/00;;C07C45/00;;B01J31/24;;C07C45/50;;C07C47/02;;C07C67/00,,0,0,,,,EXPIRED
401,BR,A,BR 8201245 A,157-594-985-510-376,1983-01-18,1983,BR 8201245 A,1982-03-09,US 24308281 A,1981-03-12,PROCESSO PARA A CONVERSAO DE HIDROPEROXIDO PRESENTE EM ETERES DE ALIL-ALCOILA,"Described herein is a process for the conversion of hydroperoxides, present in alkyl-alkyl ethers to products including alpha , beta -unsaturated aldehydes and for reducing such alpha , beta -unsaturated aldehydes to alcohols prior to the use of the ether as a feedstock in a hydroformylation reaction to produce the corresponding ether aldehyde. The process involves contacting the ether with a metal hydride, either in aqueous solution and/or by means of an ion exchange resin. Such treatment decomposes the hydroperoxides and then reduces their alpha , beta -unsaturated aldehyde decomposition products, thereby reducing the catalyst inhibition period present in the hydroformylation reaction which is observed when such alpha , beta -unsaturated aldehyde impurities are present.",UNION CARBIDE CORP,ABATIOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/157-594-985-510-376,Patent Application,no,0,0,16,17,0,C07C29/175;;C07C31/10;;C07C41/36;;C07C41/44;;C07C45/53;;C07C45/62;;C07C43/00,C07C43/18;;C07C29/17;;C07C31/10;;C07C41/00;;C07C41/34;;C07C41/36;;C07C41/44;;C07C43/00;;C07C43/15;;C07C43/188;;C07C45/53;;C07C45/62;;C07C67/00,,0,0,,,,DISCONTINUED
402,WO,A1,WO 1990/011156 A1,152-731-018-398-979,1990-10-04,1990,US 9000924 W,1990-02-16,US 32484789 A,1989-03-17,MULTILAYER COATED CEMENTED CARBIDE CUTTING INSERT,"An indexable metalcutting insert is provided having a cobalt cemented tungsten carbide substrate (32) with a multilayer refractory coating (34) thereon. The substrate (32) has a cobalt content of 6.1 to 6.5 weight percent and is characterized by a hardness of 90.8 to 91.6 Rockwell A and a magnetic coercive force of 110 to 180 ÷rstads. The coating (34) contains at least a plurality of alumina layers (42) which are separated from and bonded to each other by a group IVB metal nitride (44), such as titanium nitride, and which are bonded to the substrate (32) by a backing layer of 5 to 8 ν in thickness, composed of a carbide and/or carbonitride of titanium zirconium and/or hafnium.",KENNAMETAL INC,BRYANT WILLIAM A;;GRAB GEORGE P,,https://lens.org/152-731-018-398-979,Patent Application,yes,2,11,17,19,0,B23B27/14;;B23B27/145;;B23B2228/36;;C23C30/005,B22F7/00;;B22F7/04;;B23B27/14;;C23C16/30;;C23C30/00,,2,1,073-361-477-427-792,10.1016/0043-1648(84)90011-5,"DREYER et al, ""Development and Tool Life Behavior of Super-Wear-Resistant Multilayer Coatings on Hard Metals. ""Metals Society (Book 278), London, England (1982) pp. 112-117.;;SCHINTLMEISTER et al, ""Cutting Tool Materials Coated by Vapour Deposition,"" Wear 100 (1984 pp. 153-169).",PATENTED
403,CH,A,CH 460335 A,153-390-806-172-739,1968-07-31,1968,CH 528263 A,1963-04-26,US 18930362 A;;US 18930462 A;;US 18931362 A,1962-04-23,Compositions polyoléfiniques,,UNION CARBIDE CORP,GEORGE MACON BRYANT;;NATHAN LEWIS ZUTTY,,https://lens.org/153-390-806-172-739,Granted Patent,no,0,0,11,20,0,C08L23/02;;C08L23/10;;C08L23/12;;C08L33/26;;C08L39/04;;D06P3/79;;D06P3/79;;C08L33/26;;C08L23/10;;C08L23/12;;C08L39/04;;C08L23/02;;Y10S8/928;;Y10S8/09,C08L23/02;;C08L23/12;;C08L33/26;;C08L39/04;;D06P3/79,"39B,22/06",0,0,,,,EXPIRED
404,CA,A,CA 736005 A,164-156-950-478-963,1966-06-07,1966,CA 736005D A,,CA 736005T A,,DYEABLE POLYPROPYLENE BLENDS,,UNION CARBIDE CORP,BRYANT GEORGE M;;ZUTTY NATHAN L,,https://lens.org/164-156-950-478-963,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
405,IN,B,IN 169702 B,169-291-299-758-723,1991-12-14,1991,IN 490MA1987 A,1987-07-10,US 88419786 A,1986-07-10,AN IMPROVED NON-AQUEOUS HYDROFORMYLATION PROCESS FOR PRODUCING ALDEHYDES,,UNION CARBIDE CORP,ANTHONY GEORGE ABATHOGLOU;;DAVID ROBERT BRYANT,,https://lens.org/169-291-299-758-723,Granted Patent,no,0,0,52,52,0,C07C45/50;;C07F9/5004;;Y02P20/582;;C07B41/00;;C07C47/02;;C07C45/50;;C07F9/5004;;Y02P20/582,B01J31/00;;C07B61/00;;B01J31/24;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00;;C07F9/50,,0,0,,,,EXPIRED
406,BR,A,BR 8903931 A,179-468-699-816-287,1990-03-27,1990,BR 8903931 A,1989-08-04,US 22850788 A,1988-08-05,"LIGANTE FOSFITO IONICO,PROCESSO CATALISADO POR METAL DE TRANSICAO E PROCESSO DE HIDROFORMILACAO PARA A PRODUCAO DE ALDEIDO",,UNION CARBIDE CHEM PLASTIC,GEORGE ABATJOGLOU ANTHONY;;ROBERT BRYANT DAVID,,https://lens.org/179-468-699-816-287,Patent Application,no,0,0,22,23,0,B01J31/185;;B01J31/185;;B01J2231/321;;B01J2231/321;;B01J2531/0266;;B01J2531/0266;;B01J2531/80;;B01J2531/80;;B01J2531/822;;B01J2531/822;;C07F9/165;;C07F9/65746;;C07F9/65746;;C07C45/50;;C07C45/50;;C07F9/65744;;C07F9/65744;;Y02P20/582;;Y02P20/582,B01J31/22;;B01J31/18;;C07B61/00;;C07C45/49;;C07C45/50;;C07C47/02;;C07F9/6574;;C07F9/6578;;C07F9/6584;;C07F9/6596,,0,0,,,,DISCONTINUED
407,US,B2,US 11423407 B2,182-283-154-422-832,2022-08-23,2022,US 202016914619 A,2020-06-29,US 202016914619 A;;US 201916525242 A,2019-07-29,Computer-based systems and platforms and computer-implemented methods configured for one or more technological applications involving reduction of false-positive fraud detection incidents,"Systems and methods involving computer-based processing for proactively reducing false-positive fraud detection incidents are disclosed. In one embodiment, an exemplary computer-implemented method may comprise: detecting when a subject online transaction matches criteria indicating it is unusual; operating a browser extension application to obtain UI image data and purchase details of an item purchased by a user during the unusual online transaction; evaluating historical transactions of the user to identify a potentially fraudulent online transaction; and executing a false-positive detection routine to determine if the potentially fraudulent online transaction is valid.",CAPITAL ONE SERVICES LLC,YEE BRYANT;;BERGERON GEORGE;;BULGAKOV MYKHAYLO,,https://lens.org/182-283-154-422-832,Granted Patent,yes,14,0,3,3,0,H04W4/14;;H04L67/02;;H04L67/10;;G06F9/44526;;G06Q20/4016;;H04L67/535;;H04L67/55;;G06Q20/4016;;G06Q20/3255;;G06Q20/425;;H04L67/10;;H04L67/02;;H04W4/14;;H04L67/55,G06Q20/40;;G06Q20/32;;G06Q20/42;;G06V10/10;;H04L67/02;;H04L67/10;;H04L67/55;;H04W4/14,,0,0,,,,ACTIVE
408,US,A,US 3460336 A,141-292-647-154-44X,1969-08-12,1969,US 3460336D A,1967-04-04,US 62837167 A,1967-04-04,COMPOSITE YARN STRUCTURES AND METHOD OF PREPARING SAME,,ALLIED CHEM,COLLINGWOOD GEORGE H;;DEMAS HARRY J;;BRYANT GEORGE F,,https://lens.org/141-292-647-154-44X,Granted Patent,no,4,33,4,4,0,D02G1/20;;D02G3/346;;Y10S57/908;;D02G1/20;;D02G3/346;;Y10S57/908,D02G1/20;;D02G3/34,57/140,0,0,,,,EXPIRED
409,US,A,US 3534540 A,137-177-877-494-759,1970-10-20,1970,US 3534540D A,1967-05-03,US 63565367 A,1967-05-03,COMPOSITE MULTI-COLOR OR COLORABLE YARN STRUCTURES,,ALLIED CHEM,COLLINGWOOD GEORGE H;;DEMAS HARRY J;;BRYANT GEORGE F,,https://lens.org/137-177-877-494-759,Granted Patent,no,2,23,5,5,0,D02J1/08;;D06P3/8209;;Y10S57/908;;D02J1/08;;D06P3/8209;;Y10S57/908,D02J1/08;;D06P3/82,57/140,0,0,,,,EXPIRED
410,DE,A1,DE 1760104 A1,161-457-239-502-060,1972-11-09,1972,DE 1760104 A,1968-04-04,US 62837167 A,1967-04-04,Kombinationsgarne und Verfahren zu ihrer Herstellung,,ALLIED CHEM,H COLLINGWOOD GEORGE;;F BRYANT GEORGE;;J DEMAS HARRY,,https://lens.org/161-457-239-502-060,Patent Application,no,0,0,4,4,0,D02G1/20;;D02G3/346;;Y10S57/908;;D02G1/20;;D02G3/346;;Y10S57/908,D02G1/20;;D02G3/34,,0,0,,,,DISCONTINUED
411,DE,A1,DE 1760328 A1,148-660-229-032-707,1972-11-09,1972,DE 1760328 A,1968-05-03,US 63565367 A,1967-05-03,Vielfarbige oder vielfach faerbbare texturierte Verbundgarne und Verfahren zu ihrer Herstellung,,ALLIED CHEM,H COLLINGWOOD GEORGE;;J DEMAS HARRY;;F BRYANT GEORGE,,https://lens.org/148-660-229-032-707,Patent Application,no,0,0,5,5,0,D02J1/08;;D06P3/8209;;Y10S57/908;;D02J1/08;;D06P3/8209;;Y10S57/908,D02J1/08;;D06P3/82,,0,0,,,,DISCONTINUED
412,CA,A,CA 875263 A,115-413-905-853-012,1971-07-13,1971,CA 875263D A,,CA 875263T A,,COMPOSITE MULTI-COLOR OR COLORABLE YARN STRUCTURES,,ALLIED CHEM,COLLINGWOOD GEORGE H;;DEMAS HARRY J;;BRYANT GEORGE F,,https://lens.org/115-413-905-853-012,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
413,CA,A,CA 885713 A,107-065-246-911-830,1971-11-16,1971,CA 885713D A,,CA 885713T A,,COMPOSITE YARN STRUCTURES AND METHOD OF PREPARING SAME,,ALLIED CHEM,DEMAS HARRY J;;COLLINGWOOD GEORGE H;;BRYANT GEORGE F,,https://lens.org/107-065-246-911-830,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
414,DK,D0,DK 558988 D0,008-050-152-914-626,1988-10-06,1988,DK 558988 A,1988-10-06,US 10533087 A,1987-10-07,"FREMGANGSMAADE TIL FREMSTILLING AF 3,3-DISUBSTITUEREDE INDOLINER",,DU PONT,BRYANT III WALTER MARVIN;;HUHN GEORGE FREDERICK,,https://lens.org/008-050-152-914-626,Patent Application,no,0,0,22,22,0,C07D401/14;;C07D403/14;;C07D403/06;;C07D401/14;;C07D403/14,C07D401/06;;C07D209/34;;C07D401/14;;C07D403/06;;C07D403/14,,0,0,,,,DISCONTINUED
415,FR,A1,FR 2468424 A1,043-050-798-137-677,1981-05-08,1981,FR 8023269 A,1980-10-30,US 9021179 A,1979-11-01,ASSEMBLAGE DE MATRICES UTILISE POUR UNE OPERATION DE FORGEAGE,"<P>L'invention concerne un assemblage de matrices utilisé pour une opération de forgeage. </P><P>L'appareil de forgeage de l'invention comprend une matrice fixe 26 et une matrice mobile 28 montées sur un axe commun, ainsi que plusieurs segments de matrices courbes 30 disposés l'un près de l'autre en un groupe cylindrique entourant la matrice fixe 26 et la matrice mobile 28. Ces segments courbes 30 forment des cavités d'une géométrie qui est l'inverse de celle des éléments à former, tandis qu'ils sont solidarisés pour les empêcher de basculer dans l'assemblage de matrices. </P><P>L'invention est utilisée pour forger des pièces à profils complexes et à tolérances étroites, notamment des aubes de rotors de turbines.</P>",UNITED TECHNOLOGIES CORP,MACNITT DONALD GEORGE JR;;WALKER BRYANT HARDING,,https://lens.org/043-050-798-137-677,Patent Application,no,4,1,27,27,0,B21J5/02;;B21J9/02;;B21J13/02;;B21K1/36;;B21K29/00;;Y10T29/49488;;Y10T29/49488;;B21J5/02;;B21K1/36;;B21J9/02;;B21J13/02;;B21K29/00,B21J5/02;;B21J9/02;;B21J13/02;;B21K1/36;;B21K3/04,,0,0,,,,EXPIRED
416,DK,A,DK 558988 A,049-036-282-520-47X,1989-04-08,1989,DK 558988 A,1988-10-06,US 10533087 A,1987-10-07,"FREMGANGSMAADE TIL FREMSTILLING AF 3,3-DISUBSTITUEREDE INDOLINER",,DU PONT,BRYANT III WALTER MARVIN;;HUHN GEORGE FREDERICK,,https://lens.org/049-036-282-520-47X,Patent Application,no,0,0,22,22,0,C07D401/14;;C07D403/14;;C07D403/06;;C07D401/14;;C07D403/14,C07D401/06;;C07D209/34;;C07D401/14;;C07D403/06;;C07D403/14,,0,0,,,,DISCONTINUED
417,NO,L,NO 884442 L,128-127-366-021-747,1989-04-10,1989,NO 884442 A,1988-10-06,US 10533087 A,1987-10-07,"FREMGANGSMAATE FOR FREMSTILLING AV 3,3-DISUBSTITUERTE INDOLINER.",,DU PONT,BRYANT WALTER MARVIN III;;HUHN GEORGE FREDERICK,,https://lens.org/128-127-366-021-747,Abstract,no,0,0,22,22,0,C07D401/14;;C07D403/14;;C07D403/06;;C07D401/14;;C07D403/14,C07D401/06;;C07D401/14;;C07D209/34;;C07D403/06;;C07D403/14,,0,0,,,,DISCONTINUED
418,NO,B,NO 158288 B,067-800-900-747-078,1988-05-09,1988,NO 841872 A,1984-05-10,NO 841872 A;;NO 803209 A;;US 9018479 A,1979-11-01,"FREMGANGSM TE FOR UTSMIING AV EN KOMPONENT MED ET MKIVEPARTI SOM ER UTFORMET I ETT MED ET ANTALL UTADRAGENDE DELER, OG SMIANORDTEN.",,UNITED TECHNOLOGIES CORP,MACNITT DONALD GEORGE JR;;WALKER BRYANT HARDING,,https://lens.org/067-800-900-747-078,Unknown,no,0,0,3,35,0,,B21J/;;B21J5/12,,0,0,,,,EXPIRED
419,EP,B1,EP 3062464 B1,146-790-486-872-902,2021-11-03,2021,EP 16154342 A,2016-02-04,US 201562126168 P;;US 201615001528 A,2015-02-27,SYNONYMOUS LABELS,,CISCO TECH INC,BRYANT STEWART FREDERICK;;SWALLOW GEORGE;;SIVABALAN MUTHURAJAH,,https://lens.org/146-790-486-872-902,Granted Patent,yes,1,0,6,6,0,H04L45/50;;H04L45/507;;H04L45/50;;H04L43/0829;;H04L45/507;;H04L45/507;;H04L43/0835;;H04L45/50;;H04L43/0829,H04L45/50,,0,0,,,,ACTIVE
420,DE,A1,DE 1669555 A1,033-466-629-778-55X,1971-05-06,1971,DE U0014681 A,1968-02-20,US 61780067 A,1967-02-23,Verfahren zum Nassverspinnen von Spandex-Garn,,UNION CARBIDE CORP,PAUL JONES JUN ALLEN;;MACON BRYANT GEORGE,"UNION CARBIDE CORP., 06817 DANBURY, CONN., US (1982-12-23)",https://lens.org/033-466-629-778-55X,Patent Application,no,0,0,5,5,0,D06M15/647;;D01F6/70;;D06M15/647;;D01F6/70,D01F6/72;;D06M15/647,,0,0,,,,PENDING
421,NO,B,NO 151314 B,058-468-802-689-734,1984-12-10,1984,NO 803209 A,1980-10-28,US 9018479 A,1979-11-01,SENKESETT FOR FREMSTILLING AV EN SKIVEKONSTRUKSJON MED UTADRAGENDE DELER,,UNITED TECHNOLOGIES CORP,MACNITT DONALD GEORGE JR;;WALKER BRYANT HARDING,,https://lens.org/058-468-802-689-734,Unknown,no,0,0,30,35,0,B21J5/02;;B21J9/02;;B21J13/02;;B21K1/36;;B21K29/00;;Y10T29/49336;;Y10T29/49336;;B21J5/02;;B21K1/36;;B21J9/02;;B21J13/02;;B21K29/00,B21J5/02;;B21J9/02;;B21J13/02;;B21K1/36;;B21K3/04,,0,0,,,,EXPIRED
422,MY,A,MY 103414 A,143-448-538-388-141,1993-06-30,1993,MY PI19881115 A,1988-10-05,US 10533087 A,1987-10-07,"PROCESS FOR PREPARING 3, 3-DISUBSTITUTED INDOLINES","PROCESSES FOR PREPARING 3, 3-DISUBSTITUTED INDOLINES, PARTICULARLY 3, 3-DIPYRIDINE SUBSTITUTED INDOLINES, USEFUL TO TREAT COGNITIVE OR NEUROLOGICAL DYSFUNCTION IN A MAMMAL, ARE PROVIDED.",THE DU PONT MERCK PHARMACEUTICAL COMPANY,GEORGE FREDERICK HUNN;;WALTER MARVIN BRYANT 111,,https://lens.org/143-448-538-388-141,Granted Patent,no,0,0,22,22,0,C07D401/14;;C07D403/14;;C07D403/06;;C07D401/14;;C07D403/14,C07D209/34;;C07D401/06;;C07D401/14;;C07D403/06;;C07D403/14,,0,0,,,,EXPIRED
423,IT,A0,IT 8321254 A0,013-705-039-595-673,1983-05-24,1983,IT 2125483 A,1983-05-24,GB 8215877 A,1982-06-01,PERFEZIONAMENTI RELATIVI A MACCHINE PER LA FABBRICAZIONE DI SIGARETTE.,,BRITISH AMERICAN TOBACCO CO,COX ADRIAN ROY STEWART;;BRYANT ROBERT GEORGE,,https://lens.org/013-705-039-595-673,Patent Application,no,0,1,12,12,0,A24C5/31;;A24C5/31,A24C5/31,,0,0,,,,EXPIRED
424,GB,A,GB 190514474 A,105-379-700-928-229,1905-08-24,1905,GB 190514474D A,1905-07-13,GB 190514474T A,1905-07-13,Improvements in or connected with Lamp Shade Frames.,"14.474. Parks, r. G., and Westlake, W. J. B. July 13. Lamp-shade holders.-The flounce bl of the shade b is raised or lowered by means of levers c pivoted at c<1> on the wire shade holder d. The levers care actuated by the extension or contraction, by means of joints as in Figs. 3, 4, and 5, or an equivalent device, of bent wires or the like d.",PARKS FRANCIS GEORGE;;WESTLAKE WILLIAM JOHN BRYANT,PARKS FRANCIS GEORGE;;WESTLAKE WILLIAM JOHN BRYANT,,https://lens.org/105-379-700-928-229,Patent Application,no,0,0,1,1,0,,,,0,0,,,,DISCONTINUED
425,GB,B,GB 2122399 B,172-677-406-770-550,1986-09-10,1986,GB 8314442 A,1983-05-25,GB 8215877 A,1982-06-01,IMPROVEMENTS RELATING TO CIGARETTE MANUFACTURING MACHINES,,BRITISH AMERICAN TOBACCO CO,STEWART-COX ADRIAN ROY;;BRYANT ROBERT GEORGE,,https://lens.org/172-677-406-770-550,Granted Patent,no,0,0,12,12,0,A24C5/31;;A24C5/31,A24C5/31,G4N5A;;G4N7X;;G4NEG;;U1S1117;;U1S2186;;U1SG4N,0,0,,,,EXPIRED
426,NO,L,NO 803208 L,176-708-931-929-632,1981-05-04,1981,NO 803208 A,1980-10-28,US 9021179 A,1979-11-01,SENKE FOR ANVENDELSE VED SMIING.,,UNITED TECHNOLOGIES CORP,MACNITT DONALD GEORGE JR;;WALKER BRYANT HARDING,,https://lens.org/176-708-931-929-632,Abstract,no,0,0,27,27,0,B21J5/02;;B21J9/02;;B21J13/02;;B21K1/36;;B21K29/00;;Y10T29/49488;;Y10T29/49488;;B21J5/02;;B21K1/36;;B21J9/02;;B21J13/02;;B21K29/00,B21J5/02;;B21J9/02;;B21J13/02;;B21K1/36;;B21K3/04,,0,0,,,,EXPIRED
427,DE,A1,DE 3039707 A1,191-005-021-074-017,1981-05-14,1981,DE 3039707 A,1980-10-21,US 9018479 A,1979-11-01,"GESENKGRUPPE, MIT DIESER VERSEHENE SCHMIEDEVORRICHTUNG UND SCHMIEDEVERFAHREN",,UNITED TECHNOLOGIES CORP,MACNITT JUN DONALD GEORGE;;WALKER BRYANT HARDING,,https://lens.org/191-005-021-074-017,Patent Application,no,2,1,30,35,0,B21J5/02;;B21J9/02;;B21J13/02;;B21K1/36;;B21K29/00;;Y10T29/49336;;Y10T29/49336;;B21J5/02;;B21K1/36;;B21J9/02;;B21J13/02;;B21K29/00,B21J5/02;;B21J9/02;;B21J13/02;;B21K1/36;;B21K3/04,,0,0,,,,EXPIRED
428,IT,B,IT 1134081 B,187-507-648-100-560,1986-07-24,1986,IT 2562680 A,1980-10-29,US 9021179 A,1979-11-01,COMPLESSO DI STAMPO DA IMPIEGARE PER OPERAZIONI DI FUCINATURA,,UNITED TECHNOLOGIES CORP,MACNITT DONALD GEORGE JR;;WALKER BRYANT HARDING,,https://lens.org/187-507-648-100-560,Granted Patent,no,0,0,27,27,0,B21J5/02;;B21J9/02;;B21J13/02;;B21K1/36;;B21K29/00;;Y10T29/49488;;Y10T29/49488;;B21J5/02;;B21K1/36;;B21J9/02;;B21J13/02;;B21K29/00,B21J5/02;;B21J9/02;;B21J13/02;;B21K1/36;;B21K3/04,,0,0,,,,EXPIRED
429,EP,A3,EP 0311029 A3,025-492-672-992-390,1990-10-17,1990,EP 88116435 A,1988-10-05,US 10533087 A,1987-10-07,"PROCESS FOR PREPARING 3,3-DISUBSTITUTED INDOLINES","Compounds of formula are prepared from coumpounds of formula by stepwise addition of the 3,3 substituents.  ",E.I. DU PONT DE NEMOURS AND COMPANY,"BRYANT, WALTER MARVIN, III;;HUHN, GEORGE FREDERICK",THE DU PONT MERCK PHARMACEUTICAL COMPANY (1991-12-11),https://lens.org/025-492-672-992-390,Search Report,yes,1,0,22,22,0,C07D401/14;;C07D403/14;;C07D403/06;;C07D401/14;;C07D403/14,C07D401/06;;C07D401/14;;C07D403/06;;C07D403/14;;C07D209/34,,1,0,,,"CHEMICAL ABSTRACTS, vol. 76, 1972, page 468, abstract no. 113013u, Columbus, Ohio, US; M. MAKOSZA et al.: ""Reactions of organic anions. XXXII. Catalytic alkylation of N-substituted oxindole derivatives in aqeous medium"", & ROCZ. CHEM. 1971, 45(11), 1861-8",DISCONTINUED
430,US,B2,US 10291516 B2,062-494-370-989-197,2019-05-14,2019,US 201615001528 A,2016-01-20,US 201615001528 A;;US 201562126168 P,2015-02-27,Synonymous labels,"Particular embodiments described herein provide for a communication system that can be configured to identify a system that includes network traffic, where at least a portion of the network traffic includes packets, at least a portion of the packets include a stack, and at least a portion of each stack includes one or more previously allocated labels. The communication system can further be configured to determine a synonymous label that triggers an action and to replace a label from the one of the one or more previously allocated labels in a specific stack of a specific packet with the synonymous label. In an example, the synonymous label can be used to identify a subset of packets in the network traffic or a source of the specific packet.",CISCO TECH INC,BRYANT STEWART FREDERICK;;SWALLOW GEORGE;;SIVABALAN MUTHURAJAH,CISCO TECHNOLOGY INC (2016-01-13),https://lens.org/062-494-370-989-197,Granted Patent,yes,24,9,6,6,0,H04L45/50;;H04L45/507;;H04L45/50;;H04L43/0829;;H04L45/507;;H04L45/507;;H04L43/0835;;H04L45/50;;H04L43/0829,H04L45/50,,8,0,,,"EPO Jul. 14, 2016 Extended Search Report from European Application Serial No. 16154342.6; 6 pages.;;Frost, D., et al., “Packet Loss and Delay Measurement for MPLS Networks,” Internet Engineering Task Force (IETF) RFC6374, Sep. 2011; 52 pages.;;Capello, A., et al., “A packet based method for passive performance monitoring,” Network Working Group Internet—Draft, draft-tempia-opsawg-p3m, Feb. 25, 2013; 22 pages.;;Bryant, S., et al., “RFC6374 over UDP,” MPLS Internet—Draft, draft-bryant-mpls-RFC63740-over-udp, Feb. 18, 2015; 4 pages.;;Bryant, S., et al., “RFC6374 Synonymous Flow Labels,” MPLS Internet Draft, draft-bryant-mpls-synonymous-flow-labels-oo, Mar. 2, 2015.;;Bryant, S., et al., “A Control Protocol for Synonymous Flow Labels,” MPLS Internet-Draft, draft-bryant-mpls-sfl-control-00; Mar. 2, 2015; 11 pages.;;English translation of First Office Action in counterpart Chinese Application No. 201610109960.0, dated Aug. 22, 2018, 7 pages.;;Examination Report in counterpart European Application No. 16154342.6, dated Dec. 12, 2018, 11 pages.",ACTIVE
431,DE,A1,DE 3319248 A1,155-547-836-397-838,1983-12-01,1983,DE 3319248 A,1983-05-27,GB 8215877 A,1982-06-01,VERFAHREN UND VORRICHTUNG ZUR UEBERWACHUNG EINER ZIGARETTENFERTIGUNGSMASCHINE,,BRITISH AMERICAN TOBACCO CO,STEWART-COX ADRIAN ROY;;BRYANT ROBERT GEORGE,"MOLINS PLC, MILTON KEYNES, BUCKINGHAMSHIRE, GB (1992-05-27)",https://lens.org/155-547-836-397-838,Patent Application,no,9,4,12,12,0,A24C5/31;;A24C5/31,A24C5/31,,0,0,,,,EXPIRED
432,AU,A,AU 1983/015475 A,005-468-329-909-670,1984-12-13,1984,AU 1983/015475 A,1983-06-08,GB 8215877 A,1982-06-01,MONITORING CIGARETTE MANUFACTURING MACHINES,,BRITISH AMERICAN TOBACCO COMPANY LTD,STEWART-COX ADRIAN ROY;;BRYANT ROBERT GEORGE,,https://lens.org/005-468-329-909-670,Patent Application,no,0,0,12,12,0,A24C5/31;;A24C5/31,A24C5/31,,0,0,,,,EXPIRED
433,DE,A1,DE 3039705 A1,026-436-986-007-058,1981-05-14,1981,DE 3039705 A,1980-10-21,US 9021179 A,1979-11-01,GESENKSATZ,,UNITED TECHNOLOGIES CORP,MACNITT JUN DONALD GEORGE;;WALKER BRYANT HARDING,,https://lens.org/026-436-986-007-058,Patent Application,no,2,1,27,27,0,B21J5/02;;B21J9/02;;B21J13/02;;B21K1/36;;B21K29/00;;Y10T29/49488;;Y10T29/49488;;B21J5/02;;B21K1/36;;B21J9/02;;B21J13/02;;B21K29/00,B21J5/02;;B21J9/02;;B21J13/02;;B21K1/36;;B21K3/04,,0,0,,,,EXPIRED
434,NO,C,NO 158288 C,104-462-364-292-495,1988-08-17,1988,NO 841872 A,1984-05-10,NO 841872 A;;NO 803209 A;;US 9018479 A,1979-11-01,"FREMGANGSMAATE FOR UTSMIING AV EN KOMPONENT MED ET MIDTRE SKIVEPARTI SOM ER UTFORMET I ETT MED ET ANTALL UTADRAGENDEDELER, OG SMIANORDNING TIL UTFOERELSE AV FREMGANGSMAATEN.",,UNITED TECHNOLOGIES CORP,MACNITT DONALD GEORGE JR;;WALKER BRYANT HARDING,,https://lens.org/104-462-364-292-495,Granted Patent,no,0,0,3,35,0,,B21J/;;B21J5/12,,0,0,,,,EXPIRED
435,NO,C,NO 151142 C,138-315-512-423-797,1985-02-20,1985,NO 803208 A,1980-10-28,US 9021179 A,1979-11-01,SENKESETT FOR TILVIRKNING AV EN SKIVEKONSTRUKSJON MED UTADRAGENDE DELER,,UNITED TECHNOLOGIES CORP,MACNITT DONALD GEORGE JR;;WALKER BRYANT HARDING,,https://lens.org/138-315-512-423-797,Granted Patent,no,0,0,27,27,0,B21J5/02;;B21J9/02;;B21J13/02;;B21K1/36;;B21K29/00;;Y10T29/49488;;Y10T29/49488;;B21J5/02;;B21K1/36;;B21J9/02;;B21J13/02;;B21K29/00,B21J5/02;;B21J9/02;;B21J13/02;;B21K1/36;;B21K3/04,,0,0,,,,EXPIRED
436,AU,B2,AU 563537 B2,175-240-451-666-805,1987-07-16,1987,AU 1983/015475 A,1983-06-08,GB 8215877 A,1982-06-01,MONITORING CIGARETTE MANUFACTURING MACHINES,,BRITISH AMERICAN TOBACCO CO,STEWART-COX ADRIAN ROY;;BRYANT ROBERT GEORGE,,https://lens.org/175-240-451-666-805,Granted Patent,no,0,0,12,12,0,A24C5/31;;A24C5/31,A24C5/31,,0,0,,,,EXPIRED
437,AU,B2,AU 607814 B2,091-000-344-669-623,1991-03-14,1991,AU 1988/023506 A,1988-10-06,US 10533087 A,1987-10-07,"PROCESS FOR PREPARING 3,3-DISUBSTITUTED INDOLINES",,DU PONT,BRYANT WALTER MARVIN III;;HUHN GEORGE FREDERICK,,https://lens.org/091-000-344-669-623,Granted Patent,no,2,1,22,22,0,C07D401/14;;C07D403/14;;C07D403/06;;C07D401/14;;C07D403/14,C07D209/34;;C07D401/06;;C07D401/14;;C07D403/06;;C07D403/14,,0,0,,,,EXPIRED
438,NO,L,NO 841872 L,164-396-861-146-986,1981-05-04,1981,NO 841872 A,1984-05-10,NO 841872 A;;NO 803209 A;;US 9018479 A,1979-11-01,"FREMGANGSMAATE FOR UTSMIING AV EN KOMPONENT MED ET MIDTRE SKIVEPARTI SOM ER UTFORMET I ETT MED ET ANTALL UTADRAGENDE DELER, OG SMIANORDNING TIL UTFOERELSE AV FREMGANGSMAATEN",,UNITED TECHNOLOGIES CORP,MACNITT DONALD GEORGE JR;;WALKER BRYANT HARDING,,https://lens.org/164-396-861-146-986,Abstract,no,0,0,3,35,0,,B21J/;;B21J5/12,,0,0,,,,EXPIRED
439,WO,A3,WO 2008/041209 A3,032-538-830-796-040,2009-11-26,2009,IB 2007054118 W,2007-10-09,AU 2006/904518 A;;AU 2007/209823 A;;AU 2007/907034 A,2006-08-18,"GAMING MACHINE, SYSTEM AND METHOD WITH PROGRESSIVE GAME FEATURE","A gaming machine including a display and a user interface in communication with a game controller, which cooperate to provide a game, the gaming machine offering at least one jackpot prize and awarding at least one feature game on the occurrence of a predetermined event during play of the game. The outcomes of the feature game include a first outcome and a second outcome, wherein the gaming machine causes an increase of the jackpot prize on the occurrence of the first outcome, and causes the award of the jackpot prize on the occurrence of the second outcome. A gaming machine is also described in which an increase to a jackpot prize is variable. Also described are gaming systems including a plurality of linked gaming machines and methods for gaming.",ARISTOCRAT TECHNOLOGIES AU;;BENNETT NICHOLAS LUKE;;ROUKIS GEORGE;;BRYANT NATALIE,BENNETT NICHOLAS LUKE;;ROUKIS GEORGE;;BRYANT NATALIE,,https://lens.org/032-538-830-796-040,Search Report,yes,2,0,22,22,0,G07F17/3267;;G07F17/3267;;G07F17/32;;G07F17/32;;G07F17/3258;;G07F17/3258;;G07F17/34;;G07F17/34,A63F13/12;;A63F9/24;;A63F13/06;;A63F13/10;;G07F17/34,,0,0,,,,PENDING
440,IT,B,IT 1134080 B,043-540-843-174-461,1986-07-24,1986,IT 2562580 A,1980-10-29,US 9018479 A,1979-11-01,METODO ED APPARECCHIO DI FUCINATURA,,UNITED TECHNOLOGIES CORP,MACNITT DONALD GEORGE JR;;WALKER BRYANT HARDING,,https://lens.org/043-540-843-174-461,Granted Patent,no,0,0,30,35,0,B21J5/02;;B21J9/02;;B21J13/02;;B21K1/36;;B21K29/00;;Y10T29/49336;;Y10T29/49336;;B21J5/02;;B21K1/36;;B21J9/02;;B21J13/02;;B21K29/00,B21J5/02;;B21J9/02;;B21J13/02;;B21K1/36;;B21K3/04,,0,0,,,,EXPIRED
441,FR,A1,FR 2468425 A1,002-194-564-623-977,1981-05-08,1981,FR 8023271 A,1980-10-30,US 9018479 A,1979-11-01,PROCEDE ET APPAREIL DE FORGEAGE,"<P>L'invention concerne un procédé et un appareil de forgeage. </P><P>L'appareil de l'invention comprend des matrices de forgeage, à savoir une matrice fixe 106 et au moins deux matrices 110, 112 pouvant se déplacer séparément et montées sur un axe commun avec la matrice fixe 106. Plusieurs segments de matrices courbes 124 sont placés l'un à côté de l'autre autour de la matrice fixe 106 et des matrices mobiles 110, 112. Ces segments 124 forment des cavités d'une géométrie inverse par rapport aux éléments à former et ils sont solidarisés de façon à les empêcher de basculer dans l'assemblage de matrices. </P><P>L'invention est utilisée pour le forgeage de pièces à géométrie complexe, notamment des aubes de turbines.</P>",UNITED TECHNOLOGIES CORP,MACNITT DONALD GEORGE JR;;WALKER BRYANT HARDING,,https://lens.org/002-194-564-623-977,Patent Application,no,4,1,30,35,0,B21J5/02;;B21J9/02;;B21J13/02;;B21K1/36;;B21K29/00;;Y10T29/49336;;Y10T29/49336;;B21J5/02;;B21K1/36;;B21J9/02;;B21J13/02;;B21K29/00,B21J5/02;;B21J9/02;;B21J13/02;;B21K1/36;;B21K3/04,,0,0,,,,EXPIRED
442,PT,B,PT 88712 B,015-759-620-930-515,1992-12-31,1992,PT 8871288 A,1988-10-07,US 10533087 A,1987-10-07,"PROCESSO PARA A PREPARACAO DE INDOLINAS 3,3-DISSUBSTITUIDAS",,DU PONT MERCK PHARMA,BRYANT WALTER MARVIN III;;HUHN GEORGE FREDERICK,,https://lens.org/015-759-620-930-515,Granted Patent,no,0,0,22,22,0,C07D401/14;;C07D403/14;;C07D403/06;;C07D401/14;;C07D403/14,C07D401/06;;C07D401/14;;C07D403/06;;C07D403/14;;C07D209/34,,0,0,,,,EXPIRED
443,NO,B,NO 151142 B,069-842-545-170-291,1984-11-12,1984,NO 803208 A,1980-10-28,US 9021179 A,1979-11-01,SENKESETT FOR TILVIRKNING AV EN SKIVEKONSTRUKSJON MED UTADRAGENDE DELER,,UNITED TECHNOLOGIES CORP,MACNITT DONALD GEORGE JR;;WALKER BRYANT HARDING,,https://lens.org/069-842-545-170-291,Unknown,no,0,0,27,27,0,B21J5/02;;B21J9/02;;B21J13/02;;B21K1/36;;B21K29/00;;Y10T29/49488;;Y10T29/49488;;B21J5/02;;B21K1/36;;B21J9/02;;B21J13/02;;B21K29/00,B21J5/02;;B21J9/02;;B21J13/02;;B21K1/36;;B21K3/04,,0,0,,,,EXPIRED
444,AU,A,AU 1995/040277 A,080-982-956-955-803,1996-06-13,1996,AU 1995/040277 A,1995-12-06,AU PM993494 A;;AU 1995/040277 A,1994-12-07,Gaseous fuel vessel for motor vehicle applications and mounting arrangement therefor,,CEM INT PTY LTD,BRYANT LEONARD ANTHONY;;BOOTHEY LIONEL LESLIE GEORGE,,https://lens.org/080-982-956-955-803,Patent Application,no,0,0,1,2,0,,B60K15/04;;B60K15/07;;F17C13/08;;F17C13/12,,0,0,,,,DISCONTINUED
445,FI,A0,FI 884599 A0,168-282-414-355-452,1988-10-06,1988,FI 884599 A,1988-10-06,US 10533087 A,1987-10-07,"FOERFARANDE FOER FRAMSTAELLNING AV 3,3-DISUBSTITUERADE INDOLINER.",,DU PONT,BRYANT III WALTER MARVIN;;HUHN GEORGE FREDERICK,,https://lens.org/168-282-414-355-452,Patent Application,no,0,0,22,22,0,C07D401/14;;C07D403/14;;C07D403/06;;C07D401/14;;C07D403/14,C07D401/06;;C07D209/34;;C07D401/14;;C07D403/06;;C07D403/14,,0,0,,,,DISCONTINUED
446,AU,A1,AU 2007/209823 A1,174-434-723-001-33X,2008-03-06,2008,AU 2007/209823 A,2007-08-17,AU 2006/904518 A;;AU 2007/209823 A;;AU 2007/907034 A,2006-08-18,"Gaming machine, system and method with progressive game feature",,ARISTOCRAT TECHNOLOGIES AU,BENNETT NICHOLAS LUKE;;ROUKIS GEORGE;;BRYANT NATALIE,,https://lens.org/174-434-723-001-33X,Patent Application,no,0,4,22,22,0,G07F17/3267;;G07F17/3267;;G07F17/32;;G07F17/32;;G07F17/3258;;G07F17/3258;;G07F17/34;;G07F17/34,A63F13/12;;A63F9/24;;A63F13/06;;A63F13/10,,0,0,,,,ACTIVE
447,EP,A1,EP 3062464 A1,005-711-805-611-953,2016-08-31,2016,EP 16154342 A,2016-02-04,US 201562126168 P;;US 201615001528 A,2015-02-27,SYNONYMOUS LABELS,"Particular embodiments described herein provide for a communication system that can be configured to identify a system that includes network traffic, where at least a portion of the network traffic includes packets, at least a portion of the packets include a stack, and at least a portion of each stack includes one or more previously allocated labels. The communication system can further be configured to determine a synonymous label that triggers an action and to replace a label from the one of the one or more previously allocated labels in a specific stack of a specific packet with the synonymous label. In an example, the synonymous label can be used to identify a subset of packets in the network traffic or a source of the specific packet.
",CISCO TECH INC,BRYANT STEWART FREDERICK;;SWALLOW GEORGE;;SIVABALAN MUTHURAJAH,,https://lens.org/005-711-805-611-953,Patent Application,yes,2,0,6,6,0,H04L45/50;;H04L45/507;;H04L45/50;;H04L43/0829;;H04L45/507;;H04L45/507;;H04L43/0835;;H04L45/50;;H04L43/0829,H04L45/50,,1,1,098-716-346-320-116,10.17487/rfc6374,"PACKET LOSS AND DELAY MEASUREMENT FOR MPLS NETWORKS, September 2011 (2011-09-01)",ACTIVE
448,FI,A,FI 884599 A,026-779-115-045-539,1989-04-08,1989,FI 884599 A,1988-10-06,US 10533087 A,1987-10-07,"FOERFARANDE FOER FRAMSTAELLNING AV 3,3-DISUBSTITUERADE INDOLINER.",,DU PONT,BRYANT III WALTER MARVIN;;HUHN GEORGE FREDERICK,,https://lens.org/026-779-115-045-539,Patent Application,no,0,0,22,22,0,C07D401/14;;C07D403/14;;C07D403/06;;C07D401/14;;C07D403/14,C07D401/06;;C07D209/34;;C07D401/14;;C07D403/06;;C07D403/14,,0,0,,,,DISCONTINUED
449,US,A,US 4806651 A,160-004-847-894-741,1989-02-21,1989,US 10533087 A,1987-10-07,US 10533087 A,1987-10-07,"Process for preparing 3,3-disubstituted indolines","Processes for preparing 3,3-disubstituted indolines, particularly 3,3-dipyridine substituted indolines useful to treat cognitive or neurological dysfunction in a mammal, are provided.",DU PONT,BRYANT III WALTER M;;HUHN GEORGE F,E.I. DU PONT DE NEMOURS AND COMPANY A CORP. OF DE (1987-10-05);;DU PONT MERCK PHARMACEUTICAL COMPANY (1991-04-26),https://lens.org/160-004-847-894-741,Granted Patent,yes,1,2,22,22,0,C07D401/14;;C07D403/14;;C07D403/06;;C07D401/14;;C07D403/14,C07D401/06;;C07D209/34;;C07D401/14;;C07D403/06;;C07D403/14,546/256;;544/296;;544/333;;544/357;;544/373,6,1,071-041-757-421-023,10.1021/cr00066a003,"Ber. , 46, 3915 (1914).;;E. Klingsberg et al., Pyridines & Its Derivatives , Pt. II, 191 197 (1961).;;J. March, Advanced Organic Chemistry , 901 903 (1985).;;E. Klingsberg et al., Pyridine & Its Derivatives , Pt. II, 203 (1961).;;J. Org. Chem. , 31, 620 (1966).;;Chem. Rev. , 85, 129 170 (1985).",EXPIRED
450,GB,A,GB 2122399 A,177-696-301-727-957,1984-01-11,1984,GB 8314442 A,1983-05-25,GB 8215877 A,1982-06-01,IMPROVEMENTS RELATING TO CIGARETTE MANUFACTURING MACHINES,,BRITISH AMERICAN TOBACCO CO,STEWART-COX ADRIAN ROY;;BRYANT ROBERT GEORGE,,https://lens.org/177-696-301-727-957,Patent Application,no,1,1,12,12,0,A24C5/31;;A24C5/31,A24C5/31,G4N NEG           EG;;G4N NHX           NHX;;G4N N5A           EG;;G4N N7X           EG;;U1S S1117;;U1S S2186,0,0,,,,EXPIRED
451,NO,D0,NO 884442 D0,030-935-949-129-84X,1988-10-06,1988,NO 884442 A,1988-10-06,US 10533087 A,1987-10-07,"FREMGANGSMAATE FOR FREMSTILLING AV 3,3-DISUBSTITUERTE INDOLINER.",,DU PONT,BRYANT WALTER MARVIN III;;HUHN GEORGE FREDERICK,,https://lens.org/030-935-949-129-84X,Patent Application,no,0,0,22,22,0,C07D401/14;;C07D403/14;;C07D403/06;;C07D401/14;;C07D403/14,C07D401/06;;C07D209/34;;C07D401/14;;C07D403/06;;C07D403/14,,0,0,,,,DISCONTINUED
452,CN,A,CN 105933229 A,089-204-208-649-305,2016-09-07,2016,CN 201610109960 A,2016-02-26,US 201562126168 P;;US 201615001528 A,2015-02-27,Synonymous Labels,"The present invention discloses synonymous labels. Particular embodiments described herein provide for a communication system that can be configured to identify a system that includes network traffic, wherein at least a portion of the network traffic includes packets, at least a portion of the packets include a stack, and at least a portion of each stack includes one or more previously allocated labels. The communication system can further be configured to determine a synonymous label that triggers an action and to replace a label from the one of the one or more previously allocated labels in a specific stack of a specific packet with the synonymous label. In an example, the synonymous label can be used to identify a subset of packets in the network traffic or a source of the specific packet.",CISCO TECH INC,BRYANT STEWART FREDERICK;;SWALLOW GEORGE;;SIVABALAN MUTHURAJA,,https://lens.org/089-204-208-649-305,Patent Application,no,6,4,6,6,0,H04L45/50;;H04L45/507;;H04L45/50;;H04L43/0829;;H04L45/507;;H04L45/507;;H04L43/0835;;H04L45/50;;H04L43/0829,H04L45/50,,0,0,,,,ACTIVE
453,EP,A2,EP 0311029 A2,032-130-458-459-603,1989-04-12,1989,EP 88116435 A,1988-10-05,US 10533087 A,1987-10-07,"Process for preparing 3,3-disubstituted indolines.","Compounds of formula are prepared from coumpounds of formula by stepwise addition of the 3,3 substituents.  ",DU PONT,BRYANT WALTER MARVIN III;;HUHN GEORGE FREDERICK,THE DU PONT MERCK PHARMACEUTICAL COMPANY (1991-12-11),https://lens.org/032-130-458-459-603,Patent Application,yes,0,2,22,22,0,C07D401/14;;C07D403/14;;C07D403/06;;C07D401/14;;C07D403/14,C07D401/06;;C07D401/14;;C07D403/06;;C07D403/14;;C07D209/34,,0,0,,,,DISCONTINUED
454,WO,A8,WO 2008/041209 A8,096-833-603-361-366,2008-10-02,2008,IB 2007054118 W,2007-10-09,AU 2006/904518 A;;AU 2007/209823 A;;AU 2007/907034 A,2006-08-18,"GAMING MACHINE, SYSTEM AND METHOD WITH PROGRESSIVE GAME FEATURE","A gaming machine including a display and a user interface in communication with a game controller, which cooperate to provide a game, the gaming machine offering at least one jackpot prize and awarding at least one feature game on the occurrence of a predetermined event during play of the game. The outcomes of the feature game include a first outcome and a second outcome, wherein the gaming machine causes an increase of the jackpot prize on the occurrence of the first outcome, and causes the award of the jackpot prize on the occurrence of the second outcome. A gaming machine is also described in which an increase to a jackpot prize is variable. Also described are gaming systems including a plurality of linked gaming machines and methods for gaming.",ARISTOCRAT TECHNOLOGIES AU;;BENNETT NICHOLAS LUKE;;ROUKIS GEORGE;;BRYANT NATALIE,BENNETT NICHOLAS LUKE;;ROUKIS GEORGE;;BRYANT NATALIE,,https://lens.org/096-833-603-361-366,Patent Application,no,0,0,22,22,0,G07F17/3267;;G07F17/3267;;G07F17/32;;G07F17/32;;G07F17/3258;;G07F17/3258;;G07F17/34;;G07F17/34,,,0,0,,,,PENDING
455,AU,A,AU 1988/023506 A,182-864-153-692-932,1989-04-13,1989,AU 1988/023506 A,1988-10-06,US 10533087 A,1987-10-07,"PROCESS FOR PREPARING 3,3-DISUBSTITUTED INDOLINES",,DU PONT,BRYANT WALTER MARVIN III;;HUHN GEORGE FREDERICK,,https://lens.org/182-864-153-692-932,Patent Application,no,0,0,22,22,0,C07D401/14;;C07D403/14;;C07D403/06;;C07D401/14;;C07D403/14,C07D209/34;;C07D401/06;;C07D401/14;;C07D403/06;;C07D403/14,,0,0,,,,EXPIRED
456,CA,A1,CA 2597981 A1,023-537-761-773-142,2008-02-18,2008,CA 2597981 A,2007-08-17,AU 2006/904518 A;;AU 2007/209823 A;;AU 2007/907034 A,2006-08-18,"GAMING MACHINE, SYSTEM AND METHOD WITH PROGRESSIVE GAME FEATURE","A gaming machine (100) including a display (106) and a user interface (107) in communication with a game controller (101), which cooperate to provide a game (16), the gaming machine (100) offering at least one jackpot prize and awarding at least one feature game on the occurrence of a predetermined event during play of the game (16). The outcomes of the feature game include a first outcome and a second outcome, wherein the gaming machine (100) causes an increase of the jackpot prize on the occurrence of the first outcome, and causes the award of the jackpot prize on the occurrence of the second outcome. A gaming machine (100) is also described in which an increase to a jackpot prize is variable. Also described are gaming systems (200) including a plurality of linked gaming machines (100) and methods for gaming.",ARISTOCRAT TECHNOLOGIES AU,BRYANT NATALIE;;ROUKIS GEORGE;;BENNETT NICHOLAS LUKE,,https://lens.org/023-537-761-773-142,Patent Application,no,0,0,22,22,0,G07F17/3267;;G07F17/3267;;G07F17/32;;G07F17/32;;G07F17/3258;;G07F17/3258;;G07F17/34;;G07F17/34,G07F17/32,,0,0,,,,DISCONTINUED
457,CA,A,CA 826111 A,072-109-132-958-423,1969-10-28,1969,CA 826111D A,,CA 826111T A,,LUBRICATION OF SPANDEX YARNS,,UNION CARBIDE CORP,JONES ALLEN P JR;;BRYANT GEORGE M,,https://lens.org/072-109-132-958-423,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
458,WO,A2,WO 2008/041209 A2,080-130-046-460-561,2008-04-10,2008,IB 2007054118 W,2007-10-09,AU 2006/904518 A;;AU 2007/209823 A;;AU 2007/907034 A,2006-08-18,"GAMING MACHINE, SYSTEM AND METHOD WITH PROGRESSIVE GAME FEATURE","A gaming machine including a display and a user interface in communication with a game controller, which cooperate to provide a game, the gaming machine offering at least one jackpot prize and awarding at least one feature game on the occurrence of a predetermined event during play of the game. The outcomes of the feature game include a first outcome and a second outcome, wherein the gaming machine causes an increase of the jackpot prize on the occurrence of the first outcome, and causes the award of the jackpot prize on the occurrence of the second outcome. A gaming machine is also described in which an increase to a jackpot prize is variable. Also described are gaming systems including a plurality of linked gaming machines and methods for gaming.",ARISTOCRAT TECHNOLOGIES AU;;BENNETT NICHOLAS LUKE;;ROUKIS GEORGE;;BRYANT NATALIE,BENNETT NICHOLAS LUKE;;ROUKIS GEORGE;;BRYANT NATALIE,,https://lens.org/080-130-046-460-561,Patent Application,yes,0,0,22,22,0,G07F17/3267;;G07F17/3267;;G07F17/32;;G07F17/32;;G07F17/3258;;G07F17/3258;;G07F17/34;;G07F17/34,,,0,0,,,,PENDING
459,US,A1,US 2016/0254994 A1,143-113-236-105-420,2016-09-01,2016,US 201615001528 A,2016-01-20,US 201615001528 A;;US 201562126168 P,2015-02-27,SYNONYMOUS LABELS,"Particular embodiments described herein provide for a communication system that can be configured to identify a system that includes network traffic, where at least a portion of the network traffic includes packets, at least a portion of the packets include a stack, and at least a portion of each stack includes one or more previously allocated labels. The communication system can further be configured to determine a synonymous label that triggers an action and to replace a label from the one of the one or more previously allocated labels in a specific stack of a specific packet with the synonymous label. In an example, the synonymous label can be used to identify a subset of packets in the network traffic or a source of the specific packet.",CISCO TECH INC,BRYANT STEWART FREDERICK;;SWALLOW GEORGE;;SIVABALAN MUTHURAJAH,CISCO TECHNOLOGY INC (2016-01-13),https://lens.org/143-113-236-105-420,Patent Application,yes,26,5,6,6,0,H04L45/50;;H04L45/507;;H04L45/50;;H04L43/0829;;H04L45/507;;H04L45/507;;H04L43/0835;;H04L45/50;;H04L43/0829,H04L45/50,,2,0,,,"Ferguson US pub no 7,277,386 A1;;Nimmagadda US pat 9,397,913 B1",ACTIVE
460,CA,C,CA 1320729 C,183-215-864-891-993,1993-07-27,1993,CA 579302 A,1988-10-04,US 10533087 A,1987-10-07,"PROCESS FOR PREPARING 3,3-DISUBSTITUTED INDOLINES","Title BP-6367 PROCESS FOR PREPARING 3,3-DISUBSTITUTED INDOLINES Process for preparing 3,3-disubstituted indolines, particularly 3,3-dipyridine substituted indolines, are provided.",DU PONT,BRYANT WALTER M III;;HUHN GEORGE F,,https://lens.org/183-215-864-891-993,Granted Patent,no,0,0,22,22,0,C07D401/14;;C07D403/14;;C07D403/06;;C07D401/14;;C07D403/14,C07D401/06;;C07D401/14;;C07D209/34;;C07D403/06;;C07D403/14,D12600251    M;;26002662   S;;26002796   S,0,0,,,,EXPIRED
461,GB,A,GB 2238991 A,186-919-687-013-923,1991-06-19,1991,GB 9020785 A,1990-09-25,GB 8921749 A,1989-09-27,Fairing for aircraft control surface actuation linkage,"An externally mounted fairing arrangement for bridging an aircraft fixed structure 10 e.g. a wing and a control surface 11, e.g. an aileron hingedly mounted upon and angularly displaceable with respect to the fixed structure. The fairing arrangement includes a single element sealing diaphragm 23 which maintains continuity of the fairing aerodynamic shape whilst permitting differential movement between the respective parts 19, 20 of the fairing. <IMAGE>",BRITISH AEROSPACE,WILLIAMS GEORGE H;;YOUNG ANTHONY;;BRYANT ANTHONY,,https://lens.org/186-919-687-013-923,Patent Application,no,1,12,3,3,0,B64C7/00;;B64C7/00,B64C7/00,B7G GCM           CM;;B7G G301          CM,0,0,,,,DISCONTINUED
462,NO,L,NO 803209 L,085-011-957-720-977,1981-05-04,1981,NO 803209 A,1980-10-28,US 9018479 A,1979-11-01,E FREMGANGSMAATE TIL SMIING OG APPARAT TIL UTFOERELSE AV SAMM,,UNITED TECHNOLOGIES CORP,MACNITT DONALD GEORGE JR;;WALKER BRYANT HARDING,,https://lens.org/085-011-957-720-977,Abstract,no,0,0,30,35,0,B21J5/02;;B21J9/02;;B21J13/02;;B21K1/36;;B21K29/00;;Y10T29/49336;;Y10T29/49336;;B21J5/02;;B21K1/36;;B21J9/02;;B21J13/02;;B21K29/00,B21J5/02;;B21J9/02;;B21J13/02;;B21K1/36;;B21K3/04,,0,0,,,,EXPIRED
463,US,A,US 3548047 A,107-315-088-067-257,1970-12-15,1970,US 3548047D A,1967-02-23,US 61780067 A,1967-02-23,LUBRICATION OF SPANDEX YARNS,,UNION CARBIDE CORP,JONES ALLEN P JR;;BRYANT GEORGE M,VISKASE CORPORATION A CORP. OF PA (1986-02-01),https://lens.org/107-315-088-067-257,Granted Patent,no,9,2,5,5,0,D06M15/647;;D01F6/70;;D06M15/647;;D01F6/70,D01F6/72;;D06M15/647,264/136,0,0,,,,EXPIRED
464,NO,C,NO 151314 C,117-648-061-957-426,1985-03-20,1985,NO 803209 A,1980-10-28,US 9018479 A,1979-11-01,SENKESETT FOR FREMSTILLING AV EN SKIVEKONSTRUKSJON MED UTADRAGENDE DELER,,UNITED TECHNOLOGIES CORP,MACNITT DONALD GEORGE JR;;WALKER BRYANT HARDING,,https://lens.org/117-648-061-957-426,Granted Patent,no,0,0,30,35,0,B21J5/02;;B21J9/02;;B21J13/02;;B21K1/36;;B21K29/00;;Y10T29/49336;;Y10T29/49336;;B21J5/02;;B21K1/36;;B21J9/02;;B21J13/02;;B21K29/00,B21J5/02;;B21J9/02;;B21J13/02;;B21K1/36;;B21K3/04,,0,0,,,,EXPIRED
465,IT,B,IT 1166509 B,135-785-059-413-87X,1987-05-06,1987,IT 2125483 A,1983-05-24,GB 8215877 A,1982-06-01,PERFEZIONAMENTI RELATIVI A MACCHINE PER LA FABBRICAZIONE DI SIGARETTE,,BRITISH AMERICAN TOBACCO CO,ROY ADRIAN;;COX STEWART;;BRYANT ROBERT GEORGE,,https://lens.org/135-785-059-413-87X,Granted Patent,no,0,0,12,12,0,A24C5/31;;A24C5/31,A24C5/31,,0,0,,,,EXPIRED
466,GB,A,GB 1103108 A,172-809-905-351-862,1968-02-14,1968,GB 3939263 A,1963-10-07,GB 3939263 A,1963-10-07,Improvements in or relating to electric oscillation generators,"1,103,108. Frequency generators; multiplex systems. GENERAL ELECTRIC CO. Ltd. 26 Nov., 1964 [7 Oct., 1963; 26 Feb., 1964], Nos. 39392/63 and 8002/64. Headings H3T and H4R. An oscillation generator (e.g. a frequency divider) comprises a number of pulse delay or memory stages in a ring with one or more stage controlled by two others whereby a pulse pattern is produced at one stage from which the desired oscillation is derived. Fig. 1 shows an arrangement for producing 4 kc/s. spaced telephone channel carrier signals from a 120 kc/s. input at 1. Input oscillations are converted to pulses at 2 and applied as shift pulses to a four stage transistorized shift register 3. The outputs from the third and fourth stages 6, 7 are applied to circuit 8 which sets the first stage to its "" 1 "" state upon the occurrence of the next input pulse when the outputs from the stages 6 and 7 are different. Each stage is thus switched through a pattern which is repeated after every fifteen pulses. The frequency of pattern repetition (8 kc/s.) and its harmonics are selected by filters 9 from the output of stage 7 and part of the output of stage 7 is applied to a gate 11 together with the output of a bistable circuit 10 to provide the odd harmonics for the intermediate channel carrier filters 12. The bistable circuit 10 may be supplied alternatively with pulses at twice the input pulse frequency and narrow pulse generators may be inserted in the common input lines to filters 9 and 12 to increase the harmonic output or to provide odd harmonics for selection by additional filters 9. An alternative circuit (Fig. 2, not shown) provides 48 kc/s. input signal and uses a five stage shift register. The 48 kc/s. fundamental signal is selected and mixed with a two stage pulse sequence generator to provide a wave from which the desired harmonics are selected. Alternative shift register dividers producing different pulse sequences are referred to. In a further alternative arrangement (Fig. 3, not shown) a four section delay line replaces the shift of Fig. 1, anticoincidence of pulses in two adjacent sections controlling the flow of input pulses to the line.",GEN ELECTRIC CO LTD,BRYANT PETER RUSSELL;;INGRAM DEREK GEORGE WOODWARD,,https://lens.org/172-809-905-351-862,Granted Patent,no,0,0,1,1,0,H04J1/06;;H03B21/025,H03B21/02;;H04J1/06,H3P PRN           PRN;;H3T TFX           TFX;;H3T TRN           TRN;;H3T T1F           -;;H3T T1PX          -;;H3T T2B2          -;;H3T T2B3          -;;H3T T2B6          -;;H3T T2B9          TFX;;H3T T2D           -;;H3T T2J           -;;H3T T2T3J         -;;H3T T3X           -;;H3T T4C           -;;H3T T4M           -;;H3T T4R           -;;H4M MFC           MFC;;H4R R3D           -,0,0,,,,EXPIRED
467,CA,A,CA 406133 A,014-173-952-258-29X,1942-07-21,1942,CA 406133D A,,CA 406133T A,,SHOE,,REINHART JOHN BRYANT;;REINHART JOHN BRYANT JR;;BOLLMAN ALBERT CHARLES;;SCHNEIDER KENNETH GEORGE,SCHNEIDER KENNETH GEORGE;;BOLLMAN ALBERT CHARLES;;REINHART JOHN BRYANT JR;;REINHART JOHN BRYANT,,https://lens.org/014-173-952-258-29X,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
468,CA,A,CA 55816 A,034-247-693-021-515,1897-05-05,1897,CA 55816D A,1897-03-23,CA 55816T A,1897-03-23,DEVICE FOR CLEANING CHIMNEYS,,CLARK ROBERT W;;BRYANT WILLIAM H;;DAYRELL GEORGE R;;HUNTER GEORGE,CLARK ROBERT W;;BRYANT WILLIAM H;;DAYRELL GEORGE R;;HUNTER GEORGE,,https://lens.org/034-247-693-021-515,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
469,FI,C,FI 85863 C,021-470-728-171-821,1992-06-10,1992,FI 863569 A,1986-09-04,US 77289185 A,1985-09-05,BIS-FOSFITFOERENINGAR.,,UNION CARBIDE CORP,BILLIG ERNST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/021-470-728-171-821,Granted Patent,no,0,0,48,54,0,C07C45/50;;C07F9/65744;;C07F9/6578;;C07F15/008;;Y02P20/582;;C07F11/00;;C07F9/10;;C07F15/008;;C07F9/6578;;C07C45/50;;C07F9/65744;;Y02P20/582,B01J31/00;;B01J31/22;;C07B41/06;;C07B61/00;;B01J31/24;;C07C45/00;;C07C45/50;;C07C47/02;;C07C47/042;;C07C67/00;;C07F9/09;;C07F9/145;;C07F9/6574;;C07F9/6578;;C07F15/00,,0,0,,,,EXPIRED
470,AT,T1,AT E446122 T1,037-750-388-459-34X,2009-11-15,2009,AT 99902275 T,1999-01-15,US 7139698 P;;US 9900864 W,1998-01-15,VERBESSERTE VORRICHTUNG ZUR BEHANDLUNG MITTELS PULSIERTER ELEKTROMAGNETISCHER ENERGIE,"An apparatus for treatment of wounds using pulsed electromagnetic energy provides a constant, known and replicable dosage output which remains unaffected by the capacitance of the patient's body. The apparatus includes: a pulsed electromagnetic energy generator, one or more applicators, which may be flexible, adapted to be positioned proximate a wound and external of a patient's body, and a circuit means having a fixed capacitance. The applicators are located immediately adjacent to the patient's body, without the aid of a support member or removal of any dressings or bandages. Multiple applicators can be selected to operate simultaneously at different treatment dosage levels and are connected to the generator by multi-conductor cables and are readily located directly on the treatment area. Each applicator is a pad including etched printed circuits. The circuits are matched and pre-tuned.",REGENESIS BIOMEDICAL INC,GEORGE FRANK;;LOYA ARTHUR;;RITZ MARY;;BRYANT ROBERT,,https://lens.org/037-750-388-459-34X,Granted Patent,no,0,0,18,18,0,A61N1/326;;A61N1/40;;A61N1/40;;A61N1/326,A61N1/40,,0,0,,,,EXPIRED
471,CA,A1,CA 2660275 A1,071-378-708-935-590,2008-02-21,2008,CA 2660275 A,2007-08-09,US 83676406 P;;US 2007/0017716 W,2006-08-10,"METHODS FOR THE IDENTIFICATION, ASSESSMENT, AND TREATMENT OF PATIENTS WITH CANCER THERAPY","The present invention is directed to the identification of predictive markers that can be used to determine whether patients with cancer are expected to demonstrate long term or short term survival times. In particular, the present invention is directed to the use of certain individual and/or combinations of predictive markers, wherein the expression of the predictive markers correlates with expected short term or long term survival. Thus, by examining the expression levels of individual predictive markers and/or predictive markers comprising a marker set, it is possible to determine predicted patient survival.",MILLENNIUM PHARM INC,MULLIGAN GEORGE;;BRYANT BARBARA M;;DAMOKOSH ANDREW I,,https://lens.org/071-378-708-935-590,Patent Application,no,0,0,13,13,0,C12Q1/6886;;C12Q2600/106;;C12Q2600/158;;G01N33/57484;;A61P35/00;;C12Q1/6886;;C12Q2600/106;;C12Q2600/158;;G01N33/57484,C12Q1/68;;C07H21/00;;C40B30/04;;G01N33/574,,0,0,,,,DISCONTINUED
472,BR,A,BR 8604262 A,081-252-456-969-223,1987-05-05,1987,BR 8604262 A,1986-09-04,US 77289185 A,1985-09-05,LIGANTE DE BIOFOSFITO;BIOFOSFITO;PROCESSO PARA CARBONILACAO;PROCESSO DE HIDROFORMILACAO PARA PRODUZIR ALDEIDOS;CATALISADOR DE HIDROFORMILACAO DE COMPLEXO DE RODIO;E COMPOSICAO PRECURSORA CATALITICA,,UNION CARBIDE CORP,BILLIG ERNST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/081-252-456-969-223,Patent Application,no,0,0,48,54,0,C07C45/50;;C07F9/65744;;C07F9/6578;;C07F15/008;;Y02P20/582;;C07F11/00;;C07F9/10;;C07F15/008;;C07F9/6578;;C07C45/50;;C07F9/65744;;Y02P20/582,B01J31/24;;B01J31/00;;B01J31/22;;C07B41/06;;C07B61/00;;C07C45/00;;C07C45/50;;C07C47/02;;C07C47/042;;C07C67/00;;C07F9/09;;C07F9/145;;C07F9/6574;;C07F9/6578;;C07F15/00,,0,0,,,,DISCONTINUED
473,EP,A3,EP 0213639 A3,130-618-648-430-125,1988-01-13,1988,EP 86112256 A,1986-09-04,US 77289185 A,1985-09-05,BIS-PHOSPHITE COMPOUNDS,"Transition metal-bis-phosphite catalyzed carbonylation processes, especially hydroformylation, as well as transition metal-bis-phosphite compositions, bis-phosphite ligands and transition metal-bis-phosphite catalysts.",UNION CARBIDE CORPORATION,"BILLIG, ERNST;;ABATJOGLOU, ANTHONY GEORGE;;BRYANT, DAVID ROBERT",,https://lens.org/130-618-648-430-125,Search Report,yes,1,0,48,54,0,C07C45/50;;C07F9/65744;;C07F9/6578;;C07F15/008;;Y02P20/582;;C07F11/00;;C07F9/10;;C07F15/008;;C07F9/6578;;C07C45/50;;C07F9/65744;;Y02P20/582,B01J31/00;;B01J31/22;;C07B41/06;;C07B61/00;;B01J31/24;;C07C45/00;;C07C45/50;;C07C47/02;;C07C47/042;;C07C67/00;;C07F9/09;;C07F9/145;;C07F9/6574;;C07F9/6578;;C07F15/00,,0,0,,,,EXPIRED
474,US,A,US 814016 A,121-279-946-130-139,1906-03-06,1906,US 1904/0204590 A,1904-04-23,US 1904/0204590 A,1904-04-23,LUBRICATOR.,,MICHIGAN LUBRICATOR COMPANY,BRYANT WILLIAM E;;WOLCOTT GEORGE M;;DAVIDSON ROBERT,,https://lens.org/121-279-946-130-139,Granted Patent,no,0,0,1,1,0,F16N7/30;;F16N7/30,,,0,0,,,,EXPIRED
475,NO,C,NO 172494 C,139-132-506-533-468,1993-07-28,1993,NO 863547 A,1986-09-04,US 77289185 A,1985-09-05,BIS-FOSFITT-LIGANDER,,UNION CARBIDE CORP,BILLIG ERNST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/139-132-506-533-468,Granted Patent,no,0,0,48,54,0,C07C45/50;;C07F9/65744;;C07F9/6578;;C07F15/008;;Y02P20/582;;C07F11/00;;C07F9/10;;C07F15/008;;C07F9/6578;;C07C45/50;;C07F9/65744;;Y02P20/582,B01J31/00;;B01J31/22;;C07B41/06;;B01J31/24;;C07B61/00;;C07C45/00;;C07C45/50;;C07C47/02;;C07C47/042;;C07C67/00;;C07F9/09;;C07F9/145;;C07F9/6574;;C07F9/6578;;C07F15/00,,0,0,,,,EXPIRED
476,IN,B,IN 168017 B,141-644-583-087-845,1991-01-19,1991,IN 712MA1986 A,1986-09-04,US 77289185 A,1985-09-05,A PROCESS FOR PRODUCING ALDEHYDES BY HYDROFORMYLATION,,UNION CARBIDE CORP,ERNST BILLIG;;ANTHONY GEORGE ABATJOGLOU;;DAVID ROBERT BRYANT,,https://lens.org/141-644-583-087-845,Granted Patent,no,0,0,48,54,0,C07C45/50;;C07F9/65744;;C07F9/6578;;C07F15/008;;Y02P20/582;;C07F11/00;;C07F9/10;;C07F15/008;;C07F9/6578;;C07C45/50;;C07F9/65744;;Y02P20/582,B01J31/00;;B01J31/24;;B01J31/22;;C07B41/06;;C07B61/00;;C07C45/00;;C07C45/50;;C07C47/02;;C07C47/042;;C07C67/00;;C07F9/09;;C07F9/145;;C07F9/6574;;C07F9/6578;;C07F15/00,,0,0,,,,EXPIRED
477,FI,A0,FI 863569 A0,153-753-159-577-472,1986-09-04,1986,FI 863569 A,1986-09-04,US 77289185 A,1985-09-05,BIS-FOSFITFOERENINGAR.,,UNION CARBIDE CORP,BILLIG ERNST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/153-753-159-577-472,Patent Application,no,0,0,48,54,0,C07C45/50;;C07F9/65744;;C07F9/6578;;C07F15/008;;Y02P20/582;;C07F11/00;;C07F9/10;;C07F15/008;;C07F9/6578;;C07C45/50;;C07F9/65744;;Y02P20/582,B01J31/00;;B01J31/24;;B01J31/22;;C07B41/06;;C07B61/00;;C07C45/00;;C07C45/50;;C07C47/02;;C07C47/042;;C07C67/00;;C07F9/09;;C07F9/145;;C07F9/6574;;C07F9/6578;;C07F15/00,,0,0,,,,EXPIRED
478,HU,B,HU 204747 B,195-954-856-442-359,1992-02-28,1992,HU 382586 A,1986-09-04,US 77289185 A,1985-09-05,PROCESS FOR HYDROFORMYLATION CATALYZED SITH TRANSITION METAL-BIS-PHOSPHITE COMPLEXES,,UNION CARBIDE CORP,BILLIG ERNST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/195-954-856-442-359,Granted Patent,no,0,0,48,54,0,C07C45/50;;C07F9/65744;;C07F9/6578;;C07F15/008;;Y02P20/582;;C07F11/00;;C07F9/10;;C07F15/008;;C07F9/6578;;C07C45/50;;C07F9/65744;;Y02P20/582,B01J31/00;;B01J31/22;;C07B41/06;;C07B61/00;;B01J31/24;;C07C45/00;;C07C45/50;;C07C47/02;;C07C47/042;;C07C67/00;;C07F9/09;;C07F9/145;;C07F9/6574;;C07F9/6578;;C07F15/00,,0,0,,,,EXPIRED
479,ZA,B,ZA 895347 B,080-230-710-627-568,1990-07-25,1990,ZA 895347 A,1989-07-13,US 21891188 A,1988-07-14,PROCESS FOR CATALYST ALDEHYDE PRODUCT SEPARATION,,UNION CARBIDE CHEM PLASTIC,ABATJOGLOU ANTHONY GEORGE;;ANTHONY GEORGE ABATJOGLOU;;BRYANT DAVID ROBERT;;DAVID ROBERT BRYANT;;PETERSON RONALD ROBERT;;RONALD ROBERT PETERSON,,https://lens.org/080-230-710-627-568,Granted Patent,no,0,0,3,26,0,Y02P20/584,C07C47/02;;B01D/;;B01J/;;C01B/;;C07C45/50,,0,0,,,,EXPIRED
480,RU,C2,RU 2531918 C2,022-259-696-313-655,2014-10-27,2014,RU 2012105429 A,2010-05-22,US 22662809 P;;US 70593710 A;;US 2010/0035889 W,2009-07-17,METHODS OF INHIBITING POLYMERISATION OF VINYL AROMATIC COMPOUNDS DURING EXTRACTIVE DISTILLATION,"FIELD: chemistry.SUBSTANCE: method of inhibiting polymerisation of vinyl aromatic compounds during extractive distillation includes the following steps: a) providing a mixture containing styrene; b) adding one 2-sec-butyl-4,6-dinitrophenol (DNBP) inhibitor to the mixture; and c) performing extractive distillation of the mixture after step b) to of separate styrene; d) forming less than 200 ppmw of a polymer from the styrene.EFFECT: minimum polymer formation.5 cl, 1 tbl, 1 ex",DZHITISI TEKNOLODZHI JUEHS EHLEHLSI,SEALEY AMY;;BALL GEORGE A;;SLIMP B BRYANT,,https://lens.org/022-259-696-313-655,Granted Patent,no,0,0,14,14,0,C07C7/08;;C07C7/20;;B01D3/00;;B01D3/34;;B01D3/40;;C07C7/08;;C07C7/20;;C07C15/46;;C07C7/08;;C07C7/20,B01D11/00;;B01D3/40;;C07C7/10;;C07C7/20;;C08F2/42,,0,0,,,,INACTIVE
481,US,B2,US 9794168 B2,045-071-501-588-916,2017-10-17,2017,US 201514819346 A,2015-08-05,US 201514819346 A,2015-08-05,Scalable continuity test for a group of communication paths,"In one embodiment, a method includes generating at a network device, a continuity test packet configured to pass through a set of communication paths terminating at the network device and at least one other network device located at an opposite end of the communication paths, transmitting at the network device the continuity test packet on a first communication path in the set of communication paths, and identifying at the network device a failure in the set of communication paths if the continuity test packet is not received on a last communication path in the set of communication paths. An apparatus and logic are also disclosed herein.",CISCO TECH INC,BRYANT STEWART FREDERICK;;PIGNATARO CARLOS M;;SWALLOW GEORGE,CISCO TECHNOLOGY INC (2015-07-22),https://lens.org/045-071-501-588-916,Granted Patent,yes,5,0,2,2,0,H04L45/22;;H04L45/28;;H04L45/50;;H04L45/28;;H04L45/50;;H04L45/22;;G16H40/20;;G06Q10/00;;G08B21/245,H04L45/28;;H04L45/50,,2,1,023-793-864-292-395,10.17487/rfc6391,"IETF RFC 6391, “Flow-Aware Transport of Pseudowires over an MPLS Packet Switched Network”, S. Bryant et al., Nov. 2011.;;IETF RFC 4447, “Pseudowire Setup and Maintenance Using the Label Distribution Protocol (LDP)”, L. Martini et al., Apr. 2006.",INACTIVE
482,WO,A8,WO 2009/148528 A8,125-973-612-712-564,2010-03-18,2010,US 2009/0003237 W,2009-05-27,US 13035108 P,2008-05-30,ASSESSMENT OF CHROMOSOMAL ALTERATIONS TO PREDICT CLINICAL OUTCOME OF BORTEZOMIB TREATMENT,"Disclosed herein are chromosomal loci associated with clinical outcome to treatment for multiple myeloma. Genome-wide changes observed in myeloma relate to prognosis and treatment response to a proteasome inhibitor. Compositions and methods are provided to assess DNA copy number at corresponding to markers of loci and genes found thereon which are amplified or deleted, overexpressed or underexpressed in myeloma tumors to predict response to treatment, time-to-progression and survival upon treatment.",MILLENNIUM PHARM INC;;BRYANT BARBARA M;;DANAEE HADI;;MULLIGAN GEORGE J,BRYANT BARBARA M;;DANAEE HADI;;MULLIGAN GEORGE J,,https://lens.org/125-973-612-712-564,Amended Application,yes,0,0,5,5,0,C12Q1/6883;;C12Q2600/156;;G01N33/57407;;G01N33/57426;;G01N2800/52;;G01N2800/60;;C12Q2600/106;;C12Q2600/112;;C12Q2600/136;;C12Q2600/158;;C12Q2600/106;;C12Q2600/158;;G01N33/57407;;C12Q1/6883;;G01N2800/52;;C12Q2600/156;;G01N2800/60;;G01N33/57426;;C12Q2600/136;;C12Q2600/112;;C12Q1/6886;;C12Q2600/118,C12Q1/68;;G01N33/574,,0,0,,,,PENDING
483,CA,A,CA 1110265 A,180-012-334-394-456,1981-10-06,1981,CA 323520 A,1979-03-15,US 89183078 A,1978-03-30,ACRYLYL CAPPED URETHANE OLIGOMERS,"ACRYLYL CAPPED URETHANE OLIGOMERS The reaction produces of (A) polyoxytetramethylene diols or polycaprolactone polyols, (B) diisocyanates and (C) di- or tri-methylol carboxylic acids are capped with (D) certain defined acrylyl compounds to produce terminally unsaturated oligomers that readily cure by thermal or radiation means to soft, tack-free products. The oligomers can be used as coatings; binders and adhesives. S P E C I F I C A T I O N 1.",UNION CARBIDE CORP,PARK KISOON;;BRYANT GEORGE M;;CARR FRAZIER G,,https://lens.org/180-012-334-394-456,Granted Patent,no,0,0,10,10,0,C08G18/348;;C08G18/348;;C08G18/672;;C08G18/672;;G03F7/038;;G03F7/038,C08F20/00;;C08F20/34;;C08F290/00;;C08F299/00;;C08G18/00;;C08G18/34;;C08G18/67;;G03F7/038,260-468,0,0,,,,EXPIRED
484,CZ,B6,CZ 284301 B6,035-732-131-186-401,1998-10-14,1998,CS 642986 A,1986-09-04,US 77289185 A,1985-09-05,PROCESS FOR PREPARING ALDEHYDES BY HYDROFORMYLATION,"Postup výroby aldehydů hydroformylací, při kterém se do reakce uvádí olefinická sloučenina zvolená ze souboru zahrnujícího .alfa.-olefiny obsahující 2 až 20 atomů uhlíku, vnitřní olefiny obsahující 4 až 20 atomů uhlíku a směsi těchto .alfa.-olefinů a vnitřních olefinů, s oxidem uhelnatým a vodítkem v přítomnosti katalyzátoru tvořeného rhodium-bis-fosfitovým komplexem, který sestává z rhodia zkomplexovaného s oxidem uhelnatým a bis-fosfitovým ligandem, a v přítomnosti volného bis-fosfitového ligandu, přičemž hydroformylační reakční podmínky zahrnují reakční teplotu v rozmezí od 50 do 120.sup.o.n.C, celkový tlak plynného vodíku, oxidu uhelnatého a olefinicky nenasycené organické sloučeniny v rozmezí od 7 kPa do 1030 kPa, parciální tlak vodíku v rozmezí od 10,3 kPa do 110 kPa, parciální tlak oxidu uhelnatého od 7 kPa do 82,5 kPa, přičemž reakční prostředí obsahuje 4 až 100 dílů molárních uvedeného bis-fosfitového ligandu na 1 díl molární rhodia v tomto prostředí.ŕ",UNION CARBIDE CORP,BILLIG ERNST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/035-732-131-186-401,Granted Patent,no,0,0,48,54,0,C07C45/50;;C07F9/65744;;C07F9/6578;;C07F15/008;;Y02P20/582;;C07F11/00;;C07F9/10;;C07F15/008;;C07F9/6578;;C07C45/50;;C07F9/65744;;Y02P20/582,B01J31/24;;B01J31/00;;B01J31/22;;C07B41/06;;C07B61/00;;C07C45/00;;C07C45/50;;C07C47/02;;C07C47/042;;C07C67/00;;C07F9/09;;C07F9/145;;C07F9/6574;;C07F9/6578;;C07F15/00,,0,0,,,,EXPIRED
485,RO,B1,RO 94855 B1,053-256-857-579-122,1988-07-31,1988,RO 12470786 A,1986-09-04,RO 12470786 A,1986-09-04,PROCESS FOR PREPARING ALDEHYDES BY HYDROFORMILATION OF OLEFINS,"Inventia se refera la un procedeu pentru prepararea de aldehide prin hidroformilarea olefinelor cu monoxid de carbon si hidrogen, folosind un catalizator continînd rodiu si un ligand continînd fosfor, la o temperatura de la 50 la 120 degree C si o presiunetotala de 0,07 la 105 kgf/cm exponent 2, o presiune partiala de hidrogen de la 1,05 pîna la 11,2 kgf/cm exponent 2 si o presiune partiala de oxid de carbon de la 0,07 la 8,4 kgf/cm exponent 2.",UNION CARBIDE CORP,ERNST BILLING;;ANTHONY GEORGE ABATJOGLOU;;DAVID ROBERT BRYANT,,https://lens.org/053-256-857-579-122,Unknown,no,0,0,1,1,0,,C07C45/50,,0,0,,,,DISCONTINUED
486,WO,A2,WO 2009/148528 A2,052-684-590-154-807,2009-12-10,2009,US 2009/0003237 W,2009-05-27,US 13035108 P,2008-05-30,ASSESSMENT OF CHROMOSOMAL ALTERATIONS TO PREDICT CLINICAL OUTCOME OF BORTEZOMIB TREATMENT,"Disclosed herein are chromosomal loci associated with clinical outcome to treatment for multiple myeloma. Genome-wide changes observed in myeloma relate to prognosis and treatment response to a proteasome inhibitor. Compositions and methods are provided to assess DNA copy number at corresponding to markers of loci and genes found thereon which are amplified or deleted, overexpressed or underexpressed in myeloma tumors to predict response to treatment, time-to-progression and survival upon treatment.",MILLENNIUM PHARM INC;;BRYANT BARBARA M;;DANAEE HADI;;MULLIGAN GEORGE J,BRYANT BARBARA M;;DANAEE HADI;;MULLIGAN GEORGE J,,https://lens.org/052-684-590-154-807,Patent Application,yes,0,30,5,5,86,C12Q1/6883;;C12Q2600/156;;G01N33/57407;;G01N33/57426;;G01N2800/52;;G01N2800/60;;C12Q2600/106;;C12Q2600/112;;C12Q2600/136;;C12Q2600/158;;C12Q2600/106;;C12Q2600/158;;G01N33/57407;;C12Q1/6883;;G01N2800/52;;C12Q2600/156;;G01N2800/60;;G01N33/57426;;C12Q2600/136;;C12Q2600/112;;C12Q1/6886;;C12Q2600/118,C12Q1/68;;G01N33/574,,0,0,,,,PENDING
487,IN,A,IN 1380DEN2012 A,087-574-481-891-499,2015-06-05,2015,IN 1380DEN2012 A,2012-02-14,US 22662809 P;;US 70593710 A;;US 2010/0035889 W,2009-07-17,METHODS FOR INHIBITING POLYMERIZATION OF VINYL AROMATIC COMPOUNDS DURING EXTRACTIVE DISTILLATION,High temperatures and oxygen exposure during extractive distillation can result in polymerization of vinyl aromatic compounds. In various embodiments  the present disclosure relates to methods for inhibiting polymerization of vinyl aromatic compounds during extractive distillation. In various embodiments  the methods include a) providing a mixture containing at least one vinyl aromatic compound  b) adding at least one dinitrophenol inhibitor to the mixture  and c) after step b)  performing an extractive distillation on the mixture to isolate the at least one vinyl aromatic compound. Purified styrene can be isolated by the methods described herein. In some embodiments  the dinitrophenol inhibitor is 2-sec-butyl-4 6-dinitrophenol (DNBP).,GTC TECHNOLOGY US LLC,SEALEY AMY;;BALL  GEORGE  A;;SLIMP  B   BRYANT,,https://lens.org/087-574-481-891-499,Patent Application,no,0,0,14,14,0,C07C7/08;;C07C7/20;;B01D3/00;;B01D3/34;;B01D3/40;;C07C7/08;;C07C7/20;;C07C15/46;;C07C7/08;;C07C7/20,C09F/,,0,0,,,,PENDING
488,FI,A,FI 863569 A,195-268-474-229-026,1987-03-06,1987,FI 863569 A,1986-09-04,US 77289185 A,1985-09-05,BIS-FOSFITFOERENINGAR.,,UNION CARBIDE CORP,BILLIG ERNST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/195-268-474-229-026,Patent Application,no,0,0,48,54,0,C07C45/50;;C07F9/65744;;C07F9/6578;;C07F15/008;;Y02P20/582;;C07F11/00;;C07F9/10;;C07F15/008;;C07F9/6578;;C07C45/50;;C07F9/65744;;Y02P20/582,B01J31/00;;B01J31/24;;B01J31/22;;C07B41/06;;C07B61/00;;C07C45/00;;C07C45/50;;C07C47/02;;C07C47/042;;C07C67/00;;C07F9/09;;C07F9/145;;C07F9/6574;;C07F9/6578;;C07F15/00,,0,0,,,,EXPIRED
489,CZ,A3,CZ 642986 A3,194-311-055-522-337,1998-07-15,1998,CS 642986 A,1986-09-04,US 77289185 A,1985-09-05,PROCESS FOR PREPARING ALDEHYDES BY HYDROFORMYLATION,,UNION CARBIDE CORP,BILLIG ERNST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/194-311-055-522-337,Patent Application,no,0,0,48,54,0,C07C45/50;;C07F9/65744;;C07F9/6578;;C07F15/008;;Y02P20/582;;C07F11/00;;C07F9/10;;C07F15/008;;C07F9/6578;;C07C45/50;;C07F9/65744;;Y02P20/582,B01J31/24;;B01J31/00;;B01J31/22;;C07B41/06;;C07B61/00;;C07C45/00;;C07C45/50;;C07C47/02;;C07C47/042;;C07C67/00;;C07F9/09;;C07F9/145;;C07F9/6574;;C07F9/6578;;C07F15/00,,0,0,,,,EXPIRED
490,US,B2,US 11847658 B2,195-539-672-030-335,2023-12-19,2023,US 202017010141 A,2020-09-02,US 202017010141 A;;US 201916519463 A,2019-07-23,Crowdsourced annotation and tagging system for digital transactions,"A system for crowdsourcing annotations for transactions includes a crowdsourcing annotation database and a processor. The database stores crowdsourced annotations associated with merchants. The crowdsourced annotations are shared among, and contributed by, users of a community. The processor receives transaction data for a transaction by a user with a merchant. Relevant crowdsourced annotations associated with the merchant are retrieved from the database and sent to the user to enable to the user to annotate the transaction. The user provides an annotation for the transaction. The system dynamically updates the database based on the annotation provided by the user.",CAPITAL ONE SERVICES LLC,YEE BRYANT;;BULGAKOV MYKHAYLO;;BERGERON IV GEORGE LEON,CAPITAL ONE SERVICES LLC (2019-07-22),https://lens.org/195-539-672-030-335,Granted Patent,yes,5,0,3,6,0,G06Q20/0425;;G06F40/169;;G06Q10/101;;G06Q30/0185;;G06Q30/06;;G06Q40/02;;G06Q20/42;;G06Q20/0425;;G06F40/169,G06Q20/42;;G06F40/169;;G06Q20/04,,2,0,,,"International Search Report and Written Opinion in related application No. PCT/US2021/050374 dated Dec. 16, 2021.;;International Preliminary Report on Patentability in related application No. PCT/US2021/050374 dated Apr. 13, 2023.",ACTIVE
491,DE,D1,DE 3679945 D1,197-590-258-173-919,1991-08-01,1991,DE 3679945 T,1986-09-04,US 77289185 A,1985-09-05,BIS-PHOSPHIT-VERBINDUNGEN.,,UNION CARBIDE CORP,BILLIG ERNST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/197-590-258-173-919,Granted Patent,no,0,0,48,54,0,C07C45/50;;C07F9/65744;;C07F9/6578;;C07F15/008;;Y02P20/582;;C07F11/00;;C07F9/10;;C07F15/008;;C07F9/6578;;C07C45/50;;C07F9/65744;;Y02P20/582,B01J31/00;;B01J31/22;;C07B41/06;;B01J31/24;;C07B61/00;;C07C45/00;;C07C45/50;;C07C47/02;;C07C47/042;;C07C67/00;;C07F9/09;;C07F9/145;;C07F9/6574;;C07F9/6578;;C07F15/00,,0,0,,,,EXPIRED
492,CA,A,CA 93908 A,002-935-108-584-519,1905-06-27,1905,CA 93908D A,1905-04-17,CA 93908T A,1905-04-17,LUBRICATOR,,WOLCOTT GEORGE M;;MICHIGAN LUBRICATOR COMPANY;;BRYANT WILLIAM E;;DAVIDSON ROBERT,WOLCOTT GEORGE M;;BRYANT WILLIAM E;;DAVIDSON ROBERT,,https://lens.org/002-935-108-584-519,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
493,CH,A5,CH 650954 A5,018-540-389-530-174,1985-08-30,1985,CH 798080 A,1980-10-27,US 9018479 A,1979-11-01,"GESENKSATZ ZUM SCHMIEDEN, MIT DIESEM VERSEHENE SCHMIEDEVORRICHTUNG UND SCHMIEDEVERFAHREN.",,UNITED TECHNOLOGIES CORP,MAC NITT DONALD GEORGE JUN;;WALKER BRYANT HARDING,,https://lens.org/018-540-389-530-174,Granted Patent,no,0,1,30,35,0,B21J5/02;;B21J9/02;;B21J13/02;;B21K1/36;;B21K29/00;;Y10T29/49336;;Y10T29/49336;;B21J5/02;;B21K1/36;;B21J9/02;;B21J13/02;;B21K29/00,B21J5/02;;B21J9/02;;B21J13/02;;B21K1/36;;B21K3/04,,0,0,,,,EXPIRED
494,CZ,B6,CZ 284335 B6,023-136-653-038-303,1998-10-14,1998,CS 843488 A,1988-12-19,US 77289185 A,1985-09-05,"BIS-PHOSPHITE LIGAND, HYDROFORMYLATION CATALYST AND PRECURSOR HYDROFORMYLATION CATALYTIC COMPOSITION","Bis-fosfitový ligand, který se používá k přípravě hydroformylačního katalyzátoru a prekurzorové hydroformylační katalytická kompozice na bázi komplexu rhodia, přičemž tento hydroformylační katalyzátor je na bázi rhodia a uvedeného bis-fosfitového ligandu a uvedená prekurzorová hydroformylační katalytická kompozice obsahuje solubilizovaný výše uvedený bis-fosfitový komplex rhodia, organické roozpouštědlo a volný uvedený bis-fosfitový ligand. Uvedeného hydroformylačního katalyzátoru a prekurzorové kompozice se používá k hydroformylaci aldehydů, a obecně je možno je použít při kyrbovylačních procesech. ŕ",UNION CARBIDE CORP,BILLIG ERNST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/023-136-653-038-303,Granted Patent,no,0,0,48,54,0,C07C45/50;;C07F9/65744;;C07F9/6578;;C07F15/008;;Y02P20/582;;C07F11/00;;C07F9/10;;C07F15/008;;C07F9/6578;;C07C45/50;;C07F9/65744;;Y02P20/582,B01J31/24;;B01J31/00;;B01J31/22;;C07B41/06;;C07B61/00;;C07C45/00;;C07C45/50;;C07C47/02;;C07C47/042;;C07C67/00;;C07F9/09;;C07F9/145;;C07F9/6574;;C07F9/6578;;C07F15/00,,0,0,,,,EXPIRED
495,US,A1,US 2006/0281122 A1,042-881-495-077-954,2006-12-14,2006,US 44919506 A,2006-06-08,US 44919506 A;;US 68863405 P,2005-06-08,"Methods for the identification, assessment, and treatment of patients with cancer therapy","The present invention is directed to the identification of predictive markers that can be used to determine whether patients with cancer are clinically responsive or non-responsive to a therapeutic regimen prior to treatment. In particular, the present invention is directed to the use of certain individual and/or combinations of predictive markers, wherein the expression of the predictive markers correlates with responsiveness or non-responsiveness to a therapeutic regimen. Thus, by examining the expression levels of individual predictive markers and/or predictive markers comprising a marker set, it is possible to determine whether a therapeutic agent, or combination of agents, will be most likely to reduce the growth rate of tumors in a clinical setting.",MILLENNIUM PHARM INC,BRYANT BARBARA M;;DAMOKOSH ANDREW I;;MULLIGAN GEORGE,MILLENNIUM PHARMACEUTICALS INC (2006-07-05),https://lens.org/042-881-495-077-954,Patent Application,yes,1,141,22,22,0,C12Q2600/106;;C12Q2600/136;;G01N33/57407;;G01N33/57415;;G01N33/57419;;G01N33/57423;;G01N33/57434;;G01N33/57438;;G01N33/57449;;G01N2800/44;;G16B25/00;;G16B40/00;;A61K31/69;;C12Q1/6886;;A61P35/00;;A61P35/02;;G16H10/40;;G16H20/40;;Y02A90/10;;G16B40/10;;G16B25/10;;G16B25/00;;G16B40/00;;C12Q2600/106;;C12Q2600/136;;G01N33/57407;;G01N33/57415;;G01N33/57419;;G01N33/57423;;G01N33/57434;;G01N33/57438;;G01N33/57449;;G01N2800/44;;Y02A90/10;;G16H10/40;;G16H20/40;;G16B40/10;;G16B25/10;;C12Q1/6886;;A61K31/69;;C12Q2600/158;;G01N33/57426;;G06Q20/40,C12Q1/68;;G01N33/574;;G06Q50/00;;G16B25/10;;G16B40/10,435/6;;435/7.23;;705/2,3,2,045-807-567-174-272;;043-880-672-061-032,10.1186/gb-2003-4-9-117;;pmc193646;;12952525;;12361907;;10.1016/s0302-2838(02)00324-x,"Alberts et al. (Molecular Biology of the Cell, 3rd edition, 1994, page 465);;Greenbaum et al. (Genome Biology, 2003, Vol. 4, Issue 9, pages 117.1-117.8);;Lichtinghagen et al (European Urology, 2002, 42:398-406)",ACTIVE
496,CA,A,CA 93907 A,049-785-131-642-558,1905-06-27,1905,CA 93907D A,1905-04-17,CA 93907T A,1905-04-17,LUBRICATOR,,MICHIGAN LUBRICATOR COMPANY;;DAVIDSON ROBERT;;WOLCOTT GEORGE M;;BRYANT WILLIAM E,DAVIDSON ROBERT;;WOLCOTT GEORGE M;;BRYANT WILLIAM E,,https://lens.org/049-785-131-642-558,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
497,CS,B2,CS 275462 B2,075-185-416-479-890,1992-02-19,1992,CS 643086 A,1986-09-04,US 77285985 A,1985-09-05,METHOD OF ALDEHYDE PREPARATION BY MEANS OF HYDROFORMYLATION,,UNION CARBIDE CORP,BILLIG ERNST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/075-185-416-479-890,Granted Patent,no,0,0,44,44,0,B01J31/185;;B01J31/20;;B01J2231/321;;B01J2531/0266;;B01J2531/80;;B01J2531/822;;C07C45/50;;Y02P20/582;;C07C47/02;;B01J31/22;;C07C45/50;;C07C45/50;;B01J31/185;;B01J2531/0266;;B01J2231/321;;B01J2531/80;;B01J31/20;;B01J2531/822;;Y02P20/582,C07C47/02;;B01J31/00;;B01J31/18;;B01J31/20;;B01J31/22;;C07B61/00;;C07C45/00;;C07C45/50;;C07C67/00,,0,0,,,,EXPIRED
498,AT,T1,AT E76054 T1,110-324-655-041-014,1992-05-15,1992,AT 86112257 T,1986-09-04,EP 86112257 A;;US 77285985 A,1985-09-05,DURCH UEBERGANGSMETALLKOMPLEXE KATALYSIERTE HERSTELLUNGSVERFAHREN.,,UNION CARBIDE CORP,BILLIG ERNST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/110-324-655-041-014,Granted Patent,no,0,0,44,44,0,B01J31/185;;B01J31/20;;B01J2231/321;;B01J2531/0266;;B01J2531/80;;B01J2531/822;;C07C45/50;;Y02P20/582;;C07C47/02;;B01J31/22;;C07C45/50;;C07C45/50;;B01J31/185;;B01J2531/0266;;B01J2231/321;;B01J2531/80;;B01J31/20;;B01J2531/822;;Y02P20/582,C07C47/02;;B01J31/00;;B01J31/18;;B01J31/20;;B01J31/22;;C07B61/00;;C07C45/00;;C07C45/50;;C07C67/00,,0,0,,,,DISCONTINUED
499,US,A1,US 2008/0064055 A1,105-599-748-248-841,2008-03-13,2008,US 89121307 A,2007-08-09,US 89121307 A;;US 83676406 P,2006-08-10,"Methods for the identification, assessment, and treatment of patients with cancer therapy","The present invention is directed to the identification of predictive markers that can be used to determine whether patients with cancer are expected to demonstrate long term or short term survival times. In particular, the present invention is directed to the use of certain individual and/or combinations of predictive markers, wherein the expression of the predictive markers correlates with expected short term or long term survival. Thus, by examining the expression levels of individual predictive markers and/or predictive markers comprising a marker set, it is possible to determine predicted patient survival.",MILLENNIUM PHARM INC,BRYANT BARBARA M;;DAMOKOSH ANDREW I;;MULLIGAN GEORGE,MILLENNIUM PHARMACEUTICALS INC (2007-08-29),https://lens.org/105-599-748-248-841,Patent Application,yes,5,30,13,13,0,A61P35/00;;C12Q1/6886;;C12Q1/6886;;C12Q2600/106;;C12Q2600/106;;C12Q2600/158;;C12Q2600/158;;G01N33/57484;;G01N33/57484,C12Q1/02;;G01N33/574,435/29;;436/64,6,6,068-347-251-634-228;;021-456-993-936-150;;072-682-234-344-010;;034-134-907-055-024;;035-934-547-101-796;;020-780-193-085-309,10.1016/s0002-9440(10)63645-0;;pmc1868162;;12819026;;12949957;;10.1002/cyto.b.10025;;10.1158/0008-5472.can-03-2144;;14729608;;1563002;;12360412;;10.1038/sj.onc.1205868;;10.1056/nejmoa043445;;15958804,"Hansel et al (Am J Pathol, 2003, 163(1): 217-229);;Kern et al (Cytometry Part B Clin Cytom, 2003, 55(1): 29-36);;Ginos et al (Cancer Res, 2004, 64: 55-63);;Tockman et al (Cancer Res., 1992, 52:2711s-2718s);;De Vos et al (Oncogene, 2002, 21(44): 6848-6857);;Richardson et al (NEJM, 2005, 352(24): 2487-2498)",ACTIVE
500,US,A1,US 2016/0312309 A1,107-473-012-826-708,2016-10-27,2016,US 201615205066 A,2016-07-08,US 201615205066 A;;US 45494409 A;;US 13035108 P,2008-05-30,ASSESSMENT OF CHROMOSOMAL ALTERATIONS TO PREDICT CLINICAL OUTCOME OF BORTEZOMIB TREATMENT,"Disclosed herein are chromosomal loci associated with clinical outcome to treatment for multiple myeloma. Genome-wide changes observed in myeloma relate to prognosis and treatment response to a proteasome inhibitor. Compositions and methods are provided to assess DNA copy number at corresponding to markers of loci and genes found thereon which are amplified or deleted, overexpressed or underexpressed in myeloma tumors to predict response to treatment, time-to-progression and survival upon treatment.",MILLENNIUM PHARM INC,BRYANT BARBARA M;;DANAEE HADI;;MULLIGAN GEORGE J,MILLENNIUM PHARMACEUTICALS INC (2009-07-10),https://lens.org/107-473-012-826-708,Patent Application,yes,2,1,5,5,86,C12Q1/6883;;C12Q2600/156;;G01N33/57407;;G01N33/57426;;G01N2800/52;;G01N2800/60;;C12Q2600/106;;C12Q2600/112;;C12Q2600/136;;C12Q2600/158;;C12Q2600/106;;C12Q2600/158;;G01N33/57407;;C12Q1/6883;;G01N2800/52;;C12Q2600/156;;G01N2800/60;;G01N33/57426;;C12Q2600/136;;C12Q2600/112;;C12Q1/6886;;C12Q2600/118,C12Q1/68,,5,1,038-930-586-498-272,10675753;;10.1016/s0022-1759(99)00199-4,"Gene locus (https://genecards.weizmann.ac.il/geneloc-bin/display_map.pl?chr_nr=1&range_type=gc_id&gc_id=GC01M077088#GC01M077088, downloaded 12/2/2017);;Tai (Journal of immunological methods (2000) volume 235, pages 11-19).;;Gene locus (https://genecards.weizmann.ac.il/geneloc-bin/display_map.pl?chr_nr=1&range_type=gc_id&gc_id=GC01M077088#GC01M077088, downloaded 12/2/2017);;Net affymetrix AK5 (https://www.affymetrix.com/analysis/netaffx/fullrecord.affx?pk=HG-U133B:222862_S_AT, downloaded 12/3/201 7);;Netaffymetrix ZZZ3 (https://www.affymetrix.com/analysis/netaffx/fullrecord.affx?pk=HG-U133A:212893_AT, downloaded 2/3/2017)",DISCONTINUED
501,NO,B,NO 174622 B,138-024-773-951-280,1994-02-28,1994,NO 904906 A,1990-11-12,NO 904906 A;;NO 863547 A;;US 77289185 A,1985-09-05,Fremgangsmaate for karbonylering,,UNION CARBIDE CORP,BILLIG ERNST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/138-024-773-951-280,Unknown,no,0,0,4,54,0,,B01J31/18;;C07C/;;C07C45/50;;C07C47/02;;C07F9/141,,0,0,,,,EXPIRED
502,MX,B,MX 164384 B,151-876-624-480-818,1992-08-10,1992,MX 365486 A,1986-09-04,US 77285985 A,1985-09-05,PROCEDIMIENTOS CATALIZADOS CON COMPLEJO DE METAL DE TRANSICION,,UNION CARBIDE CORP,BILLIG ERNST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/151-876-624-480-818,Granted Patent,no,0,0,44,44,0,B01J31/185;;B01J31/20;;B01J2231/321;;B01J2531/0266;;B01J2531/80;;B01J2531/822;;C07C45/50;;Y02P20/582;;C07C47/02;;B01J31/22;;C07C45/50;;C07C45/50;;B01J31/185;;B01J2531/0266;;B01J2231/321;;B01J2531/80;;B01J31/20;;B01J2531/822;;Y02P20/582,B01J31/00;;B01J31/18;;C07C47/02;;B01J31/20;;B01J31/22;;C07B61/00;;C07C45/00;;C07C45/50;;C07C67/00,,0,0,,,,EXPIRED
503,DE,D1,DE 3685276 D1,046-652-411-336-442,1992-06-17,1992,DE 3685276 T,1986-09-04,US 77285985 A,1985-09-05,DURCH UEBERGANGSMETALLKOMPLEXE KATALYSIERTE HERSTELLUNGSVERFAHREN.,,UNION CARBIDE CORP,BILLIG ERNST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/046-652-411-336-442,Granted Patent,no,0,0,44,44,0,B01J31/185;;B01J31/20;;B01J2231/321;;B01J2531/0266;;B01J2531/80;;B01J2531/822;;C07C45/50;;Y02P20/582;;C07C47/02;;B01J31/22;;C07C45/50;;C07C45/50;;B01J31/185;;B01J2531/0266;;B01J2231/321;;B01J2531/80;;B01J31/20;;B01J2531/822;;Y02P20/582,B01J31/00;;B01J31/18;;B01J31/20;;C07C47/02;;B01J31/22;;C07B61/00;;C07C45/00;;C07C45/50;;C07C67/00,,0,0,,,,EXPIRED
504,WO,A1,WO 2011/008343 A1,052-257-973-864-447,2011-01-20,2011,US 2010/0035889 W,2010-05-22,US 22662809 P;;US 70593710 A,2009-07-17,METHODS FOR INHIBITING POLYMERIZATION OF VINYL AROMATIC COMPOUNDS DURING EXTRACTIVE DISTILLATION,"High temperatures and oxygen exposure during extractive distillation can result in polymerization of vinyl aromatic compounds. In various embodiments, the present disclosure relates to methods for inhibiting polymerization of vinyl aromatic compounds during extractive distillation. In various embodiments, the methods include a) providing a mixture containing at least one vinyl aromatic compound, b) adding at least one dinitrophenol inhibitor to the mixture, and c) after step b), performing an extractive distillation on the mixture to isolate the at least one vinyl aromatic compound. Purified styrene can be isolated by the methods described herein. In some embodiments, the dinitrophenol inhibitor is 2-sec-butyl-4,6-dinitrophenol (DNBP).",GTC TECHNOLOGY US LLC;;SEALEY AMY;;BALL GEORGE A;;SLIMP B BRYANT,SEALEY AMY;;BALL GEORGE A;;SLIMP B BRYANT,,https://lens.org/052-257-973-864-447,Patent Application,yes,9,0,14,14,0,C07C7/08;;C07C7/20;;B01D3/00;;B01D3/34;;B01D3/40;;C07C7/08;;C07C7/20;;C07C15/46;;C07C7/08;;C07C7/20,C07C7/20;;B01D3/34,,0,0,,,,PENDING
505,AT,T1,AT E64739 T1,055-378-699-306-185,1991-07-15,1991,AT 86112256 T,1986-09-04,EP 86112256 A;;US 77289185 A,1985-09-05,BIS-PHOSPHIT-VERBINDUNGEN.,,UNION CARBIDE CORP,BILLIG ERNST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/055-378-699-306-185,Granted Patent,no,0,0,48,54,0,C07C45/50;;C07F9/65744;;C07F9/6578;;C07F15/008;;Y02P20/582;;C07F11/00;;C07F9/10;;C07F15/008;;C07F9/6578;;C07C45/50;;C07F9/65744;;Y02P20/582,B01J31/24;;B01J31/00;;B01J31/22;;C07B41/06;;C07B61/00;;C07C45/00;;C07C45/50;;C07C47/02;;C07C47/042;;C07C67/00;;C07F9/09;;C07F9/145;;C07F9/6574;;C07F9/6578;;C07F15/00,,0,0,,,,DISCONTINUED
506,US,B1,US 10803464 B1,068-176-326-600-820,2020-10-13,2020,US 201916519463 A,2019-07-23,US 201916519463 A,2019-07-23,Crowdsourced annotation and tagging system for digital transactions,"A system for crowdsourcing annotations for transactions includes a crowdsourcing annotation database and a processor. The database stores crowdsourced annotations associated with merchants. The crowdsourced annotations are shared among, and contributed by, users of a community. The processor receives transaction data for a transaction by a user with a merchant. Relevant crowdsourced annotations associated with the merchant are retrieved from the database and sent to the user to enable to the user to annotate the transaction. The user provides an annotation for the transaction. The system dynamically updates the database based on the annotation provided by the user.",CAPITAL ONE SERVICES LLC,YEE BRYANT;;BULGAKOV MYKHAYLO;;BERGERON IV GEORGE LEON,CAPITAL ONE SERVICES LLC (2019-07-22),https://lens.org/068-176-326-600-820,Granted Patent,yes,2,2,3,6,0,G06Q20/0425;;G06F40/169;;G06Q10/101;;G06Q30/0185;;G06Q30/06;;G06Q40/02;;G06Q20/42;;G06Q20/0425;;G06F40/169,G06Q40/00;;G06F40/169;;G06Q20/04;;G06Q20/42,,0,0,,,,ACTIVE
507,NO,D0,NO 863547 D0,081-807-739-919-433,1986-09-04,1986,NO 863547 A,1986-09-04,US 77289185 A,1985-09-05,BIS-FOSFITTFORBINDELSER OG ANVENDELSE DERAV VED KARBONYLERING.,,UNION CARBIDE CORP,BILLING ERNST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/081-807-739-919-433,Patent Application,no,0,0,48,54,0,C07C45/50;;C07F9/65744;;C07F9/6578;;C07F15/008;;Y02P20/582;;C07F11/00;;C07F9/10;;C07F15/008;;C07F9/6578;;C07C45/50;;C07F9/65744;;Y02P20/582,B01J31/00;;B01J31/24;;B01J31/22;;C07B41/06;;C07B61/00;;C07C45/00;;C07C45/50;;C07C47/02;;C07C47/042;;C07C67/00;;C07F9/09;;C07F9/145;;C07F9/6574;;C07F9/6578;;C07F15/00,,0,0,,,,EXPIRED
508,NO,D0,NO 904906 D0,115-814-094-168-587,1990-11-12,1990,NO 904906 A,1990-11-12,NO 904906 A;;NO 863547 A;;US 77289185 A,1985-09-05,FREMGANGSMAATE FOR KARBONYLERING.,,UNION CARBIDE CORP,BILLIG ERNST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/115-814-094-168-587,Patent Application,no,0,0,4,54,0,,B01J31/18;;C07C/;;C07C45/50;;C07C47/02;;C07F9/141,,0,0,,,,EXPIRED
509,BR,A,BR 8604261 A,109-801-472-180-891,1987-05-05,1987,BR 8604261 A,1986-09-04,US 77285985 A,1985-09-05,PROCESSO PARA CARBONILACAO;PROCESSO DE HIDROFORMILACAO PARA A PRODUCAO DE ALDEIDOS;COMPOSICAO PRECURSORA DE CATALISADOR DE HIDROFORMILACAO,,UNION CARBIDE CORP,BILLIG ERNST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/109-801-472-180-891,Patent Application,no,0,0,44,44,0,B01J31/185;;B01J31/20;;B01J2231/321;;B01J2531/0266;;B01J2531/80;;B01J2531/822;;C07C45/50;;Y02P20/582;;C07C47/02;;B01J31/22;;C07C45/50;;C07C45/50;;B01J31/185;;B01J2531/0266;;B01J2231/321;;B01J2531/80;;B01J31/20;;B01J2531/822;;Y02P20/582,C07C47/02;;B01J31/00;;B01J31/18;;B01J31/20;;B01J31/22;;C07B61/00;;C07C45/00;;C07C45/50;;C07C67/00,,0,0,,,,EXPIRED
510,EP,A3,EP 0214622 A3,133-043-087-487-942,1988-05-18,1988,EP 86112257 A,1986-09-04,US 77285985 A,1985-09-05,TRANSITION METAL COMPLEX CATALYZED PROCESSES,"Transition metal-poly-phosphite complex catalyzed carbonylation processes, especially hydroformylation, as well as transition metal-poly-phosphite ligand complex compositions.",UNION CARBIDE CORPORATION,"BILLIG, ERNST;;ABATJOGLOU, ANTHONY GEORGE;;BRYANT, DAVID ROBERT",,https://lens.org/133-043-087-487-942,Search Report,yes,5,0,44,44,0,B01J31/185;;B01J31/20;;B01J2231/321;;B01J2531/0266;;B01J2531/80;;B01J2531/822;;C07C45/50;;Y02P20/582;;C07C47/02;;B01J31/22;;C07C45/50;;C07C45/50;;B01J31/185;;B01J2531/0266;;B01J2231/321;;B01J2531/80;;B01J31/20;;B01J2531/822;;Y02P20/582,B01J31/00;;B01J31/18;;B01J31/20;;C07C47/02;;B01J31/22;;C07B61/00;;C07C45/00;;C07C45/50;;C07C67/00,,0,0,,,,EXPIRED
511,ZA,B,ZA 866729 B,136-595-594-022-458,1987-04-29,1987,ZA 866729 A,1986-09-04,US 77289185 A,1985-09-05,BIS-PHOSPHITE COMPOUNDS,,UNION CARBIDE CORP,BILLIG ERNST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/136-595-594-022-458,Granted Patent,no,0,0,48,54,0,C07C45/50;;C07F9/65744;;C07F9/6578;;C07F15/008;;Y02P20/582;;C07F11/00;;C07F9/10;;C07F15/008;;C07F9/6578;;C07C45/50;;C07F9/65744;;Y02P20/582,B01J31/00;;B01J31/22;;B01J31/24;;C07B41/06;;C07B61/00;;C07C45/00;;C07C45/50;;C07C47/02;;C07C47/042;;C07C67/00;;C07F9/09;;C07F9/145;;C07F9/6574;;C07F9/6578;;C07F15/00,,0,0,,,,EXPIRED
512,JP,A,JP 2011239792 A,176-593-968-773-777,2011-12-01,2011,JP 2011193341 A,2011-09-05,US 68863405 P,2005-06-08,"METHOD FOR IDENTIFICATION, ASSESSMENT, AND TREATMENT OF PATIENT WITH CANCER THERAPY","PROBLEM TO BE SOLVED: To provide an identification of predictive markers that can be used to determine whether patients with cancer are clinically responsive or non-responsive to a therapeutic regimen prior to treatment.SOLUTION: The present invention particularly relates to the use of certain individual and/or combinations of predictive markers, wherein the expression of the predictive markers correlates with responsiveness or non-responsiveness to a therapeutic regimen. Thus, by examining the expression levels of individual predictive markers and/or predictive markers comprising a marker set, it can be determined whether a therapeutic agent, or combination of agents, will be most likely to reduce the growth rate of tumors in a clinical setting.",MILLENNIUM PHARM INC,BRYANT BARBARA M;;DAMOKOSH ANDREW I;;MULLIGAN GEORGE,,https://lens.org/176-593-968-773-777,Patent Application,no,0,0,22,22,0,C12Q2600/106;;C12Q2600/136;;G01N33/57407;;G01N33/57415;;G01N33/57419;;G01N33/57423;;G01N33/57434;;G01N33/57438;;G01N33/57449;;G01N2800/44;;G16B25/00;;G16B40/00;;A61K31/69;;C12Q1/6886;;A61P35/00;;A61P35/02;;G16H10/40;;G16H20/40;;Y02A90/10;;G16B40/10;;G16B25/10;;G16B25/00;;G16B40/00;;C12Q2600/106;;C12Q2600/136;;G01N33/57407;;G01N33/57415;;G01N33/57419;;G01N33/57423;;G01N33/57434;;G01N33/57438;;G01N33/57449;;G01N2800/44;;Y02A90/10;;G16H10/40;;G16H20/40;;G16B40/10;;G16B25/10;;C12Q1/6886;;A61K31/69;;C12Q2600/158;;G01N33/57426;;G06Q20/40,C12Q1/68;;C12N15/09;;G01N33/574;;G06Q50/00;;G16B25/10;;G16B40/10,,6,0,,,"JPN6014041895; Ｇｒａｅｍｅ Ｉ． ｅｔ ａｌ．: 'Ｔｕｍｏｒ-ｓｐｅｃｉｆｉｃ Ｅｘｐｒｅｓｓｉｏｎ ｏｆ Ｃｙｔｏｃｈｒｏｍｅ Ｐ４５０ ＣＹＰ１Ｂ１' ＣＡＮＣＥＲ ＲＥＳＥＡＲＣＨ Ｖｏｌ．５７， Ｎｏ．１４, 19970715, Ｐ．３０２６-３０３１;;JPN6014041896; Ｍｏｒａｇ Ｃ． Ｅ． ＭＣＦＡＤＹＥＮ ｅｔ ａｌ．: 'Ｃｙｔｏｃｈｒｏｍｅ Ｐ４５０ ＣＹＰ１Ｂ１ ｐｒｏｔｅｉｎ ｅｘｐｒｅｓｓｉｏｎ： Ａ ｎｏｖｅｌ ｍｅｃｈａｎｉｓｍ ｏｆ ａｎｔｉｃａｎｃｅｒ ｄｒｕｇ ｒｅｓｉｓｔａｎｃｅ' Ｂｉｏｃｈｅｍ Ｐｈａｒｍａｃｏｌ Ｖｏｌ．６２， Ｎｏ．２, 20010715, Ｐａｇｅ．２０７-２１２;;JPN6014041897; 大川清ほか: 'プロテアソーム阻害剤耐性株の性格と抗癌剤感受性の検討' 日本癌学会総会記事 Ｖｏｌ．６３ｒｄ, 20040825, Ｐａｇｅ．１９１;;JPN6014041895; Ｇｒａｅｍｅ Ｉ． ｅｔ ａｌ．: 'Ｔｕｍｏｒ-ｓｐｅｃｉｆｉｃ Ｅｘｐｒｅｓｓｉｏｎ ｏｆ Ｃｙｔｏｃｈｒｏｍｅ Ｐ４５０ ＣＹＰ１Ｂ１' ＣＡＮＣＥＲ ＲＥＳＥＡＲＣＨ Ｖｏｌ．５７， Ｎｏ．１４, 19970715, Ｐ．３０２６-３０３１;;JPN6014041896; Ｍｏｒａｇ Ｃ． Ｅ． ＭＣＦＡＤＹＥＮ ｅｔ ａｌ．: 'Ｃｙｔｏｃｈｒｏｍｅ Ｐ４５０ ＣＹＰ１Ｂ１ ｐｒｏｔｅｉｎ ｅｘｐｒｅｓｓｉｏｎ： Ａ ｎｏｖｅｌ ｍｅｃｈａｎｉｓｍ ｏｆ ａｎｔｉｃａｎｃｅｒ ｄｒｕｇ ｒｅｓｉｓｔａｎｃｅ' Ｂｉｏｃｈｅｍ Ｐｈａｒｍａｃｏｌ Ｖｏｌ．６２， Ｎｏ．２, 20010715, Ｐａｇｅ．２０７-２１２;;JPN6014041897; 大川清ほか: 'プロテアソーム阻害剤耐性株の性格と抗癌剤感受性の検討' 日本癌学会総会記事 Ｖｏｌ．６３ｒｄ, 20040825, Ｐａｇｅ．１９１",INACTIVE
513,WO,A9,WO 2008/021183 A9,012-244-836-766-978,2008-07-24,2008,US 2007/0017716 W,2007-08-09,US 83676406 P,2006-08-10,"FOR THE IDENTIFICATION, ASSESSMENT, AND TREATMENT OF PATIENTS WITH CANCER THERAPY","The present invention is directed to the identification of predictive markers that can be used to determine whether patients with cancer are expected to demonstrate long term or short term survival times. In particular, the present invention is directed to the use of certain individual and/or combinations of predictive markers, wherein the expression of the predictive markers correlates with expected short term or long term survival. Thus, by examining the expression levels of individual predictive markers and/or predictive markers comprising a marker set, it is possible to determine predicted patient survival.",MILLENNIUM PHARM INC;;BRYANT BARBARA M;;DAMOKOSH ANDREW I;;MULLIGAN GEORGE,BRYANT BARBARA M;;DAMOKOSH ANDREW I;;MULLIGAN GEORGE,,https://lens.org/012-244-836-766-978,Patent Application,no,0,0,13,13,0,A61P35/00;;C12Q1/6886;;C12Q1/6886;;C12Q2600/106;;C12Q2600/106;;C12Q2600/158;;C12Q2600/158;;G01N33/57484;;G01N33/57484,C12Q1/02;;G01N33/574,,0,0,,,,PENDING
514,DK,D0,DK 423086 D0,078-946-098-504-423,1986-09-04,1986,DK 423086 A,1986-09-04,US 77289185 A,1985-09-05,OVERGANGSMETAL-BIS-PHOSPHIT-KATALYSATORER OG DERES ANVENDELSE,,UNION CARBIDE CORP,BILLIG ERNST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/078-946-098-504-423,Patent Application,no,0,0,48,54,0,C07C45/50;;C07F9/65744;;C07F9/6578;;C07F15/008;;Y02P20/582;;C07F11/00;;C07F9/10;;C07F15/008;;C07F9/6578;;C07C45/50;;C07F9/65744;;Y02P20/582,B01J31/00;;B01J31/22;;C07B41/06;;B01J31/24;;C07B61/00;;C07C45/00;;C07C45/50;;C07C47/02;;C07C47/042;;C07C67/00;;C07F9/09;;C07F9/145;;C07F9/6574;;C07F9/6578;;C07F15/00,,0,0,,,,DISCONTINUED
515,WO,A3,WO 2006/133420 A3,084-415-807-236-439,2008-01-17,2008,US 2006/0022515 W,2006-06-08,US 68863405 P,2005-06-08,TREATMENT OF PATIENTS WITH CANCER THERAPY,"The present invention is directed to the identification of predictive markers that can be used to determine whether patients with cancer are clinically responsive or non-responsive to a therapeutic regimen prior to treatment. In particular, the present invention is directed to the use of certain individual and/or combinations of predictive markers, wherein the expression of the predictive markers correlates with responsiveness or non-responsiveness to a therapeutic regimen. Thus, by examining the expression levels of individual predictive markers and/or predictive markers comprising a marker set, it is possible to determine whether a therapeutic agent, or combination of agents, will be most likely to reduce the growth rate of tumors in a clinical setting.",MILLENNIUM PHARM INC;;BRYANT BARBARA M;;DAMOKOSH ANDREW I;;MULLIGAN GEORGE,BRYANT BARBARA M;;DAMOKOSH ANDREW I;;MULLIGAN GEORGE,,https://lens.org/084-415-807-236-439,Search Report,yes,0,0,22,22,0,C12Q2600/106;;C12Q2600/136;;G01N33/57407;;G01N33/57415;;G01N33/57419;;G01N33/57423;;G01N33/57434;;G01N33/57438;;G01N33/57449;;G01N2800/44;;G16B25/00;;G16B40/00;;A61K31/69;;C12Q1/6886;;A61P35/00;;A61P35/02;;G16H10/40;;G16H20/40;;Y02A90/10;;G16B40/10;;G16B25/10;;G16B25/00;;G16B40/00;;C12Q2600/106;;C12Q2600/136;;G01N33/57407;;G01N33/57415;;G01N33/57419;;G01N33/57423;;G01N33/57434;;G01N33/57438;;G01N33/57449;;G01N2800/44;;Y02A90/10;;G16H10/40;;G16H20/40;;G16B40/10;;G16B25/10;;C12Q1/6886;;A61K31/69;;C12Q2600/158;;G01N33/57426;;G06Q20/40,C12Q1/68;;G06Q50/00;;G16B25/10;;G16B40/10,,1,1,007-342-077-503-496,8159770;;10.1073/pnas.91.8.3463;;pmc43597,"TOCZYSKI D.P. ET AL: ""The Epstein-Barr Virus (EBV) Small RNA EBER1 Binds and Relocalizes Ribosomal Protein L22 in EBV-Infected Human B Lymphocytes"", PNAS, vol. 91, no. 8, 12 April 1994 (1994-04-12), pages 3463 - 3467, XP003022430",PENDING
516,NO,B,NO 172494 B,072-339-656-088-434,1993-04-19,1993,NO 863547 A,1986-09-04,US 77289185 A,1985-09-05,BIS-FOSFITT-LIGANDER,,UNION CARBIDE CORP,BILLIG ERNST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/072-339-656-088-434,Unknown,no,0,0,48,54,0,C07C45/50;;C07F9/65744;;C07F9/6578;;C07F15/008;;Y02P20/582;;C07F11/00;;C07F9/10;;C07F15/008;;C07F9/6578;;C07C45/50;;C07F9/65744;;Y02P20/582,B01J31/00;;B01J31/22;;C07B41/06;;B01J31/24;;C07B61/00;;C07C45/00;;C07C45/50;;C07C47/02;;C07C47/042;;C07C67/00;;C07F9/09;;C07F9/145;;C07F9/6574;;C07F9/6578;;C07F15/00,,0,0,,,,EXPIRED
517,CN,C,CN 1021202 C,124-912-712-697-941,1993-06-16,1993,CN 89107465 A,1989-09-19,US 77285985 A,1985-09-05,TRANSITION METAL COMPLEX CATALYGED PRECURSOR COMPOSITION,,UNITED CARBIDE CORP,BILLIG ERNST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBBERT,,https://lens.org/124-912-712-697-941,Granted Patent,no,0,0,44,44,0,B01J31/185;;B01J31/20;;B01J2231/321;;B01J2531/0266;;B01J2531/80;;B01J2531/822;;C07C45/50;;Y02P20/582;;C07C47/02;;B01J31/22;;C07C45/50;;C07C45/50;;B01J31/185;;B01J2531/0266;;B01J2231/321;;B01J2531/80;;B01J31/20;;B01J2531/822;;Y02P20/582,C07C47/02;;B01J31/00;;B01J31/18;;B01J31/20;;B01J31/22;;C07B61/00;;C07C45/00;;C07C45/50;;C07C67/00,,0,0,,,,EXPIRED
518,NO,D0,NO 863546 D0,162-084-423-965-417,1986-09-04,1986,NO 863546 A,1986-09-04,US 77285985 A,1985-09-05,FREMGANGSMAATE FOR KARBONYLERING AV EN ORGANISK FORBINDELSE,,UNION CARBIDE CORP,BILLING ERNST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/162-084-423-965-417,Patent Application,no,0,0,44,44,0,B01J31/185;;B01J31/20;;B01J2231/321;;B01J2531/0266;;B01J2531/80;;B01J2531/822;;C07C45/50;;Y02P20/582;;C07C47/02;;B01J31/22;;C07C45/50;;C07C45/50;;B01J31/185;;B01J2531/0266;;B01J2231/321;;B01J2531/80;;B01J31/20;;B01J2531/822;;Y02P20/582,B01J31/00;;C07C47/02;;B01J31/18;;B01J31/20;;B01J31/22;;C07B61/00;;C07C45/00;;C07C45/50;;C07C67/00,,0,0,,,,EXPIRED
519,AU,A1,AU 2007/284724 A1,170-972-211-118-860,2008-02-21,2008,AU 2007/284724 A,2007-08-09,US 83676406 P;;US 2007/0017716 W,2006-08-10,"For the identification, assessment, and treatment of patients with cancer therapy",,MILLENNIUM PHARM INC,BRYANT BARBARA M;;MULLIGAN GEORGE;;DAMOKOSH ANDREW I,,https://lens.org/170-972-211-118-860,Patent Application,no,0,0,13,13,0,A61P35/00;;C12Q1/6886;;C12Q1/6886;;C12Q2600/106;;C12Q2600/106;;C12Q2600/158;;C12Q2600/158;;G01N33/57484;;G01N33/57484,C12Q1/02;;G01N33/574,,0,0,,,,INACTIVE
520,US,A,US 2795704 A,029-777-768-716-221,1957-06-11,1957,US 42354754 A,1954-04-15,US 42354754 A,1954-04-15,Neutron ion chamber,,HARRY BRYANT;;ERICKSON GEORGE F;;KAUFMANN STEFAN G,HARRY BRYANT;;ERICKSON GEORGE F;;KAUFMANN STEFAN G,,https://lens.org/029-777-768-716-221,Granted Patent,no,3,6,1,1,0,H01J47/12;;H01J47/12,H01J47/12,,0,0,,,,EXPIRED
521,EP,A4,EP 2453999 A4,049-058-733-416-944,2013-01-23,2013,EP 10800200 A,2010-05-22,US 2010/0035889 W;;US 22662809 P;;US 70593710 A,2009-07-17,METHODS FOR INHIBITING POLYMERIZATION OF VINYL AROMATIC COMPOUNDS DURING EXTRACTIVE DISTILLATION,,GTC TECHNOLOGY US LLC,SEALEY AMY;;BALL GEORGE A;;SLIMP B BRYANT,,https://lens.org/049-058-733-416-944,Search Report,no,1,0,14,14,0,C07C7/08;;C07C7/20;;B01D3/00;;B01D3/34;;B01D3/40;;C07C7/08;;C07C7/20;;C07C15/46;;C07C7/08;;C07C7/20,B01D3/34;;C07C7/08;;C07C7/20,,0,0,,,,DISCONTINUED
522,BR,A2,BR 112012001138 A2,145-166-128-958-161,2016-02-23,2016,BR 112012001138 A,2010-05-22,US 2010/0035889 W;;US 22662809 P;;US 70593710 A,2009-07-17,método para inibir polimerização de compostos vnilaromáticos durante a destilação extrativa,,GTC TECHNOLOGY US LLC,SEALEY AMY;;SLIMP B BRYANT;;BALL GEORGE A,,https://lens.org/145-166-128-958-161,Patent Application,no,0,0,14,14,0,C07C7/08;;C07C7/20;;B01D3/00;;B01D3/34;;B01D3/40;;C07C7/08;;C07C7/20;;C07C15/46;;C07C7/08;;C07C7/20,B01D3/34;;C07C7/20,,0,0,,,,DISCONTINUED
523,EP,A1,EP 2453999 A1,184-505-969-274-571,2012-05-23,2012,EP 10800200 A,2010-05-22,US 2010/0035889 W;;US 22662809 P;;US 70593710 A,2009-07-17,METHODS FOR INHIBITING POLYMERIZATION OF VINYL AROMATIC COMPOUNDS DURING EXTRACTIVE DISTILLATION,,GTC TECHNOLOGY US LLC,SEALEY AMY;;BALL GEORGE A;;SLIMP B BRYANT,,https://lens.org/184-505-969-274-571,Patent Application,yes,0,0,14,14,0,C07C7/08;;C07C7/20;;B01D3/00;;B01D3/34;;B01D3/40;;C07C7/08;;C07C7/20;;C07C15/46;;C07C7/08;;C07C7/20,B01D3/34;;C07C7/08;;C07C7/20,,0,0,,,,DISCONTINUED
524,US,A,US 783718 A,176-592-061-038-091,1905-02-28,1905,US 1904/0219475 A,1904-08-04,US 1904/0219475 A,1904-08-04,SIGHT-FEED LUBRICATOR.,,MICHIGAN LUBRICATOR COMPANY,BRYANT WILLIAM E;;DAVIDSON ROBERT;;WOLCOTT GEORGE M,,https://lens.org/176-592-061-038-091,Granted Patent,no,0,0,1,1,0,F16N7/30;;F16N7/30,,,0,0,,,,EXPIRED
525,US,A,US 783717 A,017-333-072-101-322,1905-02-28,1905,US 1904/0219474 A,1904-08-04,US 1904/0219474 A,1904-08-04,VISIBLE AUXILIARY OILER FOR LUBRICATORS.,,MICHIGAN LUBRICATOR COMPANY,BRYANT WILLIAM E;;DAVIDSON ROBERT;;WOLCOTT GEORGE M,,https://lens.org/017-333-072-101-322,Granted Patent,no,0,0,1,1,0,F16N29/00;;F16N29/00,,,0,0,,,,EXPIRED
526,FI,B,FI 85863 B,075-842-440-430-904,1992-02-28,1992,FI 863569 A,1986-09-04,US 77289185 A,1985-09-05,BIS-FOSFITFOERENINGAR.,,UNION CARBIDE CORP,BILLIG ERNST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/075-842-440-430-904,Patent Application,no,0,0,48,54,0,C07C45/50;;C07F9/65744;;C07F9/6578;;C07F15/008;;Y02P20/582;;C07F11/00;;C07F9/10;;C07F15/008;;C07F9/6578;;C07C45/50;;C07F9/65744;;Y02P20/582,B01J31/00;;B01J31/22;;C07B41/06;;C07B61/00;;B01J31/24;;C07C45/00;;C07C45/50;;C07C47/02;;C07C47/042;;C07C67/00;;C07F9/09;;C07F9/145;;C07F9/6574;;C07F9/6578;;C07F15/00,,0,0,,,,EXPIRED
527,NO,C,NO 167652 C,085-499-271-460-201,1991-11-27,1991,NO 863546 A,1986-09-04,US 77285985 A,1985-09-05,FREMGANGSMAATE FOR FREMSTILLING AV ALDEHYDER VED HYDROFORMYLERING AV OLEFINER SAMT KATALYSATORFORLOEPERBLANDING TIL BRUK VED FREMGANGSMAATEN.,,UNION CARBIDE CORP,BILLIG ERNST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/085-499-271-460-201,Granted Patent,no,0,0,44,44,0,B01J31/185;;B01J31/20;;B01J2231/321;;B01J2531/0266;;B01J2531/80;;B01J2531/822;;C07C45/50;;Y02P20/582;;C07C47/02;;B01J31/22;;C07C45/50;;C07C45/50;;B01J31/185;;B01J2531/0266;;B01J2231/321;;B01J2531/80;;B01J31/20;;B01J2531/822;;Y02P20/582,B01J31/00;;B01J31/18;;B01J31/20;;B01J31/22;;C07B61/00;;C07C47/02;;C07C45/00;;C07C45/50;;C07C67/00,,0,0,,,,EXPIRED
528,JP,A,JP 2016101174 A,127-203-682-723-340,2016-06-02,2016,JP 2016023487 A,2016-02-10,US 68863405 P,2005-06-08,"METHODS FOR IDENTIFICATION, ASSESSMENT, AND TREATMENT OF PATIENTS RECEIVING CANCER THERAPY","PROBLEM TO BE SOLVED: To provide identification of predictive markers that can be used to clinically determine whether patients with cancer are responsive or non-responsive to a therapeutic regimen prior to treatment.SOLUTION: In particular, the present invention is directed to the use of certain individual and/or combinations of predictive markers, where the expression of the predictive markers correlates with responsiveness or non-responsiveness to a therapeutic regimen. Thus, by examining the expression levels of individual predictive markers and/or predictive markers included in a marker set, it is possible to determine whether a therapeutic agent, or a combination of agents, will be most likely to reduce the growth rate of tumors in a clinical setting.SELECTED DRAWING: None",MILLENNIUM PHARM INC,BRYANT BARBARA M;;DAMOKOSH ANDREW I;;MULLIGAN GEORGE,,https://lens.org/127-203-682-723-340,Patent Application,no,0,0,22,22,0,C12Q2600/106;;C12Q2600/136;;G01N33/57407;;G01N33/57415;;G01N33/57419;;G01N33/57423;;G01N33/57434;;G01N33/57438;;G01N33/57449;;G01N2800/44;;G16B25/00;;G16B40/00;;A61K31/69;;C12Q1/6886;;A61P35/00;;A61P35/02;;G16H10/40;;G16H20/40;;Y02A90/10;;G16B40/10;;G16B25/10;;G16B25/00;;G16B40/00;;C12Q2600/106;;C12Q2600/136;;G01N33/57407;;G01N33/57415;;G01N33/57419;;G01N33/57423;;G01N33/57434;;G01N33/57438;;G01N33/57449;;G01N2800/44;;Y02A90/10;;G16H10/40;;G16H20/40;;G16B40/10;;G16B25/10;;C12Q1/6886;;A61K31/69;;C12Q2600/158;;G01N33/57426;;G06Q20/40,C12N15/09;;A61P35/02;;C12M1/00;;C12M1/34;;C12Q1/02;;C12Q1/04;;C12Q1/68;;G01N33/53;;G01N33/574;;G06Q50/00;;G16B25/10;;G16B40/10,,0,0,,,,DISCONTINUED
529,WO,A3,WO 2009/148528 A3,151-502-273-617-571,2010-01-28,2010,US 2009/0003237 W,2009-05-27,US 13035108 P,2008-05-30,ASSESSMENT OF CHROMOSOMAL ALTERATIONS TO PREDICT CLINICAL OUTCOME OF BORTEZOMIB TREATMENT,"Disclosed herein are chromosomal loci associated with clinical outcome to treatment for multiple myeloma. Genome-wide changes observed in myeloma relate to prognosis and treatment response to a proteasome inhibitor. Compositions and methods are provided to assess DNA copy number at corresponding to markers of loci and genes found thereon which are amplified or deleted, overexpressed or underexpressed in myeloma tumors to predict response to treatment, time-to-progression and survival upon treatment.",MILLENNIUM PHARM INC;;BRYANT BARBARA M;;DANAEE HADI;;MULLIGAN GEORGE J,BRYANT BARBARA M;;DANAEE HADI;;MULLIGAN GEORGE J,,https://lens.org/151-502-273-617-571,Search Report,yes,4,0,5,5,0,C12Q1/6883;;C12Q2600/156;;G01N33/57407;;G01N33/57426;;G01N2800/52;;G01N2800/60;;C12Q2600/106;;C12Q2600/112;;C12Q2600/136;;C12Q2600/158;;C12Q2600/106;;C12Q2600/158;;G01N33/57407;;C12Q1/6883;;G01N2800/52;;C12Q2600/156;;G01N2800/60;;G01N33/57426;;C12Q2600/136;;C12Q2600/112;;C12Q1/6886;;C12Q2600/118,C12Q1/68;;G01N33/574,,11,7,001-473-416-117-63X;;123-681-022-734-096;;010-409-170-828-73X;;040-852-843-031-552;;055-139-296-709-897;;082-341-303-374-342;;001-609-346-466-550,10.1016/j.bbrc.2007.03.113;;17418808;;10.1016/s1557-9190(11)70210-4;;10.1182/blood-2006-09-044974;;17185464;;10.3816/clm.2006.n.057;;17229333;;17707122;;10.1016/j.nbd.2007.07.010;;10.1078/0171-9335-00336;;14582536;;15133472;;10.1038/modpathol.3800107,"""GENECHIP HUMAN GENOME ARRAYS - THE MOST COMPREHENSIVE COVERAGE OF ALL WELL-SUBSTANTIATED GENES IN THE HUMAN GENOME"", INTERNET CITATION, 2004, XP002449668, Retrieved from the Internet <URL:http://www.affymetrix.com/support/technical/datasheets/human_datasheet.pdf> [retrieved on 20070101];;CHEN H H ET AL: ""LMO4 mRNA stability is regulated by extracellular ATP in F11 cells"", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, vol. 357, no. 1, 25 May 2007 (2007-05-25), pages 56 - 61, XP026422374, ISSN: 0006-291X, [retrieved on 20070418];;MULLIGAN G ET AL: ""Pharmacogenomics (PGx) research in the APEX randomized multicenter international phase 3 trial comparing bortezomib and high-dose dexamethasone (Dex)."", BLOOD, vol. 106, no. 11, Part 1, November 2005 (2005-11-01), & 47TH ANNUAL MEETING OF THE AMERICAN-SOCIETY-OF-HEMATOLOGY; ATLANTA, GA, USA; DECEMBER 10 -13, 2005, pages 975A, XP002558148, ISSN: 0006-4971;;DANAEE HADI ET AL: ""High-resolution assessment of gains and losses of chromosomes in patients with multiple myeloma treated with bortezomib"", BLOOD, vol. 110, no. 11, Part 2, November 2007 (2007-11-01), & 49TH ANNUAL MEETING OF THE AMERICAN-SOCIETY-OF-HEMATOLOGY; ATLANTA, GA, USA; DECEMBER 08 -11, 2007, pages 264B, XP002548153, ISSN: 0006-4971;;DRACH JOHANNES ET AL: ""Amplification of 1q21 is associated with poor outcome after treatment with bortezomib in relapsed/refractory multiple myeloma."", BLOOD, vol. 108, no. 11, Part 1, November 2006 (2006-11-01), & 48TH ANNUAL MEETING OF THE AMERICAN-SOCIETY-OF-HEMATOLOGY; ORLANDO, FL, USA; DECEMBER 09 -12, 2006, pages 970A - 971A, XP002548154, ISSN: 0006-4971;;DRACH JOHANNES ET AL: ""Short survival, despite promising response rates, after bortezomib treatment of multiple myeloma patients with a 13q-deletion."", BLOOD, vol. 106, no. 11, Part 1, November 2005 (2005-11-01), & 47TH ANNUAL MEETING OF THE AMERICAN-SOCIETY-OF-HEMATOLOGY; ATLANTA, GA, USA; DECEMBER 10 -13, 2005, pages 152A, XP002548155, ISSN: 0006-4971;;MULLIGAN GEORGE ET AL: ""Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib"", BLOOD, vol. 109, no. 8, April 2007 (2007-04-01), pages 3177 - 3188, XP002548156, ISSN: 0006-4971;;WALKER BRIAN A ET AL: ""Use of single nucleotide polymorphism-based mapping arrays to detect copy number changes and loss of heterozygosity in multiple myeloma."", CLINICAL LYMPHOMA & MYELOMA NOV 2006, vol. 7, no. 3, November 2006 (2006-11-01), pages 186 - 191, XP009123373, ISSN: 1557-9190;;WANG ET AL: ""PINK1 mutants associated with recessive Parkinson's disease are defective in inhibiting mitochondrial release of cytochrome c"", NEUROBIOLOGY OF DISEASE, BLACKWELL SCIENTIFIC PUBLICATIONS, OXFORD, GB, vol. 28, no. 2, 24 October 2007 (2007-10-24), pages 216 - 226, XP022313146, ISSN: 0969-9961;;HATTINGER C M ET AL: ""Genomic imbalances associated with methotrexate resistance in human osteosarcoma cell lines detected by comparative genomic hybridization-based techniques"", EUROPEAN JOURNAL OF CELL BIOLOGY, WISSENSCHAFLICHE VERLAGSGESELLSCHAFT, STUTTGART, DE, vol. 82, no. 9, 1 September 2003 (2003-09-01), pages 483 - 493, XP004954496, ISSN: 0171-9335;;HASHIMOTO KIICHIRO ET AL: ""Analysis of DNA copy number aberrations in hepatitis C virus-associated hepatocellular carcinomas by conventional CGH and array CGH"", MODERN PATHOLOGY, vol. 17, no. 6, June 2004 (2004-06-01), pages 617 - 622, XP002558149, ISSN: 0893-3952",PENDING
530,CZ,A3,CZ 843488 A3,189-196-819-275-371,1998-07-15,1998,CS 843488 A,1988-12-19,US 77289185 A,1985-09-05,"BIS-PHOSPHITE LIGAND, HYDROFORMYLATION CATALYST AND PRECURSOR HYDROFORMYLATION CATALYTIC COMPOSITION",,UNION CARBIDE CORP,BILLIG ERNST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/189-196-819-275-371,Patent Application,no,0,0,48,54,0,C07C45/50;;C07F9/65744;;C07F9/6578;;C07F15/008;;Y02P20/582;;C07F11/00;;C07F9/10;;C07F15/008;;C07F9/6578;;C07C45/50;;C07F9/65744;;Y02P20/582,B01J31/24;;B01J31/00;;B01J31/22;;C07B41/06;;C07B61/00;;C07C45/00;;C07C45/50;;C07C47/02;;C07C47/042;;C07C67/00;;C07F9/09;;C07F9/145;;C07F9/6574;;C07F9/6578;;C07F15/00,,0,0,,,,EXPIRED
531,EP,A2,EP 2046973 A2,006-210-706-780-218,2009-04-15,2009,EP 07836670 A,2007-08-09,US 2007/0017716 W;;US 83676406 P,2006-08-10,"FOR THE IDENTIFICATION, ASSESSMENT, AND TREATMENT OF PATIENTS WITH CANCER THERAPY",,MILLENNIUM PHARM INC,BRYANT BARBARA M;;DAMOKOSH ANDREW I;;MULLIGAN GEORGE,,https://lens.org/006-210-706-780-218,Patent Application,yes,0,0,13,13,0,A61P35/00;;C12Q1/6886;;C12Q1/6886;;C12Q2600/106;;C12Q2600/106;;C12Q2600/158;;C12Q2600/158;;G01N33/57484;;G01N33/57484,C12Q1/02;;G01N33/53,,0,0,,,,DISCONTINUED
532,DK,A,DK 423086 A,013-058-629-923-798,1987-03-06,1987,DK 423086 A,1986-09-04,US 77289185 A,1985-09-05,OVERGANGSMETAL-BIS-PHOSPHIT-KATALYSATORER OG DERES ANVENDELSE,,UNION CARBIDE CORP,BILLIG ERNST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/013-058-629-923-798,Patent Application,no,0,0,48,54,0,C07C45/50;;C07F9/65744;;C07F9/6578;;C07F15/008;;Y02P20/582;;C07F11/00;;C07F9/10;;C07F15/008;;C07F9/6578;;C07C45/50;;C07F9/65744;;Y02P20/582,B01J31/00;;B01J31/22;;C07B41/06;;B01J31/24;;C07B61/00;;C07C45/00;;C07C45/50;;C07C47/02;;C07C47/042;;C07C67/00;;C07F9/09;;C07F9/145;;C07F9/6574;;C07F9/6578;;C07F15/00,,0,0,,,,DISCONTINUED
533,AU,A,AU 1986/062373 A,016-742-454-279-055,1987-03-12,1987,AU 1986/062373 A,1986-09-05,US 77285985 A,1985-09-05,TRANSITION METAL COMPLEX CATALYST,,UNION CARBIDE CORP,BILLIG ERNST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/016-742-454-279-055,Patent Application,no,0,0,44,44,0,B01J31/185;;B01J31/20;;B01J2231/321;;B01J2531/0266;;B01J2531/80;;B01J2531/822;;C07C45/50;;Y02P20/582;;C07C47/02;;B01J31/22;;C07C45/50;;C07C45/50;;B01J31/185;;B01J2531/0266;;B01J2231/321;;B01J2531/80;;B01J31/20;;B01J2531/822;;Y02P20/582,C07C47/02;;B01J31/00;;B01J31/18;;B01J31/20;;B01J31/22;;C07B61/00;;C07C45/00;;C07C45/50;;C07C67/00,,0,0,,,,EXPIRED
534,CS,B2,CS 275474 B2,031-217-284-913-84X,1992-02-19,1992,CS 749088 A,1986-09-04,US 77285985 A,1985-09-05,RHODIUM COMPLEX HYDROFORMULATION CATALYTIC PRECURSOR MIXTURE,,UNION CARBIDE CORP,BILLIG ERNST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/031-217-284-913-84X,Granted Patent,no,0,0,44,44,0,B01J31/185;;B01J31/20;;B01J2231/321;;B01J2531/0266;;B01J2531/80;;B01J2531/822;;C07C45/50;;Y02P20/582;;C07C47/02;;B01J31/22;;C07C45/50;;C07C45/50;;B01J31/185;;B01J2531/0266;;B01J2231/321;;B01J2531/80;;B01J31/20;;B01J2531/822;;Y02P20/582,C07C47/02;;B01J31/00;;B01J31/18;;B01J31/20;;B01J31/22;;C07B61/00;;C07C45/00;;C07C45/50;;C07C67/00,,0,0,,,,EXPIRED
535,US,A,US 4153778 A,030-244-899-198-085,1979-05-08,1979,US 89183078 A,1978-03-30,US 89183078 A,1978-03-30,Acrylyl capped urethane oligomers,"The reaction produces of (A) polyoxytetramethylene diols or polycaprolactone polyols, (B) diisocyanates and (C) di- or tri-methylol carboxylic acids are capped with (D) certain defined acrylyl compounds to produce terminally unsaturated oligomers that readily cure by thermal or radiation means to soft, tack-free products. The oligomers can be used as coatings; binders and adhesives.",UNION CARBIDE CORP,PARK KISOON;;BRYANT GEORGE M;;CARR FRAZIER G,,https://lens.org/030-244-899-198-085,Granted Patent,yes,4,49,10,10,0,C08G18/348;;C08G18/348;;C08G18/672;;C08G18/672;;G03F7/038;;G03F7/038,C08F20/00;;C08F20/34;;C08F290/00;;C08F299/00;;C08G18/00;;C08G18/34;;C08G18/67;;G03F7/038,528/76,0,0,,,,EXPIRED
536,AU,B2,AU 597593 B2,027-164-419-397-336,1990-06-07,1990,AU 1986/062373 A,1986-09-05,US 77285985 A,1985-09-05,TRANSITION METAL COMPLEX CATALYST,,UNION CARBIDE CORP,BILLIG ERNST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/027-164-419-397-336,Granted Patent,no,3,0,44,44,0,B01J31/185;;B01J31/20;;B01J2231/321;;B01J2531/0266;;B01J2531/80;;B01J2531/822;;C07C45/50;;Y02P20/582;;C07C47/02;;B01J31/22;;C07C45/50;;C07C45/50;;B01J31/185;;B01J2531/0266;;B01J2231/321;;B01J2531/80;;B01J31/20;;B01J2531/822;;Y02P20/582,C07C47/02;;B01J31/00;;B01J31/18;;B01J31/20;;B01J31/22;;C07B61/00;;C07C45/00;;C07C45/50;;C07C67/00,,0,0,,,,EXPIRED
537,CH,A5,CH 650423 A5,036-561-125-991-239,1985-07-31,1985,CH 798180 A,1980-10-27,US 9021179 A,1979-11-01,GESENKSATZ.,,UNITED TECHNOLOGIES CORP,MAC NITT DONALD GEORGE JUN;;WALKER BRYANT HARDING,,https://lens.org/036-561-125-991-239,Granted Patent,no,0,0,27,27,0,B21J5/02;;B21J9/02;;B21J13/02;;B21K1/36;;B21K29/00;;Y10T29/49488;;Y10T29/49488;;B21J5/02;;B21K1/36;;B21J9/02;;B21J13/02;;B21K29/00,B21J5/02;;B21J9/02;;B21J13/02;;B21K1/36;;B21K3/04,,0,0,,,,EXPIRED
538,FI,B,FI 88916 B,070-490-691-263-065,1993-04-15,1993,FI 863570 A,1986-09-04,US 77285985 A,1985-09-05,HYDROFORMYLERINGSFOERFARANDE FOER FRAMSTAELLNING AV ALDEHYDER SAMT PREKURSORKOMPOSITION FOER DEN VID FOERFARANDE UTNYTTJADE RODIUMKOMPLEXKATALYSATORN,,UNION CARBIDE CORP,BILLIG ERNST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/070-490-691-263-065,Patent Application,no,0,0,44,44,0,B01J31/185;;B01J31/20;;B01J2231/321;;B01J2531/0266;;B01J2531/80;;B01J2531/822;;C07C45/50;;Y02P20/582;;C07C47/02;;B01J31/22;;C07C45/50;;C07C45/50;;B01J31/185;;B01J2531/0266;;B01J2231/321;;B01J2531/80;;B01J31/20;;B01J2531/822;;Y02P20/582,B01J31/00;;B01J31/18;;B01J31/20;;B01J31/22;;C07C47/02;;C07B61/00;;C07C45/00;;C07C45/50;;C07C67/00,,0,0,,,,EXPIRED
539,MX,A,MX 2007015416 A,101-681-450-954-919,2008-02-19,2008,MX 2007015416 A,2006-06-08,US 68863405 P;;US 2006/0022515 W,2005-06-08,"METHODS FOR THE IDENTIFICATION, ASSESSMENT, AND TREATMENT OF PATIENTS WITH CANCER THERAPY.","The present invention is directed to the identification of predictive markers that can be used to determine whether patients with cancer are clinically responsive or non-responsive to a therapeutic regimen prior to treatment. In particular, the present invention is directed to the use of certain individual and/or combinations of predictive markers, wherein the expression of the predictive markers correlates with responsiveness or non-responsiveness to a therapeutic regimen. Thus, by examining the expression levels of individual predictive markers and/or predictive markers comprising a marker set, it is possible to determine whether a therapeutic agent, or combination of agents, will be most likely to reduce the growth rate of tumors in a clinical setting.",MILLENNIUM PHARM INC,MULLIGAN GEORGE;;BRYANT BARBARA M;;DAMOKOSH ANDREW I,,https://lens.org/101-681-450-954-919,Patent Application,no,0,0,22,22,0,C12Q2600/106;;C12Q2600/136;;G01N33/57407;;G01N33/57415;;G01N33/57419;;G01N33/57423;;G01N33/57434;;G01N33/57438;;G01N33/57449;;G01N2800/44;;G16B25/00;;G16B40/00;;A61K31/69;;C12Q1/6886;;A61P35/00;;A61P35/02;;G16H10/40;;G16H20/40;;Y02A90/10;;G16B40/10;;G16B25/10;;G16B25/00;;G16B40/00;;C12Q2600/106;;C12Q2600/136;;G01N33/57407;;G01N33/57415;;G01N33/57419;;G01N33/57423;;G01N33/57434;;G01N33/57438;;G01N33/57449;;G01N2800/44;;Y02A90/10;;G16H10/40;;G16H20/40;;G16B40/10;;G16B25/10;;C12Q1/6886;;A61K31/69;;C12Q2600/158;;G01N33/57426;;G06Q20/40,C12Q1/68;;G01N33/574;;G06Q50/00;;G16B25/10;;G16B40/10,,0,0,,,,ACTIVE
540,EP,A2,EP 0213639 A2,109-505-744-732-391,1987-03-11,1987,EP 86112256 A,1986-09-04,US 77289185 A,1985-09-05,Bis-phosphite compounds.,"Transition metal-bis-phosphite catalyzed carbonylation processes, especially hydroformylation, as well as transition metal-bis-phosphite compositions, bis-phosphite ligands and transition metal-bis-phosphite catalysts.",UNION CARBIDE CORP,BILLIG ERNST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/109-505-744-732-391,Patent Application,yes,4,61,48,54,0,C07C45/50;;C07F9/65744;;C07F9/6578;;C07F15/008;;Y02P20/582;;C07F11/00;;C07F9/10;;C07F15/008;;C07F9/6578;;C07C45/50;;C07F9/65744;;Y02P20/582,B01J31/00;;B01J31/22;;C07B41/06;;C07B61/00;;C07C45/00;;B01J31/24;;C07C45/50;;C07C47/02;;C07C47/042;;C07C67/00;;C07F9/09;;C07F9/145;;C07F9/6574;;C07F9/6578;;C07F15/00,,1,0,,,"J. FALBE: ""new Synthesis With Carbon Monoxide"", 1980, SPRINGER VERLAG",EXPIRED
541,GB,A,GB 189316262 A,137-289-462-946-553,1893-10-14,1893,GB 189316262D A,1893-08-29,GB 189316262T A,1893-08-29,"Improvements in Flushing Apparatus for Closets, Urinals, Sinks, and the like.",,DUNCAN EDWARD;;BENNETT GEORGE HENRY;;BRYANT HENRY WILLIAM,DUNCAN EDWARD;;BENNETT GEORGE HENRY;;BRYANT HENRY WILLIAM,,https://lens.org/137-289-462-946-553,Patent Application,no,0,0,1,1,0,,,,0,0,,,,DISCONTINUED
542,CS,A3,CS 8807490 A3,151-848-848-959-643,1992-02-19,1992,CS 749088 A,1986-09-04,US 77285985 A,1985-09-05,RHODIUM COMPLEX HYDROFORMYLATION CATALYTIC PRECURSOR MIXTURE,,UNION CARBIDE CORP,BILLIG ERNST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/151-848-848-959-643,Patent Application,no,0,0,44,44,0,B01J31/185;;B01J31/20;;B01J2231/321;;B01J2531/0266;;B01J2531/80;;B01J2531/822;;C07C45/50;;Y02P20/582;;C07C47/02;;B01J31/22;;C07C45/50;;C07C45/50;;B01J31/185;;B01J2531/0266;;B01J2231/321;;B01J2531/80;;B01J31/20;;B01J2531/822;;Y02P20/582,C07C47/02;;B01J31/00;;B01J31/18;;B01J31/20;;B01J31/22;;C07B61/00;;C07C45/00;;C07C45/50;;C07C67/00,,0,0,,,,EXPIRED
543,US,A1,US 2010/0086922 A1,155-420-097-255-44X,2010-04-08,2010,US 45494409 A,2009-05-27,US 45494409 A;;US 13035108 P,2008-05-30,Assessment of chromosomal alterations to predict clinical outcome of bortezomib treatment,"Disclosed herein are chromosomal loci associated with clinical outcome to treatment for multiple myeloma. Genome-wide changes observed in myeloma relate to prognosis and treatment response to a proteasome inhibitor. Compositions and methods are provided to assess DNA copy number at corresponding to markers of loci and genes found thereon which are amplified or deleted, overexpressed or underexpressed in myeloma tumors to predict response to treatment, time-to-progression and survival upon treatment.",MILLENNIUM PHARM INC,BRYANT BARBARA M;;DANAEE HADI;;MULLIGAN GEORGE J,MILLENNIUM PHARMACEUTICALS INC (2009-07-10),https://lens.org/155-420-097-255-44X,Patent Application,yes,5,36,5,5,86,C12Q1/6883;;C12Q2600/156;;G01N33/57407;;G01N33/57426;;G01N2800/52;;G01N2800/60;;C12Q2600/106;;C12Q2600/112;;C12Q2600/136;;C12Q2600/158;;C12Q2600/106;;C12Q2600/158;;G01N33/57407;;C12Q1/6883;;G01N2800/52;;C12Q2600/156;;G01N2800/60;;G01N33/57426;;C12Q2600/136;;C12Q2600/112;;C12Q1/6886;;C12Q2600/118,C12Q1/68;;C07H21/04,435/6;;536/24.31,4,1,083-144-332-711-612,10.1016/s0378-1119(00)00402-9;;11111040,"Entrez 51130 (http://www.ncbi.nlm.nih.gov/gene/?term=51130, downloaded 7/17/2014);;Entrez 23198 (http://www.ncbi.nlm.nih.gov/gene/?term=23198, downloaded 7/17/2014);;SACS Equivalent Applications of GCG programs (http://www.sacs.ucsf.edu/Documentation/myemboss-gcg.html 12/ downloaded 12/30/2015);;Kile (Gene (2000) volume 258, pages 31-41)",DISCONTINUED
544,FI,A,FI 863570 A,164-774-489-768-150,1987-03-06,1987,FI 863570 A,1986-09-04,US 77285985 A,1985-09-05,FOERFARANDE SOM KATALYSERAS AV ETT TRANSITIONSMETALLKOMPLEX.,,UNION CARBIDE CORP,BILLIG ERNST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/164-774-489-768-150,Patent Application,no,0,0,44,44,0,B01J31/185;;B01J31/20;;B01J2231/321;;B01J2531/0266;;B01J2531/80;;B01J2531/822;;C07C45/50;;Y02P20/582;;C07C47/02;;B01J31/22;;C07C45/50;;C07C45/50;;B01J31/185;;B01J2531/0266;;B01J2231/321;;B01J2531/80;;B01J31/20;;B01J2531/822;;Y02P20/582,B01J31/00;;C07C47/02;;B01J31/18;;B01J31/20;;B01J31/22;;C07B61/00;;C07C45/00;;C07C45/50;;C07C67/00,,0,0,,,,EXPIRED
545,RO,B,RO 96102 B,190-345-191-293-41X,1989-02-03,1989,RO 12470686 A,1986-09-04,RO 12470686 A,1986-09-04,PROCESS FOR PREPARING ALDEHYDES,"Inventia se refera la un procedeu de preparare a aldehidelor, prin hidroformilarea olefinelor cu monooxid de carbon si hidrogen, folosind un catalizator continând rodiu si un ligand continând fosfor, la care este folosit un compus bis-fosfitic cu formula generala : (vezi formula înpag.1) în care X este H, OCH&lt;sub&gt;3&lt;/sub&gt;, W este difenil, dinaftil, dimetoxi, ditertbutildifenil, 1 - bis - ditertbutil-difeniletan, iar Z este radicalul metil, fenil, p-nonilfenil, p - clorfenil, o - tolil, folosind o reactie molara ligand/rodiu de 1 ... 60, la temperatura de 50 ... 100 degree C.",UNION CARBIDE CORP,EENST BILLING;;ANTHONY GEORGE ABATJOGLOU;;DAVID ROBERT BRYANT,,https://lens.org/190-345-191-293-41X,Unknown,no,0,0,2,2,0,,C07C45/50,,0,0,,,,DISCONTINUED
546,WO,A2,WO 2008/021183 A2,179-618-284-908-295,2008-02-21,2008,US 2007/0017716 W,2007-08-09,US 83676406 P,2006-08-10,"FOR THE IDENTIFICATION, ASSESSMENT, AND TREATMENT OF PATIENTS WITH CANCER THERAPY","The present invention is directed to the identification of predictive markers that can be used to determine whether patients with cancer are expected to demonstrate long term or short term survival times. In particular, the present invention is directed to the use of certain individual and/or combinations of predictive markers, wherein the expression of the predictive markers correlates with expected short term or long term survival. Thus, by examining the expression levels of individual predictive markers and/or predictive markers comprising a marker set, it is possible to determine predicted patient survival.",MILLENNIUM PHARM INC;;BRYANT BARBARA M;;DAMOKOSH ANDREW I;;MULLIGAN GEORGE,BRYANT BARBARA M;;DAMOKOSH ANDREW I;;MULLIGAN GEORGE,,https://lens.org/179-618-284-908-295,Patent Application,yes,0,7,13,13,0,A61P35/00;;C12Q1/6886;;C12Q1/6886;;C12Q2600/106;;C12Q2600/106;;C12Q2600/158;;C12Q2600/158;;G01N33/57484;;G01N33/57484,C12Q1/02;;G01N33/574,,1,0,,,See references of EP 2046973A4,PENDING
547,EP,A2,EP 0214622 A2,003-469-840-176-306,1987-03-18,1987,EP 86112257 A,1986-09-04,US 77285985 A,1985-09-05,Transition metal complex catalyzed processes.,"Transition metal-poly-phosphite complex catalyzed carbonylation processes, especially hydroformylation, as well as transition metal-poly-phosphite ligand complex compositions.",UNION CARBIDE CORP,BILLIG ERNST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/003-469-840-176-306,Patent Application,yes,4,54,44,44,0,B01J31/185;;B01J31/20;;B01J2231/321;;B01J2531/0266;;B01J2531/80;;B01J2531/822;;C07C45/50;;Y02P20/582;;C07C47/02;;B01J31/22;;C07C45/50;;C07C45/50;;B01J31/185;;B01J2531/0266;;B01J2231/321;;B01J2531/80;;B01J31/20;;B01J2531/822;;Y02P20/582,B01J31/00;;B01J31/18;;B01J31/20;;C07C47/02;;B01J31/22;;C07B61/00;;C07C45/00;;C07C45/50;;C07C67/00,,0,0,,,,EXPIRED
548,CA,A1,CA 2611728 A1,114-817-847-180-239,2006-12-14,2006,CA 2611728 A,2006-06-08,US 68863405 P;;US 2006/0022515 W,2005-06-08,"METHODS FOR THE IDENTIFICATION, ASSESSMENT, AND TREATMENT OF PATIENTS WITH CANCER THERAPY","The present invention is directed to the identification of predictive markers that can be used to determine whether patients with cancer are clinically responsive or non-responsive to a therapeutic regimen prior to treatment. In particular, the present invention is directed to the use of certain individual and/or combinations of predictive markers, wherein the expression of the predictive markers correlates with responsiveness or non-responsiveness to a therapeutic regimen. Thus, by examining the expression levels of individual predictive markers and/or predictive markers comprising a marker set, it is possible to determine whether a therapeutic agent, or combination of agents, will be most likely to reduce the growth rate of tumors in a clinical setting.",MILLENNIUM PHARM INC,BRYANT BARBARA M;;DAMOKOSH ANDREW I;;MULLIGAN GEORGE,,https://lens.org/114-817-847-180-239,Patent Application,no,0,0,22,22,0,C12Q2600/106;;C12Q2600/136;;G01N33/57407;;G01N33/57415;;G01N33/57419;;G01N33/57423;;G01N33/57434;;G01N33/57438;;G01N33/57449;;G01N2800/44;;G16B25/00;;G16B40/00;;A61K31/69;;C12Q1/6886;;A61P35/00;;A61P35/02;;G16H10/40;;G16H20/40;;Y02A90/10;;G16B40/10;;G16B25/10;;G16B25/00;;G16B40/00;;C12Q2600/106;;C12Q2600/136;;G01N33/57407;;G01N33/57415;;G01N33/57419;;G01N33/57423;;G01N33/57434;;G01N33/57438;;G01N33/57449;;G01N2800/44;;Y02A90/10;;G16H10/40;;G16H20/40;;G16B40/10;;G16B25/10;;C12Q1/6886;;A61K31/69;;C12Q2600/158;;G01N33/57426;;G06Q20/40,C12Q1/68;;C12Q1/6809;;C40B30/04;;G01N33/48;;G01N33/68;;G06Q40/08;;G06Q50/00;;G16B25/10;;G16B40/10,,0,0,,,,DISCONTINUED
549,FI,A0,FI 863570 A0,137-876-479-520-491,1986-09-04,1986,FI 863570 A,1986-09-04,US 77285985 A,1985-09-05,FOERFARANDE SOM KATALYSERAS AV ETT TRANSITIONSMETALLKOMPLEX.,,UNION CARBIDE CORP,BILLIG ERNST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/137-876-479-520-491,Patent Application,no,0,0,44,44,0,B01J31/185;;B01J31/20;;B01J2231/321;;B01J2531/0266;;B01J2531/80;;B01J2531/822;;C07C45/50;;Y02P20/582;;C07C47/02;;B01J31/22;;C07C45/50;;C07C45/50;;B01J31/185;;B01J2531/0266;;B01J2231/321;;B01J2531/80;;B01J31/20;;B01J2531/822;;Y02P20/582,B01J31/00;;C07C47/02;;B01J31/18;;B01J31/20;;B01J31/22;;C07B61/00;;C07C45/00;;C07C45/50;;C07C67/00,,0,0,,,,EXPIRED
550,WO,A3,WO 2008/021183 A3,155-670-103-308-643,2009-04-02,2009,US 2007/0017716 W,2007-08-09,US 83676406 P,2006-08-10,"FOR THE IDENTIFICATION, ASSESSMENT, AND TREATMENT OF PATIENTS WITH CANCER THERAPY","The present invention is directed to the identification of predictive markers that can be used to determine whether patients with cancer are expected to demonstrate long term or short term survival times. In particular, the present invention is directed to the use of certain individual and/or combinations of predictive markers, wherein the expression of the predictive markers correlates with expected short term or long term survival. Thus, by examining the expression levels of individual predictive markers and/or predictive markers comprising a marker set, it is possible to determine predicted patient survival.",MILLENNIUM PHARM INC;;BRYANT BARBARA M;;DAMOKOSH ANDREW I;;MULLIGAN GEORGE,BRYANT BARBARA M;;DAMOKOSH ANDREW I;;MULLIGAN GEORGE,,https://lens.org/155-670-103-308-643,Search Report,yes,0,0,13,13,0,A61P35/00;;C12Q1/6886;;C12Q1/6886;;C12Q2600/106;;C12Q2600/106;;C12Q2600/158;;C12Q2600/158;;G01N33/57484;;G01N33/57484,C12Q1/68;;G01N33/53,,2,1,058-525-874-916-05X,9815574,"BALL ET AL.: ""Neuron specific Hel-N1 and HUD as novel molecular markers of neuroblastoma: A correlation of HUD messenger RNA levels with favorable prognostic features"", CLIN CANCER RES, vol. 3, October 1997 (1997-10-01), pages 1859 - 1865, XP008107830;;See also references of EP 2046973A4",PENDING
551,EP,A1,EP 0832888 A1,172-426-977-831-170,1998-04-01,1998,EP 97307339 A,1997-09-22,US 2744996 P,1996-09-27,"Benzothiophene compounds, compositions, and methods","The invention provides benzothiophene compounds, formulations, and methods of inhibiting bone loss or bone resorption, particularly osteoporosis, cardiovascular-related pathological conditions, including hyperlipidemia.",LILLY CO ELI,BRYANT HENRY;;CULLINAN GEORGE JOSEPH;;DODGE JEFFREY ALAN,,https://lens.org/172-426-977-831-170,Patent Application,yes,3,2,9,9,0,C07D333/56;;C07D409/12;;C07D417/12;;A61P19/10;;A61P3/06;;A61P43/00;;C07D409/12;;C07D417/12;;C07D333/56,C07D333/16;;A61K31/38;;A61K31/381;;A61K31/425;;A61K31/426;;A61K31/44;;A61K31/4433;;A61P3/06;;A61P19/10;;A61P43/00;;C07D277/20;;C07D277/24;;C07D277/34;;C07D333/32;;C07D333/56;;C07D333/64;;C07D409/12;;C07D417/12,,0,0,,,,EXPIRED
552,ES,A6,ES 2001654 A6,027-662-933-309-206,1988-06-01,1988,ES 8601618 A,1986-09-04,US 77289185 A,1985-09-05,Bis-phosphite compounds.,"Transition metal-bis-phosphite catalyzed carbonylation processes, especially hydroformylation, as well as transition metal-bis-phosphite compositions, bis-phosphite ligands and transition metal-bis-phosphite catalysts.",UNION CARBIDE CORP,BILLIG ERNST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/027-662-933-309-206,Granted Patent,no,0,1,48,54,0,C07C45/50;;C07F9/65744;;C07F9/6578;;C07F15/008;;Y02P20/582;;C07F11/00;;C07F9/10;;C07F15/008;;C07F9/6578;;C07C45/50;;C07F9/65744;;Y02P20/582,B01J31/00;;B01J31/22;;B01J31/24;;C07B41/06;;C07B61/00;;C07C45/00;;C07C45/50;;C07C47/02;;C07C47/042;;C07C67/00;;C07F9/09;;C07F9/145;;C07F9/6574;;C07F9/6578;;C07F15/00,,0,0,,,,EXPIRED
553,US,A1,US 2013/0013334 A1,051-294-793-713-226,2013-01-10,2013,US 201213600260 A,2012-08-31,US 201213600260 A;;US 44919506 A;;US 68863405 P,2005-06-08,"METHODS FOR THE IDENTIFICATION, ASSESSMENT, AND TREATMENT OF PATIENTS WITH CANCER THERAPY","The present invention is directed to the identification of predictive markers that can be used to determine whether patients with cancer are clinically responsive or non-responsive to a therapeutic regimen prior to treatment. In particular, the present invention is directed to the use of certain individual and/or combinations of predictive markers, wherein the expression of the predictive markers correlates with responsiveness or non-responsiveness to a therapeutic regimen. Thus, by examining the expression levels of individual predictive markers and/or predictive markers comprising a marker set, it is possible to determine whether a therapeutic agent, or combination of agents, will be most likely to reduce the growth rate of tumors in a clinical setting.",MILLENNIUM PHARM INC;;BRYANT BARBARA M;;DAMOKOSH ANDREW I;;MULLIGAN GEORGE,BRYANT BARBARA M;;DAMOKOSH ANDREW I;;MULLIGAN GEORGE,TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-05-03),https://lens.org/051-294-793-713-226,Patent Application,yes,0,3,22,22,1415,C12Q2600/106;;C12Q2600/136;;G01N33/57407;;G01N33/57415;;G01N33/57419;;G01N33/57423;;G01N33/57434;;G01N33/57438;;G01N33/57449;;G01N2800/44;;G16B25/00;;G16B40/00;;A61K31/69;;C12Q1/6886;;A61P35/00;;A61P35/02;;G16H10/40;;G16H20/40;;Y02A90/10;;G16B40/10;;G16B25/10;;G16B25/00;;G16B40/00;;C12Q2600/106;;C12Q2600/136;;G01N33/57407;;G01N33/57415;;G01N33/57419;;G01N33/57423;;G01N33/57434;;G01N33/57438;;G01N33/57449;;G01N2800/44;;Y02A90/10;;G16H10/40;;G16H20/40;;G16B40/10;;G16B25/10;;C12Q1/6886;;A61K31/69;;C12Q2600/158;;G01N33/57426;;G06Q20/40,C40B30/04;;A61K31/10;;A61K31/336;;A61K31/4015;;A61K31/704;;A61K38/02;;A61P35/00;;A61P35/02;;C40B40/06;;C40B40/10;;G06Q50/00;;G06Q50/22;;G16B25/10;;G16B40/10,705/2;;506/9;;506/16;;506/18;;514/19.3;;514/19.6;;514/710;;514/475;;514/423;;514/26,4,3,034-134-907-055-024;;089-309-126-902-646;;103-920-702-805-783,1563002;;11857078;;10.1038/sj.onc.1205205;;11306489,"Tockman et al (Cancer Res., 1992, 52:2711s-2718s);;Ferrandina et al (BMC Cancer, 2006, 6(182): 1-5);;Chauhan et al (Oncogene, 2002, 21: 1346-1358);;Hideshima et al (Cancer Research, 2001, 61: 3071-3076)",ACTIVE
554,EP,A2,EP 1899486 A2,128-009-182-101-235,2008-03-19,2008,EP 06784710 A,2006-06-08,US 2006/0022515 W;;US 68863405 P,2005-06-08,"METHODS FOR THE IDENTIFICATION, ASSESSMENT, AND TREATMENT OF PATIENTS WITH CANCER THERAPY",,MILLENNIUM PHARM INC,BRYANT BARBARA M;;DAMOKOSH ANDREW I;;MULLIGAN GEORGE,,https://lens.org/128-009-182-101-235,Patent Application,yes,0,0,22,22,0,C12Q2600/106;;C12Q2600/136;;G01N33/57407;;G01N33/57415;;G01N33/57419;;G01N33/57423;;G01N33/57434;;G01N33/57438;;G01N33/57449;;G01N2800/44;;G16B25/00;;G16B40/00;;A61K31/69;;C12Q1/6886;;A61P35/00;;A61P35/02;;G16H10/40;;G16H20/40;;Y02A90/10;;G16B40/10;;G16B25/10;;G16B25/00;;G16B40/00;;C12Q2600/106;;C12Q2600/136;;G01N33/57407;;G01N33/57415;;G01N33/57419;;G01N33/57423;;G01N33/57434;;G01N33/57438;;G01N33/57449;;G01N2800/44;;Y02A90/10;;G16H10/40;;G16H20/40;;G16B40/10;;G16B25/10;;C12Q1/6886;;A61K31/69;;C12Q2600/158;;G01N33/57426;;G06Q20/40,C12Q1/68;;G06Q50/00;;G16B25/10;;G16B40/10,,0,0,,,,DISCONTINUED
555,EP,A4,EP 2046973 A4,182-209-880-516-934,2010-04-07,2010,EP 07836670 A,2007-08-09,US 2007/0017716 W;;US 83676406 P,2006-08-10,"FOR THE IDENTIFICATION, ASSESSMENT, AND TREATMENT OF PATIENTS WITH CANCER THERAPY",,MILLENNIUM PHARM INC,BRYANT BARBARA M;;DAMOKOSH ANDREW I;;MULLIGAN GEORGE,,https://lens.org/182-209-880-516-934,Search Report,no,2,0,13,13,0,C12Q1/6886;;C12Q2600/106;;C12Q2600/158;;G01N33/57484;;A61P35/00;;C12Q1/6886;;C12Q2600/106;;C12Q2600/158;;G01N33/57484,C12Q1/02;;G01N33/53,,3,3,010-409-170-828-73X;;082-806-441-584-134;;014-480-876-382-087,10.1182/blood-2006-09-044974;;17185464;;16194893;;10.1080/10428190500204781;;10.1182/blood-2006-04-016907;;16946303,"MULLIGAN GEORGE ET AL: ""Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib."", BLOOD 15 APR 2007, vol. 109, no. 8, 15 April 2007 (2007-04-15), pages 3177 - 3188, XP002569544, ISSN: 0006-4971;;MONTSERRAT BATLLE ET AL: ""Usefulness of tumor markers CA 125 and CA 15.3 at diagnosis and during follow-up in non-Hodgkin's lymphoma: study of 200 patients"", LEUKEMIA AND LYMPHOMA., vol. 46, no. 10, 1 January 2005 (2005-01-01), US, pages 1471 - 1476, XP055307670, ISSN: 1042-8194, DOI: 10.1080/10428190500204781;;S. UDDIN ET AL: ""Role of phosphatidylinositol 3'-kinase/AKT pathway in diffuse large B-cell lymphoma survival"", BLOOD, vol. 108, no. 13, 15 December 2006 (2006-12-15), US, pages 4178 - 4186, XP055307681, ISSN: 0006-4971, DOI: 10.1182/blood-2006-04-016907",DISCONTINUED
556,MX,A,MX 2009001489 A,039-307-733-439-013,2009-02-18,2009,MX 2009001489 A,2007-08-09,US 83676406 P;;US 2007/0017716 W,2006-08-10,"FOR THE IDENTIFICATION, ASSESSMENT, AND TREATMENT OF PATIENTS WITH CANCER THERAPY.","The present invention is directed to the identification of predictive markers that can be used to determine whether patients with cancer are expected to demonstrate long term or short term survival times. In particular, the present invention is directed to the use of certain individual and/or combinations of predictive markers, wherein the expression of the predictive markers correlates with expected short term or long term survival. Thus, by examining the expression levels of individual predictive markers and/or predictive markers comprising a marker set, it is possible to determine predicted patient survival.",MILLENNIUM PHARM INC,MULLIGAN GEORGE;;BRYANT BARBARA M;;DAMOKOSH ANDREW I,,https://lens.org/039-307-733-439-013,Patent Application,no,0,0,13,13,0,A61P35/00;;C12Q1/6886;;C12Q1/6886;;C12Q2600/106;;C12Q2600/106;;C12Q2600/158;;C12Q2600/158;;G01N33/57484;;G01N33/57484,C12Q1/02;;G01N33/574,,0,0,,,,ACTIVE
557,US,B2,US 8278038 B2,059-477-890-134-712,2012-10-02,2012,US 44919506 A,2006-06-08,US 44919506 A;;US 68863405 P,2005-06-08,"Methods for the identification, assessment, and treatment of patients with cancer therapy","The present invention is directed to the identification of predictive markers that can be used to determine whether patients with cancer are clinically responsive or non-responsive to a therapeutic regimen prior to treatment. In particular, the present invention is directed to the use of certain individual and/or combinations of predictive markers, wherein the expression of the predictive markers correlates with responsiveness or non-responsiveness to a therapeutic regimen. Thus, by examining the expression levels of individual predictive markers and/or predictive markers comprising a marker set, it is possible to determine whether a therapeutic agent, or combination of agents, will be most likely to reduce the growth rate of tumors in a clinical setting.",BRYANT BARBARA M;;DAMOKOSH ANDREW I;;MULLIGAN GEORGE;;MILLENNIUM PHARM INC,BRYANT BARBARA M;;DAMOKOSH ANDREW I;;MULLIGAN GEORGE,MILLENNIUM PHARMACEUTICALS INC (2006-07-05),https://lens.org/059-477-890-134-712,Granted Patent,yes,2,10,22,22,1415,C12Q2600/106;;C12Q2600/136;;G01N33/57407;;G01N33/57415;;G01N33/57419;;G01N33/57423;;G01N33/57434;;G01N33/57438;;G01N33/57449;;G01N2800/44;;G16B25/00;;G16B40/00;;A61K31/69;;C12Q1/6886;;A61P35/00;;A61P35/02;;G16H10/40;;G16H20/40;;Y02A90/10;;G16B40/10;;G16B25/10;;G16B25/00;;G16B40/00;;C12Q2600/106;;C12Q2600/136;;G01N33/57407;;G01N33/57415;;G01N33/57419;;G01N33/57423;;G01N33/57434;;G01N33/57438;;G01N33/57449;;G01N2800/44;;Y02A90/10;;G16H10/40;;G16H20/40;;G16B40/10;;G16B25/10;;C12Q1/6886;;A61K31/69;;C12Q2600/158;;G01N33/57426;;G06Q20/40,C12Q1/68;;G06Q50/00;;G16B25/10;;G16B40/10,435/6.1,25,17,034-134-907-055-024;;089-309-126-902-646;;103-920-702-805-783;;045-807-567-174-272;;043-880-672-061-032;;134-684-144-981-813;;074-147-835-645-394;;082-177-571-545-468;;084-615-067-249-328;;026-978-719-988-804;;067-766-525-517-863;;002-431-300-582-282;;010-409-170-828-73X;;007-342-077-503-496;;154-649-796-265-048;;144-184-274-185-833;;064-464-672-849-072,1563002;;11857078;;10.1038/sj.onc.1205205;;11306489;;10.1186/gb-2003-4-9-117;;pmc193646;;12952525;;12361907;;10.1016/s0302-2838(02)00324-x;;10363983;;10.1634/theoncologist.7-1-9;;11854543;;10.1093/clinchem/46.5.673;;10794750;;12575774;;12826635;;10.1056/nejmoa030288;;12490681;;10.1056/nejmoa021967;;12738736;;10.1182/blood-2006-09-044974;;17185464;;8159770;;10.1073/pnas.91.8.3463;;pmc43597;;10.1093/nar/gki031;;10.1289/ehp.7690;;16203246;;pmc1281279;;15817694;;10.1093/bioinformatics/bti429,"Tockman et al (Cancer Res., 1992, 52:2711s-2718s).;;Ferrandina et al (BMC Cancer, Jul. 2006, 6(182): 1-5).;;Chauhan et al (Oncogene, 2002, 21: 1346-1358).;;Hideshima et al (Cancer Research, 2001, 61: 3071-3076).;;Alberts et al. (Molecular Biology of the Cell, 3rd edition, 1994, p. 465).;;Greenbaum et al. (Genome Biology, 2003, vol. 4, Issue 9, pp. 117.1-117.8).;;Lichtinghagen et al (European Urology, 2002, 42:398-406).;;Adams, Julian, et al., ""Proteasome Inhibitors: A Novel Class of Potent and Effective Antitumor Agents,"" Cancer Research, vol. 59 (Jun. 1, 1999) pp. 2615-2622.;;Adams, Julian, ""Development of the Proteasome Inhibitor PA-341,"" The Oncologist, vol. 7 (2002) pp. 9-16.;;Lightcap, Eric S., et al., ""Proteasome Inhibition Measurements: Clinical Application,"" Clinical Chemsitry, vol. 46, No. 5 (2000) pp. 673-683.;;Hochwald, Steven N., et al., ""Antineoplastic Therapy in Colorectal Cancer through Proteasome Inhibition,"" The American Surgeon, vol. 69 (Jan. 2003) pp. 15-23.;;Richardson, Paul G., et al., ""A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma,"" The New England Journal of Medicine, vol. 348, No. 26 (Jun. 26, 2003) pp. 2609-2617.;;van de Vijver, Marc J., et al., ""A Gene-Expression Signature as a Predictor of Survival in Breast Cancer,"" The New England Journal of Medicine, vol. 347, No. 25 (Dec. 19, 2002) pp. 1999-2009.;;Barden, Catherine B., et al., ""Classification of Follicular Thyroid Tumors by Molecular Signature: Results of Gene Profiling,"" Clinical Cancer Research, vol. 9 (May 2003) pp. 1792-1800.;;Mulligan, George, et al., ""Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib,"" Blood, vol. 109, No. 8 (Apr. 15, 2007) pp. 3177-3188.;;Toczyski, David P., et al., ""The Epstein-Barr virus (EBV) small RNA EBER1 binds and relocalizes ribosomal protein L22 in EBV-infected human B lymphocytes,"" Proceedings of the National Academy of Science USA, vol. 91 (Apr. 1994) pp. 3463-3467.;;Maglott, Donna, et al., ""Entrez Gene: gene-centered information at NCBI,"" Nucleic Acids Research, vol. 33, Database issue (2005) pp. D54-D58.;;Affymetrix, Inc., ""Annotation Methodology,"" Affymetrix-Annotation Methodology Technical Note [online] Affymetrix, Santa Clara, CA, downloaded Jul. 23, 2008 (3 pages).;;Affymetrix, Inc., ""GeneChip Human Genome U133 Set,"" [online] 701092 Rev. 3 (Nov. 2004) downloaded Jul. 23, 2008 ( 2 pages).;;Affymetrix, Inc., ""Human Genome U133 Set-Support Materials,"" Affymetrix-Technical Support Documentation for Human Genome U133 Set [online] downloaded Jul. 24, 2008 (3 pages).;;International Prelminary Examination Report (IPER) and Written Opinion of the International Searching Authority dated Dec. 11, 2007 in corresponding PCT Application PCT/US06/022515.;;Office Action dated Jun. 23, 2008 in co-pending U.S. Appl. No. 10/728,055.;;Supplementary Partial European Search Report dated Jun. 24, 2009 in European Patent Application No. 06784710.3 which corresponds to U.S. Appl. No. 11/449,195.;;Glatt, Christine M., et al., ""Molecular characterization of thyroid toxicity: anchoring gene expression profiles to biochemical and pathologic end points,"" Environmental Health Perspectives, vol. 113, No. 10 (Oct. 2005) pp. 1354-1361.;;Wessels, Lodewyk F. A., et al., ""A protocol for building and evaluating predictors of disease state based on microarray data,"" Bioinformatics, vol. 21, No. 19 (Apr. 7, 2005) pp. 3755-3762.",ACTIVE
558,EP,B1,EP 0214622 B1,139-964-610-916-452,1992-05-13,1992,EP 86112257 A,1986-09-04,US 77285985 A,1985-09-05,TRANSITION METAL COMPLEX CATALYZED PROCESSES,,UNION CARBIDE CORPORATION,"BILLIG, ERNST;;ABATJOGLOU, ANTHONY GEORGE;;BRYANT, DAVID ROBERT",,https://lens.org/139-964-610-916-452,Granted Patent,yes,5,17,44,44,0,B01J31/185;;B01J31/20;;B01J2231/321;;B01J2531/0266;;B01J2531/80;;B01J2531/822;;C07C45/50;;Y02P20/582;;C07C47/02;;B01J31/22;;C07C45/50;;C07C45/50;;B01J31/185;;B01J2531/0266;;B01J2231/321;;B01J2531/80;;B01J31/20;;B01J2531/822;;Y02P20/582,B01J31/00;;B01J31/18;;B01J31/20;;C07C47/02;;B01J31/22;;C07B61/00;;C07C45/00;;C07C45/50;;C07C67/00,,0,0,,,,EXPIRED
559,ES,A6,ES 2001416 A6,168-672-991-881-106,1988-05-16,1988,ES 8601617 A,1986-09-04,US 77285985 A,1985-09-05,Transition metal complex catalyzed processes.,"Transition metal-poly-phosphite complex catalyzed carbonylation processes, especially hydroformylation, as well as transition metal-poly-phosphite ligand complex compositions.",UNION CARBIDE CORP,BILLIG ERNST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/168-672-991-881-106,Granted Patent,no,0,0,44,44,0,B01J31/185;;B01J31/20;;B01J2231/321;;B01J2531/0266;;B01J2531/80;;B01J2531/822;;C07C45/50;;Y02P20/582;;C07C47/02;;B01J31/22;;C07C45/50;;C07C45/50;;B01J31/185;;B01J2531/0266;;B01J2231/321;;B01J2531/80;;B01J31/20;;B01J2531/822;;Y02P20/582,B01J31/00;;B01J31/18;;B01J31/20;;C07C47/02;;B01J31/22;;C07B61/00;;C07C45/00;;C07C45/50;;C07C67/00,,0,0,,,,EXPIRED
560,HU,A,HU T46642 A,046-973-400-129-437,1988-11-28,1988,HU 382086 A,1986-09-04,US 77285985 A,1985-09-05,CARBONYLATION PROCESS BY USING TRANSITION METAL-COMPLEX CATALYST,,UNION CARBIDE CORP,BILLIG ERNST;;ABATJOGLOU GEORGE A;;BRYANT ROBERT D,,https://lens.org/046-973-400-129-437,Unknown,no,0,0,44,44,0,B01J31/185;;B01J31/20;;B01J2231/321;;B01J2531/0266;;B01J2531/80;;B01J2531/822;;C07C45/50;;Y02P20/582;;C07C47/02;;B01J31/22;;C07C45/50;;C07C45/50;;B01J31/185;;B01J2531/0266;;B01J2231/321;;B01J2531/80;;B01J31/20;;B01J2531/822;;Y02P20/582,B01J31/00;;B01J31/18;;B01J31/20;;B01J31/22;;C07C47/02;;C07B61/00;;C07C45/00;;C07C45/50;;C07C67/00,,0,0,,,,EXPIRED
561,EP,A4,EP 1899486 A4,051-609-291-617-414,2009-07-22,2009,EP 06784710 A,2006-06-08,US 2006/0022515 W;;US 68863405 P,2005-06-08,"METHODS FOR THE IDENTIFICATION, ASSESSMENT, AND TREATMENT OF PATIENTS WITH CANCER THERAPY",,MILLENNIUM PHARM INC,BRYANT BARBARA M;;DAMOKOSH ANDREW I;;MULLIGAN GEORGE,,https://lens.org/051-609-291-617-414,Search Report,no,1,0,22,22,0,C12Q2600/106;;C12Q2600/136;;G01N33/57407;;G01N33/57415;;G01N33/57419;;G01N33/57423;;G01N33/57434;;G01N33/57438;;G01N33/57449;;G01N2800/44;;G16B25/00;;G16B40/00;;A61K31/69;;C12Q1/6886;;A61P35/00;;A61P35/02;;G16H10/40;;G16H20/40;;Y02A90/10;;G16B40/10;;G16B25/10;;G16B25/00;;G16B40/00;;C12Q2600/106;;C12Q2600/136;;G01N33/57407;;G01N33/57415;;G01N33/57419;;G01N33/57423;;G01N33/57434;;G01N33/57438;;G01N33/57449;;G01N2800/44;;Y02A90/10;;G16H10/40;;G16H20/40;;G16B40/10;;G16B25/10;;C12Q1/6886;;A61K31/69;;C12Q2600/158;;G01N33/57426;;G06Q20/40,C12Q1/68;;G06Q50/00;;G16B25/10;;G16B40/10,,2,2,144-184-274-185-833;;064-464-672-849-072,10.1289/ehp.7690;;16203246;;pmc1281279;;15817694;;10.1093/bioinformatics/bti429,"GLATT CHRISTINE M ET AL: ""Molecular characterization of thyroid toxicity: anchoring gene expression profiles to biochemical and pathologic end points."", ENVIRONMENTAL HEALTH PERSPECTIVES OCT 2005, vol. 113, no. 10, October 2005 (2005-10-01), pages 1354 - 1361, XP002530267, ISSN: 0091-6765;;WESSELS LODEWYK F A ET AL: ""A protocol for building and evaluating predictors of disease state based on microarray data"", BIOINFORMATICS, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 21, no. 19, 7 April 2005 (2005-04-07), pages 3755 - 3762, XP002517267, ISSN: 1367-4803, [retrieved on 20050407]",DISCONTINUED
562,IN,B,IN 168034 B,079-178-018-682-447,1991-01-26,1991,IN 713MA1986 A,1986-09-04,US 77285985 A,1985-09-05,A HYDROFORMYLATION PROCESS FOR PRODUCING ALDEHYDES,,UNION CARBIDE CORP,ERNST BILLIG;;ANTHONY GEORGE ABATJOGLOU;;DAVID ROBERT BRYANT,,https://lens.org/079-178-018-682-447,Granted Patent,no,0,0,44,44,0,B01J31/185;;B01J31/20;;B01J2231/321;;B01J2531/0266;;B01J2531/80;;B01J2531/822;;C07C45/50;;Y02P20/582;;C07C47/02;;B01J31/22;;C07C45/50;;C07C45/50;;B01J31/185;;B01J2531/0266;;B01J2231/321;;B01J2531/80;;B01J31/20;;B01J2531/822;;Y02P20/582,B01J31/00;;C07C47/02;;B01J31/18;;B01J31/20;;B01J31/22;;C07B61/00;;C07C45/00;;C07C45/50;;C07C67/00,,0,0,,,,EXPIRED
563,WO,A2,WO 2006/133420 A2,088-725-080-437-65X,2006-12-14,2006,US 2006/0022515 W,2006-06-08,US 68863405 P,2005-06-08,"METHODS FOR THE IDENTIFICATION, ASSESSMENT, AND TREATMENT OF PATIENTS WITH CANCER THERAPY","The present invention is directed to the identification of predictive markers that can be used to determine whether patients with cancer are clinically responsive or non-responsive to a therapeutic regimen prior to treatment. In particular, the present invention is directed to the use of certain individual and/or combinations of predictive markers, wherein the expression of the predictive markers correlates with responsiveness or non-responsiveness to a therapeutic regimen. Thus, by examining the expression levels of individual predictive markers and/or predictive markers comprising a marker set, it is possible to determine whether a therapeutic agent, or combination of agents, will be most likely to reduce the growth rate of tumors in a clinical setting.",MILLENNIUM PHARM INC;;BRYANT BARBARA M;;DAMOKOSH ANDREW I;;MULLIGAN GEORGE,BRYANT BARBARA M;;DAMOKOSH ANDREW I;;MULLIGAN GEORGE,,https://lens.org/088-725-080-437-65X,Patent Application,yes,0,6,22,22,0,C12Q2600/106;;C12Q2600/136;;G01N33/57407;;G01N33/57415;;G01N33/57419;;G01N33/57423;;G01N33/57434;;G01N33/57438;;G01N33/57449;;G01N2800/44;;G16B25/00;;G16B40/00;;A61K31/69;;C12Q1/6886;;A61P35/00;;A61P35/02;;G16H10/40;;G16H20/40;;Y02A90/10;;G16B40/10;;G16B25/10;;G16B25/00;;G16B40/00;;C12Q2600/106;;C12Q2600/136;;G01N33/57407;;G01N33/57415;;G01N33/57419;;G01N33/57423;;G01N33/57434;;G01N33/57438;;G01N33/57449;;G01N2800/44;;Y02A90/10;;G16H10/40;;G16H20/40;;G16B40/10;;G16B25/10;;C12Q1/6886;;A61K31/69;;C12Q2600/158;;G01N33/57426;;G06Q20/40,C12Q1/68;;G01N33/574;;G06Q50/00;;G16B25/10;;G16B40/10,,0,0,,,,PENDING
564,US,A1,US 2017/0041219 A1,111-405-493-021-694,2017-02-09,2017,US 201514819346 A,2015-08-05,US 201514819346 A,2015-08-05,SCALABLE CONTINUITY TEST FOR A GROUP OF COMMUNICATION PATHS,"In one embodiment, a method includes generating at a network device, a continuity test packet configured to pass through a set of communication paths terminating at the network device and at least one other network device located at an opposite end of the communication paths, transmitting at the network device the continuity test packet on a first communication path in the set of communication paths, and identifying at the network device a failure in the set of communication paths if the continuity test packet is not received on a last communication path in the set of communication paths. An apparatus and logic are also disclosed herein.",CISCO TECH INC,BRYANT STEWART FREDERICK;;PIGNATARO CARLOS M;;SWALLOW GEORGE,CISCO TECHNOLOGY INC (2015-07-22),https://lens.org/111-405-493-021-694,Patent Application,yes,2,2,2,2,0,H04L45/22;;H04L45/28;;H04L45/50;;H04L45/28;;H04L45/50;;H04L45/22;;G16H40/20;;G06Q10/00;;G08B21/245,H04L45/50;;H04L45/28,,0,0,,,,INACTIVE
565,AU,A,AU 1986/062372 A,142-645-798-278-439,1987-03-12,1987,AU 1986/062372 A,1986-09-05,US 77289185 A,1985-09-05,BIS-PHOSPHITE COMPOUNDS,,UNION CARBIDE CORP,BILLIG ERNST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/142-645-798-278-439,Patent Application,no,0,0,48,54,0,C07C45/50;;C07F9/65744;;C07F9/6578;;C07F15/008;;Y02P20/582;;C07F11/00;;C07F9/10;;C07F15/008;;C07F9/6578;;C07C45/50;;C07F9/65744;;Y02P20/582,B01J31/24;;B01J31/00;;B01J31/22;;C07B41/06;;C07B61/00;;C07C45/00;;C07C45/50;;C07C47/02;;C07C47/042;;C07C67/00;;C07F9/09;;C07F9/145;;C07F9/6574;;C07F9/6578;;C07F15/00,,0,0,,,,EXPIRED
566,AU,B2,AU 2007/284724 B2,174-408-822-375-100,2014-03-13,2014,AU 2007/284724 A,2007-08-09,US 83676406 P;;US 2007/0017716 W,2006-08-10,"For the identification, assessment, and treatment of patients with cancer therapy","The present invention is directed to the identification of predictive markers that can be used to determine whether patients with cancer are expected to demonstrate long term or short term survival times. In particular, the present invention is directed to the use of certain individual and/or combinations of predictive markers, wherein the expression of the predictive markers correlates with expected short term or long term survival. Thus, by examining the expression levels of individual predictive markers and/or predictive markers comprising a marker set, it is possible to determine predicted patient survival.",MILLENNIUM PHARM INC,MULLIGAN GEORGE;;DAMOKOSH ANDREW I;;BRYANT BARBARA M,,https://lens.org/174-408-822-375-100,Granted Patent,no,1,0,13,13,0,A61P35/00;;C12Q1/6886;;C12Q1/6886;;C12Q2600/106;;C12Q2600/106;;C12Q2600/158;;C12Q2600/158;;G01N33/57484;;G01N33/57484,C12Q1/68;;G01N33/53,,1,0,,,"Ball, N. S. and King, P. H., Clinical Cancer Research, 1997, Vol. 3, pages 1859-1865",INACTIVE
567,FI,C,FI 88916 C,014-236-878-943-963,1993-07-26,1993,FI 863570 A,1986-09-04,US 77285985 A,1985-09-05,HYDROFORMYLERINGSFOERFARANDE FOER FRAMSTAELLNING AV ALDEHYDER SAMT PREKURSORKOMPOSITION FOER DEN VID FOERFARANDE UTNYTTJADE RODIUMKOMPLEXKATALYSATORN,,UNION CARBIDE CORP,BILLIG ERNST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/014-236-878-943-963,Granted Patent,no,0,0,44,44,0,B01J31/185;;B01J31/20;;B01J2231/321;;B01J2531/0266;;B01J2531/80;;B01J2531/822;;C07C45/50;;Y02P20/582;;C07C47/02;;B01J31/22;;C07C45/50;;C07C45/50;;B01J31/185;;B01J2531/0266;;B01J2231/321;;B01J2531/80;;B01J31/20;;B01J2531/822;;Y02P20/582,B01J31/00;;B01J31/18;;B01J31/20;;B01J31/22;;C07C47/02;;C07B61/00;;C07C45/00;;C07C45/50;;C07C67/00,,0,0,,,,EXPIRED
568,EP,B1,EP 0213639 B1,029-873-515-399-686,1991-06-26,1991,EP 86112256 A,1986-09-04,US 77289185 A,1985-09-05,BIS-PHOSPHITE COMPOUNDS,,UNION CARBIDE CORPORATION,"BILLIG, ERNST;;ABATJOGLOU, ANTHONY GEORGE;;BRYANT, DAVID ROBERT",,https://lens.org/029-873-515-399-686,Granted Patent,yes,1,5,48,54,0,C07C45/50;;C07F9/65744;;C07F9/6578;;C07F15/008;;Y02P20/582;;C07F11/00;;C07F9/10;;C07F15/008;;C07F9/6578;;C07C45/50;;C07F9/65744;;Y02P20/582,B01J31/00;;B01J31/22;;C07B41/06;;B01J31/24;;C07B61/00;;C07C45/00;;C07C45/50;;C07C47/02;;C07C47/042;;C07C67/00;;C07F9/09;;C07F9/145;;C07F9/6574;;C07F9/6578;;C07F15/00,,0,0,,,,EXPIRED
569,HU,B,HU 204489 B,033-849-299-641-021,1992-01-28,1992,HU 382086 A,1986-09-04,US 77285985 A,1985-09-05,HYDROFORMILATING PROCESS WITH UTILIZING TRANSITION METAL CATALYST AND HYDROFORMILATING CATALYST PRECURZOR COMPOSITION,,UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT;;BILLING ERNEST,,https://lens.org/033-849-299-641-021,Granted Patent,no,0,0,44,44,0,B01J31/185;;B01J31/20;;B01J2231/321;;B01J2531/0266;;B01J2531/80;;B01J2531/822;;C07C45/50;;Y02P20/582;;C07C47/02;;B01J31/22;;C07C45/50;;C07C45/50;;B01J31/185;;B01J2531/0266;;B01J2231/321;;B01J2531/80;;B01J31/20;;B01J2531/822;;Y02P20/582,B01J31/00;;B01J31/18;;B01J31/20;;C07C47/02;;B01J31/22;;C07B61/00;;C07C45/00;;C07C45/50;;C07C67/00,,0,0,,,,EXPIRED
570,CN,A,CN 1041761 A,064-772-820-006-435,1990-05-02,1990,CN 89107465 A,1989-09-19,US 77285985 A,1985-09-05,TRANSITION METAL COMPLEX CATALYZED PRECURSOR COMPOSITION,,UNION CARBIDE CORP,BILLIG ERNST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/064-772-820-006-435,Patent Application,no,0,6,44,44,0,B01J31/185;;B01J31/20;;B01J2231/321;;B01J2531/0266;;B01J2531/80;;B01J2531/822;;C07C45/50;;Y02P20/582;;C07C47/02;;B01J31/22;;C07C45/50;;C07C45/50;;B01J31/185;;B01J2531/0266;;B01J2231/321;;B01J2531/80;;B01J31/20;;B01J2531/822;;Y02P20/582,C07C47/02;;B01J31/00;;B01J31/18;;B01J31/20;;B01J31/22;;C07B61/00;;C07C45/00;;C07C45/50;;C07C67/00,,0,0,,,,EXPIRED
571,KR,A,KR 20120049270 A,077-010-241-107-742,2012-05-16,2012,KR 20127004130 A,2010-05-22,US 70593710 A;;US 22662809 P,2009-07-17,METHODS FOR INHIBITING POLYMERIZATION OF VINYL AROMATIC COMPOUNDS DURING EXTRACTIVE DISTILLATION,,GTC TECHNOLOGY US LLC,SEALEY AMY;;BALL GEORGE A;;SLIMP B BRYANT,,https://lens.org/077-010-241-107-742,Patent Application,no,0,0,14,14,0,C07C7/08;;C07C7/20;;B01D3/00;;B01D3/34;;B01D3/40;;C07C7/08;;C07C7/20;;C07C15/46;;C07C7/08;;C07C7/20,B01D3/40;;C07C7/20;;C07C15/46,,0,0,,,,DISCONTINUED
572,AU,B2,AU 2006/254834 B2,142-134-706-759-856,2012-09-20,2012,AU 2006/254834 A,2006-06-08,US 68863405 P;;US 2006/0022515 W,2005-06-08,Treatment of patients with cancer therapy,"The present invention is directed to the identification of predictive markers that can be used to determine whether patients with cancer are clinically responsive or non-responsive to a therapeutic regimen prior to treatment. In particular, the present invention is directed to the use of certain individual and/or combinations of predictive markers, wherein the expression of the predictive markers correlates with responsiveness or non-responsiveness to a therapeutic regimen. Thus, by examining the expression levels of individual predictive markers and/or predictive markers comprising a marker set, it is possible to determine whether a therapeutic agent, or combination of agents, will be most likely to reduce the growth rate of tumors in a clinical setting.",MILLENNIUM PHARM INC,DAMOKOSH ANDREW I;;MULLIGAN GEORGE;;BRYANT BARBARA M,,https://lens.org/142-134-706-759-856,Granted Patent,no,1,0,22,22,0,C12Q2600/106;;C12Q2600/136;;G01N33/57407;;G01N33/57415;;G01N33/57419;;G01N33/57423;;G01N33/57434;;G01N33/57438;;G01N33/57449;;G01N2800/44;;G16B25/00;;G16B40/00;;A61K31/69;;C12Q1/6886;;A61P35/00;;A61P35/02;;G16H10/40;;G16H20/40;;Y02A90/10;;G16B40/10;;G16B25/10;;G16B25/00;;G16B40/00;;C12Q2600/106;;C12Q2600/136;;G01N33/57407;;G01N33/57415;;G01N33/57419;;G01N33/57423;;G01N33/57434;;G01N33/57438;;G01N33/57449;;G01N2800/44;;Y02A90/10;;G16H10/40;;G16H20/40;;G16B40/10;;G16B25/10;;C12Q1/6886;;A61K31/69;;C12Q2600/158;;G01N33/57426;;G06Q20/40,C12Q1/68;;G01N33/574;;G06Q50/00;;G16B25/10;;G16B40/10,,2,0,,,"""Affymetrix GeneChip Human Genome U133 Array Set HG-U133B"" GEO EXPRESSION, 11 March 2002; Accessed on 21/08/2012;;""Affymetrix GeneChip Human Genome U133 Array Set HG-U133A"" GEO EXPRESSION, 11 March 2002; Accessed on 21/08/2012",INACTIVE
573,US,A1,US 2021/0027303 A1,145-077-265-808-018,2021-01-28,2021,US 202017010141 A,2020-09-02,US 202017010141 A;;US 201916519463 A,2019-07-23,CROWDSOURCED ANNOTATION AND TAGGING SYSTEM FOR DIGITAL TRANSACTIONS,"A system for crowdsourcing annotations for transactions includes a crowdsourcing annotation database and a processor. The database stores crowdsourced annotations associated with merchants. The crowdsourced annotations are shared among, and contributed by, users of a community. The processor receives transaction data for a transaction by a user with a merchant. Relevant crowdsourced annotations associated with the merchant are retrieved from the database and sent to the user to enable to the user to annotate the transaction. The user provides an annotation for the transaction. The system dynamically updates the database based on the annotation provided by the user.",CAPITAL ONE SERVICES LLC,YEE BRYANT;;BULGAKOV MYKHAYLO;;BERGERON IV GEORGE LEON,CAPITAL ONE SERVICES LLC (2019-07-22),https://lens.org/145-077-265-808-018,Patent Application,yes,1,1,3,6,0,G06Q20/0425;;G06F40/169;;G06Q10/101;;G06Q30/0185;;G06Q30/06;;G06Q40/02;;G06Q20/42;;G06Q20/0425;;G06F40/169,G06Q20/42;;G06F40/169;;G06Q20/04,,0,0,,,,ACTIVE
574,NO,B,NO 167652 B,177-776-227-760-416,1991-08-19,1991,NO 863546 A,1986-09-04,US 77285985 A,1985-09-05,FREMGANGSMAATE FOR FREMSTILLING AV ALDEHYDER VED HYDROFORMYLERING AV OLEFINER SAMT KATALYSATORFORLOEPERBLANDING TIL BRUK VED FREMGANGSMAATEN.,,UNION CARBIDE CORP,BILLIG ERNST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/177-776-227-760-416,Unknown,no,0,0,44,44,0,B01J31/185;;B01J31/20;;B01J2231/321;;B01J2531/0266;;B01J2531/80;;B01J2531/822;;C07C45/50;;Y02P20/582;;C07C47/02;;B01J31/22;;C07C45/50;;C07C45/50;;B01J31/185;;B01J2531/0266;;B01J2231/321;;B01J2531/80;;B01J31/20;;B01J2531/822;;Y02P20/582,B01J31/00;;B01J31/18;;B01J31/20;;B01J31/22;;C07B61/00;;C07C47/02;;C07C45/00;;C07C45/50;;C07C67/00,,0,0,,,,EXPIRED
575,DE,A1,DE 2912574 A1,194-936-757-638-262,1979-10-04,1979,DE 2912574 A,1979-03-29,US 89183078 A,1978-03-30,MIT ACRYLYLGRUPPEN ABGESCHLOSSENE URETHANOLIGOMERE,,UNION CARBIDE CORP,PARK KISOON;;BRYANT GEORGE MACON;;CARR FRAZIER GLEN,"UNION CARBIDE CORP., 06817 DANBURY, CONN., US (1982-12-23)",https://lens.org/194-936-757-638-262,Patent Application,no,0,3,10,10,0,C08G18/348;;C08G18/348;;C08G18/672;;C08G18/672;;G03F7/038;;G03F7/038,C08F20/00;;C08F20/34;;C08F290/00;;C08F299/00;;C08G18/00;;C08G18/34;;C08G18/67;;G03F7/038,,2,0,,,"Chem.Abstr., Vol. 79, 1973, Ref. 106218y;;Ullmann: Encyklopädie der technischen Chemie, Bd. 15, 4. Aufl., 1978, S. 633-637",EXPIRED
576,NO,L,NO 904906 L,047-814-360-659-633,1987-03-06,1987,NO 904906 A,1990-11-12,NO 904906 A;;NO 863547 A;;US 77289185 A,1985-09-05,FREMGANGSMAATE FOR KARBONYLERING.,,UNION CARBIDE CORP,BILLIG ERNST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/047-814-360-659-633,Abstract,no,0,0,4,54,0,,B01J31/18;;C07C/;;C07C45/50;;C07C47/02;;C07F9/141,,0,0,,,,EXPIRED
577,AU,A1,AU 2006/254834 A1,049-422-044-475-023,2006-12-14,2006,AU 2006/254834 A,2006-06-08,US 68863405 P;;US 2006/0022515 W,2005-06-08,"Methods for the identification, assessment, and treatment of patients with cancer therapy",,MILLENNIUM PHARM INC,BRYANT BARBARA M;;DAMOKOSH ANDREW I;;MULLIGAN GEORGE,,https://lens.org/049-422-044-475-023,Patent Application,no,0,0,22,22,0,C12Q2600/106;;C12Q2600/136;;G01N33/57407;;G01N33/57415;;G01N33/57419;;G01N33/57423;;G01N33/57434;;G01N33/57438;;G01N33/57449;;G01N2800/44;;G16B25/00;;G16B40/00;;A61K31/69;;C12Q1/6886;;A61P35/00;;A61P35/02;;G16H10/40;;G16H20/40;;Y02A90/10;;G16B40/10;;G16B25/10;;G16B25/00;;G16B40/00;;C12Q2600/106;;C12Q2600/136;;G01N33/57407;;G01N33/57415;;G01N33/57419;;G01N33/57423;;G01N33/57434;;G01N33/57438;;G01N33/57449;;G01N2800/44;;Y02A90/10;;G16H10/40;;G16H20/40;;G16B40/10;;G16B25/10;;C12Q1/6886;;A61K31/69;;C12Q2600/158;;G01N33/57426;;G06Q20/40,C12Q1/68;;G01N33/574;;G06Q50/00;;G16B25/10;;G16B40/10,,0,0,,,,INACTIVE
578,AU,B2,AU 598749 B2,077-348-312-826-241,1990-07-05,1990,AU 1986/062372 A,1986-09-05,US 77289185 A,1985-09-05,BIS-PHOSPHITE COMPOUNDS,,UNION CARBIDE CORP,BILLIG ERNST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/077-348-312-826-241,Granted Patent,no,0,0,48,54,0,C07C45/50;;C07F9/65744;;C07F9/6578;;C07F15/008;;Y02P20/582;;C07F11/00;;C07F9/10;;C07F15/008;;C07F9/6578;;C07C45/50;;C07F9/65744;;Y02P20/582,B01J31/24;;B01J31/00;;B01J31/22;;C07B41/06;;C07B61/00;;C07C45/00;;C07C45/50;;C07C47/02;;C07C47/042;;C07C67/00;;C07F9/09;;C07F9/145;;C07F9/6574;;C07F9/6578;;C07F15/00,,0,0,,,,EXPIRED
579,US,B2,US 9500656 B2,130-127-160-131-555,2016-11-22,2016,US 89121307 A,2007-08-09,US 89121307 A;;US 83676406 P,2006-08-10,"Methods for the identification, assessment, and treatment of patients with cancer therapy","The present invention is directed to the identification of predictive markers that can be used to determine whether patients with cancer are expected to demonstrate long term or short term survival times. In particular, the present invention is directed to the use of certain individual and/or combinations of predictive markers, wherein the expression of the predictive markers correlates with expected short term or long term survival. Thus, by examining the expression levels of individual predictive markers and/or predictive markers comprising a marker set, it is possible to determine predicted patient survival.",BRYANT BARBARA M;;DAMOKOSH ANDREW I;;MULLIGAN GEORGE;;MILLENNIUM PHARM INC,BRYANT BARBARA M;;DAMOKOSH ANDREW I;;MULLIGAN GEORGE,MILLENNIUM PHARMACEUTICALS INC (2007-08-29),https://lens.org/130-127-160-131-555,Granted Patent,yes,5,0,13,13,0,A61P35/00;;C12Q1/6886;;C12Q1/6886;;C12Q2600/106;;C12Q2600/106;;C12Q2600/158;;C12Q2600/158;;G01N33/57484;;G01N33/57484,C12Q1/68;;G01N33/574,,30,25,034-134-907-055-024;;167-314-783-507-324;;000-593-301-503-75X;;056-155-059-361-926;;068-347-251-634-228;;021-456-993-936-150;;072-682-234-344-010;;035-934-547-101-796;;020-780-193-085-309;;058-525-874-916-05X;;010-409-170-828-73X;;030-452-336-676-211;;031-953-266-848-373;;096-909-831-558-222;;076-315-481-437-063;;018-414-727-065-627;;050-766-860-076-180;;031-412-700-934-484;;034-727-252-741-325;;029-257-549-603-631;;056-155-059-361-926;;004-324-136-280-950;;035-838-631-342-912;;026-266-776-966-85X;;085-216-933-751-612,1563002;;9816288;;10.1038/sj.onc.1206148;;12545167;;pmc362118;;10.1172/jci20032;;10.1172/jci200420032;;15067324;;10.1016/s0002-9440(10)63645-0;;pmc1868162;;12819026;;12949957;;10.1002/cyto.b.10025;;10.1158/0008-5472.can-03-2144;;14729608;;12360412;;10.1038/sj.onc.1205868;;10.1056/nejmoa043445;;15958804;;9815574;;10.1182/blood-2006-09-044974;;17185464;;16461304;;10741743;;10.1177/172460080001500204;;10883888;;15170136;;10.1097/01.coc.0000054894.64867.80;;12469156;;10.3892/or.10.1.121;;10.1046/j.1365-2257.2003.00492.x;;12542441;;15111617;;10.1200/jco.2004.05.111;;16855634;;10.1038/sj.leu.2404284;;9743306;;pmc2062970;;10.1038/bjc.1998.584;;pmc362118;;10.1172/jci20032;;10.1172/jci200420032;;15067324;;10.1054/bjoc.2001.1796;;pmc2363645;;11355958;;10.1093/annonc/mdi818;;15888750;;10.1111/j.1365-2141.2005.05867.x;;16412016;;16026739;;10.1016/j.beha.2005.01.011,"Tockman et al (Cancer Res., 1992, 52:2711s-2718s.;;Oesterreich, S et al, 1996 (Clin Cancer Res, 2: 1199-1206.;;Vandesompele J et al, 2003 (Oncogene, 22(3): 456-60).;;Barlow et al, 2004, Blood, 104(11): p. 414A.;;Glinsky et al, 2004, J Clin Invest, 113: 913-923.;;Hansel et al (Am J Pathol, 2003, 163(1): 217-229).;;Kern et al (Cytometry Part B Clin Cytom, 2003, 55(1): 29-36).;;Ginos et al (Cancer Res, 2004, 64: 55-63).;;Tockman et al (Cancer Res., 1992, 52:2711s-2718s).;;De Vos et al (Oncogene, 2002, 21(44): 6848-6857).;;Richardson et al (NEJM, 2005, 352(24): 2487-2498).;;Ball, N. Sharie, et al., ""Neuron-specific Hel-N1 and HuD as novel molecular markers of neuroblastoma: a correlation of HuD messenger RNA levels with favorable prognostic features,"" Clinical Cancer Research, vol. 3 (Oct. 1997) pp. 1859-1865.;;Mulligan, George, et al., ""Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib,"" Blood, vol. 109, No. 8 (Apr. 15, 2007) pp. 3177-3188.;;Van de Broek, Isabelle, et al., ""Clinical significance of chemokine receptor (CCR1, CCR2 and CXCR4) expression in human myeloma cells: the association with disease activity and survival,"" The Hematology Journal, vol. 91, No. 2 (2006) pp. 200-206.;;Moldvay, Judith, et al., ""Predictive survival markers in patients with surgically resected non-small cell lung carcinoma,"" Clinical Cancer Research, vol. 6 (Mar. 2000) pp. 1125-1134.;;Colakovic, S., et al., ""Prognostic value of CA125 kinetics and half-life in advanced ovarian cancer,"" The International Journal of Biological Markers, vol. 15, No. 2 (Apr.-Jun. 2000) pp. 147-152.;;Oshita, F., et al., ""High expression of integrin betal and p53 is a greater poor prognostic factor than clinical stage in small-cell lung cancer,"" American Journal of Clinical Oncology, vol. 27, No. 3 (Jun. 2004) pp. 215-219.;;Yang, Q., et al., ""Prognostic value of Bcl-2 in invasive breast cancer receiving chemotherapy and endocrine therapy,"" Oncology Reports, vol. 10, No. 1 (Jan.-Feb. 2003) pp. 121-125.;;Alexandrakis, M. G., et al., ""The clinical and prognostic significance of erythrocyte sedimentation rate (ESR), serum interleukin-6 (IL-6) and acute phase protein levels in multiple myeloma,"" Clinical Laboratory Haematology, vol. 25, No. 1 (Feb. 2003) pp. 41-46.;;International Search Report and Written Opinion dated Sep. 18, 2008 from corresponding PCT Application PCT/US07/17716, page? cannot publish.;;Levine, David M., et al., ""Statistics for Managers Using Microsoft Exce;"" Fifth Edition, published by Pearson Prentice Hall, Upper Saddle River, New Jersey, 2008, pp. 265-270.;;Richardson, Paul G., et al., ""Prognostic factors for response parameters and overall survival in patients with multiple myeloma (MM) following treatment with Bortezomib,"" 45th Annual Meeting of the American Society of Hematology, San Diego, CA, USA, Dec. 6-9, 2003, Poster 1629 (entire poster and magnified central portion of poster).;;Durie, Brian G.M. et al., ""Magnitude of Response With Myeloma Frontline Therapy Does Not Predict Outcome: Importance of Time to Progression in Southwest Oncology Group Chemotherapy Trials,"" Journal of Clinical Oncology, vol. 22, No. 10 (May 15, 2004) pp. 1857-1863.;;Durie, Brian G.M. et al., ""International Uniform Response Criteria for Multiple Myeloma,"" Leukemia, vol. 20, (2006) pp. 1467-1473.;;Sjostrom, J. et al., ""A Multivariate Analysis of Tumour Biological Factors Predicting Response to Cytotoxic Treatment in Advanced Breast Cancer,"" British Journal of Cancer, vol. 78, No. 6 (1998) pp. 812-815.;;Glinsky, Gennadi, V., et al., ""Gene expression profiling predicts clinical outcome of prostate cancer,"" The Journal of Clinical Investigation, vol. 113, No. 6 (Mar. 2004) Supplemental Data (21 pages). Downloaded from http://www.jci.org/cgi/content/full/113/6/913/DC1 [on-line], downloaded Nov. 17, 2010.;;Johnson, J. I., et al., ""Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials,"" British Journal of Cancer, vol. 84, No. 10 (2001) pp. 1424-1431.;;Harrouseau, JL, et al., ""ESMO Minimum Clinical Recommendations for Diagnosis, Treatment and Follow-up of Multiple Myeloma"", Ann. Oncol., 2005, vol. 16, Suppl 1, pp. i45-47.;;Smith A, et al., ""Guidelines on the Diagnosis and Management of Multiple Myeloma 2005"", Brittish Journal of Haematology., 2005, vol. 132, pp. 410-451.;;Rajkumar SV, et al., ""Conventional Therapy and Approach to Management"", Best Practice & Research Clinical Haematology, 2005, vol. 18, No. 4, pp. 585-601.",ACTIVE
580,CS,A3,CS 8606430 A3,130-584-991-373-399,1992-02-19,1992,CS 643086 A,1986-09-04,US 77285985 A,1985-09-05,PROCESS FOR PREPARING ALDEHYDES BY HYDROFORMYLATION,,UNION CARBIDE CORP,BILLIG ERNST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/130-584-991-373-399,Patent Application,no,0,0,44,44,0,B01J31/185;;B01J31/20;;B01J2231/321;;B01J2531/0266;;B01J2531/80;;B01J2531/822;;C07C45/50;;Y02P20/582;;C07C47/02;;B01J31/22;;C07C45/50;;C07C45/50;;B01J31/185;;B01J2531/0266;;B01J2231/321;;B01J2531/80;;B01J31/20;;B01J2531/822;;Y02P20/582,C07C47/02;;B01J31/00;;B01J31/18;;B01J31/20;;B01J31/22;;C07B61/00;;C07C45/00;;C07C45/50;;C07C67/00,,0,0,,,,EXPIRED
581,CA,A,CA 840964 A,001-152-867-431-065,1970-05-05,1970,CA 840964D A,,CA 840964T A,,ELASTOMER-BACKED CARPET,,UNION CARBIDE CORP,BRYANT GEORGE M;;CAREY ROBERT J;;WALTER ANDREW T,,https://lens.org/001-152-867-431-065,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
582,CA,A,CA 692029 A,034-578-083-537-553,1964-08-04,1964,CA 692029D A,,CA 692029T A,,POLYOLEFIN COMPOSITIONS,,UNION CARBIDE CORP,BRYANT GEORGE M;;ZUTTY NATHAN L;;BAUM BERNARD O,,https://lens.org/034-578-083-537-553,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
583,EP,B1,EP 0350922 B1,054-068-438-036-033,1994-09-21,1994,EP 89112857 A,1989-07-13,US 21891188 A;;US 37320689 A,1988-07-14,Process for catalyst-aldehyde product separation.,,UNION CARBIDE CHEM PLASTIC,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT;;PETERSON RONALD ROBERT,,https://lens.org/054-068-438-036-033,Granted Patent,yes,4,0,20,26,0,C07C45/80;;C07C47/02;;C07C45/50,C07C45/50;;C07C45/80,,0,0,,,,EXPIRED
584,NO,D0,NO 981726 D0,112-034-597-326-456,1998-04-16,1998,NO 981726 A,1998-04-16,US 83740197 A,1997-04-17,Br÷nnskjerm med alternativ bane som har beskyttet shuntforbindelse,,MOBIL OIL CORP;;U S FILTER JOHNSON SCREENS,BRYANT DAVID WADE;;TUPY STEVEN J;;GILLESPIE GEORGE A,,https://lens.org/112-034-597-326-456,Patent Application,no,0,0,11,11,0,E21B43/04;;E21B43/08;;E21B43/04;;E21B43/08,E21B43/04;;E21B43/08,,0,0,,,,EXPIRED
585,US,A,US 4562097 A,129-938-770-399-800,1985-12-31,1985,US 55657383 A,1983-11-30,US 55657383 A;;US 14822680 A,1980-05-09,Process of treating fabrics with foam,"A continuous process for the application of a textile treating composition in the form of a froth or foam to a substrate such as textiles. The process enables the application in a uniform manner of any foamable functional composition that can be used in the treatment of a textile fabric to improve its properties. In the process of foamed functional treating composition is continuously conveyed to the applicator nozzle, the substrate is continuously passed across and in contact with the applicator nozzle so as to simultaneously contact said substrate with the foamed composition and the applicator nozzle at a rate such that a predetermined controlled amount of the foamed functional treating composition is uniformly applied to the surface of the substrate and the foam immediately breaks on contact with the substrate and is readily absorbed. The process of this invention generally leaves the textile material essentially dry to the touch and thus requires less energy consumption in drying and further treatment of the textile.",UNION CARBIDE CORP,WALTER ANDREW T;;BRYANT GEORGE M;;READSHAW RONALD L,UNION CARBIDE CORPORATION (1983-11-18),https://lens.org/129-938-770-399-800,Granted Patent,yes,15,64,1,1,0,D06B19/0094;;D06M23/04;;D06P1/965;;D06B19/0094;;D06P1/965;;D06M23/04,D06B19/00;;D06M23/04;;D06P1/96,B2E EBB           BB          -;;B2E E1107         BB          -;;B2E E1123         BB          -;;B2E E1204         BB          -;;B2E E1306         BB          -;;B2E E1701         BB          -;;B2E E403S         BB          -;;B2E E404S         BB          -;;B2E E422T         BB          -;;B2E E423T         BB          -;;B2E E438T         BB          -;;B2E E443S         BB          -;;U1S S1597,3,3,107-472-516-737-00X;;067-744-992-254-954;;065-317-716-740-738,10.1021/bk-1979-0107.ch012;;10.1177/004051758205200607;;10.1177/004051758405400401,"Bryant, G. M., Energy and Related Savings From Controlled Low Wet Pick Up Application Of Textile Chemicals And Dyes Via Semistable Foams , American Chemical Society Symposium Series No. 107, 1979, pp. 145 154.;;Baker, K. L., et al., Foam Finishing Technology , Textile Research Journal, vol. 52, No. 6, Jun. 1982, pp. 395 403.;;Bryant, G. M., Dynamic Sorption Of Semistable Foams By Fabrics , Textile Research Journal, vol. 54, No. 4, Apr. 1984, pp. 217 226.",EXPIRED
586,CZ,A3,CZ 57894 A3,157-194-691-751-42X,1994-12-15,1994,CZ 57894 A,1994-03-14,US 3512193 A,1993-03-19,SULFONATE AND CARBAMATE DERIVATIVE OF 3-AROYLBENZO(b)THIOPHENES AND PHARMACEUTICAL PREPARATION IN WHICH IT IS COMPRISED,"The present invention relates to sulfonate and carbamate derivatives of 3-aroylbenzo[b]thiophenes, pharmaceutical formulations containing these compounds and methods of using such compounds for inhibiting the loss of bone, lowering serum cholesterol levels and therapeutically treating hormone dependent mammalian breast and uterine carcinoma.",LILLY CO ELI,BLACK LARRY JOHN;;BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH,,https://lens.org/157-194-691-751-42X,Patent Application,no,0,1,32,32,0,C07D333/56;;A61P19/10;;A61P35/00;;A61P3/06;;A61P37/08;;A61P43/00;;A61P9/10;;C07D333/56,A61K31/40;;A61K31/38;;A61K31/445;;A61K31/55;;A61P3/06;;A61P9/10;;A61P19/10;;A61P35/00;;A61P37/08;;A61P43/00;;C07D333/56;;C07D409/12,,0,0,,,,PENDING
587,CA,A1,CA 2214922 A1,192-038-639-775-437,1998-03-27,1998,CA 2214922 A,1997-09-02,US 2744996 P,1996-09-27,"BENZOTHIOPHENE COMPOUNDS, COMPOSITIONS, AND METHODS","The invention provides benzothiophene compounds, formulations, and methods of inhibiting bone loss or bone resorption, particularly osteoporosis, cardiovascular-related pathological conditions, including hyperlipidemia.",LILLY CO ELI,CULLINAN GEORGE JOSEPH;;BRYANT HENRY UHLMAN;;DODGE JEFFREY ALAN,,https://lens.org/192-038-639-775-437,Patent Application,no,0,0,9,9,0,C07D333/56;;C07D409/12;;C07D417/12;;A61P19/10;;A61P3/06;;A61P43/00;;C07D409/12;;C07D417/12;;C07D333/56,C07D333/16;;A61K31/38;;A61K31/381;;A61K31/425;;A61K31/426;;A61K31/44;;A61K31/4433;;A61P3/06;;A61P19/10;;A61P43/00;;C07D277/20;;C07D277/24;;C07D277/34;;C07D333/32;;C07D333/56;;C07D333/64;;C07D409/12;;C07D417/12,,0,0,,,,DISCONTINUED
588,AU,B2,AU 670177 B2,185-543-585-785-077,1996-07-04,1996,AU 1994/057863 A,1994-03-16,US 3512193 A,1993-03-19,Sulfonate and carbamate derivatives of 3-aroylbenzo(b)thiophenes,"The present invention relates to sulfonate and carbamate derivatives of 3-aroylbenzo[b]thiophenes, pharmaceutical formulations containing these compounds and methods of using such compounds for inhibiting the loss of bone, lowering serum cholesterol levels and therapeutically treating hormone dependent mammalian breast and uterine carcinoma.",LILLY CO ELI,BLACK LARRY JOHN;;BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH,,https://lens.org/185-543-585-785-077,Granted Patent,no,1,0,32,32,0,C07D333/56;;A61P19/10;;A61P35/00;;A61P3/06;;A61P37/08;;A61P43/00;;A61P9/10;;C07D333/56,A61K31/40;;A61K31/38;;A61K31/445;;A61K31/55;;A61P3/06;;A61P9/10;;A61P19/10;;A61P35/00;;A61P37/08;;A61P43/00;;C07D333/56;;C07D409/12,,0,0,,,,EXPIRED
589,CN,A,CN 1046731 A,020-717-513-692-051,1990-11-07,1990,CN 89107320 A,1989-07-13,US 21891188 A;;US 37320689 A,1988-07-14,PROCESS FOR CATALYST ALDEHYDE PRODUCT SEPARATION,,UNION CARBIDE CORP,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT;;PETERSON RONALD ROBERT,,https://lens.org/020-717-513-692-051,Patent Application,no,0,0,20,26,0,C07C45/80;;C07C47/02;;C07C45/50,C07C45/50;;C07C45/80,,0,0,,,,EXPIRED
590,US,A,US 5798351 A,045-639-838-289-822,1998-08-25,1998,US 95853597 A,1997-10-27,US 95853597 A;;US 39244595 A;;US 3512193 A,1993-03-19,Sulfonate and carbamate derivatives of 3-aroylbenzo[b]thiophenes,"The present invention relates to sulfonate and carbamate derivatives of 3-aroylbenzo�b!thiophenes, pharmaceutical formulations containing these compounds and methods of using such compounds for inhibiting the loss of bone, lowering serum cholesterol levels and therapeutically treating hormone dependent mammalian breast and uterine carcinoma.",LILLY CO ELI,BLACK LARRY J;;BRYANT HENRY U;;CULLINAN GEORGE J,,https://lens.org/045-639-838-289-822,Granted Patent,yes,3,0,32,32,0,C07D333/56;;A61P19/10;;A61P35/00;;A61P3/06;;A61P37/08;;A61P43/00;;A61P9/10;;C07D333/56,A61K31/38;;A61K31/445;;A61K31/55;;A61K31/40;;A61P3/06;;A61P9/10;;A61P19/10;;A61P35/00;;A61P37/08;;A61P43/00;;C07D333/56;;C07D409/12,514/212;;514/444;;540/596,0,0,,,,EXPIRED
591,EP,A1,EP 0697391 A1,052-468-079-127-40X,1996-02-21,1996,EP 95113051 A,1995-08-18,US 29302894 A,1994-08-19,Stabilization of phosphite ligands in hydroformylation process,"The present invention provides a hydroformylation process comprising: (1) forming a reaction mixture containing: (a) an olefinic compound, (b) hydrogen, (c) carbon monoxide, (d) a phosphite in which each phosphorus atom is bonded to three oxygen atoms and at least one such oxygen atom is bonded to a carbon atom of an aromatic ring that is adjacent to another carbon atom of said ring having a pendant monovalent group having a steric hindrance at least as great as the steric hindrance of the isopropyl group, (e) a catalytic amount of rhodium, and (f) a Group VIII metal (other than a rhodium) in an amount sufficient to reduce the rhodium-catalyzed decomposition of the phosphite during the hydroformylation process; and (2) maintaining the reaction mixture under conditions at which the olefinic compound reacts with the hydrogen and carbon monoxide to form an aldehyde.",UNION CARBIDE CHEM PLASTIC,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT;;MAHER JOHN MICHAEL,,https://lens.org/052-468-079-127-40X,Patent Application,yes,11,5,9,9,0,B01J31/185;;B01J2231/321;;B01J2531/0288;;B01J2531/80;;B01J2531/821;;B01J2531/824;;B01J2531/845;;C07C45/50;;C07C45/50;;B01J2531/80;;B01J31/185;;B01J2531/821;;B01J2231/321;;B01J2531/0288;;B01J2531/845;;B01J2531/824,B01J31/18;;C07C45/50,,0,0,,,,EXPIRED
592,DE,D1,DE 69418639 D1,062-754-384-800-250,1999-07-01,1999,DE 69418639 T,1994-03-16,US 3512193 A,1993-03-19,Sulfonat- und Carbamatderivate von 3-aroyl-benzo(beta)Thiophenen,"The present invention relates to sulfonate and carbamate derivatives of 3-aroylbenzo[b]thiophenes, pharmaceutical formulations containing these compounds and methods of using such compounds for inhibiting the loss of bone, lowering serum cholesterol levels and therapeutically treating hormone dependent mammalian breast and uterine carcinoma.",LILLY CO ELI,BLACK LARRY JOHN;;BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH,,https://lens.org/062-754-384-800-250,Granted Patent,no,0,0,32,32,0,C07D333/56;;A61P19/10;;A61P35/00;;A61P3/06;;A61P37/08;;A61P43/00;;A61P9/10;;C07D333/56,A61K31/40;;A61K31/38;;A61K31/445;;A61K31/55;;A61P3/06;;A61P9/10;;A61P19/10;;A61P35/00;;A61P37/08;;A61P43/00;;C07D333/56;;C07D409/12,,0,0,,,,EXPIRED
593,CA,A1,CA 2878845 A1,094-353-870-215-464,2014-01-16,2014,CA 2878845 A,2013-03-13,US 201261671485 P;;US 2013/0030713 W,2012-07-13,SQUEEZABLE BOTTLE INCLUDING AN ORNAMENTAL FEATURE,"A squeezable bottle includes a panel having at least one ornamental feature thereon. The panel includes a first facet having a length and a width and a second facet having a length and width. The lengths of the first and second facets extend in a direction generally parallel to a length of the squeezable bottle. The second facet is disposed adjacent to and defines a first interface with the first facet, and the first interface defines a first one of the at least one ornamental features. A generally planar surface of the first facet is disposed at an angle relative to a generally planar surface of the second facet such that the panel is reversibly deformable.",HEINZ CO H J,BRYANT MICHAEL P;;MCMAHON MICHAEL D;;NUKUTO GEORGE IKUYA,,https://lens.org/094-353-870-215-464,Patent Application,no,0,0,11,11,0,B65D1/32;;B65D23/102;;B65D47/0804;;B65D23/102;;B65D1/32;;B65D47/0804;;B65D2501/0081;;B65D23/102;;B65D47/0804;;B65D1/32;;B65D2501/0081;;B65D1/0223;;B65D2203/00,B65D35/08,,0,0,,,,DISCONTINUED
594,FI,A0,FI 941262 A0,115-244-251-060-472,1994-03-17,1994,FI 941262 A,1994-03-17,US 3512193 A,1993-03-19,3-aroyylibentso(b)tiofeenien sulfonaatti- ja karbamaattijohdannaisia,"The present invention relates to sulfonate and carbamate derivatives of 3-aroylbenzo[b]thiophenes, pharmaceutical formulations containing these compounds and methods of using such compounds for inhibiting the loss of bone, lowering serum cholesterol levels and therapeutically treating hormone dependent mammalian breast and uterine carcinoma.",LILLY CO ELI,BLACK LARRY JOHN;;BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH,,https://lens.org/115-244-251-060-472,Patent Application,no,0,0,32,32,0,C07D333/56;;A61P19/10;;A61P35/00;;A61P3/06;;A61P37/08;;A61P43/00;;A61P9/10;;C07D333/56,A61K31/38;;A61K31/40;;A61K31/445;;A61K31/55;;A61P3/06;;A61P9/10;;A61P19/10;;A61P35/00;;A61P37/08;;A61P43/00;;C07D333/56;;C07D409/12,,0,0,,,,DISCONTINUED
595,EP,A2,EP 0897721 A2,112-736-981-269-878,1999-02-24,1999,EP 98306551 A,1998-08-18,US 5620297 P,1997-08-21,Benzo(b)thiophene derivatives for inhibiting detrimental side-effects due to GnRH or GnRH agonist administration,"The use of a compound of formula I
   wherein R 1  and R 3  are, independently, -H, -CH 3 , -CO(C 1 -C 6  alkyl), or -COAr, where Ar is optionally substituted phenyl;
 R 3  is selected from the group consisting of pyrrolidine, piperidine, and hexamethyleneimino; or a pharmaceutically acceptable salt or solvate thereof, in the preparation of a pharmaceutical formulation for inhibiting detrimental side-effects of GnRH or a GnRH agonist in a mammal.",LILLY CO ELI,BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH;;DODGE JEFFREY ALAN,,https://lens.org/112-736-981-269-878,Patent Application,yes,0,1,7,7,0,A61K31/44;;A61K31/44;;A61K31/4535;;A61K31/4535;;A61K38/09;;A61K38/09;;A61P43/00,C07D333/56;;A61K31/4025;;A61K31/44;;A61K31/4535;;A61K31/55;;A61K38/09;;A61P43/00,,0,0,,,,DISCONTINUED
596,US,A,US 1607387 A,115-705-221-174-072,1926-11-16,1926,US 72057424 A,1924-06-17,GB 1607387X A,1923-06-26,Party-line telephone,,RELAY AUTOMATIC TELEPHONE CO,HENRY BRYANT GEORGE;;BERTIE JOHNSON BENJAMIN;;GRANT VANNECK RICHARD,,https://lens.org/115-705-221-174-072,Granted Patent,no,0,0,1,1,0,H04Q3/0008;;H04Q3/0008,H04Q3/00,,0,0,,,,EXPIRED
597,DK,T3,DK 0617030 T3,148-433-983-074-175,1999-11-08,1999,DK 94301871 T,1994-03-16,US 3512193 A,1993-03-19,Sulfonat- og carbamatderivater af 3-aroylbenzo(beta)thiophener,"The present invention relates to sulfonate and carbamate derivatives of 3-aroylbenzo[b]thiophenes, pharmaceutical formulations containing these compounds and methods of using such compounds for inhibiting the loss of bone, lowering serum cholesterol levels and therapeutically treating hormone dependent mammalian breast and uterine carcinoma.",LILLY CO ELI,BLACK LARRY JOHN;;BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH,,https://lens.org/148-433-983-074-175,Granted Patent,no,0,0,32,32,0,C07D333/56;;A61P19/10;;A61P35/00;;A61P3/06;;A61P37/08;;A61P43/00;;A61P9/10;;C07D333/56,A61K31/40;;A61K31/38;;A61K31/445;;A61K31/55;;A61P3/06;;A61P9/10;;A61P19/10;;A61P35/00;;A61P37/08;;A61P43/00;;C07D333/56;;C07D409/12,,0,0,,,,EXPIRED
598,JP,A,JP H10109984 A,149-855-793-149-611,1998-04-28,1998,JP 25995097 A,1997-09-25,US 2744996 P,1996-09-27,"BENZOTHIOPHENE COMPOUND, COMPOSITION AND THEIR USING METHOD","PROBLEM TO BE SOLVED: To provide a new benzothiophene compound useful for preventing and curing of postmenopausal syndrome such as cardiovascular relative pathosis containing osseous loss or osseous reabsorption, especially osteoporosis and hyperlipidemia. SOLUTION: This benzothiophene compound is exemplified by a compound of formula I [R<1> is H, OH, an O (1-4C alkyl), an OCO (1-6C alkyl), etc.; R<2> is H, OH, an O (1-4C alkyl), OCOAr, etc.; Ar is phenyl or an OSO2 (2-6C alkyl); R<3> is CH3 , thiophenyl, etc.; (n) is 0-10], e.g. [6-hydroxy-2-(4-hydroxyphenyl) benzo[b]thien-3-yl][4- 2-(cyclohexyl)ethoxy}phenyl] methanone. The compound of the formula I is obtained by reacting a compound of formula II with K2 CO3 and a compound of the formula RBr, etc. A dosage of the compound of the formula I is 15-1,000mg/1 day, preferably 15-80mg (×1-3 times/1 day) per an adult, during 30 days-6 months or chronically.",LILLY CO ELI,BRYANT HENRY ALMAN;;CULLINAN GEORGE JOSEPH;;DODGE JEFFREY ALAN,,https://lens.org/149-855-793-149-611,Patent Application,no,0,0,9,9,0,C07D333/56;;C07D409/12;;C07D417/12;;A61P19/10;;A61P3/06;;A61P43/00;;C07D409/12;;C07D417/12;;C07D333/56,A61K31/38;;A61K31/381;;A61K31/425;;A61K31/426;;A61K31/44;;A61K31/4433;;A61P3/06;;A61P19/10;;A61P43/00;;C07D277/20;;C07D333/16;;C07D277/24;;C07D277/34;;C07D333/32;;C07D333/56;;C07D333/64;;C07D409/12;;C07D417/12,,0,0,,,,DISCONTINUED
599,FI,A,FI 861221 A,169-800-296-340-420,1986-09-23,1986,FI 861221 A,1986-03-21,US 71516985 A,1985-03-22,SKUMBLANDNINGAR FOER ANVAENDNING VID PAPPERSBEHANDLING.,"Foamable compositions having low concentrations of select foaming agents provide uniform distribution of paper treating agents onto moving paper, including high speed applications, and treated paper having unimpaired properties.",UNION CARBIDE CORP,BROWN RUSSEL LEE;;BRYANT GEORGE MACON;;CUNNINGHAM CHARLES JAMES,,https://lens.org/169-800-296-340-420,Patent Application,no,0,0,11,11,0,D21H17/00;;D21H17/07;;D21H17/10;;D21H17/14;;D21H21/56;;Y10T428/277;;Y10T428/249987;;Y10T428/277;;Y10T428/249987;;D21H17/07;;D21H17/14;;D21H17/10;;D21H21/56;;D21H17/00,C08J9/06;;C08L101/00;;D21H17/00;;D21H17/07;;D21H17/10;;D21H17/14;;D21H19/00;;D21H19/10;;D21H21/56,,0,0,,,,DISCONTINUED
600,US,A,US 3300548 A,159-389-717-288-799,1967-01-24,1967,US 14954161 A,1961-11-02,US 14954161 A,1961-11-02,Polyolefins containing copolymers of ethylene and nu-vinyl-nu-hydrocarbyl acetamides,,UNION CARBIDE CORP,BAUM BERNARD O;;BRYANT GEORGE M;;ZUTTY NATHAN L,,https://lens.org/159-389-717-288-799,Granted Patent,no,4,6,8,20,0,C04B35/521;;C08L23/02;;C08L23/06;;C08L23/08;;C08L23/0815;;C08L23/0892;;C08L23/10;;C08L23/12;;C08L23/18;;C08L2203/12;;D01F6/46;;C08L23/08;;C08L23/18;;C08L23/10;;C08L23/02;;C08L23/0892;;C08L23/0815;;C08L2203/12;;C04B35/521;;C08L23/06;;C08L23/12;;D01F6/46;;Y10S8/928,C04B35/52;;C08L23/02;;C08L23/06;;C08L23/08;;C08L23/12;;C08L23/18;;D01F6/04,,0,0,,,,EXPIRED
601,NO,B1,NO 319237 B1,043-546-204-366-229,2005-07-04,2005,NO 981726 A,1998-04-16,US 83740197 A,1997-04-17,Bronnfilter med alternativ stromningsbane,,MOBIL OIL CORP;;U S FILTER JOHNSON SCREENS,BRYANT DAVID WADE;;TUPY STEVEN J;;GILLESPIE GEORGE A,,https://lens.org/043-546-204-366-229,Granted Patent,no,0,0,11,11,0,E21B43/04;;E21B43/08;;E21B43/04;;E21B43/08,E21B43/04;;E21B43/08,,0,0,,,,EXPIRED
602,DK,A,DK 423486 A,050-852-828-404-771,1987-03-06,1987,DK 423486 A,1986-09-04,US 77285985 A,1985-09-05,OVERGANGSMETAL-POLYPHOSPHIT-KATALYSATORER OG DERES ANVENDELSE,,UNION CARBIDE CORP,BILLIG ERNST NMN;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/050-852-828-404-771,Patent Application,no,0,0,44,44,0,B01J31/185;;B01J31/20;;B01J2231/321;;B01J2531/0266;;B01J2531/80;;B01J2531/822;;C07C45/50;;Y02P20/582;;C07C47/02;;B01J31/22;;C07C45/50;;C07C45/50;;B01J31/185;;B01J2531/0266;;B01J2231/321;;B01J2531/80;;B01J31/20;;B01J2531/822;;Y02P20/582,B01J31/00;;B01J31/18;;B01J31/20;;C07C47/02;;B01J31/22;;C07B61/00;;C07C45/00;;C07C45/50;;C07C67/00,,0,0,,,,DISCONTINUED
603,US,A,US 1225291 A,071-985-446-399-509,1917-05-08,1917,US 10176916 A,1916-06-05,US 10176916 A,1916-06-05,TELEPHONE SYSTEM.,,RELAY AUTOMATIC TELEPHONE CO,WARD FRANCIS MORLEY;;BRYANT GEORGE HENRY;;INMAN THOMAS MONTAGU,,https://lens.org/071-985-446-399-509,Granted Patent,no,0,1,1,1,0,H04M3/12;;H04M3/12,,,0,0,,,,EXPIRED
604,NO,L,NO 981726 L,060-788-823-974-811,1998-10-19,1998,NO 981726 A,1998-04-16,US 83740197 A,1997-04-17,Br°nnskjerm med alternativ bane som har beskyttet shuntforbindelse,,MOBIL OIL CORP;;U S FILTER JOHNSON SCREENS,BRYANT DAVID WADE;;TUPY STEVEN J;;GILLESPIE GEORGE A,,https://lens.org/060-788-823-974-811,Abstract,no,0,0,11,11,0,E21B43/04;;E21B43/08;;E21B43/04;;E21B43/08,E21B43/04;;E21B43/08,,0,0,,,,EXPIRED
605,US,A,US 4099913 A,086-726-994-814-951,1978-07-11,1978,US 67038076 A,1976-03-25,US 67038076 A;;GB 2036177 A,1976-03-25,Foams for treating fabrics,"Foams containing a functional textile treating compound for application to a substrate such as a fabric or textile. The use of foams enables the application in uniform manner of many functional compositions that can be used in the treatment of a textile fabric to improve its properties. The foam compositions of this invention generally leave the textile material essentially dry to the touch and thus require less energy consumption in drying and further treatment of the textile. The foams have a foam density of 0.005 to 0.3 gram per cc, and average bubble size of from 0.05 to 0.5 millimeters in diameter and a foam half-life of from one to sixty minutes.",UNION CARBIDE CORP,WALTER ANDREW TAINTER;;BRYANT GEORGE MACON;;READSHAW RONALD LOUIS,,https://lens.org/086-726-994-814-951,Granted Patent,yes,7,101,2,6,0,C09B67/0097;;D06B19/0094;;D06M15/423;;D06M15/647;;D06M23/04;;D06P1/965;;D21H21/56;;D06L4/664;;D06M15/423;;D06M15/647;;D06P1/965;;D06M23/04;;C09B67/0097;;D21H21/56;;D06B19/0094;;D06L4/664,C09B67/02;;D06B19/00;;D06L3/12;;D06M15/423;;D06M15/647;;D06M23/04;;D06P1/96;;D21H21/56,8/173,0,0,,,,EXPIRED
606,US,B2,US 6715250 B2,085-718-483-035-298,2004-04-06,2004,US 18693902 A,2002-06-28,US 18693902 A;;US 76602401 A;;US 39200499 A,1999-09-08,Plastic siding panel,"
    A plastic panel for attachment to an exterior wall of a building includes a body, an attachment hem attached to the body and defining at least one aperture for a fastener, and a side flange extending laterally outwardly of the body. The side flange defines a fastening slot for attaching the panel to a building wall. The fastening slot extends at a predetermined acute angle relative to horizontal, preferably about 10-20 relative to horizontal, and about 15 in a particularly preferred embodiment. The fastening slot is preferably elongated and narrow so that the head of a metal fastener extends over opposed upper and lower edges of the slot. 
",ALCOA INC,BRYANT DAVID A;;ERNST DANIEL J;;GRIMAN GEORGE A,ALCOA INC (2002-07-28);;ALCOA HOME EXTERIORS INC (2006-09-01),https://lens.org/085-718-483-035-298,Granted Patent,yes,13,52,2,8,0,E04F13/0864;;E04F13/0864,E04F13/08,52/528;;52/522;;52/523;;52/544;;52/553;;52/555;;52/573.1,0,0,,,,EXPIRED
607,DE,T2,DE 69714666 T2,116-207-370-157-369,2003-04-03,2003,DE 69714666 T,1997-06-25,US 2151396 P,1996-07-10,Benzothiophen-Verbindungen und Verfahren zur Anwendung,,LILLY CO ELI,BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH;;FAHEY KENNAN JOSEPH,,https://lens.org/116-207-370-157-369,Granted Patent,no,0,0,7,7,0,A61K31/565;;A61K31/57;;A61K31/66;;A61K38/29;;C07D333/56;;A61P13/02;;A61P15/00;;A61P35/00;;A61P43/00,A61K31/38;;A61K31/381;;A61K31/565;;A61K31/57;;A61K31/66;;A61K38/29;;A61P13/02;;A61P15/00;;A61P35/00;;A61P43/00;;C07D333/56,,0,0,,,,EXPIRED
608,WO,A1,WO 1999/008677 A1,116-257-004-214-234,1999-02-25,1999,US 9817116 W,1998-08-18,US 5620297 P,1997-08-21,METHODS FOR INHIBITING DETRIMENTAL SIDE-EFFECTS DUE TO GnRH OR GnRH AGONIST ADMINISTRATION,"A method of inhibiting detrimental side-effects of GnRH or GnRH agonist administration in a mammal which comprises the administration to a mammal in need thereof of an effective amount of a compound of formula (I), wherein R?1 and R3¿ are, independently, -H, -CH¿3?, -CO(C1-C6 alkyl), or -COAr, where Ar is optionally substituted phenyl; R?3¿ is selected from the group consisting of pyrrolidine, piperidine, and hexamethyleneimino; or a pharmaceutically acceptable salt or solvate thereof.",LILLY CO ELI;;BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH;;DODGE JEFFREY ALAN,BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH;;DODGE JEFFREY ALAN,,https://lens.org/116-257-004-214-234,Patent Application,yes,3,0,7,7,0,A61K31/44;;A61K31/44;;A61K31/4535;;A61K31/4535;;A61K38/09;;A61K38/09;;A61P43/00,C07D333/56;;A61K31/4025;;A61K31/44;;A61K31/4535;;A61K31/55;;A61K38/09;;A61P43/00,,0,0,,,,PENDING
609,EP,A3,EP 0897721 A3,105-688-759-597-101,1999-03-03,1999,EP 98306551 A,1998-08-18,US 5620297 P,1997-08-21,Benzo(b)thiophene derivatives for inhibiting detrimental side-effects due to GnRH or GnRH agonist administration,"The use of a compound of formula I
   wherein R 1  and R 3  are, independently, -H, -CH 3 , -CO(C 1 -C 6  alkyl), or -COAr, where Ar is optionally substituted phenyl;
 R 3  is selected from the group consisting of pyrrolidine, piperidine, and hexamethyleneimino; or a pharmaceutically acceptable salt or solvate thereof, in the preparation of a pharmaceutical formulation for inhibiting detrimental side-effects of GnRH or a GnRH agonist in a mammal.",LILLY CO ELI,"Bryant, Henry Uhlman;;Cullinan, George Joseph;;Dodge, Jeffrey Alan",,https://lens.org/105-688-759-597-101,Search Report,yes,5,0,7,7,0,A61K31/44;;A61K31/44;;A61K31/4535;;A61K31/4535;;A61K38/09;;A61K38/09;;A61P43/00,C07D333/56;;A61K31/4025;;A61K31/44;;A61K31/4535;;A61K31/55;;A61K38/09;;A61P43/00,,6,5,055-459-038-375-719;;007-023-645-974-416;;131-124-089-123-140;;102-762-409-593-892;;062-013-065-012-750,10.1210/endo.137.10.8828469;;10.1210/en.137.10.4139;;8828469;;8282823;;10.1172/jci116985;;pmc293730;;8700270;;8996192;;10.1016/8756-3282(96)00085-3;;8806005,"EVANS ET AL: ""raloxifene inhibits bone turnover and prevents further cancellous bone loss in adult avariectomized rats with established osteopenia"", ENDOCRINOLOGY, vol. 137, no. 10, 1996, pages 4139 - 4144, XP002088886;;BLACK ET AL: ""raloxifene prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats"", J CLIN INVEST, vol. 93, no. 1, 1994, pages 63 - 69, XP002088887;;LIPS ET AL: ""estrogen agonists, in particular raloxifene, in the treatment of osteoporosis"", NEDERLANDS TIJDSCHRIFT VOOR GENEESKUNDE, vol. 140, no. 23, 1996, pages 1215 - 1217, XP002088888;;KAUFFMAN ET AL: ""hypocholesterolemic acivity of raloxifene"", J PHARMA EXP THER, vol. 280, no. 1, January 1997 (1997-01-01), pages 146 - 153, XP002088889;;WANG ET AL: ""raloxifene prevents bone loss in lumbar spine and femur in aged ovariectomized rats"", EUR J EXP MUSCULOSKELETAL RES, vol. 4, no. 3-4, 1995, pages 171 - 175, XP002088890;;FROLIK ET AL: ""time-dependent changes in biochemical bone markers and serum cholesterol in ovariectomized rats: effects of raloxifene hcl, tamoxifenen, estrogen and alendronate"", BONE, vol. 18, no. 6, 1996, pages 621 - 627, XP002088891",DISCONTINUED
610,US,A,US 2968532 A,134-655-319-952-326,1961-01-17,1961,US 47253454 A,1954-12-01,US 47253454 A,1954-12-01,Preparation of potassium borohydride,,CALLERY CHEMICAL CO,CUNNINGHAM GEORGE L;;BRYANT JOHN M;;GAUSE EMILY M,,https://lens.org/134-655-319-952-326,Granted Patent,no,3,3,1,1,0,C01B6/00;;C01B6/00,C01B6/00,,0,0,,,,EXPIRED
611,US,A,US 3684897 A,133-489-169-905-120,1972-08-15,1972,US 6522570 A,1970-08-19,US 6522570 A,1970-08-19,DYNAMIC MOS MEMORY ARRAY TIMING SYSTEM,"A dynamic MOS memory array timing system. If a mode signal is at a first (""automatic mode"") level, a refresh pulse is generated during every cycle defined by the system clock; if the mode signal is at a second (""fast mode"") level, a refresh pulse is generated only when a refresh input to the timing system is energized. Where speed is not of the utmost importance, the system can be operated in the automatic mode and there is no need to provide externally controlled refresh input signals. On the other hand, where speed is important, each system cycle can be speeded up by generating refresh signals only periodically; the increased speed is gained at the expense of the additional control circuits required to generate the refresh input signals. Thus the same timing system can be used in many different applications. The timing system utilizes delay elements for generating the many pulses necessary during each cycle. The delay elements are tapped so that fewer separate elements are required. To prevent loading of the delay elements, high-input impedance ECL circuits are used in the timing system. However, to make the system compatible with TTL inputs and outputs, various TTL-ECL and ECL-TTL converter circuits are used throughout the system.",COGAR CORP,ANDERSON STANLEY R;;BRYANT RICHARD W;;TU GEORGE K,,https://lens.org/133-489-169-905-120,Granted Patent,no,3,15,7,7,0,G11C11/406;;G11C11/4067;;G11C11/4076;;H03K19/01806;;H03K19/01812;;G11C11/4076;;H03K19/01806;;G11C11/4067;;G11C11/406;;H03K19/01812,G11C11/406;;G11C11/4067;;G11C11/4076;;H03K19/018,307/208;;307/214;;307/218;;307/238;;307/269;;307/279;;340173   FF,1,0,,,"Pub. I Random Access MOS Memory Packs More Bits to the Chip by Boysel et al., in Electronics dated Feb. 16, 1970, pp. 109 115.",EXPIRED
612,NO,L,NO 863547 L,198-792-370-926-951,1987-03-06,1987,NO 863547 A,1986-09-04,US 77289185 A,1985-09-05,BIS-FOSFITT-FORBINDELSER.,,UNION CARBIDE CORP,BILLIG ERNST NMN;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/198-792-370-926-951,Abstract,no,0,0,48,54,0,C07C45/50;;C07F9/65744;;C07F9/6578;;C07F15/008;;Y02P20/582;;C07F11/00;;C07F9/10;;C07F15/008;;C07F9/6578;;C07C45/50;;C07F9/65744;;Y02P20/582,B01J31/00;;B01J31/24;;B01J31/22;;C07B41/06;;C07B61/00;;C07C45/00;;C07C45/50;;C07C47/02;;C07C47/042;;C07C67/00;;C07F9/09;;C07F9/145;;C07F9/6574;;C07F9/6578;;C07F15/00,,0,0,,,,EXPIRED
613,BR,A,BR 9401183 A,026-455-600-511-547,1994-11-01,1994,BR 9401183 A,1994-03-16,US 3512193 A,1993-03-19,Composto e formulação farmacêutica,"The present invention relates to sulfonate and carbamate derivatives of 3-aroylbenzo[b]thiophenes, pharmaceutical formulations containing these compounds and methods of using such compounds for inhibiting the loss of bone, lowering serum cholesterol levels and therapeutically treating hormone dependent mammalian breast and uterine carcinoma.",LILLY CO ELI,BLACK LARRY JOHN;;BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH,,https://lens.org/026-455-600-511-547,Patent Application,no,0,0,32,32,0,C07D333/56;;A61P19/10;;A61P35/00;;A61P3/06;;A61P37/08;;A61P43/00;;A61P9/10;;C07D333/56,A61K31/40;;A61K31/38;;A61K31/445;;A61K31/55;;A61P3/06;;A61P9/10;;A61P19/10;;A61P35/00;;A61P37/08;;A61P43/00;;C07D333/56;;C07D409/12,,0,0,,,,DISCONTINUED
614,AT,T1,AT E245637 T1,047-593-303-299-073,2003-08-15,2003,AT 97307339 T,1997-09-22,US 2744996 P,1996-09-27,"BENZOTHIOPHENVERBINDUNGEN, ZUBEREITUNGEN UND VERFAHREN","The invention provides benzothiophene compounds, formulations, and methods of inhibiting bone loss or bone resorption, particularly osteoporosis, cardiovascular-related pathological conditions, including hyperlipidemia.",LILLY CO ELI,BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH;;DODGE JEFFREY ALAN,,https://lens.org/047-593-303-299-073,Granted Patent,no,0,0,9,9,0,C07D333/56;;C07D409/12;;C07D417/12;;A61P19/10;;A61P3/06;;A61P43/00;;C07D409/12;;C07D417/12;;C07D333/56,C07D333/16;;A61K31/38;;A61K31/381;;A61K31/425;;A61K31/426;;A61K31/44;;A61K31/4433;;A61P3/06;;A61P19/10;;A61P43/00;;C07D277/20;;C07D277/24;;C07D277/34;;C07D333/32;;C07D333/56;;C07D333/64;;C07D409/12;;C07D417/12,,0,0,,,,DISCONTINUED
615,EP,B1,EP 0818453 B1,051-030-189-710-740,2002-08-14,2002,EP 97304484 A,1997-06-25,US 2151396 P,1996-07-10,Benzothiophene compounds and methods of use,,LILLY CO ELI,BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH;;FAHEY KENNAN JOSEPH,,https://lens.org/051-030-189-710-740,Granted Patent,yes,2,2,7,7,0,A61K31/565;;A61K31/57;;A61K31/66;;A61K38/29;;C07D333/56;;A61P13/02;;A61P15/00;;A61P35/00;;A61P43/00,A61K31/38;;A61K31/381;;A61K31/565;;A61K31/57;;A61K31/66;;A61K38/29;;A61P13/02;;A61P15/00;;A61P35/00;;A61P43/00;;C07D333/56,,2,0,,,"JONES ET AL.: ""Antiestrogens. 2. Structure-Activity Studies in a Series of 3-Aroyl-2-arylbenzo[b]thiophene Derivatives"" J. MED. CHEM., vol. 27, no. 8, 1984, pages 1057-1066, XP000560343;;KYM ET AL.: ""Molecular Structures, Conformational Analysis, and Preferential Modes of Binding of 3-Aroyl-2-arylbenzo[b]thiophene estrogen Receptor ligands: LY117018 and Aryl Azide Photoaffinity Labeling Analogs"" J. MED. CHEM., vol. 36, no. 24, 1993, pages 3910-3922, XP002043926",EXPIRED
616,DK,D0,DK 423486 D0,044-189-108-607-049,1986-09-04,1986,DK 423486 A,1986-09-04,US 77285985 A,1985-09-05,OVERGANGSMETAL-POLYPHOSPHIT-KATALYSATORER OG DERES ANVENDELSE,,UNION CARBIDE CORP,BILLIG ERNST NMN;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/044-189-108-607-049,Patent Application,no,0,0,44,44,0,B01J31/185;;B01J31/20;;B01J2231/321;;B01J2531/0266;;B01J2531/80;;B01J2531/822;;C07C45/50;;Y02P20/582;;C07C47/02;;B01J31/22;;C07C45/50;;C07C45/50;;B01J31/185;;B01J2531/0266;;B01J2231/321;;B01J2531/80;;B01J31/20;;B01J2531/822;;Y02P20/582,B01J31/00;;B01J31/18;;B01J31/20;;C07C47/02;;B01J31/22;;C07B61/00;;C07C45/00;;C07C45/50;;C07C67/00,,0,0,,,,DISCONTINUED
617,NO,C,NO 174622 C,062-673-157-784-866,1994-06-08,1994,NO 904906 A,1990-11-12,NO 904906 A;;NO 863547 A;;US 77289185 A,1985-09-05,Fremgangsmåte for karbonylering,,UNION CARBIDE CORP,BILLIG ERNST NMN;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/062-673-157-784-866,Granted Patent,no,0,0,4,54,0,,B01J31/18;;C07C/;;C07C45/50;;C07C47/02;;C07F9/141,,0,0,,,,EXPIRED
618,US,A1,US 2015/0252430 A1,064-180-114-039-716,2015-09-10,2015,US 201414516719 A,2014-10-17,US 201414516719 A;;US 201213600260 A;;US 44919506 A;;US 68863405 P,2005-06-08,"METHODS FOR THE IDENTIFICATION, ASSESSMENT, AND TREATMENT OF PATIENTS WITH CANCER THERAPY","The present invention is directed to the identification of predictive markers that can be used to determine whether patients with cancer are clinically responsive or non-responsive to a therapeutic regimen prior to treatment. In particular, the present invention is directed to the use of certain individual and/or combinations of predictive markers, wherein the expression of the predictive markers correlates with responsiveness or non-responsiveness to a therapeutic regimen. Thus, by examining the expression levels of individual predictive markers and/or predictive markers comprising a marker set, it is possible to determine whether a therapeutic agent, or combination of agents, will be most likely to reduce the growth rate of tumors in a clinical setting.",MILLENNIUM PHARM INC,BRYANT BARBARA M;;DAMOKOSH ANDREW I;;MULLIGAN GEORGE J,MILLENNIUM PHARMACEUTICALS INC (2006-08-01);;TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-05-03),https://lens.org/064-180-114-039-716,Patent Application,yes,0,4,22,22,1415,C12Q2600/106;;C12Q2600/136;;G01N33/57407;;G01N33/57415;;G01N33/57419;;G01N33/57423;;G01N33/57434;;G01N33/57438;;G01N33/57449;;G01N2800/44;;G16B25/00;;G16B40/00;;A61K31/69;;C12Q1/6886;;A61P35/00;;A61P35/02;;G16H10/40;;G16H20/40;;Y02A90/10;;G16B40/10;;G16B25/10;;G16B25/00;;G16B40/00;;C12Q2600/106;;C12Q2600/136;;G01N33/57407;;G01N33/57415;;G01N33/57419;;G01N33/57423;;G01N33/57434;;G01N33/57438;;G01N33/57449;;G01N2800/44;;Y02A90/10;;G16H10/40;;G16H20/40;;G16B40/10;;G16B25/10;;C12Q1/6886;;A61K31/69;;C12Q2600/158;;G01N33/57426;;G06Q20/40,C12Q1/68;;A61K31/69;;G01N33/574;;G06Q20/40;;G06Q50/00;;G16B25/10;;G16B40/10,,0,0,,,,ACTIVE
619,GR,T3,GR 3030317 T3,084-940-017-681-859,1999-09-30,1999,GR 990401404 T,1999-05-27,US 3512193 A,1993-03-19,Sulfonate and carbamate derivatives of 3-aroylbenzo (beta) thiophenes.,"The present invention relates to sulfonate and carbamate derivatives of 3-aroylbenzo[b]thiophenes, pharmaceutical formulations containing these compounds and methods of using such compounds for inhibiting the loss of bone, lowering serum cholesterol levels and therapeutically treating hormone dependent mammalian breast and uterine carcinoma.",LILLY CO ELI,BLACK LARRY JOHN;;BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH,,https://lens.org/084-940-017-681-859,Granted Patent,no,0,0,32,32,0,C07D333/56;;A61P19/10;;A61P35/00;;A61P3/06;;A61P37/08;;A61P43/00;;A61P9/10;;C07D333/56,A61K31/38;;A61K31/445;;A61K31/55;;A61K31/40;;A61P3/06;;A61P9/10;;A61P19/10;;A61P35/00;;A61P37/08;;A61P43/00;;C07D333/56;;C07D409/12,,0,0,,,,EXPIRED
620,US,A,US 5981570 A,085-191-748-747-090,1999-11-09,1999,US 93537497 A,1997-09-22,US 93537497 A;;US 2744996 P,1996-09-27,"Benzothiophene compounds, compositions, and methods","The invention provides benzothiophene compounds, formulations, and methods of inhibiting bone loss or bone resorption, particularly osteoporosis, cardiovascular-related pathological conditions, including hyperlipidemia.",LILLY CO ELI,BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH;;DODGE JEFFREY ALAN,ELI LILLY AND COMPANY (1997-09-19),https://lens.org/085-191-748-747-090,Granted Patent,yes,18,4,9,9,0,C07D333/56;;C07D409/12;;C07D417/12;;A61P19/10;;A61P3/06;;A61P43/00;;C07D409/12;;C07D417/12;;C07D333/56,A61K31/38;;A61K31/381;;A61K31/425;;C07D333/16;;A61K31/426;;A61K31/44;;A61K31/4433;;A61P3/06;;A61P19/10;;A61P43/00;;C07D277/20;;C07D277/24;;C07D277/34;;C07D333/32;;C07D333/56;;C07D333/64;;C07D409/12;;C07D417/12,514/432;;514/337;;514/365;;514/369;;514/443;;546/281.1;;548/203;;548/204;;549/13;;549/49;;549/57;;549/28,3,3,008-159-651-906-048;;039-179-689-155-908;;105-610-128-085-169,10.1021/jm00294a011;;5116231;;6431104;;10.1021/jm00374a021;;1473726;;10.1139/g92-143,"Crenshaw, R.R., et al, J. Med. Chem. 14 (12):1185 1190 (1971).;;Jones, C.D., et al. J. Med. Chem. 27 : 1057 1066) 1984.;;Jones, C.D., et al, J. Med. Chem . 35: 931 938 1992.",EXPIRED
621,US,A1,US 2013/0144193 A1,086-788-326-455-475,2013-06-06,2013,US 201113805165 A,2011-06-24,US 201113805165 A;;US 35833610 P;;US 2011/0041787 W,2010-06-24,HYDROGEL ULTRASOUND COUPLING DEVICE,"The present invention relates to an ultrasound coupling device that includes a gel component and a coupling compartment. The present invention also relates to various kits and methods for using the ultrasound coupling device with low-intensity ultrasound transducers and therapy. The present invention also relates to methods of making the ultrasound coupling device of the present invention. The present invention further relates to an array that includes a plurality of ultrasound coupling devices of the present invention, and methods of using the array.",LEWIS JR GEORGE K;;GUARINO JOANNE L;;GUFFEY BRYANT;;ZETROZ LLC,LEWIS JR GEORGE K;;GUARINO JOANNE L;;GUFFEY BRYANT,ZETROZ INC (2013-06-12);;ZETROZ SYSTEMS LLC (2016-02-29),https://lens.org/086-788-326-455-475,Patent Application,yes,9,19,6,7,0,A61N7/00;;A61N7/00;;A61B8/4236;;A61B8/4236;;A61B8/4281;;A61B8/4281;;A61N2007/0034;;A61N2007/0034;;A61N2007/0056;;A61N2007/0056;;A61N2007/006;;A61N2007/006;;A61N2007/0078;;A61N2007/0078,A61N7/00,601/2,0,0,,,,DISCONTINUED
622,US,A,US 5756855 A,117-306-928-097-781,1998-05-26,1998,US 29302894 A,1994-08-19,US 29302894 A,1994-08-19,Stabilization of phosphite ligands in hydroformylation process,"The present invention provides a hydroformylation process comprising: (1) forming a reaction mixture containing: (a) an olefinic compound, (b) hydrogen, (c) carbon monoxide, (d) a phosphite in which each phosphorus atom is bonded to three oxygen atoms and at least one such oxygen atom is bonded to a carbon atom of an aromatic ring that is adjacent to another carbon atom of said ring having a pendant monovalent group having a steric hindrance at least as great as the steric hindrance of the isopropyl group, (e) a catalytic amount of rhodium, and (f) a Group VIII metal (other than a rhodium) in an amount sufficient to reduce the rhodium-catalyzed decomposition of the phosphite during the hydroformylation process; and (2) maintaining the reaction mixture under conditions at which the olefinic compound reacts with the hydrogen and carbon monoxide to form an aldehyde.",UNION CARBIDE CHEM PLASTIC,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT;;MAHER JOHN MICHAEL,UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (1994-10-13),https://lens.org/117-306-928-097-781,Granted Patent,yes,26,19,9,9,0,B01J31/185;;B01J2231/321;;B01J2531/0288;;B01J2531/80;;B01J2531/821;;B01J2531/824;;B01J2531/845;;C07C45/50;;C07C45/50;;B01J2531/80;;B01J31/185;;B01J2531/821;;B01J2231/321;;B01J2531/0288;;B01J2531/845;;B01J2531/824,B01J31/18;;C07C45/50,568/454;;568/451;;568/492;;558/71;;502/161,3,3,060-941-221-842-06X;;060-652-475-138-418;;118-503-123-872-41X,10.1002/zaac.19895770129;;10.1021/ja00209a029;;10.1021/ja00270a036,"Anna M. Trzeciak et al., Synthesis and Properties of the Orthometallated Rhodium Complex Rh P ( OPh ) 3 3 P ( OC 6 H 4 )( OPh ) 2 Z. anorg. allg. Chem. 577 (1989), pp. 255 262.;;F.H. Westheimer, et al., Rates and Mechanisms of Hydrolysis of Esters of Phosphorous Acid, J. Am. Chem. Soc. 1988, 110,pp. 181 185.;;L.N. Lewis et al, Catalytic C C Bond Formation via Ortho Metalated Complexes, J. Am. Chem. Soc., vol. 108, No. 10, 1986, 1986, pp. 2728 2735.",EXPIRED
623,US,B2,US 9963747 B2,114-335-247-412-372,2018-05-08,2018,US 201414516719 A,2014-10-17,US 201414516719 A;;US 201213600260 A;;US 44919506 A;;US 68863405 P,2005-06-08,"Methods for the identification, assessment, and treatment of patients with cancer therapy","The present invention is directed to the identification of predictive markers that can be used to determine whether patients with cancer are clinically responsive or non-responsive to a therapeutic regimen prior to treatment. In particular, the present invention is directed to the use of certain individual and/or combinations of predictive markers, wherein the expression of the predictive markers correlates with responsiveness or non-responsiveness to a therapeutic regimen. Thus, by examining the expression levels of individual predictive markers and/or predictive markers comprising a marker set, it is possible to determine whether a therapeutic agent, or combination of agents, will be most likely to reduce the growth rate of tumors in a clinical setting.",MILLENNIUM PHARM INC,BRYANT BARBARA M;;DAMOKOSH ANDREW I;;MULLIGAN GEORGE J,MILLENNIUM PHARMACEUTICALS INC (2006-08-01);;TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-05-03),https://lens.org/114-335-247-412-372,Granted Patent,yes,6,5,22,22,1415,C12Q2600/106;;C12Q2600/136;;G01N33/57407;;G01N33/57415;;G01N33/57419;;G01N33/57423;;G01N33/57434;;G01N33/57438;;G01N33/57449;;G01N2800/44;;G16B25/00;;G16B40/00;;A61K31/69;;C12Q1/6886;;A61P35/00;;A61P35/02;;G16H10/40;;G16H20/40;;Y02A90/10;;G16B40/10;;G16B25/10;;G16B25/00;;G16B40/00;;C12Q2600/106;;C12Q2600/136;;G01N33/57407;;G01N33/57415;;G01N33/57419;;G01N33/57423;;G01N33/57434;;G01N33/57438;;G01N33/57449;;G01N2800/44;;Y02A90/10;;G16H10/40;;G16H20/40;;G16B40/10;;G16B25/10;;C12Q1/6886;;A61K31/69;;C12Q2600/158;;G01N33/57426;;G06Q20/40,C12Q1/68;;A61K31/69;;G01N33/574;;G06Q20/40;;G06Q50/00;;G06Q50/22;;G16B25/10;;G16B40/10,,37,23,134-684-144-981-813;;074-147-835-645-394;;082-177-571-545-468;;084-615-067-249-328;;026-978-719-988-804;;067-766-525-517-863;;002-431-300-582-282;;010-409-170-828-73X;;007-342-077-503-496;;154-649-796-265-048;;144-184-274-185-833;;064-464-672-849-072;;034-134-907-055-024;;035-331-941-295-67X;;089-309-126-902-646;;103-920-702-805-783;;045-807-567-174-272;;043-880-672-061-032;;064-464-672-849-072;;007-342-077-503-496;;089-309-126-902-646;;033-580-462-919-793;;052-130-043-164-905,10363983;;10.1634/theoncologist.7-1-9;;11854543;;10.1093/clinchem/46.5.673;;10794750;;12575774;;12826635;;10.1056/nejmoa030288;;12490681;;10.1056/nejmoa021967;;12738736;;10.1182/blood-2006-09-044974;;17185464;;8159770;;10.1073/pnas.91.8.3463;;pmc43597;;10.1093/nar/gki031;;10.1289/ehp.7690;;16203246;;pmc1281279;;15817694;;10.1093/bioinformatics/bti429;;1563002;;16831230;;10.1186/1471-2407-6-182;;pmc1534059;;11857078;;10.1038/sj.onc.1205205;;11306489;;10.1186/gb-2003-4-9-117;;pmc193646;;12952525;;12361907;;10.1016/s0302-2838(02)00324-x;;15817694;;10.1093/bioinformatics/bti429;;8159770;;10.1073/pnas.91.8.3463;;pmc43597;;11857078;;10.1038/sj.onc.1205205;;12571354;;pmc149935;;10.1073/pnas.0437875100;;12969978;;10.1182/blood-2003-04-1045,"Adams, Julian, et al., “Proteasome Inhibitors: A Novel Class of Potent and Effective Antitumor Agents,” Cancer Research, vol. 59 (Jun. 1, 1999) pp. 2615-2622.;;Adams, Julian, “Development of the Proteasome Inhibitor PS-341,” The Oncologist, vol. 7 (2002) pp. 9-16.;;Lightcap, Eric S., et al., “Proteasome Inhibition Measurements: Clinical Application,” Clinical Chemsitry, vol. 46, No. 5 (2000) pp. 673-683.;;Hochwald, Steven N., et al., “Antineoplastic Therapy in Colorectal Cancer through Proteasome Inhibition,” The American Surgeon, vol. 69 (Jan. 2003) pp. 15-23.;;Richardson, Paul G., et al., “A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma,” The New England Journal of Medicine, vol. 348, No. 26 (Jun. 26, 2003) pp. 2609-2617.;;Van de Vijver, Marc J., et al., “A Gene-Expression Signature as a Predictor of Survival in Breast Cancer,” The New England Journal of Medicine, vol. 347, No. 25 (Dec. 19, 2002) pp. 1999-2009.;;Barden, Catherine B., et al., “Classification of Follicular Thyroid Tumors by Molecular Signature: Results of Gene Profiling,” Clinical Cancer Research, vol. 9 (May 2003) pp. 1792-1800.;;Mulligan, George, et al., “Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib,” Blood, vol. 109, No. 8 (Apr. 15, 2007) pp. 3177-3188.;;Toczyski, David P., et al., “The Epstein-Barr virus (EBV) small RNA EBER1 binds and relocalizes ribosomal protein L22 in EBV-infected human B lymphocytes,” Proceedings of the National Academy of Science USA, vol. 91 (Apr. 1994) pp. 3463-3467.;;Maglott, Donna, et al., “Entrez Gene: gene-centered information at NCBI ,” Nucleic Acids Research, vol. 33, Database issue (2005) pp. D54-D58.;;Affymetrix, Inc., “Annotation Methodology,” Affymetrix—Annotation Methodology Technical Note [online] Affymetrix, Santa Clara, CA, downloaded Jul. 23, 2008 (3 pages).;;Affymetrix, Inc., “GeneChip Human Genome U133 Set,” [online] 701092 Rev. 3 (Nov. 2004) downloaded Jul. 23, 2008 ( 2 pages).;;Affyrnetrix, Inc., “Human Genome U133 Set— Support Materials,” Affymetrix—Technical Support Documentation for Human Genome U133 Set [online] downloaded Jul. 24, 2008 (3 pages).;;International Prelminary Examination Report (IPER) and Written Opinion of the International Searching Authority dated Dec. 11, 2007 in corresponding PCT Application PCT/US06/022515.;;Office Action dated Jun. 23, 2008 in co-pending U.S. Appl. No. 10/728,055.;;Supplementary Partial European Search Report dated Jun. 24, 2009 in European Patent Application No. 06784710.3 which corresponds to U.S. Appl. No. 11/449,195.;;Glatt, Christine M., et al., “Molecular characterization of thyroid toxicity: anchoring gene expression profiles to biochemical and pathologic end points,” Environmental Health Perspectives, vol. 113, No. 10 (Oct. 2005) pp. 1354-1361.;;Wessels, Lodewyk F. A., et al., “A protocol for building and evaluating predictors of disease state based on microarray data,” Bioinfomatics, vol. 21, No. 19 (Apr. 7, 2005) pp. 3755-3762.;;Tockman, Melvyn S., et al., “Considerations in bringing a cancer biomarker to clinical application,” Cancer Research (Supplement), vol. 52 (May 1, 1992) pp. 2711s-27182.;;Ferrandina, Gabriella, et al., “Cyclooxygenase-2 (Cox-2) expression and resistance to platinum versus platinum/paclitaxel containing chemotherapy in advanced ovarian cancer,” BMC Cancer, vol. 6 No. 182 (Jul. 11, 2006) pp. 1-5.;;Chauhan, Dharminder, et al., “Identification of genes regulated by Dexamethasone in multiple myeloma cells using oligonudeotide arrays,” Oncogene, vol. 21 (2002) pp. 1346-1358.;;Hideshima, Teru, et al., “The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells,” Cancer Research, vol. 61 (Apr. 1, 2001) pp. 3071-3076.;;Alberts, Bruce, et al., Molecular Biology of the Cell, Third Edition, published by Garland Publishing, Inc., New York, New York (1994) p. 465.;;Greenbaum, Dov, et al., “Comparing protein abundance and mRNA expression levels on a genomic scale,” Genome Biology, vol. 4, No. 9 (2003) pp. 117.1-117.8.;;Lichtinghagen, Ralf, et al., “Different mRNA and protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 in benign and malignant prostate tissue,” European Urology, vol. 42 (2002) pp. 398-406.;;Wessels, Lodewyk F. A., et al., “A protocol for building and evaluating predictors of disease state based on microarray data,” Bioinformatics, vol. 21, No. 19 (Apr. 7, 2005) pp. 3755-3762.;;International Preliminary Examination Report (IPER) and Written Opinion of the International Seaarching Authority dated Dec. 11, 2007 in corresponding PCT Application PCT/US06/022515.;;Office Action dated Jun. 23. 2008 in co-pending U.S. Appl. No. 10/728,055.;;Maglott, Donna, et al., “Entrez Gene: gene-centered information at NCBI,” Nucleic Acids Research, vol. 33, Database issue (2005) pp. D54-D58.;;Affymetrix, Inc., “Human Genome U133 Set—Support Materials,” Affymetrix—Technical Support Documentation for Human Genome U133 Set [online] downloaded Jul. 24, 2008 (3 pages).;;Toczyski, David P., et al., “The Epstein-Barr virus (EBV) small RNA EBER1 binds and relocalizes ribosomal protein L22 in EBV-infected human B lymphocytes,” Proceedings of the National Academy of Science US, vol. 91 (Apr. 1994) pp. 3463-3467.;;Chauhan, Dharminder, et al., “Identification of genes regulated by Dexamethasone in multiple myeloma cells using oligonucleotide arrays,” Oncogene, vol. 21 (2002) pp. 1346-1358.;;International Search Report of the International Searching Authority dated Nov. 26, 2007 issued in International Application No. PCT/US06/022515, which corresponds to U.S. Appl. No. 11/449,195.;;Search Report dated Jan. 2, 2014 of co-pending European patent application No. 13181515.1;;Bohen et al., “Variation in Gene Expression Patterns in Follicular Lymphoma and the Response to Rituximab”, PNAS, 2003, vol. 100, No. 4, pp. 1926-1930.;;Barlow, et al., Predicting Event-Free and Overall Survival after Treatment of Myeloma with the Proteasome Inhibitor Bortezomib, Blood, 2004, vol. 104, Abstract 1481.;;Barlogie, et al., “Treatment of Multiple Myeloma”, Blood, 2004, vol. 103, pp. 20-32.",ACTIVE
624,AT,T1,AT E180479 T1,117-751-073-743-949,1999-06-15,1999,AT 94301871 T,1994-03-16,US 3512193 A,1993-03-19,SULFONAT- UND CARBAMATDERIVATE VON 3-AROYL- BENZO(BETA)THIOPHENEN,"The present invention relates to sulfonate and carbamate derivatives of 3-aroylbenzo[b]thiophenes, pharmaceutical formulations containing these compounds and methods of using such compounds for inhibiting the loss of bone, lowering serum cholesterol levels and therapeutically treating hormone dependent mammalian breast and uterine carcinoma.",LILLY CO ELI,BLACK LARRY JOHN;;BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH,,https://lens.org/117-751-073-743-949,Granted Patent,no,0,0,32,32,0,C07D333/56;;A61P19/10;;A61P35/00;;A61P3/06;;A61P37/08;;A61P43/00;;A61P9/10;;C07D333/56,A61K31/40;;A61K31/38;;A61K31/445;;A61K31/55;;A61P3/06;;A61P9/10;;A61P19/10;;A61P35/00;;A61P37/08;;A61P43/00;;C07D333/56;;C07D409/12,,0,0,,,,DISCONTINUED
625,ZA,B,ZA 941786 B,114-356-996-509-799,1995-09-14,1995,ZA 941786 A,1994-03-14,US 3512193 A,1993-03-19,Sulfonate and carbamate derivatives of 3-aroylbenzo(b)thiophenes,"The present invention relates to sulfonate and carbamate derivatives of 3-aroylbenzo[b]thiophenes, pharmaceutical formulations containing these compounds and methods of using such compounds for inhibiting the loss of bone, lowering serum cholesterol levels and therapeutically treating hormone dependent mammalian breast and uterine carcinoma.",LILLY CO ELI,BLACK LARRY JOHN;;BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH,,https://lens.org/114-356-996-509-799,Granted Patent,no,0,0,32,32,0,C07D333/56;;A61P19/10;;A61P35/00;;A61P3/06;;A61P37/08;;A61P43/00;;A61P9/10;;C07D333/56,A61K31/38;;A61K31/445;;A61K31/40;;A61K31/55;;A61P3/06;;A61P9/10;;A61P19/10;;A61P35/00;;A61P37/08;;A61P43/00;;C07D333/56;;C07D409/12,,0,0,,,,EXPIRED
626,WO,A1,WO 2014/011223 A1,128-113-956-917-706,2014-01-16,2014,US 2013/0030713 W,2013-03-13,US 201261671485 P,2012-07-13,SQUEEZABLE BOTTLE INCLUDING AN ORNAMENTAL FEATURE,"A squeezable bottle includes a panel having at least one ornamental feature thereon. The panel includes a first facet having a length and a width and a second facet having a length and width. The lengths of the first and second facets extend in a direction generally parallel to a length of the squeezable bottle. The second facet is disposed adjacent to and defines a first interface with the first facet, and the first interface defines a first one of the at least one ornamental features. A generally planar surface of the first facet is disposed at an angle relative to a generally planar surface of the second facet such that the panel is reversibly deformable.",HEINZ CO H J,BRYANT MICHAEL P;;MCMAHON MICHAEL D;;NUKUTO GEORGE IKUYA,,https://lens.org/128-113-956-917-706,Patent Application,yes,5,6,11,11,0,B65D1/32;;B65D23/102;;B65D47/0804;;B65D23/102;;B65D1/32;;B65D47/0804;;B65D2501/0081;;B65D23/102;;B65D47/0804;;B65D1/32;;B65D2501/0081;;B65D1/0223;;B65D2203/00,B65D90/02,,1,0,,,See also references of EP 2872422A4,PENDING
627,CN,A,CN 1094042 A,134-245-020-473-10X,1994-10-26,1994,CN 93121277 A,1993-12-22,US 99522292 A,1992-12-22,Improvements in or relating to benzothiophenes,,LILLY CO ELI,BLACK LARRY JOHN;;BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH,,https://lens.org/134-245-020-473-10X,Patent Application,no,0,0,47,47,0,A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;A61K31/4535;;A61K31/4025;;A61K31/55;;A61K2300/00;;A61K31/4535;;A61K31/40;;A61K31/55;;A61K31/445;;A61K31/4025,A61K31/385;;A61K31/365;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4453;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;C07D333/56,,0,0,,,,EXPIRED
628,CA,A,CA 23418 A,136-155-860-006-903,1886-02-13,1886,CA 23418D A,,CA 23418T A,,GAS MACHINE,,BRYANT ELLSWORTH S;;COULS GEORGE R;;FINLAYSON ALEXANDER W,BRYANT ELLSWORTH S;;COULS GEORGE R;;FINLAYSON ALEXANDER W,,https://lens.org/136-155-860-006-903,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
629,NO,L,NO 940940 L,143-127-146-457-315,1994-09-20,1994,NO 940940 A,1994-03-16,US 3512193 A,1993-03-19,Sulfonat og karbamatderivater av 3-aroylbenzo[bÅtiofener,"The present invention relates to sulfonate and carbamate derivatives of 3-aroylbenzo[b]thiophenes, pharmaceutical formulations containing these compounds and methods of using such compounds for inhibiting the loss of bone, lowering serum cholesterol levels and therapeutically treating hormone dependent mammalian breast and uterine carcinoma.",LILLY CO ELI,BLACK LARRY JOHN;;BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH,,https://lens.org/143-127-146-457-315,Abstract,no,0,0,32,32,0,C07D333/56;;A61P19/10;;A61P35/00;;A61P3/06;;A61P37/08;;A61P43/00;;A61P9/10;;C07D333/56,A61K31/38;;A61K31/445;;A61K31/40;;A61K31/55;;A61P3/06;;A61P9/10;;A61P19/10;;A61P35/00;;A61P37/08;;A61P43/00;;C07D333/56;;C07D409/12,,0,0,,,,PENDING
630,US,A,US 5122141 A,147-582-336-581-616,1992-06-16,1992,US 57526790 A,1990-08-30,US 57526790 A,1990-08-30,Modular intramedullary nail,"An intramedullary nail system and method for providing the capability of creating intramedullary nails of any desired length by a combination of a small number of base nail members adapted to be joined to any one of a variety of hollow extension nail members. Any selected extension nail member may be axially connected to any selected base nail member in order to prevent axial separation of the members. Additionally, each extension nail member is provided with transverse openings adapted to receive a bone screw to secure the intramedullary nail within the bone to be repaird. The extension nail member is infinitely rotationally adjustable about the axis of the base nail member in order to enable the fixation of the extension member with any desired degree of anteversion prior to final assembly of the base nail member with the extension nail member.",ZIMMER INC,SIMPSON GEORGE E;;MISER JOHN D;;BRYANT MARK A,ZIMMER INC (2002-01-14);;ZIMMER TECHNOLOGY INC (2002-06-28),https://lens.org/147-582-336-581-616,Granted Patent,yes,8,329,1,1,0,A61B17/72;;A61B17/7241;;A61B17/7283;;A61B17/744;;A61B17/7241;;A61B17/72;;A61B17/7283;;A61B17/744,A61B17/72;;A61B17/78,606/62;;606/63;;606/64,0,0,,,,EXPIRED
631,DE,T2,DE 69418639 T2,148-854-277-803-428,1999-10-07,1999,DE 69418639 T,1994-03-16,US 3512193 A,1993-03-19,Sulfonat- und Carbamatderivate von 3-aroyl-benzo(beta)Thiophenen,"The present invention relates to sulfonate and carbamate derivatives of 3-aroylbenzo[b]thiophenes, pharmaceutical formulations containing these compounds and methods of using such compounds for inhibiting the loss of bone, lowering serum cholesterol levels and therapeutically treating hormone dependent mammalian breast and uterine carcinoma.",LILLY CO ELI,BLACK LARRY JOHN;;BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH,,https://lens.org/148-854-277-803-428,Granted Patent,no,0,0,32,32,0,C07D333/56;;A61P19/10;;A61P35/00;;A61P3/06;;A61P37/08;;A61P43/00;;A61P9/10;;C07D333/56,A61K31/40;;A61K31/38;;A61K31/445;;A61K31/55;;A61P3/06;;A61P9/10;;A61P19/10;;A61P35/00;;A61P37/08;;A61P43/00;;C07D333/56;;C07D409/12,,0,0,,,,EXPIRED
632,DE,A1,DE 2722083 A1,170-071-461-453-313,1978-11-23,1978,DE 2722083 A,1977-05-16,DE 2722083 A,1977-05-16,"Fabric treatment process - uses a foamed preparation contg. active component and wetting agent, applied to material surface by jet","In a treatment process to apply a prepn. to a porous substrate, such as a fabric, the prepn. is foamed to give a froth with a density of 0.005-0.3 g/cm3, and the foam is passed to an applicator jet. The substrate is passed continuously over and in contact with the applicator jet so that the foamed prepn. and the jet are moved together and the machine contact time is equal to or less than the equilibrium contact time. A present and controlled volume of foamed matter is applied to the surface of the substrate by the application jet to give the treated fabric. The treatment prepn. is composed of 5-75 wt.% a functional chemical, 0.2-5 wt.% foaming agent and 0-5 wt.% wetting agent. The remainder is water. The process can be used to treat fabrics, non-woven fabrics, paper or wood veneers. It can apply a flame retardant, a waterproof or water resistant cladding, a latex, a fabric softener, a lubricant, a hand builder, a dye or pigment, a lightener or bleach, a bonding agent or a scouring agent. The process is more economical as water extraction and drying are reduced so that less energy is required to finish the treatment process.",UNION CARBIDE CORP,WALTER ANDREW TAINTER;;BRYANT GEORGE MACON;;READSHAW RONALD LOUIS,,https://lens.org/170-071-461-453-313,Patent Application,no,0,12,2,2,0,D06M23/06;;D06M15/647;;D06P1/965,D06M15/647;;D06M23/06;;D06P1/96,,0,0,,,,EXPIRED
633,US,A,US 5760030 A,197-398-075-202-879,1998-06-02,1998,US 88657597 A,1997-06-30,US 88657597 A,1997-06-30,Benzothiophene compounds and methods of use,"The instant invention provides novel benzothiophene compounds, pharmaceutical formulations, and methods of use.",LILLY CO ELI,BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH;;FAHEY KENNAN JOSEPH,ELI LILLY AND COMPANY (1997-06-27),https://lens.org/197-398-075-202-879,Granted Patent,yes,21,24,1,1,0,C07D333/22;;C07D333/22,C07D333/22,514/213;;514/324;;514/422;;514/444;;540/596;;546/202;;548/527;;549/51;;549/57,3,3,008-159-651-906-048;;039-179-689-155-908;;105-610-128-085-169,10.1021/jm00294a011;;5116231;;6431104;;10.1021/jm00374a021;;1473726;;10.1139/g92-143,"Crenshaw, R.R., et al, J. Med. Chem. 14 (12):1185 1190 (1971).;;Jones, C.D., et al, J. Med. Chem. 27 : 1057 1066, 1984.;;Jones, C.D., et al, J. Med. Chem. 35: 931 938 1992.",EXPIRED
634,DE,T2,DE 69505612 T2,025-483-664-202-104,1999-05-20,1999,DE 69505612 T,1995-08-18,US 29302894 A,1994-08-19,Stabilisierung von Phosphiteliganden in das Hydroformylierungsverfahren,"The present invention provides a hydroformylation process comprising: (1) forming a reaction mixture containing: (a) an olefinic compound, (b) hydrogen, (c) carbon monoxide, (d) a phosphite in which each phosphorus atom is bonded to three oxygen atoms and at least one such oxygen atom is bonded to a carbon atom of an aromatic ring that is adjacent to another carbon atom of said ring having a pendant monovalent group having a steric hindrance at least as great as the steric hindrance of the isopropyl group, (e) a catalytic amount of rhodium, and (f) a Group VIII metal (other than a rhodium) in an amount sufficient to reduce the rhodium-catalyzed decomposition of the phosphite during the hydroformylation process; and (2) maintaining the reaction mixture under conditions at which the olefinic compound reacts with the hydrogen and carbon monoxide to form an aldehyde.",UNION CARBIDE CHEM PLASTIC,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT;;MAHER JOHN MICHAEL,,https://lens.org/025-483-664-202-104,Granted Patent,no,0,0,9,9,0,B01J31/185;;B01J2231/321;;B01J2531/0288;;B01J2531/80;;B01J2531/821;;B01J2531/824;;B01J2531/845;;C07C45/50;;C07C45/50;;B01J2531/80;;B01J31/185;;B01J2531/821;;B01J2231/321;;B01J2531/0288;;B01J2531/845;;B01J2531/824,B01J31/18;;C07C45/50,,0,0,,,,EXPIRED
635,HU,D0,HU 9400774 D0,062-031-249-051-737,1994-06-28,1994,HU 9400774 A,1994-03-16,US 3512193 A,1993-03-19,SULFONATE AND CARBAMATE DERIVATIVES OF 3-AROYLBENZO[B] THIOPHENES,"The present invention relates to sulfonate and carbamate derivatives of 3-aroylbenzo[b]thiophenes, pharmaceutical formulations containing these compounds and methods of using such compounds for inhibiting the loss of bone, lowering serum cholesterol levels and therapeutically treating hormone dependent mammalian breast and uterine carcinoma.",LILLY CO ELI,CULLINAN GEORGE JOSEPH;;BLACK LARRY JOHN;;BRYANT HENRY ULMAN,,https://lens.org/062-031-249-051-737,Patent Application,no,0,0,32,32,0,C07D333/56;;A61P19/10;;A61P35/00;;A61P3/06;;A61P37/08;;A61P43/00;;A61P9/10;;C07D333/56,A61K31/40;;A61K31/38;;A61K31/445;;A61K31/55;;A61P3/06;;A61P9/10;;A61P19/10;;A61P35/00;;A61P37/08;;A61P43/00;;C07D333/56;;C07D409/12,,0,0,,,,DISCONTINUED
636,EP,A4,EP 2872422 A4,062-595-679-173-236,2016-02-17,2016,EP 13816716 A,2013-03-13,US 201261671485 P;;US 2013/0030713 W,2012-07-13,SQUEEZABLE BOTTLE INCLUDING AN ORNAMENTAL FEATURE,,HEINZ CO H J,BRYANT MICHAEL P;;MCMAHON MICHAEL D;;NUKUTO GEORGE IKUYA,H.J. HEINZ COMPANY BRANDS LLC (2016-07-13),https://lens.org/062-595-679-173-236,Search Report,no,4,0,11,11,0,B65D1/32;;B65D23/102;;B65D47/0804;;B65D23/102;;B65D1/32;;B65D47/0804;;B65D2501/0081;;B65D23/102;;B65D47/0804;;B65D1/32;;B65D2501/0081;;B65D1/0223;;B65D2203/00,B65D1/32,,1,0,,,See also references of WO 2014011223A1,DISCONTINUED
637,US,A,US 5994371 A,075-445-823-934-30X,1999-11-30,1999,US 39244595 A,1995-02-22,US 39244595 A;;US 3512193 A,1993-03-19,Carbamate derivatives of 3-aroylbenzo[b] thiophenes,"The present invention relates to sulfonate and carbamate derivatives of 3-aroylbenzo[b]thiophenes, pharmaceutical formulations containing these compounds and methods of using such compounds for inhibiting the loss of bone, lowering serum cholesterol levels and therapeutically treating hormone dependent mammalian breast and uterine carcinoma.",LILLY CO ELI,BLACK LARRY J;;BRYANT HENRY U;;CULLINAN GEORGE J,,https://lens.org/075-445-823-934-30X,Granted Patent,yes,6,9,32,32,0,C07D333/56;;A61P19/10;;A61P35/00;;A61P3/06;;A61P37/08;;A61P43/00;;A61P9/10;;C07D333/56,A61K31/38;;A61K31/445;;A61K31/40;;A61K31/55;;A61P3/06;;A61P9/10;;A61P19/10;;A61P35/00;;A61P37/08;;A61P43/00;;C07D333/56;;C07D409/12,514/324;;546/202,23,17,039-179-689-155-908;;051-092-766-473-41X;;015-563-808-197-111;;077-541-290-910-710;;014-249-411-385-438;;127-447-976-152-732;;073-997-237-056-690;;042-908-114-132-030;;077-684-894-287-921;;027-640-947-779-05X;;019-662-136-158-986;;046-081-900-781-495;;108-551-556-370-574;;001-666-466-422-174;;052-921-119-546-67X;;008-297-202-323-176;;007-200-277-746-819,6431104;;10.1021/jm00374a021;;2558750;;10.1016/0169-6009(89)90081-0;;3689979;;10.1007/bf01806132;;10.1007/bf02405304;;6423228;;10.1002/jbmr.5650020513;;3455628;;10.1016/0169-6009(91)90023-s;;1932893;;3342747;;10.1210/endo-122-3-1146;;10.1056/nejm199203263261302;;1542321;;3626776;;10.1007/bf02540366;;10.1139/o90-027;;2350488;;10.1210/jcem-73-5-925;;1939531;;10.7326/0003-4819-115-11-860;;1952472;;1922206;;10.1056/nejm199110243251702;;2318936;;10.1210/jcem-70-4-1132;;10.1093/jnci/82.16.1327;;2199681;;1573630;;10.1021/jm00086a002;;3199816;;10.1016/0022-4731(88)90284-1,"Williams, et al., Journal of Bone and Mineral Research , 6 (1991).;;FDC Reports , T&G 11, Mar. 30, 1992.;;Jones, et al., J. Med. Chem., 27 , 1057 1066 (1984).;;Feldmann, et al., Bone and Mineral, 7 , 245 254 (1989).;;Tamoxifen Trial Restricted , SCRIP No. 1702 Mar. 20, 1992, p. 22.;;Jordan, et al., Breast Cancer Research Treatment, 10 : 31 35 (1987).;;Beall, et al., Calcif Tissue Int., 36 : 123 125 (1984).;;Turner, et al., Journal of Bone and Mineral Research, 2 , No. 5, 449 456 (1987).;;Williams, et al., Bone and Mineral, 14 , 205 220 (1991).;;Turner, et al., Endocrinology, 122 , No. 3, 1146 1150 (1988).;;Love, et al., The New England Journal of Medicine, 326 , No. 13, 852 856 (1992).;;Breckenridge, et al., Lipids, 22 , No. 7, 505 512 (1987).;;Lazier, et al., Biochem. Cell Biol., 68 , 210 217 (1990).;;Lobo, J. Clin. Endocrinol. Metab., 73 , No. 5, 925 930 (1991).;;Love, et al., Ann. Intern. Med., 115 , No. 11, 860 864 (1991).;;Walsh, et al., N. Engl. J. Med., 325 , No. 17, 1196 1204 (1991).;;Bagdade, et al., J. Clin. Endocrinol. Metab., 70 , No. 4, 1132 1135 (1990).;;Love, et al., J. Natl. Cancer Inst., 82 , No. 16, 1327 1332 (1990).;;Teo, et al., J. Med. Chem., 35 , 1330 1339 (1992).;;Cypriani, et al., J. Steroid Biochem., 31 , No. 5, 763 771 (1988).;;Cypriani, et al., Chemical Abstracts , CA 110: 1189 v, 1989.;;Cypriani, et al., Chemical Abstracts , 110:69550v, 1989.;;American Chemical Society, Registry , RN 63676 25 5.",EXPIRED
638,HU,A,HU T70549 A,118-273-847-615-020,1995-10-30,1995,HU 9400774 A,1994-03-16,US 3512193 A,1993-03-19,SULFONATE AND CARBAMATE DERIVATIVES OF 3-AROYLBENZO[B] THIOPHENES PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESS FOR THEIR PREPARATION,"The present invention relates to sulfonate and carbamate derivatives of 3-aroylbenzo[b]thiophenes, pharmaceutical formulations containing these compounds and methods of using such compounds for inhibiting the loss of bone, lowering serum cholesterol levels and therapeutically treating hormone dependent mammalian breast and uterine carcinoma.",LILLY CO ELI,CULLINAN GEORGE JOSEPH;;BLACK LARRY JOHN;;BRYANT HENRY ULMAN,,https://lens.org/118-273-847-615-020,Unknown,no,0,0,32,32,0,C07D333/56;;A61P19/10;;A61P35/00;;A61P3/06;;A61P37/08;;A61P43/00;;A61P9/10;;C07D333/56,A61K31/38;;A61K31/445;;A61K31/55;;A61K31/40;;A61P3/06;;A61P9/10;;A61P19/10;;A61P35/00;;A61P37/08;;A61P43/00;;C07D333/56;;C07D409/12,,0,0,,,,DISCONTINUED
639,US,A,US 3321819 A,114-452-301-182-233,1967-05-30,1967,US 42116064 A,1964-12-24,US 42116064 A;;US 61629167 A,1964-12-24,Process for sizing and desizing textile fibers,,UNION CARBIDE CORP,WALTER ANDREW T;;BRYANT GEORGE M;;PURCELL CHESTER L,,https://lens.org/114-452-301-182-233,Granted Patent,no,5,20,9,9,0,C08F8/44;;C08F8/44;;D06M15/263;;D06M15/263;;D06M15/21;;D06M15/21;;Y10S526/932;;Y10S526/932;;Y10T428/2933;;Y10T428/2933,C08F8/44;;D06M15/21;;D06M15/263,,0,0,,,,EXPIRED
640,FR,A1,FR 2762356 A1,148-488-058-541-694,1998-10-23,1998,FR 9804764 A,1998-04-16,US 83740197 A,1997-04-17,Joint for drilling shaft screen with bypass circuits,"Screen for a drilling shaft with bypass circuits containing at least one upper and one lower screen joint (11a, 11b) each of which have the same structure. These have a permeable section (12a, 12b) designed to allow fluid to flow across it whilst blocking particles, and at least one bypass pipe extending over the length of the joint (11) and containing a bypass tube (14) with a number of openings (15a, 15b) in its length. This tube is open at its upper and lower ends. The screen also has means (26) of connecting the lower end of the upper screen (11a) to the upper end of the lower screen (11b), and a collection tube (30) extending between the lower end of the upper screen joint and the upper end of the lower screen joint and surrounding the lower end of at least one bypass tube on the upper screen and the upper end of at least one bypass tube on the lower screen so it offers a passage for fluid flow between the bypass tubes. SImilar screen, with an envelope (17) enclosing the permeable section to protect the flow passage during installation.",MOBIL OIL CORP,BRYANT DAVID WADE;;TUPY STEVEN J;;GILLESPIE GEORGE A,,https://lens.org/148-488-058-541-694,Patent Application,no,13,3,11,11,0,E21B43/04;;E21B43/08;;E21B43/04;;E21B43/08,E21B43/04;;E21B43/08,,0,0,,,,EXPIRED
641,KR,B1,KR 810001218 B1,166-309-303-681-84X,1981-09-29,1981,KR 770001164 A,1977-05-16,KR 770001164 A,1977-05-16,FOAMS FOR TREATING FABRICS,"A froth compn. for surface treating a fabric or paper substrate, has a foam d. 0.005-0.3 g/cc, a foam bubble size 0.05-0.5 mm and a foam half-life 1-60 min and contains 5-75 wt.% functional textile treating compd., 0.2-5wt.% frothing agent, 0-5wt.% wetting agent and water. For example, a mech. foamed mixt. of 45% aq. 1,3-dimethylol-4,5-dihydroxy-2-imidazolidone 73.8, 3% aq. Zn(NO3)2 16.4, 30% aq. modified polyethylene softener 8.2, RO(CH2CH2O)20H(R = C11-15 sec-alkyl) frothing agent 2.2., and RO(CH2CH2O)9H(R = C11-15 sec-alkyl) wetting agent 0.4, with initial foam d. 0.06 g/cc was applied to cotton fabric by a roll-down technigue.",UNION CARBIDE CORP,READSHAW RONALD LOUIS;;WALTER ANDREW TAINTER;;BRYANT GEORGE MACON,,https://lens.org/166-309-303-681-84X,Granted Patent,no,0,0,1,1,0,C09B67/00;;D06P1/00;;D06P2001/0092,D06B1/04;;D06P1/16,,0,0,,,,EXPIRED
642,CA,A,CA 734563 A,003-809-297-577-56X,1966-05-17,1966,CA 734563D A,,CA 734563T A,,DYEABLE POLYPROPYLENE COMPOSITIONS,,UNION CARBIDE CORP,ZUTTY NATHAN L;;BRYANT GEORGE M;;WALTER ANDREW T,,https://lens.org/003-809-297-577-56X,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
643,GB,B,GB 2327960 B,052-923-057-401-326,2002-01-16,2002,GB 9807911 A,1998-04-14,US 83740197 A,1997-04-17,Alternate-path well screen having protected shunt connection,,MOBIL OIL CORP;;UNITED STATES FILTER CORP,BRYANT DAVID WADE;;GILLESPIE GEORGE A;;TUPY STEVEN J,,https://lens.org/052-923-057-401-326,Granted Patent,no,1,0,11,11,0,E21B43/04;;E21B43/08;;E21B43/04;;E21B43/08,E21B43/04;;E21B43/08,E1F FJF           FJF,0,0,,,,EXPIRED
644,US,A,US 6096764 A,081-632-296-156-614,2000-08-01,2000,US 13431698 A,1998-08-14,US 13431698 A;;US 5620297 P,1997-08-21,Methods for inhibiting detrimental side-effects due to GnRH of GnRH agonist administration,"A method of inhibiting detrimental side-effects of GnRH or GnRH agonist administration in a mammal which comprises the administration to a mannal in need thereof of an effective amount of a compound of formula I ##STR1## wherein R.sup.1 and R.sup.3 are, independently, --H, --CH.sub.3, --CO(C.sub.1 -C.sub.6 alkyl), or --COAr, where Ar is optionally substituted phenyl; R.sup.3 is selected from the group consisting of pyrrolidine, piperidine, and hexamethyleneimino; or a pharmaceutically acceptable salt or solvate thereof.",LILLY CO ELI,BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH;;DODGE JEFFREY ALAN,ELI LILLY AND COMPANY (1998-08-11),https://lens.org/081-632-296-156-614,Granted Patent,yes,4,23,7,7,0,A61K31/44;;A61K31/44;;A61K31/4535;;A61K31/4535;;A61K38/09;;A61K38/09;;A61P43/00,C07D333/56;;A61K31/4025;;A61K31/44;;A61K31/4535;;A61K31/55;;A61K38/09;;A61P43/00,514/324;;514/422;;514/443,8,5,055-459-038-375-719;;007-023-645-974-416;;131-124-089-123-140;;102-762-409-593-892;;062-013-065-012-750,10.1210/endo.137.10.8828469;;10.1210/en.137.10.4139;;8828469;;8282823;;10.1172/jci116985;;pmc293730;;8700270;;8996192;;10.1016/8756-3282(96)00085-3;;8806005,"Evans, et al, Endocrinology , 137(10):4139 4144 (1996).;;Black, et al, J. Clin. Ivest ., 93(1):63 69 (1994).;;Lips, et al, Nederlands Tijischrift Voor GeneeSkunde, 140(23):1215 1217 (1996).;;Kauffman, et al, J. Pharma. Exp. Ther ., 280 (1):146 153 (1997).;;Wang, et al., Eur. J. Exp. Musculoskeletal Res. , 4(3 4):171 175 (1995).;;Frolik, et al., Bone , 18(6):621 627 (1996).;;CA 109:86521, Ortmann et al., 1988.;;CA 124:155994, Draper, Sep. 1995.",EXPIRED
645,PT,B,PT 91162 B,095-270-769-426-93X,1995-03-01,1995,PT 9116289 A,1989-07-13,US 21891188 A;;US 37320689 A,1988-07-14,"PROCESSO PARA A SEPARACAO DO ALDEIDO PRODUZIDO, DO CATALISADOR USADO NA REACCAO DE HIDROFORMILACAO",,UNION CARBIDE CHEM PLASTIC,BRYANT DAVID ROBERT;;ABATJOGLOU ANTHONY GEORGE;;PETERSON RONALD ROBERT,,https://lens.org/095-270-769-426-93X,Granted Patent,no,0,0,20,26,0,C07C45/80;;C07C47/02;;C07C45/50,C07C45/50;;C07C45/80,,0,0,,,,EXPIRED
646,DE,D1,DE 68918355 D1,114-075-325-730-82X,1994-10-27,1994,DE 68918355 T,1989-07-13,US 21891188 A;;US 37320689 A,1988-07-14,Verfahren zur Trennung eines Aldehyds und seines Katalysators.,,UNION CARBIDE CHEM PLASTIC,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT;;PETERSON RONALD ROBERT,"DOW TECHNOLOGY INVESTMENTS LLC, MIDLAND, MICH., US (2008-12-24)",https://lens.org/114-075-325-730-82X,Granted Patent,no,0,0,20,26,0,C07C45/80;;C07C47/02;;C07C45/50,C07C45/50;;C07C45/80,,0,0,,,,EXPIRED
647,WO,A2,WO 2011/163570 A2,161-565-736-004-386,2011-12-29,2011,US 2011/0041787 W,2011-06-24,US 35833610 P,2010-06-24,HYDROGEL ULTRASOUND COUPLING DEVICE,"The present invention relates to an ultrasound coupling device that includes a gel component and a coupling compartment. The present invention also relates to various kits and methods for using the ultrasound coupling device with low-intensity ultrasound transducers and therapy. The present invention also relates to methods of making the ultrasound coupling device of the present invention. The present invention further relates to an array that includes a plurality of ultrasound coupling devices of the present invention, and methods of using the array.",ZETROZ LLC;;LEWIS JR GEORGE K;;GUARINO JOANNE L;;GUFFEY BRYANT,LEWIS JR GEORGE K;;GUARINO JOANNE L;;GUFFEY BRYANT,,https://lens.org/161-565-736-004-386,Patent Application,yes,0,16,6,7,0,A61N7/00;;A61N7/00;;A61B8/4236;;A61B8/4236;;A61B8/4281;;A61B8/4281;;A61N2007/0034;;A61N2007/0034;;A61N2007/0056;;A61N2007/0056;;A61N2007/006;;A61N2007/006;;A61N2007/0078;;A61N2007/0078,A61B8/00;;A61N7/00,,0,0,,,,PENDING
648,EP,A3,EP 0350922 A3,148-729-028-732-013,1991-07-10,1991,EP 89112857 A,1989-07-13,US 21891188 A;;US 37320689 A,1988-07-14,PROCESS FOR CATALYST-ALDEHYDE PRODUCT SEPARATION,"Process for the separation and recovery of aldehyde product from a non-aqueous hydroformylation reaction product composition comprising the aldehyde product, a rhodium-ionically charged phosphorus ligand complex, a free ionically charged phosphorus ligand and an organic solubilizing agent for said complex and said free ligand via phase separation using added water or both added water and an added non-polar hydrocarbon compound.  ",UNION CARBIDE CHEMICALS AND PLASTICS COMPANY INC. (A NEW YORK CORPORATION),"ABATJOGLOU, ANTHONY GEORGE;;BRYANT, DAVID ROBERT;;PETERSON, RONALD ROBERT",,https://lens.org/148-729-028-732-013,Search Report,yes,4,0,20,26,0,C07C45/80;;C07C47/02;;C07C45/50,C07C45/50;;C07C45/80,,0,0,,,,EXPIRED
649,DE,D1,DE 3663159 D1,170-579-511-975-361,1989-06-08,1989,DE 3663159 T,1986-03-21,US 71516985 A,1985-03-22,FOAM COMPOSITION USED IN PAPER TREATMENT,"Foamable compositions having low concentrations of select foaming agents provide uniform distribution of paper treating agents onto moving paper, including high speed applications, and treated paper having unimpaired properties.",UNION CARBIDE CORP,BROWN RUSSEL LEE;;BRYANT GEORGE MACON;;CUNNINGHAM CHARLES JAMES,,https://lens.org/170-579-511-975-361,Granted Patent,no,0,0,11,11,0,D21H17/00;;D21H17/07;;D21H17/10;;D21H17/14;;D21H21/56;;Y10T428/277;;Y10T428/249987;;Y10T428/277;;Y10T428/249987;;D21H17/07;;D21H17/14;;D21H17/10;;D21H21/56;;D21H17/00,C08J9/06;;D21H17/00;;C08L101/00;;D21H17/07;;D21H17/10;;D21H17/14;;D21H19/00;;D21H19/10;;D21H21/56,,0,0,,,,EXPIRED
650,FR,B1,FR 2762356 B1,171-466-996-058-689,2002-09-27,2002,FR 9804764 A,1998-04-16,US 83740197 A,1997-04-17,ECRAN DE PUITS DE FORAGE A CIRCUITS DE SUBSTITUTION,,MOBIL OIL CORP,BRYANT DAVID WADE;;TUPY STEVEN J;;GILLESPIE GEORGE A,,https://lens.org/171-466-996-058-689,Granted Patent,no,0,0,11,11,0,E21B43/04;;E21B43/08;;E21B43/04;;E21B43/08,E21B43/04;;E21B43/08,,0,0,,,,EXPIRED
651,AU,A,AU 1989/038068 A,007-069-177-675-75X,1990-01-18,1990,AU 1989/038068 A,1989-07-13,US 21891188 A;;US 37320689 A,1988-07-14,PROCESS FOR CATALYST ALDEHYDE PRODUCT SEPARATION,,UNION CARBIDE CHEM PLASTIC,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT;;PETERSON RONALD ROBERT,,https://lens.org/007-069-177-675-75X,Patent Application,no,0,0,20,26,0,C07C45/80;;C07C47/02;;C07C45/50,C07C45/50;;C07C45/80,,0,0,,,,EXPIRED
652,US,A,US 2829946 A,024-938-416-681-072,1958-04-08,1958,US 47253354 A,1954-12-01,US 47253354 A,1954-12-01,Preparation of lithium borohydride,,CALLERY CHEMICAL CO,CUNNINGHAM GEORGE L;;BRYANT JOHN M;;GAUSE EMILY M,,https://lens.org/024-938-416-681-072,Granted Patent,no,3,3,1,1,0,C01B6/00;;C01B6/00,C01B6/00,,0,0,,,,EXPIRED
653,BR,A2,BR 112012033078 A2,025-621-649-608-897,2016-11-22,2016,BR 112012033078 A,2011-06-24,US 2011/0041787 W;;US 35833610 P,2010-06-24,"dispositivo de acoplamento de ultrassom, kit de ultrassom terapêutico, método para realizar fisioterapia, método para aplicar energia de ultrassom, sistema, e, método para aplicar energia de ultrassom","dispositivo de acoplamento de ultrassom, kit de ultrassom terapêutico, método para realizar fisioterapia, método para aplicar energia de ultrassom, sistema, e, método para aplicar energia de ultrassom. a presente invenção é relativa a um dispositivo de acoplamento de ultrassom que inclui um componente gel e um componente compartimento de acoplamento. a presente invenção também é relativa a diversos kits e métodos para utilizar o dispositivo de acoplamento de ultrassom com transdutores de ultrassom e terapia de baixa intensidade. a presente invenção também é relativa a métodos de fazer o dispositivo de acoplamento de ultrassom da presente invenção. a presente invenção ainda é relativa a um sistema que inclui uma pluralidade de dispositivos de acoplamento de ultrassom da presente invenção e métodos de utilizar o sistema.",ZETROZ LLC,GUFFEY BRYANT;;LEWIS GEORGE K JR;;GUARINO JOANNE L,ZETROZ LLC (US) (2017-08-22),https://lens.org/025-621-649-608-897,Patent Application,no,0,0,6,7,0,A61N7/00;;A61N7/00;;A61B8/4236;;A61B8/4236;;A61B8/4281;;A61B8/4281;;A61N2007/0034;;A61N2007/0034;;A61N2007/0056;;A61N2007/0056;;A61N2007/006;;A61N2007/006;;A61N2007/0078;;A61N2007/0078,A61B8/00;;A61N7/00,,0,0,,,,DISCONTINUED
654,CA,A1,CA 2300995 A1,018-723-972-145-304,1999-02-25,1999,CA 2300995 A,1998-08-18,US 5620297 P;;US 9817116 W,1997-08-21,METHODS FOR INHIBITING DETRIMENTAL SIDE-EFFECTS DUE TO GNRH OR GNRH AGONIST ADMINISTRATION,"A method of inhibiting detrimental side-effects of GnRH or GnRH agonist administration in a mammal which comprises the administration to a mammal in need thereof of an effective amount of a compound of formula (I), wherein R1 and R3 are, independently, -H, -CH3, -CO(C1-C6 alkyl), or -COAr, where Ar is optionally substituted phenyl; R3 is selected from the group consisting of pyrrolidine, piperidine, and hexamethyleneimino; or a pharmaceutically acceptable salt or solvate thereof.",LILLY CO ELI,CULLINAN GEORGE JOSEPH;;DODGE JEFFREY ALAN;;BRYANT HENRY UHLMAN,,https://lens.org/018-723-972-145-304,Patent Application,no,0,0,7,7,0,A61K31/44;;A61K31/44;;A61K31/4535;;A61K31/4535;;A61K38/09;;A61K38/09;;A61P43/00,C07D333/56;;A61K31/4025;;A61K31/44;;A61K31/4535;;A61K31/55;;A61K38/09;;A61P43/00,,0,0,,,,DISCONTINUED
655,DE,D1,DE 69723639 D1,056-074-932-475-297,2003-08-28,2003,DE 69723639 T,1997-09-22,US 2744996 P,1996-09-27,"Benzothiophenverbindungen, Zubereitungen und Verfahren","The invention provides benzothiophene compounds, formulations, and methods of inhibiting bone loss or bone resorption, particularly osteoporosis, cardiovascular-related pathological conditions, including hyperlipidemia.",LILLY CO ELI,BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH;;DODGE JEFFREY ALAN,,https://lens.org/056-074-932-475-297,Granted Patent,no,0,0,9,9,0,C07D333/56;;C07D409/12;;C07D417/12;;A61P19/10;;A61P3/06;;A61P43/00;;C07D409/12;;C07D417/12;;C07D333/56,C07D333/16;;A61K31/38;;A61K31/381;;A61K31/425;;A61K31/426;;A61K31/44;;A61K31/4433;;A61P3/06;;A61P19/10;;A61P43/00;;C07D277/20;;C07D277/24;;C07D277/34;;C07D333/32;;C07D333/56;;C07D333/64;;C07D409/12;;C07D417/12,,0,0,,,,EXPIRED
656,US,A,US 5599833 A,081-145-347-818-609,1997-02-04,1997,US 58867096 A,1996-01-17,US 58867096 A;;US 39244595 A;;US 3512193 A,1993-03-19,Sulfonate and carbamate derivatives of 3-aroylbenzo[B]thiophenes,"The present invention relates to sulfonate and carbamate derivatives of 3-aroylbenzo[b]thiophenes, pharmaceutical formulations containing these compounds and methods of using such compounds for inhibiting the loss of bone, lowering serum cholesterol levels and therapeutically treating hormone dependent mammalian breast and uterine carcinoma.",LILLY CO ELI,BLACK LARRY J;;BRYANT HENRY U;;CULLINAN GEORGE J,,https://lens.org/081-145-347-818-609,Granted Patent,yes,6,0,32,32,0,C07D333/56;;A61P19/10;;A61P35/00;;A61P3/06;;A61P37/08;;A61P43/00;;A61P9/10;;C07D333/56,A61K31/38;;A61K31/445;;A61K31/40;;A61K31/55;;A61P3/06;;A61P9/10;;A61P19/10;;A61P35/00;;A61P37/08;;A61P43/00;;C07D333/56;;C07D409/12,514/422;;548/525,23,17,039-179-689-155-908;;051-092-766-473-41X;;015-563-808-197-111;;077-541-290-910-710;;014-249-411-385-438;;127-447-976-152-732;;073-997-237-056-690;;042-908-114-132-030;;077-684-894-287-921;;027-640-947-779-05X;;019-662-136-158-986;;046-081-900-781-495;;108-551-556-370-574;;001-666-466-422-174;;052-921-119-546-67X;;008-297-202-323-176;;007-200-277-746-819,6431104;;10.1021/jm00374a021;;2558750;;10.1016/0169-6009(89)90081-0;;3689979;;10.1007/bf01806132;;10.1007/bf02405304;;6423228;;10.1002/jbmr.5650020513;;3455628;;10.1016/0169-6009(91)90023-s;;1932893;;3342747;;10.1210/endo-122-3-1146;;10.1056/nejm199203263261302;;1542321;;3626776;;10.1007/bf02540366;;10.1139/o90-027;;2350488;;10.1210/jcem-73-5-925;;1939531;;10.7326/0003-4819-115-11-860;;1952472;;1922206;;10.1056/nejm199110243251702;;2318936;;10.1210/jcem-70-4-1132;;10.1093/jnci/82.16.1327;;2199681;;1573630;;10.1021/jm00086a002;;3199816;;10.1016/0022-4731(88)90284-1,"Williams, et al., Journal of Bone and Mineral Research , 6 (1991).;;FDC Reports , T&G 11, Mar. 30, 1992.;;Jones, et al., J. Med. Chem. , 27, 1057 1066 (1984).;;Feldmann, et al., Bone and Mineral , 7, 245 254 (1989).;;Tamoxifen Trial Restricted , SCRIP No. 1702 Mar. 20, 1992, p. 22.;;Jordan, et al., Breast Cancer Research Treatment , 10:31 35 (1987).;;Beall, et al., Calcif Tissue Int. , 36: 123 125 (1984).;;Turner, et al., Journal of Bone and Mineral Research , 2, No. 5, 449 456 (1987).;;Williams, et al., Bone and Mineral , 14, 205 220 (1991).;;Turner, et al., Endocrinology , 122, No. 3, 1146 1150 (1988).;;Love, et al., The New England Journal of Medicine , 326, No. 13, 852 856 (1992).;;Breckenridge, et al., Lipids , 22, No. 7, 505 512 (1987).;;Lazier, et al., Biochem. Cell Biol. , 68, 210 217 (1990).;;Lobo, J. Clin. Endocrinol. Metab. , 73, No. 5, 925 930 (1991).;;Love, et al., Ann. Intern. Med. , 115, No. 11, 860 864 (1991).;;Walsh, et al., N. Engl. J. Med. , 325, No. 17, 1196 1204 (1991).;;Bagdade, et al., J. Clin. Endocrinol. Metab. , 70, No. 4, 1132 1135 (1990).;;Love, et al., J. Natl. Cancer Inst. , 82, No. 16, 1327 1332 (1990).;;Teo, et al., J. Med. Chem. , 35, 1330 1339 (1992).;;Cypriani, et al., J. Steroid Biochem., 31, No. 5, 763 771 (1988).;;Cypriani, et al., Chemical Abstracts , CA 110: 1189 v, 1989.;;Cypriani, et al., Chemical Abstracts , 110:69550v, 1989.;;American Chemical Society, Registry , RN 63676 25 5, 1993.",EXPIRED
657,BR,A2,BR 112015000700 A2,077-014-095-406-207,2017-06-27,2017,BR 112015000700 A,2013-03-13,US 2013/0030713 W;;US 201261671485 P,2012-07-13,garrafa espremível incluindo uma característica ornamental,"1/1 resumo garrafa espremível incluindo uma característica ornamental uma garrafa espremível inclui um painel que possui pelo menos uma característica ornamental em si. o painel inclui uma primeira faceta que possui um comprimento e uma largura e uma segunda faceta que possui um comprimento e uma largura. os comprimentos das primeira e segunda facetas se estendem em uma direção geralmente paralela ao comprimento da garrafa espremível. a segunda faceta é disposta adjacente a e define a primeira interface com a primeira faceta, e a primeira interface define uma primeira de pelo menos uma características ornamentais. uma superfície geralmente plana da primeira faceta é disposta em um ângulo em relação a uma superfície geralmente plana da segunda faceta de tal modo que o painel seja reversivelmente deformável.",HEINZ CO H J,GEORGE IKUYA NUKUTO;;MICHAEL D MCMAHON;;MICHAEL P BRYANT,,https://lens.org/077-014-095-406-207,Patent Application,no,0,0,11,11,0,B65D1/32;;B65D23/102;;B65D47/0804;;B65D23/102;;B65D1/32;;B65D47/0804;;B65D2501/0081;;B65D23/102;;B65D47/0804;;B65D1/32;;B65D2501/0081;;B65D1/0223;;B65D2203/00,B65D90/02,,0,0,,,,DISCONTINUED
658,EP,A2,EP 2584972 A2,096-280-721-254-257,2013-05-01,2013,EP 11798978 A,2011-06-24,US 35833610 P;;US 2011/0041787 W,2010-06-24,HYDROGEL ULTRASOUND COUPLING DEVICE,,ZETROZ LLC,LEWIS JR GEORGE K;;GUARINO JOANNE L;;GUFFEY BRYANT,"ZETROZ, INC. (2013-10-23)",https://lens.org/096-280-721-254-257,Patent Application,yes,0,0,6,7,0,A61N7/00;;A61N7/00;;A61B8/4236;;A61B8/4236;;A61B8/4281;;A61B8/4281;;A61N2007/0034;;A61N2007/0034;;A61N2007/0056;;A61N2007/0056;;A61N2007/006;;A61N2007/006;;A61N2007/0078;;A61N2007/0078,A61B8/00;;A61N7/00,,1,0,,,See references of WO 2011163570A3,DISCONTINUED
659,US,B1,US 8915609 B1,116-760-340-110-467,2014-12-23,2014,US 201213441491 A,2012-04-06,US 201213441491 A;;US 93358809 A;;US 2009/0037840 W;;US 201161472536 P;;US 3821108 P,2008-03-20,"Systems, methods, and devices for providing a track light and portable light","A light module for use as a portable light or as a light source in a track lighting system is described herein. The light module may include a module housing containing a light emitting aperture, and a light emitting diode (LED) light source located inside the module housing, where the LED light source is aligned with the light emitting aperture. The light module further includes a driver electrically connected to the LED light source, and a chargeable power supply component electrically connected to the driver. The light module also includes at least two magnets attached to the exterior of the module housing, where at least one magnet is associated with a positive electrical terminal and another magnet is associated with a negative terminal, and where at least one magnet provides electrical power to at least one of the chargeable power supply component or driver.",SHAH ASHOK DEEPAK;;BERESINSKI KENNETH GEORGE;;BRYANT CHRISTOPHER MICHAEL;;COOPER TECHNOLOGIES CO,SHAH ASHOK DEEPAK;;BERESINSKI KENNETH GEORGE;;BRYANT CHRISTOPHER MICHAEL,EATON INTELLIGENT POWER LIMITED (2017-12-31);;SIGNIFY HOLDING B.V (2020-03-02);;COOPER TECHNOLOGIES COMPANY (2012-04-05),https://lens.org/116-760-340-110-467,Granted Patent,yes,113,55,1,54,0,F21S2/005;;F21S8/035;;F21V21/096;;F21L4/00;;F21L4/08;;F21S9/02;;F21V21/30;;F21V21/35;;F21W2131/405;;F21S4/10;;F21Y2105/00;;F21Y2105/10;;F21K9/23;;F21Y2115/10;;F21Y2115/15;;H05B45/24;;H05B47/18;;H05B45/30;;F21V21/096;;F21V21/30;;F21W2131/405;;F21L4/08;;F21L4/00;;F21V21/35;;F21S8/035;;F21S2/005;;F21S9/02;;F21S4/10;;F21Y2105/00;;F21K9/23;;F21Y2115/10;;F21Y2105/10;;F21Y2115/15;;H05B47/18;;H05B45/24;;H05B45/30,F21L4/00;;F21L13/00,362/183;;362/648,13,0,,,"U.S. Notice of Allowance dated Oct. 31, 2011 in U.S. Appl. No. 12/408,503.;;U.S. Official Action dated Dec. 7, 2010 in U.S. Appl. No. 12/408,503.;;International Search Report and Written Opinion Apr. 29, 2009 in International Application No. PCT/US09/37859.;;International Search Report and Written Opinion dated May 22, 2009 in International Application No. PCT/US09/37866.;;International Search Report and Written Opinion dated May 27, 2009 in International Application No. PCT/US09/37843.;;International Search Report and Written Opinion dated Jun. 4, 2009 in International Application No. PCT/US09/037840.;;U.S. Official Action dated Jul. 22, 2009 in U.S. Appl. No. 12/408,464.;;U.S. Notice of Allowance dated Jan. 11, 2010 in U.S. Appl. No. 12/408,464.;;U.S. Official Action dated Jun. 9, 2011 in U.S. Appl. No. 12/408,503.;;Renesas, ""Renesas Board 10TM"" Renesas Technology America, Inc., 2008, 2 pages.;;Ramatchandirane et aI., ""Board 10-An Improved Approach to Achieving Robust Machineto-Machine Authentication that Reduces Operating Risks and Enables Profitable Business Strategies,"" White Paper, Renesas Technology America, Inc., Jul. 8, 2008, 5 pages.;;Chinese Official Office Action dated Nov. 30, 2012 in Chinese Application No. 200980119572.9.;;Chinese Official Office Action dated Jul. 16, 2013 in Chinese Application No. 200980119572.9.",INACTIVE
660,NO,L,NO 863546 L,146-390-681-446-009,1987-03-06,1987,NO 863546 A,1986-09-04,US 77285985 A,1985-09-05,OVERGANGSMETALLKOMPLEKS-KATALYSERTE PROSESSER.,,UNION CARBIDE CORP,BILLIG ERNST NMN;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/146-390-681-446-009,Abstract,no,0,0,44,44,0,B01J31/185;;B01J31/20;;B01J2231/321;;B01J2531/0266;;B01J2531/80;;B01J2531/822;;C07C45/50;;Y02P20/582;;C07C47/02;;B01J31/22;;C07C45/50;;C07C45/50;;B01J31/185;;B01J2531/0266;;B01J2231/321;;B01J2531/80;;B01J31/20;;B01J2531/822;;Y02P20/582,B01J31/00;;C07C47/02;;B01J31/18;;B01J31/20;;B01J31/22;;C07B61/00;;C07C45/00;;C07C45/50;;C07C67/00,,0,0,,,,EXPIRED
661,EP,A1,EP 0195459 A1,163-040-939-742-646,1986-09-24,1986,EP 86103924 A,1986-03-21,US 71516985 A,1985-03-22,Foam composition used in paper treatment.,"Foamable compositions having low concentrations of select foaming agents provide uniform distribution of paper treating agents onto moving paper, including high speed applications, and treated paper having unimpaired properties.",UNION CARBIDE CORP,BROWN RUSSEL LEE;;BRYANT GEORGE MACON;;CUNNINGHAM CHARLES JAMES,,https://lens.org/163-040-939-742-646,Patent Application,yes,1,0,11,11,0,D21H17/00;;D21H17/07;;D21H17/10;;D21H17/14;;D21H21/56;;Y10T428/277;;Y10T428/249987;;Y10T428/277;;Y10T428/249987;;D21H17/07;;D21H17/14;;D21H17/10;;D21H21/56;;D21H17/00,C08J9/06;;C08L101/00;;D21H17/00;;D21H17/07;;D21H17/10;;D21H17/14;;D21H19/00;;D21H19/10;;D21H21/56,,0,0,,,,EXPIRED
662,FI,A0,FI 861221 A0,006-333-848-180-381,1986-03-21,1986,FI 861221 A,1986-03-21,US 71516985 A,1985-03-22,SKUMBLANDNINGAR FOER ANVAENDNING VID PAPPERSBEHANDLING.,"Foamable compositions having low concentrations of select foaming agents provide uniform distribution of paper treating agents onto moving paper, including high speed applications, and treated paper having unimpaired properties.",UNION CARBIDE CORP,BROWN RUSSEL LEE;;BRYANT GEORGE MACON;;CUNNINGHAM CHARLES JAMES,,https://lens.org/006-333-848-180-381,Patent Application,no,0,0,11,11,0,D21H17/00;;D21H17/07;;D21H17/10;;D21H17/14;;D21H21/56;;Y10T428/277;;Y10T428/249987;;Y10T428/277;;Y10T428/249987;;D21H17/07;;D21H17/14;;D21H17/10;;D21H21/56;;D21H17/00,C08J9/06;;C08L101/00;;D21H17/00;;D21H17/07;;D21H17/10;;D21H17/14;;D21H19/00;;D21H19/10;;D21H21/56,,0,0,,,,DISCONTINUED
663,ES,T3,ES 2132339 T3,016-102-266-555-82X,1999-08-16,1999,ES 94301871 T,1994-03-16,US 3512193 A,1993-03-19,DERIVADOS SULFONATO Y CARBAMATO DE LOS 3-AROILBENZO(BETA)TIOFENOS.,"The present invention relates to sulfonate and carbamate derivatives of 3-aroylbenzo[b]thiophenes, pharmaceutical formulations containing these compounds and methods of using such compounds for inhibiting the loss of bone, lowering serum cholesterol levels and therapeutically treating hormone dependent mammalian breast and uterine carcinoma.",LILLY CO ELI,BLACK LARRY JOHN;;BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH,,https://lens.org/016-102-266-555-82X,Granted Patent,no,0,0,32,32,0,C07D333/56;;A61P19/10;;A61P35/00;;A61P3/06;;A61P37/08;;A61P43/00;;A61P9/10;;C07D333/56,A61K31/38;;A61K31/445;;A61K31/40;;A61K31/55;;A61P3/06;;A61P9/10;;A61P19/10;;A61P35/00;;A61P37/08;;A61P43/00;;C07D333/56;;C07D409/12,,0,0,,,,EXPIRED
664,ZA,B,ZA 866728 B,030-513-693-187-455,1987-04-29,1987,ZA 866728 A,1986-09-04,US 77285985 A,1985-09-05,TRANSITION METAL COMPLEX CATALYZED PROCESSES,,UNION CARBIDE CORP,BILLIG ERNST NMN;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT,,https://lens.org/030-513-693-187-455,Granted Patent,no,0,0,44,44,0,B01J31/185;;B01J31/20;;B01J2231/321;;B01J2531/0266;;B01J2531/80;;B01J2531/822;;C07C45/50;;Y02P20/582;;C07C47/02;;B01J31/22;;C07C45/50;;C07C45/50;;B01J31/185;;B01J2531/0266;;B01J2231/321;;B01J2531/80;;B01J31/20;;B01J2531/822;;Y02P20/582,B01J31/00;;B01J31/18;;C07C47/02;;B01J31/20;;B01J31/22;;C07B61/00;;C07C45/00;;C07C45/50;;C07C67/00,,0,0,,,,EXPIRED
665,EP,B1,EP 0617030 B1,050-666-433-121-698,1999-05-26,1999,EP 94301871 A,1994-03-16,US 3512193 A,1993-03-19,Sulfonate and carbamate derivatives of 3-aroylbenzo (beta) thiophenes,"The present invention relates to sulfonate and carbamate derivatives of 3-aroylbenzo[b]thiophenes, pharmaceutical formulations containing these compounds and methods of using such compounds for inhibiting the loss of bone, lowering serum cholesterol levels and therapeutically treating hormone dependent mammalian breast and uterine carcinoma.",LILLY CO ELI,BLACK LARRY JOHN;;BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH,,https://lens.org/050-666-433-121-698,Granted Patent,yes,2,0,32,32,0,C07D333/56;;A61P19/10;;A61P35/00;;A61P3/06;;A61P37/08;;A61P43/00;;A61P9/10;;C07D333/56,A61K31/40;;A61K31/38;;A61K31/445;;A61K31/55;;A61P3/06;;A61P9/10;;A61P19/10;;A61P35/00;;A61P37/08;;A61P43/00;;C07D333/56;;C07D409/12,,0,0,,,,EXPIRED
666,CN,A,CN 1097420 A,045-214-128-681-295,1995-01-18,1995,CN 94102910 A,1994-03-17,US 3512193 A,1993-03-19,Sulfonate and carbamate derivatives of 3-aroylbenzo|B¨thiophenes,"The present invention relates to sulfonate and carbamate derivatives of 3-aroylbenzo[b]thiophenes, pharmaceutical formulations containing these compounds and methods of using such compounds for inhibiting the loss of bone, lowering serum cholesterol levels and therapeutically treating hormone dependent mammalian breast and uterine carcinoma.",LILLY CO ELI,BLACK LARRY JOHN;;BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH,,https://lens.org/045-214-128-681-295,Patent Application,no,0,0,32,32,0,C07D333/56;;A61P19/10;;A61P35/00;;A61P3/06;;A61P37/08;;A61P43/00;;A61P9/10;;C07D333/56,A61K31/40;;A61K31/38;;A61K31/445;;A61K31/55;;A61P3/06;;A61P9/10;;A61P19/10;;A61P35/00;;A61P37/08;;A61P43/00;;C07D333/56;;C07D409/12,,0,0,,,,DISCONTINUED
667,US,A,US 5929289 A,060-666-770-320-586,1999-07-27,1999,US 3363398 A,1998-03-03,US 3363398 A;;US 29302894 A,1994-08-19,Stabilization of phosphite ligands in hydroformylation process,"The present invention provides a hydroformylation process comprising: (1) forming a reaction mixture containing: (a) an olefinic compound, (b) hydrogen, (c) carbon monoxide, (d) a phosphite in which each phosphorus atom is bonded to three oxygen atoms and at least one such oxygen atom is bonded to a carbon atom of an aromatic ring that is adjacent to another carbon atom of said ring having a pendant monovalent group having a steric hindrance at least as great as the steric hindrance of the isopropyl group, (e) a catalytic amount of rhodium, and (f) a Group VIII metal (other than a rhodium) in an amount sufficient to reduce the rhodium-catalyzed decomposition of the phosphite during the hydroformylation process; and (2) maintaining the reaction mixture under conditions at which the olefinic compound reacts with the hydrogen and carbon monoxide to form an aldehyde.",UNION CARBIDE CHEM PLASTIC,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT;;MAHER JOHN MICHAEL,,https://lens.org/060-666-770-320-586,Granted Patent,yes,16,70,9,9,0,B01J31/185;;B01J2231/321;;B01J2531/0288;;B01J2531/80;;B01J2531/821;;B01J2531/824;;B01J2531/845;;C07C45/50;;C07C45/50;;B01J2531/80;;B01J31/185;;B01J2531/821;;B01J2231/321;;B01J2531/0288;;B01J2531/845;;B01J2531/824,B01J31/18;;C07C45/50,568/454;;568/451;;502/158;;502/161;;502/166;;502/167,3,3,060-941-221-842-06X;;060-652-475-138-418;;118-503-123-872-41X,10.1002/zaac.19895770129;;10.1021/ja00209a029;;10.1021/ja00270a036,"Anna M. Trzeciak et al., Synthesis and Properties of the Orthometallated Rhodium Complex Rh P(OPh) 3 3 P(OC 6 H 4 )(OPh) 2 Z. anorg. allg. Chem. 577 (1989), pp. 255 262.;;F.H. Westheimer, et al., Rates and Mechanisms of Hydrolysis of Esters of Phosphorous Acid , J. Am. Chem Soc. 1988, 110,pp. 181 185.;;L.N. Lewis et al, Catalytic C C Bond Formation via Ortho Metalated Complexes , J. Am. Chem. Soc., vol. 108, No. 10, 1986, 1986, pp. 2728 2735.",EXPIRED
668,US,A,US 3402222 A,065-290-443-629-294,1968-09-17,1968,US 31999363 A,1963-10-30,US 31999363 A,1963-10-30,Dyeable polypropylene compositions containing alkoxyethyl acrylate copolymers,,UNION CARBIDE CORP,ZUTTY NATHAN L;;BRYANT GEORGE M;;WALTER ANDREW T,,https://lens.org/065-290-443-629-294,Granted Patent,no,7,5,1,1,0,C08F20/58;;C08F28/00;;C08L23/10;;C08L33/26;;C08L2203/12;;C08F28/00;;C08L2203/12;;C08L33/26;;C08F20/58;;C08L23/10;;Y10S8/928,C08F20/58;;C08F28/00;;C08L23/10;;C08L23/12;;C08L33/26,260/897,0,0,,,,EXPIRED
669,CA,A1,CA 2316567 A1,103-867-464-194-47X,2001-03-08,2001,CA 2316567 A,2000-08-21,US 39200499 A,1999-09-08,MOLDED PLASTIC-SIDING PANEL,"A molded plastic panel for covering an exterior building wall includes a laterally directed lead fin, a laterally extending groove below the lead fin , and a rearwardly directed middle wall between rows of simulated shingles, all for joining laterally adjacent panels. A side flange extending outwardly of the panel ma y also be included. The molded plastic panel preferably also includes at least one row of simulated shingles separated by a plurality of gaps each having a randomly varying width in order to camouflage spacings between adjacent panels that change because of thermal contraction and expansion. In a particularly preferred embodiment, the panel body includes a locki ng tab and a folding flange. The folding flange includes a locking lip for engaging a locking tab on an adjacent panel and a flexible hinge connecting the locking lip to the panel body. The flexible hinge allows the folding flange to be disconnected from the locking tab when replacing a single panel.",ALCOA INC,ERNST DANIEL J;;GRIMAN GEORGE A;;BRYANT DAVID A,,https://lens.org/103-867-464-194-47X,Patent Application,no,0,1,6,8,0,E04F13/0864;;Y10T428/24669;;Y10T156/1036;;Y10T156/1051;;Y10T428/24669;;Y10T156/1036;;Y10T156/1051;;E04F13/0864,E04F13/08,,0,0,,,,EXPIRED
670,PT,A,PT 91162 A,154-142-736-674-701,1990-02-08,1990,PT 9116289 A,1989-07-13,US 21891188 A;;US 37320689 A,1988-07-14,"PROCESSO PARA A SEPARACAO DO ALDEIDO PRODUZIDO, DO CATALISADOR USADO NA REACCAO DE HIDROFORMILACAO",,UNION CARBIDE CHEM PLASTIC,BRYANT DAVID ROBERT;;ABATJOGLOU ANTHONY GEORGE;;PETERSON RONALD ROBERT,,https://lens.org/154-142-736-674-701,Patent Application,no,0,0,20,26,0,C07C45/80;;C07C47/02;;C07C45/50,C07C45/50;;C07C45/80,,0,0,,,,EXPIRED
671,DE,A1,DE 2722082 A1,156-415-159-166-240,1978-11-23,1978,DE 2722082 A,1977-05-16,DE 2722082 A,1977-05-16,"Foam compsns. for treating paper and textiles etc. - contg. treating agent, frothing agent, wetting agent and water","Froth compsn. for continuously and directly treating a fabric or paper has froth from density 0.005-0.3 g/cc; average foam bubble dia. 0.05-0.5 mm; and foam half life 1-60 min. The foam compsn. consists of 5-75 wt. % functional textile treating cpd. (I), 0.2-5 wt. % frothing agent (II), 0-5 wt. % wetting agent (III), and H2O (to 100 wt. %). In use, the foam immediately breaks on contact with the substrate and is absorbed rapidly leaving the surface dry to the touch. Thus the compsn. allows a variety of (I) (flame retardants, fabric softeners, bacteriostats, etc.) to be applied to paper and fabrics without the conventional use of large vols. of H2O. process also allows one side of the fabric to be treated without affecting the other side.",UNION CARBIDE CORP,WALTER ANDREW TAINTER;;BRYANT GEORGE MACON;;READSHAW RONALD LOUIS,"UNION CARBIDE CORP., 06817 DANBURY, CONN., US (1982-12-23)",https://lens.org/156-415-159-166-240,Patent Application,no,2,5,1,1,0,D06M23/06;;D06M15/647;;D06P1/965,D06M15/647;;D06M23/06;;D06P1/96,,0,0,,,,DISCONTINUED
672,AU,B2,AU 617835 B2,022-852-502-374-984,1991-12-05,1991,AU 1989/038068 A,1989-07-13,US 21891188 A;;US 37320689 A,1988-07-14,PROCESS FOR CATALYST ALDEHYDE PRODUCT SEPARATION,,UNION CARBIDE CHEM PLASTIC,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT;;PETERSON RONALD ROBERT,,https://lens.org/022-852-502-374-984,Granted Patent,no,3,0,20,26,0,C07C45/80;;C07C47/02;;C07C45/50,C07C45/50;;C07C45/80,,0,0,,,,EXPIRED
673,US,A,US 5605924 A,082-976-457-763-884,1997-02-25,1997,US 58866396 A,1996-01-17,US 58866396 A;;US 39244595 A;;US 3512193 A,1993-03-19,Sulfonate and carbamate derivatives of 3-aroylbenzo[b] thiophenes,"The present invention relates to compounds of the formula ##STR1## where X is a bond or --CH2--; R.sup.2 is pyrrolidino; R is OH, --OSO.sub.2 --(CH.sub.2).sub.n --CH.sub.3 or ##STR2## R.sup.1 is hydrogen, OH, fluoro, chloro, --OSO.sub.2 --(CH.sub.2).sub.n --CH.sub.3 or ##STR3## each R.sup.3 is independently C.sub.1 -C.sub.6 alkyl, C.sub.3 -C.sub.6 cycloalkyl, unsubstituted or substituted phenyl where the substituent is fluoro, chloro, C.sub.1 -C.sub.3 alkyl or C.sub.1 -C.sub.3 alkoxy; each n is independently 3, 4 or 5; and pharmaceutically acceptable salts and solvates thereof; provided that at least one of R and R.sup.1 is ##STR4## The invention also relates to methods of use of the compounds of formula I and pharmaceutical compositions which comprise compounds of formula I.",LILLY CO ELI,BLACK LARRY J;;BRYANT HENRY U;;CULLINAN GEORGE J,,https://lens.org/082-976-457-763-884,Granted Patent,yes,12,1,32,32,0,C07D333/56;;A61P19/10;;A61P35/00;;A61P3/06;;A61P37/08;;A61P43/00;;A61P9/10;;C07D333/56,A61K31/38;;A61K31/445;;A61K31/55;;A61K31/40;;A61P3/06;;A61P9/10;;A61P19/10;;A61P35/00;;A61P37/08;;A61P43/00;;C07D333/56;;C07D409/12,514/422;;514/443;;514/444;;514/448;;548/525;;549/33;;549/58,25,17,039-179-689-155-908;;051-092-766-473-41X;;015-563-808-197-111;;077-541-290-910-710;;014-249-411-385-438;;127-447-976-152-732;;073-997-237-056-690;;042-908-114-132-030;;077-684-894-287-921;;027-640-947-779-05X;;019-662-136-158-986;;046-081-900-781-495;;108-551-556-370-574;;001-666-466-422-174;;052-921-119-546-67X;;008-297-202-323-176;;007-200-277-746-819,6431104;;10.1021/jm00374a021;;2558750;;10.1016/0169-6009(89)90081-0;;3689979;;10.1007/bf01806132;;10.1007/bf02405304;;6423228;;10.1002/jbmr.5650020513;;3455628;;10.1016/0169-6009(91)90023-s;;1932893;;3342747;;10.1210/endo-122-3-1146;;10.1056/nejm199203263261302;;1542321;;3626776;;10.1007/bf02540366;;10.1139/o90-027;;2350488;;10.1210/jcem-73-5-925;;1939531;;10.7326/0003-4819-115-11-860;;1952472;;1922206;;10.1056/nejm199110243251702;;2318936;;10.1210/jcem-70-4-1132;;10.1093/jnci/82.16.1327;;2199681;;1573630;;10.1021/jm00086a002;;3199816;;10.1016/0022-4731(88)90284-1,"Williams, et al., Journal of Bone and Mineral Research, 6 (1991).;;FDC Reports, T&G 11, Mar. 30, 1992.;;Jones, et al., J. Med. Chem., 27, 1057 1066 (1984).;;Feldmann, et al., Bone and Mineral, 7, 245 254 (1989).;;Tamoxifen Trial Restricted , SCRIP No. 1702 Mar. 20, 1992, p. 22.;;Jordan, et al., Brease Cancer Research Treatment, 10:31 35 (1987).;;Beall, et al., Calcif Tissue Int., 36: 123 125 (1984).;;Turner, et al., Journal of Bone and Mineral Research, 2, No. 5, 449 456 (1987).;;Williams, et al., Bone and Mineral, 14, 205 220 (1991).;;U.S. Application No. 07/920,933 Black, et al. filed Jul. 28, 1992.;;U.S. Application No. 07/995,222 Black et al. filed Dec. 22, 1992.;;Turner, et al., Endocrinology, 122, No. 3, 1146 1150 (1988).;;Love, et al., The New England Journal of Medicine, 326, No. 13, 852 856 (1992).;;Breckenridge, et al., Lipids, 22, No. 7, 505 512 (1987).;;Lazier, et al., Biochem. Cell Biol., 68, 210 217 (1990).;;Lobo, J. Clin. Endocrinol. Metab., 73, No. 5, 925 930 (1991).;;Love, et al., Ann. Intern. Med., 115, No. 11, 860 864 (1991).;;Walsh, et al., N. Engl. J. Med., 325, No. 17, 1196 1204 (1991).;;Bagdade, et al., J. Clin. Endocrinol. Metab., 70, No. 4, 1132 1135 (1990).;;Love, et al., J. Natl. Cancer Inst., 82, No. 116, 1327 1332 (1990).;;Teo, et al., J. Med. Chem., 35, 1330 1339 (1992.;;Cypriani, et al., J. Steroid Biochem., 31, No. 5, 763 771 (1988).;;Cypriani, et al., Chemical Abstracts, CA 110: 1189 v, 1989.;;Cypriani, et al., Chemical Abstracts, 110:69550v, 1989.;;American Chemical Society, Registry, RN 63676 25 5, 1989.",EXPIRED
674,DE,B2,DE 2722083 B2,104-887-541-353-345,1980-10-02,1980,DE 2722083 A,1977-05-16,DE 2722083 A,1977-05-16,DE 2722083 B2,,"UNION CARBIDE CORP., NEW YORK, N.Y. (V.ST.A.)","WALTER, ANDREW TAINTER;;BRYANT, GEORGE MACON;;READSHAW, RONALD LOUIS",,https://lens.org/104-887-541-353-345,Patent Application,no,0,1,2,2,0,D06M23/06;;D06M15/647;;D06P1/965,D06M15/647;;D06M23/06;;D06P1/96,,0,0,,,,EXPIRED
675,CA,A,CA 1263802 A,139-401-291-066-526,1989-12-12,1989,CA 504485 A,1986-03-19,US 71516985 A,1985-03-22,FOAM COMPOSITIONS USED IN PAPER TREATMENT,"FOAM COMPOSITIONS USED IN PAPER TREATMENT Foamable compositions having low concentrations of select foaming agents provide uniform distribution of paper treating agents onto moving paper, including high speed applications, and treated paper having unimpaired properties.",UNION CARBIDE CORP,BROWN RUSSELL L;;BRYANT GEORGE M;;CUNNINGHAM CHARLES J,,https://lens.org/139-401-291-066-526,Granted Patent,no,0,0,11,11,0,D21H17/00;;D21H17/07;;D21H17/10;;D21H17/14;;D21H21/56;;Y10T428/277;;Y10T428/249987;;Y10T428/277;;Y10T428/249987;;D21H17/07;;D21H17/14;;D21H17/10;;D21H21/56;;D21H17/00,C08L101/00;;C08J9/06;;D21H17/00;;D21H17/07;;D21H17/10;;D21H17/14;;D21H19/00;;D21H19/10;;D21H21/56,8-93.26,0,0,,,,EXPIRED
676,CN,A,CN 1087619 A,129-545-721-176-144,1994-06-08,1994,CN 93116946 A,1993-08-24,US 21891188 A;;US 37320689 A,1988-07-14,Process for catalyst-aldehde product separation,,UNION CARBIDE CHEM PLASTIC,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT;;PETERSON RONALD ROBERT,,https://lens.org/129-545-721-176-144,Patent Application,no,0,0,20,26,0,C07C45/80;;C07C47/02;;C07C45/50,C07C45/50;;C07C45/80,,0,0,,,,PENDING
677,US,A,US 4571360 A,141-745-961-148-477,1986-02-18,1986,US 71516985 A,1985-03-22,US 71516985 A,1985-03-22,Foam composition used in paper treatment,"Foamable compositions having low concentrations of select foaming agents provide uniform distribution of paper treating agents onto moving paper, including high speed applications, and treated paper having unimpaired properties.",UNION CARBIDE CORP,BROWN RUSSELL L;;BRYANT GEORGE M;;CUNNINGHAM CHARLES J,UNION CARBIDE CORPORATION A CORP OF NY (1985-03-22),https://lens.org/141-745-961-148-477,Granted Patent,yes,5,42,11,11,0,D21H17/00;;D21H17/07;;D21H17/10;;D21H17/14;;D21H21/56;;Y10T428/277;;Y10T428/249987;;Y10T428/277;;Y10T428/249987;;D21H17/07;;D21H17/14;;D21H17/10;;D21H21/56;;D21H17/00,C08J9/06;;C08L101/00;;D21H17/00;;D21H17/07;;D21H17/10;;D21H17/14;;D21H19/00;;D21H19/10;;D21H21/56,B2E EM            EMFT        -;;B2E E1544         EMFT        -;;B2E E1714         EMFT        -;;B2E E1724         EMFT        -;;B2E E1729         EMFT        -;;B2E E1748         EMFT        -;;B2E E400S         EMFT        -;;B2E E400T         EMFT        -;;B2E E404S         EMFT        -;;B2E E422S         EMFT        -;;B2E E422T         EMFT        -;;B2E E423S         EMFT        -;;B2E E423T         EMFT        -;;B2E E424S         EMFT        -;;B2E E427S         EMFT        -;;B2E E427T         EMFT        -;;B2E E429S         EMFT        -;;B2E E429T         EMFT        -;;B2E E430S         EMFT        -;;B2E E430T         EMFT        -;;B2E E443S         EMFT        -;;B2E E443T         EMFT        -;;B2E E447S         EMFT        -;;B2E E447T         EMFT        -;;B2E E473S         EMFT        -;;B2E E473T         EMFT        -;;B2E E482S         EMFT        -;;B2E E482T         EMFT        -;;B2E E489S         EMFT        -;;B2E E489T         EMFT        -;;B2E E490S         EMFT        -;;B2E E490T         EMFT        -;;B2E E509S         EMFT        -;;B2E E509T         EMFT        -;;B2E E551T         EMFT        -;;B2E E627T         EMFT        -,0,0,,,,EXPIRED
678,EP,A1,EP 1083272 A1,166-395-157-919-584,2001-03-14,2001,EP 00116696 A,2000-08-02,US 39200499 A,1999-09-08,Molded plastic siding panel,"A molded plastic panel (11) for covering an exterior building wall (10) includes a laterally directed lead fin, a laterally extending groove below the lead fin, and a rearwardly directed middle wall between rows of simulated shingles (12), all for joining laterally adjacent panels (11). A side flange extending outwardly of the panel (11) may also be included. The molded plastic panel (11) preferably also includes at least one row of simulated shingles (12) separated by a plurality of gaps (15) each having a randomly varying width in order to camouflage spacings between adjacent panels (11) that change because of thermal contraction and expansion. In a particularly preferred embodiment, the panel body includes a locking tab and a folding flange. The folding flange includes a locking lip for engaging a locking tab on an adjacent panel (11) and a flexible hinge connecting the locking lip to the panel body. The flexible hinge allows the folding flange to be disconnected from the locking tab when replacing a single panel (11).",ALCOA INC,BRYANT DAVID A;;ERNST DANIEL J;;GRIMAN GEORGE A,,https://lens.org/166-395-157-919-584,Patent Application,yes,4,1,6,8,0,E04F13/0864;;Y10T428/24669;;Y10T156/1036;;Y10T156/1051;;Y10T428/24669;;Y10T156/1036;;Y10T156/1051;;E04F13/0864,E04F13/08,,0,0,,,,DISCONTINUED
679,US,B2,US 8771476 B2,175-608-427-978-692,2014-07-08,2014,US 70593710 A,2010-02-15,US 70593710 A;;US 22662809 P,2009-07-17,Methods for inhibiting polymerization of vinyl aromatic compounds during extractive distillation,"High temperatures and oxygen exposure during extractive distillation can result in polymerization of vinyl aromatic compounds. In various embodiments, the present disclosure relates to methods for inhibiting polymerization of vinyl aromatic compounds during extractive distillation. In various embodiments, the methods include a) providing a mixture containing at least one vinyl aromatic compound, b) adding at least one dinitrophenol inhibitor to the mixture, and c) after step b), performing an extractive distillation on the mixture to isolate the at least one vinyl aromatic compound. Purified styrene can be isolated by the methods described herein. In some embodiments, the dinitrophenol inhibitor is 2-sec-butyl-4,6-dinitrophenol (DNBP).",SEALEY AMY;;BALL GEORGE A;;SLIMP JR B BRYANT;;GTC TECHNOLOGY LP,SEALEY AMY;;BALL GEORGE A;;SLIMP JR B BRYANT,GTC TECHNOLOGY LP (2009-11-03),https://lens.org/175-608-427-978-692,Granted Patent,yes,13,0,14,14,0,C07C7/08;;C07C7/20;;B01D3/00;;B01D3/34;;B01D3/40;;C07C7/08;;C07C7/20;;C07C15/46;;C07C7/08;;C07C7/20,C07C7/08;;C07C7/20,203/9;;203/8;;203/50;;203/57;;203/68;;585/833;;585/864,1,0,,,"Young, Lee W., ""International Search Report"" for PCT/US10/35889 as mailed Jul. 12, 2010, 2 pages.",INACTIVE
680,CA,A,CA 1106556 A,199-391-205-288-473,1981-08-11,1981,CA 278130 A,1977-05-09,CA 278130 A,1977-05-09,PROCESS OF TREATING FABRICS WITH FOAM,PROCESS OF TREATING FABRICS WITH FOAM A continuous process for the application of a textile treating composition in the form of a froth or foam to a substrate such as textiles. The process enables the application in a uniform manner of any formable functional composition that can be used in the treatment of a textile fabric to improve its properties. It generally leaves the textile material essentially dry to the touch and thus requires less energy consumption in drying and further treatment of the textile. S P E C I F I C A T I O N 1.,UNION CARBIDE CORP,WALTER ANDREW T;;BRYANT GEORGE M;;READSHAW RONALD L,,https://lens.org/199-391-205-288-473,Granted Patent,no,0,0,1,1,0,,D06B1/00,8-128,0,0,,,,EXPIRED
681,IN,B,IN 146324 B,030-300-893-942-786,1979-04-28,1979,IN 733CA1977 A,1977-05-16,IN 733CA1977 A,1977-05-16,PROCESS OF TREATING FABRICS WITH FOAM,,UNION CARBIDE CORP,READSHAW R L;;BRYANT GEORGE MACON;;WALTER ANDREW TAINTER,,https://lens.org/030-300-893-942-786,Granted Patent,no,0,0,1,1,0,,D06M13/00;;D06M15/00,,0,0,,,,EXPIRED
682,EP,A2,EP 0350922 A2,028-725-586-447-306,1990-01-17,1990,EP 89112857 A,1989-07-13,US 21891188 A;;US 37320689 A,1988-07-14,Process for catalyst-aldehyde product separation.,"Process for the separation and recovery of aldehyde product from a non-aqueous hydroformylation reaction product composition comprising the aldehyde product, a rhodium-ionically charged phosphorus ligand complex, a free ionically charged phosphorus ligand and an organic solubilizing agent for said complex and said free ligand via phase separation using added water or both added water and an added non-polar hydrocarbon compound.  ",UNION CARBIDE CHEM PLASTIC,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT;;PETERSON RONALD ROBERT,,https://lens.org/028-725-586-447-306,Patent Application,yes,0,8,20,26,0,C07C45/80;;C07C47/02;;C07C45/50,C07C45/50;;C07C45/80,,0,0,,,,EXPIRED
683,US,A,US 2968523 A,033-476-434-866-380,1961-01-17,1961,US 45736754 A,1954-09-21,US 45736754 A,1954-09-21,Preparation of sodium-potassium borohydride,,CALLERY CHEMICAL CO,CUNNINGHAM GEORGE L;;BRYANT JOHN M;;GAUSE EMILY M,,https://lens.org/033-476-434-866-380,Granted Patent,no,1,10,1,1,0,C01B6/00;;C01B6/00,C01B6/00,,0,0,,,,EXPIRED
684,CA,A1,CA 2206997 A1,032-396-432-928-801,1998-01-10,1998,CA 2206997 A,1997-06-04,US 2151396 P,1996-07-10,BENZOTHIOPHENE COMPOUNDS AND METHODS OF USE,"The instant invention provides novel benzothiophene compounds, pharmaceutical formulations, and methods of use.",LILLY CO ELI,BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH;;FAHEY KENNAN JOSEPH,,https://lens.org/032-396-432-928-801,Patent Application,no,0,0,7,7,0,A61K31/565;;A61K31/57;;A61K31/66;;A61K38/29;;C07D333/56;;A61P13/02;;A61P15/00;;A61P35/00;;A61P43/00,A61K31/38;;A61K31/381;;A61K31/565;;A61K31/57;;A61K31/66;;A61K38/29;;A61P13/02;;A61P15/00;;A61P35/00;;A61P43/00;;C07D333/56,,0,0,,,,DISCONTINUED
685,DE,T2,DE 69723639 T2,065-965-971-033-083,2004-04-15,2004,DE 69723639 T,1997-09-22,US 2744996 P,1996-09-27,"Benzothiophenverbindungen, Zubereitungen und Verfahren","The invention provides benzothiophene compounds, formulations, and methods of inhibiting bone loss or bone resorption, particularly osteoporosis, cardiovascular-related pathological conditions, including hyperlipidemia.",LILLY CO ELI,BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH;;DODGE JEFFREY ALAN,,https://lens.org/065-965-971-033-083,Granted Patent,no,0,0,9,9,0,C07D333/56;;C07D409/12;;C07D417/12;;A61P19/10;;A61P3/06;;A61P43/00;;C07D409/12;;C07D417/12;;C07D333/56,C07D333/16;;A61K31/38;;A61K31/381;;A61K31/425;;A61K31/426;;A61K31/44;;A61K31/4433;;A61P3/06;;A61P19/10;;A61P43/00;;C07D277/20;;C07D277/24;;C07D277/34;;C07D333/32;;C07D333/56;;C07D333/64;;C07D409/12;;C07D417/12,,0,0,,,,EXPIRED
686,CA,A,CA 1093259 A,087-444-513-280-065,1981-01-13,1981,CA 278131 A,1977-05-09,CA 278131 A,1977-05-09,FOAMS FOR TREATING FABRICS,"10,624 FOAMS FOR TREATING FABRICS Foams containing a functional textile treating compound for application to a substrate such as a fabric or textile. The use of foams enables the application in uniform manner of many functional compositions that can be used in the treatment of a textile fabric to improve its properties. The foam compositions of this invention generally leave the textile material essentially dry to the touch and thus require less energy consumption in drying and further treatment of the textile. The foams have a form density of 0.005 to 0.3 gram per cc, and average bubble size of from 0.05 to 0.5 millimeters in diameter and a foam half-life of from one to sixty minutes. S P E C I F I C A T I O N 1.",UNION CARBIDE CORP,WALTER ANDREW T;;BRYANT GEORGE M;;READSHAW RONALD L,,https://lens.org/087-444-513-280-065,Granted Patent,no,0,0,1,1,0,,B01J13/00;;D06C29/00,8-128,0,0,,,,EXPIRED
687,US,A,US 2784053 A,097-062-618-029-730,1957-03-05,1957,US 45421254 A,1954-09-03,US 45421254 A,1954-09-03,Preparation of alkaline earth metal borohydrides,,CALLERY CHEMICAL CO,CUNNINGHAM GEORGE L;;BRYANT JOHN M;;GAUSE EMILY M,,https://lens.org/097-062-618-029-730,Granted Patent,no,0,6,1,1,0,C01B6/00;;C01B6/00,C01B6/00,,0,0,,,,EXPIRED
688,EP,B1,EP 0195459 B1,097-090-743-317-780,1989-05-03,1989,EP 86103924 A,1986-03-21,US 71516985 A,1985-03-22,FOAM COMPOSITION USED IN PAPER TREATMENT,"Foamable compositions having low concentrations of select foaming agents provide uniform distribution of paper treating agents onto moving paper, including high speed applications, and treated paper having unimpaired properties.",UNION CARBIDE CORPORATION,"BROWN, RUSSEL LEE;;BRYANT, GEORGE MACON;;CUNNINGHAM, CHARLES JAMES",,https://lens.org/097-090-743-317-780,Granted Patent,yes,1,0,11,11,0,D21H17/00;;D21H17/07;;D21H17/10;;D21H17/14;;D21H21/56;;Y10T428/277;;Y10T428/249987;;Y10T428/277;;Y10T428/249987;;D21H17/07;;D21H17/14;;D21H17/10;;D21H21/56;;D21H17/00,C08J9/06;;C08L101/00;;D21H17/00;;D21H17/07;;D21H17/10;;D21H17/14;;D21H19/00;;D21H19/10;;D21H21/56,,0,0,,,,EXPIRED
689,SI,T1,SI 0617030 T1,102-043-515-125-768,1999-10-31,1999,SI 9430259 T,1994-03-16,EP 94301871 A;;US 3512193 A,1993-03-19,Sulfonate and carbamate derivatives of 3-aroylbenzo (beta) thiophenes,"The present invention relates to sulfonate and carbamate derivatives of 3-aroylbenzo[b]thiophenes, pharmaceutical formulations containing these compounds and methods of using such compounds for inhibiting the loss of bone, lowering serum cholesterol levels and therapeutically treating hormone dependent mammalian breast and uterine carcinoma.",LILLY CO ELI,BLACK LARRY JOHN;;BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH,,https://lens.org/102-043-515-125-768,Granted Patent,no,0,0,32,32,0,C07D333/56;;A61P19/10;;A61P35/00;;A61P3/06;;A61P37/08;;A61P43/00;;A61P9/10;;C07D333/56,A61K31/38;;A61K31/445;;A61K31/40;;A61K31/55;;A61P3/06;;A61P9/10;;A61P19/10;;A61P35/00;;A61P37/08;;A61P43/00;;C07D333/56;;C07D409/12,,0,0,,,,EXPIRED
690,AT,T1,AT E172708 T1,106-786-847-417-882,1998-11-15,1998,AT 95113051 T,1995-08-18,US 29302894 A,1994-08-19,STABILISIERUNG VON PHOSPHITELIGANDEN IN DAS HYDROFORMYLIERUNGSVERFAHREN,"The present invention provides a hydroformylation process comprising: (1) forming a reaction mixture containing: (a) an olefinic compound, (b) hydrogen, (c) carbon monoxide, (d) a phosphite in which each phosphorus atom is bonded to three oxygen atoms and at least one such oxygen atom is bonded to a carbon atom of an aromatic ring that is adjacent to another carbon atom of said ring having a pendant monovalent group having a steric hindrance at least as great as the steric hindrance of the isopropyl group, (e) a catalytic amount of rhodium, and (f) a Group VIII metal (other than a rhodium) in an amount sufficient to reduce the rhodium-catalyzed decomposition of the phosphite during the hydroformylation process; and (2) maintaining the reaction mixture under conditions at which the olefinic compound reacts with the hydrogen and carbon monoxide to form an aldehyde.",UNION CARBIDE CHEM PLASTIC,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT;;MAHER JOHN MICHAEL,,https://lens.org/106-786-847-417-882,Granted Patent,no,0,0,9,9,0,B01J31/185;;B01J2231/321;;B01J2531/0288;;B01J2531/80;;B01J2531/821;;B01J2531/824;;B01J2531/845;;C07C45/50;;C07C45/50;;B01J2531/80;;B01J31/185;;B01J2531/821;;B01J2231/321;;B01J2531/0288;;B01J2531/845;;B01J2531/824,B01J31/18;;C07C45/50,,0,0,,,,DISCONTINUED
691,US,A1,US 2001/0001411 A1,142-446-108-530-018,2001-05-24,2001,US 76602401 A,2001-01-19,US 76602401 A;;US 39200499 A,1999-09-08,Molded plastic siding panel,"
   A molded plastic panel for covering an exterior building wall includes a laterally directed lead fin, a laterally extending groove below the lead fin, and a rearwardly directed middle wall between rows of simulated shingles, all for joining laterally adjacent panels. A side flange extending outwardly of the panel may also be included. 

   The molded plastic panel preferably also includes at least one row of simulated shingles separated by a plurality of gaps each having a randomly varying width in order to camouflage spacings between adjacent panels that change because of thermal contraction and expansion. 

   In a particularly preferred embodiment, the panel body includes a locking tab and a folding flange. The folding flange includes a locking lip for engaging a locking tab on an adjacent panel and a flexible hinge connecting the locking lip to the panel body. The flexible hinge allows the folding flange to be disconnected from the locking tab when replacing a single panel. 
",BRYANT DAVID A.;;ERNST DANIEL J.;;GRIMAN GEORGE A.,BRYANT DAVID A;;ERNST DANIEL J;;GRIMAN GEORGE A,ALCOA HOME EXTERIORS INC (2006-09-01),https://lens.org/142-446-108-530-018,Patent Application,yes,0,1,6,8,0,E04F13/0864;;Y10T428/24669;;Y10T156/1036;;Y10T156/1051;;Y10T428/24669;;Y10T156/1036;;Y10T156/1051;;E04F13/0864,E04F13/08,156/217;;428/179,0,0,,,,EXPIRED
692,MY,A,MY 8200097 A,164-188-531-342-814,1982-12-31,1982,MY 8200097 A,1982-12-30,GB 2036277 A,1977-05-14,FOAM COMPOSITIONS FOR TREATING POROUS SUBSTRATES,,UNION CARBIDE CORP,WALTER ANDREE TAINTER;;BRYANT GEORGE MACON;;READSHAW RONALD LOUIS,,https://lens.org/164-188-531-342-814,Granted Patent,no,0,0,3,3,0,D06B19/0094;;D06M23/04;;D06P1/965,D06B19/00;;D06M23/04;;D06P1/96,,0,0,,,,EXPIRED
693,US,A,US 5482949 A,193-452-449-987-228,1996-01-09,1996,US 3512193 A,1993-03-19,US 3512193 A,1993-03-19,Sulfonate derivatives of 3-aroylbenzo[b]thiophenes,"The present invention relates to sulfonate derivatives of 3-aroylbenzo[b]thiophenes, pharmaceutical formulations containing these compounds and methods of using such compounds for inhibiting the loss of bone, lowering serum cholesterol levels and therapeutically treating hormone dependent mammalian breast and uterine carcinoma.",LILLY CO ELI,BLACK LARRY J;;BRYANT HENRY U;;CULLINAN GEORGE J,ELI LILLY AND COMPANY (1993-03-19),https://lens.org/193-452-449-987-228,Granted Patent,yes,6,67,32,32,0,C07D333/56;;A61P19/10;;A61P35/00;;A61P3/06;;A61P37/08;;A61P43/00;;A61P9/10;;C07D333/56,A61K31/38;;A61K31/445;;A61K31/40;;A61K31/55;;A61P3/06;;A61P9/10;;A61P19/10;;A61P35/00;;A61P37/08;;A61P43/00;;C07D333/56;;C07D409/12,514/324;;514/212;;514/422;;540/596;;546/202;;548/525,26,17,039-179-689-155-908;;051-092-766-473-41X;;015-563-808-197-111;;077-541-290-910-710;;014-249-411-385-438;;127-447-976-152-732;;073-997-237-056-690;;042-908-114-132-030;;077-684-894-287-921;;027-640-947-779-05X;;019-662-136-158-986;;046-081-900-781-495;;108-551-556-370-574;;001-666-466-422-174;;052-921-119-546-67X;;008-297-202-323-176;;007-200-277-746-819,6431104;;10.1021/jm00374a021;;2558750;;10.1016/0169-6009(89)90081-0;;3689979;;10.1007/bf01806132;;10.1007/bf02405304;;6423228;;10.1002/jbmr.5650020513;;3455628;;10.1016/0169-6009(91)90023-s;;1932893;;3342747;;10.1210/endo-122-3-1146;;10.1056/nejm199203263261302;;1542321;;3626776;;10.1007/bf02540366;;10.1139/o90-027;;2350488;;10.1210/jcem-73-5-925;;1939531;;10.7326/0003-4819-115-11-860;;1952472;;1922206;;10.1056/nejm199110243251702;;2318936;;10.1210/jcem-70-4-1132;;10.1093/jnci/82.16.1327;;2199681;;1573630;;10.1021/jm00086a002;;3199816;;10.1016/0022-4731(88)90284-1,"U.S. application Ser. No. 07/920,933 Black, et al. Aug. 28, 1992.;;U.S. application Ser. No. 07/995,222 Black, et al. Dec. 22, 1992.;;Williams, et al., Journal of Bone and Mineral Research , 6 (1991).;;FDC Reports , T&G 11, Mar. 30, 1992.;;Jones, et al., J. Med. Chem., 27, 1057 1066 (1984).;;Feldmann, et al., Bone and Mineral , 7, 245 254 (1989).;;Tamoxifen Trial Restricted , SCRIP No. 1702 Mar. 20, 1992, p. 22.;;Jordan, et al., Breast Cancer Research Treatment , 10: 31 35 (1987).;;Beall, et al., Calcif Tissue Int., 36: 123 125 (1984).;;Turner, et al., Journal of Bone and Mineral Research , 2, No. 5, 449 456 (1987).;;Williams, et al., Bone and Mineral, 14, 205 220 (1991).;;Turner, et al., Endocrinology , 122, No. 3, 1146 1150 (1988).;;Love, et al., The New England Journal of Medicine , 326, No. 13, 852 856 (1992).;;Breckenridge, et al., Lipids , 22, No. 7, 505 512 (1987).;;Lazier, et al., Biochem. Cell Biol., 68, 210 217 (1990).;;Lobo, J. Clin. Endocrinol. Metab., 73, No. 5, 925 930 (1991).;;Love, et al., Ann. Intern. Med., 115, No. 11, 860 864 (1991).;;Walsh, et al., N. Engl. J. Med., 325, No. 17, 1196 1204 (1991).;;Bagdade, et al., J. Clin. Endocrinol. Metab., 70, No. 4, 1132 1135 (1990).;;Love, et al., J. Natl. Cancer Inst., 82, No. 16, 1327 1332 (1990).;;Teo, et al., J. Med. Chem., 35, 1330 1339 (1992).;;Cypriani, et al., J. Steroid Biochem., 31, No. 5, 763 771 (1988).;;Cypriani, et al., Chemical Abstracts , CA 110: 1189 v, 1989.;;Cypriani, et al., Chemical Abstracts , 110:69550v, 1989.;;American Chemical Society, Registry , RN 63676 25 5 1989.;;Bundgaard, H. Design of prodrugs Elsevier Publishing, pp. 1 10, ((1985).",EXPIRED
694,EP,A1,EP 0617030 A1,056-707-128-526-863,1994-09-28,1994,EP 94301871 A,1994-03-16,US 3512193 A,1993-03-19,Sulfonate and carbamate derivatives of 3-aroylbenzo (beta) thiophenes.,"The present invention relates to sulfonate and carbamate derivatives of 3-aroylbenzo[b]thiophenes, pharmaceutical formulations containing these compounds and methods of using such compounds for inhibiting the loss of bone, lowering serum cholesterol levels and therapeutically treating hormone dependent mammalian breast and uterine carcinoma.",LILLY CO ELI,BLACK LARRY JOHN;;BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH,,https://lens.org/056-707-128-526-863,Patent Application,yes,2,89,32,32,0,C07D333/56;;A61P19/10;;A61P35/00;;A61P3/06;;A61P37/08;;A61P43/00;;A61P9/10;;C07D333/56,A61K31/40;;A61K31/38;;A61K31/445;;A61K31/55;;A61P3/06;;A61P9/10;;A61P19/10;;A61P35/00;;A61P37/08;;A61P43/00;;C07D333/56;;C07D409/12,,0,0,,,,EXPIRED
695,AU,A,AU 1998/059691 A,123-783-661-543-007,1998-10-22,1998,AU 1998/059691 A,1998-03-30,US 83740197 A,1997-04-17,Alternate-path well screen having protected shunt connection,,MOBIL OIL CORP;;UNITED STATES FILTER CORP,BRYANT DAVID WADE;;GILLESPIE GEORGE A;;TUPY STEVEN J,,https://lens.org/123-783-661-543-007,Patent Application,no,0,0,11,11,0,E21B43/04;;E21B43/08;;E21B43/04;;E21B43/08,E21B43/04;;E21B43/08,,0,0,,,,EXPIRED
696,US,A,US 2991221 A,128-890-477-983-104,1961-07-04,1961,US 81336259 A,1959-05-15,US 81336259 A,1959-05-15,Urea-ethylene dibromide adducts,,DOW CHEMICAL CO,BRYANT BURL E;;TRUCHELUT GEORGE B;;HUDGINS HARRY R,,https://lens.org/128-890-477-983-104,Granted Patent,no,2,2,1,1,0,C07C19/00;;C07C19/00,C07C19/00,,0,0,,,,EXPIRED
697,BR,A,BR 8601296 A,128-945-374-541-106,1986-12-02,1986,BR 8601296 A,1986-03-21,US 71516985 A,1985-03-22,COMPOSICAO DE ESPUMA UTILIZADA NO TRATAMENTO DE PAPEL,"Foamable compositions having low concentrations of select foaming agents provide uniform distribution of paper treating agents onto moving paper, including high speed applications, and treated paper having unimpaired properties.",UNION CARBIDE CORP,BROWN RUSSELL LEE;;BRYANT GEORGE MACON;;CUNNINGHAM CHARLES JAMES,,https://lens.org/128-945-374-541-106,Patent Application,no,0,0,11,11,0,D21H17/00;;D21H17/07;;D21H17/10;;D21H17/14;;D21H21/56;;Y10T428/277;;Y10T428/249987;;Y10T428/277;;Y10T428/249987;;D21H17/07;;D21H17/14;;D21H17/10;;D21H21/56;;D21H17/00,C08L101/00;;C08J9/06;;D21H17/00;;D21H17/07;;D21H17/10;;D21H17/14;;D21H19/00;;D21H19/10;;D21H21/56,,0,0,,,,PENDING
698,US,A,US 2874024 A,130-175-295-079-244,1959-02-17,1959,US 47253554 A,1954-12-01,US 47253554 A,1954-12-01,Preparation of potassium borohydride,,CALLERY CHEMICAL CO,CUNNINGHAM GEORGE L;;BRYANT JOHN M;;GAUSE EMILY M,,https://lens.org/130-175-295-079-244,Granted Patent,no,3,1,1,1,0,C01B6/00;;C01B6/00,C01B6/00,,0,0,,,,EXPIRED
699,EP,B1,EP 0697391 B1,159-639-724-429-931,1998-10-28,1998,EP 95113051 A,1995-08-18,US 29302894 A,1994-08-19,Stabilization of phosphite ligands in hydroformylation process,"The present invention provides a hydroformylation process comprising: (1) forming a reaction mixture containing: (a) an olefinic compound, (b) hydrogen, (c) carbon monoxide, (d) a phosphite in which each phosphorus atom is bonded to three oxygen atoms and at least one such oxygen atom is bonded to a carbon atom of an aromatic ring that is adjacent to another carbon atom of said ring having a pendant monovalent group having a steric hindrance at least as great as the steric hindrance of the isopropyl group, (e) a catalytic amount of rhodium, and (f) a Group VIII metal (other than a rhodium) in an amount sufficient to reduce the rhodium-catalyzed decomposition of the phosphite during the hydroformylation process; and (2) maintaining the reaction mixture under conditions at which the olefinic compound reacts with the hydrogen and carbon monoxide to form an aldehyde.",UNION CARBIDE CHEM PLASTIC,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT;;MAHER JOHN MICHAEL,,https://lens.org/159-639-724-429-931,Granted Patent,yes,2,2,9,9,0,B01J31/185;;B01J2231/321;;B01J2531/0288;;B01J2531/80;;B01J2531/821;;B01J2531/824;;B01J2531/845;;C07C45/50;;C07C45/50;;B01J2531/80;;B01J31/185;;B01J2531/821;;B01J2231/321;;B01J2531/0288;;B01J2531/845;;B01J2531/824,B01J31/18;;C07C45/50,,0,0,,,,EXPIRED
700,EP,B1,EP 0832888 B1,152-873-342-993-685,2003-07-23,2003,EP 97307339 A,1997-09-22,US 2744996 P,1996-09-27,"Benzothiophene compounds, compositions, and methods","The invention provides benzothiophene compounds, formulations, and methods of inhibiting bone loss or bone resorption, particularly osteoporosis, cardiovascular-related pathological conditions, including hyperlipidemia.",LILLY CO ELI,BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH;;DODGE JEFFREY ALAN,,https://lens.org/152-873-342-993-685,Granted Patent,yes,2,0,9,9,0,C07D333/56;;C07D409/12;;C07D417/12;;A61P19/10;;A61P3/06;;A61P43/00;;C07D409/12;;C07D417/12;;C07D333/56,C07D333/16;;A61K31/38;;A61K31/381;;A61K31/425;;A61K31/426;;A61K31/44;;A61K31/4433;;A61P3/06;;A61P19/10;;A61P43/00;;C07D277/20;;C07D277/24;;C07D277/34;;C07D333/32;;C07D333/56;;C07D333/64;;C07D409/12;;C07D417/12,,0,0,,,,EXPIRED
701,AU,A,AU 1994/057863 A,159-745-501-247-304,1994-09-22,1994,AU 1994/057863 A,1994-03-16,US 3512193 A,1993-03-19,Sulfonate and carbamate derivatives of 3-aroylbenzo(b)thiophenes,"The present invention relates to sulfonate and carbamate derivatives of 3-aroylbenzo[b]thiophenes, pharmaceutical formulations containing these compounds and methods of using such compounds for inhibiting the loss of bone, lowering serum cholesterol levels and therapeutically treating hormone dependent mammalian breast and uterine carcinoma.",LILLY CO ELI,BLACK LARRY JOHN;;BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH,,https://lens.org/159-745-501-247-304,Patent Application,no,0,0,32,32,0,C07D333/56;;A61P19/10;;A61P35/00;;A61P3/06;;A61P37/08;;A61P43/00;;A61P9/10;;C07D333/56,A61K31/40;;A61K31/38;;A61K31/445;;A61K31/55;;A61P3/06;;A61P9/10;;A61P19/10;;A61P35/00;;A61P37/08;;A61P43/00;;C07D333/56;;C07D409/12,,0,0,,,,EXPIRED
702,NZ,A,NZ 260085 A,192-672-237-182-987,1995-12-21,1995,NZ 26008594 A,1994-03-14,US 3512193 A,1993-03-19,HETEROCYCLICALLY-SUBSTITUTED-AROYL BENZO[B]THIOPHENES AND MEDICAMENTS,"The present invention relates to sulfonate and carbamate derivatives of 3-aroylbenzo[b]thiophenes, pharmaceutical formulations containing these compounds and methods of using such compounds for inhibiting the loss of bone, lowering serum cholesterol levels and therapeutically treating hormone dependent mammalian breast and uterine carcinoma.",LILLY CO ELI,BLACK LARRY JOHN;;BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH,,https://lens.org/192-672-237-182-987,Patent Application,no,0,0,32,32,0,C07D333/56;;A61P19/10;;A61P35/00;;A61P3/06;;A61P37/08;;A61P43/00;;A61P9/10;;C07D333/56,A61K31/38;;A61K31/445;;A61K31/55;;A61P3/06;;A61P9/10;;A61K31/40;;A61P19/10;;A61P35/00;;A61P37/08;;A61P43/00;;C07D333/56;;C07D409/12,,0,0,,,,PENDING
703,ES,T3,ES 2124940 T3,196-198-247-134-890,1999-02-16,1999,ES 95113051 T,1995-08-18,US 29302894 A,1994-08-19,ESTABILIZACION DE LOS LIGANDOS FOSFITOS EN EL PROCEDIMIENTO DE HIDROFORMILACION.,"The present invention provides a hydroformylation process comprising: (1) forming a reaction mixture containing: (a) an olefinic compound, (b) hydrogen, (c) carbon monoxide, (d) a phosphite in which each phosphorus atom is bonded to three oxygen atoms and at least one such oxygen atom is bonded to a carbon atom of an aromatic ring that is adjacent to another carbon atom of said ring having a pendant monovalent group having a steric hindrance at least as great as the steric hindrance of the isopropyl group, (e) a catalytic amount of rhodium, and (f) a Group VIII metal (other than a rhodium) in an amount sufficient to reduce the rhodium-catalyzed decomposition of the phosphite during the hydroformylation process; and (2) maintaining the reaction mixture under conditions at which the olefinic compound reacts with the hydrogen and carbon monoxide to form an aldehyde.",UNION CARBIDE CHEM PLASTIC,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT;;MAHER JOHN MICHAEL,,https://lens.org/196-198-247-134-890,Granted Patent,no,0,0,9,9,0,B01J31/185;;B01J2231/321;;B01J2531/0288;;B01J2531/80;;B01J2531/821;;B01J2531/824;;B01J2531/845;;C07C45/50;;C07C45/50;;B01J2531/80;;B01J31/185;;B01J2531/821;;B01J2231/321;;B01J2531/0288;;B01J2531/845;;B01J2531/824,B01J31/18;;C07C45/50,,0,0,,,,EXPIRED
704,DE,D1,DE 69505612 D1,012-360-324-500-314,1998-12-03,1998,DE 69505612 T,1995-08-18,US 29302894 A,1994-08-19,Stabilisierung von Phosphiteliganden in das Hydroformylierungsverfahren,"The present invention provides a hydroformylation process comprising: (1) forming a reaction mixture containing: (a) an olefinic compound, (b) hydrogen, (c) carbon monoxide, (d) a phosphite in which each phosphorus atom is bonded to three oxygen atoms and at least one such oxygen atom is bonded to a carbon atom of an aromatic ring that is adjacent to another carbon atom of said ring having a pendant monovalent group having a steric hindrance at least as great as the steric hindrance of the isopropyl group, (e) a catalytic amount of rhodium, and (f) a Group VIII metal (other than a rhodium) in an amount sufficient to reduce the rhodium-catalyzed decomposition of the phosphite during the hydroformylation process; and (2) maintaining the reaction mixture under conditions at which the olefinic compound reacts with the hydrogen and carbon monoxide to form an aldehyde.",UNION CARBIDE CHEM PLASTIC,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT;;MAHER JOHN MICHAEL,,https://lens.org/012-360-324-500-314,Granted Patent,no,0,0,9,9,0,B01J31/185;;B01J2231/321;;B01J2531/0288;;B01J2531/80;;B01J2531/821;;B01J2531/824;;B01J2531/845;;C07C45/50;;C07C45/50;;B01J2531/80;;B01J31/185;;B01J2531/821;;B01J2231/321;;B01J2531/0288;;B01J2531/845;;B01J2531/824,B01J31/18;;C07C45/50,,0,0,,,,EXPIRED
705,MX,A,MX 2015000534 A,020-161-008-368-161,2015-05-11,2015,MX 2015000534 A,2013-03-13,US 201261671485 P;;US 2013/0030713 W,2012-07-13,SQUEEZABLE BOTTLE INCLUDING AN ORNAMENTAL FEATURE.,"A squeezable bottle includes a panel having at least one ornamental feature thereon. The panel includes a first facet having a length and a width and a second facet having a length and width. The lengths of the first and second facets extend in a direction generally parallel to a length of the squeezable bottle. The second facet is disposed adjacent to and defines a first interface with the first facet, and the first interface defines a first one of the at least one ornamental features. A generally planar surface of the first facet is disposed at an angle relative to a generally planar surface of the second facet such that the panel is reversibly deformable.",HEINZ CO H J,BRYANT MICHAEL P;;NUKUTO GEORGE IKUYA;;MCMAHON MICHAEL D,,https://lens.org/020-161-008-368-161,Patent Application,no,0,0,11,11,0,B65D1/32;;B65D23/102;;B65D47/0804;;B65D23/102;;B65D1/32;;B65D47/0804;;B65D2501/0081;;B65D23/102;;B65D47/0804;;B65D1/32;;B65D2501/0081;;B65D1/0223;;B65D2203/00,B65D90/02,,0,0,,,,PENDING
706,CH,A,CH 419603 A,035-835-257-539-964,1966-08-31,1966,CH 1278162 A,1962-10-31,US 14954161 A,1961-11-02,Composition polyoléfinique,,UNION CARBIDE CORP,BERNARD OSCAR BAUM;;GEORGE MACON BRYANT;;NATHAN LEWIS ZUTTY,,https://lens.org/035-835-257-539-964,Granted Patent,no,0,0,8,20,0,C04B35/521;;C08L23/02;;C08L23/06;;C08L23/08;;C08L23/0815;;C08L23/0892;;C08L23/10;;C08L23/12;;C08L23/18;;C08L2203/12;;D01F6/46;;C08L23/08;;C08L23/18;;C08L23/10;;C08L23/02;;C08L23/0892;;C08L23/0815;;C08L2203/12;;C04B35/521;;C08L23/06;;C08L23/12;;D01F6/46;;Y10S8/928,C04B35/52;;C08L23/02;;C08L23/06;;C08L23/08;;C08L23/12;;C08L23/18;;D01F6/04,"39B,22/06",0,0,,,,EXPIRED
707,US,B1,US 6224701 B1,028-756-698-349-120,2001-05-01,2001,US 39200499 A,1999-09-08,US 39200499 A,1999-09-08,Molded plastic siding panel,"A molded plastic panel for covering an exterior building wall includes a laterally directed lead fin, a laterally extending groove below the lead fin, and a rearwardly directed middle wall between rows of simulated shingles, all for joining laterally adjacent panels. A side flange extending outwardly of the panel may also be included. The molded plastic panel preferably also includes at least one row of simulated shingles separated by a plurality of gaps each having a randomly varying width in order to camouflage spacings between adjacent panels that change because of thermal contraction and expansion. In a particularly preferred embodiment, the panel body includes a locking tab and a folding flange. The folding flange includes a locking tip for engaging a locking tab on an adjacent panel and a flexible hinge connecting the locking lip to the panel body. The flexible hinge allows the folding flange to be disconnected from the locking tab when replacing a single panel.",ALCOA INC,BRYANT DAVID A;;ERNST DANIEL J;;GRIMAN GEORGE A,ALCOA INC (1999-10-22);;ALCOA HOME EXTERIORS INC (2006-09-01),https://lens.org/028-756-698-349-120,Granted Patent,yes,9,35,6,8,0,E04F13/0864;;Y10T428/24669;;Y10T156/1036;;Y10T156/1051;;Y10T428/24669;;Y10T156/1036;;Y10T156/1051;;E04F13/0864,E04F13/08,156/73.1;;156/227;;156/242,0,0,,,,EXPIRED
708,US,A1,US 2011/0259185 A1,024-571-180-447-002,2011-10-27,2011,US 88784210 A,2010-09-22,US 88784210 A;;US 24642309 P,2009-09-28,LETHAL THREAT PROTECTION SYSTEM FOR VEHICLE,"A lethal threat protection system for a vehicle, each side of the vehicle having an A pillar and a B pillar and a vehicle body positioned outwardly of the A pillar and the B pillar, the vehicle including a rocker panel area below and spanning between the A and B pillars and including a roof line area above and spanning between the A and B pillars, comprises a perimeter inner layer adapted to be mounted to the vehicle body and comprising an inner monolithic ballistic metal plate having a door opening and including portions adapted to overlie the A pillar, the B pillar, the rocker panel area, and the roof line area, a perimeter outer layer removably mounted to the perimeter inner layer and comprising an outer monolithic ballistic metal plate having a door opening and including portions overlying the portions of the inner monolithic ballistic metal plate, the perimeter outer layer further comprising ballistic fiber secured to an inner surface of the outer monolithic ballistic metal plate, and an armored door mounted to the outer monolithic ballistic metal plate.",BAE SYSTEMS SURVIVABILITY SYSTEMS L L C,BERNING THOMAS MATTHEW;;BRYANT GEORGE E;;KROEGER TODD MICHAEL,BAE SYSTEMS SURVIVABILITY SYSTEMS L.L.C (2010-12-02),https://lens.org/024-571-180-447-002,Patent Application,yes,1,14,1,1,0,F41H5/0457;;F41H7/04;;Y10T29/49716;;Y10T29/49716;;F41H7/04;;F41H5/0457,F41H7/04;;B23P17/04;;F41H5/04;;F41H7/02,89/36.02;;29/401.1;;89/911;;89/930;;89/937;;89/912,0,0,,,,DISCONTINUED
709,GB,A,GB 2327960 A,037-548-908-725-797,1999-02-10,1999,GB 9807911 A,1998-04-14,US 83740197 A,1997-04-17,Well screen : shunt tubes : flow connection,"A well screen has joints 11a, 11b carrying spaced shunt tubes 14. At connection 16 between the joints, external sleeve or manifold 30 provides a flow connection between the tube ends which does not require individual connection of the ends or the alignment of the tubes. Shrouds 17 protect the tubes. If the tube ends are individually flow connected (Fig. 4, not shown), a sleeve (30a) surrounds and protects the tube connections.",MOBIL OIL CORP;;UNITED STATES FILTER CORP,BRYANT DAVID WADE;;GILLESPIE GEORGE A;;TUPY STEVEN J,,https://lens.org/037-548-908-725-797,Patent Application,no,1,1,11,11,0,E21B43/04;;E21B43/08;;E21B43/04;;E21B43/08,E21B43/04;;E21B43/08,E1F FJF           FJF,0,0,,,,EXPIRED
710,US,A1,US 2011/0015462 A1,077-838-694-517-058,2011-01-20,2011,US 70593710 A,2010-02-15,US 70593710 A;;US 22662809 P,2009-07-17,METHODS FOR INHIBITING POLYMERIZATION OF VINYL AROMATIC COMPOUNDS DURING EXTRACTIVE DISTILLATION,"High temperatures and oxygen exposure during extractive distillation can result in polymerization of vinyl aromatic compounds. In various embodiments, the present disclosure relates to methods for inhibiting polymerization of vinyl aromatic compounds during extractive distillation. In various embodiments, the methods include a) providing a mixture containing at least one vinyl aromatic compound, b) adding at least one dinitrophenol inhibitor to the mixture, and c) after step b), performing an extractive distillation on the mixture to isolate the at least one vinyl aromatic compound. Purified styrene can be isolated by the methods described herein. In some embodiments, the dinitrophenol inhibitor is 2-sec-butyl-4,6-dinitrophenol (DNBP).",SEALEY AMY;;BALL GEORGE A;;SLIMP JR B BRYANT,SEALEY AMY;;BALL GEORGE A;;SLIMP JR B BRYANT,GTC TECHNOLOGY LP (2009-11-03),https://lens.org/077-838-694-517-058,Patent Application,yes,13,0,14,14,0,C07C7/08;;C07C7/20;;B01D3/00;;B01D3/34;;B01D3/40;;C07C7/08;;C07C7/20;;C07C15/46;;C07C7/08;;C07C7/20,C07C7/08,585/863,0,0,,,,INACTIVE
711,AU,A,AU 1998/089128 A,097-605-410-720-803,1999-03-08,1999,AU 1998/089128 A,1998-08-18,US 5620297 P;;US 9817116 W,1997-08-21,Methods for inhibiting detrimental side-effects due to gnrh or gnrh agonist administration,,LILLY CO ELI,BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH;;DODGE JEFFREY ALAN,,https://lens.org/097-605-410-720-803,Patent Application,no,0,0,7,7,0,A61K31/44;;A61K31/44;;A61K31/4535;;A61K31/4535;;A61K38/09;;A61K38/09;;A61P43/00,C07D333/56;;A61K31/4025;;A61K31/44;;A61K31/4535;;A61K31/55;;A61K38/09;;A61P43/00,,0,0,,,,DISCONTINUED
712,ES,T3,ES 2059651 T3,097-554-150-921-256,1994-11-16,1994,ES 89112857 T,1989-07-13,US 21891188 A;;US 37320689 A,1988-07-14,PROCEDIMIENTO PARA SEPARAR UN CATALIZADOR Y UN PRODUCTO ALDEHIDICO.,"PROCESO PARA LA SEPARACION Y RECUPERACION DE UN PRODUCTO ALDEHIDO A PARTIR DE COMPOSICIONES PRODUCTO DE REACCION DE HIDROFORMILACION NO ACUOSA COMPRENDIENDO EL PRODUCTO ALDEHIDO, UN COMPUESTO LIGANTE FOSFOROSO CARGADO DE RODIO IONICAMENTE Y UN AGENTE ORGANICO DE SOLUBILIDAD PARA DICHO COMPUESTO Y DICHO LIGANTE LIBRE VIA UNA FASE DE SEPARACION USANDO AGUA O AGUA AÑADIDA Y UN COMPUESTO DE HIDROCARBURO NO POLARIZADO.",UNION CARBIDE CHEM PLASTIC,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT;;PETERSON RONALD ROBERT,,https://lens.org/097-554-150-921-256,Granted Patent,no,0,0,20,26,0,C07C45/80;;C07C47/02;;C07C45/50,C07C45/50;;C07C45/80,,0,0,,,,EXPIRED
713,WO,A3,WO 2011/163570 A3,147-226-520-838-468,2012-04-19,2012,US 2011/0041787 W,2011-06-24,US 35833610 P,2010-06-24,HYDROGEL ULTRASOUND COUPLING DEVICE,"The present invention relates to an ultrasound coupling device that includes a gel component and a coupling compartment. The present invention also relates to various kits and methods for using the ultrasound coupling device with low-intensity ultrasound transducers and therapy. The present invention also relates to methods of making the ultrasound coupling device of the present invention. The present invention further relates to an array that includes a plurality of ultrasound coupling devices of the present invention, and methods of using the array.",ZETROZ LLC;;LEWIS JR GEORGE K;;GUARINO JOANNE L;;GUFFEY BRYANT,LEWIS JR GEORGE K;;GUARINO JOANNE L;;GUFFEY BRYANT,,https://lens.org/147-226-520-838-468,Search Report,yes,6,0,6,7,0,A61N7/00;;A61N7/00;;A61B8/4236;;A61B8/4236;;A61B8/4281;;A61B8/4281;;A61N2007/0034;;A61N2007/0034;;A61N2007/0056;;A61N2007/0056;;A61N2007/006;;A61N2007/006;;A61N2007/0078;;A61N2007/0078,A61B8/00;;A61N7/00,,0,0,,,,PENDING
714,CA,A,CA 735348 A,142-302-003-536-808,1966-05-31,1966,CA 735348D A,,CA 735348T A,,DYEING OF POLYOLEFINS,,UNION CARBIDE CORP,WALTER ANDREW T;;BRYANT GEORGE M;;CURTIS ROBERT G,,https://lens.org/142-302-003-536-808,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
715,CA,A,CA 258220 A,012-192-748-988-421,1926-02-16,1926,CA 258220D A,,CA 258220T A,,PARTY LINE TELEPHONE,,RELAY AUTOMATIC TELEPHONE CO,BRYANT GEORGE HENRY;;JOHNSON BENJAMIN BERTIE;;VANNECK RICHARD GRANT,,https://lens.org/012-192-748-988-421,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
716,CA,A,CA 1140328 A,028-237-900-093-452,1983-02-01,1983,CA 354947 A,1980-06-26,US 5353479 A;;US 15485080 A,1979-06-29,AQUEOUS SOLUTIONS CONTAINING CROSSLINKED HYDROXYETHYL CARBOXYETHYL CELLULOSE,"12,534-1 AQUEOUS SOLUTIONS CONTAINING CROSSLINKED HYDROXYETHYL CARBOXYETHYL CELLULOSE This invention concerns crosslinkable hydroxyethyl carboxyethyl cellulose provided in aqueous solutions particularly suitable for use in oil or gas drilling, fracturing, flow diversion, completion and workover. Crosslinking is effected through polyvalent metals as derived from polyvalent metals in the form of inorganic or organic acid salts, hydroxides and oxides. SPECIFICATION",UNION CARBIDE CORP,RAINES RUSSELL H;;BRYANT GEORGE M;;WEINTRITT DONALD J,,https://lens.org/028-237-900-093-452,Granted Patent,no,0,0,5,5,0,C09K8/887;;C08B15/005;;C09K8/10;;C09K8/685;;C09K8/90,C08B15/00;;C09K8/10;;C09K8/68;;C09K8/88;;C09K8/90,31-26,0,0,,,,EXPIRED
717,US,A,US 3385652 A,054-310-685-998-072,1968-05-28,1968,US 30366163 A,1963-08-21,US 30366163 A,1963-08-21,Dyeing polyolefin articles with soluble dye and a short chain polyethylene glycol ether,,UNION CARBIDE CORP,WALTER ANDREW T;;BRYANT GEORGE M;;CURTIS ROBERT G,,https://lens.org/054-310-685-998-072,Granted Patent,no,4,9,1,1,0,D06P1/6136;;D06P1/65131;;D06P3/79;;D06P1/65131;;D06P3/79;;D06P1/6136,D06P1/613;;D06P1/651;;D06P3/79,8/4,0,0,,,,EXPIRED
718,FI,A,FI 941262 A,097-370-317-393-373,1994-09-20,1994,FI 941262 A,1994-03-17,US 3512193 A,1993-03-19,3-aroyylibentso(b)tiofeenien sulfonaatti- ja karbamaattijohdannaisia,"The present invention relates to sulfonate and carbamate derivatives of 3-aroylbenzo[b]thiophenes, pharmaceutical formulations containing these compounds and methods of using such compounds for inhibiting the loss of bone, lowering serum cholesterol levels and therapeutically treating hormone dependent mammalian breast and uterine carcinoma.",LILLY CO ELI,BLACK LARRY JOHN;;BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH,,https://lens.org/097-370-317-393-373,Patent Application,no,0,0,32,32,0,C07D333/56;;A61P19/10;;A61P35/00;;A61P3/06;;A61P37/08;;A61P43/00;;A61P9/10;;C07D333/56,A61K31/38;;A61K31/40;;A61K31/445;;A61K31/55;;A61P3/06;;A61P9/10;;A61P19/10;;A61P35/00;;A61P37/08;;A61P43/00;;C07D333/56;;C07D409/12,,0,0,,,,DISCONTINUED
719,NO,D0,NO 940940 D0,107-247-889-951-665,1994-03-16,1994,NO 940940 A,1994-03-16,US 3512193 A,1993-03-19,Sulfonat og karbamatderivater av 3-aroylbenzo[bÅtiofener,"The present invention relates to sulfonate and carbamate derivatives of 3-aroylbenzo[b]thiophenes, pharmaceutical formulations containing these compounds and methods of using such compounds for inhibiting the loss of bone, lowering serum cholesterol levels and therapeutically treating hormone dependent mammalian breast and uterine carcinoma.",LILLY CO ELI,BLACK LARRY JOHN;;BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH,,https://lens.org/107-247-889-951-665,Patent Application,no,0,0,32,32,0,C07D333/56;;A61P19/10;;A61P35/00;;A61P3/06;;A61P37/08;;A61P43/00;;A61P9/10;;C07D333/56,A61K31/38;;A61K31/445;;A61K31/40;;A61K31/55;;A61P3/06;;A61P9/10;;A61P19/10;;A61P35/00;;A61P37/08;;A61P43/00;;C07D333/56;;C07D409/12,,0,0,,,,PENDING
720,MY,A,MY 8200096 A,155-063-559-993-760,1982-12-31,1982,MY 8200096 A,1982-12-30,GB 2036177 A,1977-05-14,PROCESS OF TREATING POROUS SUBSTRATES WITH FOAM,,UNION CARBIDE CORP,WALTER ANDREW TAINTER;;BRYANT GEORGE MACON;;READSHAW RONALD LOUIS,,https://lens.org/155-063-559-993-760,Granted Patent,no,0,0,3,6,0,,D06B19/00;;D06P1/00;;D06P1/44,,0,0,,,,EXPIRED
721,US,A,US 2972021 A,148-830-873-393-123,1961-02-14,1961,US 74655158 A,1958-07-03,US 74655158 A,1958-07-03,Telephone substation apparatus,,BELL TELEPHONE LABOR INC,BRYANT HERBERT W;;JORDAN HOMER G;;PORTER GEORGE C,,https://lens.org/148-830-873-393-123,Granted Patent,no,1,6,1,1,0,H04M1/08;;H04M1/08,H04M1/08,,0,0,,,,EXPIRED
722,US,A1,US 2015/0203237 A1,144-584-616-731-914,2015-07-23,2015,US 201314413525 A,2013-03-13,US 201314413525 A;;US 201261671485 P;;US 2013/0030713 W,2012-07-13,SQUEEZABLE BOTTLE INCLUDING AN ORNAMENTAL FEATURE,"A squeezable bottle includes a panel having at least one ornamental feature thereon. The panel includes a first facet having a length and a width and a second facet having a length and width. The lengths of the first and second facets extend in a direction generally parallel to a length of the squeezable bottle. The second facet is disposed adjacent to and defines a first interface with the first facet, and the first interface defines a first one of the at least one ornamental features. A generally planar surface of the first facet is disposed at an angle relative to a generally planar surface of the second facet such that the panel is reversibly deformable.",HEINZ CO H J,BRYANT MICHAEL P;;MCMAHON MICHAEL D;;NUKUTO GEORGE IKUYA,H.J. HEINZ COMPANY (2013-03-06);;H.J. HEINZ COMPANY BRANDS LLC (2015-06-30),https://lens.org/144-584-616-731-914,Patent Application,yes,2,3,11,11,0,B65D1/32;;B65D23/102;;B65D47/0804;;B65D23/102;;B65D1/32;;B65D47/0804;;B65D2501/0081;;B65D23/102;;B65D47/0804;;B65D1/32;;B65D2501/0081;;B65D1/0223;;B65D2203/00,B65D1/02,,0,0,,,,DISCONTINUED
723,CN,A,CN 104619611 A,196-420-604-928-475,2015-05-13,2015,CN 201380046520 A,2013-03-13,US 2013/0030713 W;;US 201261671485 P,2012-07-13,Squeezable bottle including an ornamental feature,"A squeezable bottle includes a panel having at least one ornamental feature thereon. The panel includes a first facet having a length and a width and a second facet having a length and width. The lengths of the first and second facets extend in a direction generally parallel to a length of the squeezable bottle. The second facet is disposed adjacent to and defines a first interface with the first facet, and the first interface defines a first one of the at least one ornamental features. A generally planar surface of the first facet is disposed at an angle relative to a generally planar surface of the second facet such that the panel is reversibly deformable.",HEINZ CO H J,BRYANT MICHAEL P;;MCMAHON MICHAEL D;;NUKUTO GEORGE IKUYA,,https://lens.org/196-420-604-928-475,Patent Application,no,4,0,11,11,0,B65D1/32;;B65D23/102;;B65D47/0804;;B65D23/102;;B65D1/32;;B65D47/0804;;B65D2501/0081;;B65D23/102;;B65D47/0804;;B65D1/32;;B65D2501/0081;;B65D1/0223;;B65D2203/00,B65D90/02,,0,0,,,,DISCONTINUED
724,US,A,US 3519526 A,002-117-653-297-828,1970-07-07,1970,US 3519526D A,1966-07-21,US 56698866 A,1966-07-21,ELASTOMER-BACKED CARPET,,UNION CARBIDE CORP,CAREY ROBERT J;;BRYANT GEORGE M;;WALTER ANDREW T,,https://lens.org/002-117-653-297-828,Granted Patent,no,11,20,2,2,0,D06N7/0071;;D06N7/0071;;D06N2203/068;;D06N2203/068;;D06N2205/04;;D06N2205/04;;D06N2205/20;;D06N2205/20;;D06N2209/106;;D06N2209/106;;D06N2211/066;;D06N2211/066;;Y10T428/23979;;Y10T428/23979;;Y10T428/23986;;Y10T428/23986;;Y10T428/23993;;Y10T428/23993;;Y10T428/249994;;Y10T428/249994;;Y10T428/31591;;Y10T428/31591,D06N7/00,B5S S17X          --          -;;B5S S17Y          --          -;;B5S S188          --          -;;B5S S19X          --          -;;B5S S191          --          -;;B5S S211          --          -;;B5S S22Y          --          -;;B5S S239          --          -;;B5S S250          --          -;;B5S S29X          --          -;;B5S S298          --          -;;B5S S32X          --          -;;B5S S320          --          -;;B5S S326          --          -;;B5S S344          --          -;;B5S S348          --          -;;B5S S353          --          -;;B5S S371          --          -;;B5S S54X          --          -;;B5S S56X          --          -;;B5S S598          --          -;;B5S S62Y          --          -;;B5S S620          --          -;;B5S S624          --          -;;B5S S626          --          -;;B5S S627          --          -;;B5S S64Y          --          -;;B5S S658          --          -;;B5S S670          --          -;;B5S S674          --          -;;B5S S679          --          -;;B5S S682          --          -;;B5S S687          --          -;;B5S S69X          --          -;;B5S S732          --          -;;B5S S751          --          -;;B5S S758          --          -;;B5S S763          --          -;;B5S S774          --          -;;B5S S790          --          -;;B5S S794          --          -,0,0,,,,EXPIRED
725,CA,A1,CA 2119091 A1,006-020-832-175-150,1994-09-20,1994,CA 2119091 A,1994-03-15,US 3612193 A,1993-03-23,SULFONATE AND CARBAMATE DERIVATIVES OF 3-AROYLBENZO[B]THIOPHENES,"The present invention relates to sulfonate and carbamate derivatives of 3-aroylbenzo¢b!thiophenes, pharmaceutical formulations containing these compounds and methods of using such compounds for inhibiting the loss of bone, lowering serum cholesterol levels and therapeutically treating hormone dependent mammalian breast and uterine carcinoma.",LILLY CO ELI,BLACK LARRY J;;BRYANT HENRY U;;CULLINAN GEORGE J,,https://lens.org/006-020-832-175-150,Patent Application,no,0,0,3,3,0,C08K7/14;;C08K9/04;;C08L33/24;;C08L63/00;;H05K1/0346;;H05K1/0366;;C08K3/013;;C08K7/14;;H05K1/0366;;C08L63/00;;H05K1/0346;;C08L33/24;;C08K9/04;;C08K3/013,C08K3/00;;C08K7/14;;C08K9/04;;C08L33/24;;C08L63/02;;C08L71/08;;C08L71/10;;H05K1/03,,0,0,,,,DISCONTINUED
726,CA,A,CA 833094 A,018-912-820-740-748,1970-01-27,1970,CA 833094D A,,CA 833094T A,,ALKALI METAL SALTS OF ETHYLENE-ACRYLIC ACID INTERPOLYMERS,,UNION CARBIDE CORP,WALTER ANDREW T;;BRYANT GEORGE M;;PURCELL CHESTER L,,https://lens.org/018-912-820-740-748,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
727,CN,A,CN 103140173 A,032-384-733-860-451,2013-06-05,2013,CN 201180039715 A,2011-06-24,US 2011/0041787 W;;US 35833610 P,2010-06-24,Hydrogel ultrasound coupling device,"The present invention relates to an ultrasound coupling device that includes a gel component and a coupling compartment. The present invention also relates to various kits and methods for using the ultrasound coupling device with low-intensity ultrasound transducers and therapy. The present invention also relates to methods of making the ultrasound coupling device of the present invention. The present invention further relates to an array that includes a plurality of ultrasound coupling devices of the present invention, and methods of using the array.",ZETROZ LLC,LEWIS JR GEORGE K;;GUARINO JOANNE L;;GUFFEY BRYANT,,https://lens.org/032-384-733-860-451,Patent Application,no,5,6,6,7,0,A61N7/00;;A61N7/00;;A61B8/4236;;A61B8/4236;;A61B8/4281;;A61B8/4281;;A61N2007/0034;;A61N2007/0034;;A61N2007/0056;;A61N2007/0056;;A61N2007/006;;A61N2007/006;;A61N2007/0078;;A61N2007/0078,A61B8/00;;A61N7/00,,0,0,,,,DISCONTINUED
728,US,B2,US 6421975 B2,043-523-053-547-804,2002-07-23,2002,US 76602401 A,2001-01-19,US 76602401 A;;US 39200499 A,1999-09-08,Molded plastic siding panel,"
    A molded plastic panel for covering an exterior building wall includes a laterally directed lead fin, a laterally extending groove below the lead fin, and a rearwardly directed middle wall between rows of simulated shingles, all for joining laterally adjacent panels. A side flange extending outwardly of the panel may also be included. The molded plastic panel preferably also includes at least one row of simulated shingles separated by a plurality of gaps each having a randomly varying width in order to camouflage spacings between adjacent panels that change because of thermal contraction and expansion. In a particularly preferred embodiment, the panel body includes a locking tab and a folding flange. The folding flange includes a locking lip for engaging a locking tab on an adjacent panel and a flexible hinge connecting the locking lip to the panel body. The flexible hinge allows the folding flange to be disconnected from the locking tab when replacing a single panel. 
",ALCOA INC,BRYANT DAVID A;;ERNST DANIEL J;;GRIMAN GEORGE A,ALCOA HOME EXTERIORS INC (2006-09-01),https://lens.org/043-523-053-547-804,Granted Patent,yes,17,40,6,8,0,E04F13/0864;;Y10T428/24669;;Y10T156/1036;;Y10T156/1051;;Y10T428/24669;;Y10T156/1036;;Y10T156/1051;;E04F13/0864,E04F13/08,52/528;;52/522;;52/523;;52/544;;52/553;;52/555,1,0,,,"USSN 09/392,004.",EXPIRED
729,CN,B,CN 101955409 B,070-612-099-722-86X,2014-11-26,2014,CN 201010158962 A,2010-04-23,US 22662809 P;;US 70593710 A,2009-07-17,Methods for inhibiting polymerization of vinyl aromatic compounds during extractive distillation,,GTC TECHNOLOGY US LLC,SEALEY AMY;;BALL GEORGE A;;SLIMP JR B BRYANT,,https://lens.org/070-612-099-722-86X,Granted Patent,no,0,0,14,14,0,C07C7/08;;C07C7/20;;B01D3/00;;B01D3/34;;B01D3/40;;C07C7/08;;C07C7/20;;C07C15/46;;C07C7/08;;C07C7/20,C07C15/40;;C07C7/08;;C07C7/20;;C07C15/46,,0,0,,,,INACTIVE
730,CN,A,CN 1087620 A,075-113-556-137-70X,1994-06-08,1994,CN 93116940 A,1993-08-24,US 21891188 A;;US 37320689 A,1988-07-14,Process for catalyst-aldehyde product separation,,UNION CARBIDE CHEM PLASTIC,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT;;PETERSON RONALD ROBERT,,https://lens.org/075-113-556-137-70X,Patent Application,no,0,1,20,26,0,C07C45/80;;C07C47/02;;C07C45/50,C07C45/50;;C07C45/80,,0,0,,,,DISCONTINUED
731,DK,T3,DK 0697391 T3,097-892-243-709-459,1999-07-05,1999,DK 95113051 T,1995-08-18,US 29302894 A,1994-08-19,Stabilisering af phosphitligander ved hydroformyleringsprocessen,"The present invention provides a hydroformylation process comprising: (1) forming a reaction mixture containing: (a) an olefinic compound, (b) hydrogen, (c) carbon monoxide, (d) a phosphite in which each phosphorus atom is bonded to three oxygen atoms and at least one such oxygen atom is bonded to a carbon atom of an aromatic ring that is adjacent to another carbon atom of said ring having a pendant monovalent group having a steric hindrance at least as great as the steric hindrance of the isopropyl group, (e) a catalytic amount of rhodium, and (f) a Group VIII metal (other than a rhodium) in an amount sufficient to reduce the rhodium-catalyzed decomposition of the phosphite during the hydroformylation process; and (2) maintaining the reaction mixture under conditions at which the olefinic compound reacts with the hydrogen and carbon monoxide to form an aldehyde.",UNION CARBIDE CHEM PLASTIC,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT;;MAHER JOHN MICHAEL,,https://lens.org/097-892-243-709-459,Granted Patent,no,0,0,9,9,0,B01J31/185;;B01J2231/321;;B01J2531/0288;;B01J2531/80;;B01J2531/821;;B01J2531/824;;B01J2531/845;;C07C45/50;;C07C45/50;;B01J2531/80;;B01J31/185;;B01J2531/821;;B01J2231/321;;B01J2531/0288;;B01J2531/845;;B01J2531/824,B01J31/18;;C07C45/50,,0,0,,,,EXPIRED
732,AU,B2,AU 731041 B2,105-064-278-293-996,2001-03-22,2001,AU 1998/059691 A,1998-03-30,US 83740197 A,1997-04-17,Alternate-path well screen having protected shunt connection,,MOBIL OIL CORP;;UNITED STATES FILTER CORP,BRYANT DAVID WADE;;GILLESPIE GEORGE A;;TUPY STEVEN J,,https://lens.org/105-064-278-293-996,Granted Patent,no,1,1,11,11,0,E21B43/04;;E21B43/08;;E21B43/04;;E21B43/08,E21B43/04;;E21B43/08,,0,0,,,,EXPIRED
733,NO,L,NO 861128 L,131-630-803-696-176,1986-09-23,1986,NO 861128 A,1986-03-21,US 71516985 A,1985-03-22,SKUMPREPARAT FOR PAPIRBEHANDLING.,"Foamable compositions having low concentrations of select foaming agents provide uniform distribution of paper treating agents onto moving paper, including high speed applications, and treated paper having unimpaired properties.",UNION CARBIDE CORP,BROWN RUSSELL LEE;;CUNNINGHAM CHARLES JAMES;;BRYANT GEORGE MACON,,https://lens.org/131-630-803-696-176,Abstract,no,0,0,11,11,0,D21H17/00;;D21H17/07;;D21H17/10;;D21H17/14;;D21H21/56;;Y10T428/277;;Y10T428/249987;;Y10T428/277;;Y10T428/249987;;D21H17/07;;D21H17/14;;D21H17/10;;D21H21/56;;D21H17/00,C08J9/06;;C08L101/00;;D21H17/00;;D21H17/07;;D21H17/10;;D21H17/14;;D21H19/00;;D21H19/10;;D21H21/56,,0,0,,,,DISCONTINUED
734,BR,A,BR 8903476 A,179-558-641-702-809,1990-03-06,1990,BR 8903476 A,1989-07-14,US 21891188 A;;US 37320689 A,1988-07-14,PROCESSO PARA SEPARACAO DE ALDEIDO A PARTIR DE UMA COMPOSICAO DE PRODUTO DE REACAO DE HIDROFORMILACAO NAO-AQUOSA;PROCESSO DE HIDROFORMILACAO NAO;E PROCESSO PARA A REMOCAO DE GOTAS DISPERSAS DE UMA EMULSAO FINAMENTE DIVIDIDA,,UNION CARBIDE CHEM PLASTIC,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT;;PETERSON RONALD ROBERT,,https://lens.org/179-558-641-702-809,Patent Application,no,0,0,20,26,0,C07C45/80;;C07C47/02;;C07C45/50,C07C45/50;;C07C45/80,,0,0,,,,DISCONTINUED
735,US,A,US 5868200 A,007-681-191-595-845,1999-02-09,1999,US 83740197 A,1997-04-17,US 83740197 A,1997-04-17,Alternate-path well screen having protected shunt connection,"An alternate-path, well screen made-up of joints and having a sleeve positioned between the ends of adjacent joints which acts as a manifold for fluidly-connecting the alternate-paths on one joint with the alternate-paths on an adjacent joint.",MOBIL OIL CORP,BRYANT DAVID WADE;;GILLESPIE GEORGE A;;TUPY STEVEN J,MOBIL OIL CORPORATION (1997-04-15);;WEATHERFORD TECHNOLOGY HOLDINGS LLC (2014-09-01);;UNITED STATES FILTER CORPORATION (1999-04-05);;WEATHERFORD/LAMB INC (2001-11-27),https://lens.org/007-681-191-595-845,Granted Patent,yes,12,229,11,11,0,E21B43/04;;E21B43/08;;E21B43/04;;E21B43/08,E21B43/04;;E21B43/08,166/51;;166/242.3,0,0,,,,EXPIRED
736,ES,T3,ES 2203758 T3,013-267-683-326-450,2004-04-16,2004,ES 97307339 T,1997-09-22,US 2744996 P,1996-09-27,"COMPUESTOS DE BENZOTIOFENO, COMPOSICIONES Y PROCEDIMIENTOS.","The invention provides benzothiophene compounds, formulations, and methods of inhibiting bone loss or bone resorption, particularly osteoporosis, cardiovascular-related pathological conditions, including hyperlipidemia.",LILLY CO ELI,BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH;;DODGE JEFFREY ALAN,,https://lens.org/013-267-683-326-450,Granted Patent,no,0,0,9,9,0,C07D333/56;;C07D409/12;;C07D417/12;;A61P19/10;;A61P3/06;;A61P43/00;;C07D409/12;;C07D417/12;;C07D333/56,A61K31/38;;A61K31/381;;A61K31/425;;A61K31/426;;A61K31/44;;A61K31/4433;;C07D333/16;;A61P3/06;;A61P19/10;;A61P43/00;;C07D277/20;;C07D277/24;;C07D277/34;;C07D333/32;;C07D333/56;;C07D333/64;;C07D409/12;;C07D417/12,,0,0,,,,EXPIRED
737,US,A,US 3584019 A,054-132-759-522-378,1971-06-08,1971,US 3584019D A,1968-11-26,US 77922968 A,1968-11-26,PROCESS FOR THE PREPARATION OF ALIPHATIC ESTERS,,PURDUE RESEARCH FOUNDATION,BACHMAN GUSTAVE BRYANT;;TULLMAN GERALD M;;KITE GEORGE F,,https://lens.org/054-132-759-522-378,Granted Patent,no,0,0,1,1,0,C07C67/00;;C07C67/00,C07C67/00,260/410.9,0,0,,,,EXPIRED
738,DE,T2,DE 68918355 T2,087-406-132-750-775,1995-03-23,1995,DE 68918355 T,1989-07-13,US 21891188 A;;US 37320689 A,1988-07-14,Verfahren zur Trennung eines Aldehyds und seines Katalysators.,,UNION CARBIDE CHEM PLASTIC,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT;;PETERSON RONALD ROBERT,"DOW TECHNOLOGY INVESTMENTS LLC, MIDLAND, MICH., US (2008-12-24)",https://lens.org/087-406-132-750-775,Granted Patent,no,0,0,20,26,0,C07C45/80;;C07C47/02;;C07C45/50,C07C45/50;;C07C45/80,,0,0,,,,EXPIRED
739,ES,T3,ES 2181996 T3,100-004-337-275-557,2003-03-01,2003,ES 97304484 T,1997-06-25,US 2151396 P,1996-07-10,COMPUESTOS DE BENZOTIOFENO Y PROCEDIMIENTOS EN USO.,"LA PRESENTE INVENCION PROPORCIONA NUEVOS COMPUESTOS DE BENZOTIOFENO DE FORMULA I: EN LOS QUE: R{SUB,1} ES O(ALQUILO C{SUB,1} {SUB,6}), CO STITUIDO, O B,2} ES (ALQUILO C{SUB,1} NALMENTE SUSTITUIDO, NILO OPCIONALMENTE SUSTITUIDO, O ,4} CH{SUB,2}NR{SUB,3}R{SUB,4}; R{SUB,3} Y R{SUB,4} SON CADA UNO INDEPENDIENTEMENTE ALQUILO C{SUB,1} PARA FORMAR, CON EL NITROGENO AL QUE ESTAN UNIDOS, PIPERIDINILO, PIRROLIDINILO, METILPIRROLIDINILO, DIMETILPIRROLIDINILO O HEXAMETILENIMINO; O UNA SAL O SOLVATO FARMACEUTICAMENTE ACEPTABLE DEL MISMO PPARA LA INHIBICION DE LA DEPRIVACION DE ESTROGENO, SINTOMAS DE POSTMENOPAUSIA, EN PARTICULAR OSTEOPOROSIS, ESTADOS PATOLOGICOS RELACIONADOS CON EL SISTEMA CARDIOVASCULAR INCLUYENDO HIPERLIPIDEMIAS Y PATOLOGIAS CARDIOVASCULARES RELACIONADAS, Y CANCER DEPENDIENTE DE ESTROGENO.",LILLY CO ELI,BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH;;FAHEY KENNAN JOSEPH,,https://lens.org/100-004-337-275-557,Granted Patent,no,0,0,7,7,0,A61K31/565;;A61K31/57;;A61K31/66;;A61K38/29;;C07D333/56;;A61P13/02;;A61P15/00;;A61P35/00;;A61P43/00,A61K31/38;;A61K31/381;;A61K31/565;;A61K31/57;;A61K31/66;;A61K38/29;;A61P13/02;;A61P15/00;;A61P35/00;;A61P43/00;;C07D333/56,,0,0,,,,EXPIRED
740,CA,C,CA 2316567 C,098-295-579-112-93X,2009-09-22,2009,CA 2316567 A,2000-08-21,US 39200499 A,1999-09-08,MOLDED PLASTIC SIDING PANEL,"A molded plastic panel for covering an exterior building wall includes a laterally directed lead fin, a laterally extending groove below the lead fin , and a rearwardly directed middle wall between rows of simulated shingles, all for joining laterally adjacent panels. A side flange extending outwardly of the panel ma y also be included. The molded plastic panel preferably also includes at least one row of simulated shingles separated by a plurality of gaps each having a randomly varying width in order to camouflage spacings between adjacent panels that change because of thermal contraction and expansion. In a particularly preferred embodiment, the panel body includes a locking tab and a folding flange. The folding flange includes a locking lip for engaging a locking tab on an adjacent panel and a flexible hinge connecting the locking lip to the panel body. The flexible hinge allows the folding flange to be disconnected from the locking tab when replacing a single panel.",ALCOA INC,BRYANT DAVID A;;GRIMAN GEORGE A;;ERNST DANIEL J,,https://lens.org/098-295-579-112-93X,Granted Patent,no,0,0,6,8,0,E04F13/0864;;Y10T428/24669;;Y10T156/1036;;Y10T156/1051;;Y10T428/24669;;Y10T156/1036;;Y10T156/1051;;E04F13/0864,E04F13/00;;E04C2/20;;E04F13/08,,0,0,,,,EXPIRED
741,DE,D1,DE 69714666 D1,147-816-752-793-596,2002-09-19,2002,DE 69714666 T,1997-06-25,US 2151396 P,1996-07-10,Benzothiophen-Verbindungen und Verfahren zur Anwendung,,LILLY CO ELI,BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH;;FAHEY KENNAN JOSEPH,,https://lens.org/147-816-752-793-596,Granted Patent,no,0,0,7,7,0,A61K31/565;;A61K31/57;;A61K31/66;;A61K38/29;;C07D333/56;;A61P13/02;;A61P15/00;;A61P35/00;;A61P43/00,A61K31/38;;A61K31/381;;A61K31/565;;A61K31/57;;A61K31/66;;A61K38/29;;A61P13/02;;A61P15/00;;A61P35/00;;A61P43/00;;C07D333/56,,0,0,,,,EXPIRED
742,JP,A,JP H1067777 A,136-970-348-912-844,1998-03-10,1998,JP 17415297 A,1997-06-30,US 2151396 P,1996-07-10,BENZOTHIOPHENE COMPOUND AND ITS USE,"PROBLEM TO BE SOLVED: To obtain the subject new compound useful for treating and preventing estrogenic deprivation, postmenopausal syndrome, estrogen-dependent cancer, endometritis, etc. SOLUTION: This compound is represented by formula I [R1 is H, OH, O(1-4C alkyl), OCO-(1-6C alkyl), etc.; R2 is H, OH, O(1-4C alkyl), F, Cl, Br, etc.; A is a group, etc., of formula II [B is a group, etc., of OCH2 CH2 NR3 R4 (R3 and R4 are each independently a 1-4C alkyl, etc.)] or its pharmaceutically permissible salt or solvated material, e.g. [2-(4-methoxyphenyl)-6-methoxybenzo[b]thien-3- yl][4'-[2-(1-piperidinyl)ethoxy]biphenyl-4-yl]methanone. The compound of formula I can be obtained by acylating, e.g. desired benzothiophene precursor under Friedel-Crafts' condition by activated carboxyl compound.",LILLY CO ELI,BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH;;FAHEY KENNAN JOSEPH,,https://lens.org/136-970-348-912-844,Patent Application,no,0,0,7,7,0,A61K31/565;;A61K31/57;;A61K31/66;;A61K38/29;;C07D333/56;;A61P13/02;;A61P15/00;;A61P35/00;;A61P43/00,A61K31/38;;A61K31/381;;A61K31/565;;A61K31/57;;A61K31/66;;A61K38/29;;A61P13/02;;A61P15/00;;A61P35/00;;A61P43/00;;C07D333/56,,0,0,,,,DISCONTINUED
743,EP,A1,EP 2872422 A1,169-007-628-819-777,2015-05-20,2015,EP 13816716 A,2013-03-13,US 201261671485 P;;US 2013/0030713 W,2012-07-13,SQUEEZABLE BOTTLE INCLUDING AN ORNAMENTAL FEATURE,,HEINZ CO H J,BRYANT MICHAEL P;;MCMAHON MICHAEL D;;NUKUTO GEORGE IKUYA,H.J. HEINZ COMPANY BRANDS LLC (2016-07-13),https://lens.org/169-007-628-819-777,Patent Application,yes,0,0,11,11,0,B65D1/32;;B65D23/102;;B65D47/0804;;B65D23/102;;B65D1/32;;B65D47/0804;;B65D2501/0081;;B65D23/102;;B65D47/0804;;B65D1/32;;B65D2501/0081;;B65D1/0223;;B65D2203/00,B65D1/32,,0,0,,,,DISCONTINUED
744,US,A,US 3472825 A,019-932-740-033-706,1969-10-14,1969,US 3472825D A,1967-02-15,US 42116064 A;;US 61629167 A,1964-12-24,ALKALI METAL SALTS OF ETHYLENE-ACRYLIC ACID INTERPOLYMERS,,UNION CARBIDE CORP,WALTER ANDREW T;;BRYANT GEORGE M;;PURCELL CHESTER L,,https://lens.org/019-932-740-033-706,Granted Patent,no,6,58,9,9,0,C08F8/44;;C08F8/44;;D06M15/263;;D06M15/263;;D06M15/21;;D06M15/21;;Y10S526/932;;Y10S526/932;;Y10T428/2933;;Y10T428/2933,C08F8/44;;D06M15/21;;D06M15/263,260/88.1,0,0,,,,EXPIRED
745,DE,B,DE 1224037 B,037-310-562-443-097,1966-09-01,1966,DE U0009339 A,1962-10-24,US 14954161 A,1961-11-02,Form- und Klebemassen aus Polyolefinen,,UNION CARBIDE CORP,BAUM BERNARD OSCAR;;BRYANT GEORGE MACON;;ZUTTY NATHAN LEWIS,,https://lens.org/037-310-562-443-097,Patent Application,no,2,0,8,20,0,C04B35/521;;C08L23/02;;C08L23/06;;C08L23/08;;C08L23/0815;;C08L23/0892;;C08L23/10;;C08L23/12;;C08L23/18;;C08L2203/12;;D01F6/46;;C08L23/08;;C08L23/18;;C08L23/10;;C08L23/02;;C08L23/0892;;C08L23/0815;;C08L2203/12;;C04B35/521;;C08L23/06;;C08L23/12;;D01F6/46;;Y10S8/928,C04B35/52;;C08L23/02;;C08L23/06;;C08L23/08;;C08L23/12;;C08L23/18;;D01F6/04,,0,0,,,,DISCONTINUED
746,CN,A,CN 101955409 A,055-882-981-197-35X,2011-01-26,2011,CN 201010158962 A,2010-04-23,US 22662809 P;;US 70593710 A,2009-07-17,Methods for inhibiting polymerization of vinyl aromatic compounds during extractive distillation,"Methods for inhibiting polymerization of vinyl aromatic compounds during extractive distillation are disclosed. High temperatures and oxygen exposure during extractive distillation can result in polymerization of vinyl aromatic compounds. In various embodiments, the present disclosure relates to methods for inhibiting polymerization of vinyl aromatic compounds during extractive distillation. In various embodiments, the methods include a) providing a mixture containing at least one vinyl aromatic compound, b) adding at least one dinitrophenol inhibitor to the mixture, and c) after step b), performing an extractive distillation on the mixture to isolate the at least one vinyl aromatic compound. Purified styrene can be isolated by the methods described herein. In some embodiments, the dinitrophenol inhibitor is 2-sec-butyl-4,6-dinitrophenol (DNBP).",GTC TECHNOLOGY US LLC,AMY SEALEY;;BALL GEORGE A;;BRYANT SLIMP JR B,,https://lens.org/055-882-981-197-35X,Patent Application,no,6,0,14,14,0,C07C7/08;;C07C7/20;;B01D3/00;;B01D3/34;;B01D3/40;;C07C7/08;;C07C7/20;;C07C15/46;;C07C7/08;;C07C7/20,C07C15/40;;C07C7/08;;C07C7/20;;C07C15/46,,0,0,,,,INACTIVE
747,IN,B,IN 146305 B,075-773-315-985-699,1979-04-21,1979,IN 731CA1977 A,1977-05-16,US 67038076 A,1976-03-25,A FOAM COMPOSITION FOR TREATING A FABRIC OR PAPER SUBSTRATE,,UNION CARBIDE CORP,READSHAW RONAL LOUIS;;WALTER ANDREW TAINTER;;BRYANT GEORGE MACON,,https://lens.org/075-773-315-985-699,Granted Patent,no,0,0,1,6,0,,D06M13/00;;D06M15/00,,0,0,,,,EXPIRED
748,CN,A,CN 1109751 A,095-402-160-879-076,1995-10-11,1995,CN 94119313 A,1994-12-12,US 16678893 A,1993-12-14,"Aqueous solution inclusion complexes of benzothiophene compounds with water soluble cyclodextrins, and pharmaceutical formulations and methods thereof","The present invention provides aqueous inclusion complexes of certain known benzothiophene compounds, particularly Raloxifene, and water soluble cyclodextrins. Also provided are pharmaceutical compositions of such inclusion complexes, and methods of using these complexes for inhibiting bone loss and reducing serum cholesterol in mammals.",LILLY CO ELI,BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH;;FRANCIS PAUL CLIFTON,,https://lens.org/095-402-160-879-076,Patent Application,no,0,1,35,35,0,A61K31/38;;A61K31/381;;A61K31/40;;A61K31/445;;B82Y5/00;;A61K47/6951;;A61P19/08;;A61P19/10;;A61P3/06;;A61P43/00;;A61P7/00;;C07D409/12;;B82Y5/00;;A61K31/445;;A61K31/40;;A61K31/38;;A61K31/381;;A61K47/6951,C07D333/56;;A61K9/08;;A61K31/365;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4535;;A61K31/55;;A61K47/40;;A61K47/48;;A61P3/06;;A61P7/00;;A61P19/08;;A61P19/10;;A61P43/00;;C08B37/16,,0,0,,,,DISCONTINUED
749,PH,A,PH 30177 A,110-605-996-812-041,1997-01-21,1997,PH 47918 A,1994-03-14,US 3512193 A,1993-03-19,Sulfonate derivatives of 3-aroylbenzo(b) thiophenes,"The present invention relates to sulfonate and carbamate derivatives of 3-aroylbenzo[b]thiophenes, pharmaceutical formulations containing these compounds and methods of using such compounds for inhibiting the loss of bone, lowering serum cholesterol levels and therapeutically treating hormone dependent mammalian breast and uterine carcinoma.",LILLY CO ELI,BLACK LARRY J;;BRYANT HENRY U;;CULLINAN GEORGE J,,https://lens.org/110-605-996-812-041,Granted Patent,no,0,0,32,32,0,C07D333/56;;A61P19/10;;A61P35/00;;A61P3/06;;A61P37/08;;A61P43/00;;A61P9/10;;C07D333/56,A61K31/38;;A61K31/445;;A61K31/55;;A61K31/40;;A61P3/06;;A61P9/10;;A61P19/10;;A61P35/00;;A61P37/08;;A61P43/00;;C07D333/56;;C07D409/12,,0,0,,,,EXPIRED
750,US,A1,US 2002/0189187 A1,094-517-143-232-602,2002-12-19,2002,US 18693902 A,2002-06-28,US 18693902 A;;US 76602401 A;;US 39200499 A,1999-09-08,Plastic siding panel,"
   A plastic panel for attachment to an exterior wall of a building includes a body, an attachment hem attached to the body and defining at least one aperture for a fastener, and a side flange extending laterally outwardly of the body. The side flange defines a fastening slot for attaching the panel to a building wall. The fastening slot extends at a predetermined acute angle relative to horizontal, preferably about 10-20 relative to horizontal, and about 15 in a particularly preferred embodiment. The fastening slot is preferably elongated and narrow so that the head of a metal fastener extends over opposed upper and lower edges of the slot. 
",BRYANT DAVID A.;;ERNST DANIEL J.;;GRIMAN GEORGE A.,BRYANT DAVID A;;ERNST DANIEL J;;GRIMAN GEORGE A,ALCOA INC (2002-07-28);;ALCOA HOME EXTERIORS INC (2006-09-01),https://lens.org/094-517-143-232-602,Patent Application,yes,8,4,2,8,0,E04F13/0864;;E04F13/0864,E04F13/08,52/528;;52/522;;52/523;;52/544;;52/553;;52/555,0,0,,,,EXPIRED
751,AU,A1,AU 2013/289192 A1,138-959-830-350-857,2015-02-26,2015,AU 2013/289192 A,2013-03-13,US 201261671485 P;;US 2013/0030713 W,2012-07-13,Squeezable bottle including an ornamental feature,"A squeezable bottle includes a panel having at least one ornamental feature thereon. The panel includes a first facet having a length and a width and a second facet having a length and width. The lengths of the first and second facets extend in a direction generally parallel to a length of the squeezable bottle. The second facet is disposed adjacent to and defines a first interface with the first facet, and the first interface defines a first one of the at least one ornamental features. A generally planar surface of the first facet is disposed at an angle relative to a generally planar surface of the second facet such that the panel is reversibly deformable.",HEINZ CO H J,BRYANT MICHAEL P;;MCMAHON MICHAEL D;;NUKUTO GEORGE IKUYA,H.J. HEINZ COMPANY BRANDS LLC (2016-08-04),https://lens.org/138-959-830-350-857,Patent Application,no,0,0,11,11,0,B65D1/32;;B65D23/102;;B65D47/0804;;B65D23/102;;B65D1/32;;B65D47/0804;;B65D2501/0081;;B65D23/102;;B65D47/0804;;B65D1/32;;B65D2501/0081;;B65D1/0223;;B65D2203/00,B65D90/02,,0,0,,,,DISCONTINUED
752,US,B2,US 9657783 B2,152-072-673-244-662,2017-05-23,2017,US 201514600574 A,2015-01-20,US 201514600574 A;;US 201461939405 P,2014-02-13,Wet friction clutch,"A clutch module for a dual clutch transmission (DCT) is designed to improve circumferential fluid distribution to reduce or eliminate an unpleasant noise during engagement. In some embodiments, the reaction plate is restrained in a position offset 1-3 degrees from perpendicular to the housing axis. Consequently, 0.2-0.7 mm of clearance remains on one radial side of the clutch when all clearance has been removed on the other radial side of the clutch. Relative rotation between the hub and the housing pushes fluid from the tight side toward the loose side. In an alternative embodiment, the piston is designed to orient the pressure plate non-perpendicular to the housing axis.",FORD GLOBAL TECH LLC,TRENT MATTHEW THOMAS;;MACDONALD GEORGE FREDERICK;;GRYTZELIUS BRYANT DAVID,FORD GLOBAL TECHNOLOGIES LLC (2015-01-14),https://lens.org/152-072-673-244-662,Granted Patent,yes,7,1,6,8,0,F16D13/70;;F16D25/123;;F16D13/74;;F16D21/06;;F16D2300/22;;F16D2021/0661;;F16D25/0638;;F16D25/10;;F16D13/74;;F16D21/06;;F16D2300/22;;F16D2021/0661;;F16D13/70;;F16D25/0638;;F16D25/123,F16D25/0638;;F16D13/70;;F16D13/74;;F16D21/06;;F16D25/10;;F16D25/12,,0,0,,,,ACTIVE
753,EP,A1,EP 0818453 A1,172-901-217-103-242,1998-01-14,1998,EP 97304484 A,1997-06-25,US 2151396 P,1996-07-10,Benzothiophene compounds and methods of use,"The instant invention provides novel benzothiophene compounds of formula I,
   wherein:
 R 1 is -H, -OH, -O(C 1 -C 4  alkyl), -O-CO-(C 1 -C 6  alkyl), -O-CO-O(C 1 -C 6  alkyl), -O-CO-Ar where Ar is phenyl or optionally substituted phenyl, -O-CO-O-Ar where Ar is phenyl or optionally substituted phenyl, or -OSO 2 -(C 4 -C 6  alkyl); R 2 is -H, -OH, -O(C 1 -C 4  alkyl), -O-CO-(C 1 -C 6  alkyl), -O-CO-O(C 1 -C 6  alkyl), -O-CO-Ar where Ar is phenyl or optionally substituted phenyl, -O-CO-O-Ar where Ar is phenyl or optionally substituted phenyl, -OSO 2 -(C 4 -C 6  alkyl), -F-, -Cl, or Br; A is
  B is -OCH 2 CH 2 NR 3 R 4 ; R 3  and R 4 each are independently C 1 -C 4  alkyl, or combine to form, with the nitrogen to which they are attached, piperidinyl, pyrrolidinyl, methylpyrrolidinyl, dimethylpyrrolidinyl, or hexamethyleneimino;      or a pharmaceutically acceptable salt or solvate thereof for the inhibition of estrogen deprivation, postmenopausal symptoms, particularly osteoporosis, cardiovascular-related pathological conditions including hyperlipidemia and related cardiovascular pathologies, and estrogen-dependent cancer.",LILLY CO ELI,BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH;;FAHEY KENNAN JOSEPH,,https://lens.org/172-901-217-103-242,Patent Application,yes,2,7,7,7,0,A61K31/565;;A61K31/57;;A61K31/66;;A61K38/29;;C07D333/56;;A61P13/02;;A61P15/00;;A61P35/00;;A61P43/00,A61K31/38;;A61K31/381;;A61K31/565;;A61K31/57;;A61K31/66;;A61K38/29;;A61P13/02;;A61P15/00;;A61P35/00;;A61P43/00;;C07D333/56,,2,2,039-179-689-155-908;;078-079-358-236-320,6431104;;10.1021/jm00374a021;;10.1021/jm00076a020;;8254621,"JONES ET AL.: ""Antiestrogens. 2. Structure-Activity Studies in a Series of 3-Aroyl-2-arylbenzo[b]thiophene Derivatives"", J. MED. CHEM., vol. 27, no. 8, 1984, pages 1057 - 1066, XP000560343;;KYM ET AL.: ""Molecular Structures, Conformational Analysis, and Preferential Modes of Binding of 3-Aroyl-2-arylbenzo[b]thiophene estrogen Receptor ligands: LY117018 and Aryl Azide Photoaffinity Labeling Analogs"", J. MED. CHEM., vol. 36, no. 24, 1993, pages 3910 - 3922, XP002043926",EXPIRED
754,AT,T1,AT E42780 T1,180-822-005-918-33X,1989-05-15,1989,AT 86103924 T,1986-03-21,EP 86103924 A;;US 71516985 A,1985-03-22,IN DER PAPIERBEHANDLUNG VERWENDETE SCHAUMZUSAMMENSETZUNG.,"Foamable compositions having low concentrations of select foaming agents provide uniform distribution of paper treating agents onto moving paper, including high speed applications, and treated paper having unimpaired properties.",UNION CARBIDE CORP,BROWN RUSSEL LEE;;BRYANT GEORGE MACON;;CUNNINGHAM CHARLES JAMES,,https://lens.org/180-822-005-918-33X,Granted Patent,no,0,0,11,11,0,D21H17/00;;D21H17/07;;D21H17/10;;D21H17/14;;D21H21/56;;Y10T428/277;;Y10T428/249987;;Y10T428/277;;Y10T428/249987;;D21H17/07;;D21H17/14;;D21H17/10;;D21H21/56;;D21H17/00,C08L101/00;;C08J9/06;;D21H17/00;;D21H17/07;;D21H17/10;;D21H17/14;;D21H19/00;;D21H19/10;;D21H21/56,,0,0,,,,EXPIRED
755,US,B2,US 8889354 B2,185-175-912-288-961,2014-11-18,2014,US 201213600260 A,2012-08-31,US 201213600260 A;;US 44919506 A;;US 68863405 P,2005-06-08,"Methods for the identification, assessment, and treatment of patients with cancer therapy","The present invention is directed to the identification of predictive markers that can be used to determine whether patients with cancer are clinically responsive or non-responsive to a therapeutic regimen prior to treatment. In particular, the present invention is directed to the use of certain individual and/or combinations of predictive markers, wherein the expression of the predictive markers correlates with responsiveness or non-responsiveness to a therapeutic regimen. Thus, by examining the expression levels of individual predictive markers and/or predictive markers comprising a marker set, it is possible to determine whether a therapeutic agent, or combination of agents, will be most likely to reduce the growth rate of tumors in a clinical setting.",BRYANT BARBARA M;;DAMOKOSH ANDREW I;;MULLIGAN GEORGE J;;MILLENNIUM PHARM INC,BRYANT BARBARA M;;DAMOKOSH ANDREW I;;MULLIGAN GEORGE J,TAKEDA PHARMACEUTICAL COMPANY LIMITED (2021-05-03),https://lens.org/185-175-912-288-961,Granted Patent,yes,2,5,22,22,1415,C12Q2600/106;;C12Q2600/136;;G01N33/57407;;G01N33/57415;;G01N33/57419;;G01N33/57423;;G01N33/57434;;G01N33/57438;;G01N33/57449;;G01N2800/44;;G16B25/00;;G16B40/00;;A61K31/69;;C12Q1/6886;;A61P35/00;;A61P35/02;;G16H10/40;;G16H20/40;;Y02A90/10;;G16B40/10;;G16B25/10;;G16B25/00;;G16B40/00;;C12Q2600/106;;C12Q2600/136;;G01N33/57407;;G01N33/57415;;G01N33/57419;;G01N33/57423;;G01N33/57434;;G01N33/57438;;G01N33/57449;;G01N2800/44;;Y02A90/10;;G16H10/40;;G16H20/40;;G16B40/10;;G16B25/10;;C12Q1/6886;;A61K31/69;;C12Q2600/158;;G01N33/57426;;G06Q20/40,C12Q1/68;;G01N33/574;;G06Q50/00;;G06Q50/22;;G16B25/10;;G16B40/10,435/6.1,29,21,034-134-907-055-024;;089-309-126-902-646;;103-920-702-805-783;;134-684-144-981-813;;074-147-835-645-394;;082-177-571-545-468;;084-615-067-249-328;;026-978-719-988-804;;067-766-525-517-863;;002-431-300-582-282;;010-409-170-828-73X;;007-342-077-503-496;;154-649-796-265-048;;144-184-274-185-833;;064-464-672-849-072;;034-134-907-055-024;;035-331-941-295-67X;;089-309-126-902-646;;103-920-702-805-783;;045-807-567-174-272;;043-880-672-061-032,1563002;;11857078;;10.1038/sj.onc.1205205;;11306489;;10363983;;10.1634/theoncologist.7-1-9;;11854543;;10.1093/clinchem/46.5.673;;10794750;;12575774;;12826635;;10.1056/nejmoa030288;;12490681;;10.1056/nejmoa021967;;12738736;;10.1182/blood-2006-09-044974;;17185464;;8159770;;10.1073/pnas.91.8.3463;;pmc43597;;10.1093/nar/gki031;;10.1289/ehp.7690;;16203246;;pmc1281279;;15817694;;10.1093/bioinformatics/bti429;;1563002;;16831230;;10.1186/1471-2407-6-182;;pmc1534059;;11857078;;10.1038/sj.onc.1205205;;11306489;;10.1186/gb-2003-4-9-117;;pmc193646;;12952525;;12361907;;10.1016/s0302-2838(02)00324-x,"Tockman et al (Cancer Res., 1992, 52:2711s-2718s).;;Ferrandina et al (BMC Cancer, 2006, 6(182): 1-5).;;Chauhan et al (Oncogene, 2002, 21: 1346-1358).;;Hideshima et al (Cancer Research, 2001, 61: 3071-3076).;;Adams, Julian, et al., ""Proteasome Inhibitors: A Novel Class of Potent and Effective Antitumor Agents,"" Cancer Research, vol. 59 (Jun. 1, 1999) pp. 2615-2622.;;Adams, Julian, ""Development of the Proteasome Inhibitor PS-341,"" The Oncologist, vol. 7 (2002) pp. 9-16.;;Lightcap, Eric S., et al., ""Proteasome Inhibition Measurements: Clinical Application,"" Clinical Chemsitry, vol. 46, No. 5 (2000) pp. 673-683.;;Hochwald, Steven N., et al., ""Antineoplastic Therapy in Colorectal Cancer through Proteasome Inhibition,"" The American Surgeon, vol. 69 (Jan. 2003) pp. 15-23.;;Richardson, Paul G., et al., ""A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma,"" The New England Journal of Medicine, vol. 348, No. 26 (Jun. 26, 2003) pp. 2609-2617.;;van de Vijver, Marc J., et al., ""A Gene-Expression Signature as a Predictor of Survival in Breast Cancer,"" The New England Journal of Medicine, vol. 347, No. 25 (Dec. 19, 2002) pp. 1999-2009.;;Barden, Catherine B., et al., ""Classification of Follicular Thyroid Tumors by Molecular Signature: Results of Gene Profiling,"" Clinical Cancer Research, vol. 9 (May 2003) pp. 1792-1800.;;Mulligan, George, et al., ""Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib,"" Blood, vol. 109, No. 8 (Apr. 15, 2007) pp. 3177-3188.;;Toczyski, David P., et al., ""The Epstein-Barr virus (EBV) small RNA EBER1 binds and relocalizes ribosomal protein L22 in EBV-infected human B lymphocytes,"" Proceedings of the National Academy of Science USA, vol. 91 (Apr. 1994) pp. 3463-3467.;;Maglott, Donna, et al., ""Entrez Gene: gene-centered information at NCBI,"" Nucleic Acids Research, vol. 33, Database issue (2005) pp. D54-D58.;;Affymetrix, Inc., ""Annotation Methodology,"" Affymetrix-Annotation Methodology Technical Note [online] Affymetrix, Santa Clara, CA, downloaded Jul. 23, 2008 (3 pages).;;Affymetrix, Inc., ""GeneChip Human Genome U133 Set,"" [online] 701092 Rev. 3 (Nov. 2004) downloaded Jul. 23, 2008 ( 2 pages).;;Affymetrix, Inc., ""Human Genome U133 Set-Support Materials,"" Affymetrix-Technical Support Documentation for Human Genome U133 Set [online] downloaded Jul. 24, 2008 (3 pages).;;International Prelminary Examination Report (IPER) and Written Opinion of the International Searching Authority dated Dec. 11, 2007 in corresponding PCT Application PCT/US06/022515.;;Office Action dated Jun. 23, 2008 in co-pending U.S. Appl. No. 10/728,055.;;Supplementary Partial European Search Report dated Jun. 24, 2009 in European Patent Application No. 06784710.3 which corresponds to U.S. Appl. No. 11/449,195.;;Glatt, Christine M., et al., ""Molecular characterization of thyroid toxicity: anchoring gene expression profiles to biochemical and pathologic end points,"" Environmental Health Perspectives, vol. 113, No. 10 (Oct. 2005) pp. 1354-1361.;;Wessels, Lodewyk F. A., et al., ""A protocol for building and evaluating predictors of disease state based on microarray data,"" Bioinformatics, vol. 21, No. 19 (Apr. 7, 2005) pp. 3755-3762.;;Tockman, Melvyn S., et al., ""Considerations in bringing a cancer biomarker to clinical application,"" Cancer Research (Supplement), vol. 52 (May 1, 1992) pp. 2711s-27182.;;Ferrandina, Gabriella, et al., ""Cyclooxygenase-2 (Cox-2) expression and resistance to platinum versus platinum/paclitaxel containing chemotherapy in advanced ovarian cancer,"" BMC Cancer, vol. 6 No. 182 (Jul. 11, 2006) pp. 1-5.;;Chauhan, Dharminder, et al., ""Identification of genes regulated by Dexamethasone in multiple myeloma cells using oligonucleotide arrays,"" Oncogene, vol. 21 (2002) pp. 1346-1358.;;Hideshima, Teru, et al., ""The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells,"" Cancer Research, vol. 61 (Apr. 1, 2001) pp. 3071-3076.;;Alberts, Bruce, et al., Molecular Biology of The Cell, Third Edition, published by Garland Publishing, Inc., New York, New York (1994) p. 465.;;Greenbaum, Dov, et al., ""Comparing protein abundance and mRNA expression levels on a genomic scale,"" Genome Biology, vol. 4, No. 9 (2003) pp. 117.1-117.8.;;Lichtinghagen, Ralf, et al., ""Different mRNA and protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 in benign and malignant prostate tissue,"" European Urology, vol. 42 (2002) pp. 398-406.",ACTIVE
756,DE,T2,DE 69923831 T2,123-201-200-532-927,2006-04-06,2006,DE 69923831 T,1999-02-01,US 1745798 A;;US 9901998 W,1998-02-02,TRENNUNGSVERFAHREN,,UNION CARBIDE CHEM PLASTIC,ARGYROPOULOS N;;BRYANT ROBERT;;MORRISON LEE;;STOCKMAN ELWOOD;;ABATJOGLOU GEORGE,"DOW TECHNOLOGY INVESTMENTS LLC, MIDLAND, MICH., US (2009-01-02)",https://lens.org/123-201-200-532-927,Granted Patent,no,0,0,24,24,0,B01J31/0259;;B01J31/0267;;B01J31/185;;B01J31/2208;;B01J31/24;;B01J31/2404;;B01J31/2457;;B01J31/2495;;B01J31/4015;;B01J31/4046;;B01J31/4053;;B01J2231/32;;B01J2231/321;;B01J2231/52;;B01J2231/641;;B01J2531/822;;C07C45/50;;C07C45/80;;C07C51/48;;C07F9/025;;Y02P20/584;;Y02P20/582;;C07C45/50;;B01J31/0267;;B01J31/0259;;B01J31/2457;;B01J31/2495;;B01J31/4015;;B01J31/4046;;B01J2231/32;;B01J31/2404;;C07C45/80;;B01J2231/321;;C07C45/50;;B01J31/185;;B01J2231/52;;B01J31/2208;;B01J2231/641;;B01J31/4053;;C07C51/48;;C07F9/025;;B01J31/24;;B01J2531/822;;Y02P20/584;;Y02P20/582,B01J31/18;;C07C45/50;;B01J31/40;;C07B63/00;;C07C45/80;;C07C49/92;;C07C51/373;;C07C51/48;;C07C59/147;;C07F9/02;;C07F9/50;;C07F9/655;;C07F9/6574,,0,0,,,,EXPIRED
757,WO,A1,WO 2023/144568 A1,143-070-374-090-75X,2023-08-03,2023,GB 2023050214 W,2023-01-31,GB 202201249 A;;GB 202216817 A,2022-01-31,DEVICE AND METHOD,"There is described a device comprising a processor, wherein the processor is configured to be connected with an electrical component and a proximity sensor, and wherein the processor is configured to control a setting of the electrical component in dependence on a sensor output corresponding to an activation intensity within an activation intensity range.",BRYANT MEDICAL LTD,BRYANT CONNOR;;PATEL PRIYAM;;MILBORROW CHRISTOPHER;;FORSYTHE GEORGE;;VERBANCIC MARKO,,https://lens.org/143-070-374-090-75X,Patent Application,yes,7,0,1,3,0,H05B47/105;;H05B47/115,H05B47/105;;H05B47/115,,0,0,,,,PENDING
758,US,B1,US 7869350 B1,014-540-769-431-666,2011-01-11,2011,US 34605103 A,2003-01-15,US 34605103 A,2003-01-15,Method and apparatus for determining a data communication network repair strategy,"A method is disclosed for determining a repair strategy for a data communication network. The data communication network has as components nodes and links. The method comprises a step of implementing a link repair strategy for an adjacent link to an adjacent node. The method further monitors for a probe packet to the adjacent node and, if such a packet is received, implements a node repair strategy.",CISCO TECH INC,BRYANT STEWART FREDERICK;;MILES KEVIN GEORGE;;SHAND IAN MICHAEL CHARLES,CISCO TECHNOLOGY (2003-01-09),https://lens.org/014-540-769-431-666,Granted Patent,yes,95,16,1,1,0,H04L41/0654;;H04L43/10;;H04L41/0654;;H04L43/10,H04J1/16,370/228;;242/225;;242/248,28,1,046-310-355-238-214,10.1145/99517.99548,"http://en.wikipedia.org/wiki/IP-protocol, Oct. 28, 2006.;;http://en.wikipedia.org/wiki/Ping, Jan. 17, 2007.;;Wang, Zheng et al., ""Shortest Path First with Emergency Exits,"" ACM 089791-405-8/90/0009/0166, 1990, pp. 166-176.;;International Searching Authority, International Search Report, PCT/US04/33827, dated Mar. 28, 2005, 8 pages.;;Current Claims, PCT/US04/33827, 6 pages.;;Mikkel Thorup, ""Fortifying OSPF/IS-IS against link-failure,"" Sep. 7, 2001, pp. 1-10.;;Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration as received in corresponding International application No. PCT/US06/06238.;;Pending claims in PCT/US06/06238.;;International Searching Authority, ""Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration"", international application No. PCT/US06/28083, Received Nov. 30, 2007, 11 pages.;;Claims, international application No. PCT/US06/28083, 3 pages.;;AU Examiner's First Report for foreign patent application No. 2004311004 dated Jun. 23, 2008 (1 pg).;;AU Examiner's Second Report for foreign patent application No. 2004311004 dated Aug. 18, 2008 (1 pg).;;Current claims for AU foreign patent application No. 2004311004 (6 pgs).;;Office Action from CN for foreign application No. 200480033007.8 dated Apr. 11, 2008 (10 pgs) with English translation (11 pgs).;;Current claims for CN foreign patent application No. 200480033007.8 (6 pgs).;;European Patent Office, ""Supplementary European Search Report"", application No. EP 04795045, May 27, 2009, 4 pages.;;Claims, application No. EP 04795045, 4 pages.;;Raju et al., ""A New Approach to On-Demand Loop-Free Multipath Routing"", Computer Communications and Networks, 1999, IEEE, Oct. 1999, XP010359531, ISBN: 978-0-7803-5794-5, 6 pages.;;State Intellectual Property Office of the People'S Republic of China, ""The First Office Action"", filing No. 200680001652.0, May 8, 2009, 15 pages.;;Claims, filing No. 200680001652.0, 4 pages.;;European Patent Office, ""Supplementary European Search Report"", application No. EP 06720965, dated Jul. 21, 2009, 6 pages.;;Claims, application No. EP 06720965, 4 pages.;;European Patent Office, ""Communication pursuant to Article 94(3) EPC"", Application No. 04795045.6-2416, dated Sep. 7, 2009, 5 pages.;;Current Claims, Application No. 04795045.6-2416, 5 pages.;;Moy, J et al., ""OSPF Version 2"", IETF Standard, Network Working Group, Internet Engineering Task Force, IETF, Apr. 1998, XP015008112, NFC 2328, 245 pages.;;European Patent Office, ""Supplementary Search Report"", application No. EP 04812468, dated May 27, 2010, 4 pages.;;CLAIMS, application No. EP 04812468, 4 pages.;;U.S. Appl. No. 10/719,003, filed Nov. 21, 2003, Office Action Mailing Date May 9, 2007.",INACTIVE
759,FR,A,FR 556633 A,026-782-233-346-241,1923-07-24,1923,FR 556633D A,1922-09-27,FR 556633T A,1922-09-27,Procédé et appareils pour extraire les métaux de leurs minerais,,,THORNHILL EDWIN BRYANT;;ANDERSON HECTOR GEORGE SYLVEST;;FRANKLIN EDWARD JOSEPH,,https://lens.org/026-782-233-346-241,Granted Patent,no,0,3,1,1,0,C21B13/00;;C21B13/105,C21B13/00;;C21B13/10,,0,0,,,,EXPIRED
760,CA,A,CA 720495 A,154-354-620-846-473,1965-10-26,1965,CA 720495D A,,CA 720495T A,,DYEABLE POLYPROPYLENE COMPOSITIONS,,UNION CARBIDE CORP,BRYANT GEORGE M;;WALTER ANDREW T;;COMBE EDWARD M LA,,https://lens.org/154-354-620-846-473,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
761,DE,D1,DE 69923831 D1,130-052-133-074-600,2005-03-31,2005,DE 69923831 T,1999-02-01,US 1745798 A;;US 9901998 W,1998-02-02,TRENNUNGSVERFAHREN,,UNION CARBIDE CHEM PLASTIC,ARGYROPOULOS N;;BRYANT ROBERT;;MORRISON LEE;;STOCKMAN ELWOOD;;ABATJOGLOU GEORGE,"DOW TECHNOLOGY INVESTMENTS LLC, MIDLAND, MICH., US (2009-01-02)",https://lens.org/130-052-133-074-600,Granted Patent,no,0,0,24,24,0,B01J31/0259;;B01J31/0267;;B01J31/185;;B01J31/2208;;B01J31/24;;B01J31/2404;;B01J31/2457;;B01J31/2495;;B01J31/4015;;B01J31/4046;;B01J31/4053;;B01J2231/32;;B01J2231/321;;B01J2231/52;;B01J2231/641;;B01J2531/822;;C07C45/50;;C07C45/80;;C07C51/48;;C07F9/025;;Y02P20/584;;Y02P20/582;;C07C45/50;;B01J31/0267;;B01J31/0259;;B01J31/2457;;B01J31/2495;;B01J31/4015;;B01J31/4046;;B01J2231/32;;B01J31/2404;;C07C45/80;;B01J2231/321;;C07C45/50;;B01J31/185;;B01J2231/52;;B01J31/2208;;B01J2231/641;;B01J31/4053;;C07C51/48;;C07F9/025;;B01J31/24;;B01J2531/822;;Y02P20/584;;Y02P20/582,B01J31/18;;B01J31/40;;C07B63/00;;C07C45/50;;C07C45/80;;C07C49/92;;C07C51/373;;C07C51/48;;C07C59/147;;C07F9/02;;C07F9/50;;C07F9/655;;C07F9/6574,,0,0,,,,EXPIRED
762,DE,A1,DE 1469500 A1,093-505-328-358-944,1969-01-23,1969,DE U0012313 A,1965-12-24,US 42116064 A;;US 61629167 A,1964-12-24,Verfahren zur Herstellung von Alkalisalzen von Mischpolymerisaten aus AEthylen/Acrylsaeure und Verfahren zum Schlichten und Entschlichten von Textilfasern,,UNION CARBIDE CORP,TAINTER WALTER ANDREW;;SO BRYANT GEORGE MACON;;LEE PURCELL CHESTER,,https://lens.org/093-505-328-358-944,Patent Application,no,0,0,9,9,0,C08F8/44;;C08F8/44;;D06M15/263;;D06M15/263;;D06M15/21;;D06M15/21;;Y10S526/932;;Y10S526/932;;Y10T428/2933;;Y10T428/2933,C08F8/44;;D06M15/21;;D06M15/263,,0,0,,,,DISCONTINUED
763,US,B2,US 11186360 B2,127-341-232-211-415,2021-11-30,2021,US 201916713525 A,2019-12-13,US 201916713525 A;;US 201615271945 A,2016-09-21,"Aircraft landing gear, aircraft, and related methods","Methods of retracting a strut assembly for stowing aircraft landing gear comprise longitudinally translating an upper bulkhead within an upper tubular housing from a lower position to an upper position by pressurizing an upper bulkhead space between an upper plate of the upper bulkhead and an upper bulkhead restriction structure that is fixed to the upper tubular housing. Other methods of retracting a strut assembly for stowing aircraft landing gear comprise flowing liquid from an upper liquid chamber positioned above an upper bulkhead within an upper tubular housing to a recoil chamber, wherein during the flowing, the liquid is prevented from passing from the recoil chamber to a pressure chamber that is defined between the upper bulkhead and a lower bulkhead, thereby longitudinally translating a lower tubular housing upward.",BOEING CO,COTTET JUSTIN DUANE;;CUSWORTH JAMES E;;BRYANT MALCOLM SCOTT;;SONNENBURG GEORGE,THE BOEING COMPANY (2016-09-20),https://lens.org/127-341-232-211-415,Granted Patent,yes,36,0,15,15,0,B64C25/58;;B64C25/60;;B64C25/60;;F16F9/06;;B64C2025/008;;B64C25/22;;B64C25/22;;B64C25/34;;B64C25/60;;F16F9/06;;B64C2025/008,B64C25/22;;B64C25/00;;B64C25/34;;B64C25/60;;F16F9/06,,2,0,,,"European Patent Office, Extended European Search Report for related European Application No. 17190605, dated Nov. 16, 2017.;;Machine-generated English translation of the abstract of JP 2018172106 downloaded from Espacenet on Jul. 11, 2019.",ACTIVE
764,AU,A1,AU 2017/204470 A1,141-272-244-284-110,2018-04-05,2018,AU 2017/204470 A,2017-06-29,US 201615271945 A,2016-09-21,"Aircraft landing gear, aircraft, and related methods","AIRCRAFT LANDING GEAR, AIRCRAFT, AND RELATED METHODS An aircraft landing gear structure (18) includes a strut assembly (100) configured to transition between a compressed configuration, an extended configuration, and a retracted configuration. The strut assembly (100) has a compressed length (110), an extended length (112), and a retracted length (114), such that the compressed length (110) and retracted length (114) are less than the extended length (112). The strut assembly includes an upper tubular housing (120), an upper bulkhead (122) configured to be translated between a lower position and an upper position, a lower tubular housing (140) operatively coupled to the upper tubular housing (120), a lower bulkhead (142) supported by the lower tubular housing (140), and a pressure chamber (150) defined between the lower bulkhead (142) and the upper bulkhead (122). A volume of strut liquid (152) and a mass of strut gas (154) are positioned within the pressure chamber (150). A method of retracting a strut assembly (100) includes longitudinally translating an upper bulkhead (122) within an upper tubular housing (120) from a lower position to an upper position.",BOEING CO,COTTET JUSTIN DUANE;;CUSWORTH JAMES E;;BRYANT MALCOLM SCOTT;;SONNENBURG GEORGE,,https://lens.org/141-272-244-284-110,Patent Application,no,0,0,15,15,0,B64C25/58;;B64C25/60;;B64C25/60;;F16F9/06;;B64C2025/008;;B64C25/22;;B64C25/22;;B64C25/34;;B64C25/60;;F16F9/06;;B64C2025/008,B64C25/32,,0,0,,,,ACTIVE
765,WO,A1,WO 2004/050173 A1,107-334-824-708-010,2004-06-17,2004,US 0338079 W,2003-12-01,US 43053802 P,2002-12-02,SINGLE-USE COVER SYSTEM FOR ELECTROMAGNETIC TREATMENT APPLICATOR,"An electromagnetic treatment device (200) includes a treatment pad (206) and a generating unit (218) connected to the treatment pad by a coaxial cable (205). The treatment pad has an antenna (211) on one side of the treatment pad. The generating unit includes a start/stop button (220), a radio frequency generator (208) and a covertest board (212). A single-use cover system (201) includes the electromagnetic treatment device and a disposable cover (203) including a RFID tag (202). The single-use cover system verifies that the disposable cover is placed over the treatment pad properly and that the disposable cover has not been used previously.",REGENESIS BIOMEDICAL INC;;GEORGE FRANK R;;BRYANT ROBERT T;;LOYA ARTHUR A;;MEYER MARLA,GEORGE FRANK R;;BRYANT ROBERT T;;LOYA ARTHUR A;;MEYER MARLA,,https://lens.org/107-334-824-708-010,Patent Application,yes,6,1,6,6,0,A61N1/08;;A61N1/08;;A61N1/37229;;A61N1/40,A61N1/16;;A61N1/40,,1,0,,,See also references of EP 1567222A4,PENDING
766,EP,A1,EP 1567222 A1,100-071-136-252-172,2005-08-31,2005,EP 03812468 A,2003-12-01,US 0338079 W;;US 43053802 P,2002-12-02,SINGLE-USE COVER SYSTEM FOR ELECTROMAGNETIC TREATMENT APPLICATOR,,REGENESIS BIOMEDICAL INC,GEORGE FRANK R;;BRYANT ROBERT T;;LOYA ARTHUR A;;MEYER MARLA,,https://lens.org/100-071-136-252-172,Patent Application,yes,0,0,6,6,0,A61N1/08;;A61N1/08;;A61N1/37229;;A61N1/40,A61N1/375;;A61N1/08;;A61N1/16;;A61N1/40,,0,0,,,,DISCONTINUED
767,CA,A1,CA 2974139 A1,148-692-052-322-392,2018-03-21,2018,CA 2974139 A,2017-07-20,US 201615271945 A,2016-09-21,"AIRCRAFT LANDING GEAR, AIRCRAFT, AND RELATED METHODS","An aircraft landing gear structure includes a strut assembly configured to transition between a compressed configuration, an extended configuration, and a retracted configuration. The strut assembly has a compressed length, an extended length, and a retracted length, such that the compressed length and retracted length are less than the extended length. The strut assembly includes an upper tubular housing, an upper bulkhead configured to be translated between a lower position and an upper position, a lower tubular housing operatively coupled to the upper tubular housing, a lower bulkhead supported by the lower tubular housing, and a pressure chamber defined between the lower bulkhead and the upper bulkhead. A volume of strut liquid and a mass of strut gas are positioned within the pressure chamber. A method of retracting a strut assembly includes longitudinally translating an upper bulkhead within an upper tubular housing from a lower position to an upper position.",BOEING CO,COTTET JUSTIN DUANE;;CUSWORTH JAMES E;;BRYANT MALCOLM SCOTT;;SONNENBURG GEORGE,,https://lens.org/148-692-052-322-392,Patent Application,no,0,0,15,15,0,B64C25/58;;B64C25/60;;B64C25/60;;F16F9/06;;B64C2025/008;;B64C25/22;;B64C25/22;;B64C25/34;;B64C25/60;;F16F9/06;;B64C2025/008,B64C25/58;;B64C25/02;;B64C25/60,,0,0,,,,PENDING
768,US,A1,US 2020/0115042 A1,156-945-176-963-661,2020-04-16,2020,US 201916713525 A,2019-12-13,US 201916713525 A;;US 201615271945 A,2016-09-21,"AIRCRAFT LANDING GEAR, AIRCRAFT, AND RELATED METHODS","Methods of retracting a strut assembly for stowing aircraft landing gear comprise longitudinally translating an upper bulkhead within an upper tubular housing from a lower position to an upper position by pressurizing an upper bulkhead space between an upper plate of the upper bulkhead and an upper bulkhead restriction structure that is fixed to the upper tubular housing. Other methods of retracting a strut assembly for stowing aircraft landing gear comprise flowing liquid from an upper liquid chamber positioned above an upper bulkhead within an upper tubular housing to a recoil chamber, wherein during the flowing, the liquid is prevented from passing from the recoil chamber to a pressure chamber that is defined between the upper bulkhead and a lower bulkhead, thereby longitudinally translating a lower tubular housing upward.",BOEING CO,COTTET JUSTIN DUANE;;CUSWORTH JAMES E;;BRYANT MALCOLM SCOTT;;SONNENBURG GEORGE,THE BOEING COMPANY (2016-09-20),https://lens.org/156-945-176-963-661,Patent Application,yes,0,0,15,15,0,B64C25/58;;B64C25/60;;B64C25/60;;F16F9/06;;B64C2025/008;;B64C25/22;;B64C25/22;;B64C25/34;;B64C25/60;;F16F9/06;;B64C2025/008,B64C25/22;;B64C25/34;;B64C25/60;;F16F9/06,,0,0,,,,ACTIVE
769,EP,A1,EP 3299281 A1,046-452-044-616-787,2018-03-28,2018,EP 17190605 A,2017-09-12,US 201615271945 A,2016-09-21,"AIRCRAFT LANDING GEAR, AIRCRAFT, AND RELATED METHODS","An aircraft landing gear structure includes a strut assembly configured to transition between a compressed configuration, an extended configuration, and a retracted configuration. The strut assembly has a compressed length, an extended length, and a retracted length, such that the compressed length and retracted length are less than the extended length. The strut assembly includes an upper tubular housing, an upper bulkhead configured to be translated between a lower position and an upper position, a lower tubular housing operatively coupled to the upper tubular housing, a lower bulkhead supported by the lower tubular housing, and a pressure chamber defined between the lower bulkhead and the upper bulkhead. A volume of strut liquid and a mass of strut gas are positioned within the pressure chamber. A method of retracting a strut assembly includes longitudinally translating an upper bulkhead within an upper tubular housing from a lower position to an upper position.
 
",BOEING CO,COTTET JUSTIN DUANE;;CUSWORTH JAMES E;;BRYANT MALCOLM SCOTT;;SONNENBURG GEORGE,,https://lens.org/046-452-044-616-787,Patent Application,yes,7,0,15,15,0,B64C25/58;;B64C25/60;;B64C25/60;;F16F9/06;;B64C2025/008;;B64C25/22;;B64C25/22;;B64C25/34;;B64C25/60;;F16F9/06;;B64C2025/008,B64C25/60;;B64C25/00;;B64C25/22;;F16F9/06,,0,0,,,,ACTIVE
770,AU,B2,AU 2017/204470 B2,111-689-228-898-759,2022-12-15,2022,AU 2017/204470 A,2017-06-29,US 201615271945 A,2016-09-21,"Aircraft landing gear, aircraft, and related methods","AIRCRAFT LANDING GEAR, AIRCRAFT, AND RELATED METHODS An aircraft landing gear structure (18) includes a strut assembly (100) configured to transition between a compressed configuration, an extended configuration, and a retracted configuration. The strut assembly (100) has a compressed length (110), an extended length (112), and a retracted length (114), such that the compressed length (110) and retracted length (114) are less than the extended length (112). The strut assembly includes an upper tubular housing (120), an upper bulkhead (122) configured to be translated between a lower position and an upper position, a lower tubular housing (140) operatively coupled to the upper tubular housing (120), a lower bulkhead (142) supported by the lower tubular housing (140), and a pressure chamber (150) defined between the lower bulkhead (142) and the upper bulkhead (122). A volume of strut liquid (152) and a mass of strut gas (154) are positioned within the pressure chamber (150). A method of retracting a strut assembly (100) includes longitudinally translating an upper bulkhead (122) within an upper tubular housing (120) from a lower position to an upper position.",BOEING CO,COTTET JUSTIN DUANE;;CUSWORTH JAMES E;;BRYANT MALCOLM SCOTT;;SONNENBURG GEORGE,,https://lens.org/111-689-228-898-759,Granted Patent,no,5,0,15,15,0,B64C25/58;;B64C25/60;;B64C25/60;;F16F9/06;;B64C2025/008;;B64C25/22;;B64C25/22;;B64C25/34;;B64C25/60;;F16F9/06;;B64C2025/008,B64C25/32,,0,0,,,,ACTIVE
771,US,A1,US 2014/0269714 A1,008-050-695-699-117,2014-09-18,2014,US 201313835190 A,2013-03-15,US 201313835190 A,2013-03-15,UNIVERSAL LABELS IN INTERNETWORKING,"In an embodiment, a method comprises: receiving a data communications packet comprising one or more labels in a label stack; determining whether a table identifier is present in the label stack. In response to determining that the table identifier is present in the label stack: based, at least in part, on the table identifier, a label table is determined; a next hop for the data communications packet is determined by performing a next-hop lookup in the label table using at least one of the one or more labels; and the data communications packet is forwarded to the next hop. In an embodiment, the method is performed by one or more computing devices.",CISCO TECH INC,BRYANT STEWART FREDERICK;;FROST DANIEL C;;JARVIS NEIL;;SWALLOW GEORGE L,CISCO TECHNOLOGY INC (2013-03-12),https://lens.org/008-050-695-699-117,Patent Application,yes,15,7,3,3,0,H04L45/50;;H04L45/50,H04L45/50,370/392,6,5,016-405-491-046-034;;093-867-386-513-613;;123-313-808-848-635;;057-680-078-990-244;;057-680-078-990-244,10.17487/rfc3032;;10.17487/rfc5462;;10.17487/rfc3473;;10.17487/rfc7274;;10.17487/rfc7274,"Rosen et al.; RFC 3032: MPLS Label Stack Encoding; IETF; January 2001;;Andersson et al.; RFC 5462: Multiprotocol Label Switching (MPLS) Label Stack Entry: ""EXP"" Field Renamed to ""Traffic Class"" Field; IETF; February 2009;;Berger et al.; RFC 3473: Generalized Multi-Protocol Label Switching (GMPLS) Signaling Resource Reservation Protocol-Traffic Engineering (RSVP-TE) Extensions; IETF; January 2003;;Kompella et al., Allocating and Retiring Special-Purpose MPLS Labels, June 2014, Internet Engineering Task Force (IETF), Pgs. 1-11;;Rosen et al., BGP/MPLS IP Virtual Private Networks (VPNs), February 2006, Internet Engineering Task Force (IETF), Network Working Group, Pgs. 1-47;;Kompella et al., Allocating and Retiring Special-Purpose MPLS Labels: draft-kompella-mpls-special-purpose-labels-01, 15 October 2012, Internet Engineering Task Force (IETF), Pgs. 1-10",ACTIVE
772,ES,T3,ES 2884127 T3,080-301-451-808-22X,2021-12-10,2021,ES 17190605 T,2017-09-12,US 201615271945 A,2016-09-21,"Tren de aterrizaje de aeronave, aeronave y métodos relacionados.","Una estructura de tren de aterrizaje de aeronave (18), que comprende: un ensamble de puntal (100) que tiene un eje longitudinal (102), donde el ensamble de puntal (100) está configurado para hacer una transición entre una configuración comprimida en la que el ensamble de puntal (100) tiene una longitud comprimida (110) cuando el ensamble de puntal (100) está totalmente lastrado por una aeronave (10), una configuración extendida en la que el ensamble de puntal (100) tiene una longitud extendida (112) cuando el ensamble de puntal (100) no es lastrado por la aeronave (10), y una configuración retraída para guardar la estructura del tren de aterrizaje de la aeronave (18) dentro de un pozo de rueda de la aeronave (16) y en la que el ensamble de puntal (100) tiene una longitud retraída (114), en la que la longitud comprimida (110) y la longitud retraída (114) son menores que la longitud extendida (112), y en el que el ensamble de puntales (100) comprende: una carcasa tubular superior (120); un mamparo superior (122) soportado por la carcasa tubular superior (120) y configurado para trasladarse de forma selectiva y longitudinal entre una posición inferior y una posición superior, donde el mamparo superior (122) está en la posición inferior cuando el ensamble de puntal (100) está en la configuración comprimida y cuando el ensamble de puntal (100) está en la configuración extendida, y donde el mamparo superior (122) está en la posición superior cuando el ensamble de puntal (100) está en la configuración retraída; una carcasa tubular inferior (140) acoplada operativamente a la carcasa tubular superior (120) y configurada para trasladarse longitudinalmente con respecto a la carcasa tubular superior (120); un mamparo inferior (142) soportado por la carcasa tubular inferior (140) y configurado para trasladarse longitudinalmente entre una posición comprimida cuando el ensamble de puntal (100) está en la configuración comprimida y una posición extendida cuando el ensamble de puntal (100) está en la configuración extendida, donde el mamparo inferior (142) está configurado además para trasladarse de forma selectiva y longitudinal a una posición retraída cuando el ensamble de puntal (100) está en la configuración retraída, y donde una cámara de presión (150) está definida entre el mamparo inferior (142) y el mamparo superior (122); y un volumen de líquido de puntal (152) y una masa de gas de puntal (154) colocados dentro de la cámara de presión (150), en donde la masa de gas de puntal (154) tiene una presión comprimida cuando el ensamble de puntal (100) está en el configuración, una presión extendida cuando el ensamble de puntal (100) está en la configuración extendida, y una presión retraída cuando el ensamble de puntal (100) está en la configuración retraída, y donde la presión comprimida es mayor que la presión extendida y la presión retraída; y donde al menos uno de la carcasa tubular superior (120) y la carcasa tubular inferior (140) define una cámara de retroceso (180), y donde el ensamble de puntal (100) incluye además una válvula de retroceso (182) colocada entre la cámara de presión (150) y la cámara de retroceso (180), donde la válvula de retroceso (182) está configurada para regular el flujo del líquido del puntal (152) entre la cámara de presión (150) y la cámara de retroceso (180) cuando el ensamble de puntal (100) cambia entre la configuración extendida y la configuración comprimida; donde la carcasa tubular superior (120) define una cámara de líquido superior (130) colocada sobre el mamparo superior (122), donde el ensamble de puntal (100) incluye además un conducto de líquido (184) que conecta de forma fluida la cámara de líquido superior (130) a la cámara de retroceso (180), donde el líquido del puntal (152) fluye desde la cámara de líquido superior (130) a la cámara de retroceso (180) cuando el ensamble de puntal (100) pasa de la configuración extendida a la configuración retraída, y donde el líquido de puntal (152) fluye desde la cámara de retroceso (180) a la cámara de líquido superior (130) cuando el ensamble de puntal (100) pasa de la configuración retraída a la configuración extendida.",BOEING CO,COTTET JUSTIN DUANE;;CUSWORTH JAMES E;;BRYANT MALCOLM SCOTT;;SONNENBURG GEORGE,,https://lens.org/080-301-451-808-22X,Granted Patent,no,0,0,15,15,0,B64C25/58;;B64C25/60;;B64C25/60;;F16F9/06;;B64C2025/008;;B64C25/22;;B64C25/22;;B64C25/34;;B64C25/60;;F16F9/06;;B64C2025/008,B64C25/60;;B64C25/00;;B64C25/22;;F16F9/06,,0,0,,,,ACTIVE
773,US,A1,US 2018/0079494 A1,152-952-826-036-772,2018-03-22,2018,US 201615271945 A,2016-09-21,US 201615271945 A,2016-09-21,"AIRCRAFT LANDING GEAR, AIRCRAFT, AND RELATED METHODS","An aircraft landing gear structure includes a strut assembly configured to transition between a compressed configuration, an extended configuration, and a retracted configuration. The strut assembly has a compressed length, an extended length, and a retracted length, such that the compressed length and retracted length are less than the extended length. The strut assembly includes an upper tubular housing, an upper bulkhead configured to be translated between a lower position and an upper position, a lower tubular housing operatively coupled to the upper tubular housing, a lower bulkhead supported by the lower tubular housing, and a pressure chamber defined between the lower bulkhead and the upper bulkhead. A volume of strut liquid and a mass of strut gas are positioned within the pressure chamber. A method of retracting a strut assembly includes longitudinally translating an upper bulkhead within an upper tubular housing from a lower position to an upper position.",BOEING CO,COTTET JUSTIN DUANE;;CUSWORTH JAMES E;;BRYANT MALCOLM SCOTT;;SONNENBURG GEORGE,THE BOEING COMPANY (2016-09-20),https://lens.org/152-952-826-036-772,Patent Application,yes,3,1,15,15,0,B64C25/58;;B64C25/60;;B64C25/60;;F16F9/06;;B64C2025/008;;B64C25/22;;B64C25/22;;B64C25/34;;B64C25/60;;F16F9/06;;B64C2025/008,B64C25/22;;B64C25/34,,0,0,,,,ACTIVE
774,CN,A,CN 107856847 A,116-471-589-887-254,2018-03-30,2018,CN 201710685495 A,2017-08-11,US 201615271945 A,2016-09-21,"AIRCRAFT LANDING GEAR, AIRCRAFT, AND RELATED METHODS","The invention discloses an aircraft landing gear, an aircraft and related methods. An aircraft landing gear structure includes a strut assembly configured to transition between a compressed configuration, an extended configuration, and a retracted configuration. The strut assembly has a compressed length, an extended length, and a retracted length, such that the compressed length and retracted length are less than the extended length. The strut assembly includes an upper tubular housing, an upper bulkhead configured to be translated between a lower position and an upper position, a lower tubular housing operatively coupled to the upper tubular housing, a lower bulkhead supported by the lower tubular housing, and a pressure chamber defined between the lower bulkhead and the upper bulkhead.A volume of strut liquid and a mass of strut gas are positioned within the pressure chamber. A method of retracting a strut assembly includes longitudinally translating an upper bulkhead within an upper tubular housing from a lower position to an upper position.",BOEING CO,JAMES E CUSWORTH;;GEORGE SONNENBURG;;MALCOLM SCOTT BRYANT;;JUSTIN DUANE COTTET,,https://lens.org/116-471-589-887-254,Patent Application,no,5,0,15,15,0,B64C25/58;;B64C25/60;;B64C25/60;;F16F9/06;;B64C2025/008;;B64C25/22;;B64C25/22;;B64C25/34;;B64C25/60;;F16F9/06;;B64C2025/008,B64C25/58;;B64C25/60,,0,0,,,,ACTIVE
775,AU,A1,AU 2003/297591 A1,170-024-600-926-634,2004-06-23,2004,AU 2003/297591 A,2003-12-01,US 43053802 P;;US 0338079 W,2002-12-02,SINGLE-USE COVER SYSTEM FOR ELECTROMAGNETIC TREATMENT APPLICATOR,,REGENESIS BIOMEDICAL INC,GEORGE FRANK R;;BRYANT ROBERT T;;LOYA ARTHUR A;;MEYER MARLA,,https://lens.org/170-024-600-926-634,Patent Application,no,0,0,6,6,0,A61N1/08;;A61N1/08;;A61N1/37229;;A61N1/40,A61N1/16;;A61N1/40,,0,0,,,,DISCONTINUED
776,EP,B1,EP 3299281 B1,034-928-752-016-200,2021-05-26,2021,EP 17190605 A,2017-09-12,US 201615271945 A,2016-09-21,"AIRCRAFT LANDING GEAR, AIRCRAFT, AND RELATED METHODS",,BOEING CO,COTTET JUSTIN DUANE;;CUSWORTH JAMES E;;BRYANT MALCOLM SCOTT;;SONNENBURG GEORGE,,https://lens.org/034-928-752-016-200,Granted Patent,yes,6,0,15,15,0,B64C25/58;;B64C25/60;;B64C25/60;;F16F9/06;;B64C2025/008;;B64C25/22;;B64C25/22;;B64C25/34;;B64C25/60;;F16F9/06;;B64C2025/008,B64C25/60;;B64C25/00;;B64C25/22;;F16F9/06,,0,0,,,,ACTIVE
777,JP,A,JP 2018083607 A,067-782-126-817-850,2018-05-31,2018,JP 2017137762 A,2017-07-14,US 201615271945 A,2016-09-21,"AIRCRAFT LANDING GEAR, AIRCRAFT, AND RELATED METHODS","PROBLEM TO BE SOLVED: To provide a landing gear structure that may minimize the volume of wheel wells.SOLUTION: An aircraft landing gear structure includes a shock strut assembly 100 configured to transition between a compressed configuration, an extended configuration, and a retracted configuration. The shock strut assembly has a compressed length, an extended length, and a retracted length. The shock strut assembly includes an upper tubular housing 120, an upper bulkhead 122 configured to be translated between a lower position and an upper position, a lower tubular housing 140 operatively coupled to the upper tubular housing, a lower bulkhead 142 supported by the lower tubular housing, and a pressure chamber 150 defined between the lower bulkhead and the upper bulkhead. A volume of shock strut liquid 152 and a mass of shock strut gas 154 are positioned within the pressure chamber. A method of retracting the shock strut assembly includes longitudinally translating the upper bulkhead within the upper tubular housing from the lower position to the upper position.SELECTED DRAWING: Figure 2",BOEING CO,JUSTIN DUANE COTTET;;JAMES E CUSWORTH;;MALCOLM SCOTT BRYANT;;GEORGE SONNENBURG,,https://lens.org/067-782-126-817-850,Patent Application,no,3,0,15,15,0,B64C25/58;;B64C25/60;;B64C25/60;;F16F9/06;;B64C2025/008;;B64C25/22;;B64C25/22;;B64C25/34;;B64C25/60;;F16F9/06;;B64C2025/008,B64C25/60;;F16F9/32;;F16F9/56,,0,0,,,,ACTIVE
778,CA,C,CA 2974139 C,185-276-534-270-926,2022-11-29,2022,CA 2974139 A,2017-07-20,US 201615271945 A,2016-09-21,"AIRCRAFT LANDING GEAR, AIRCRAFT, AND RELATED METHODS","An aircraft landing gear structure includes a strut assembly configured to transition between a compressed configuration, an extended configuration, and a retracted configuration. The strut assembly has a compressed length, an extended length, and a retracted length, such that the compressed length and retracted length are less than the extended length. The strut assembly includes an upper tubular housing, an upper bulkhead configured to be translated between a lower position and an upper position, a lower tubular housing operatively coupled to the upper tubular housing, a lower bulkhead supported by the lower tubular housing, and a pressure chamber defined between the lower bulkhead and the upper bulkhead. A volume of strut liquid and a mass of strut gas are positioned within the pressure chamber. A method of retracting a strut assembly includes longitudinally translating an upper bulkhead within an upper tubular housing from a lower position to an upper position.",BOEING CO,COTTET JUSTIN DUANE;;CUSWORTH JAMES E;;BRYANT MALCOLM SCOTT;;SONNENBURG GEORGE,,https://lens.org/185-276-534-270-926,Granted Patent,no,0,0,15,15,0,B64C25/58;;B64C25/60;;B64C25/60;;F16F9/06;;B64C2025/008;;B64C25/22;;B64C25/22;;B64C25/34;;B64C25/60;;F16F9/06;;B64C2025/008,B64C25/58;;B64C25/02;;B64C25/60,,0,0,,,,PENDING
779,EP,A4,EP 1567222 A4,097-816-707-639-985,2011-11-02,2011,EP 03812468 A,2003-12-01,US 0338079 W;;US 43053802 P,2002-12-02,SINGLE-USE COVER SYSTEM FOR ELECTROMAGNETIC TREATMENT APPLICATOR,,REGENESIS BIOMEDICAL INC,GEORGE FRANK R;;BRYANT ROBERT T;;LOYA ARTHUR A;;MEYER MARLA,,https://lens.org/097-816-707-639-985,Search Report,no,2,0,6,6,0,A61N1/08;;A61N1/37229;;A61N1/40;;A61N1/08,A61N1/375;;A61N1/08;;A61N1/16;;A61N1/40,,1,0,,,See also references of WO 2004050173A1,DISCONTINUED
780,US,B2,US 8380762 B2,061-036-627-873-735,2013-02-19,2013,US 79611610 A,2010-06-08,US 79611610 A;;US 15976305 A,2005-06-23,Database application including spilt views,"A database application is provided which includes functionality for providing split views. The database application includes an object model having a number of objects, methods, and properties. The object model preferably includes a form object which includes a split view representation. A number of properties are associated with the split view which provides for the presentation of data to a user of the database application.",MICROSOFT CORP;;BRYANT CHRISTOPHER;;FORDHAM GEORGE R;;MARKIEWICZ MARCUS;;MCCORMACK MICHAEL;;NARAMORE THERESA,BRYANT CHRISTOPHER;;FORDHAM GEORGE R;;MARKIEWICZ MARCUS;;MCCORMACK MICHAEL;;NARAMORE THERESA,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14),https://lens.org/061-036-627-873-735,Granted Patent,yes,18,1,4,4,0,G06F2203/04803;;G06F16/248;;G06F16/248;;G06F2203/04803,G06F17/30,707/805,6,0,,,"Roger Jennings, Special Edition Using Microsoft Access 2002, Jun. 21, 2002, Que, Chapters 1, 5, 14, and 15; 33 pages.;;U.S. Office Action dated Jul. 31, 2007 cited in U.S. Appl. No. 11/159,763.;;U.S. Office Action dated May 30, 2008 cited in U.S. Appl. No. 11/159,763.;;U.S. Office Action dated Dec. 1, 2008 cited in U.S. Appl. No. 11/159,763.;;U.S. Office Action dated Jun. 19, 2009 cited in U.S. Appl. No. 11/159,763.;;U.S. Notice of Allowance dated Jan. 27, 2010 cited in U.S. Appl. No. 11/159,763.",INACTIVE
781,CA,A1,CA 2507452 A1,159-786-398-832-193,2004-06-17,2004,CA 2507452 A,2003-12-01,US 43053802 P;;US 0338079 W,2002-12-02,SINGLE-USE COVER SYSTEM FOR ELECTROMAGNETIC TREATMENT APPLICATOR,"An electromagnetic treatment device (200) includes a treatment pad (206) and a generating unit (218) connected to the treatment pad by a coaxial cable (205 ). The treatment pad has an antenna (211) on one side of the treatment pad. The generating unit includes a start/stop button (220), a radio frequency generator (208) and a covertest board (212). A single-use cover system (201) includes the electromagnetic treatment device and a disposable cover (203) including a RFID tag (202). The single-use cover system verifies that the disposable cover is placed over the treatment pad properly and that the disposable cover has not been used previously.",REGENESIS BIOMEDICAL INC,GEORGE FRANK R;;LOYA ARTHUR A;;MEYER MARLA;;BRYANT ROBERT T,,https://lens.org/159-786-398-832-193,Patent Application,no,0,0,6,6,0,A61N1/08;;A61N1/08;;A61N1/37229;;A61N1/40,A61N1/16;;A61N1/40,,0,0,,,,EXPIRED
782,US,B2,US 9467367 B2,016-443-958-253-254,2016-10-11,2016,US 201313835190 A,2013-03-15,US 201313835190 A,2013-03-15,Universal labels in internetworking,"In an embodiment, a method comprises: receiving a data communications packet comprising one or more labels in a label stack; determining whether a table identifier is present in the label stack. In response to determining that the table identifier is present in the label stack: based, at least in part, on the table identifier, a label table is determined; a next hop for the data communications packet is determined by performing a next-hop lookup in the label table using at least one of the one or more labels; and the data communications packet is forwarded to the next hop. In an embodiment, the method is performed by one or more computing devices.",CISCO TECH INC,BRYANT STEWART FREDERICK;;FROST DANIEL C;;JARVIS NEIL;;SWALLOW GEORGE L,CISCO TECHNOLOGY INC (2013-03-12),https://lens.org/016-443-958-253-254,Granted Patent,yes,16,4,3,3,0,H04L45/50;;H04L45/50,H04L45/50,,9,6,016-405-491-046-034;;093-867-386-513-613;;123-313-808-848-635;;057-680-078-990-244;;057-680-078-990-244;;066-336-584-775-137,10.17487/rfc3032;;10.17487/rfc5462;;10.17487/rfc3473;;10.17487/rfc7274;;10.17487/rfc7274;;10.17487/rfc3031,"Rosen et al.; RFC 3032: MPLS Label Stack Encoding; IETF; Jan. 2001.;;Andersson et al.; RFC 5462: Multiprotocol Label Switching (MPLS) Label Stack Entry: ""EXP"" Field Renamed to ""Traffic Class"" Field; IETF; Feb. 2009.;;Berger et al.; RFC 3473: Generalized Multi-Protocol Label Switching (GMPLS) Signaling Resource Reservation Protocol-Traffic Engineering (RSVP-TE) Extensions; IETF; Jan. 2003.;;Kompella et al., Allocating and Retiring Special-Purpose MPLS Labels, Jun. 2014, Internet Engineering Task Force (IETF), pp. 1-11.;;Rosen et al., BGP/MPLS IP Virtual Private Networks (VPNs), Feb. 2006, Internet Engineering Task Force (IETF), Network Working Group, pp. 1-47.;;Kompella et al., Allocating and Retiring Special-Purpose MPLS Labels: draft-kompella-mpls-special-purpose-labels-01, Oct. 15, 2012, Internet Engineering Task Force (IETF), pp. 1-10.;;Rosen Cisco Systems et al., ""Multiprotocol Label Switching Architecture"", dated Jan. 1, 2001, 62 pages.;;European Patent Office, ""Search Report"" in application No. PCT/US2014/021380, dated Jun. 20, 2014, 11 pages.;;Claims in European Case, in application No. PCT/2014/021380, dated Jun. 2014, 5 pages.",ACTIVE
783,CA,C,CA 2507452 C,138-792-276-285-725,2011-10-11,2011,CA 2507452 A,2003-12-01,US 43053802 P;;US 0338079 W,2002-12-02,SINGLE-USE COVER SYSTEM FOR ELECTROMAGNETIC TREATMENT APPLICATOR,"An electromagnetic treatment device (200) includes a treatment pad (206) and a generating unit (218) connected to the treatment pad by a coaxial cable (205). The treatment pad has an antenna (211) on one side of the treatment pad. The generating unit includes a start/stop button (220), a radio frequency generator (208) and a covertest board (212). A single-use cover system (201) includes the electromagnetic treatment device and a disposable cover (203) including a RFID tag (202). The single-use cover system verifies that the disposable cover is placed over the treatment pad properly and that the disposable cover has not been used previously.",REGENESIS BIOMEDICAL INC,GEORGE FRANK R;;BRYANT ROBERT T;;LOYA ARTHUR A;;MEYER MARLA,,https://lens.org/138-792-276-285-725,Granted Patent,no,0,0,6,6,0,A61N1/08;;A61N1/08;;A61N1/37229;;A61N1/40,A61N1/04;;A61N1/16;;A61N1/40,,0,0,,,,EXPIRED
784,US,B2,US 10562614 B2,172-779-027-159-062,2020-02-18,2020,US 201615271945 A,2016-09-21,US 201615271945 A,2016-09-21,"Aircraft landing gear, aircraft, and related methods","An aircraft landing gear structure includes a strut assembly configured to transition between a compressed configuration, an extended configuration, and a retracted configuration. The strut assembly has a compressed length, an extended length, and a retracted length, such that the compressed length and retracted length are less than the extended length. The strut assembly includes an upper tubular housing, an upper bulkhead configured to be translated between a lower position and an upper position, a lower tubular housing operatively coupled to the upper tubular housing, a lower bulkhead supported by the lower tubular housing, and a pressure chamber defined between the lower bulkhead and the upper bulkhead. A volume of strut liquid and a mass of strut gas are positioned within the pressure chamber. A method of retracting a strut assembly includes longitudinally translating an upper bulkhead within an upper tubular housing from a lower position to an upper position.",BOEING CO,COTTET JUSTIN DUANE;;CUSWORTH JAMES E;;BRYANT MALCOLM SCOTT;;SONNENBURG GEORGE,THE BOEING COMPANY (2016-09-20),https://lens.org/172-779-027-159-062,Granted Patent,yes,34,0,15,15,0,B64C25/58;;B64C25/60;;B64C25/60;;F16F9/06;;B64C2025/008;;B64C25/22;;B64C25/22;;B64C25/34;;B64C25/60;;F16F9/06;;B64C2025/008,B64C25/22;;B64C25/34;;B64C25/60,,1,0,,,"European Patent Office, Extended European Search Report for related European Application No. 17190605, dated Nov. 16, 2017.",ACTIVE
785,US,B2,US 7734664 B2,043-560-025-224-955,2010-06-08,2010,US 15976305 A,2005-06-23,US 15976305 A,2005-06-23,Database application including split views,"A database application is provided which includes functionality for providing split views. The database application includes an object model having a number of objects, methods, and properties. The object model preferably includes a form object which includes a split view representation. A number of properties are associated with the split view which provides for the presentation of data to a user of the database application.",MICROSOFT CORP,BRYANT CHRISTOPHER;;FORDHAM GEORGE R;;MARKIEWICZ MARCUS;;MCCORMACK MICHAEL;;NARAMORE THERESA,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2005-06-21),https://lens.org/043-560-025-224-955,Granted Patent,yes,16,7,4,4,0,G06F2203/04803;;G06F16/248;;G06F16/248;;G06F2203/04803,G06F7/00;;G06F3/048;;G06F17/30,707/805;;715/764,1,0,,,"Roger Jennings, Special Edition Using Microsoft Access 2002, Jun. 21, 2002, Que, Chapters 1, 5, 14, and 15.",INACTIVE
786,WO,A1,WO 2014/149888 A1,088-440-242-627-263,2014-09-25,2014,US 2014/0021380 W,2014-03-06,US 201313835190 A,2013-03-15,UNIVERSAL LABELS IN INTERNETWORKING,"In an embodiment, a method comprises: receiving a data communications packet comprising one or more labels in a label stack; determining whether a table identifier is present in the label stack. In response to determining that the table identifier is present in the label stack: based, at least in part, on the table identifier, a label table is determined; a next hop for the data communications packet is determined by performing a next-hop lookup in the label table using at least one of the one or more labels; and the data communications packet is forwarded to the next hop. In an embodiment, the method is performed by one or more computing devices.",CISCO TECH INC,BRYANT STEWART FREDERICK;;FROST DANIEL C;;JARVIS NEIL;;SWALLOW GEORGE L,,https://lens.org/088-440-242-627-263,Patent Application,yes,1,0,3,3,0,H04L45/50;;H04L45/50,H04L45/50,,1,0,,,"ROSEN CISCO SYSTEMS E ET AL: ""Multiprotocol Label Switching Architecture; rfc3031.txt"", 20010101, 1 January 2001 (2001-01-01), XP015008814, ISSN: 0000-0003",PENDING
787,HK,A1,HK 1208014 A1,121-825-245-537-521,2016-02-19,2016,HK 15108585 A,2015-09-02,US 2013/0030713 W;;US 201261671485 P,2012-07-13,SQUEEZABLE BOTTLE INCLUDING AN ORNAMENTAL FEATURE,,HEINZ CO H J,BRYANT MICHAEL P P;;MCMAHON MICHAEL D D;;NUKUTO GEORGE IKUYA,,https://lens.org/121-825-245-537-521,Patent Application,no,0,0,11,11,0,B65D1/32;;B65D23/102;;B65D47/0804;;B65D23/102;;B65D1/32;;B65D47/0804;;B65D2501/0081;;B65D23/102;;B65D47/0804;;B65D1/32;;B65D2501/0081;;B65D1/0223;;B65D2203/00,B65D/,,0,0,,,,PENDING
788,SK,B6,SK 279271 B6,006-557-614-900-158,1998-08-05,1998,SK 142193 A,1993-12-15,US 99522292 A,1992-12-22,USE OF BENZOTHIOPHENE DERIVATIVE IN PRODUCTION OF A MEDICAMENT USEFUL FOR THE TREATMENT OF HYPERCHOLESTEROLAEMIA,"Use of a compound of formula (I): wherein n is 0, 1 or 2; R is hydroxyl, metoxy, C1-7 alkanoyloxy, C3-7 cycloalkanoyloxy, C1-6 alkoxy C1-7-alkanoyloxy, an aroyloxy group, wherein aryl portion is selected from the set of phenyl, naphthyl, thienyl and furyl. The aryl portion is monosubstituted by a group from the hydroxyl set, halogen, C1-3 alkyl and C1-3 alkoxy or it represents aryloxycarbonyloxy, wherein aryl portion is selected from the set of phenyl, naphthyl, thienyl and furyl. The aryl portion is monosubstituted by a group from the hydroxyl set, halogen, C1-3 alkyl and C1-3 alkoxy, R1 is hydrogen, hydroxyl, halogen, metoxy, C1-7 alkanoyloxy, C3-7 cycloalkanoyloxy, C1-6 alkoxy C1-7 alkanoyloxy, an aroyloxy group, wherein aryl portion is selected from the set of phenyl, naphthyl, thienyl and furyl. The aryl portion is monosubstituted by a group from the hydroxyl set, halogen, C1-3 alkyl and C1-3 alkoxy or it represents an aryloxycarbonyloxy group, wherein aryl portion is selected from the set of phenyl, naphthyl, thienyl and furyl. The aryl portion is monosubstituted by the hydroxyl set, halogen, C1-3 alkyl and C1-3 alkoxy, R2 is a heterocyclic group selected from the set containing a pyrrolidino, piperidino and hexamethyleneimino group; or a pharmaceutically acceptable salt or solvate thereof; in the preparation of a medicament useful for lowering serum cholesterol levels in humans.",BLACK LARRY J.;;BRYANT HENRY U.;;CULLINAN GEORGE J.;;KAUFFMAN RAYMOND F.,BLACK LARRY J;;BRYANT HENRY U;;CULLINAN GEORGE J;;KAUFFMAN RAYMOND F,,https://lens.org/006-557-614-900-158,Granted Patent,no,0,0,47,47,0,A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;A61K31/4535;;A61K31/4025;;A61K31/55;;A61K2300/00;;A61K31/4535;;A61K31/40;;A61K31/55;;A61K31/445;;A61K31/4025,A61K31/365;;A61K31/38;;A61K31/381;;A61K31/385;;A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4453;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;C07D333/56,,0,0,,,,EXPIRED
789,EP,A1,EP 2110157 A1,054-088-729-757-808,2009-10-21,2009,EP 09009399 A,1999-01-15,EP 99902275 A;;US 7139698 P,1998-01-15,Improved pulsed electromagnetic treatment apparatus,"An apparatus for treatment of wounds using pulsed electromagnetic energy provides a constant, known and replicable dosage output which remains unaffected by the capacitance of the patient's body. The apparatus includes: a pulsed electromagnetic energy generator, one or more applicators, which may be flexible, adapted to be positioned proximate a wound and external of a patient's body, and a circuit means having a fixed capacitance. The applicators are located immediately adjacent to the patient's body, without the aid of a support member or removal of any dressings or bandages. Multiple applicators can be selected to operate simultaneously at different treatment dosage levels and are connected to the generator by multi-conductor cables and are readily located directly on the treatment area. Each applicator is a pad including etched printed circuits. The circuits are matched and pre-tuned.
",REGENESIS BIOMEDICAL INC,GEORGE FRANK R;;LOYA ARTHUR A;;RITZ MARY C;;BRYANT ROBERT T,,https://lens.org/054-088-729-757-808,Patent Application,yes,12,1,18,18,0,A61N1/326;;A61N1/40;;A61N1/40;;A61N1/326,A61N1/40,,1,0,,,"""Russian variable capacitor"", Retrieved from the Internet <URL:http://www.ebay.com/itm/Russian-Variable-Capacitor-1-8-6-5-pF-350V-Lot-24-/250816723464>",DISCONTINUED
790,US,A1,US 2008/0233380 A1,069-023-529-716-232,2008-09-25,2008,US 7499608 A,2008-03-06,US 7499608 A;;US 51188104 A;;US 0312520 W;;US 37487902 P,2002-04-23,Off-axis fiber reinforced composite core for an aluminum conductor,"A composite core for an electrical cable, the composite core defining a longitudinal axis that defines a center of the composite core, the core comprising a plurality of longitudinally extending reinforcing fibers embedded in a resin matrix, the fibers oriented substantially parallel to the longitudinal axis and a sheath surrounding the plurality of longitudinally oriented fibers. The sheath may further comprise a plurality of off-axis reinforcing fibers oriented at an angle relative to the longitudinal axis surrounding the longitudinally extending fibers. The sheath may comprise a type of resin, including for example, thermosetting resin or thermoplastic resin.",HIEL CLEMENT;;KORZENIOWSKI GEORGE;;BRYANT DAVID;;PILLING DOUGLAS;;FERGUSON WILLIAM;;BOSZE ERIC,HIEL CLEMENT;;KORZENIOWSKI GEORGE;;BRYANT DAVID;;PILLING DOUGLAS;;FERGUSON WILLIAM;;BOSZE ERIC,CTC GLOBAL CORPORATION (2012-07-03);;CTC CABLE CORPORATION (2008-03-30),https://lens.org/069-023-529-716-232,Patent Application,yes,80,34,3,99,0,B32B15/04;;B32B15/04;;B32B27/04;;B32B27/04;;H01B5/105;;H01B5/105;;H01B7/1825;;H01B7/1825;;H01B9/006;;H01B9/006;;H01B13/0016;;H01B13/0016;;H02G7/04;;H02G7/04;;H02G7/056;;H02G7/056;;H02G15/06;;H02G15/06;;H02G15/18;;H02G15/18;;Y10T428/249946;;Y10T428/249946;;Y10T428/24995;;Y10T428/24995;;Y10T428/2933;;Y10T428/2933;;Y10T428/2938;;Y10T428/2938;;Y10T428/294;;Y10T428/294,B32B17/02,428/299.4;;428/300.7,0,0,,,,EXPIRED
791,BR,A,BR 9403472 A,084-890-530-207-119,1995-05-16,1995,BR 9403472 A,1994-09-08,US 11890593 A,1993-09-09,Dispositivo e processo para armazenar e/ou ministrar uma proporção eficaz de material biológico ou farmacêutico a um animal,,MILES INC,SHIBLEY GEORGE P;;BROWN KAREN K;;CHOROMANSKI LESZEK J;;BRYANT SHARON A,,https://lens.org/084-890-530-207-119,Patent Application,no,0,0,10,10,0,A61D7/00;;A61D7/00,A61M31/00;;A61D7/00,,0,0,,,,DISCONTINUED
792,US,B1,US 6387378 B1,096-692-834-299-719,2002-05-14,2002,US 11890593 A,1993-09-09,US 11890593 A,1993-09-09,Device for storage and mucosal delivery of biological or pharmaceutical materials to animals,"
    Disclosed herein is a device for storing and/or delivering an effective amount of biological or pharmaceutical material to an animal comprising a tube disposed to contain said biological or pharmaceutical material and sealed at its ends and adapted to provide an opening through which the biological or pharmaceutical material exits and is administered to an intended site of the animal. 
",SHIBLEY GEORGE P.;;BROWN KAREN K.;;CHOROMANSKI LESZEK J.;;BRYANT SHARON A.,SHIBLEY GEORGE P;;BROWN KAREN K;;CHOROMANSKI LESZEK J;;BRYANT SHARON A,BAYER CORPORATION (1993-10-01),https://lens.org/096-692-834-299-719,Granted Patent,yes,19,1,10,10,0,A61D7/00;;A61D7/00,A61D7/00;;A61M31/00,424/273.1;;424/434;;424/435;;424/438;;424/422;;424/430;;424/184.1;;604/48;;604/77;;604/200;;604/187;;604/244;;514/2,0,0,,,,EXPIRED
793,EP,B1,EP 0605193 B1,182-532-267-909-019,2003-03-05,2003,EP 93310438 A,1993-12-22,US 99522292 A,1992-12-22,Use of benzothiophenes for treatment of hypercholesterolaemia,,LILLY CO ELI,BLACK LARRY JOHN;;BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH;;KAUFFMAN RAYMOND FRANCIS,,https://lens.org/182-532-267-909-019,Granted Patent,yes,0,0,47,47,0,A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;A61K31/4535;;A61K31/4025;;A61K31/55;;A61K2300/00;;A61K31/4535;;A61K31/40;;A61K31/55;;A61K31/445;;A61K31/4025,A61K31/385;;A61K31/365;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4453;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;C07D333/56,,3,0,,,"THE JOURNAL OF CLINICAL INVESTIGATION vol. 93, no. 1 , January 1994 pages 63 - 69 BLACK, L.J. ET AL 'RALOXIFENE (LY139481) PREVENTS BONE LOSS AND REDUCES SERUM CHOLESTEROL WITHOUT CAUSING UTERINE HYPERTROPHY IN OVARECTOMIZED RATS';;BIOCHIMICA ET BIOPHYSICA ACTA vol. 972, no. 2 , 1988 pages 167 - 178 CYPRIANI, B. ET AL 'EFFECT OF ESTRADIOL AND ANTIESTROGENS ON CHOLESTEROL BIOSYNTHESIS IN HORMONE-DEPENDENT AND -INDEPENDENT BREAST CANCER CELL LINES';;BIOCHEMICAL PHARMACOLOGY vol. 37, no. 2 , 1988 pages 319 - 326 WEINSTEIN, I. ET AL 'EFFECTS OF THE ANTIOESTROGEN LY 117018 ON THE MODULATION BY ESTRADIOL OF THE METABOLISM OF[1-14C]OLEIC ACID BY PERFUSED LIVERS FROM NORMAL AND OVARECTOMIZED RATS'",EXPIRED
794,US,A,US 5464845 A,041-502-017-864-022,1995-11-07,1995,US 15915993 A,1993-11-30,US 15915993 A;;US 99522292 A,1992-12-22,Methods for lowering serum cholesterol,"A method of lowering serum cholesterol levels comprising administering to a patient a serum cholesterol lowering amount of a compound having the formula ##STR1## wherein n is 0, 1 or 2; R is hydroxyl, methoxy, C.sub.1 -C.sub.7 alkanoyloxy, C.sub.3 -C.sub.7 cycloalkanoyloxy, (C.sub.1 -C.sub.6 alkoxy)-C.sub.1 -C.sub.7 alkanoyloxy, substituted or unsubstituted aroyloxy, or substituted or unsubstituted aryloxycarbonyloxy; R.sup.1 is hydrogen, hydroxyl, chloro, bromo, methoxy, C.sub.1 -C.sub.7 alkanoyloxy, C.sub.3 -C.sub.7 cycloalkanoyloxy, (C.sub.1 -C.sub.6 alkoxy)-C.sub.1 -C.sub.7 alkanoyloxy, substituted or unsubstituted aroyloxy, or substituted or unsubstituted aryloxycarbonyloxy; R.sup.2 is a heterocyclic ring selected from the group consisting of pyrrolidino, piperidino, or hexamethyleneimino; or a pharmaceutically acceptable salt or solvate thereof.",LILLY CO ELI,BLACK LARRY J;;BRYANT HENRY U;;CULLINAN GEORGE J;;KAUFFMAN RAYMOND F,ELI LILLY AND COMPANY (1993-11-30),https://lens.org/041-502-017-864-022,Granted Patent,yes,4,33,47,47,0,A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;A61K31/4535;;A61K31/4025;;A61K31/55;;A61K2300/00;;A61K31/4535;;A61K31/40;;A61K31/55;;A61K31/445;;A61K31/4025,A61K31/365;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/385;;A61K31/4025;;A61K31/445;;A61K31/4453;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;C07D333/56,514/326;;514/443;;514/422;;514/171,18,15,039-179-689-155-908;;051-092-766-473-41X;;127-447-976-152-732;;014-249-411-385-438;;077-684-894-287-921;;027-640-947-779-05X;;019-662-136-158-986;;046-081-900-781-495;;108-551-556-370-574;;001-666-466-422-174;;052-921-119-546-67X;;008-297-202-323-176;;007-200-277-746-819;;121-762-194-117-598;;007-200-277-746-819,6431104;;10.1021/jm00374a021;;2558750;;10.1016/0169-6009(89)90081-0;;10.1016/0169-6009(91)90023-s;;1932893;;10.1002/jbmr.5650020513;;3455628;;3626776;;10.1007/bf02540366;;10.1139/o90-027;;2350488;;10.1210/jcem-73-5-925;;1939531;;10.7326/0003-4819-115-11-860;;1952472;;1922206;;10.1056/nejm199110243251702;;2318936;;10.1210/jcem-70-4-1132;;10.1093/jnci/82.16.1327;;2199681;;1573630;;10.1021/jm00086a002;;3199816;;10.1016/0022-4731(88)90284-1;;10.1016/s0005-2728(88)80077-x;;3191162;;10.1016/0167-4889(88)90115-2;;3199816;;10.1016/0022-4731(88)90284-1,"U.S. application No. 07/920,933 Larry J. Black et al. filed on Jul. 28, 1992.;;Williams, et al., Journal of Bone and Mineral Research, 6 (1991).;;Jones, et al., J. Med. Chem., 27, 1057 1066 (1984).;;Feldman, et al., Bone and Mineral, 7, 245 254 (1989).;;Williams, et al., Bone and Mineral, 14, 205 220 (1991).;;Turner, et al., J. Bone and Min. Res., 2, No. 5, 449 456 (1987).;;Breckenridge, et al., Lipids, 22, No. 7, 505 512 (1987).;;Lazier, et al., Biochem. Cell Biol., 68, 210 217 (1990).;;Lobo, J. Clin. Endocrinol. Metab., 73, No. 5, 925 930 (1991).;;Love, et al., Ann. Intern. Med., 115, No. 11, 860 864 (1991).;;Walsh, et al., N. Engl. J. Med., 325, No. 17, 1196 1204 (1991).;;Bagdade, et al., J. Clin. Endocrinol. Metab., 70, No. 4, 1132 1135 (1990).;;Love, et al., J. Natl. Cancer Inst., 82, No. 16, 1327 1332 (1990).;;Teo, et al., J. Med. Chem., 35, 1330 1339 (1992).;;Cypriani, et al., J. Steroid Biochem., 31, No. 5, 763 771 (1988).;;Cypriani, et al., Effect of Estradiol and Antiestrogens on Cholesterol Synthesis in Hormone Dependent and Independent Breast Cancer Cell Lines , Biochem. Biophys. ACTA 972 167 178 (1988).;;Cypriani, et al., Role of Estrogen Receptors and Antiestrogen Binding Sites in an Early Effect of Antiestrogens, the Inhibition of Cholesterol Biosynthesis , Chem. Abstr. 110: 6958v, (1989).;;American Chemical Society Registry, RN 63676 25 5, 1993.",EXPIRED
795,EP,A1,EP 0642772 A1,048-843-382-164-788,1995-03-15,1995,EP 94113439 A,1994-08-29,US 11890593 A,1993-09-09,A device for storage and mucosal delivery of biological or pharmaceutical materials to animals.,"Disclosed herein is a device for storing and/or delivering an effective amount of biological or pharmaceutical material (6) to an animal comprising a tube (1) disposed to contain said biological or pharmaceutical material and sealed at its ends (2,3) and adapted to provide an opening through which the biological or pharmaceutical material exits and is administered to an intended site of the animal.",MILES INC,SHIBLEY GEORGE P;;BROWN KAREN K;;CHOROMANSKI LESZEK J;;BRYANT SHARON A,BAYER CORPORATION (1997-10-01),https://lens.org/048-843-382-164-788,Patent Application,yes,5,1,10,10,0,A61D7/00;;A61D7/00,A61M31/00;;A61D7/00,,0,0,,,,DISCONTINUED
796,CA,A1,CA 2295134 A1,063-371-419-409-541,1999-07-22,1999,CA 2295134 A,1999-01-15,US 7139698 P;;US 9900864 W,1998-01-15,IMPROVED PULSED ELECTROMAGNETIC ENERGY TREATMENT APPARATUS AND METHOD,"A method of and apparatus for the treatment of chronic wounds using pulsed electromagnetic energy provides a constant, known and replicable dosage output which remains unaffected by the capacitance of the patient's body. The apparatus includes a pulsed electromagnetic energy generator, a power level controller and one or more thin applicators which can be flexible. The applicators are located immediately adjacent to the patient's body, without the aid of a support member or removal of any dressings or bandages. The generator output is automatically adjusted in response to instructions from a field strength sensor located on or near the applicator. Multiple applicators selected to operate simultaneously at different treatment dosage levels are connected to the generator by multi-conductor cables and readily located directly on the treatment area. Each applicator is a pad including etched printed circuits. The circuits are matched and pre-tuned. An applicator-to-patient proximity detector is also incorporated in or on each applicator and connected to the generator via a power controller to provide for direct monitoring of the treatment site and precise control of treatment dosage.",AMETHYST TECHNOLOGIES INC,RITZ MARY C;;BRYANT ROBERT T;;GEORGE FRANK R;;LOYA ARTHUR A,,https://lens.org/063-371-419-409-541,Patent Application,no,0,7,18,18,0,A61N1/326;;A61N1/40;;A61N1/40;;A61N1/326,A61N1/40,,0,0,,,,DISCONTINUED
797,EP,B1,EP 3218009 B1,071-788-623-657-124,2021-04-07,2021,EP 15782050 A,2015-10-08,GB 201418186 A;;GB 201418989 A;;GB 201418986 A;;GB 201418984 A;;GB 201509037 A;;GB 2015052952 W,2014-10-14,PROCESS FOR THE CONJUGATION OF A PEPTIDE OR PROTEIN WITH A REAGENT COMPRISING A LEAVING GROUP INCLUDING A PORTION OF PEG,,POLYTHERICS LTD,GODWIN ANTONY;;BADESCU GEORGE;;BIRD MATTHEW;;BRYANT PENNY;;MORRIS DAVID;;FRIGERIO MARK,,https://lens.org/071-788-623-657-124,Granted Patent,yes,1,0,13,40,0,C07K1/107;;C07K1/107;;A61K47/6889;;A61K47/6835;;A61K47/6803;;A61K47/6889;;A61K47/6803;;A61K47/6835;;C07K1/107;;C07K1/107;;A61K47/6835;;A61K47/6889;;A61K47/6803;;A61K47/56;;A61K47/00;;C07K1/00,A61K47/50;;A61K47/68;;C07K1/107,,0,0,,,,ACTIVE
798,AT,T1,AT E233559 T1,079-634-167-697-200,2003-03-15,2003,AT 93310438 T,1993-12-22,US 99522292 A,1992-12-22,VERWENDUNG VON BENZOTHIOPHENE ZUR BEHANDLUNG VON HYPERCHOLESTEROLÄMIE,,LILLY CO ELI,BLACK LARRY JOHN;;BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH;;KAUFFMAN RAYMOND FRANCIS,,https://lens.org/079-634-167-697-200,Granted Patent,no,0,0,47,47,0,A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;A61K31/4535;;A61K31/4025;;A61K31/55;;A61K2300/00;;A61K31/4535;;A61K31/40;;A61K31/55;;A61K31/445;;A61K31/4025,A61K31/385;;A61K31/365;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4453;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;C07D333/56,,0,0,,,,DISCONTINUED
799,US,B1,US 6334069 B1,093-068-341-196-633,2001-12-25,2001,US 23179099 A,1999-01-15,US 23179099 A;;US 7139698 P,1998-01-15,Pulsed electromagnetic energy treatment apparatus and method,"A method of and apparatus for the treatment of chronic wounds using pulsed electromagnetic energy provides a constant, known and replicable dosage output which remains unaffected by the capacitance of the patient's body. The apparatus is simple to operate, requiring little operator training or interaction with the apparatus. All specifications of the apparatus relating to the generation and emission of electromagnetic energy are fixed, with the specifications based on actual scientific studies of the various technical parameters involved, such as pulse width and RF dosage. The apparatus includes a pulsed electromagnetic energy generator, a power level controller and one or more thin applicators which can be flexible. The applicators are located immediately adjacent to the patient's body, without the aid of a support member or removal of any dressings or bandages. The generator, which can be battery-operated, is a low power, programmable compact unit whose output is controlled by multiple control circuits for ensuring accurate treatment dosage, for confirming that the treatment was properly administered, and for disabling the generator when appropriate. The generator output is automatically adjusted in response to instructions from the field strength sensor located on or near the applicator. Multiple applicators selected to operate simultaneously at different treatment dosage levels are connected to the generator by multi-conductor cables and readily located directly on the treatment area. Each applicator is a pad including etched printed circuits. The circuits are matched and pre-tuned. An applicator-to-patient proximity detector is also incorporated in or on each applicator and connected to the generator via a power controller to provide for direct monitoring of the treatment site and precise control of treatment dosage.",REGENESIS BIOMEDICAL INC,GEORGE FRANK R;;LOYA ARTHUR A;;RITZ MARY C;;BRYANT ROBERT T,AMETHYST TECHNOLOGIES (1999-01-12);;REGENESIS BIOMEDICAL INC (2001-01-01),https://lens.org/093-068-341-196-633,Granted Patent,yes,95,203,18,18,0,A61N1/326;;A61N1/40;;A61N1/40;;A61N1/326,A61N1/40,607/2;;607/50;;607/155,4,3,042-456-106-694-135;;027-280-896-493-097;;147-597-603-749-287,10.1016/0007-1226(81)90006-0;;7023583;;7598479;;10.1146/annurev.med.46.1.467;;7546114,"J.H. Goldin et al, ""The effects of Diapulse on the healing wounds: a double-blind randomised controlled trial in man"", Journal of Plastic Surgery, 1981, 34, pp. 267-270.;;Christopher J. Schaffer et al, ""Cell Biology of Wound Healing"", pp. 151-181, Vanderbilt University School of Medicine, Plastic Surgery Research Laboratories, International Review of Cytology, vol. 169, 1996.;;Glenn F. Pierce et al, ""Pharmacologic Enhancement of Wound Healing"", Annu. Rev. Med. 1995, 46:467-81, 1995.;;CA Salzberg et al, The effects of non-thermal pulsed electromagnetic energy on wound healing of pressure ulcers in spinal cord-injured patients: a randomized, double-blind study, Ostomy Wound Management, 41(3): 42-4, 46, 48 passim, 1995 Abstract only.",EXPIRED
800,NZ,A,NZ 264406 A,106-288-038-312-771,1997-01-29,1997,NZ 26440694 A,1994-09-06,US 11890593 A,1993-09-09,MEDICAMENT DELIVERY DEVICE FOR ANIMALS; CAPILLARY TUBE ENDS SEALED AND CUTTING GROOVES OPENABLE PRIOR TO DELIVERY,,BAYER CORP FORMERLY MILES INC,SHIBLEY GEORGE P;;BROWN KAREN K;;CHOROMANSKI LESZEK J;;BRYANT SHARON A,,https://lens.org/106-288-038-312-771,Patent Application,no,0,0,10,10,0,A61D7/00;;A61D7/00,A61M31/00;;A61D7/00,,0,0,,,,DISCONTINUED
801,CZ,A3,CZ 279093 A3,139-238-600-956-593,1994-07-13,1994,CZ 279093 A,1993-12-16,US 99522292 A,1992-12-22,BENZOTHIOPHENE DERIVATIVE FOR DECREASING CHOLESTEROL LEVEL IN HUMAN SERUM,,LILLY CO ELI,BLACK LARRY JOHN;;BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH;;KAUFFMAN RAYMOND FRANCIS,,https://lens.org/139-238-600-956-593,Patent Application,no,0,0,47,47,0,A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;A61K31/4535;;A61K31/4025;;A61K31/55;;A61K2300/00;;A61K31/4535;;A61K31/40;;A61K31/55;;A61K31/445;;A61K31/4025,A61K31/385;;A61K31/365;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4453;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;C07D333/56,,0,0,,,,EXPIRED
802,AU,B2,AU 669235 B2,175-526-350-515-067,1996-05-30,1996,AU 1993/052578 A,1993-12-21,US 99522292 A,1992-12-22,Improvements in or relating to benzothiophenes,,LILLY CO ELI,BLACK LARRY JOHN;;BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH;;KAUFFMAN RAYMOND FRANCIS,,https://lens.org/175-526-350-515-067,Granted Patent,no,2,0,47,47,0,A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;A61K31/4535;;A61K31/4025;;A61K31/55;;A61K2300/00;;A61K31/4535;;A61K31/40;;A61K31/55;;A61K31/445;;A61K31/4025,A61K31/385;;A61K31/365;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4453;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;C07D333/56,,0,0,,,,EXPIRED
803,WO,A1,WO 2016/059377 A1,004-251-333-403-601,2016-04-21,2016,GB 2015052952 W,2015-10-08,GB 201418186 A;;GB 201418989 A;;GB 201418986 A;;GB 201418984 A;;GB 201509037 A,2014-10-14,PROCESS FOR THE CONJUGATION OF A PEPTIDE OR PROTEIN WITH A REAGENT COMPRISING A LEAVING GROUP INCLUDING A PORTION OF PEG,"The invention relates to novel conjugating reagents capable of reaction with at least one nucleophile present in a peptide or protein, which contain at least one leaving group which is lost on reaction with said nucleophile, in which the leaving group includes a portion -(CH 2 CH 2 O) n- in which n is a number of six or more; and novel processes for the preparation of conjugates containing peptides or proteins made using such reagents.",POLYTHERICS LTD,GODWIN ANTONY;;BADESCU GEORGE;;BIRD MATTHEW;;BRYANT PENNY;;MORRIS DAVID;;FRIGERIO MARK,,https://lens.org/004-251-333-403-601,Patent Application,yes,4,10,13,40,0,C07K1/107;;C07K1/107;;A61K47/6889;;A61K47/6835;;A61K47/6803;;A61K47/6889;;A61K47/6803;;A61K47/6835;;C07K1/107;;C07K1/107;;A61K47/6835;;A61K47/6889;;A61K47/6803;;A61K47/56;;A61K47/00;;C07K1/00,A61K47/48;;C07K1/107,,2,2,019-531-600-990-611;;070-423-803-841-924,20023829;;10.1039/b915036f;;24853662;;10.1039/c4cc02107j,"SIMONE KRAKERT ET AL: ""Adjustment of the bioresistivity by electron irradiation: self-assembled monolayers of oligo(ethyleneglycol)-terminated alkanethiols with embedded cleavable group"", PHYSICAL CHEMISTRY CHEMICAL PHYSICS., vol. 12, no. 2, 1 January 2010 (2010-01-01), GB, pages 507 - 515, XP055237477, ISSN: 1463-9076, DOI: 10.1039/B915036F;;CRISTINA MARCULESCU ET AL: ""Aryloxymaleimides for cysteine modification, disulfide bridging and the dual functionalization of disulfide bonds"", CHEMICAL COMMUNICATIONS, vol. 50, no. 54, 1 January 2014 (2014-01-01), pages 7139 - 7142, XP055200791, ISSN: 1359-7345, DOI: 10.1039/C4CC02107J",PENDING
804,PL,A1,PL 301579 A1,018-827-138-206-984,1994-06-27,1994,PL 30157993 A,1993-12-20,US 99522292 A,1992-12-22,PHARMACEUTICAL PREPARATION,,LILLY CO ELI,BLACK LARRY JOHN;;BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH;;KAUFFMAN RAYMOND FRANCIS,,https://lens.org/018-827-138-206-984,Patent Application,no,0,0,47,47,0,A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;A61K31/4535;;A61K31/4025;;A61K31/55;;A61K2300/00;;A61K31/4535;;A61K31/40;;A61K31/55;;A61K31/445;;A61K31/4025,A61K31/365;;A61K31/385;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4453;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;C07D333/56,,0,0,,,,EXPIRED
805,US,A,US 3193009 A,015-667-932-835-391,1965-07-06,1965,US 26168463 A,1963-02-28,US 26168463 A,1963-02-28,Use of low-grade steam containing dissolved salts in an oil production method,,SHELL OIL CO,WALLACE EUGENE W;;PRYOR JOHN A;;BRADLEY BRYANT W;;HOLLIDAY GEORGE H,,https://lens.org/015-667-932-835-391,Granted Patent,no,9,49,2,3,0,C02F5/08;;C02F5/08;;E21B43/24;;E21B43/24,C02F5/08;;E21B43/24,,0,0,,,,EXPIRED
806,ES,T3,ES 2899159 T3,065-841-750-165-838,2022-03-10,2022,ES 14818371 T,2014-06-24,US 201361838773 P;;US 201361838811 P;;US 2014/0043953 W,2013-06-24,Dispositivo portátil de ultrasonido,"Un dispositivo portátil de ultrasonido (100) que comprende: un controlador de potencia (170) que comprende una fuente de alimentación (274) y al menos un circuito integrado, en donde el controlador de potencia (170) suministra energía eléctrica a un primer aplicador (110); el primer aplicador (110) está acoplado eléctricamente al controlador de potencia (170) mediante un cable de alimentación flexible (180), en donde el controlador de potencia (170) suministra potencia a una amplitud de corriente continua (CC) estable al aplicador (110), durante un período de tiempo definido o en donde el controlador de potencia (170) comprende controles de usuario, en donde los controles permiten al usuario seleccionar la duración del tratamiento, en donde una superficie del primer aplicador (110) transmite ultrasonido a un usuario durante una duración determinada, comprendiendo el primer aplicador (110) un sistema electrónico de accionamiento de radiofrecuencia (RF); un primer transductor de ultrasonidos acoplado al sistema electrónico de accionamiento; un primer aparato de monitoreo que comprende un primer dispositivo de corte térmico (120) acoplado al sistema electrónico de accionamiento, en donde el primer aparato de monitoreo monitorea una temperatura de la superficie del primer aplicador y el primer dispositivo de corte térmico (120) apaga el primer aplicador (110), si la temperatura excede un umbral predefinido el dispositivo portátil de ultrasonido (100) comprende además: un segundo aplicador (710b) acoplado eléctricamente al controlador de potencia (770), en donde el controlador de potencia (770) suministra energía eléctrica simultáneamente al primer aplicador y al segundo aplicador, en donde una segunda superficie del segundo aplicador (710b) transmite ultrasonido a un usuario durante un segundo período de tiempo determinado, comprendiendo el segundo aplicador (710b): un segundo sistema electrónico de accionamiento de radiofrecuencia (RF); un segundo transductor de ultrasonido acoplado al segundo sistema electrónico de accionamiento; un segundo aparato de monitoreo acoplado al sistema electrónico de accionamiento, comprendiendo el segundo sistema de monitoreo un segundo dispositivo de corte térmico, en donde el segundo aparato de monitoreo monitorea una temperatura de la superficie del segundo aplicador y el dispositivo de corte térmico apaga el segundo aplicador, si la temperatura de la superficie del segundo aplicador supera un umbral predefinido; y un primer apósito de acoplamiento (130) acoplado al primer aplicador (110) en donde el primer apósito (130) coloca la superficie del primer aplicador (110) cerca de un usuario en una primera ubicación en el cuerpo del usuario y un segundo apósito de acoplamiento acoplado al segundo aplicador, en donde el segundo apósito coloca la segunda superficie cerca de un usuario en una segunda ubicación en el cuerpo del usuario, en donde la ubicación del primer aplicador y la segunda ubicación no son la misma ubicación y en donde el primer aplicador (710a) comprende además un sensor de proximidad para detectar la ubicación del segundo aplicador (710b), en donde el primer aparato de monitoreo comprende además al menos uno de: un sensor, o un transductor receptor, y en donde el aparato de monitoreo está configurado para obtener información relacionada con el usuario o el aplicador (110) y en donde la información preferentemente comprende al menos uno de: temperatura de la piel, temperatura del aplicador, pulsioximetría, flujo sanguíneo, contenido de oxígeno en la sangre, elastografía mecánica, emisiones sónicas o información biométrica, preferentemente en donde, basándose en la obtención de la información, el sistema electrónico de accionamiento de RF ajusta una secuencia de control o señal de accionamiento ultrasónico del primer aplicador (110), en donde el primer aplicador (110) comprende una envoltura (435) con una saliente, en donde el primer apósito de acoplamiento (130) se acopla al primer aplicador (110) en la saliente, preferentemente que comprende un reborde de enclavamiento (140).",ZETROZ SYSTEMS LLC,LEWIS JR GEORGE K;;GUFFEY BRYANT;;GUARINO JOANNE;;FLESHMAN SHANE;;LANGER MATTHEW,,https://lens.org/065-841-750-165-838,Granted Patent,no,0,0,7,7,0,A61B2017/00106;;A61B2017/2253;;A61N2007/0073;;A61N2007/0078;;A61H2201/0184;;A61H23/0245;;A61H2201/0176;;A61H2201/5015;;A61H2201/5043;;A61H2201/5058;;A61H2201/5097;;A61H2230/207;;A61H2230/25;;A61H2230/505;;A61B2018/00791;;A61N2007/006;;A61N7/00;;A61N2007/0073;;A61N2007/0078;;A61B2017/00106;;A61B2017/2253;;A61H2201/5097;;A61H2230/207;;A61H2201/0184;;A61H2230/505;;A61H2201/5015;;A61H2201/5043;;A61H2201/5058;;A61H23/0245;;A61H2201/0176;;A61H2230/25;;A61B2018/00791;;A61N2007/006;;A61N7/00,A61N7/00;;A61B17/225;;A61H23/02,,0,0,,,,ACTIVE
807,US,A1,US 2016/0136462 A1,064-315-980-229-511,2016-05-19,2016,US 201414900000 A,2014-06-24,US 201414900000 A;;US 201361838773 P;;US 201361838811 P;;US 2014/0043953 W,2013-06-24,WEARABLE ULTRASOUND DEVICE,"A wearable ultrasound device and method of using the device includes a power controller with a power source and at least one integrated circuit that delivers electrical power to an applicator. The applicator is electrically coupled to the power controller and a surface of the applicator transmits ultrasound to a wearer for a given duration. The applicator includes radio frequency (RF) drive electronics, an ultrasound transducer coupled to the drive electronics, a monitoring apparatus that includes a thermal cutoff coupled to the drive electronics, where the monitoring apparatus monitors a temperature of the applicator surface and the thermal cutoff turns off the applicator, if the temperature exceeds a pre-defined threshold, and a coupling bandage coupled to the applicator, where the bandage positions the surface of the applicator proximate to a wearer at a location on the body of a wearer.",ZETROZ INC,LEWIS JR GEORGE K;;GUFFEY BRYANT;;GUARINO JOANNE;;FLESHMAN SHANE;;LANGER MATTHEW,ZETROZ INC (2014-03-26);;ZETROZ SYSTEMS LLC (2016-01-29),https://lens.org/064-315-980-229-511,Patent Application,yes,8,53,7,7,0,A61B2017/00106;;A61B2017/2253;;A61N2007/0073;;A61N2007/0078;;A61H2201/0184;;A61H23/0245;;A61H2201/0176;;A61H2201/5015;;A61H2201/5043;;A61H2201/5058;;A61H2201/5097;;A61H2230/207;;A61H2230/25;;A61H2230/505;;A61B2018/00791;;A61N2007/006;;A61N7/00;;A61N2007/0073;;A61N2007/0078;;A61B2017/00106;;A61B2017/2253;;A61H2201/5097;;A61H2230/207;;A61H2201/0184;;A61H2230/505;;A61H2201/5015;;A61H2201/5043;;A61H2201/5058;;A61H23/0245;;A61H2201/0176;;A61H2230/25;;A61B2018/00791;;A61N2007/006;;A61N7/00,A61N7/00,,1,0,,,wo2011082407,ACTIVE
808,EP,A2,EP 2038757 A2,087-045-306-050-154,2009-03-25,2009,EP 07810012 A,2007-06-28,US 2007/0015064 W;;US 48292006 A,2006-07-07,METHODS AND APPARATUS FOR PROVIDING OPTIMAL IDENTIFICATION AND PROCESSING OF LAYER 3 CONTROL CHANNELS,,CISCO TECH INC,NADEAU THOMAS D;;BRYANT STEWART F;;BARBER SIMON;;WARD DAVID;;SWALLOW GEORGE,,https://lens.org/087-045-306-050-154,Patent Application,yes,0,0,6,6,0,H04L69/22;;H04L69/22;;H04L69/325;;H04L69/325;;H04W80/04;;H04W80/04,G06F15/16;;H04L12/46;;H04L29/06;;H04L29/08;;H04W80/04,,0,0,,,,DISCONTINUED
809,NO,L,NO 943317 L,193-409-073-064-623,1995-03-10,1995,NO 943317 A,1994-09-08,US 11890593 A,1993-09-09,Innretning for lagring og slimhinneadministrering av biologiske og farmasöytiske stoffer til dyr,,MILES INC,SHIBLEY GEORGE P;;BROWN KAREN K;;CHOROMANSKI LESZEK J;;BRYANT SHARON A,,https://lens.org/193-409-073-064-623,Abstract,no,0,0,10,10,0,A61D7/00;;A61D7/00,A61M31/00;;A61D7/00,,0,0,,,,PENDING
810,US,A1,US 2011/0015698 A1,014-703-020-371-01X,2011-01-20,2011,US 89059310 A,2010-09-24,US 89059310 A;;US 34445506 A;;US 99459801 A;;US 23179099 A;;US 7139698 P,1998-01-15,PULSED ELECTROMAGNETIC ENERGY TREATMENT APPARATUS AND METHOD,An apparatus and method for the treatment of chronic wounds using electromagnetic energy. The apparatus includes a generator and at least one applicator. The generator can produce electromagnetic energy and the applicator can apply the electromagnetic energy produced by the generator. A detector is disposed on the applicator that can measure the field strength of the electromagnetic energy applied.,REGENESIS BIOMEDICAL INC,GEORGE FRANK R;;LOYA ARTHUR A;;RITZ MARY C;;BRYANT ROBERT T,,https://lens.org/014-703-020-371-01X,Patent Application,yes,99,0,18,18,0,A61N1/326;;A61N1/40;;A61N1/40;;A61N1/326,A61N1/40;;A61N1/06,607/50;;607/154,0,0,,,,DISCONTINUED
811,HU,B1,HU 223342 B1,045-980-938-603-662,2004-06-28,2004,HU 9303676 A,1993-12-20,US 99522292 A,1992-12-22,PROCESS FOR PREPARING PHARMACEUTICAL COMPOSITIONS HAVING SERUM CHOLESTEROL LOWERING EFFECT CONTAINING BENZOTIOPHENES,"A találmány tárgya eljárás gyógyszerkészítmény előállítására, amelyalkalmas ilyen kezelést igénylő betegekben a szérumkoleszterin-koncentráció csökkentésére. A találmány szerint úgy járnak el, hogy az(I) általános képletű vegyületet, ahol az általános képletben n értéke0 vagy 1; R és R1 jelentése hidroxil-, metoxi-, 1–7 szénatomosalkanoil-oxi-csoport, vagy adott esetben fenilgyűrűjénhidroxilcsoport- tal, halogénatommal, 1–3 szénatomos alkil- vagyalkoxicsoporttal helyettesített benzoil-oxi-csoport; R2 jelentésepirrolidino-, piperidino- vagy hexametilén-imino-csoport, vagygyógyszerészetileg elfogadható sóját vagy szolvátformáját alkalmashordozóanyagokkal gyógyszerkészítménnyé feldolgozzák. Agyógyszerkészítmény alkalmas szérumkoleszterin-szint csökkentésére,anélkül hogy ösztrogénhatást fejtene ki. ŕ",LILLY CO ELI,BLACK LARRY JOHN;;BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH;;KAUFFMAN RAYMOND FRANCIS,,https://lens.org/045-980-938-603-662,Granted Patent,no,0,0,47,47,0,A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;A61K31/4535;;A61K31/4025;;A61K31/55;;A61K2300/00;;A61K31/4535;;A61K31/40;;A61K31/55;;A61K31/445;;A61K31/4025,A61K31/385;;A61K31/365;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4453;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;C07D333/56,,0,0,,,,EXPIRED
812,US,A,US 3237692 A,088-068-639-578-772,1966-03-01,1966,US 45521965 A,1965-05-12,US 45521965 A;;US 26168463 A,1963-02-28,Use of low-grade steam containing dissolved salts in an oil production method,,SHELL OIL CO,WALLACE EUGENE W;;PRYOR JOHN A;;BRADLEY BRYANT W;;HOLLIDAY GEORGE H,,https://lens.org/088-068-639-578-772,Granted Patent,no,3,22,1,3,0,E21B43/24;;E21B43/24,E21B43/24,,0,0,,,,EXPIRED
813,US,A1,US 2006/0129189 A1,094-463-224-102-411,2006-06-15,2006,US 34445506 A,2006-01-30,US 34445506 A;;US 99459801 A;;US 23179099 A;;US 7139698 P,1998-01-15,Pulsed electromagnetic energy treatment apparatus and method,An apparatus and method for the treatment of chronic wounds using electromagnetic energy. The apparatus includes a generator and at least one applicator. The generator can produce electromagnetic energy and the applicator can apply the electromagnetic energy produced by the generator. A detector is disposed on the applicator that can measure the field strength of the electromagnetic energy applied.,REGENESIS BIOMEDICAL INC,GEORGE FRANK R;;LOYA ARTHUR A;;RITZ MARY C;;BRYANT ROBERT T,AMETHYST TECHNOLOGIES INC (1999-01-12);;REGENESIS BIOMEDICAL INC (2001-01-01),https://lens.org/094-463-224-102-411,Patent Application,yes,99,23,18,18,0,A61N1/326;;A61N1/40;;A61N1/40;;A61N1/326,A61N1/00;;A61N1/40,607/2,0,0,,,,DISCONTINUED
814,WO,A2,WO 1999/036127 A2,102-718-014-364-608,1999-07-22,1999,US 9900864 W,1999-01-15,US 7139698 P,1998-01-15,IMPROVED PULSED ELECTROMAGNETIC ENERGY TREATMENT APPARATUS AND METHOD,"A method of and apparatus for the treatment of chronic wounds using pulsed electromagnetic energy provides a constant, known and replicable dosage output which remains unaffected by the capacitance of the patient's body. The apparatus includes a pulsed electromagnetic energy generator, a power level controller and one or more thin applicators which can be flexible. The applicators are located immediately adjacent to the patient's body, without the aid of a support member or removal of any dressings or bandages. The generator output is automatically adjusted in response to instructions from a field strength sensor located on or near the applicator. Multiple applicators selected to operate simultaneously at different treatment dosage levels are connected to the generator by multi-conductor cables and readily located directly on the treatment area. Each applicator is a pad including etched printed circuits. The circuits are matched and pre-tuned. An applicator-to-patient proximity detector is also incorporated in or on each applicator and connected to the generator via a power controller to provide for direct monitoring of the treatment site and precise control of treatment dosage.",AMETHYST TECHNOLOGIES INC,GEORGE FRANK R;;LOYA ARTHUR A;;RITZ MARY C;;BRYANT ROBERT T,,https://lens.org/102-718-014-364-608,Patent Application,no,5,9,18,18,0,A61N1/326;;A61N1/40;;A61N1/40;;A61N1/326,A61N1/40,,0,0,,,,PENDING
815,AU,B2,AU 688340 B2,145-437-896-780-61X,1998-03-12,1998,AU 1994/071618 A,1994-09-01,US 11890593 A,1993-09-09,A device for storage and mucosal delivery of biological or pharmaceutical materials to animals,,BAYER AG,SHIBLEY GEORGE P;;BROWN KAREN K;;CHOROMANSKI LESZEK J;;BRYANT SHARON A,,https://lens.org/145-437-896-780-61X,Granted Patent,no,3,0,10,10,0,A61D7/00;;A61D7/00,A61M31/00;;A61D7/00,,0,0,,,,EXPIRED
816,CA,A1,CA 2112017 A1,153-901-300-719-495,1994-06-23,1994,CA 2112017 A,1993-12-21,US 99522292 A,1992-12-22,USE OF BENZOTHIOPHENES FOR LOWERING SERUM CHOLESTEROL,"Use of a compound of formula (I): <IMG> (I) wherein n is 0, 1 or 2; R is hydroxyl, methoxy, C1-C7 alkanoyloxy, C3-C7 cycloalkanoyloxy, (C1-C6 alkoxy)-C1-C7 alkanoyloxy, substituted or unsubstituted aroyloxy, or substituted or unsubstituted aryloxycarbonyloxy; R1 is hydrogen, hydroxyl, chloro, bromo, methoxy, C1C7 alkanoyloxy, C3-C7 cycloalkanoyloxy, (C1-C6 alkoxy)-C1-C7 alkanoyloxy, substituted or unsubstituted or aroyloxy, or substituted or unsubstituted aryloxycarbonyloxy; R2 is a heterocyclic ring selected from the group consisting of pyrrolidino, piperidino, or hexamethyleneimino; or a pharmaceutically acceptable salt or solvate thereof; in the preparation of a medicament useful for lowering serum cholesterol levels in animals.",LILLY CO ELI,BLACK LARRY J;;BRYANT HENRY U;;CULLINAN GEORGE J;;KAUFFMAN RAYMOND F,,https://lens.org/153-901-300-719-495,Patent Application,no,0,0,47,47,0,A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;A61K31/4535;;A61K31/4025;;A61K31/55;;A61K2300/00;;A61K31/4535;;A61K31/40;;A61K31/55;;A61K31/445;;A61K31/4025,A61K31/385;;A61K31/365;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4453;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;C07D333/56,,0,0,,,,EXPIRED
817,NO,B1,NO 304924 B1,159-592-294-518-284,1999-03-08,1999,NO 934740 A,1993-12-21,US 99522292 A,1992-12-22,Anvendelse av benzotiofener for fremstilling av et medikament for reduksjon av serumkolesterolnivÕene,,LILLY CO ELI,BLACK LARRY JOHN;;CULLINAN GEORGE JOSEPH;;BRYANT HENRY UHLMAN;;KAUFFMAN RAYMOND FRANCIS,,https://lens.org/159-592-294-518-284,Granted Patent,no,0,4,47,47,0,A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;A61K31/4535;;A61K31/4025;;A61K31/55;;A61K2300/00;;A61K31/4535;;A61K31/40;;A61K31/55;;A61K31/445;;A61K31/4025,A61K31/365;;A61K31/385;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4453;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;C07D333/56,,0,0,,,,EXPIRED
818,ES,T3,ES 2885854 T3,179-457-147-443-271,2021-12-15,2021,ES 15782050 T,2015-10-08,GB 201418186 A;;GB 201418989 A;;GB 201418986 A;;GB 201418984 A;;GB 201509037 A;;GB 2015052952 W,2014-10-14,Proceso para la conjugación de un péptido o proteína con un reactivo que comprende un grupo saliente que incluye una porción de PEG,"Un reactivo de conjugación capaz de reaccionar con al menos un nucleófilo presente en un péptido o proteína, cuyo reactivo lleva una carga útil que es un agente de diagnóstico, terapéutico o de marcado o un agente de unión para un agente de diagnóstico, terapéutico o de marcado, y cuyo reactivo contiene en al menos un grupo saliente que se pierde al reaccionar con dicho nucleófilo, caracterizado por que dicho grupo saliente incluye una porción -(CH2CH2O)n- en la que n es un número de seis o más, y en donde: a) dicho reactivo de conjugación es de fórmula (Ic), (Ic'), (Id), (Id'), (Ie), (Ie'), (IIa) o (IIIb): **(Ver fórmula)** o D-Q-W-CR4R4'-CR4.L.L' (IIa) D-Q-N H-CO-Ar-CO-(CH2)2-L (Illb) en donde: D representa una carga útil que es un agente de diagnóstico, terapéutico o de marcado o un agente de unión para un agente de diagnóstico, terapéutico o de marcado; Q representa un grupo de enlace; W representa un grupo captador de electrones; A representa una cadena de alquileno o alquenileno C1-5; B representa un enlace o una cadena de alquileno o alquenileno C1-4; Ar representa un arilo opcionalmente sustituido; cada R4 representa un átomo de hidrógeno o un grupo alquilo C1-C4; R4' representa un átomo de hidrógeno o R4' y L' juntos representan un enlace; m es de 0 a 4; L es un grupo saliente que incluye una porción -(CH2CH2O)n- en la que n es un número de seis o más; y L' es un grupo saliente que incluye una porción -(CH2CH2O)n- en la que n es un número de seis o más, es un grupo saliente de otra estructura, o R4' y L' juntos representan un enlace; o los dos L de un reactivo de conjugación juntos representan un grupo saliente que incluye una porción - (CH2CH2O)n- en la que n es un número de seis o más; o L y L' juntos representan un grupo saliente que incluye una porción -(CH2CH2O)n- en la que n es un número de seis o más; o b) dicho reactivo de conjugación incluye uno de los siguientes grupos funcionales: **(Ver fórmula)** en el que un L es un grupo saliente que incluye una parte -(CH2CH2O)n- en el que n es un número de seis o más y el otro L es un grupo saliente que incluye una parte -(CH2CH2O)n- en el que n es un número de seis o más o es un grupo saliente de otra estructura; o **(Ver fórmula)** en la que L es un grupo saliente que incluye una porción -(CH2CH2O)n- en el que n es un número de seis o más; y en donde el átomo de nitrógeno de cada anillo de maleimida está unido a un grupo de fórmula D-Q, en donde D y Q son como se han definido anteriormente; y en donde la porción -(CH2CH2O)n- tiene un peso molecular de hasta 5 kDa; y también, en donde dicho grupo saliente es de la fórmula -SP, -OP, -SO2P, -OSO2P, -N+PR2R3, o es un grupo de fórmula -S-P-S-, -O-P-O-, -SO2-P-SO2-, -OSO2-P-OSO2- o - N+R2R3-P-N+R2R3-, en la que P es un grupo que incluye un porción -(CH2CH2O)n- y cada uno de R2 y R3 representa independientemente un átomo de hidrógeno o un grupo alquilo C1-4 o un grupo P.",POLYTHERICS LTD,GODWIN ANTONY;;BADESCU GEORGE;;BIRD MATTHEW;;BRYANT PENNY;;MORRIS DAVID;;FRIGERIO MARK,,https://lens.org/179-457-147-443-271,Granted Patent,no,0,0,13,40,0,C07K1/107;;C07K1/107;;A61K47/6889;;A61K47/6835;;A61K47/6803;;A61K47/6889;;A61K47/6803;;A61K47/6835;;C07K1/107;;C07K1/107;;A61K47/6835;;A61K47/6889;;A61K47/6803;;A61K47/56;;A61K47/00;;C07K1/00,A61K47/50;;A61K47/68;;C07K1/107,,0,0,,,,ACTIVE
819,DE,D1,DE 69332735 D1,178-755-725-914-733,2003-04-10,2003,DE 69332735 T,1993-12-22,US 99522292 A,1992-12-22,Verwendung von Benzothiophene zur Behandlung von Hypercholesterolämie,,LILLY CO ELI,BLACK LARRY JOHN;;BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH;;KAUFFMAN RAYMOND FRANCIS,,https://lens.org/178-755-725-914-733,Granted Patent,no,0,0,47,47,0,A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;A61K31/4535;;A61K31/4025;;A61K31/55;;A61K2300/00;;A61K31/4535;;A61K31/40;;A61K31/55;;A61K31/445;;A61K31/4025,A61K31/385;;A61K31/365;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4453;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;C07D333/56,,0,0,,,,EXPIRED
820,PL,B1,PL 177349 B1,187-798-772-959-025,1999-10-29,1999,PL 30157993 A,1993-12-20,US 99522292 A,1992-12-22,PHARMACEUTICAL PREPARATION,,LILLY CO ELI,BLACK LARRY J;;BRYANT HENRY U;;CULLINAN GEORGE J;;KAUFFMAN RAYMOND FRANCIS,,https://lens.org/187-798-772-959-025,Granted Patent,no,0,0,47,47,0,A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;A61K31/4535;;A61K31/4025;;A61K31/55;;A61K2300/00;;A61K31/4535;;A61K31/40;;A61K31/55;;A61K31/445;;A61K31/4025,A61K31/365;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/385;;A61K31/4025;;A61K31/445;;A61K31/4453;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;C07D333/56,,0,0,,,,EXPIRED
821,US,S,US D0697415 S,024-671-070-674-51X,2014-01-14,2014,US 201229413690 F,2012-02-17,US 201229413690 F;;US 201129385898 F;;US 201129385902 F,2011-02-22,Container,,BRYANT MICHAEL PATRICK;;MCMAHON MICHAEL D;;NUKUTO GEORGE I;;ZIMMER JONATHAN H;;HEINZ CO H J,BRYANT MICHAEL PATRICK;;MCMAHON MICHAEL D;;NUKUTO GEORGE I;;ZIMMER JONATHAN H,H.J. HEINZ COMPANY (2012-02-13);;H.J. HEINZ COMPANY BRANDS LLC (2015-06-30),https://lens.org/024-671-070-674-51X,Design Right,no,0,8,1,8,0,,,0901;;D 9542;;D9/563;;D9/569;;D9/571;;D9/574;;D9/454,0,0,,,,ACTIVE
822,TW,B,TW 383306 B,040-072-247-549-366,2000-03-01,2000,TW 82100751 A,1993-02-04,US 99522292 A,1992-12-22,New use of 2-phenyl-3-aroylbenzothiophenes in lowering serum cholesterol,"A compound having the formula (I) wherein X is a bond or -CH2-; R is hydroxyl, methoxy, C1-C7 alkanoyloxy, C3-C7 cycloalkanoyloxy, (C1-C6 alkosy)-C1-C7 alkanoyloxy, substituted or unsubstituted aroyloxy, or substituted or unsubstituted aryloxycarbonyloxy; R1 is hydrogen, hydroxyl, chloro, bromo, methoxy, C1-C7 alkanoyloxy, C3-C7 cycloalkanoyloxy, (C1-C6 alkoxy)-C1-C7 alkanoyloxy, substituted or unsubstituted or aroyloxy, or substituted or unsubstituted aryloxycarbonyloxy; R2 is a heterocyclic ring selected from the group consisting of pyrrolidino, piperidino, or hexamethyleneimino; or a pharmaceutically acceptable salt or solvate thereof for use in lowering serum cholesterol levels in a human.",LILLY CO ELI,BLACK LARRY JOHN;;BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH;;KAUFFMAN RAYMOND FRANCIS,,https://lens.org/040-072-247-549-366,Granted Patent,no,0,0,47,47,0,A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;A61K31/4535;;A61K31/4025;;A61K31/55;;A61K2300/00;;A61K31/4535;;A61K31/40;;A61K31/55;;A61K31/445;;A61K31/4025,A61K31/365;;A61K31/38;;A61K31/385;;A61K31/381;;A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4453;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;C07D333/56,,0,0,,,,EXPIRED
823,MY,A,MY 109345 A,058-848-007-096-248,1997-01-31,1997,MY PI19932719 A,1993-12-15,US 99522292 A,1992-12-22,IMPROVEMENTS IN OR RELATING TO BENZOTHIOPHENES.,"USE OF A COMPOUND OF FORMULA (I): WHEREIN N IS 0, 1 OR 2; R IS HYDROXYL, METHOXY, C1-C7 ALKANOYLOXY, C3-C7 CYCLOALKANOYLOXY, (C1-C6 ALKOXY) -C1-C7 ALKANOYLOXY, SUBSTITUTED OR UNSUBSTITUTED AROYLOXY, OR SUBSTITUTED OR UNSUBSTITUTED ARYLOXYCARBONYLOXY; R1 IS HYDROGEN, HYDROXYL, CHLORO, BROMO, METHOXY, C1-C7 ALKANOYLOXY, C3-C7 CYCLOALKANOYLOXY, (C1-C6 ALKOXY) -C1-C7 ALKANOYLOXY, SUBSTITUTED OR UNSUBSTITUTED AROYLOXY, OR SUBSTITUTED OR UNSUBSTITUTED ARYLOXYCARBONYLOXY; R2 IS A HETEROCYCLIC RING SELECTED FROM THE GROUP CONSISTING OF PYRROLIDINO, PIPERIDINO, OR HEXAMETHYLENEIMINO; OR PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF; IN THE PREPARATION OF A MEDICAMENT USEFUL FOR LOWERING SERUM CHOLESTEROL LEVELS IN ANIMALS.",LILLY CO ELI,HENRY UHLMAN BRYANT;;GEORGE JOSEPH CULLINAN;;RAYMOND FRANCIS KAUFFMAN;;LARRY JOHN BLACK,,https://lens.org/058-848-007-096-248,Granted Patent,no,0,0,47,47,0,A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;A61K31/4535;;A61K31/4025;;A61K31/55;;A61K2300/00;;A61K31/4535;;A61K31/40;;A61K31/55;;A61K31/445;;A61K31/4025,A61K31/385;;A61K31/365;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4453;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;C07D333/56,,0,0,,,,EXPIRED
824,EP,A1,EP 3013420 A1,067-634-676-483-627,2016-05-04,2016,EP 14818371 A,2014-06-24,US 201361838773 P;;US 201361838811 P;;US 2014/0043953 W,2013-06-24,WEARABLE ULTRASOUND DEVICE,,ZETROZ INC,LEWIS JR GEORGE K;;GUFFEY BRYANT;;GUARINO JOANNE;;FLESHMAN SHANE;;LANGER MATTHEW,"ZETROZ SYSTEMS, LLC (2016-12-21)",https://lens.org/067-634-676-483-627,Patent Application,yes,0,0,7,7,0,A61B2017/00106;;A61B2017/2253;;A61N2007/0073;;A61N2007/0078;;A61H2201/0184;;A61H23/0245;;A61H2201/0176;;A61H2201/5015;;A61H2201/5043;;A61H2201/5058;;A61H2201/5097;;A61H2230/207;;A61H2230/25;;A61H2230/505;;A61B2018/00791;;A61N2007/006;;A61N7/00;;A61N2007/0073;;A61N2007/0078;;A61B2017/00106;;A61B2017/2253;;A61H2201/5097;;A61H2230/207;;A61H2201/0184;;A61H2230/505;;A61H2201/5015;;A61H2201/5043;;A61H2201/5058;;A61H23/0245;;A61H2201/0176;;A61H2230/25;;A61B2018/00791;;A61N2007/006;;A61N7/00,A61N7/00;;A61B17/225;;A61H23/02,,0,0,,,,ACTIVE
825,US,A1,US 2002/0040233 A1,077-993-261-541-458,2002-04-04,2002,US 99459801 A,2001-11-20,US 99459801 A;;US 23179099 A;;US 7139698 P,1998-01-15,Pulsed electromagnetic energy treatment apparatus and method,"
   An apparatus and method for the treatment of chronic wounds using electromagnetic energy. The apparatus includes a generator and at least one applicator. The generator can produce electromagnetic energy and the applicator can apply the electromagnetic energy produced by the generator. A detector is disposed on the applicator that can measure the field strength of the electromagnetic energy applied. 
",GEORGE FRANK R.;;LOYA ARTHUR A.;;RITZ MARY C.;;BRYANT ROBERT T.,GEORGE FRANK R;;LOYA ARTHUR A;;RITZ MARY C;;BRYANT ROBERT T,AMETHYST TECHNOLOGIES INC (1999-01-12);;REGENESIS BIOMEDICAL INC (2001-01-01),https://lens.org/077-993-261-541-458,Patent Application,yes,98,25,18,18,0,A61N1/326;;A61N1/40;;A61N1/40;;A61N1/326,A61N1/40,607/2,0,0,,,,EXPIRED
826,ES,T3,ES 2193142 T3,098-238-363-777-309,2003-11-01,2003,ES 93310438 T,1993-12-22,US 99522292 A,1992-12-22,USO DE BENZOTIOFENOS PARA EL TRATAMIENTO DE HIPERCOLESTEROLEMIA.,"EMPLEO DE UN COMPUESTO DE FORMULA (I): EN DONDE N ES 0, 1 O 2; R ES HIDROXILO METOXI, ALCANOILOXI C1 OXI C3 SUBSTITUIDO O NO SUBSTITUIDO, O ARILOXICARBONILOXI SUBSTITUIDO O NO SUBSTITUIDO; R1 ES HIDROGENO, HIDROXILO, CLORO, BROMO, METOXI, ALCANOILOXI C1 XI C1 ITUIDO, O ARILOXICARBONILOXI SUBSTITUIDO O NO SUBSTITUIDO; R2 ES UN ANILLO HETEROCICLICO SELECCIONADO DEL GRUPO QUE CONSISTE EN PIRROLIDINO, PIPERIDINO, O HEXAMETILENOIMINO; O UNA SAL O SOLVATO FARMACEUTICAMENTE ACEPTABLE DEL MISMO EN LA PREPARACION DE UN MEDICAMENTO UTIL PARA REDUCIR LOS NIVELES DE COLESTEROL EN SUERO EN LOS ANIMALES.",LILLY CO ELI,BLACK LARRY JOHN;;BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH;;KAUFFMAN RAYMOND FRANCIS,,https://lens.org/098-238-363-777-309,Granted Patent,no,0,0,47,47,0,A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;A61K31/4535;;A61K31/4025;;A61K31/55;;A61K2300/00;;A61K31/4535;;A61K31/40;;A61K31/55;;A61K31/445;;A61K31/4025,A61K31/385;;A61K31/365;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4453;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;C07D333/56,,0,0,,,,EXPIRED
827,IT,A1,IT 202000019522 A1,190-417-401-100-744,2022-02-06,2022,IT 202000019522 A,2020-08-06,IT 202000019522 A,2020-08-06,"Impianti medici fatti di poliimidi resistenti all'usura e ad alte prestazioni, processo per la realizzazione degli stessi e uso medico degli stessi",,MMATECH LTD,BUCHMAN ALISA;;SIBONI SIMHA;;BRYANT ROBERT GEORGE;;ELIAZ ARI;;BURN JAMES PETER,,https://lens.org/190-417-401-100-744,Patent Application,no,10,0,1,1,0,A61L27/18;;A61L2430/02;;A61L2430/24,A61L/,,20,11,175-798-859-611-990;;034-437-736-492-964;;018-420-600-283-388;;010-484-172-084-084;;012-881-659-324-790;;006-989-874-488-672;;019-894-478-345-151;;079-674-038-946-73X;;070-850-446-610-779;;094-435-833-965-978;;075-141-340-099-095,10.11648/j.ajbls.20190703.11;;4449425;;7559676;;10.1016/0021-9290(94)00158-z;;10718048;;10.1243/0954411001535219;;10537250;;10.1016/s0883-5403(99)90025-6;;2929310;;10.3109/00016488909127474;;10.1002/jbm.820100104;;1249088;;10.1097/00002480-199609000-00116;;8945009;;10.1088/0954-0083/8/4/009;;3490;;pmc1231823;;10.1002/jbm.820030402;;5360011,"JAMES BURN PETER: ""MP-1(TM) Polyimide for Medical Devices: 1. Pre Clinical Studies"", AMERICAN JOURNAL OF BIOMEDICAL AND LIFE SCIENCES, vol. 7, no. 3, 1 January 2019 (2019-01-01), pages 42, XP055793554, ISSN: 2330-8818, DOI: 10.11648/j.ajbls.20190703.11;;A.MOVSHOVICHG.I.ROITBERG, MEDITSINSKAYA TEKHNIKA, no. 5, 1974, pages 15 - 19;;DURASUL - POLYETHYLENE, SULZER ORTHOPEDICS LTD. (INTERNET SITE;;K. MANND. L. BARTELT.M. WRIGHTA. H. BURSTEIN, J. OF BIOMECHANICS, vol. 28, no. 9, 1995, pages 1067;;L. AMBROSIO ET AL., J. OF MAT. SCI. (MAT. IN MEDICINE, vol. 7, 1996, pages 723;;E. INGHAMJ. FISHER, PROC. INSTN. MECH. ENGRS., vol. 214, 2000, pages 21;;L. M. JAZRAWIM.D. BOGNER ET AL., J. OF ARTHOPLASTY, vol. 14, no. 7, 1999, pages 781;;H. L. AMSSIAN ET AL., ACTA ORTHOPEDICA, SCAND, vol. 70, no. 6, 1999, pages 578;;T. STIEGLITZJ. U. MEYERS, MED.DEV.TECHNOL., vol. 10, no. 6, 1999, pages 28 - 30;;H. S. HAGGERTYH. S. LUSTED, ACTA OTOLARYNGOLOGY, vol. 107, no. 1-2, 1989, pages 13;;H. C. AMSTUTZM. LODWIG, J. BIOMEDICAL MATERIALS RES., vol. 10, no. 1, 1976, pages 25;;R. A. JESINGERV. 1. STONICK, IEEE ENGINEERING IN MEDICINE, INT. CONF. PROC. SAN DIEGO, 1993;;R. R. RICHARDSONJ. A. MILLERW. M. RICHERT, BIOCOMPATIBLE MATERIALS, vol. 14, no. 3, 1993, pages 627;;H. KAWAKAMIS. NAGAOKAS. KUBOTA, ASAIO J, vol. 42, no. 5, 1996, pages M871;;ROBERT G. BRYANT, HIGH PERFORM. POLYM., vol. 19, 1996, pages 607 - 615;;C.P. ANTHONYG.A. THILBODEAN: ""Text book of Anatomy and Physiology"", vol. 170, 1979, MOSBY PUBL. LONDON;;WRIGHT, DOWSON, J. ANATOMY, vol. 121, no. 1, 1976, pages 107;;H. C. AMSTUTZ, J. BIOMEDICAL MATERIALS RES., vol. 3, 1968, pages 547;;""Polyimides"", 1990, BLACKIE AND SONS LTD;;R. A. OLIVERC. CHRISTOUT. WANGA. BUCHMANS. SIBONYW. R.WALSH: ""The Influence of Polyimide MP-1TM Wear Particles on a Rodent Closed Fracture Healing Model"", ORS ORTHOPAEDIC RESEARCH SOC. - THE 2020 ANNUAL MEETING, 8 February 2020 (2020-02-08)",PENDING
828,US,A1,US 2008/0008168 A1,199-858-193-429-844,2008-01-10,2008,US 48292006 A,2006-07-07,US 48292006 A,2006-07-07,Methods and apparatus for providing optimal identification and processing of layer 3 control channels,"A method for processing token identifiers for Layer 3 (L3) control channels when encapsulated in a tunneling protocol. Rather than encapsulating an L3 control channel with a secondary L3 (or Layer 4 ‘L4 ’) header, a generic (non-Layer 3 header) identifier, or token identifier, is used to encapsulate the control channel. For example, the token identifier may be a simple bit pattern that does not require a complex, confusing or redundant IP/UDP routing table lookup. Instead, the token identifier simply alerts the forwarding entity that local processing of the packet's data is required (e.g., that the packet contains control channel data).",NADEAU THOMAS D;;BRYANT STEWART F;;BARBER SIMON;;WARD DAVID;;SWALLOW GEORGE,NADEAU THOMAS D;;BRYANT STEWART F;;BARBER SIMON;;WARD DAVID;;SWALLOW GEORGE,CISCO TECHNOLOGY INC (2006-07-04),https://lens.org/199-858-193-429-844,Patent Application,yes,2,26,6,6,0,H04L69/22;;H04L69/22;;H04L69/325;;H04L69/325;;H04W80/04;;H04W80/04,H04L12/56,370/389,0,0,,,,DISCONTINUED
829,WO,A3,WO 1999/036127 A3,013-369-636-492-429,1999-07-22,1999,US US9900864,1999-01-15,"US 60/0/071,396",1998-01-15,IMPROVED PULSED ELECTROMAGNETIC ENERGY TREATMENT APPARATUS AND METHOD,"A method of and apparatus for the treatment of chronic wounds using pulsed electromagnetic energy provides a constant, known and replicable dosage output which remains unaffected by the capacitance of the patient's body. The apparatus includes a pulsed electromagnetic energy generator, a power level controller and one or more thin applicators which can be flexible. The applicators are located immediately adjacent to the patient's body, without the aid of a support member or removal of any dressings or bandages. The generator output is automatically adjusted in response to instructions from a field strength sensor located on or near the applicator. Multiple applicators selected to operate simultaneously at different treatment dosage levels are connected to the generator by multi-conductor cables and readily located directly on the treatment area. Each applicator is a pad including etched printed circuits. The circuits are matched and pre-tuned. An applicator-to-patient proximity detector is also incorporated in or on each applicator and connected to the generator via a power controller to provide for direct monitoring of the treatment site and precise control of treatment dosage.","AMETHYST TECHNOLOGIES, INC.","GEORGE, Frank, R.;;LOYA, Arthur, A.;;RITZ, Mary, C.;;BRYANT, Robert, T.",,https://lens.org/013-369-636-492-429,Search Report,yes,0,0,1,1,0,,A61N1/40,,0,0,,,,UNKNOWN
830,US,A,US 4229247 A,028-248-541-922-135,1980-10-21,1980,US 97284478 A,1978-12-26,US 97284478 A,1978-12-26,Glow discharge etching process for chromium,"Chromium is etched in a glow discharge without attack on Al/Cu, Si, SiO.sub.2, and Si.sub.3 N.sub.4 layers by etching in a low pressure ambient atmosphere containing a polychlorinated organic compound such as CCl.sub.4, water, and a material selected from the group consisting of the noble gases and oxygen.",IBM,CHIU GEORGE T;;KITCHER JAMES R;;OZOLS GUNARS M;;ZINGERMAN BRYANT N,,https://lens.org/028-248-541-922-135,Granted Patent,yes,5,23,10,10,0,C23F4/00;;H01L21/32136;;C23F4/00;;H01L21/32136,C23F4/00;;H01L21/302;;H01L21/3065;;H01L21/308;;H01L21/3213,156/643,3,0,,,"Kodak Microelectronics Seminar 1976, A Study of the Optical Emission from a R7 Plasma During Semiconductor Etching, by W. R. Harshbarger et al, pp. 1-14.;;IBM Technical Disclosure Bulletin, vol. 19, No. 3, Aug. 1976, Etching Fine Patterns in Chromium and Refractory Metals by H. C. Kluge et al, p. 900.;;IBM Technical Disclosure Bulletin, vol. 20, No. 2, Jul. 1977, Increasing the Selectivity of the Plasma Etch Rate of SiO.sub.2 Relative to Si, p. 757.",EXPIRED
831,BG,B1,BG 61524 B1,040-721-700-479-536,1997-11-28,1997,BG 9831793 A,1993-12-21,US 99522292 A,1992-12-22,USE OF BENZOTHIOPHENES FOR REDUCING THE CHOLESTEROL IN THE BLOOD,"The invention relates to compounds having the formula (formula) where n has the value of 0, 1 or 2; R hydroxyl, ethoxy, C1-C7 alkanoyloxy, C3-7 cycloalkanoyloxy, (C1-6 alkoxy)-C1-C7 alkanoyloxy, substituted or not substituted aroyloxy or substituted or not substituted aryloxycarbonyloxy; R1 is hydrogen, hydroxyl, halogen, methoxy, C1-C7 alkanoyloxy, C3-C7 cycloalkanoyloxy, (C1-C6alkoxy)-C1-C7 alkanoyloxy, substituted or not substituted aroyloxy or substituted or not substituted aroyloxycarbohyloxy; R2 is heteocyclic ring selected from the group consisting of pyrrolidine, pepiridine or hexamethyleneimine, to its pharmaceutically acceptable salt or the respective solvate which are applied for reducing the cholesterol levels in the serum.",LILLY CO ELI,BLACK LARRY J;;BRYANT HENRY U;;CULLINAN GEORGE J;;KAUFFMAN RAYMOND F,,https://lens.org/040-721-700-479-536,Granted Patent,no,0,0,47,47,0,A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;A61K31/4535;;A61K31/4025;;A61K31/55;;A61K2300/00;;A61K31/4535;;A61K31/40;;A61K31/55;;A61K31/445;;A61K31/4025,A61K31/385;;A61K31/365;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4453;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;C07D333/56,,0,0,,,,EXPIRED
832,DE,D1,DE 69941557 D1,089-889-168-187-373,2009-12-03,2009,DE 69941557 T,1999-01-15,US 7139698 P;;US 9900864 W,1998-01-15,VERBESSERTE VORRICHTUNG ZUR BEHANDLUNG MITTELS PULSIERTER ELEKTROMAGNETISCHER ENERGIE,"An apparatus for treatment of wounds using pulsed electromagnetic energy provides a constant, known and replicable dosage output which remains unaffected by the capacitance of the patient's body. The apparatus includes: a pulsed electromagnetic energy generator, one or more applicators, which may be flexible, adapted to be positioned proximate a wound and external of a patient's body, and a circuit means having a fixed capacitance. The applicators are located immediately adjacent to the patient's body, without the aid of a support member or removal of any dressings or bandages. Multiple applicators can be selected to operate simultaneously at different treatment dosage levels and are connected to the generator by multi-conductor cables and are readily located directly on the treatment area. Each applicator is a pad including etched printed circuits. The circuits are matched and pre-tuned.",REGENESIS BIOMEDICAL INC,GEORGE FRANK R;;LOYA ARTHUR A;;RITZ MARY C;;BRYANT ROBERT T,,https://lens.org/089-889-168-187-373,Granted Patent,no,0,0,18,18,0,A61N1/326;;A61N1/40;;A61N1/40;;A61N1/326,A61N1/40,,0,0,,,,EXPIRED
833,KR,A,KR 20230158134 A,159-180-455-998-16X,2023-11-17,2023,KR 20237038415 A,2015-10-08,GB 201418186 A;;GB 201418989 A;;GB 201418986 A;;GB 201418984 A;;GB 201509037 A;;KR 20177008924 A;;GB 2015052952 W,2014-10-14,PEG PROCESS FOR THE CONJUGATION OF A PEPTIDE OR PROTEIN WITH A REAGENT COMPRISING A LEAVING GROUP INCLUDING A PORTION OF PEG,"본 발명은 펩타이드 또는 단백질에 존재하는 적어도 하나의 친핵체와 반응할 수 있는 신규 컨쥬게이트(접합) 형성 시약에 관한 것으로, 상기 친핵체와의 반응시 손실되는 하나 이상의 이탈기를 포함하며, 여기서 이탈기는 -(CH2CH2O)n- 부분을 포함하고(여기서 n은 6 이상의 수), 또한 본 발명은 상기 시약을 사용하여 제조된 펩티드 또는 단백질을 함유하는 접합체의 신규 제조방법에 관한 것이다.",POLYTHERICS LTD,GODWIN ANTONY;;BADESCU GEORGE;;BIRD MATTHEW;;BRYANT PENNY;;MORRIS DAVID;;FRIGERIO MARK,,https://lens.org/159-180-455-998-16X,Patent Application,no,9,0,13,40,0,C07K1/107;;C07K1/107;;A61K47/6889;;A61K47/6835;;A61K47/6803;;A61K47/6889;;A61K47/6803;;A61K47/6835;;C07K1/107;;C07K1/107;;A61K47/6835;;A61K47/6889;;A61K47/6803;;A61K47/56;;A61K47/00;;C07K1/00,A61K47/68;;C07K1/107,,2,1,070-423-803-841-924,24853662;;10.1039/c4cc02107j,"Liberatore et al, Bioconj. Chem 1990, 1, 36-50, and del Rosario et al, Bioconj. Chem. 1990, 1, 51-59;;Marculescu et al, Chem. Commun. 2014, 50, 7139-7142",PENDING
834,DE,T2,DE 69332735 T2,062-938-122-760-70X,2003-10-23,2003,DE 69332735 T,1993-12-22,US 99522292 A,1992-12-22,Verwendung von Benzothiophene zur Behandlung von Hypercholesterolämie,,LILLY CO ELI,BLACK LARRY JOHN;;BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH;;KAUFFMAN RAYMOND FRANCIS,,https://lens.org/062-938-122-760-70X,Granted Patent,no,0,0,47,47,0,A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;A61K31/4535;;A61K31/4025;;A61K31/55;;A61K2300/00;;A61K31/4535;;A61K31/40;;A61K31/55;;A61K31/445;;A61K31/4025,A61K31/385;;A61K31/365;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4453;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;C07D333/56,,0,0,,,,EXPIRED
835,US,B1,US 6353763 B1,109-064-578-679-570,2002-03-05,2002,US 60432800 A,2000-06-27,US 60432800 A;;US 23179099 A;;US 7139698 P,1998-01-15,Pulsed electromagnetic energy treatment apparatus and method,"
    A method of and apparatus for the treatment of chronic wounds using pulsed electromagnetic energy provides a constant, known and replicable dosage output which remains unaffected by the capacitance of the patient's body. The apparatus is simple to operate, requiring little operator training or interaction with the apparatus. All specifications of the apparatus relating to the generation and emission of electromagnetic energy are fixed, with the specifications based on actual scientific studies of the various technical parameters involved, such as pulse width and RF dosage. The apparatus includes a pulsed electromagnetic energy generator, a power level controller and one or more thin applicators which can be flexible. The applicators are located immediately adjacent to the patient's body, without the aid of a support member or removal of any dressings or bandages. The generator, which can be battery-operated, is a low power, programmable compact unit whose output is controlled by multiple control circuits for ensuring accurate treatment dosage, for confirming that the treatment was properly administered, and for disabling the generator when appropriate. The generator output is automatically adjusted in response to instructions from the field strength sensor located on or near the applicator. Multiple applicators selected to operate simultaneously at different treatment dosage levels are connected to the generator by multi-conductor cables and readily located directly on the treatment area. Each applicator is a pad including etched printed circuits. The circuits are matched and pre-tuned. An applicator-to-patient proximity detector is also incorporated in or on each applicator and connected to the generator via a power controller to provide for direct monitoring of the treatment site and precise control of treatment dosage. 
",REGENESIS BIOMEDICAL INC,GEORGE FRANK R;;LOYA ARTHUR A;;RITZ MARY C;;BRYANT ROBERT T,AMETHYST TECHNOLOGIES INC (1999-01-12);;REGENESIS BIOMEDICAL INC (2001-01-01),https://lens.org/109-064-578-679-570,Granted Patent,yes,96,135,18,18,0,A61N1/326;;A61N1/40;;A61N1/40;;A61N1/326,A61N1/40,607/50;;128/898;;607/154,4,3,042-456-106-694-135;;027-280-896-493-097;;147-597-603-749-287,10.1016/0007-1226(81)90006-0;;7023583;;7598479;;10.1146/annurev.med.46.1.467;;7546114,"J.H. Goldin et al, ""The effects of Diapulse on the healing wounds: a double-blind randomised controlled trial in man"", Journal of Plastic Surgery, 1981, 34, pp. 267-270.;;Christopher J. Schaffer et al, ""Cell Biology of Wound Healing"", pp. 151-181, Vanderbilt University School of Medicine, Plastic Surgery Research Laboratories, International Review of Cytology, vol. 169, 1996.;;Glenn F. Pierce et al, ""Pharmacologic Enhancement of Wound Healing"", Annu. Rev. Med. 1995, 46:467-81, 1995.;;CA Salzberg et al, The effects of non-thermal pulsed electromagnetic energy on wound healing of pressure ulcers in spinal cord-injured patients: a randomized, double-blind study, Ostomy Wound Management, 41(3): 42-4, 46, 48 passim, 1995 Abstract only.",EXPIRED
836,US,B2,US 7024239 B2,159-388-369-640-308,2006-04-04,2006,US 99459801 A,2001-11-20,US 99459801 A;;US 23179099 A;;US 7139698 P,1998-01-15,Pulsed electromagnetic energy treatment apparatus and method,An apparatus and method for the treatment of chronic wounds using electromagnetic energy. The apparatus includes a generator and at least one applicator. The generator can produce electromagnetic energy and the applicator can apply the electromagnetic energy produced by the generator. A detector is disposed on the applicator that can measure the field strength of the electromagnetic energy applied.,REGENESIS BIOMEDICAL INC,GEORGE FRANK R;;LOYA ARTHUR A;;RITZ MARY C;;BRYANT ROBERT T,AMETHYST TECHNOLOGIES INC (1999-01-12);;REGENESIS BIOMEDICAL INC (2001-01-01),https://lens.org/159-388-369-640-308,Granted Patent,yes,100,48,18,18,0,A61N1/326;;A61N1/40;;A61N1/40;;A61N1/326,A61N1/06;;A61N1/40,607/2;;607/50;;607/154;;607/155,4,3,042-456-106-694-135;;027-280-896-493-097;;147-597-603-749-287,10.1016/0007-1226(81)90006-0;;7023583;;7598479;;10.1146/annurev.med.46.1.467;;7546114,"J.H. Goldin et al, ""The effects of Diapulse on the healing wounds: a double-blind randomised controlled trial in man"", Journal of Plastic Surgery, 1981, 34, pp. 267-270.;;Christopher J. Schaffer et al, ""Cell Biology of Wound Healing"", pp. 151-181, Vanderbilt University School of Medicine, Plastic Surgery Research Laboratories, International Review of Cytology, vol. 169, 1996.;;Glenn F. Pierce et al, ""Pharmacologic Enhancement of Wound Healing"", Annu. Rev. Med. 1995, 46:467-81, 1995.;;CA Salzberg et al, The effects of non-thermal pulsed electromagnetic energy on wound healing of pressure ulcers in spinal cord-injured patients: a randomized, double-blind study, Ostomy Wound Management, 41(3): 42-4, 46, 48 passim, 1995 Abstract only.",EXPIRED
837,SK,A3,SK 142193 A3,013-197-340-225-999,1995-01-12,1995,SK 142193 A,1993-12-15,US 99522292 A,1992-12-22,PHARMACEUTICAL AGENT FOR LOWERING OF CHOLESTEROL LEVEL IN ANIMAL SERUM,,LILLY CO ELI,BLACK LARRY J;;BRYANT HENRY U;;CULLINAN GEORGE J;;KAUFFMAN RAYMOND F,,https://lens.org/013-197-340-225-999,Patent Application,no,0,0,47,47,0,A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;A61K31/4535;;A61K31/4025;;A61K31/55;;A61K2300/00;;A61K31/4535;;A61K31/40;;A61K31/55;;A61K31/445;;A61K31/4025,A61K31/365;;A61K31/385;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4453;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;C07D333/56,,0,0,,,,EXPIRED
838,US,A1,US 2022/0063294 A1,137-505-139-689-52X,2022-03-03,2022,US 202017007848 A,2020-08-31,US 202017007848 A,2020-08-31,LINER-LESS LABEL PRINTER SYSTEM AND METHOD,A pre-feed system and method for a liner-less label printer includes a drive roll that is configured to peel liner-less labels from a reel and pass the labels to an in-line label printer at a consistent rate. An idler roll disposed in proximity to the drive roll creates a nip for pulling labels from the reel. The idler roll is comprised of silicone which prevents the adhesive side of the liner-less label from sticking. A print controller monitors a non-contact reflective object sensor disposed in proximity to the path of the liner-less labels between the drive roll and the in-line printer. The print controller adjusts the speed of the drive roll to maintain a consistent rate for labels entering the print feed of the in-line label printer and reduces the amount of force required to feed labels into the printer.,TOSHIBA TEC KK,CONNORS WILLIAM M;;BRYANT DONN D;;LAWRENCE MICHAEL W;;WOOLCOTT GEORGE N,TOSHIBA TEC KABUSHIKI KAISHA (2020-08-19),https://lens.org/137-505-139-689-52X,Patent Application,yes,4,0,1,1,0,B41J3/4075;;B41J15/005;;B65H2511/112;;B65H20/02;;B65H2513/11;;B65H23/185;;B65H2701/194;;B41J3/4075;;B41J11/0095;;B41J13/02;;B65C9/46;;B65H2401/10;;B65C9/42;;B65H5/062;;B65H7/14;;B65C9/1892,B41J3/407;;B41J11/00;;B41J13/02;;B65C9/18;;B65C9/42;;B65C9/46;;B65H5/06;;B65H7/14,,0,0,,,,DISCONTINUED
839,NO,D0,NO 943317 D0,152-172-046-917-651,1994-09-08,1994,NO 943317 A,1994-09-08,US 11890593 A,1993-09-09,Innmating for lagring og slimhinneadministrering av biologiske og farmasöytiske materialer til pattedyr,,MILES INC,SHIBLEY GEORGE P;;BROWN KAREN K;;CHOROMANSKI LESZEK J;;BRYANT SHARON A,,https://lens.org/152-172-046-917-651,Patent Application,no,0,0,10,10,0,A61D7/00;;A61D7/00,A61M31/00;;A61D7/00,,0,0,,,,PENDING
840,US,S,US D0690601 S,188-225-317-665-998,2013-10-01,2013,US 201229413696 F,2012-02-17,US 201229413696 F;;US 201129385898 F;;US 201129385902 F,2011-02-22,Container,,BRYANT MICHAEL PATRICK;;MCMAHON MICHAEL D;;NUKUTO GEORGE I;;ZIMMER JONATHAN H;;H J HEINZ,BRYANT MICHAEL PATRICK;;MCMAHON MICHAEL D;;NUKUTO GEORGE I;;ZIMMER JONATHAN H,H.J. HEINZ COMPANY (2012-02-13);;H.J. HEINZ COMPANY BRANDS LLC (2015-06-30),https://lens.org/188-225-317-665-998,Design Right,no,0,4,1,8,0,,,0901;;D 9542;;D9/563;;D9/569;;D9/571;;D9/574,0,0,,,,ACTIVE
841,AU,A,AU 1999/022295 A,063-270-400-270-807,1999-08-02,1999,AU 1999/022295 A,1999-01-15,US 7139698 P;;US 9900864 W,1998-01-15,Improved pulsed electromagnetic energy treatment apparatus and method,"An apparatus for treatment of wounds using pulsed electromagnetic energy provides a constant, known and replicable dosage output which remains unaffected by the capacitance of the patient's body. The apparatus includes: a pulsed electromagnetic energy generator, one or more applicators, which may be flexible, adapted to be positioned proximate a wound and external of a patient's body, and a circuit means having a fixed capacitance. The applicators are located immediately adjacent to the patient's body, without the aid of a support member or removal of any dressings or bandages. Multiple applicators can be selected to operate simultaneously at different treatment dosage levels and are connected to the generator by multi-conductor cables and are readily located directly on the treatment area. Each applicator is a pad including etched printed circuits. The circuits are matched and pre-tuned.",AMETHYST TECHNOLOGIES INC,GEORGE FRANK R;;LOYA ARTHUR A;;RITZ MARY C;;BRYANT ROBERT T,,https://lens.org/063-270-400-270-807,Patent Application,no,0,0,18,18,0,A61N1/326;;A61N1/40;;A61N1/40;;A61N1/326,A61N1/40,,0,0,,,,DISCONTINUED
842,HU,A,HU T69686 A,119-545-555-462-686,1995-09-28,1995,HU 9303676 A,1993-12-20,US 99522292 A,1992-12-22,PROCESS FOR PREPARING PHARMACEUTICAL COMPOSITIONS HAVING SERUM CHOLESTEROL LOWERING EFFECT,,LILLY CO ELI,CULLINAN GEORGE JOSEPH;;BRYANT HENRY UHLMAN;;KAUFFMAN RAYMOND FRANCIS;;BLACK LARRY JOHN,,https://lens.org/119-545-555-462-686,Unknown,no,0,0,47,47,0,A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;A61K31/4535;;A61K31/4025;;A61K31/55;;A61K2300/00;;A61K31/4535;;A61K31/40;;A61K31/55;;A61K31/445;;A61K31/4025,A61K31/385;;A61K31/365;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4453;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;C07D333/56,,0,0,,,,EXPIRED
843,YU,B,YU 48918 B,113-934-241-509-657,2002-11-15,2002,YU 79893 A,1993-12-20,US 99522292 A,1992-12-22,PHARMACEUTICAL FORMULATION ON THE BASIS OF BENZOTHIOPHENE,"Farmaceutska formulacija na bazi bezotiofena, za snižavanje holesterola kod čoveka, naznač ena time, što sadrži ekscipijent, razblaživač ili nosač i jedinjenje formule (I) u kojoj n predstavlja 0, 1 ili 2, R je hidroksil, metoksi, C1-C7 alkanoiloksi, C3-C7 cikloalkanoiloksi, (C1-C6 alkoksi)-C1-C7 alkanoiloksi, supstituisan ili nesupstituisan aroiloksi ili supstituisan ili nesupstituisan ariloksikarboniloksi, R1 je vodonik, hidroksil, halo, metoksi, C1-C7 alkanoiloksi, C3-C7 cikloalkanoiloksi, (C1-C6alkoksi)-C1-C7-alkanoiloksi, supstituisan ili nesupstituisan aroiloksi ili supstituisan ili nesupstituisan ariloksikarboniloksi, R2 je heterociklični prsten odabran iz grupe koju sačinjavaju pirolidino, piperidino ili heksametilenimino, ili farmaceutski prihvatljive soli ili solvete tog jedinjenja i po potrebi estrogen.",LILLY CO ELI,JOHN BLACK LARRY;;UHLMAN BRYANT HENRY;;JOSEPH CULLINAN GEORGE;;FRANCIS KAUFFMAN RAYMOND,,https://lens.org/113-934-241-509-657,Granted Patent,no,0,0,47,47,0,A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;A61K31/4535;;A61K31/4025;;A61K31/55;;A61K2300/00;;A61K31/4535;;A61K31/40;;A61K31/55;;A61K31/445;;A61K31/4025,A61K31/385;;A61K31/365;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4453;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;C07D333/56,,0,0,,,,EXPIRED
844,WO,A2,WO 2008/008196 A2,122-583-886-039-327,2008-01-17,2008,US 2007/0015064 W,2007-06-28,US 48292006 A,2006-07-07,METHODS AND APPARATUS FOR PROVIDING OPTIMAL IDENTIFICATION AND PROCESSING OF LAYER 3 CONTROL CHANNELS,"A method for processing token identifiers for Layer 3 (L3) control channels when encapsulated in a tunneling protocol. Rather than encapsulating an L3 control channel with a secondary L3 (or Layer 4 'L4') header, a generic (non-Layer 3 header) identifier, or token identifier, is used to encapsulate the control channel. For example, the token identifier may be a simple bit pattern that does not require a complex, confusing or redundant IP/UDP routing table lookup. Instead, the token identifier simply alerts the forwarding entity that local processing of the packet's data is required (e.g., that the packet contains control channel data).",CISCO TECH INC;;NADEAU THOMAS D;;BRYANT STEWART F;;BARBER SIMON;;WARD DAVID;;SWALLOW GEORGE,NADEAU THOMAS D;;BRYANT STEWART F;;BARBER SIMON;;WARD DAVID;;SWALLOW GEORGE,,https://lens.org/122-583-886-039-327,Patent Application,yes,1,0,6,6,0,H04L69/22;;H04L69/22;;H04L69/325;;H04L69/325;;H04W80/04;;H04W80/04,H04L12/56,,1,0,,,See also references of EP 2038757A4,PENDING
845,SG,A,SG 11201701384X A,151-623-407-945-556,2017-03-30,2017,SG 11201701384X A,2015-10-08,GB 201418186 A;;GB 201418989 A;;GB 201418986 A;;GB 201418984 A;;GB 201509037 A;;GB 2015052952 W,2014-10-14,PROCESS FOR THE CONJUGATION OF A PEPTIDE OR PROTEIN WITH A REAGENT COMPRISING A LEAVING GROUP INCLUDING A PORTION OF PEG,,POLYTHERICS LTD,GODWIN ANTONY;;BADESCU GEORGE;;BIRD MATTHEW;;BRYANT PENNY;;MORRIS DAVID;;FRIGERIO MARK,,https://lens.org/151-623-407-945-556,Unknown,no,0,0,13,40,0,C07K1/107;;C07K1/107;;A61K47/6889;;A61K47/6835;;A61K47/6803;;A61K47/6889;;A61K47/6803;;A61K47/6835;;C07K1/107;;C07K1/107;;A61K47/6835;;A61K47/6889;;A61K47/6803;;A61K47/56;;A61K47/00;;C07K1/00,C07K1/107,,0,0,,,,PENDING
846,CA,A,CA 719929 A,010-841-926-479-510,1965-10-19,1965,CA 719929D A,,CA 719929T A,,OIL PRODUCTION METHOD,,SHELL OIL CO,BRADLEY BRYANT W;;HOLLIDAY GEORGE H;;PRYOR JOHN A;;WALLACE EUGENE W,,https://lens.org/010-841-926-479-510,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
847,KR,A,KR 20170071485 A,026-991-472-171-304,2017-06-23,2017,KR 20177008924 A,2015-10-08,GB 201418186 A;;GB 201418989 A;;GB 201418986 A;;GB 201418984 A;;GB 201509037 A;;GB 2015052952 W,2014-10-14,PEG PROCESS FOR THE CONJUGATION OF A PEPTIDE OR PROTEIN WITH A REAGENT COMPRISING A LEAVING GROUP INCLUDING A PORTION OF PEG,"본 발명은 펩타이드 또는 단백질에 존재하는 적어도 하나의 친핵체와 반응할 수 있는 신규 컨쥬게이트(접합) 형성 시약에 관한 것으로, 상기 친핵체와의 반응시 손실되는 하나 이상의 이탈기를 포함하며, 여기서 이탈기는 -(CHCHO)- 부분을 포함하고(여기서 n은 6 이상의 수), 또한 본 발명은 상기 시약을 사용하여 제조된 펩티드 또는 단백질을 함유하는 접합체의 신규 제조방법에 관한 것이다.",POLYTHERICS LTD,GODWIN ANTONY;;BADESCU GEORGE;;BIRD MATTHEW;;BRYANT PENNY;;MORRIS DAVID;;FRIGERIO MARK,,https://lens.org/026-991-472-171-304,Patent Application,no,0,0,13,40,0,C07K1/107;;C07K1/107;;A61K47/6889;;A61K47/6835;;A61K47/6803;;A61K47/6889;;A61K47/6803;;A61K47/6835;;C07K1/107;;C07K1/107;;A61K47/6835;;A61K47/6889;;A61K47/6803;;A61K47/56;;A61K47/00;;C07K1/00,A61K47/50;;C07K1/107,,0,0,,,,DISCONTINUED
848,US,B2,US 11724130 B2,055-534-243-419-802,2023-08-15,2023,US 201414900000 A,2014-06-24,US 201414900000 A;;US 201361838773 P;;US 201361838811 P;;US 2014/0043953 W,2013-06-24,Wearable ultrasound device,"A wearable ultrasound device and method of using the device includes a power controller with a power source and at least one integrated circuit that delivers electrical power to an applicator. The applicator is electrically coupled to the power controller and a surface of the applicator transmits ultrasound to a wearer for a given duration. The applicator includes radio frequency (RF) drive electronics, an ultrasound transducer coupled to the drive electronics, a monitoring apparatus that includes a thermal cutoff coupled to the drive electronics, where the monitoring apparatus monitors a temperature of the applicator surface and the thermal cutoff turns off the applicator, if the temperature exceeds a pre-defined threshold, and a coupling bandage coupled to the applicator, where the bandage positions the surface of the applicator proximate to a wearer at a location on the body of a wearer.",ZETROZ INC;;ZETROZ SYSTEMS LLC,LEWIS JR GEORGE K;;GUFFEY BRYANT;;GUARINO JOANNE;;FLESHMAN SHANE;;LANGER MATTHEW,ZETROZ INC (2014-03-26);;ZETROZ SYSTEMS LLC (2016-01-29),https://lens.org/055-534-243-419-802,Granted Patent,yes,15,0,7,7,0,A61B2017/00106;;A61B2017/2253;;A61N2007/0073;;A61N2007/0078;;A61H2201/0184;;A61H23/0245;;A61H2201/0176;;A61H2201/5015;;A61H2201/5043;;A61H2201/5058;;A61H2201/5097;;A61H2230/207;;A61H2230/25;;A61H2230/505;;A61B2018/00791;;A61N2007/006;;A61N7/00;;A61N2007/0073;;A61N2007/0078;;A61B2017/00106;;A61B2017/2253;;A61H2201/5097;;A61H2230/207;;A61H2201/0184;;A61H2230/505;;A61H2201/5015;;A61H2201/5043;;A61H2201/5058;;A61H23/0245;;A61H2201/0176;;A61H2230/25;;A61B2018/00791;;A61N2007/006;;A61N7/00,A61N7/00;;A61B17/00;;A61B17/225;;A61B18/00;;A61H23/02,,2,0,,,"European Patent Office, Supplementary European Search Report, issued in European Patent Application No. 14818371, dated Jan. 26, 2017.;;ISA/KR International Search Report, issued in PCT/US2014/043953, dated Oct. 14, 2014.",ACTIVE
849,HU,D0,HU 9303676 D0,053-702-342-590-258,1994-04-28,1994,HU 9303676 A,1993-12-20,US 99522292 A,1992-12-22,IMPROVEMENTS IN OR RELATING TO BENZOTHIOPHENES,,LILLY CO ELI,BLACK LARRY JOHN;;BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH;;KAUFFMAN RAYMOND FRANCIS,,https://lens.org/053-702-342-590-258,Patent Application,no,0,0,47,47,0,A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;A61K31/4535;;A61K31/4025;;A61K31/55;;A61K2300/00;;A61K31/4535;;A61K31/40;;A61K31/55;;A61K31/445;;A61K31/4025,A61K31/385;;A61K31/365;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4453;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;C07D333/56,,0,0,,,,EXPIRED
850,EP,B1,EP 0988091 B1,060-762-796-020-127,2009-10-21,2009,EP 99902275 A,1999-01-15,US 9900864 W;;US 7139698 P,1998-01-15,IMPROVED PULSED ELECTROMAGNETIC ENERGY TREATMENT APPARATUS,"An apparatus for treatment of wounds using pulsed electromagnetic energy provides a constant, known and replicable dosage output which remains unaffected by the capacitance of the patient's body. The apparatus includes: a pulsed electromagnetic energy generator, one or more applicators, which may be flexible, adapted to be positioned proximate a wound and external of a patient's body, and a circuit means having a fixed capacitance. The applicators are located immediately adjacent to the patient's body, without the aid of a support member or removal of any dressings or bandages. Multiple applicators can be selected to operate simultaneously at different treatment dosage levels and are connected to the generator by multi-conductor cables and are readily located directly on the treatment area. Each applicator is a pad including etched printed circuits. The circuits are matched and pre-tuned.",REGENESIS BIOMEDICAL INC,GEORGE FRANK R;;LOYA ARTHUR A;;RITZ MARY C;;BRYANT ROBERT T,"REGENESIS BIOMEDICAL, INC. (2002-01-09)",https://lens.org/060-762-796-020-127,Granted Patent,yes,4,1,18,18,0,A61N1/326;;A61N1/40;;A61N1/40;;A61N1/326,A61N1/40,,0,0,,,,EXPIRED
851,EP,A2,EP 0988091 A2,064-717-911-150-094,2000-03-29,2000,EP 99902275 A,1999-01-15,US 9900864 W;;US 7139698 P,1998-01-15,IMPROVED PULSED ELECTROMAGNETIC ENERGY TREATMENT APPARATUS,"An apparatus for treatment of wounds using pulsed electromagnetic energy provides a constant, known and replicable dosage output which remains unaffected by the capacitance of the patient's body. The apparatus includes: a pulsed electromagnetic energy generator, one or more applicators, which may be flexible, adapted to be positioned proximate a wound and external of a patient's body, and a circuit means having a fixed capacitance. The applicators are located immediately adjacent to the patient's body, without the aid of a support member or removal of any dressings or bandages. Multiple applicators can be selected to operate simultaneously at different treatment dosage levels and are connected to the generator by multi-conductor cables and are readily located directly on the treatment area. Each applicator is a pad including etched printed circuits. The circuits are matched and pre-tuned.",AMETHYST TECHNOLOGIES INC,GEORGE FRANK R;;LOYA ARTHUR A;;RITZ MARY C;;BRYANT ROBERT T,"REGENESIS BIOMEDICAL, INC. (2002-01-09)",https://lens.org/064-717-911-150-094,Patent Application,yes,0,0,18,18,0,A61N1/326;;A61N1/40;;A61N1/40;;A61N1/326,A61N1/40,,0,0,,,,EXPIRED
852,EP,A1,EP 3218009 A1,154-345-031-022-148,2017-09-20,2017,EP 15782050 A,2015-10-08,GB 201418186 A;;GB 201418989 A;;GB 201418986 A;;GB 201418984 A;;GB 201509037 A;;GB 2015052952 W,2014-10-14,PROCESS FOR THE CONJUGATION OF A PEPTIDE OR PROTEIN WITH A REAGENT COMPRISING A LEAVING GROUP INCLUDING A PORTION OF PEG,,POLYTHERICS LTD,GODWIN ANTONY;;BADESCU GEORGE;;BIRD MATTHEW;;BRYANT PENNY;;MORRIS DAVID;;FRIGERIO MARK,,https://lens.org/154-345-031-022-148,Patent Application,yes,0,0,13,40,0,C07K1/107;;C07K1/107;;A61K47/6889;;A61K47/6835;;A61K47/6803;;A61K47/6889;;A61K47/6803;;A61K47/6835;;C07K1/107;;C07K1/107;;A61K47/6835;;A61K47/6889;;A61K47/6803;;A61K47/56;;A61K47/00;;C07K1/00,A61K47/50;;C07K1/107,,0,0,,,,ACTIVE
853,US,A1,US 2022/0204205 A1,159-866-964-340-696,2022-06-30,2022,US 202117552053 A,2021-12-15,US 202117552053 A;;US 202063125543 P;;US 202163239944 P,2020-12-15,LINER-LESS LABEL PRE-FEED SYSTEM,"A system and method for feeding a ribbon of un-lined label stock to a printer includes first and second, abutting rollers that cooperatively remove label stock from a roll. An optical sensor is disposed in a ribbon path between the rollers and the printer. The optical sensor determines a slackness level of the ribbon between rollers and the printer. Speed of a drive roller drive motor is increased when the slackness level is below a prescribed threshold. Speed of the drive roller motor is decreased when the slackness level is above a prescribed threshold.",TOSHIBA AMERICA BUSINESS SOLUTIONS INC,CONNORS WILLIAM M;;BRYANT DONN D;;LAWRENCE MICHAEL W;;WOOLCOTT GEORGE N,,https://lens.org/159-866-964-340-696,Patent Application,yes,14,1,3,3,0,B65C9/18;;B65C11/02;;B41J13/076;;B65H5/06;;B65H3/0638;;B65H3/06;;B65H2404/182;;B65H2404/19;;B65H2801/75;;B65H2701/1722;;B65H2701/192;;B65H27/00;;B65C9/183;;B65H2404/14;;B65H2404/11;;B65H2701/192;;B41J15/04;;B41J15/16;;B65C9/18;;B65C9/42,B65C9/42;;B41J15/04;;B41J15/16;;B65C9/18,,0,0,,,,DISCONTINUED
854,CZ,B6,CZ 283863 B6,196-931-663-370-090,1998-06-17,1998,CZ 279093 A,1993-12-16,US 99522292 A,1992-12-22,USE OF BENZOTHIOPHENE DERIVATIVE FOR PREPARING PHARMACEUTICAL PREPARATION DECREASING CHOLESTEROL IN HUMANS,"Farmaceutický prostředek pro hladiny cholesterolu v seru živočichů obsahuje jako účinnou látku sloučeninu obecného vzorce I, kde znamená n 0, 1 nebo 2, R OH, methoxy, C.sub.1-7.n.alkanoyloxy, C.sub.3-7.n.cykloalkanoyloxy, (C.sub.1-6.n.alkoxy)-C.sub.1-7.n.alkanoyloxy, popřípadě substituovaný aroyloxy nebo popřípadě substituovaný aryloxykarbonyloxy, R.sup.1 .n.H, OH, halogen, methoxy, C.sub.1-7.n.alkanoyloxy, C.sub.3-7.n.cyklo- alkanoyloxy, (C.sub.1-6.n.alkoxy)-C.sub.1-7.n.alkanoyloxy, popřípadě substituovaný aroyloxy nebo popřípadě substituovaný aryloxykarbonyloxy, R.sup.2 .sup..n.heterocyklickou skupinu ze souboru pyrrolidino, piperidino a hexamethylenimino, nebo její vhodnou sůl nebo solvát.ŕ",LILLY CO ELI,BLACK LARRY JOHN;;BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH;;KAUFFMAN RAYMOND FRANCIS,,https://lens.org/196-931-663-370-090,Granted Patent,no,0,0,47,47,0,A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;A61K31/4535;;A61K31/4025;;A61K31/55;;A61K2300/00;;A61K31/4535;;A61K31/40;;A61K31/55;;A61K31/445;;A61K31/4025,A61K31/385;;A61K31/365;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4453;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;C07D333/56,,0,0,,,,EXPIRED
855,US,B2,US 10835616 B2,078-167-643-021-804,2020-11-17,2020,US 201515517971 A,2015-10-08,GB 201418186 A;;GB 201418984 A;;GB 201418986 A;;GB 201418989 A;;GB 201509037 A;;GB 2015052952 W,2014-10-14,Process for the conjugation of a peptide or protein with a reagent comprising a leaving group including a portion of PEG,"The invention relates to novel conjugating reagents capable of reaction with at least one nucleophile present in a peptide or protein, which contain at least one leaving group which is lost on reaction with said nucleophile, in which the leaving group includes a portion —(CH 2 CH 2 O) n —, in which n is a number of six or more; and novel processes for the preparation of conjugates containing peptides or proteins made using such reagents.",POLYTHERICS LTD,GODWIN ANTONY;;BADESCU GEORGE;;BIRD MATTHEW;;BRYANT PENNY;;MORRIS DAVID;;FRIGERIO MARK,ABZENA (UK) LIMITED (2017-03-10),https://lens.org/078-167-643-021-804,Granted Patent,yes,29,0,13,40,0,C07K1/107;;C07K1/107;;A61K47/6889;;A61K47/6835;;A61K47/6803;;A61K47/6889;;A61K47/6803;;A61K47/6835;;C07K1/107;;C07K1/107;;A61K47/6835;;A61K47/6889;;A61K47/6803;;A61K47/56;;A61K47/00;;C07K1/00,A61K47/68;;A61K47/00;;A61K47/56;;C07K1/00;;C07K1/10;;C07K1/107,,16,13,142-657-154-789-717;;100-801-934-296-913;;139-399-324-818-879;;033-769-778-688-716;;038-336-928-144-406;;019-168-577-486-180;;008-725-589-356-535;;049-335-323-208-627;;019-531-600-990-611;;082-815-240-679-465;;070-423-803-841-924;;077-153-238-850-285;;146-894-480-964-183,16151407;;10.1038/nbt1141;;18234994;;10.1167/iovs.07-1175;;22387378;;10.1016/j.abb.2012.02.011;;25455482;;10.1016/j.bmcl.2014.10.021;;22994419;;10.1021/bc300372r;;10.1021/bc0601471;;17226958;;9556758;;10.1163/156856298x00613;;2128870;;10.1021/bc00001a006;;20023829;;10.1039/b915036f;;10.1021/bc00001a005;;2095204;;24853662;;10.1039/c4cc02107j;;21271715;;10.1021/bc1004685;;pmc3039925;;pmc2842020;;20092331;;10.1021/ja908610s,"Wu et al (Nature Biotechnology 23(9): 1137-1146, Sep. 2005).;;Yu et al (Investigative Ophthalmology & Visual Science 49(2): 522-527, Feb. 2008).;;Golay et al (Archives of Biochemistry and Biophysics 526: 146-153, 2012).;;Bouchard et al (Bioorganic and Medicinal Chemistry Letters 24: 5357-5363, 2014).;;Khalili et al. (Bioconjugate Chem. 2012, 23, p. 2262-2277).;;Balan et al. (Bioconjugate Chem. 2007, 18, p. 61-76).;;International Search Report and Written Opinion issued in corresponding International Patent Application No. PCT/GB2015/052952 dated Jan. 7, 2016 (14 pages).;;Belcheva et al., “Synthesis and characterization of polymer-(multi)-peptide conjugates for control of specific cell aggregation,” J. Biomater. Sci. Polymer Edn., 1998, vol. 9, No. 3, pp. 207-226.;;Del Rosario et al., “Sulfhydryl Site-Specific Cross-Linking and Labeling of Monoclonal Antibodies by a Fluorescent Equilibrium Transfer Alkylation Cross-Link Reagent,” Bioconjugate Chemistry, 1990, vol. 1, No. 1, pp. 51-59.;;Krakert et al., “Adjustment of the bioresistivity by electron irradiation: self-assembled monolayers of oligo(ethyleneglycol)-terminated alkanethiols with embedded cleavable group,” Physical Chemistry Chemical Physics, 2010, vol. 12, No. 2, pp. 507-515.;;Liberatore et al., “Site-Directed Chemical Modification and Cross-Linking of a Monoclonal Antibody Using Equilibrium Transfer Alkylating Cross-Link Reagents,” Bioconjugate Chemistry, 1990, vol. 1, No. 1, pp. 36-50, (12 pages).;;Lyon, R.P., Seattle Genetics, “Novel ADC Chemistry for Improved Stability and Pharmacokinetics,” Presentation (slide set believed to have been presented at Cambridge Healthtech Institute's 4th Annual Characterization of Biotherapeutics, on May 5, 2014), 25 pages.;;Marculescu et al., “Aryloxymaleimides for cysteine modification, disulfide bridging and the dual functionalization of disulfide bonds,” Chemical Communications, 2014, vol. 50, No. 54, pp. 7139-7142.;;Schumacher et al., “In Situ Maleimide Bridging of Disulfides and a New Approach to Protein PEGylation,” Bioconjugate Chemistry, 2011, vol. 22, pp. 132-136.;;Smith et al., “Protein Modification, Bioconjugation, and Disulfide Bridging Using Bromomaleimides,” J. Am. Chem. Soc., 2010, vol. 132, No. 6, pp. 1960-1965.;;Marculescu, “Development of Novel Maleimide Reagents for Protein Modification,” University College London, Aug. 2014, pp. 1-262.",ACTIVE
856,CA,A1,CA 2129307 A1,100-671-793-551-905,1995-03-10,1995,CA 2129307 A,1994-08-02,US 11890593 A,1993-09-09,DEVICE FOR STORAGE AND MUCOSAL DELIVERY OF BIOLOGICAL OR PHARMACEUTICAL MATERIALS TO ANIMALS,A DEVICE FOR STORAGE AND MUCOSAL DELIVERY OF BIOLOGICAL OR PHARMACEUTICAL MATERIALS TO ANIMALS Disclosed herein is a device for storing and/or delivering an effective amount of biological or pharmaceutical material to an animal comprising a tube disposed to contain said biological or pharmaceutical material and sealed at its ends and adapted to provide an opening through which the biological or pharmaceutical material exits and is administered to an intended site of the animal.,MILES INC,SHIBLEY GEORGE P;;BROWN KAREN K;;CHOROMANSKI LESZEK J;;BRYANT SHARON A,,https://lens.org/100-671-793-551-905,Patent Application,no,0,0,10,10,0,A61D7/00;;A61D7/00,A61M31/00;;A61D7/00,,0,0,,,,DISCONTINUED
857,EP,B1,EP 3013420 B1,140-353-058-146-396,2021-09-15,2021,EP 14818371 A,2014-06-24,US 201361838773 P;;US 201361838811 P;;US 2014/0043953 W,2013-06-24,WEARABLE ULTRASOUND DEVICE,,ZETROZ SYSTEMS LLC,LEWIS JR GEORGE K;;GUFFEY BRYANT;;GUARINO JOANNE;;FLESHMAN SHANE;;LANGER MATTHEW,"ZETROZ SYSTEMS, LLC (2016-12-21)",https://lens.org/140-353-058-146-396,Granted Patent,yes,13,0,7,7,0,A61B2017/00106;;A61B2017/2253;;A61N2007/0073;;A61N2007/0078;;A61H2201/0184;;A61H23/0245;;A61H2201/0176;;A61H2201/5015;;A61H2201/5043;;A61H2201/5058;;A61H2201/5097;;A61H2230/207;;A61H2230/25;;A61H2230/505;;A61B2018/00791;;A61N2007/006;;A61N7/00;;A61N2007/0073;;A61N2007/0078;;A61B2017/00106;;A61B2017/2253;;A61H2201/5097;;A61H2230/207;;A61H2201/0184;;A61H2230/505;;A61H2201/5015;;A61H2201/5043;;A61H2201/5058;;A61H23/0245;;A61H2201/0176;;A61H2230/25;;A61B2018/00791;;A61N2007/006;;A61N7/00,A61N7/00;;A61B17/225;;A61H23/02,,0,0,,,,ACTIVE
858,WO,A3,WO 2008/008196 A3,191-528-873-775-529,2008-03-27,2008,US 2007/0015064 W,2007-06-28,US 48292006 A,2006-07-07,METHODS AND APPARATUS FOR PROVIDING OPTIMAL IDENTIFICATION AND PROCESSING OF LAYER 3 CONTROL CHANNELS,"A method for processing token identifiers for Layer 3 (L3) control channels when encapsulated in a tunneling protocol. Rather than encapsulating an L3 control channel with a secondary L3 (or Layer 4 'L4') header, a generic (non-Layer 3 header) identifier, or token identifier, is used to encapsulate the control channel. For example, the token identifier may be a simple bit pattern that does not require a complex, confusing or redundant IP/UDP routing table lookup. Instead, the token identifier simply alerts the forwarding entity that local processing of the packet's data is required (e.g., that the packet contains control channel data).",CISCO TECH INC;;NADEAU THOMAS D;;BRYANT STEWART F;;BARBER SIMON;;WARD DAVID;;SWALLOW GEORGE,NADEAU THOMAS D;;BRYANT STEWART F;;BARBER SIMON;;WARD DAVID;;SWALLOW GEORGE,,https://lens.org/191-528-873-775-529,Search Report,yes,5,0,6,6,0,H04L69/22;;H04L69/22;;H04L69/325;;H04L69/325;;H04W80/04;;H04W80/04,G06F15/16,,1,0,,,See also references of EP 2038757A4,PENDING
859,EP,A1,EP 0605193 A1,194-048-440-356-085,1994-07-06,1994,EP 93310438 A,1993-12-22,US 99522292 A,1992-12-22,Use of benzothiophenes for treatment of hypercholesterolaemia.,"Use of a compound of formula (I):
  
 wherein 
   n is 0, 1 or 2; 
   R is hydroxyl, methoxy, C₁-C₇ alkanoyloxy, C₃-C₇ cycloalkanoyloxy, (C₁-C₆ alkoxy)-C₁-C₇ alkanoyloxy, substituted or unsubstituted aroyloxy, or substituted or unsubstituted aryloxycarbonyloxy; 
   R¹ is hydrogen, hydroxyl, chloro, bromo, methoxy, C₁-C₇ alkanoyloxy, C₃-C₇ cycloalkanoyloxy, (C₁-C₆ alkoxy)-C₁-C₇ alkanoyloxy, substituted or unsubstituted or aroyloxy, or substituted or unsubstituted aryloxycarbonyloxy; 
   R² is a heterocyclic ring selected from the group consisting of pyrrolidino, piperidino, or hexamethyleneimino; or a pharmaceutically acceptable salt or solvate thereof; in the preparation of a medicament useful for lowering serum cholesterol levels in animals.",LILLY CO ELI,BLACK LARRY JOHN;;BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH;;KAUFFMAN RAYMOND FRANCIS,,https://lens.org/194-048-440-356-085,Patent Application,yes,0,68,47,47,0,A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;A61K31/4535;;A61K31/4025;;A61K31/55;;A61K2300/00;;A61K31/4535;;A61K31/40;;A61K31/55;;A61K31/445;;A61K31/4025,A61K31/385;;A61K31/365;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4453;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;C07D333/56,,3,3,007-023-645-974-416;;121-762-194-117-598;;085-699-952-213-894,8282823;;10.1172/jci116985;;pmc293730;;10.1016/s0005-2728(88)80077-x;;3191162;;10.1016/0167-4889(88)90115-2;;3342088;;10.1016/0006-2952(88)90735-6,"BLACK, L.J. ET AL: ""RALOXIFENE (LY139481) PREVENTS BONE LOSS AND REDUCES SERUM CHOLESTEROL WITHOUT CAUSING UTERINE HYPERTROPHY IN OVARECTOMIZED RATS"", THE JOURNAL OF CLINICAL INVESTIGATION, vol. 93, no. 1, January 1994 (1994-01-01), pages 63 - 69;;CYPRIANI, B. ET AL: ""EFFECT OF ESTRADIOL AND ANTIESTROGENS ON CHOLESTEROL BIOSYNTHESIS IN HORMONE-DEPENDENT AND -INDEPENDENT BREAST CANCER CELL LINES"", BIOCHIMICA ET BIOPHYSICA ACTA, vol. 972, no. 2, 1988, pages 167 - 178, XP023578601, DOI: doi:10.1016/0167-4889(88)90115-2;;WEINSTEIN, I. ET AL: ""EFFECTS OF THE ANTIOESTROGEN LY 117018 ON THE MODULATION BY ESTRADIOL OF THE METABOLISM OF[1-14C]OLEIC ACID BY PERFUSED LIVERS FROM NORMAL AND OVARECTOMIZED RATS"", BIOCHEMICAL PHARMACOLOGY, vol. 37, no. 2, 1988, pages 319 - 326",EXPIRED
860,EP,A2,EP 1238667 A2,082-401-184-387-053,2002-09-11,2002,EP 02013421 A,1993-12-22,EP 93310438 A;;US 99522292 A,1992-12-22,Use of benzothiophenes for treatment of hypercholesterolaemia,Use of 2-phenyl-3-aroylbenzothiophens in the preparation of a medicament for lowering serum cholesterol levels.,LILLY CO ELI,BLACK LARRY JOHN;;BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH;;KAUFFMANN RAYJOND FRANCIS,,https://lens.org/082-401-184-387-053,Patent Application,yes,0,0,47,47,0,A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;A61K31/4535;;A61K31/4025;;A61K31/55;;A61K2300/00;;A61K31/4535;;A61K31/40;;A61K31/55;;A61K31/445;;A61K31/4025,A61K31/385;;A61K31/365;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4453;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;C07D333/56,,0,0,,,,DISCONTINUED
861,EP,A4,EP 3013420 A4,115-648-275-419-33X,2017-03-08,2017,EP 14818371 A,2014-06-24,US 201361838773 P;;US 201361838811 P;;US 2014/0043953 W,2013-06-24,WEARABLE ULTRASOUND DEVICE,,ZETROZ SYSTEMS LLC,LEWIS JR GEORGE K;;GUFFEY BRYANT;;GUARINO JOANNE;;FLESHMAN SHANE;;LANGER MATTHEW,"ZETROZ SYSTEMS, LLC (2016-12-21)",https://lens.org/115-648-275-419-33X,Search Report,no,6,0,7,7,0,A61B2017/00106;;A61B2017/2253;;A61N2007/0073;;A61N2007/0078;;A61H2201/0184;;A61H23/0245;;A61H2201/0176;;A61H2201/5015;;A61H2201/5043;;A61H2201/5058;;A61H2201/5097;;A61H2230/207;;A61H2230/25;;A61H2230/505;;A61B2018/00791;;A61N2007/006;;A61N7/00;;A61N2007/0073;;A61N2007/0078;;A61B2017/00106;;A61B2017/2253;;A61H2201/5097;;A61H2230/207;;A61H2201/0184;;A61H2230/505;;A61H2201/5015;;A61H2201/5043;;A61H2201/5058;;A61H23/0245;;A61H2201/0176;;A61H2230/25;;A61B2018/00791;;A61N2007/006;;A61N7/00,A61N7/00;;A61B17/225;;A61H23/02,,0,0,,,,ACTIVE
862,EP,A4,EP 2038757 A4,196-228-604-302-245,2014-08-06,2014,EP 07810012 A,2007-06-28,US 2007/0015064 W;;US 48292006 A,2006-07-07,METHODS AND APPARATUS FOR PROVIDING OPTIMAL IDENTIFICATION AND PROCESSING OF LAYER 3 CONTROL CHANNELS,,CISCO TECH INC,NADEAU THOMAS D;;BRYANT STEWART F;;BARBER SIMON;;WARD DAVID;;SWALLOW GEORGE,,https://lens.org/196-228-604-302-245,Search Report,no,4,0,6,6,0,H04W80/04;;H04L69/22;;H04L69/325;;H04L69/22;;H04W80/04;;H04L69/325,G06F15/16;;H04L12/46;;H04L29/06;;H04L29/08;;H04W80/04,,1,0,,,See also references of WO 2008008196A2,DISCONTINUED
863,WO,A1,WO 2014/210065 A1,001-452-836-395-983,2014-12-31,2014,US 2014/0043953 W,2014-06-24,US 201361838773 P;;US 201361838811 P,2013-06-24,WEARABLE ULTRASOUND DEVICE,"A wearable ultrasound device and method of using the device includes a power controller with a power source and at least one integrated circuit that delivers electrical power to an applicator. The applicator is electrically coupled to the power controller and a surface of the applicator transmits ultrasound to a wearer for a given duration. The applicator includes radio frequency (RF) drive electronics, an ultrasound transducer coupled to the drive electronics, a monitoring apparatus that includes a thermal cutoff coupled to the drive electronics, where the monitoring apparatus monitors a temperature of the applicator surface and the thermal cutoff turns off the applicator, if the temperature exceeds a pre-defined threshold, and a coupling bandage coupled to the applicator, where the bandage positions the surface of the applicator proximate to a wearer at a location on the body of a wearer.",ZETROZ INC,LEWIS JR GEORGE K;;GUFFEY BRYANT;;GUARINO JOANNE;;FLESHMAN SHANE;;LANGER MATTHEW,,https://lens.org/001-452-836-395-983,Patent Application,yes,5,6,7,7,0,A61B2017/00106;;A61B2017/2253;;A61N2007/0073;;A61N2007/0078;;A61H2201/0184;;A61H23/0245;;A61H2201/0176;;A61H2201/5015;;A61H2201/5043;;A61H2201/5058;;A61H2201/5097;;A61H2230/207;;A61H2230/25;;A61H2230/505;;A61B2018/00791;;A61N2007/006;;A61N7/00;;A61N2007/0073;;A61N2007/0078;;A61B2017/00106;;A61B2017/2253;;A61H2201/5097;;A61H2230/207;;A61H2201/0184;;A61H2230/505;;A61H2201/5015;;A61H2201/5043;;A61H2201/5058;;A61H23/0245;;A61H2201/0176;;A61H2230/25;;A61B2018/00791;;A61N2007/006;;A61N7/00,A61N7/00;;A61H23/02,,0,0,,,,PENDING
864,ZA,B,ZA 939427 B,010-872-279-566-109,1995-06-15,1995,ZA 939427 A,1993-12-15,US 99522292 A,1992-12-22,Benzothiophenes,,LILLY CO ELI,BLACK LARRY JOHN;;BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH;;KAUFFMAN RAYMOND FRANCIS,,https://lens.org/010-872-279-566-109,Granted Patent,no,0,0,47,47,0,A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;A61K31/4535;;A61K31/4025;;A61K31/55;;A61K2300/00;;A61K31/4535;;A61K31/40;;A61K31/55;;A61K31/445;;A61K31/4025,A61K31/365;;A61K31/385;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4453;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;C07D333/56,,0,0,,,,EXPIRED
865,BR,A,BR 9305182 A,010-480-497-527-156,1994-08-16,1994,BR 9305182 A,1993-12-21,US 99522292 A,1992-12-22,Composto e formulação farmaceûtica,,LILLY CO ELI,BLACK LARRY JOHN;;BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH;;KAUFFMAN RAYMOND FRANCIS,,https://lens.org/010-480-497-527-156,Patent Application,no,0,0,47,47,0,A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;A61K31/4535;;A61K31/4025;;A61K31/55;;A61K2300/00;;A61K31/4535;;A61K31/40;;A61K31/55;;A61K31/445;;A61K31/4025,A61K31/385;;A61K31/365;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4453;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;C07D333/56,,0,0,,,,DISCONTINUED
866,AU,A,AU 1993/052578 A,040-906-291-184-956,1994-07-07,1994,AU 1993/052578 A,1993-12-21,US 99522292 A,1992-12-22,Improvements in or relating to benzothiophenes,,LILLY CO ELI,BLACK LARRY JOHN;;BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH;;KAUFFMAN RAYMOND FRANCIS,,https://lens.org/040-906-291-184-956,Patent Application,no,0,2,47,47,0,A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;A61K31/4535;;A61K31/4025;;A61K31/55;;A61K2300/00;;A61K31/4535;;A61K31/40;;A61K31/55;;A61K31/445;;A61K31/4025,A61K31/385;;A61K31/365;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4453;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;C07D333/56,,0,0,,,,EXPIRED
867,BG,A,BG 98317 A,052-533-138-704-819,1995-02-28,1995,BG 9831793 A,1993-12-21,US 99522292 A,1992-12-22,IMPROVED BENZOTHIOPHENES,"The invention relates to compounds having the formula (formula) where n has the value of 0, 1 or 2; R hydroxyl, ethoxy, C1-C7 alkanoyloxy, C3-7 cycloalkanoyloxy, (C1-6 alkoxy)-C1-C7 alkanoyloxy, substituted or not substituted aroyloxy or substituted or not substituted aryloxycarbonyloxy; R1 is hydrogen, hydroxyl, halogen, methoxy, C1-C7 alkanoyloxy, C3-C7 cycloalkanoyloxy, (C1-C6alkoxy)-C1-C7 alkanoyloxy, substituted or not substituted aroyloxy or substituted or not substituted aroyloxycarbohyloxy; R2 is heteocyclic ring selected from the group consisting of pyrrolidine, pepiridine or hexamethyleneimine, to its pharmaceutically acceptable salt or the respective solvate which are applied for reducing the cholesterol levels in the serum.",LILLY CO ELI,BLACK LARRY J;;BRYANT HENRY U;;CULLINAN GEORGE J;;KAUFFMAN RAYMOND F,,https://lens.org/052-533-138-704-819,Patent Application,no,0,0,47,47,0,A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;A61K31/4535;;A61K31/4025;;A61K31/55;;A61K2300/00;;A61K31/4535;;A61K31/40;;A61K31/55;;A61K31/445;;A61K31/4025,A61K31/385;;A61K31/365;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4453;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;C07D333/56,,0,0,,,,EXPIRED
868,US,A1,US 2017/0304461 A1,069-030-478-325-113,2017-10-26,2017,US 201515517971 A,2015-10-08,GB 201418186 A;;GB 201418984 A;;GB 201418986 A;;GB 201418989 A;;GB 201509037 A;;GB 2015052952 W,2014-10-14,Process For The Conjugation Of A Peptide Or Protein With A Reagent Comprising A Leaving Group Including A Portion Of PEG,"The invention relates to novel conjugating reagents capable of reaction with at least one nucleophile present in a peptide or protein, which contain at least one leaving group which is lost on reaction with said nucleophile, in which the leaving group includes a portion —(CH 2 CH 2 O) n —, in which n is a number of six or more; and novel processes for the preparation of conjugates containing peptides or proteins made using such reagents.",POLYTHERICS LTD,GODWIN ANTONY;;BADESCU GEORGE;;BIRD MATTHEW;;BRYANT PENNY;;MORRIS DAVID;;FRIGERIO MARK,ABZENA (UK) LIMITED (2017-03-10),https://lens.org/069-030-478-325-113,Patent Application,yes,1,0,13,40,0,C07K1/107;;C07K1/107;;A61K47/6889;;A61K47/6835;;A61K47/6803;;A61K47/6889;;A61K47/6803;;A61K47/6835;;C07K1/107;;C07K1/107;;A61K47/6835;;A61K47/6889;;A61K47/6803;;A61K47/56;;A61K47/00;;C07K1/00,A61K47/68;;A61K47/00;;A61K47/56;;C07K1/00;;C07K1/107,,0,0,,,,ACTIVE
869,EP,A3,EP 1238667 A3,111-024-248-503-084,2003-12-10,2003,EP 02013421 A,1993-12-22,EP 93310438 A;;US 99522292 A,1992-12-22,Use of benzothiophenes for treatment of hypercholesterolaemia,Use of 2-phenyl-3-aroylbenzothiophens in the preparation of a medicament for lowering serum cholesterol levels.,LILLY CO ELI,BLACK LARRY JOHN;;BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH;;KAUFFMANN RAYJOND FRANCIS,,https://lens.org/111-024-248-503-084,Search Report,yes,0,0,47,47,0,A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;A61K31/4535;;A61K31/4025;;A61K31/55;;A61K2300/00;;A61K31/4535;;A61K31/40;;A61K31/55;;A61K31/445;;A61K31/4025,A61K31/385;;A61K31/365;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4453;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;C07D333/56,,3,3,007-023-645-974-416;;121-762-194-117-598;;085-699-952-213-894,8282823;;10.1172/jci116985;;pmc293730;;10.1016/s0005-2728(88)80077-x;;3191162;;10.1016/0167-4889(88)90115-2;;3342088;;10.1016/0006-2952(88)90735-6,"BLACK, L.J. ET AL: ""RALOXIFENE (LY139481) PREVENTS BONE LOSS AND REDUCES SERUM CHOLESTEROL WITHOUT CAUSING UTERINE HYPERTROPHY IN OVARECTOMIZED RATS"", THE JOURNAL OF CLINICAL INVESTIGATION, vol. 93, no. 1, January 1994 (1994-01-01), pages 63 - 69, XP002088887;;CYPRIANI, B. ET AL: ""EFFECT OF ESTRADIOL AND ANTIESTROGENS ON CHOLESTEROL BIOSYNTHESIS IN HORMONE-DEPENDENT AND -INDEPENDENT BREAST CANCER CELL LINES"", BIOCHIMICA ET BIOPHYSICA ACTA, vol. 972, no. 2, 1988, pages 167 - 178, XP000987368;;WEINSTEIN, I. ET AL: ""EFFECTS OF THE ANTIOESTROGEN LY 117018 ON THE MODULATION BY ESTRADIOL OF THE METABOLISM OF[1-14C]OLEIC ACID BY PERFUSED LIVERS FROM NORMAL AND OVARECTOMIZED RATS"", BIOCHEMICAL PHARMACOLOGY, vol. 37, no. 2, 1988, pages 319 - 326, XP008023452",DISCONTINUED
870,CA,C,CA 2112017 C,185-136-469-470-133,2005-06-14,2005,CA 2112017 A,1993-12-21,US 99522292 A,1992-12-22,USE OF BENZOTHIOPHENES FOR LOWERING SERUM CHOLESTEROL,"Use of a compound of formula (I): (See formula I) wherein n is 0, 1 or 2; R is hydroxyl, methoxy, C1-C7 alkanoyloxy, C3-C7 cycloalkanoyloxy, (C1-C6 alkoxy)-C1-C7 alkanoyloxy, substituted or unsubstituted aroyloxy, or substituted or unsubstituted aryloxycarbonyloxy; R1 is hydrogen, hydroxyl, chloro, bromo, methoxy, C1- C7 alkanoyloxy, C3-C7 cycloalkanoyloxy, (C1-C6 alkoxy)-C1-C7 alkanoyloxy, substituted or unsubstituted or aroyloxy, or substituted or unsubstituted aryloxycarbonyloxy; R2 is a heterocyclic ring selected from the group consisting of pyrrolidino, piperidino, or hexamethyleneimino; or a pharmaceutically acceptable salt or solvate thereof; in the preparation of a medicament useful for lowering serum cholesterol levels in animals.",LILLY CO ELI,BLACK LARRY JOHN;;BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH;;KAUFFMAN RAYMOND FRANCIS,,https://lens.org/185-136-469-470-133,Granted Patent,no,0,0,47,47,0,A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;A61K31/4535;;A61K31/4025;;A61K31/55;;A61K2300/00;;A61K31/4535;;A61K31/40;;A61K31/55;;A61K31/445;;A61K31/4025,A61K31/385;;A61K31/365;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4453;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;C07D333/56,,0,0,,,,EXPIRED
871,NO,L,NO 934740 L,017-353-722-427-892,1994-06-23,1994,NO 934740 A,1993-12-21,US 99522292 A,1992-12-22,Forbindinger vedrörende benzotiofener,,LILLY CO ELI,BLACK LARRY JOHN;;CULLINAN GEORGE JOSEPH;;BRYANT HENRY UHLMAN;;KAUFFMAN RAYMOND FRANCIS,,https://lens.org/017-353-722-427-892,Abstract,no,0,0,47,47,0,A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;A61K31/4535;;A61K31/4025;;A61K31/55;;A61K2300/00;;A61K31/4535;;A61K31/40;;A61K31/55;;A61K31/445;;A61K31/4025,A61K31/365;;A61K31/38;;A61K31/385;;A61K31/381;;A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4453;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;C07D333/56,,0,0,,,,EXPIRED
872,DK,T3,DK 0605193 T3,064-893-315-877-484,2003-03-31,2003,DK 93310438 T,1993-12-22,US 99522292 A,1992-12-22,Anvendelse af benzothiophener til behandling af hypercholesterolæmi,,LILLY CO ELI,BLACK LARRY JOHN;;BRYANT HENRY UHLMAN;;KAUFFMAN RAYMOND FRANCIS;;CULLINAN GEORGE JOSEPH,,https://lens.org/064-893-315-877-484,Granted Patent,no,0,0,47,47,0,A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;A61K31/4535;;A61K31/4025;;A61K31/55;;A61K2300/00;;A61K31/4535;;A61K31/40;;A61K31/55;;A61K31/445;;A61K31/4025,A61K31/385;;A61K31/365;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4453;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;C07D333/56,,0,0,,,,EXPIRED
873,US,A1,US 2006/0276845 A1,103-271-025-163-666,2006-12-07,2006,US 50275906 A,2006-08-11,US 50275906 A;;US 34445506 A;;US 99459801 A;;US 23179099 A;;US 7139698 P,1998-01-15,Pulsed electromagnetic energy treatment apparatus and method,An apparatus and method for the treatment of chronic wounds using electromagnetic energy. The apparatus includes a generator and at least one applicator. The generator can produce electromagnetic energy and the applicator can apply the electromagnetic energy produced by the generator. A detector is disposed on the applicator that can measure the field strength of the electromagnetic energy applied.,REGENESIS BIOMEDICAL INC,GEORGE FRANK R;;LOYA ARTHUR A;;RITZ MARY C;;BRYANT ROBERT T,AMETHYST TECHNOLOGIES INC (1999-01-12);;REGENESIS BIOMEDICAL INC (2001-01-01),https://lens.org/103-271-025-163-666,Patent Application,yes,99,20,18,18,0,A61N1/326;;A61N1/40;;A61N1/40;;A61N1/326,A61N1/40;;A61N1/00,607/2,0,0,,,,DISCONTINUED
874,WO,A3,WO 1999/036127 A3,015-559-049-225-350,1999-09-23,1999,US 9900864 W,1999-01-15,US 7139698 P,1998-01-15,IMPROVED PULSED ELECTROMAGNETIC ENERGY TREATMENT APPARATUS AND METHOD,"A method of and apparatus for the treatment of chronic wounds using pulsed electromagnetic energy provides a constant, known and replicable dosage output which remains unaffected by the capacitance of the patient's body. The apparatus includes a pulsed electromagnetic energy generator, a power level controller and one or more thin applicators which can be flexible. The applicators are located immediately adjacent to the patient's body, without the aid of a support member or removal of any dressings or bandages. The generator output is automatically adjusted in response to instructions from a field strength sensor located on or near the applicator. Multiple applicators selected to operate simultaneously at different treatment dosage levels are connected to the generator by multi-conductor cables and readily located directly on the treatment area. Each applicator is a pad including etched printed circuits. The circuits are matched and pre-tuned. An applicator-to-patient proximity detector is also incorporated in or on each applicator and connected to the generator via a power controller to provide for direct monitoring of the treatment site and precise control of treatment dosage.",AMETHYST TECHNOLOGIES INC,GEORGE FRANK R;;LOYA ARTHUR A;;RITZ MARY C;;BRYANT ROBERT T,,https://lens.org/015-559-049-225-350,Search Report,yes,4,0,18,18,0,A61N1/326;;A61N1/40;;A61N1/40;;A61N1/326,A61N1/40,,0,0,,,,PENDING
875,US,B1,US 7042838 B1,019-631-017-667-516,2006-05-09,2006,US 84866904 A,2004-05-18,US 84866904 A,2004-05-18,Method and apparatus for forwarding data in a data communications network,"A method of forwarding data in a data communications network comprising a plurality of nodes comprises the step of forwarding data according to a forwarding strategy implemented at a forwarding node. Where the implemented strategy comprises a repair strategy to compensate for a change in the network, the method further comprises the step of encapsulating the data in a primary repair encapsulating packet and marking the primary repairing encapsulating packet as repaired.",CISCO TECH IND,SHAND IAN MICHAEL CHARLES;;BRYANT STEWART FREDERICK;;FILSFILS CLARENCE;;MILES KEVIN GEORGE,CISCO TECHNOLOGY INC (2004-05-11),https://lens.org/019-631-017-667-516,Granted Patent,yes,12,60,1,1,0,H04L45/18;;H04L45/22;;H04L45/28;;H04L45/22;;H04L45/18;;H04L45/00;;H04L45/28,G01R31/08,370/225;;370/221,3,1,111-755-572-875-25X,10.1145/99508.99548,"International Searching Authority, International Search Report, PCT/US04/33827, dated Mar. 28, 2005, 8 pages.;;Current Claims, PCT/US04/33827, 6 pages.;;Wang, et al., ""Shortest Path First with Emergency Exits,"" ACM, 1990, 11 pages.",INACTIVE
876,US,S,US D0690602 S,074-666-210-066-039,2013-10-01,2013,US 201229413703 F,2012-02-17,US 201229413703 F;;US 201129385898 F,2011-02-22,Container,,BRYANT MICHAEL PATRICK;;MCMAHON MICHAEL D;;NUKUTO GEORGE I;;ZIMMER JONATHAN H;;HEINZ CO H J,BRYANT MICHAEL PATRICK;;MCMAHON MICHAEL D;;NUKUTO GEORGE I;;ZIMMER JONATHAN H,H.J. HEINZ COMPANY (2012-02-13);;H.J. HEINZ COMPANY BRANDS LLC (2015-06-30),https://lens.org/074-666-210-066-039,Design Right,no,0,6,1,8,0,,,0901;;D 9542;;D9/563;;D9/569;;D9/571;;D9/574,0,0,,,,ACTIVE
877,SG,A1,SG 52696 A1,090-900-416-299-236,1998-09-28,1998,SG 1996008021 A,1993-12-22,US 99522292 A,1992-12-22,Improvements in or relating to benzothiophenes,,LILLY CO ELI,BLACK LARRY JOHN;;BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH;;KAUFFMAN RAYMOND FRANCIS,,https://lens.org/090-900-416-299-236,Patent Application,no,0,0,47,47,0,A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;A61K31/4535;;A61K31/4025;;A61K31/55;;A61K2300/00;;A61K31/4535;;A61K31/40;;A61K31/55;;A61K31/445;;A61K31/4025,A61K31/365;;A61K31/385;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4453;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;C07D333/56,,0,0,,,,PENDING
878,NZ,A,NZ 250486 A,134-980-073-622-587,1997-06-24,1997,NZ 25048693 A,1993-12-16,US 99522292 A,1992-12-22,BENZOTHIOPHENE DERIVATIVES USED TO LOWER SERUM CHOLESTEROL,,LILLY CO ELI,BLACK LARRY JOHN;;BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH;;KAUFFMAN RAYMOND FRANCIS,,https://lens.org/134-980-073-622-587,Patent Application,no,0,0,47,47,0,A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;A61K31/4535;;A61K31/4025;;A61K31/55;;A61K2300/00;;A61K31/4535;;A61K31/40;;A61K31/55;;A61K31/445;;A61K31/4025,A61K31/365;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/385;;A61K31/4025;;A61K31/445;;A61K31/4453;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;C07D333/56,,0,0,,,,EXPIRED
879,RO,B1,RO 113806 B1,173-790-256-871-487,1998-11-30,1998,RO 9301739 A,1993-12-20,US 99522292 A,1992-12-22,METHOD FOR LOWERING SERUM CHOLESTEROL LEVELS IN HUMAN BEINGS,,LILLY CO ELI,BLACK LARRY JOHN;;BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH;;KAUFFMAN RAYMOND FRANCIS,,https://lens.org/173-790-256-871-487,Granted Patent,no,0,0,47,47,0,A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;A61K31/4535;;A61K31/4025;;A61K31/55;;A61K2300/00;;A61K31/4535;;A61K31/40;;A61K31/55;;A61K31/445;;A61K31/4025,A61K31/365;;A61K31/38;;A61K31/385;;A61K31/381;;A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4453;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;C07D333/56,,0,0,,,,EXPIRED
880,CN,A,CN 106794259 A,112-440-182-611-62X,2017-05-31,2017,CN 201580055608 A,2015-10-08,GB 201418186 A;;GB 201418989 A;;GB 201418986 A;;GB 201418984 A;;GB 201509037 A;;GB 2015052952 W,2014-10-14,Process for the conjugation of a peptide or protein with a reagent comprising a leaving group including a portion of peg,"The invention relates to novel conjugating reagents capable of reaction with at least one nucleophile present in a peptide or protein, which contain at least one leaving group which is lost on reaction with said nucleophile, in which the leaving group includes a portion -(CH2CH2O)n- in which n is a number of six or more; and novel processes for the preparation of conjugates containing peptides or proteins made using such reagents.",POLYTHERICS LTD,GODWIN ANTONY;;BADESCU GEORGE;;BIRD MATTHEW;;BRYANT PENNY;;MORRIS DAVID;;FRIGERIO MARK,,https://lens.org/112-440-182-611-62X,Patent Application,no,4,2,13,40,0,C07K1/107;;C07K1/107;;A61K47/6889;;A61K47/6835;;A61K47/6803;;A61K47/6889;;A61K47/6803;;A61K47/6835;;C07K1/107;;C07K1/107;;A61K47/6835;;A61K47/6889;;A61K47/6803;;A61K47/56;;A61K47/00;;C07K1/00,A61K47/68;;C07K1/107,,4,0,,,"SIMONE KRAKERT等: ""Adjustment of the bioresistivity by electron irradiation: self-assembled monolayers of oligo(ethyleneglycol)-terminated alkanethiols with embedded cleavable group"", 《PHYSICAL CHEMISTRY CHEMICAL PHYSICS》;;HANIEH KHALILI等: ""Comparative Binding of Disulfide-Bridged PEG-Fabs"", 《BIOCONJUGATE CHEMISTRY》;;SIBU BALAN等: ""Site-Specific PEGylation of Protein Disulfide Bonds Using a Three-Carbon Bridge"", 《BIOCONJUGATE CHEM》;;CRISTINA MARCULESCU等: ""Aryloxymaleimides for cysteine modification, disulfide bridging and the dual functionalization of disulfide bonds"", 《CHEMICAL COMMUNICATION》",ACTIVE
881,US,A1,US 2012/0253098 A1,146-413-985-717-487,2012-10-04,2012,US 201213472392 A,2012-05-15,US 201213472392 A;;US 50275906 A;;US 34445506 A;;US 99459801 A;;US 23179099 A;;US 7139698 P,1998-01-15,PULSED ELECTROMAGNETIC ENERGY TREATMENT APPARATUS AND METHOD,An apparatus and method for the treatment of chronic wounds using electromagnetic energy. The apparatus includes a generator and at least one applicator. The generator can produce electromagnetic energy and the applicator can apply the electromagnetic energy produced by the generator. A detector is disposed on the applicator that can measure the field strength of the electromagnetic energy applied.,GEORGE FRANK R;;LOYA ARTHUR A;;RITZ MARY C;;BRYANT ROBERT T;;REGENESIS BIOMEDICAL INC,GEORGE FRANK R;;LOYA ARTHUR A;;RITZ MARY C;;BRYANT ROBERT T,AMETHYST TECHNOLOGIES INC (1999-01-12);;REGENESIS BIOMEDICAL INC (2001-01-01),https://lens.org/146-413-985-717-487,Patent Application,yes,0,39,18,18,0,A61N1/326;;A61N1/40;;A61N1/40;;A61N1/326,A61N5/00;;A61N1/40;;A61N2/04,600/2,0,0,,,,DISCONTINUED
882,HK,A1,HK 1027517 A1,155-819-097-700-114,2001-01-19,2001,HK 00106157 A,2000-09-28,US 9900864 W;;US 7139698 P,1998-01-15,IMPROVED PULSED ELECTROMAGNETIC ENERGY TREATMENT APPARATUS,"An apparatus for treatment of wounds using pulsed electromagnetic energy provides a constant, known and replicable dosage output which remains unaffected by the capacitance of the patient's body. The apparatus includes: a pulsed electromagnetic energy generator, one or more applicators, which may be flexible, adapted to be positioned proximate a wound and external of a patient's body, and a circuit means having a fixed capacitance. The applicators are located immediately adjacent to the patient's body, without the aid of a support member or removal of any dressings or bandages. Multiple applicators can be selected to operate simultaneously at different treatment dosage levels and are connected to the generator by multi-conductor cables and are readily located directly on the treatment area. Each applicator is a pad including etched printed circuits. The circuits are matched and pre-tuned.",REGENESIS BIOMEDICAL INC,GEORGE FRANK R;;LOYA ARTHUR A;;RITZ MARY C;;BRYANT ROBERT T,,https://lens.org/155-819-097-700-114,Patent Application,no,0,0,18,18,0,A61N1/326;;A61N1/40;;A61N1/40;;A61N1/326,A61N/;;A61N1/40,,0,0,,,,DISCONTINUED
883,NO,D0,NO 934740 D0,146-792-146-192-897,1993-12-21,1993,NO 934740 A,1993-12-21,US 99522292 A,1992-12-22,Forbindinger vedroerende benzotiofener,,LILLY CO ELI,BLACK LARRY JOHN;;CULLINAN GEORGE JOSEPH;;BRYANT HENRY UHLMAN;;KAUFFMAN RAYMOND FRANCIS,,https://lens.org/146-792-146-192-897,Patent Application,no,0,0,47,47,0,A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;A61K31/4535;;A61K31/4025;;A61K31/55;;A61K2300/00;;A61K31/4535;;A61K31/40;;A61K31/55;;A61K31/445;;A61K31/4025,A61K31/365;;A61K31/385;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4453;;A61K31/4535;;A61K31/55;;A61P3/00;;A61P3/06;;A61P7/00;;C07D333/56,,0,0,,,,EXPIRED
884,US,B1,US 7871378 B1,187-563-106-302-973,2011-01-18,2011,US 30555105 A,2005-12-16,US 30555105 A;;US 63905904 P;;US 66226005 P;;US 66527105 P,2004-12-22,Device and method to measure corneal biomechanical properties and its application to intraocular pressure measurement,"This invention is a system, an apparatus and a method for measuring biomechanical properties of cornea and the intraocular pressure in vivo. More than one dimensional topographic information of the cornea is recorded and analyzed before and during the fluid discharge and converted to the stress-strain relationship and other cornea parameters, for example the cornea thickness and radius of curvature, etc. The deformation of cornea is initiated by a non-contact fluid discharge whose profile is predetermined and monitored in real time. Utilizing this non-contact topographer, the true intraocular pressure can be derived from the response of the cornea due to the impact of fluid discharge and the corneal topographic parameters. One embodiment of this invention includes the use of a multiple color strobe light/multiple detector system to record the corneal topographic deformation due to the impact of fluid discharge.",ACHEVE TECHNOLOGY INC,CHOU JIM-SON;;HEINOLD STEVEN SCOTT;;ISMAEL GEORGE BRYANT;;MOORE RICHARD ARNOLD,JIM-SON CHOU ACHEVE TECHNOLOGY INC (2006-01-12),https://lens.org/187-563-106-302-973,Granted Patent,yes,10,29,1,1,0,A61B3/165;;A61B3/165,A61B3/16,600/398;;600/401,7,6,148-870-653-123-46X;;071-744-000-282-878;;012-662-723-501-377;;069-523-345-019-513;;034-347-418-722-817;;007-674-249-504-745,10.1006/bulm.1999.0102;;17883231;;10.1088/0031-9155/42/3/007;;9080534;;15721707;;10.1016/j.jcrs.2004.09.031;;pmc1618927;;16849148;;10.1098/rsif.2004.0002;;15721709;;10.1016/j.jcrs.2004.09.042;;15721708;;10.1016/j.jcrs.2004.10.044,"Young, W.C.(1989) Roark's Formulas for Stress and Strain, McGraw-Hill, 6th Edn., pp. 523-546.;;Orssengo G, Pye D, Determination of the true Intraocular Pressure and Modulus of Elasticity of the Human Cornea in vivo, Bulle. Of Mathematical Biology(1999) 61, 551-572.;;Lu Wang, et.al Fast Fourier Transform analysis of dynamic data : stress-strain analysis of biological tissue, Phys. Med. Biol. (1997), 537-547.;;Liu, C. Roberts, Influence of corneal biomedical properties on intraocular pressure measurement, Quantitative Analysis, J cataract refract surg. 2005, 31, 146-155.;;Anderson , A. El-Sheikh, T.Newson Application of structural Analysis to the mechanical behaviour of Cornea, J. R. Soc. Lond. Interface 2004 (1): pp. 1-13.;;G. Grabner, R. Eilmsteiner, C Steindl, J, Ruckhofer, R. Mattioli, W. Husinsky, Dynamic corneal imaging, J cataract refract surg. 31, (2005), pp. 163-174.;;D. Luce, Determining in vivo bio-mechanical properties of the cornea with an ocular analyzer, J cataract refract surg. 31, (2005), pp. 156-162.",INACTIVE
885,IT,B,IT 1165430 B,064-151-097-937-30X,1987-04-22,1987,IT 2812679 A,1979-12-18,US 97284478 A,1978-12-26,PROCESSO DI ATTACCO DI CROMO MEDINATE SCARICA A BAGLIORE,,IBM,CHIU GEORGE TEIN-CHU;;KITCHER JAMES ROBERT;;OZOLS GUNARS MIERVALDIS;;ZINGERMAN BRYANT NILS,,https://lens.org/064-151-097-937-30X,Granted Patent,no,0,0,10,10,0,C23F4/00;;H01L21/32136;;C23F4/00;;H01L21/32136,C23F4/00;;H01L21/302;;H01L21/3065;;H01L21/308;;H01L21/3213,,0,0,,,,EXPIRED
886,US,A1,US 2010/0241672 A1,140-607-475-057-383,2010-09-23,2010,US 79611610 A,2010-06-08,US 79611610 A;;US 15976305 A,2005-06-23,Database Application Including Spilt Views,"A database application is provided which includes functionality for providing split views. The database application includes an object model having a number of objects, methods, and properties. The object model preferably includes a form object which includes a split view representation. A number of properties are associated with the split view which provides for the presentation of data to a user of the database application.",MICROSOFT CORP,BRYANT CHRISTOPHER W;;FORDHAM GEORGE R;;MARKIEWICZ MARCUS;;MCCORMACK MICHAEL J;;NARAMORE THERESA,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14),https://lens.org/140-607-475-057-383,Patent Application,yes,18,7,4,4,0,G06F2203/04803;;G06F16/248;;G06F16/248;;G06F2203/04803,G06F17/30;;G06F3/048,707/805;;715/781;;X707E17044;;715/764,0,0,,,,INACTIVE
887,US,A1,US 2004/0156854 A1,028-601-267-018-526,2004-08-12,2004,US 72805503 A,2003-12-04,US 72805503 A;;US 43151402 P,2002-12-06,"Methods for the identification, assessment, and treatment of patients with proteasome inhibition therapy","
   The present invention is directed to the identification of markers that can be used to determine whether patients with cancer are clinically responsive or non-responsive to a therapeutic regimen prior to treatment. In particular, the present invention is directed to the use of certain combinations of markers, wherein the expression of the markers correlates with responsiveness or non-responsiveness to a therapeutic regimen comprising proteasome inhibition. Thus, by examining the expression levels of individual markers and those comprising a marker set, it is possible to determine whether a therapeutic agent, or combination of agents, will be most likely to reduce the growth rate of tumors in a clinical setting. 
",MILLENNIUM PHARM INC,MULLIGAN GEORGE;;BRYANT BARBARA M;;MORRISSEY MICHAEL P;;BOLT ANDREW;;DAMOKOSH ANDREW I,MILLENNIUM PHARMACEUTICALS INC (2004-03-09),https://lens.org/028-601-267-018-526,Patent Application,yes,0,88,19,19,0,C07K14/47;;C12Q1/6883;;C12Q1/6886;;C12Q2600/106;;C12Q2600/112;;C12Q2600/136;;C12Q2600/158;;G01N33/574;;G01N2500/04;;A61K38/05;;A61P35/00;;A61P35/02;;A61P43/00;;Y02A90/10;;C12Q1/6886;;C12Q2600/106;;C12Q2600/112;;C12Q2600/158;;C07K14/47;;C12Q1/6883;;C12Q2600/136;;G01N2500/04;;G01N33/574;;A61K38/05;;C12Q2600/118;;G01N33/57484;;G01N2333/8107,A61K39/395;;C07K14/47;;C12Q1/68;;G01N33/574,424/155.1;;435/6,0,0,,,,DISCONTINUED
888,US,A1,US 2017/0023577 A1,038-540-465-883-568,2017-01-26,2017,US 201615080709 A,2016-03-25,US 201615080709 A;;US 31675608 A;;US 72805503 A;;US 43151402 P,2002-12-06,"METHODS FOR THE IDENTIFICATION, ASSESSMENT, AND TREATMENT OF PATIENTS WITH PROTEASOME INHIBITION THERAPY","The present invention is directed to the identification of markers that can be used to determine whether patients with cancer are clinically responsive or non-responsive to a therapeutic regimen prior to treatment. In particular, the present invention is directed to the use of certain combinations of markers, wherein the expression of the markers correlates with responsiveness or non-responsiveness to a therapeutic regimen comprising proteasome inhibition. Thus, by examining the expression levels of individual markers and those comprising a marker set, it is possible to determine whether a therapeutic agent, or combination of agents, will be most likely to reduce the growth rate of tumors in a clinical setting.",MILLENNIUM PHARM INC,MULLIGAN GEORGE;;BRYANT BARBARA M;;MORRISSEY MICHAEL P;;BOLT ANDREW;;DAMOKOSH ANDREW I,,https://lens.org/038-540-465-883-568,Patent Application,yes,0,5,19,19,0,C07K14/47;;C12Q1/6883;;C12Q1/6886;;C12Q2600/106;;C12Q2600/112;;C12Q2600/136;;C12Q2600/158;;G01N33/574;;G01N2500/04;;A61K38/05;;A61P35/00;;A61P35/02;;A61P43/00;;Y02A90/10;;C12Q1/6886;;C12Q2600/106;;C12Q2600/112;;C12Q2600/158;;C07K14/47;;C12Q1/6883;;C12Q2600/136;;G01N2500/04;;G01N33/574;;A61K38/05;;C12Q2600/118;;G01N33/57484;;G01N2333/8107,G01N33/574;;A61K38/05;;A61K39/395;;C07K14/47;;C12Q1/68,,0,0,,,,DISCONTINUED
889,DE,C2,DE 2536732 C2,194-241-023-226-057,1982-05-13,1982,DE 2536732 A,1975-08-18,US 49851374 A,1974-08-19,DE 2536732 C2,,"EMPIRE SCIENTIFIC CORP., GARDEN CITY, N.Y.,, US","SHAPER, HARRY BRYANT, EAST HILLS, N.Y., US;;LITCHER, DONALD GEORGE, COMMACK, N.Y., US",,https://lens.org/194-241-023-226-057,Granted Patent,no,0,0,7,7,0,H04R11/08;;H04R11/12;;H04R11/08;;H04R11/12,G11B3/50;;H04R11/08;;H04R11/12,,0,0,,,,EXPIRED
890,US,A1,US 2006/0294137 A1,194-527-089-930-788,2006-12-28,2006,US 15976305 A,2005-06-23,US 15976305 A,2005-06-23,Database application including split views,"A database application is provided which includes functionality for providing split views. The database application includes an object model having a number of objects, methods, and properties. The object model preferably includes a form object which includes a split view representation. A number of properties are associated with the split view which provides for the presentation of data to a user of the database application.",MICROSOFT CORP,BRYANT CHRISTOPHER W;;FORDHAM GEORGE R;;MARKIEWICZ MARCUS;;MCCORMACK MICHAEL J;;NARAMORE THERESA,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2005-06-21),https://lens.org/194-527-089-930-788,Patent Application,yes,16,5,4,4,0,G06F2203/04803;;G06F16/248;;G06F16/248;;G06F2203/04803,G06F7/00,70710300R,0,0,,,,INACTIVE
891,EP,A2,EP 1581629 A2,083-582-412-421-594,2005-10-05,2005,EP 03796633 A,2003-12-04,US 0338539 W;;US 43151402 P,2002-12-06,"METHODS FOR THE IDENTIFICATION, ASSESSMENT, AND TREATMENT OF PATIENTS WITH PROTEASOME INHIBITION THERAPY",,MILLENNIUM PHARM INC,MULLIGAN GEORGE;;BRYANT BARBARA M;;MORRISSEY MICHAEL P;;BOLT ANDREW;;DAMOKOSH ANDREW I,,https://lens.org/083-582-412-421-594,Patent Application,yes,0,0,19,19,0,C07K14/47;;C12Q1/6883;;C12Q1/6886;;C12Q2600/106;;C12Q2600/112;;C12Q2600/136;;C12Q2600/158;;G01N33/574;;G01N2500/04;;A61K38/05;;A61P35/00;;A61P35/02;;A61P43/00;;Y02A90/10;;C12Q1/6886;;C12Q2600/106;;C12Q2600/112;;C12Q2600/158;;C07K14/47;;C12Q1/6883;;C12Q2600/136;;G01N2500/04;;G01N33/574;;A61K38/05;;C12Q2600/118;;G01N33/57484;;G01N2333/8107,C12Q1/68;;A61K39/395;;C07K14/47;;G01N33/574,,0,0,,,,EXPIRED
892,JP,A,JP 2010207230 A,004-661-461-320-597,2010-09-24,2010,JP 2010092346 A,2010-04-13,US 43151402 P,2002-12-06,"METHOD FOR IDENTIFICATION, ASSESSMENT, AND TREATMENT OF PATIENT WITH PROTEASOME INHIBITION THERAPY","<P>PROBLEM TO BE SOLVED: To provide a method for identifying or selecting a patient with cancer who is responsive to a therapeutic regimen comprising proteasome inhibition therapy. <P>SOLUTION: A marker set correlates with responsiveness or non-responsiveness of the patient with the cancer to the therapeutic regimen comprising the proteasome inhibition therapy. By examining the expression level of an mRNA or peptide of an individual marker and marker set, it is possible to determine whether a therapeutic agent, or combination of agents will be most likely to reduce the growth rate of tumors in a clinical setting. <P>COPYRIGHT: (C)2010,JPO&INPIT",MILLENNIUM PHARM INC,MULLIGAN GEORGE;;BRYANT BARBARA M;;MORRISSEY MICHAEL P;;BOLT ANDREW;;DAMOKOSH ANDREW I,,https://lens.org/004-661-461-320-597,Patent Application,no,4,1,19,19,0,C07K14/47;;C12Q1/6883;;C12Q1/6886;;C12Q2600/106;;C12Q2600/112;;C12Q2600/136;;C12Q2600/158;;G01N33/574;;G01N2500/04;;A61K38/05;;A61P35/00;;A61P35/02;;A61P43/00;;Y02A90/10;;C12Q1/6886;;C12Q2600/106;;C12Q2600/112;;C12Q2600/158;;C07K14/47;;C12Q1/6883;;C12Q2600/136;;G01N2500/04;;G01N33/574;;A61K38/05;;C12Q2600/118;;G01N33/57484;;G01N2333/8107,C12Q1/68;;A61K39/395;;A61K45/00;;A61P35/00;;A61P43/00;;C07K14/47;;G01N33/574,,2,0,,,"JPN6011003461; Ｂｌｏｏｄ Ｖｏｌ． １００， Ｎｏ． １１, 20021116, ｐｐ． Ａｂｓｔｒａｃｔ Ｎｏ． １５１９．;;JPN6009052590; Ｏｎｃｏｇｅｎｅ Ｖｏｌ． １９, 2000, ｐｐ．２９１３-２９２０",INACTIVE
893,HK,A1,HK 1086027 A1,143-710-396-747-508,2006-09-08,2006,HK 06104178 A,2006-04-06,US 0338539 W;;US 43151402 P,2002-12-06,"METHODS FOR THE IDENTIFICATION, ASSESSMENT, AND TREATMENT OF PATIENTS WITH PROTEASOME INHIBITION THERAPY",,MILLENNIUM PHARM INC,MULLIGAN GEORGE;;BRYANT BARBARA M;;MORRISSEY MICHAEL P;;BOLT ANDREW;;DAMOKOSH ANDREW I,,https://lens.org/143-710-396-747-508,Patent Application,no,0,0,19,19,0,C07K14/47;;C12Q1/6883;;C12Q1/6886;;C12Q2600/106;;C12Q2600/112;;C12Q2600/136;;C12Q2600/158;;G01N33/574;;G01N2500/04;;A61K38/05;;A61P35/00;;A61P35/02;;A61P43/00;;Y02A90/10;;C12Q1/6886;;C12Q2600/106;;C12Q2600/112;;C12Q2600/158;;C07K14/47;;C12Q1/6883;;C12Q2600/136;;G01N2500/04;;G01N33/574;;A61K38/05;;C12Q2600/118;;G01N33/57484;;G01N2333/8107,C12Q/;;A61K39/395;;C07K14/47;;C12Q1/68;;G01N33/574,,0,0,,,,DISCONTINUED
894,AU,A1,AU 2003/298873 A1,156-165-622-527-185,2004-06-30,2004,AU 2003/298873 A,2003-12-04,US 43151402 P;;US 0338539 W,2002-12-06,"METHODS FOR THE IDENTIFICATION, ASSESSMENT, AND TREATMENT OF PATIENTS WITH PROTEASOME INHIBITION THERAPY",,MILLENNIUM PHARM INC,MULLIGAN GEORGE;;BRYANT BARBARA M;;MORRISSEY MICHAEL P;;BOLT ANDREW;;DAMOKOSH ANDREW I,,https://lens.org/156-165-622-527-185,Patent Application,no,0,0,19,19,0,C07K14/47;;C12Q1/6883;;C12Q1/6886;;C12Q2600/106;;C12Q2600/112;;C12Q2600/136;;C12Q2600/158;;G01N33/574;;G01N2500/04;;A61K38/05;;A61P35/00;;A61P35/02;;A61P43/00;;Y02A90/10;;C12Q1/6886;;C12Q2600/106;;C12Q2600/112;;C12Q2600/158;;C07K14/47;;C12Q1/6883;;C12Q2600/136;;G01N2500/04;;G01N33/574;;A61K38/05;;C12Q2600/118;;G01N33/57484;;G01N2333/8107,A61K39/395;;C07K14/47;;C12Q1/68;;G01N33/574,,0,0,,,,EXPIRED
895,GB,A,GB 189602056 A,068-294-425-114-104,1897-01-02,1897,GB 189602056D A,1896-01-29,GB 189602056T A,1896-01-29,Improvements in and connected with Magneto-electric Machines for Electrically Lighting Cycles and other Vehicles.,,BRYAN-HAYMES ROBERT;;WALCOTT HENRY EDWARD CHARLES;;COLLIER JOHN BRUCE;;BRYANT EDWIN GEORGE,BRYAN-HAYMES ROBERT;;WALCOTT HENRY EDWARD CHARLES;;COLLIER JOHN BRUCE;;BRYANT EDWIN GEORGE,,https://lens.org/068-294-425-114-104,Patent Application,no,0,0,1,1,0,,,,0,0,,,,DISCONTINUED
896,EP,A4,EP 1581629 A4,137-877-427-999-490,2007-05-16,2007,EP 03796633 A,2003-12-04,US 0338539 W;;US 43151402 P,2002-12-06,"METHODS FOR THE IDENTIFICATION, ASSESSMENT, AND TREATMENT OF PATIENTS WITH PROTEASOME INHIBITION THERAPY",,MILLENNIUM PHARM INC,MULLIGAN GEORGE;;BRYANT BARBARA M;;MORRISSEY MICHAEL P;;BOLT ANDREW;;DAMOKOSH ANDREW I,,https://lens.org/137-877-427-999-490,Search Report,no,0,0,19,19,0,C07K14/47;;C12Q1/6883;;C12Q1/6886;;C12Q2600/106;;C12Q2600/112;;C12Q2600/136;;C12Q2600/158;;G01N33/574;;G01N2500/04;;A61K38/05;;A61P35/00;;A61P35/02;;A61P43/00;;Y02A90/10;;C12Q1/6886;;C12Q2600/106;;C12Q2600/112;;C12Q2600/158;;C07K14/47;;C12Q1/6883;;C12Q2600/136;;G01N2500/04;;G01N33/574;;A61K38/05;;C12Q2600/118;;G01N33/57484;;G01N2333/8107,A61K39/395;;C07K14/47;;C12Q1/68;;G01N33/574,,4,3,039-853-066-287-447;;134-911-212-823-874;;008-268-890-560-614,10914553;;10.1038/sj.leu.2401812;;12171876;;10.1038/sj.onc.1203606;;10871842,"""Affymetrix GeneChip Human Genome U95 Set HG-U95A"", GENBANK GEO, 11 March 2002 (2002-03-11), XP002293987;;AN W G ET AL: ""PROTEASE INHIBITOR-INDUCED APOPTOSIS: ACCUMULATION OF WT P53, P21WAF1/CIP1, AND INDUCTION OF APOPTOSIS ARE INDEPENDENT MARKERS OF PROTEASOME INHIBITION"", LEUKEMIA, MACMILLAN PRESS LTD, US, vol. 14, no. 7, July 2000 (2000-07-01), pages 1276 - 1283, XP009081378, ISSN: 0887-6924;;AGHAJANIAN CAROL ET AL: ""A phase I trial of the novel proteasome inhibitor PS341 in advanced solid tumor malignancies."", CLINICAL CANCER RESEARCH : AN OFFICIAL JOURNAL OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH AUG 2002, vol. 8, no. 8, August 2002 (2002-08-01), pages 2505 - 2511, XP002427558, ISSN: 1078-0432;;ZIMMERMANN J ET AL: ""Proteasome inhibitor induced gene expression profiles reveal overexpression of transcriptional regulators ATF3, GADD153 and MAD1."", ONCOGENE 8 JUN 2000, vol. 19, no. 25, 8 June 2000 (2000-06-08), pages 2913 - 2920, XP002427559, ISSN: 0950-9232",EXPIRED
897,EP,B1,EP 0013711 B1,092-154-622-558-295,1984-02-15,1984,EP 79104716 A,1979-11-27,US 97284478 A,1978-12-26,PROCESS FOR THE ETCHING OF CHROME,,INTERNATIONAL BUSINESS MACHINES CORPORATION,"CHIU, GEORGE TEIN-CHU;;KITCHER, JAMES ROBERT;;OZOLS, GUNARS MIERVALDIS;;ZINGERMAN, BRYANT NILS",,https://lens.org/092-154-622-558-295,Granted Patent,yes,1,0,10,10,0,C23F4/00;;H01L21/32136;;C23F4/00;;H01L21/32136,C23F4/00;;H01L21/302;;H01L21/3065;;H01L21/308;;H01L21/3213,,0,0,,,,EXPIRED
898,EP,A2,EP 0013711 A2,095-300-469-703-389,1980-08-06,1980,EP 79104716 A,1979-11-27,US 97284478 A,1978-12-26,Process for the etching of chrome.,"Das zu ätzende Chrom wird einer Glimmentladung in einer Sauerstoff oder ein Edelgas, eine mehrfach chlorierte organische Verbindung und Wasserdampf enthaltenden Gasatmosphäre ausgesetzt. In einer solchen Gasatmosphäre werden Chrom mit einer vernünftigen Ätzgeschwindigkeit und Aluminium-Kupferlegierungen praktisch gar nicht geätzt. Die Ätzgeschwindigkeit, mit der siliciumhaltige Materialien geätzt werden, läßt sich durch Variation des Mengenverhältnisses in der Gasatmosphäre in weiten Grenzen verändern. Enthält die Gasmischung 2 Volumteile der mehrfach chlorierten organischen Verbindung, 8 Volumteile Sauerstoff oder Edelgas und 1 bis 2 Volumteile Wasserdampf, so läßt sich das Ätzen von siliciumhaltigen Materialien praktisch vollständig unterdrücken. Aufgrund dieser Eigenschaften wird das Verfahren insbesondere bei der Herstellung von integrierten Schaltungen angewandt, beispielsweise beim Ätzen einer Chromschicht (3), welche auf einem Halbleiterplättchen (1) aufgebracht und von diesem durch eine Si0 2 -Schicht (2) getrennt ist, und welche mit einer Schicht aus einer Aluminium-Kupferlegierung (4) teilweise bedeckt ist.",IBM,CHIU GEORGE TEIN-CHU;;KITCHER JAMES ROBERT;;OZOLS GUNARS MIERVALDIS;;ZINGERMAN BRYANT NILS,,https://lens.org/095-300-469-703-389,Patent Application,yes,0,1,10,10,0,C23F4/00;;H01L21/32136;;C23F4/00;;H01L21/32136,C23F4/00;;H01L21/302;;H01L21/3065;;H01L21/308;;H01L21/3213,,0,0,,,,EXPIRED
899,ES,T3,ES 2542328 T3,163-154-866-047-84X,2015-08-04,2015,ES 03796633 T,2003-12-04,US 43151402 P;;US 0338539 W,2002-12-06,"Métodos para la identificación, evaluación y tratamiento de pacientes con terapia de inhibición del proteasoma","Un método in vitro para determinar un régimen de terapia de inhibición del proteasoma para tratar un tumor en un paciente que comprende: a) determinar el nivel de expresión de marcadores en un conjunto de marcadores que comprende al menos dos marcadores de predicción seleccionados del grupo que consiste en los marcadores identificados en la Tabla 1, Tabla 2 y Tabla 3 en una muestra de paciente que comprende células tumorales; y b) determinar un régimen basado en la inhibición del proteasoma para tratar el tumor basándose en la expresión de los marcadores de predicción, en el que un nivel de expresión significativo es indicativo de que el paciente es tanto un paciente sensible como un paciente no sensible.",MILLENNIUM PHARM INC,MULLIGAN GEORGE;;BRYANT BARBARA M;;MORRISSEY MICHAEL P;;BOLT ANDREW;;DAMOKOSH ANDREW I,,https://lens.org/163-154-866-047-84X,Granted Patent,no,0,0,19,19,0,C07K14/47;;C12Q1/6883;;C12Q1/6886;;C12Q2600/106;;C12Q2600/112;;C12Q2600/136;;C12Q2600/158;;G01N33/574;;G01N2500/04;;A61K38/05;;A61P35/00;;A61P35/02;;A61P43/00;;Y02A90/10;;C12Q1/6886;;C12Q2600/106;;C12Q2600/112;;C12Q2600/158;;C07K14/47;;C12Q1/6883;;C12Q2600/136;;G01N2500/04;;G01N33/574;;A61K38/05;;C12Q2600/118;;G01N33/57484;;G01N2333/8107,C12Q1/68;;A61K39/395;;C07K14/47;;G01N33/574,,0,0,,,,EXPIRED
900,US,A1,US 2009/0181393 A1,031-266-429-331-834,2009-07-16,2009,US 31675608 A,2008-12-16,US 31675608 A;;US 72805503 A;;US 43151402 P,2002-12-06,"Methods for the identification, assessment, and treatment of patients with proteasome inhibition therapy","The present invention is directed to the identification of markers that can be used to determine whether patients with cancer are clinically responsive or non-responsive to a therapeutic regimen prior to treatment. In particular, the present invention is directed to the use of certain combinations of markers, wherein the expression of the markers correlates with responsiveness or non-responsiveness to a therapeutic regimen comprising proteasome inhibition. Thus, by examining the expression levels of individual markers and those comprising a marker set, it is possible to determine whether a therapeutic agent, or combination of agents, will be most likely to reduce the growth rate of tumors in a clinical setting.",MILLENNIUM PHARM INC,MULLIGAN GEORGE;;BRYANT BARBARA M;;MORRISSEY MICHAEL P;;BOLT ANDREW;;DAMOKOSH ANDREW I,,https://lens.org/031-266-429-331-834,Patent Application,yes,7,10,19,19,0,C07K14/47;;C12Q1/6883;;C12Q1/6886;;C12Q2600/106;;C12Q2600/112;;C12Q2600/136;;C12Q2600/158;;G01N33/574;;G01N2500/04;;A61K38/05;;A61P35/00;;A61P35/02;;A61P43/00;;Y02A90/10;;C12Q1/6886;;C12Q2600/106;;C12Q2600/112;;C12Q2600/158;;C07K14/47;;C12Q1/6883;;C12Q2600/136;;G01N2500/04;;G01N33/574;;A61K38/05;;C12Q2600/118;;G01N33/57484;;G01N2333/8107,C12Q1/68;;A61K39/395;;C07K14/47;;G01N33/574,435/6;;435/7.23,6,3,089-309-126-902-646;;103-920-702-805-783;;067-766-525-517-863,11857078;;10.1038/sj.onc.1205205;;11306489;;12490681;;10.1056/nejmoa021967,"Chauhan et al (Oncogene, February 21, 2002, 21: 1346-1358);;Hideshima et al (Cancer Research, 2001, 61: 3071-3076);;HG-U133A Annotations, CSV format, Release 34 (16 MB, 10/24/13, http://www.affymetrix.com/support/technical/annotationfilesmain.affx);;Affymetrix Library Files (http://www.affymetrix.com/support/technical/libraryfilesmain.affx, 4/28/14);;Homo sapiens DNA for HBV integration sites (GenBank: X0401.1, http://www.ncbi.nlm.nih.gov/nuccore/x04014, Nov. 16, 1998);;Van de Vijver et al. (New Engl. J. Med. 12/19/2002, 347 (25): 1999-2009)",DISCONTINUED
901,WO,A2,WO 2004/053066 A2,114-506-059-199-934,2004-06-24,2004,US 0338539 W,2003-12-04,US 43151402 P,2002-12-06,"METHODS FOR THE IDENTIFICATION, ASSESSMENT, AND TREATMENT OF PATIENTS WITH PROTEASOME INHIBITION THERAPY","The present invention is directed to the identification of markers that can be used to determine whether patients with cancer are clinically responsive or non-responsive to a therapeutic regimen prior to treatment. In particular, the present invention is directed to the use of certain combinations of markers, wherein the expression of the markers correlates with responsiveness or non-responsiveness to a therapeutic regimen comprising proteasome inhibition. Thus, by examining the expression levels of individual markers and those comprising a marker set, it is possible to determine whether a therapeutic agent, or combination of agents, will be most likely to reduce the growth rate of tumors in a clinical setting.",MILLENNIUM PHARM INC;;MULLIGAN GEORGE;;BRYANT BARBARA M;;MORRISSEY MICHAEL P;;BOLT ANDREW;;DAMOKOSH ANDREW I,MULLIGAN GEORGE;;BRYANT BARBARA M;;MORRISSEY MICHAEL P;;BOLT ANDREW;;DAMOKOSH ANDREW I,,https://lens.org/114-506-059-199-934,Patent Application,yes,35,32,19,19,0,C07K14/47;;C12Q1/6883;;C12Q1/6886;;C12Q2600/106;;C12Q2600/112;;C12Q2600/136;;C12Q2600/158;;G01N33/574;;G01N2500/04;;A61K38/05;;A61P35/00;;A61P35/02;;A61P43/00;;Y02A90/10;;C12Q1/6886;;C12Q2600/106;;C12Q2600/112;;C12Q2600/158;;C07K14/47;;C12Q1/6883;;C12Q2600/136;;G01N2500/04;;G01N33/574;;A61K38/05;;C12Q2600/118;;G01N33/57484;;G01N2333/8107,A61K39/395;;C07K14/47;;C12Q1/68;;G01N33/574,,72,57,016-133-453-246-127;;028-707-719-109-847;;029-220-392-568-41X;;005-423-448-543-174;;017-940-142-904-249;;146-606-185-618-094;;014-524-302-477-134;;145-487-172-274-602;;053-874-592-037-229;;007-722-517-643-025;;046-181-737-791-770;;040-203-335-012-937;;126-118-291-132-196;;045-087-036-200-168;;030-008-290-346-565;;080-324-372-538-905;;058-990-803-058-389;;074-458-381-494-234;;038-753-600-041-697;;045-797-364-176-052;;104-671-987-814-588;;064-342-722-122-563;;031-055-461-279-132;;092-276-393-504-749;;049-205-240-885-192;;026-164-216-541-151;;085-764-009-624-439;;106-753-778-592-300;;020-026-345-586-213;;018-961-022-027-383;;062-779-212-471-375;;020-390-505-416-055;;001-381-289-401-09X;;001-935-952-259-651;;052-629-043-995-883;;028-064-435-048-820;;023-676-781-371-861;;057-611-511-425-029;;043-108-278-056-872;;040-701-579-915-050;;101-640-792-825-42X;;055-600-609-923-599;;150-515-489-797-539;;052-083-752-569-893;;024-768-689-005-88X;;055-600-609-923-599;;019-067-182-140-449;;060-459-542-715-007;;093-342-184-971-366;;013-242-768-882-463;;073-649-029-337-454;;084-688-197-295-776;;181-995-345-726-803;;009-069-193-386-694;;009-186-473-238-939;;018-275-105-296-01X;;029-742-983-481-795,8939846;;10.1126/science.274.5293.1652;;7538441;;10.1016/1074-7613(95)90030-6;;8400144;;8864118;;10.1126/science.274.5288.782;;10.1073/pnas.88.1.189;;pmc50775;;1986365;;2308948;;10.1073/pnas.87.5.1874;;pmc53586;;pmc286648;;10.1073/pnas.86.4.1173;;2919166;;10.1038/nbt1088-1197;;7608891;;10.1021/jm00013a002;;10.1016/j.bmc.2003.09.018;;14604649;;pmc43576;;10.1073/pnas.91.8.3358;;8159752;;pmc21209;;9192616;;10.1073/pnas.94.13.6629;;pmc17900;;10468620;;10.1073/pnas.96.18.10403;;10383134;;10.7164/antibiotics.53.105;;10805568;;10.1016/s1074-5521(00)80016-2;;10508680;;10.1074/jbc.m004209200;;11278274;;8689239;;10.1016/0968-0896(95)00171-9;;pmc26193;;10.1073/pnas.93.25.14670;;8962112;;10.1093/nar/24.17.3357;;8811090;;pmc146105;;10.1093/nar/17.15.5973;;2771637;;pmc318254;;10.1073/pnas.86.17.6553;;2771942;;pmc297882;;10.1073/pnas.84.3.648;;pmc304272;;3027696;;2483657;;10.1023/a:1015985728434;;3073387;;3382986;;10.1093/bioinformatics/4.1.11;;10.1073/pnas.85.8.2444;;pmc280013;;3162770;;1172191;;10.1038/256495a0;;25291284;;10.1016/0167-5699(83)90123-8;;10.1126/science.3285471;;3285471;;pmc304886;;3106970;;10.1073/pnas.84.10.3439;;10.4049/jimmunol.139.10.3521;;3119711;;10.1073/pnas.84.1.214;;pmc304173;;3025856;;2948638;;3920532;;10.1038/314446a0;;3143014;;10.1093/jnci/80.19.1553;;10.1126/science.3929380;;3929380;;10.4049/jimmunol.141.11.4053;;3141512;;7494109;;10.3109/08830189509061738;;7521646;;10.1038/nbt0994-899;;7042536;;10.1111/j.1600-065x.1982.tb00392.x;;8064796;;10.1021/jm00043a007;;9154108;;10.1073/pnas.90.15.6909;;8394002;;pmc47044;;7972077;;pmc45243;;10.1073/pnas.91.24.11422;;8064796;;10.1021/jm00043a007;;10.1126/science.7689747;;7689747;;10.1021/jm00035a001;;8176700;;1382470;;10.1038/354082a0;;1944576;;7687751;;10.1038/364555a0;;1347427;;10.1073/pnas.89.5.1865;;pmc48554;;1696028;;10.1126/science.1696028;;2143033;;10.1126/science.2143033;;10.1073/pnas.87.16.6378;;2201029;;pmc54537;;10.1016/0022-2836(91)90213-p;;1720463;;10.1126/science.286.5439.531;;10521349,"SCIENCE, vol. 274, 1996, pages 1652 - 1659;;IMMUNITY, vol. 2, 1995, pages 493 - 506;;SEMINARS IN CANCER BIOLOGY, vol. 4, 1993, pages 219 - 229;;SCIENCE, vol. 274, 1996, pages 782;;BARANY, PROC. NATL. ACAD. SCI. USA, vol. 88, 1991, pages 189 - 193;;GUATELLI ET AL., PROC. NATL. ACAD SCI. USA, vol. 87, 1990, pages 1874 - 1878;;KWOH ET AL., PROC. NATL. ACAD. SCI. USA, vol. 86, 1989, pages 1173 - 1177;;LIZARDI ET AL., BIO/TECHNOLOGY, vol. 6, 1988, pages 1197;;IQBAL ET AL., J. MED. CHEM., vol. 38, 1995, pages 2276 - 2277;;BOUGET ET AL., BIOORG MED CHEM, vol. 17, 2003, pages 4881 - 4889;;FENTEANY ET AL., PROC. NATL. ACAD. SCI. USA, vol. 91, 1994, pages 3358;;BOGYO ET AL., PROC. NATL. ACAD. SCI., vol. 94, 1997, pages 6629;;SPALTENSTEIN ET AL., TETRAHEDRON LETT., vol. 37, 1996, pages 1343;;MENG L, PROC. NATL. ACAD SCI, vol. 96, 1999, pages 10403;;MENG LH, CANCER RES, vol. 59, 1999, pages 2798;;KOGUCHI Y, ANTIBIOT (TOKYO, vol. 53, 2000, pages 105;;KROLL M, CHEM BIOL, vol. 6, 1999, pages 689;;NAM S, J. BIOL CHEM, vol. 276, 2001, pages 13322;;""Molecular Cloning: A Laboratory Manual"", 1989, COLD SPRING HARBOR LABORATORY PRESS;;HYRUP ET AL., BIOORGANIC & MEDICINAL CHEMISTRY, vol. 4, no. 1, 1996, pages 5 - 23;;PERRY-O'KEEFE ET AL., PROC. NATL. ACAD SCI. USA, vol. 93, 1996, pages 14670 - 675;;PERRY-O'KEEFE ET AL., PROC. NATL. ACAD. SCI. USA, vol. 93, 1996, pages 14670 - 675;;FINN ET AL., NUCLEIC ACIDS RES., vol. 24, no. 17, 1996, pages 3357 - 63;;MAG ET AL., NUCLEIC ACIDS RES., vol. 17, 1989, pages 5973 - 88;;PETERSER ET AL., BIOORGANIC MED. CHEM. LETT., vol. 5, 1975, pages 1119 - 11124;;LETSINGER ET AL., PROC. NATL. ACAD SCI. USA, vol. 86, 1989, pages 6553 - 6556;;LEMAITRE ET AL., PROC. NATL. ACAD. SCI. USA, vol. 84, 1987, pages 648 - 652;;KROL ET AL., BIOLTECHNIQUES, vol. 6, 1988, pages 958 - 976;;ZON, PHARM. RES., vol. 5, 1988, pages 539 - 549;;MYERS; MILLER, CABIOS, vol. 4, 1988, pages 11 - 17;;PEARSON; LIPMAN, PROC. NATL. SCI. USA, vol. 85, 1988, pages 2444 - 2448;;KOHLER; MILSTEIN, NATURE, vol. 256, 1975, pages 495 - 497;;KOZBOR ET AL., IMMUNOL. TODAY, vol. 4, 1983, pages 72;;COLE ET AL.: ""Monoclonal Antibodies and Cancer Therapy"", 1985, ALAN R. LISS, INC., pages: 77 - 96;;""Current Protocols in Immunology"", 1994, JOHN WILEY & SONS;;BETTER ET AL., SCIENCE, vol. 240, 1988, pages 1041 - 1043;;LIU ET AL., PROC. NATL. ACAD SCI. USA, vol. 84, 1987, pages 3439 - 3443;;LIU ET AL., J IMMUNOL., vol. 139, 1987, pages 3521 - 3526;;SUN ET AL., PROC. NATL. ACAD. SCI. USA, vol. 84, 1987, pages 214 - 218;;NISHIMURA ET AL., CANCER RES., vol. 47, 1987, pages 999 - 1005;;WOOD ET AL., NATURE, vol. 314, 1985, pages 446 - 449;;SHAW ET AL., J NATL. CANCER INST., vol. 80, 1988, pages 1553 - 1559;;MORRISON, SCIENCE, vol. 229, 1985, pages 1202 - 1207;;OI ET AL., BIO/TECHNIQUES, vol. 4, 1986, pages 214;;JONES ET AL., NATURE, vol. 321, 1986, pages 552 - 525;;VERHOEYAN ET AL., SCIENCE, vol. 239, 1988, pages 1534;;BEIDLER ET AL., J. IMMUNOL., vol. 141, 1988, pages 4053 - 4060;;LONBERG; HUSZAR, INT. REV. LMMUNOL., vol. 13, 1995, pages 65 - 93;;JESPERS ET AL., BIO/TECHNOLOGY, vol. 12, 1994, pages 899 - 903;;""Monoclonal Antibodies'84: Biological And Clinical Applications"", 1985, pages: 475 - 506;;""Monoclonal Antibodies For Cancer Detection And Therapy"", 1985, ACADEMIC PRESS, article ""Analysis, Results, And Future Prospective Of The Therapeutic Use Of Radiolabeled Antibody In Cancer Therapy"", pages: 303 - 16;;THORPE ET AL.: ""Immunol. Rev."", vol. 62, 1982, article ""The Preparation And Cytotoxic Properties Of Antibody-Toxin Conjugates"", pages: 119 - 58;;ZUCKERMANN ET AL., J. MED. CHEM., vol. 37, 1994, pages 2678 - 85;;LAM, ANTICANCER DRUG DES., vol. 12, 1997, pages 145;;DEWITT ET AL., PROC. NATL. ACAD. SCI. U.S.A., vol. 90, 1993, pages 6909;;ERB ET AL., PROC. NATL. ACAD. SCI. USA, vol. 91, 1994, pages 11422;;ZUCKERMANN ET AL., J. MED. CHEM., vol. 37, 1994, pages 2678;;CHO ET AL., SCIENCE, vol. 261, 1993, pages 1303;;CARRELL ET AL., ANGEW. CHEM. INT. ED. ENGL., vol. 33, 1994, pages 2059;;CARELL ET AL., ANGEW. CHEM. INT. ED. ENGL., vol. 33, 1994, pages 2061;;GALLOP ET AL., J. MED. CHEM., vol. 37, 1994, pages 1233;;HOUGHTEN, BIOTECHNIQUES, vol. 13, 1992, pages 412 - 421;;LAM, NATURE, vol. 354, 1991, pages 82 - 84;;FODOR, NATURE, vol. 364, 1993, pages 555 - 556;;CULL ET AL., PROC NATL ACAD SCI USA, vol. 89, 1992, pages 1865 - 1869;;SCOTT; SMITH, SCIENCE, vol. 249, 1990, pages 386 - 390;;DEVLIN, SCIENCE, vol. 249, 1990, pages 404 - 406;;CWIRLA ET AL., PROC. NATL. ACAD SCI., vol. 87, 1990, pages 6378 - 6382;;FELICI, J. MOL. BIOL., vol. 222, 1991, pages 301 - 310;;GOLUB ET AL.: ""Molecular Classification of Cancer: Class discovery and class prediction by marker expression monitoring"", SCIENCE, vol. 286, 1999, pages 531 - 537;;CONOVER, W. J.: ""Practical Nonparametric Statistics"", 1980, JOHN WILEY & SONS;;GOLUB ET AL.: ""Molecular Classification of Cancer: Class discovery and class prediction by marker expression monitoring."", SCIENCE, vol. 286, 1999, pages 531 - 537",PENDING
902,CA,C,CA 2508348 C,059-027-628-734-669,2016-07-12,2016,CA 2508348 A,2003-12-04,US 43151402 P;;US 0338539 W,2002-12-06,"METHODS FOR THE IDENTIFICATION, ASSESSMENT, AND TREATMENT OF PATIENTS WITH PROTEASOME INHIBITION THERAPY","The present invention is directed to the identification of markers that can be used to determine whether patients with cancer are clinically responsive or non-responsive to a therapeutic regimen prior to treatment. In particular, the present invention is directed to the use of certain combinations of markers, wherein the expression of the markers correlates with responsiveness or non-responsiveness to a therapeutic regimen comprising proteasome inhibition. Thus, by examining the expression levels of individual markers and those comprising a marker set, it is possible to determine whether a therapeutic agent, or combination of agents, will be most likely to reduce the growth rate of tumors in a clinical setting.",MILLENNIUM PHARM INC,MULLIGAN GEORGE;;BRYANT BARBARA M;;MORRISSEY MICHAEL P;;BOLT ANDREW;;DAMOKOSH ANDREW I,,https://lens.org/059-027-628-734-669,Granted Patent,no,0,0,19,19,0,C07K14/47;;C12Q1/6883;;C12Q1/6886;;C12Q2600/106;;C12Q2600/112;;C12Q2600/136;;C12Q2600/158;;G01N33/574;;G01N2500/04;;A61K38/05;;A61P35/00;;A61P35/02;;A61P43/00;;Y02A90/10;;C12Q1/6886;;C12Q2600/106;;C12Q2600/112;;C12Q2600/158;;C07K14/47;;C12Q1/6883;;C12Q2600/136;;G01N2500/04;;G01N33/574;;A61K38/05;;C12Q2600/118;;G01N33/57484;;G01N2333/8107,C12Q1/68;;A61K31/4965;;A61K38/05;;A61K39/395;;C07K14/47;;G01N33/574,,0,0,,,,EXPIRED
903,IT,A0,IT 7928126 A0,148-045-317-102-846,1979-12-18,1979,IT 2812679 A,1979-12-18,US 97284478 A,1978-12-26,PROCESSO DI ATTACCO DI CROMO MEDIANTE SCARICA A BAGLIORE.,,IBM,TEIN-CHU CHIU GEORGE;;ROBERT KITCHER JAMES;;MIERVALDIS OZOLS GUNARS;;NILS ZINGERMAN BRYANT,,https://lens.org/148-045-317-102-846,Patent Application,no,0,0,10,10,0,C23F4/00;;H01L21/32136;;C23F4/00;;H01L21/32136,C23F4/00;;H01L21/302;;H01L21/3065;;H01L21/308;;H01L21/3213,,0,0,,,,EXPIRED
904,EP,A3,EP 0013711 A3,170-159-362-514-295,1981-09-16,1981,EP 79104716 A,1979-11-27,US 97284478 A,1978-12-26,PROCESS FOR THE ETCHING OF CHROME,"Das zu ätzende Chrom wird einer Glimmentladung in einer Sauerstoff oder ein Edelgas, eine mehrfach chlorierte organische Verbindung und Wasserdampf enthaltenden Gasatmosphäre ausgesetzt. In einer solchen Gasatmosphäre werden Chrom mit einer vernünftigen Ätzgeschwindigkeit und Aluminium-Kupferlegierungen praktisch gar nicht geätzt. Die Ätzgeschwindigkeit, mit der siliciumhaltige Materialien geätzt werden, läßt sich durch Variation des Mengenverhältnisses in der Gasatmosphäre in weiten Grenzen verändern. Enthält die Gasmischung 2 Volumteile der mehrfach chlorierten organischen Verbindung, 8 Volumteile Sauerstoff oder Edelgas und 1 bis 2 Volumteile Wasserdampf, so läßt sich das Ätzen von siliciumhaltigen Materialien praktisch vollständig unterdrücken. Aufgrund dieser Eigenschaften wird das Verfahren insbesondere bei der Herstellung von integrierten Schaltungen angewandt, beispielsweise beim Ätzen einer Chromschicht (3), welche auf einem Halbleiterplättchen (1) aufgebracht und von diesem durch eine Si0 2 -Schicht (2) getrennt ist, und welche mit einer Schicht aus einer Aluminium-Kupferlegierung (4) teilweise bedeckt ist.",INTERNATIONAL BUSINESS MACHINES CORPORATION,"CHIU, GEORGE TEIN-CHU;;KITCHER, JAMES ROBERT;;OZOLS, GUNARS MIERVALDIS;;ZINGERMAN, BRYANT NILS",,https://lens.org/170-159-362-514-295,Search Report,yes,2,0,10,10,0,C23F4/00;;H01L21/32136;;C23F4/00;;H01L21/32136,C23F4/00;;H01L21/302;;H01L21/3065;;H01L21/308;;H01L21/3213,,2,1,038-253-057-604-134,10.1149/1.2133230,"JOURNAL OF THE ELECTROCHEMICAL SOCIETY, vol. 124, no. 1, Januar 1977, Princeton, (US) J.F. BATTEY: ""The reduction of photoresist stripping rates in an oxygen plasma by by-product inhibition and thermal mass"", Seiten 147-152;;PROCEEDINGS OF THE 6th CONFERENCE ON SOLID STATE DEVICES, Tokyo 1974, Supplement to the journal of the Japan Society of Applied Physics, vol. 44, 1975, Tokyo, (JP) H. ABE: ""The application of gas plasma to the fabrication of MOS LSI"", Seiten 287-295",EXPIRED
905,CA,A1,CA 2508348 A1,000-093-204-308-468,2004-06-24,2004,CA 2508348 A,2003-12-04,US 43151402 P;;US 0338539 W,2002-12-06,"METHODS FOR THE IDENTIFICATION, ASSESSMENT, AND TREATMENT OFPATIENTS WITH PROTEASOME INHIBITION THERAPY",,MILLENNIUM PHARM INC,BOLT ANDREW;;MORRISSEY MICHAEL P;;MULLIGAN GEORGE;;DAMOKOSH ANDREW I;;BRYANT BARBARA M,,https://lens.org/000-093-204-308-468,Patent Application,no,0,0,19,19,0,C07K14/47;;C12Q1/6883;;C12Q1/6886;;C12Q2600/106;;C12Q2600/112;;C12Q2600/136;;C12Q2600/158;;G01N33/574;;G01N2500/04;;A61K38/05;;A61P35/00;;A61P35/02;;A61P43/00;;Y02A90/10;;C12Q1/6886;;C12Q2600/106;;C12Q2600/112;;C12Q2600/158;;C07K14/47;;C12Q1/6883;;C12Q2600/136;;G01N2500/04;;G01N33/574;;A61K38/05;;C12Q2600/118;;G01N33/57484;;G01N2333/8107,A61K39/395;;C07K14/47;;C12Q1/68;;G01N33/574,,0,0,,,,EXPIRED
906,EP,B1,EP 1581629 B1,097-145-919-249-917,2015-04-01,2015,EP 03796633 A,2003-12-04,US 0338539 W;;US 43151402 P,2002-12-06,"METHODS FOR THE IDENTIFICATION, ASSESSMENT, AND TREATMENT OF PATIENTS WITH PROTEASOME INHIBITION THERAPY",,MILLENNIUM PHARM INC,MULLIGAN GEORGE;;BRYANT BARBARA M;;MORRISSEY MICHAEL P;;BOLT ANDREW;;DAMOKOSH ANDREW I,,https://lens.org/097-145-919-249-917,Granted Patent,yes,0,0,19,19,0,C07K14/47;;C12Q1/6883;;C12Q1/6886;;C12Q2600/106;;C12Q2600/112;;C12Q2600/136;;C12Q2600/158;;G01N33/574;;G01N2500/04;;A61K38/05;;A61P35/00;;A61P35/02;;A61P43/00;;Y02A90/10;;C12Q1/6886;;C12Q2600/106;;C12Q2600/112;;C12Q2600/158;;C07K14/47;;C12Q1/6883;;C12Q2600/136;;G01N2500/04;;G01N33/574;;A61K38/05;;C12Q2600/118;;G01N33/57484;;G01N2333/8107,C12Q1/68;;A61K39/395;;C07K14/47;;G01N33/574,,1,1,059-577-188-234-21X,10699311;;10.1016/s0169-409x(99)00062-9,"SUDIMACK J ET AL: ""TARGETED DRUG DELIVERY VIA THE FOLATE RECEPTOR"", ADVANCED DRUG DELIVERY REVIEWS, ELSEVIER, AMSTERDAM, NL, vol. 41, no. 2, 1 January 2000 (2000-01-01), pages 147 - 162, XP000990851, ISSN: 0169-409X, DOI: 10.1016/S0169-409X(99)00062-9",EXPIRED
907,DE,D1,DE 2966686 D1,135-936-142-133-954,1984-03-22,1984,DE 2966686 T,1979-11-27,US 97284478 A,1978-12-26,PROCESS FOR THE ETCHING OF CHROME,,IBM,CHIU GEORGE TEIN-CHU;;KITCHER JAMES ROBERT;;OZOLS GUNARS MIERVALDIS;;ZINGERMAN BRYANT NILS,,https://lens.org/135-936-142-133-954,Granted Patent,no,0,0,10,10,0,C23F4/00;;H01L21/32136;;C23F4/00;;H01L21/32136,C23F4/00;;H01L21/302;;H01L21/3065;;H01L21/308;;H01L21/3213,,0,0,,,,EXPIRED
908,WO,A3,WO 2004/053066 A3,025-753-120-328-259,2006-09-08,2006,US 0338539 W,2003-12-04,US 43151402 P,2002-12-06,"METHODS FOR THE IDENTIFICATION, ASSESSMENT, AND TREATMENT OF PATIENTS WITH PROTEASOME INHIBITION THERAPY","The present invention is directed to the identification of markers that can be used to determine whether patients with cancer are clinically responsive or non-responsive to a therapeutic regimen prior to treatment. In particular, the present invention is directed to the use of certain combinations of markers, wherein the expression of the markers correlates with responsiveness or non-responsiveness to a therapeutic regimen comprising proteasome inhibition. Thus, by examining the expression levels of individual markers and those comprising a marker set, it is possible to determine whether a therapeutic agent, or combination of agents, will be most likely to reduce the growth rate of tumors in a clinical setting.",MILLENNIUM PHARM INC;;MULLIGAN GEORGE;;BRYANT BARBARA M;;MORRISSEY MICHAEL P;;BOLT ANDREW;;DAMOKOSH ANDREW I,MULLIGAN GEORGE;;BRYANT BARBARA M;;MORRISSEY MICHAEL P;;BOLT ANDREW;;DAMOKOSH ANDREW I,,https://lens.org/025-753-120-328-259,Search Report,no,0,0,19,19,0,C07K14/47;;C12Q1/6883;;C12Q1/6886;;C12Q2600/106;;C12Q2600/112;;C12Q2600/136;;C12Q2600/158;;G01N33/574;;G01N2500/04;;A61K38/05;;A61P35/00;;A61P35/02;;A61P43/00;;Y02A90/10;;C12Q1/6886;;C12Q2600/106;;C12Q2600/112;;C12Q2600/158;;C07K14/47;;C12Q1/6883;;C12Q2600/136;;G01N2500/04;;G01N33/574;;A61K38/05;;C12Q2600/118;;G01N33/57484;;G01N2333/8107,C12Q1/00;;A01N55/08;;A61K39/395;;C07H21/02;;C07K14/47;;C12Q1/60;;C12Q1/68;;G01N33/53;;G01N33/574,,4,4,134-684-144-981-813;;074-147-835-645-394;;082-177-571-545-468;;084-615-067-249-328,10363983;;10.1634/theoncologist.7-1-9;;11854543;;10.1093/clinchem/46.5.673;;10794750;;12575774,"ADAMS J. ET AL.: ""Protease Inhibitors: A Novel Class of Potent and Effective Antitumor Agents"", CANCER RESEARCH, vol. 59, 1 June 1999 (1999-06-01), pages 2615 - 2622, XP002168152;;ADAMS J. ET AL.: ""J. Development of The Proteasome Inhibitor PS-341"", THE ONCOLOGIST, vol. 7, February 2002 (2002-02-01), pages 9 - 16, XP003000262;;LIGHTCAP E.S. ET AL.: ""Proteasome Inhibition Measurements"", CLINICAL APPLICATION. CLINICAL CHEMISTRY, vol. 46, no. 5, 2000, pages 673 - 683, XP003000263;;HOCHWALD ET AL: ""Antineoplastic Therapy in Colorectal Cancer Through Proteasome Inhibition"", THE AMERICAN SURGEON, vol. 69, no. 1, January 2003 (2003-01-01), pages 15 - 23, XP008068421",PENDING
909,AU,B2,AU 2003/298873 B2,046-471-573-461-614,2011-09-01,2011,AU 2003/298873 A,2003-12-04,US 43151402 P;;US 0338539 W,2002-12-06,"Methods for the identification, assessment, and treatment of patients with proteasome inhibition therapy","The present invention is directed to the identification of markers that can be used to determine whether patients with cancer are clinically responsive or non-responsive to a therapeutic regimen prior to treatment. In particular, the present invention is directed to the use of certain combinations of markers, wherein the expression of the markers correlates with responsiveness or non-responsiveness to a therapeutic regimen comprising proteasome inhibition. Thus, by examining the expression levels of individual markers and those comprising a marker set, it is possible to determine whether a therapeutic agent, or combination of agents, will be most likely to reduce the growth rate of tumors in a clinical setting.",MILLENNIUM PHARM INC,MORRISSEY MICHAEL P;;MULLIGAN GEORGE;;BOLT ANDREW;;DAMOKOSH ANDREW I;;BRYANT BARBARA M,,https://lens.org/046-471-573-461-614,Granted Patent,no,0,0,19,19,0,C07K14/47;;C12Q1/6883;;C12Q1/6886;;C12Q2600/106;;C12Q2600/112;;C12Q2600/136;;C12Q2600/158;;G01N33/574;;G01N2500/04;;A61K38/05;;A61P35/00;;A61P35/02;;A61P43/00;;Y02A90/10;;C12Q1/6886;;C12Q2600/106;;C12Q2600/112;;C12Q2600/158;;C07K14/47;;C12Q1/6883;;C12Q2600/136;;G01N2500/04;;G01N33/574;;A61K38/05;;C12Q2600/118;;G01N33/57484;;G01N2333/8107,C12Q1/68;;A61K39/395;;C07K14/47;;G01N33/574,,2,1,022-156-682-553-621,9836559;;10.1016/s0090-4295(98)00360-4,"""Affymetrix GeneChip Human Genome U95 Set HG-U95A"" GENBANK GEO, 11 March 2002;;MACKEY, T. J. et al., Urology, 1998, Vol. 52, pages 1085-1090.",EXPIRED
910,DE,C2,DE 3739064 C2,096-088-379-524-919,1990-12-20,1990,DE 3739064 A,1987-11-17,US 93200286 A,1986-11-18,DE 3739064 C2,,"UNION CARBIDE CORP., DANBURY, CONN., US","ABATJOGLOU, ANTHONY GEORGE, CARLESTON, VA., US;;BRYANT, DAVID ROBERT, SOUTH CHARLESTON, VA., US",,https://lens.org/096-088-379-524-919,Granted Patent,no,0,2,53,53,0,C07C45/50;;Y02P20/582;;C07C47/55;;C07C47/02;;C07C45/50;;Y02P20/582,B01J31/24;;B01J31/00;;B01J31/28;;C07B61/00;;C07C45/00;;C07C45/50;;C07C47/02;;C07C67/00,,0,0,,,,EXPIRED
911,WO,A1,WO 1985/003702 A1,027-424-061-044-808,1985-08-29,1985,US 8500231 W,1985-02-15,US 58135284 A;;US 68502584 A,1984-02-17,TRANSITION METAL COMPLEX CATALYZED REACTIONS,"Transition metal-diorganophosphite complex catalyzed carbonylation processes, especially hydroformylation, as well as transition metal-diorganophosphite ligand complex compositions, diorganophosphite ligands and transition metal-diorganophosphite catalysts.",UNION CARBIDE CORP,BILLIG ERNEST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT;;MURRAY REX EUGENE;;MAHER JOHN MICHAEL,,https://lens.org/027-424-061-044-808,Patent Application,yes,4,26,45,77,0,B01J31/185;;B01J2231/321;;B01J2531/0266;;B01J2531/822;;C07C45/50;;C07F9/65744;;C07F9/6578;;C07F15/008;;Y02P20/582;;C07F15/008;;C07C45/50;;C07F9/6578;;B01J31/185;;B01J2531/0266;;B01J2231/321;;C07F9/65744;;B01J2531/822;;Y02P20/582,B01J27/18;;B01J31/18;;C07C47/02;;B01J31/20;;C07B61/00;;C07C45/00;;C07C45/50;;C07C67/00;;C07F9/06;;C07F9/547;;C07F9/6564;;C07F9/6574;;C07F9/6578;;C07F15/00,C2C CJE;;C2C CTH;;C2C C20Y;;C2C C228;;C2C C248;;C2C C30Y;;C2C C304;;C2C C350;;C2C C40Y;;C2C C408;;C2C C54X;;C2C C568;;C2C C569;;C2C C65Y;;C2P PG            P2E;;C2P PG            P3B;;C2P PG            P3C;;C2P P1L1          P3B;;C2P P2E12B        P2E;;C2P P2E15C        P2E;;C2P P2E26A        P2E;;C2P P2E26B        P2E;;C2P P2E26C        P2E;;C2P P3B12B        P3B;;C2P P3B14B        P3B;;C2P P3B15B        P3B;;C2P P3B18C        P3B;;C2P P3B19B        P3B;;C2P P3B19C        P3B;;C2P P3B19D        P3B;;C2P P3B19E        P3B;;C2P P3B20         P3B;;C2P P3B21         P3B;;C2P P3C12B        P3C;;C2P P3C15         P3C;;C2P P3C30A        P3C;;C2P P3C30B        P3C;;C2P P6            P2E;;C2P P6            P3B;;C2P P6            P3C;;C2P P7            P2E;;C2P P7            P3B;;C2P P7            P3C;;U1S S1345,0,0,,,,PATENTED
912,FI,A0,FI 854059 A0,040-505-181-756-530,1985-10-17,1985,FI 854059 A,1985-10-17,US 58135284 A;;US 68502584 A;;US 8500231 W,1984-02-17,REAKTIONER KATALYSERADE MED TRANSITIONSMETALLKOMPLEX.,"Transition metal-diorganophosphite complex catalyzed carbonylation processes, especially hydroformylation, as well as transition metal-diorganophosphite ligand complex compositions, diorganophosphite ligands and transition metal-diorganophosphite catalysts.",UNION CARBIDE CORP,BILLIG ERNEST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT;;MURRAY REX EUGENE;;MAHER JOHN MICHAEL,,https://lens.org/040-505-181-756-530,Patent Application,no,0,0,45,77,0,B01J31/185;;B01J2231/321;;B01J2531/0266;;B01J2531/822;;C07C45/50;;C07F9/65744;;C07F9/6578;;C07F15/008;;Y02P20/582;;C07F15/008;;C07C45/50;;C07F9/6578;;B01J31/185;;B01J2531/0266;;B01J2231/321;;C07F9/65744;;B01J2531/822;;Y02P20/582,B01J27/18;;B01J31/18;;C07C47/02;;B01J31/20;;C07B61/00;;C07C45/00;;C07C45/50;;C07C67/00;;C07F9/06;;C07F9/547;;C07F9/6564;;C07F9/6574;;C07F9/6578;;C07F15/00,,0,0,,,,EXPIRED
913,DK,D0,DK 473485 D0,144-693-007-302-033,1985-10-16,1985,DK 473485 A,1985-10-16,US 58135284 A;;US 68502584 A;;US 8500231 W,1984-02-17,MED OVERGANGSMETALKOMPLEKS KATALYSEREDE REAKTIONER,"Transition metal-diorganophosphite complex catalyzed carbonylation processes, especially hydroformylation, as well as transition metal-diorganophosphite ligand complex compositions, diorganophosphite ligands and transition metal-diorganophosphite catalysts.",UNION CARBIDE CORP,BILLIG ERNEST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT;;MURAY REX EUGENE;;MAHER JOHN MICHAEL,,https://lens.org/144-693-007-302-033,Patent Application,no,0,0,45,77,0,B01J31/185;;B01J2231/321;;B01J2531/0266;;B01J2531/822;;C07C45/50;;C07F9/65744;;C07F9/6578;;C07F15/008;;Y02P20/582;;C07F15/008;;C07C45/50;;C07F9/6578;;B01J31/185;;B01J2531/0266;;B01J2231/321;;C07F9/65744;;B01J2531/822;;Y02P20/582,B01J27/18;;B01J31/18;;B01J31/20;;C07C47/02;;C07B61/00;;C07C45/00;;C07C45/50;;C07C67/00;;C07F9/06;;C07F9/547;;C07F9/6564;;C07F9/6574;;C07F9/6578;;C07F15/00,,0,0,,,,DISCONTINUED
914,DE,T2,DE 3586878 T2,086-737-798-682-940,1993-06-24,1993,DE 3586878 T,1985-02-15,US 58135284 A;;US 68502584 A,1984-02-17,DURCH UEBERGANGSMETALL-KOMPLEXVERBINDUNGEN KATALYSIERTE REAKTIONEN.,"Transition metal-diorganophosphite complex catalyzed carbonylation processes, especially hydroformylation, as well as transition metal-diorganophosphite ligand complex compositions, diorganophosphite ligands and transition metal-diorganophosphite catalysts.",UNION CARBIDE CORP,BILLIG ERNST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT;;MURRAY REX EUGENE;;MAHER JOHN MICHAEL,,https://lens.org/086-737-798-682-940,Granted Patent,no,0,0,45,77,0,B01J31/185;;B01J2231/321;;B01J2531/0266;;B01J2531/822;;C07C45/50;;C07F9/65744;;C07F9/6578;;C07F15/008;;Y02P20/582;;C07F15/008;;C07C45/50;;C07F9/6578;;B01J31/185;;B01J2531/0266;;B01J2231/321;;C07F9/65744;;B01J2531/822;;Y02P20/582,B01J27/18;;B01J31/18;;B01J31/20;;C07B61/00;;C07C47/02;;C07C45/00;;C07C45/50;;C07C67/00;;C07F9/06;;C07F9/547;;C07F9/6564;;C07F9/6574;;C07F9/6578;;C07F15/00,,0,0,,,,EXPIRED
915,FI,B,FI 88709 B,132-824-385-609-165,1993-03-15,1993,FI 854059 A,1985-10-17,US 58135284 A;;US 68502584 A;;US 8500231 W,1984-02-17,"Hydroformylation process for production of aldehydes, rhodium-diorganophosphite-based catalysts, precursor mixtures thereof and diorganophosphites","Transition metal-diorganophosphite complex catalyzed carbonylation processes, especially hydroformylation, as well as transition metal-diorganophosphite ligand complex compositions, diorganophosphite ligands and transition metal-diorganophosphite catalysts.",UNION CARBIDE CORP,BILLIG ERNEST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT;;MURRAY REX EUGENE;;MAHER JOHN MICHAEL,,https://lens.org/132-824-385-609-165,Patent Application,no,0,0,45,77,0,B01J31/185;;B01J2231/321;;B01J2531/0266;;B01J2531/822;;C07C45/50;;C07F9/65744;;C07F9/6578;;C07F15/008;;Y02P20/582;;C07F15/008;;C07C45/50;;C07F9/6578;;B01J31/185;;B01J2531/0266;;B01J2231/321;;C07F9/65744;;B01J2531/822;;Y02P20/582,B01J27/18;;B01J31/18;;C07C47/02;;B01J31/20;;C07B61/00;;C07C45/00;;C07C45/50;;C07C67/00;;C07F9/06;;C07F9/547;;C07F9/6564;;C07F9/6574;;C07F9/6578;;C07F15/00,,0,0,,,,EXPIRED
916,US,A1,US 2006/0087965 A1,139-576-605-762-909,2006-04-27,2006,US 97607604 A,2004-10-27,US 97607604 A,2004-10-27,Method and apparatus for forwarding data in a data communications network,"A method of forwarding data in a data communications network having a plurality of nodes comprises the steps, performed at a repairing node, of computing the repair path around a network component to a target node and forwarding data along the repair path. The computing step comprises the step of computing an intermediate node reachable by the repairing node and from which the target node can be reached. The forwarding step includes the step of constructing a Multi-Protocol Label Switching (MPLS) packet for forwarding to the intermediate node.",SHAND IAN MICHAEL C;;BRYANT STEWART F;;CHARNY ANNA;;DAVIE BRUCE S;;SWALLOW GEORGE,SHAND IAN MICHAEL C;;BRYANT STEWART F;;CHARNY ANNA;;DAVIE BRUCE S;;SWALLOW GEORGE,CISCO TECHNOLOGY INC (2004-10-18),https://lens.org/139-576-605-762-909,Patent Application,yes,99,29,2,2,0,H04L41/0663;;H04L45/22;;H04L45/28;;H04L45/50;;H04Q3/66;;H04Q2213/13141;;H04Q2213/13145;;H04Q2213/13166;;H04Q2213/13204;;H04Q2213/13348;;H04Q2213/13389;;H04L69/40;;H04L45/00;;H04Q2213/13141;;H04Q2213/13166;;H04Q2213/13348;;H04L45/22;;H04Q2213/13145;;H04Q2213/13389;;H04Q2213/13204;;H04Q3/66;;H04L45/50;;H04L41/0663;;H04L45/28;;H04L69/40,H04J3/14;;H04J1/16;;H04L12/56,370/218;;370/389;;370/222,0,0,,,,INACTIVE
917,FI,L,FI 854059 L,193-760-794-781-612,1985-10-17,1985,FI 854059 A,1985-10-17,US 58135284 A;;US 68502584 A;;US 8500231 W,1984-02-17,REAKTIONER KATALYSERADE MED TRANSITIONSMETALLKOMPLEX.,"The invention relates to transition metal- diorganophosphite complex-catalysed carbonylation processes, especially hydroformylation, and also transition metals, diorganophosphite ligand complex mixtures, diorganophosphite ligands and transition metal- diorganophosphite catalysts.",UNION CARBIDE CORP,BILLIG ERNEST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT;;MURRAY REX EUGENE;;MAHER JOHN MICHAEL,,https://lens.org/193-760-794-781-612,Abstract,no,0,0,45,77,0,B01J31/185;;B01J2231/321;;B01J2531/0266;;B01J2531/822;;C07C45/50;;C07F9/65744;;C07F9/6578;;C07F15/008;;Y02P20/582;;C07F15/008;;C07C45/50;;C07F9/6578;;B01J31/185;;B01J2531/0266;;B01J2231/321;;C07F9/65744;;B01J2531/822;;Y02P20/582,B01J27/18;;C07C47/02;;B01J31/18;;B01J31/20;;C07B61/00;;C07C45/00;;C07C45/50;;C07C67/00;;C07F9/06;;C07F9/547;;C07F9/6564;;C07F9/6574;;C07F9/6578;;C07F15/00,,0,0,,,,EXPIRED
918,CN,B,CN 1019110 B,002-056-975-752-655,1992-11-18,1992,CN 85104683 A,1985-06-19,CN 85104683 A;;US 58135284 A,1984-02-17,TRANSITION METAL COMPLEX CATALYZE REACTION,,UNION CARBIDE CORP,BILLIG ERNEST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT;;MURRAY REX EUGENE;;MAHER JOHN MICHAEL,,https://lens.org/002-056-975-752-655,Patent Application,no,0,0,5,77,0,,C07C47/02;;B01J/;;B01J31/22;;C07B41/06;;C07C27/22;;C07C29/16;;C07C45/49;;C07C45/50;;C07C47/00,,0,0,,,,EXPIRED
919,YU,B,YU 44255 B,057-895-427-692-148,1990-04-30,1990,YU 22585 A,1985-02-15,US 58135284 A;;US 68502584 A,1984-02-17,CONTINUAL PROCESS FOR OBTAINING ALDEHIDES BY HYDROFORMYLATING OLEPHINES IN CATALYZER PRESENCE,"Transition metal-diorganophosphite complex catalyzed carbonylation processes, especially hydroformylation, as well as transition metal-diorganophosphite ligand complex compositions, diorganophosphite ligands and transition metal-diorganophosphite catalysts.",UNION CARBIDE CORP,BILLIG ERNEST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT;;MURRAY REX EUGENE;;MAHER JOHN MICHAEL,,https://lens.org/057-895-427-692-148,Granted Patent,no,0,0,45,77,0,B01J31/185;;B01J2231/321;;B01J2531/0266;;B01J2531/822;;C07C45/50;;C07F9/65744;;C07F9/6578;;C07F15/008;;Y02P20/582;;C07F15/008;;C07C45/50;;C07F9/6578;;B01J31/185;;B01J2531/0266;;B01J2231/321;;C07F9/65744;;B01J2531/822;;Y02P20/582,B01J27/18;;B01J31/18;;B01J31/20;;C07B61/00;;C07C47/02;;C07C45/00;;C07C45/50;;C07C67/00;;C07F9/06;;C07F9/547;;C07F9/6564;;C07F9/6574;;C07F9/6578;;C07F15/00,,0,0,,,,EXPIRED
920,HU,B,HU 202176 B,077-779-143-210-896,1991-02-28,1991,HU 105885 A,1985-02-15,US 8500231 W;;US 58135284 A;;US 68502584 A,1984-02-17,PROCESS FOR PRODUCING ALDEHYDES BY CATALYTIC HYDROFORMYLATION OF OLEFINS WITH RHODIUM COMPLEXES,"Transition metal-diorganophosphite complex catalyzed carbonylation processes, especially hydroformylation, as well as transition metal-diorganophosphite ligand complex compositions, diorganophosphite ligands and transition metal-diorganophosphite catalysts.",UNION CARBIDE CORP,BILLIG ERNEST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT;;MURRAY REX EUGENE;;MAHER JOHN MICHAEL,,https://lens.org/077-779-143-210-896,Granted Patent,no,0,0,45,77,0,B01J31/185;;B01J2231/321;;B01J2531/0266;;B01J2531/822;;C07C45/50;;C07F9/65744;;C07F9/6578;;C07F15/008;;Y02P20/582;;C07F15/008;;C07C45/50;;C07F9/6578;;B01J31/185;;B01J2531/0266;;B01J2231/321;;C07F9/65744;;B01J2531/822;;Y02P20/582,B01J27/18;;B01J31/18;;C07C47/02;;B01J31/20;;C07B61/00;;C07C45/00;;C07C45/50;;C07C67/00;;C07F9/06;;C07F9/547;;C07F9/6564;;C07F9/6574;;C07F9/6578;;C07F15/00,,0,0,,,,EXPIRED
921,HU,A,HU T41724 A,168-462-371-346-879,1987-05-28,1987,HU 105885 A,1985-02-15,US 8500231 W;;US 58135284 A;;US 68502584 A,1984-02-17,"PROCESS FOR THE HYDROFORMYLATION OF OLEFINS, CATALYZED WITH COMPLEXES OF TRANSITION METALS","Transition metal-diorganophosphite complex catalyzed carbonylation processes, especially hydroformylation, as well as transition metal-diorganophosphite ligand complex compositions, diorganophosphite ligands and transition metal-diorganophosphite catalysts.",UNION CARBIDE CORP,BILLIG ERNEST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT;;MURRAY REX EUGENE;;MAHER JOHN MICHAEL,,https://lens.org/168-462-371-346-879,Unknown,no,0,0,45,77,0,B01J31/185;;B01J2231/321;;B01J2531/0266;;B01J2531/822;;C07C45/50;;C07F9/65744;;C07F9/6578;;C07F15/008;;Y02P20/582;;C07F15/008;;C07C45/50;;C07F9/6578;;B01J31/185;;B01J2531/0266;;B01J2231/321;;C07F9/65744;;B01J2531/822;;Y02P20/582,B01J27/18;;B01J31/18;;C07C47/02;;B01J31/20;;C07B61/00;;C07C45/00;;C07C45/50;;C07C67/00;;C07F9/06;;C07F9/547;;C07F9/6564;;C07F9/6574;;C07F9/6578;;C07F15/00,,0,0,,,,EXPIRED
922,NO,B,NO 165915 B,010-028-809-745-603,1991-01-21,1991,NO 854113 A,1985-10-16,US 58135284 A;;US 68502584 A;;US 8500231 W,1984-02-17,"HYDROFORMYLERINGSPROSESS, DIORGANOFOSFITT-LIGAND OG RHODIUM-KOMPLEKSKATALYSATOR TIL BRUK VED FREMGANGSMAATEN SAMT ETKATALYSATORFORLOEPERPREPARAT.","Transition metal-diorganophosphite complex catalyzed carbonylation processes, especially hydroformylation, as well as transition metal-diorganophosphite ligand complex compositions, diorganophosphite ligands and transition metal-diorganophosphite catalysts.",UNION CARBIDE CORP,BILLIG ERNST;;ABATJOGLOU ANTONY GEORGE;;BRYANT DAVID ROBERT;;MURRAY REX EUGENE;;MAHER JOHN MICHAEL,,https://lens.org/010-028-809-745-603,Unknown,no,0,0,45,77,0,B01J31/185;;B01J2231/321;;B01J2531/0266;;B01J2531/822;;C07C45/50;;C07F9/65744;;C07F9/6578;;C07F15/008;;Y02P20/582;;C07F15/008;;C07C45/50;;C07F9/6578;;B01J31/185;;B01J2531/0266;;B01J2231/321;;C07F9/65744;;B01J2531/822;;Y02P20/582,B01J27/18;;B01J31/18;;B01J31/20;;C07B61/00;;C07C47/02;;C07C45/00;;C07C45/50;;C07C67/00;;C07F9/06;;C07F9/547;;C07F9/6564;;C07F9/6574;;C07F9/6578;;C07F15/00,,0,0,,,,EXPIRED
923,MX,B,MX 164254 B,000-782-712-135-827,1992-07-27,1992,MX 20434785 A,1985-01-15,US 58135284 A;;US 68502584 A,1984-02-17,REACCIONES CATALIZADAS CON COMPLEJO DE METAL DE TRANSICION,"Transition metal-diorganophosphite complex catalyzed carbonylation processes, especially hydroformylation, as well as transition metal-diorganophosphite ligand complex compositions, diorganophosphite ligands and transition metal-diorganophosphite catalysts.",UNION CARBIDE CORP,BILLIG ERNST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT;;MURRAY REX EUGENE;;MAHER JOHN MICHAEL,,https://lens.org/000-782-712-135-827,Granted Patent,no,0,0,45,77,0,B01J31/185;;B01J2231/321;;B01J2531/0266;;B01J2531/822;;C07C45/50;;C07F9/65744;;C07F9/6578;;C07F15/008;;Y02P20/582;;C07F15/008;;C07C45/50;;C07F9/6578;;B01J31/185;;B01J2531/0266;;B01J2231/321;;C07F9/65744;;B01J2531/822;;Y02P20/582,B01J27/18;;C07C47/02;;B01J31/18;;B01J31/20;;C07B61/00;;C07C45/00;;C07C45/50;;C07C67/00;;C07F9/06;;C07F9/547;;C07F9/6564;;C07F9/6574;;C07F9/6578;;C07F15/00,,0,0,,,,EXPIRED
924,ZA,B,ZA 851189 B,096-400-205-701-907,1985-09-25,1985,ZA 851189 A,1985-02-15,US 58135284 A,1984-02-17,TRANSITION METAL COMPLEX CATALYZED REACTIONS,,UNION CARBIDE CORP,BILLIG ERNST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT;;MURRAY REX EUGENE;;MAHER JOHN MICHAEL,,https://lens.org/096-400-205-701-907,Granted Patent,no,0,0,5,77,0,,C07C47/02;;B01J/;;B01J31/22;;C07B41/06;;C07C27/22;;C07C29/16;;C07C45/49;;C07C45/50;;C07C47/00,,0,0,,,,EXPIRED
925,EP,B1,EP 0155508 B1,093-567-158-679-393,1992-12-09,1992,EP 85101693 A,1985-02-15,US 58135284 A;;US 68502584 A,1984-02-17,TRANSITION METAL COMPLEX CATALYZED REACTIONS,"Transition metal-diorganophosphite complex catalyzed carbonylation processes, especially hydroformylation, as well as transition metal-diorganophosphite ligand complex compositions, diorganophosphite ligands and transition metal-diorganophosphite catalysts.",UNION CARBIDE CORPORATION,"BILLIG, ERNST;;ABATJOGLOU, ANTHONY GEORGE;;BRYANT, DAVID ROBERT;;MURRAY, REX EUGENE;;MAHER, JOHN MICHAEL",,https://lens.org/093-567-158-679-393,Granted Patent,yes,4,4,45,77,0,B01J31/185;;B01J2231/321;;B01J2531/0266;;B01J2531/822;;C07C45/50;;C07F9/65744;;C07F9/6578;;C07F15/008;;Y02P20/582;;C07F15/008;;C07C45/50;;C07F9/6578;;B01J31/185;;B01J2531/0266;;B01J2231/321;;C07F9/65744;;B01J2531/822;;Y02P20/582,B01J27/18;;B01J31/18;;B01J31/20;;C07B61/00;;C07C47/02;;C07C45/00;;C07C45/50;;C07C67/00;;C07F9/06;;C07F9/547;;C07F9/6564;;C07F9/6574;;C07F9/6578;;C07F15/00,,0,0,,,,EXPIRED
926,AU,B2,AU 617362 B2,095-585-683-119-169,1991-11-28,1991,AU 1988/022788 A,1988-09-26,US 58135284 A;;US 68502584 A,1984-02-17,DIORGANOPHOSPHITE LIGANDS AND COMPLEXES THEREOF,"Transition metal-diorganophosphite complex catalyzed carbonylation processes, especially hydroformylation, as well as transition metal-diorganophosphite ligand complex compositions, diorganophosphite ligands and transition metal-diorganophosphite catalysts.",UNION CARBIDE CORP,BILLIG ERNST;;MAHER JOHN MICHAEL;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT;;MURRAY REX EUGENE,,https://lens.org/095-585-683-119-169,Granted Patent,no,1,1,45,77,0,B01J31/185;;B01J2231/321;;B01J2531/0266;;B01J2531/822;;C07C45/50;;C07F9/65744;;C07F9/6578;;C07F15/008;;Y02P20/582;;C07F15/008;;C07C45/50;;C07F9/6578;;B01J31/185;;B01J2531/0266;;B01J2231/321;;C07F9/65744;;B01J2531/822;;Y02P20/582,C07C47/02;;B01J27/18;;B01J31/18;;B01J31/20;;C07B61/00;;C07C45/00;;C07C45/50;;C07C67/00;;C07F9/06;;C07F9/547;;C07F9/6564;;C07F9/6574;;C07F9/6578;;C07F15/00,,0,0,,,,EXPIRED
927,AT,T1,AT E83230 T1,039-010-157-603-905,1992-12-15,1992,AT 85101693 T,1985-02-15,EP 85101693 A;;US 58135284 A;;US 68502584 A,1984-02-17,DURCH UEBERGANGSMETALL-KOMPLEXVERBINDUNGEN KATALYSIERTE REAKTIONEN.,"Transition metal-diorganophosphite complex catalyzed carbonylation processes, especially hydroformylation, as well as transition metal-diorganophosphite ligand complex compositions, diorganophosphite ligands and transition metal-diorganophosphite catalysts.",UNION CARBIDE CORP,BILLIG ERNST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT;;MURRAY REX EUGENE;;MAHER JOHN MICHAEL,,https://lens.org/039-010-157-603-905,Granted Patent,no,0,0,45,77,0,B01J31/185;;B01J2231/321;;B01J2531/0266;;B01J2531/822;;C07C45/50;;C07F9/65744;;C07F9/6578;;C07F15/008;;Y02P20/582;;C07F15/008;;C07C45/50;;C07F9/6578;;B01J31/185;;B01J2531/0266;;B01J2231/321;;C07F9/65744;;B01J2531/822;;Y02P20/582,C07C47/02;;B01J27/18;;B01J31/18;;B01J31/20;;C07B61/00;;C07C45/00;;C07C45/50;;C07C67/00;;C07F9/06;;C07F9/547;;C07F9/6564;;C07F9/6574;;C07F9/6578;;C07F15/00,,0,0,,,,DISCONTINUED
928,YU,A,YU 22585 A,096-856-937-569-900,1988-02-29,1988,YU 22585 A,1985-02-15,US 58135284 A;;US 68502584 A,1984-02-17,PROCESS FOR OBTAINING ALDEHIDES BY HYDROFORMYLATION OLEPHINES IN CATALYZER PRESENCE,"Transition metal-diorganophosphite complex catalyzed carbonylation processes, especially hydroformylation, as well as transition metal-diorganophosphite ligand complex compositions, diorganophosphite ligands and transition metal-diorganophosphite catalysts.",UNION CARBIDE CORP,BILLIG ERNEST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT;;MURRAY REX EUGENE;;MAHER JOHN MICHAEL,,https://lens.org/096-856-937-569-900,Patent Application,no,0,0,45,77,0,B01J31/185;;B01J2231/321;;B01J2531/0266;;B01J2531/822;;C07C45/50;;C07F9/65744;;C07F9/6578;;C07F15/008;;Y02P20/582;;C07F15/008;;C07C45/50;;C07F9/6578;;B01J31/185;;B01J2531/0266;;B01J2231/321;;C07F9/65744;;B01J2531/822;;Y02P20/582,B01J27/18;;B01J31/18;;B01J31/20;;C07C47/02;;C07B61/00;;C07C45/00;;C07C45/50;;C07C67/00;;C07F9/06;;C07F9/547;;C07F9/6564;;C07F9/6574;;C07F9/6578;;C07F15/00,,0,0,,,,EXPIRED
929,EP,A1,EP 0155508 A1,102-862-805-251-200,1985-09-25,1985,EP 85101693 A,1985-02-15,US 58135284 A;;US 68502584 A,1984-02-17,Transition metal complex catalyzed reactions.,"Transition metal-diorganophosphite complex catalyzed carbonylation processes, especially hydroformylation, as well as transition metal-diorganophosphite ligand complex compositions, diorganophosphite ligands and transition metal-diorganophosphite catalysts.",UNION CARBIDE CORP,BILLIG ERNST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT;;MURRAY REX EUGENE;;MAHER JOHN MICHAEL,,https://lens.org/102-862-805-251-200,Patent Application,yes,14,55,45,77,0,B01J31/185;;B01J2231/321;;B01J2531/0266;;B01J2531/822;;C07C45/50;;C07F9/65744;;C07F9/6578;;C07F15/008;;Y02P20/582;;C07F15/008;;C07C45/50;;C07F9/6578;;B01J31/185;;B01J2531/0266;;B01J2231/321;;C07F9/65744;;B01J2531/822;;Y02P20/582,B01J27/18;;B01J31/18;;B01J31/20;;C07B61/00;;C07C47/02;;C07C45/00;;C07C45/50;;C07C67/00;;C07F9/06;;C07F9/547;;C07F9/6564;;C07F9/6574;;C07F9/6578;;C07F15/00,,1,0,,,"J. FALBE: ""New Synthesis With Carbon Monoxide"", 1980, SPRINGER VERLAG",EXPIRED
930,AU,A,AU 1985/039970 A,122-847-608-454-076,1985-09-10,1985,AU 1985/039970 A,1985-02-15,US 58135284 A;;US 68502584 A,1984-02-17,TRANSITION METAL COMPLEX CATALYZED REACTIONS,"Transition metal-diorganophosphite complex catalyzed carbonylation processes, especially hydroformylation, as well as transition metal-diorganophosphite ligand complex compositions, diorganophosphite ligands and transition metal-diorganophosphite catalysts.",UNION CARBIDE CORP,BILLIG ERNEST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT;;MURRAY REX EUGENE;;MAHER JOHN MICHAEL,,https://lens.org/122-847-608-454-076,Patent Application,no,0,0,45,77,0,B01J31/185;;B01J2231/321;;B01J2531/0266;;B01J2531/822;;C07C45/50;;C07F9/65744;;C07F9/6578;;C07F15/008;;Y02P20/582;;C07F15/008;;C07C45/50;;C07F9/6578;;B01J31/185;;B01J2531/0266;;B01J2231/321;;C07F9/65744;;B01J2531/822;;Y02P20/582,C07C47/02;;B01J27/18;;B01J31/18;;B01J31/20;;C07B61/00;;C07C45/00;;C07C45/50;;C07C67/00;;C07F9/06;;C07F9/547;;C07F9/6564;;C07F9/6574;;C07F9/6578;;C07F15/00,,0,0,,,,EXPIRED
931,DE,C2,DE 3039707 C2,023-291-714-862-372,1989-12-07,1989,DE 3039707 A,1980-10-21,US 9018479 A,1979-11-01,DE 3039707 C2,,"UNITED TECHNOLOGIES CORP., HARTFORD, CONN., US","MACNITT JUN., DONALD GEORGE, SINGER ISLAND, FLA., US;;WALKER, BRYANT HARDING., STUART, FLA., US",,https://lens.org/023-291-714-862-372,Granted Patent,no,0,0,30,35,0,B21J5/02;;B21J9/02;;B21J13/02;;B21K1/36;;B21K29/00;;Y10T29/49336;;Y10T29/49336;;B21J5/02;;B21K1/36;;B21J9/02;;B21J13/02;;B21K29/00,B21J5/02;;B21J9/02;;B21J13/02;;B21K1/36;;B21K3/04,,0,0,,,,EXPIRED
932,NO,C,NO 165915 C,035-138-273-363-096,1991-05-02,1991,NO 854113 A,1985-10-16,US 58135284 A;;US 68502584 A;;US 8500231 W,1984-02-17,"HYDROFORMYLERINGSPROSESS, DIORGANOFOSFITT-LIGAND OG RHODIUM-KOMPLEKSKATALYSATOR TIL BRUK VED FREMGANGSMAATEN SAMT ETKATALYSATORFORLOEPERPREPARAT.","Transition metal-diorganophosphite complex catalyzed carbonylation processes, especially hydroformylation, as well as transition metal-diorganophosphite ligand complex compositions, diorganophosphite ligands and transition metal-diorganophosphite catalysts.",UNION CARBIDE CORP,BILLIG ERNST;;ABATJOGLOU ANTONY GEORGE;;BRYANT DAVID ROBERT;;MURRAY REX EUGENE;;MAHER JOHN MICHAEL,,https://lens.org/035-138-273-363-096,Granted Patent,no,0,0,45,77,0,B01J31/185;;B01J2231/321;;B01J2531/0266;;B01J2531/822;;C07C45/50;;C07F9/65744;;C07F9/6578;;C07F15/008;;Y02P20/582;;C07F15/008;;C07C45/50;;C07F9/6578;;B01J31/185;;B01J2531/0266;;B01J2231/321;;C07F9/65744;;B01J2531/822;;Y02P20/582,B01J27/18;;B01J31/18;;B01J31/20;;C07B61/00;;C07C47/02;;C07C45/00;;C07C45/50;;C07C67/00;;C07F9/06;;C07F9/547;;C07F9/6564;;C07F9/6574;;C07F9/6578;;C07F15/00,,0,0,,,,EXPIRED
933,DK,A,DK 473485 A,080-921-548-619-051,1985-12-11,1985,DK 473485 A,1985-10-16,US 58135284 A;;US 68502584 A;;US 8500231 W,1984-02-17,MED OVERGANGSMETALKOMPLEKS KATALYSEREDE REAKTIONER,"Transition metal-diorganophosphite complex catalyzed carbonylation processes, especially hydroformylation, as well as transition metal-diorganophosphite ligand complex compositions, diorganophosphite ligands and transition metal-diorganophosphite catalysts.",UNION CARBIDE CORP,BILLIG ERNEST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT;;MURAY REX EUGENE;;MAHER JOHN MICHAEL,,https://lens.org/080-921-548-619-051,Patent Application,no,0,0,45,77,0,B01J31/185;;B01J2231/321;;B01J2531/0266;;B01J2531/822;;C07C45/50;;C07F9/65744;;C07F9/6578;;C07F15/008;;Y02P20/582;;C07F15/008;;C07C45/50;;C07F9/6578;;B01J31/185;;B01J2531/0266;;B01J2231/321;;C07F9/65744;;B01J2531/822;;Y02P20/582,B01J27/18;;B01J31/18;;B01J31/20;;C07C47/02;;C07B61/00;;C07C45/00;;C07C45/50;;C07C67/00;;C07F9/06;;C07F9/547;;C07F9/6564;;C07F9/6574;;C07F9/6578;;C07F15/00,,0,0,,,,DISCONTINUED
934,AU,B2,AU 579144 B2,006-853-252-487-883,1988-11-17,1988,AU 1985/039970 A,1985-02-15,US 58135284 A;;US 68502584 A,1984-02-17,CARBOXYLATION PROCESS,"Transition metal-diorganophosphite complex catalyzed carbonylation processes, especially hydroformylation, as well as transition metal-diorganophosphite ligand complex compositions, diorganophosphite ligands and transition metal-diorganophosphite catalysts.",UNION CARBIDE CORP,BILLIG ERNST;;BRYANT DAVID ROBERT;;MURRAY REX EUGENE;;MAHER JOHN MICHAEL;;ABATJOGLOU ANTHONY GEORGE,,https://lens.org/006-853-252-487-883,Granted Patent,no,3,0,45,77,0,B01J31/185;;B01J2231/321;;B01J2531/0266;;B01J2531/822;;C07C45/50;;C07F9/65744;;C07F9/6578;;C07F15/008;;Y02P20/582;;C07F15/008;;C07C45/50;;C07F9/6578;;B01J31/185;;B01J2531/0266;;B01J2231/321;;C07F9/65744;;B01J2531/822;;Y02P20/582,C07C47/02;;B01J27/18;;B01J31/18;;B01J31/20;;C07B61/00;;C07C45/00;;C07C45/50;;C07C67/00;;C07F9/06;;C07F9/547;;C07F9/6564;;C07F9/6574;;C07F9/6578;;C07F15/00,,0,0,,,,EXPIRED
935,MX,B,MX 166107 B,035-370-518-697-235,1992-12-21,1992,MX 656687 A,1987-05-20,US 86506186 A;;US 4682187 A,1986-05-20,METODO PARA REDUCIR AL MINIMO O IMPEDIR LA PRECIPITACION DEL RODIO,"La presente invención se refiere a un método para reducir al mínimo o impedir la precipitación del rodio, de un catalizador complejo de rodio-fosfito de una solución como metal de rodio o grupos de rodio que puede ocurrir durante el procedimiento de hidroformilación de recirculación de líquido catalizada por complejo de rodio-fosfito solubilizado, para producir aldehído hciendo reaccionar un compuesto alefínico insaturado con monóxido de carbono e hidrógeno, y que involugra la recuperación del producto de aldehído mediante destilación de una solución del producto de reacción que contiene el catalizador complejo de rodio-fosfito solubilizado y el producto de aldehído, consistiendo el método de llevar a cabo la destilación del producto de aldehído de una solución del producto de reacción que contiene el catalizador complejo de rodio-fosfito solubilizado, el producto de aldehído y además un polímero orgánico que contiene grupos funcionales polares, en donde los grupos se seleccionan de la clase que consiste de radicales de amida, cetona, carbamato, urea y carbonato.",UNION CARBIDE CORP,EUGENE MURRAY REX;;ERNST BILLIG;;MAHER JOHN MICHAEL;;BRYANT DAVID ROBERT;;GEORGE ABATJOGLOU ANTHONY,,https://lens.org/035-370-518-697-235,Granted Patent,no,0,0,20,77,0,C07C45/50;;C07C45/50;;C07C45/82;;C07C45/82;;Y02P20/582;;Y02P20/582,C07C47/02;;B01J23/96;;B01J31/22;;C07B61/00;;C07C/;;C07C45/00;;C07C45/50;;C07C45/82;;C07C67/00,,0,0,,,,EXPIRED
936,DE,D1,DE 3586878 D1,040-535-620-705-223,1993-01-21,1993,DE 3586878 T,1985-02-15,US 58135284 A;;US 68502584 A,1984-02-17,DURCH UEBERGANGSMETALL-KOMPLEXVERBINDUNGEN KATALYSIERTE REAKTIONEN.,"Transition metal-diorganophosphite complex catalyzed carbonylation processes, especially hydroformylation, as well as transition metal-diorganophosphite ligand complex compositions, diorganophosphite ligands and transition metal-diorganophosphite catalysts.",UNION CARBIDE CORP,BILLIG ERNST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT;;MURRAY REX EUGENE;;MAHER JOHN MICHAEL,,https://lens.org/040-535-620-705-223,Granted Patent,no,0,0,45,77,0,B01J31/185;;B01J2231/321;;B01J2531/0266;;B01J2531/822;;C07C45/50;;C07F9/65744;;C07F9/6578;;C07F15/008;;Y02P20/582;;C07F15/008;;C07C45/50;;C07F9/6578;;B01J31/185;;B01J2531/0266;;B01J2231/321;;C07F9/65744;;B01J2531/822;;Y02P20/582,B01J27/18;;B01J31/18;;B01J31/20;;C07B61/00;;C07C47/02;;C07C45/00;;C07C45/50;;C07C67/00;;C07F9/06;;C07F9/547;;C07F9/6564;;C07F9/6574;;C07F9/6578;;C07F15/00,,0,0,,,,EXPIRED
937,CA,A1,CA 2319780 A1,171-899-285-443-314,1999-08-05,1999,CA 2319780 A,1999-02-01,US 1745798 A;;US 9901998 W,1998-02-02,IMPROVED SEPARATION PROCESSES,"This invention relates to a process for separating one or more products from a reaction product fluid comprising a metal-organophosphorus ligand complex catalyst, optionally free organophosphorus ligand, a polar solvent and said one or more products, wherein said process comprises (1) mixing said reaction product fluid with a nonpolar solvent to obtain by phase separation a polar phase comprising said metal-organophosphorus ligand complex catalyst, optionally free organophosphorus ligand and said polar solvent and nonpolar phase comprising said one or more products and nonpolar solvent, and (2) recovering said nonpolar phase from said polar phase; wherein said organophosphorus ligand has a partition coefficient between the polar solvent and the nonpolar solvent of greater than about 10, and said one or more products have a partition coefficient between the nonpolar solvent and the polar solvent of greater than about 0.5.",UNION CARBIDE CHEM PLASTIC,BRYANT DAVID ROBERT;;ABATJOGLOU ANTHONY GEORGE;;ARGYROPOULOS JOHN N;;MORRISON DONALD LEE;;STOCKMAN KENNETH,,https://lens.org/171-899-285-443-314,Patent Application,no,0,0,24,24,0,B01J31/0259;;B01J31/0267;;B01J31/185;;B01J31/2208;;B01J31/24;;B01J31/2404;;B01J31/2457;;B01J31/2495;;B01J31/4015;;B01J31/4046;;B01J31/4053;;B01J2231/32;;B01J2231/321;;B01J2231/52;;B01J2231/641;;B01J2531/822;;C07C45/50;;C07C45/80;;C07C51/48;;C07F9/025;;Y02P20/584;;Y02P20/582;;C07C45/50;;B01J31/0267;;B01J31/0259;;B01J31/2457;;B01J31/2495;;B01J31/4015;;B01J31/4046;;B01J2231/32;;B01J31/2404;;C07C45/80;;B01J2231/321;;C07C45/50;;B01J31/185;;B01J2231/52;;B01J31/2208;;B01J2231/641;;B01J31/4053;;C07C51/48;;C07F9/025;;B01J31/24;;B01J2531/822;;Y02P20/584;;Y02P20/582,B01J31/18;;B01J31/40;;C07B63/00;;C07C45/50;;C07C45/80;;C07C49/92;;C07C51/373;;C07C51/48;;C07C59/147;;C07F9/02;;C07F9/50;;C07F9/655;;C07F9/6574,,0,0,,,,EXPIRED
938,IN,B,IN 164243 B,046-864-354-840-902,1989-02-04,1989,IN 133MA1985 A,1985-02-16,US 58135284 A;;US 8500231 W,1984-02-17,A HYROFORMYLATION PROCESS FOR PRODUCING ALDEHYDES,,UNION CARBIDE CORP,ERNEST BILLIG;;ANTHONY GEORGE ABATJOGLOU;;DAVID ROBERT BRYANT;;REX EUGENE MURRAY;;JOHN MICHAEL MAHER,,https://lens.org/046-864-354-840-902,Granted Patent,no,0,0,5,77,0,,C07C47/02;;B01J/;;B01J31/22;;C07B41/06;;C07C27/22;;C07C29/16;;C07C45/49;;C07C45/50;;C07C47/00,,0,0,,,,EXPIRED
939,NO,L,NO 854113 L,028-881-514-384-291,1985-10-16,1985,NO 854113 A,1985-10-16,US 58135284 A;;US 68502584 A;;US 8500231 W,1984-02-17,REAKSJONER KATALYSERT AV OVERGANGSMETALLKOMPLEKSER.,"Transition metal-diorganophosphite complex catalyzed carbonylation processes, especially hydroformylation, as well as transition metal-diorganophosphite ligand complex compositions, diorganophosphite ligands and transition metal-diorganophosphite catalysts.",UNION CARBIDE CORP,BILLIG ERNEST;;ABATJOGLOU ANTONY GEORGE;;BRYANT DAVID ROBERT;;MURRAY REX EUGENE;;MAHER JOHN MICHAEL,,https://lens.org/028-881-514-384-291,Abstract,no,0,0,45,77,0,B01J31/185;;B01J2231/321;;B01J2531/0266;;B01J2531/822;;C07C45/50;;C07F9/65744;;C07F9/6578;;C07F15/008;;Y02P20/582;;C07F15/008;;C07C45/50;;C07F9/6578;;B01J31/185;;B01J2531/0266;;B01J2231/321;;C07F9/65744;;B01J2531/822;;Y02P20/582,B01J27/18;;B01J31/18;;C07C47/02;;B01J31/20;;C07B61/00;;C07C45/00;;C07C45/50;;C07C67/00;;C07F9/06;;C07F9/547;;C07F9/6564;;C07F9/6574;;C07F9/6578;;C07F15/00,,0,0,,,,EXPIRED
940,CA,C,CA 2319780 C,158-107-061-000-259,2006-05-23,2006,CA 2319780 A,1999-02-01,US 1745798 A;;US 9901998 W,1998-02-02,IMPROVED SEPARATION PROCESSES,"This invention relates to a process for separating one or more products from a reaction product fluid comprising a metal-organophosphorus ligand complex catalyst, optionally free organophosphorus ligand, a polar solvent and said one or more products, wherein said process comprises (1) mixing said reaction product fluid with a nonpolar solvent to obtain by phase separation a polar phase comprising said metal-organophosphorus ligand complex catalyst, optionally free organophosphorus ligand and said polar solvent and nonpolar phase comprising said one or more products and nonpolar solvent, an d (2) recovering said nonpolar phase from said polar phase; wherein said organophosphorus ligand has a partition coefficient between the polar solvent and the nonpolar solvent of greater than about 10, and said one or more products have a partition coefficient between the nonpolar solvent and the polar solvent of greater than about 0.5.",UNION CARBIDE CHEM PLASTIC,MORRISON DONALD LEE;;ARGYROPOULOS JOHN N;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT;;STOCKMAN KENNETH,,https://lens.org/158-107-061-000-259,Granted Patent,no,0,0,24,24,0,B01J31/0259;;B01J31/0267;;B01J31/185;;B01J31/2208;;B01J31/24;;B01J31/2404;;B01J31/2457;;B01J31/2495;;B01J31/4015;;B01J31/4046;;B01J31/4053;;B01J2231/32;;B01J2231/321;;B01J2231/52;;B01J2231/641;;B01J2531/822;;C07C45/50;;C07C45/80;;C07C51/48;;C07F9/025;;Y02P20/584;;Y02P20/582;;C07C45/50;;B01J31/0267;;B01J31/0259;;B01J31/2457;;B01J31/2495;;B01J31/4015;;B01J31/4046;;B01J2231/32;;B01J31/2404;;C07C45/80;;B01J2231/321;;C07C45/50;;B01J31/185;;B01J2231/52;;B01J31/2208;;B01J2231/641;;B01J31/4053;;C07C51/48;;C07F9/025;;B01J31/24;;B01J2531/822;;Y02P20/584;;Y02P20/582,B01J31/18;;C07C59/147;;B01J31/40;;C07B63/00;;C07C45/50;;C07C45/80;;C07C49/92;;C07C51/373;;C07C51/48;;C07F9/02;;C07F9/50;;C07F9/655;;C07F9/6574,,0,0,,,,EXPIRED
941,FI,C,FI 88709 C,065-371-294-521-638,1993-06-28,1993,FI 854059 A,1985-10-17,US 58135284 A;;US 68502584 A;;US 8500231 W,1984-02-17,"Hydroformyleringsfoerfarande foer framstaellning av aldehyder, rodium-diorganofosfitbaserade katalysatorer, deras prekursorblandningar och diorganofosfiter","Transition metal-diorganophosphite complex catalyzed carbonylation processes, especially hydroformylation, as well as transition metal-diorganophosphite ligand complex compositions, diorganophosphite ligands and transition metal-diorganophosphite catalysts.",UNION CARBIDE CORP,BILLIG ERNEST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT;;MURRAY REX EUGENE;;MAHER JOHN MICHAEL,,https://lens.org/065-371-294-521-638,Granted Patent,no,0,0,45,77,0,B01J31/185;;B01J2231/321;;B01J2531/0266;;B01J2531/822;;C07C45/50;;C07F9/65744;;C07F9/6578;;C07F15/008;;Y02P20/582;;C07F15/008;;C07C45/50;;C07F9/6578;;B01J31/185;;B01J2531/0266;;B01J2231/321;;C07F9/65744;;B01J2531/822;;Y02P20/582,B01J27/18;;B01J31/18;;C07C47/02;;B01J31/20;;C07B61/00;;C07C45/00;;C07C45/50;;C07C67/00;;C07F9/06;;C07F9/547;;C07F9/6564;;C07F9/6574;;C07F9/6578;;C07F15/00,,0,0,,,,EXPIRED
942,BR,A,BR 8505278 A,009-050-669-033-49X,1986-02-18,1986,BR 8505278 A,1985-02-15,US 58135284 A;;US 68502584 A;;US 8500231 W,1984-02-17,REACOES CATALISADAS COM COMPLEXO DE METAL DE TRANSICAO,"Transition metal-diorganophosphite complex catalyzed carbonylation processes, especially hydroformylation, as well as transition metal-diorganophosphite ligand complex compositions, diorganophosphite ligands and transition metal-diorganophosphite catalysts.",UNION CARBIDE CORP,BILLIG ERNEST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT;;MURRAY REX EUGENE;;MAHER JOHN MICHAEL,,https://lens.org/009-050-669-033-49X,Patent Application,no,0,0,45,77,0,B01J31/185;;B01J2231/321;;B01J2531/0266;;B01J2531/822;;C07C45/50;;C07F9/65744;;C07F9/6578;;C07F15/008;;Y02P20/582;;C07F15/008;;C07C45/50;;C07F9/6578;;B01J31/185;;B01J2531/0266;;B01J2231/321;;C07F9/65744;;B01J2531/822;;Y02P20/582,C07C47/02;;B01J27/18;;B01J31/18;;B01J31/20;;C07B61/00;;C07C45/00;;C07C45/50;;C07C67/00;;C07F9/06;;C07F9/547;;C07F9/6564;;C07F9/6574;;C07F9/6578;;C07F15/00,,0,0,,,,EXPIRED
943,DE,B2,DE 2141680 B2,043-965-402-426-663,1980-08-28,1980,DE 2141680 A,1971-08-19,US 6522570 A,1970-08-19,DE 2141680 B2,,"INTERNATIONAL COMPUTERS LTD., LONDON","ANDERSEN, STANLEY R., HOPEWELL JUNCTION;;BRYANT, RICHARD W., POUGHKEEPSIE;;TU, GEORGE K., WAPPINGERS FALLS",,https://lens.org/043-965-402-426-663,Patent Application,no,0,0,7,7,0,G11C11/406;;G11C11/4067;;G11C11/4076;;H03K19/01806;;H03K19/01812;;G11C11/4076;;H03K19/01806;;G11C11/4067;;G11C11/406;;H03K19/01812,G11C11/406;;G11C11/4067;;G11C11/4076;;H03K19/018,,0,0,,,,EXPIRED
944,DE,C2,DE 3319248 C2,072-135-100-650-570,1992-12-17,1992,DE 3319248 A,1983-05-27,GB 8215877 A,1982-06-01,DE 3319248 C2,,"MOLINS PLC, MILTON KEYNES, BUCKINGHAMSHIRE, GB","STEWART-COX, ADRIAN ROY, EASTLEIGH, HAMPSHIRE, GB;;BRYANT, ROBERT GEORGE, RUSHINGTON TOTTON, HAMPSHIRE, GB","MOLINS PLC, MILTON KEYNES, BUCKINGHAMSHIRE, GB (1992-05-27)",https://lens.org/072-135-100-650-570,Granted Patent,no,9,2,12,12,0,A24C5/31;;A24C5/31,A24C5/31,,0,0,,,,EXPIRED
945,AU,A,AU 1988/022788 A,125-422-895-862-94X,1989-01-19,1989,AU 1988/022788 A,1988-09-26,US 58135284 A;;US 68502584 A,1984-02-17,DIORGANOPHOSPHITE LIGANDS AND COMPLEXES THEREOF,"Transition metal-diorganophosphite complex catalyzed carbonylation processes, especially hydroformylation, as well as transition metal-diorganophosphite ligand complex compositions, diorganophosphite ligands and transition metal-diorganophosphite catalysts.",UNION CARBIDE CORP,BILLIG ERNST;;ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT;;MURRAY REX EUGENE;;MAHER JOHN MICHAEL,,https://lens.org/125-422-895-862-94X,Patent Application,no,0,0,45,77,0,B01J31/185;;B01J2231/321;;B01J2531/0266;;B01J2531/822;;C07C45/50;;C07F9/65744;;C07F9/6578;;C07F15/008;;Y02P20/582;;C07F15/008;;C07C45/50;;C07F9/6578;;B01J31/185;;B01J2531/0266;;B01J2231/321;;C07F9/65744;;B01J2531/822;;Y02P20/582,C07C47/02;;B01J27/18;;B01J31/18;;B01J31/20;;C07B61/00;;C07C45/00;;C07C45/50;;C07C67/00;;C07F9/06;;C07F9/547;;C07F9/6564;;C07F9/6574;;C07F9/6578;;C07F15/00,,0,0,,,,EXPIRED
946,DE,C2,DE 3039705 C2,129-167-814-054-642,1989-11-30,1989,DE 3039705 A,1980-10-21,US 9021179 A,1979-11-01,DE 3039705 C2,,"UNITED TECHNOLOGIES CORP., HARTFORD, CONN., US","MACNITT JUN., DONALD GEORGE, SINGER ISLAND, FLA., US;;WALKER, BRYANT HARDING, STUART, FLA., US",,https://lens.org/129-167-814-054-642,Granted Patent,no,0,0,27,27,0,B21J5/02;;B21J9/02;;B21J13/02;;B21K1/36;;B21K29/00;;Y10T29/49488;;Y10T29/49488;;B21J5/02;;B21K1/36;;B21J9/02;;B21J13/02;;B21K29/00,B21J5/02;;B21J9/02;;B21J13/02;;B21K1/36;;B21K3/04,,0,0,,,,EXPIRED
947,RO,B,RO 92321 B,163-578-358-291-044,1987-09-01,1987,RO 12042685 A,1985-02-15,US 58135284 A;;US 68502584 A,1984-02-17,HYDROFORMYLATION PROCESS,"Transition metal-diorganophosphite complex catalyzed carbonylation processes, especially hydroformylation, as well as transition metal-diorganophosphite ligand complex compositions, diorganophosphite ligands and transition metal-diorganophosphite catalysts.",UNION CARBIDE CORP,BILLIG ERNEST;;ABATJOGLU ANTHONY GEORGE;;BRYANT DAVID ROBERT;;MURRAY REX EUGENE;;MAHER JOHN MICHAEL,,https://lens.org/163-578-358-291-044,Unknown,no,0,0,45,77,0,B01J31/185;;B01J2231/321;;B01J2531/0266;;B01J2531/822;;C07C45/50;;C07F9/65744;;C07F9/6578;;C07F15/008;;Y02P20/582;;C07F15/008;;C07C45/50;;C07F9/6578;;B01J31/185;;B01J2531/0266;;B01J2231/321;;C07F9/65744;;B01J2531/822;;Y02P20/582,C07C47/02;;B01J27/18;;B01J31/18;;B01J31/20;;C07B61/00;;C07C45/00;;C07C45/50;;C07C67/00;;C07F9/06;;C07F9/547;;C07F9/6564;;C07F9/6574;;C07F9/6578;;C07F15/00,,0,0,,,,DISCONTINUED
948,DE,T1,DE 463000 T1,015-882-312-033-816,1992-04-09,1992,DE 90904146 T,1990-02-16,US 9000924 W;;US 32484789 A,1989-03-17,MULTISCHICHTIGER HARTMETALL-SCHNEIDEINSATZ.,,"KENNAMETAL INC., LATROBE, PA., US","BRYANT, A., WILLIAM, MCKEESPORT, PA 15135, US;;GRAB, P., GEORGE, GREENSBURG, PA 15601, US",,https://lens.org/015-882-312-033-816,Granted Patent,no,0,0,1,19,0,,B23B27/14,,0,0,,,,EXPIRED
949,US,B2,US 7630298 B2,022-903-196-519-862,2009-12-08,2009,US 97607604 A,2004-10-27,US 97607604 A,2004-10-27,Method and apparatus for forwarding data in a data communications network,"A method of forwarding data in a data communications network having a plurality of nodes comprises the steps, performed at a repairing node, of computing the repair path around a network component to a target node and forwarding data along the repair path. The computing step comprises the step of computing an intermediate node reachable by the repairing node and from which the target node can be reached. The forwarding step includes the step of constructing a Multi-Protocol Label Switching (MPLS) packet for forwarding to the intermediate node.",CISCO TECH INC,SHAND IAN MICHAEL CHARLES;;BRYANT STEWART FREDERICK;;CHARNY ANNA;;DAVIE BRUCE STUART;;SWALLOW GEORGE,CISCO TECHNOLOGY INC (2004-10-18),https://lens.org/022-903-196-519-862,Granted Patent,yes,110,10,2,2,0,H04L41/0663;;H04L45/22;;H04L45/28;;H04L45/50;;H04Q3/66;;H04Q2213/13141;;H04Q2213/13145;;H04Q2213/13166;;H04Q2213/13204;;H04Q2213/13348;;H04Q2213/13389;;H04L69/40;;H04L45/00;;H04Q2213/13141;;H04Q2213/13166;;H04Q2213/13348;;H04L45/22;;H04Q2213/13145;;H04Q2213/13389;;H04Q2213/13204;;H04Q3/66;;H04L45/50;;H04L41/0663;;H04L45/28;;H04L69/40,H04J1/16;;H04L12/28,370/218;;370/392,15,1,046-310-355-238-214,10.1145/99517.99548,"Wikipedia, ""List of IPv4 Protocol Numbers,"" located on the internet at http://en.wikipedia.org/wiki/IP-protocol, retrieved on Feb. 1, 2007, 7 pages.;;Wikipedia, ""Ping,"" located in the internet at , retrieved on Feb. 1, 2007, 3 pages.;;Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration as received in corresponding International application No. PCT/US06/06238.;;Pending claims in PCT/US06/06238.;;Wang, Zheng et al., ""Shortest Path First with Emergency Exits,"" ACM 089791-405-8/90/0009/0166, 1990, pp. 166-176.;;International Searching Authority, International Search Report, PCT/US04/33827, dated Mar. 28, 2005, 8 pages.;;Current Claims, PCT/US04/33827, 6 pages.;;International Searching Authority, ""Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority, or the Declaration"", international application No. pct/us06/28083, Received Nov. 30, 2007, 11 pages.;;Claims, international application No. pct/us06/28083, 3 pages.;;AU Examiner's First Report for foreign patent application No. 2004311004 dated Jun. 23, 2008 (1 pg).;;AU Examiner's Second Report for foreign patent application No. 2004311004 dated Aug. 18, 2008 (1 pg).;;Current claims for AU foreign patent application No. 2004311004 (6 pgs).;;Office Action from CN for foreign application No. 200480033007.8 dated Apr. 11, 2008 (10 pgs) with English translation (11 pgs).;;Current claims for CN foreign patent application No. 200480033007.8 (6 pgs).;;Canadian Intellectual Property Office. Requisition. Method and Apparatus For Advertising a Link Cost In a Data Communications Network. Application No. 2509359. Mar. 26, 2008. pp. 1-3.",INACTIVE
950,US,B1,US 6407243 B1,057-463-201-309-75X,2002-06-18,2002,US 43543795 A,1995-05-10,US 43543795 A;;US 30927194 A,1994-09-20,"Benzofuran compounds, compositions, and methods","
    The present invention provides novel compound of the formula: 

    wherein 

    R ^{ a } is OH or 

    O(C _{ 1 } -C _{ 4 } alkyl); 

    R ^{ 1a } is OH or 

    O(C _{ 1 } -C _{ 4 } alkyl); 

    n is 2 or 3; 

    R ^{ 2 } and R ^{ 3 } are each independently: 

    C _{ 1 } -C _{ 4 } alkyl, or 

    combine to form 

    1-piperidinyl, 

    1-pyrrolidinyl, 

    1-pyrrolidinyl substituted with one or two methyl groups, 

    4-morpholino or 

    1-hexamethyleneimino; 

    or a pharmaceutically acceptable salt thereof. 
",LILLY CO ELI,BRYANT HENRY U;;CULLINAN GEORGE J;;DODGE JEFFREY A;;FAHEY KENNAN J;;JONES CHARLES D,,https://lens.org/057-463-201-309-75X,Granted Patent,yes,24,13,11,11,0,C07D307/80;;C07D307/80,C07D307/80,546/196;;540/596;;544/153;;548/525;;549/462;;514/212;;514/255;;514/320;;514/422;;514/443,9,7,039-179-689-155-908;;030-054-907-377-079;;008-159-651-906-048;;105-610-128-085-169;;096-139-523-737-271;;065-946-033-703-470;;073-721-902-968-562,6431104;;10.1021/jm00374a021;;1764164;;10.1021/jm00294a011;;5116231;;1473726;;10.1139/g92-143;;10.1016/s0040-4039(01)84412-9;;14287267;;10.1021/jm00325a013;;10.1021/jm00313a016;;6031707,"Jones et al. ""Antiestrogens. 2. Structure-activity studies . . . "" J. Med. Chem. p. 1057, 1984.*;;Erber et al. ""2-phenylbenzo[b]furans:relationship between structure, estrogen receptor affinity and cytostatic activity against mammary tumor cells"" CA 116:120397 (1991).*;;Crenshaw, R.R., et al., J. Med. Chem., 14(12):1185-1190 (1971).;;Durani, N., et al., Indian J. Chem., 22B:489-490 (1983).;;Jones, C.D., et al., J. Med. Chem., 35:931-938 (1992).;;Cerny, et al., Tetrahedran Letters, 8:691-694 (1972).;;Lednicer, D., et al., J. Med. Chem., 8:52-57 (1964).;;Lednicer, D., et al., J. Med. Chem., 9:172-175 (1965).;;Lednicer, D., et al., J. Med. Chem., 10:78-84 (1967).",EXPIRED
951,GB,A,GB 2232355 A,081-546-302-686-945,1990-12-12,1990,GB 9008855 A,1990-04-19,US 34203289 A,1989-04-24,Intramedullary nail,,KYLE RICHARD F;;WINQUIST ROBERT A;;SIMPSON GEORGE E;;MISER JOHN D;;BRYANT MARK A,KYLE RICHARD F;;WINQUIST ROBERT A;;SIMPSON GEORGE E;;MISER JOHN D;;BRYANT MARK A,,https://lens.org/081-546-302-686-945,Patent Application,no,0,6,9,10,0,A61B17/72;;A61B17/7283;;A61B17/744,A61B17/58;;A61B17/72;;A61B17/78,A5R RFB           RX4;;A5R RX4           RX4,0,0,,,,EXPIRED
952,NO,L,NO 20021267 L,101-940-353-078-594,2002-05-10,2002,NO 20021267 A,2002-03-14,US 15443599 P;;US 0040903 W,1999-09-17,Deksel for elektromagnetisk behandlingsapplikator,,REGENESIS BIOMEDICAL INC,GEORGE FRANK R;;BRYANT ROBERT T;;DALY MICHAEL F;;LOYA ARTHUR A;;RITZ MARY C,,https://lens.org/101-940-353-078-594,Abstract,no,0,0,13,20,0,H05K9/0022;;H05K9/0043,A61B18/12;;A61N5/00;;H05K9/00;;A61B19/02,,0,0,,,,DISCONTINUED
953,CA,C,CA 1327277 C,006-896-639-525-645,1994-03-01,1994,CA 612218 A,1989-09-21,US 32484789 A,1989-03-17,MULTILAYER COATED CEMENTED CARBIDE CUTTING INSERT,"An indexable metalcutting insert is provided having a cobalt cemented tungsten carbide substrate with a multilayer refractory coating thereon. The substrate has a cobalt content of 6.1 to 6.5 weight percent and is characterized by a hardness of 90.8 to 91.6 Rockwell A and a magnetic coercive force of 110 to 180 oerstads. The coating contains at least a plurality of alumina layers which are separated from and bonded to each other by a group IVB metal nitride, such as titanium nitride, and which are bonded to the substrate by a backing layer of 5 to 8 .mu. in thickness, composed of a carbide and/or carbonitride of titanium, zirconium and/or hafnium.",KENNAMETAL INC,BRYANT WILLIAM A;;GRAB GEORGE P;;SANTHANAM ANAKKAVUR T;;QUINTO DENNIS T;;HUNT JAMES L,,https://lens.org/006-896-639-525-645,Granted Patent,no,0,0,17,19,0,B23B27/14;;B23B27/145;;B23B2228/36;;C23C30/005,B22F7/00;;B22F7/04;;B23B27/14;;C23C16/30;;C23C30/00,D20570017    M,0,0,,,,EXPIRED
954,US,B1,US 6974961 B1,045-934-138-757-690,2005-12-13,2005,US 66160400 A,2000-09-14,US 66160400 A;;US 15443599 P,1999-09-17,Cover for electromagnetic treatment applicator,"A disposable cover for electromagnetic treatment applicators prevents undesired exposure to potentially harmful radiation. The cover is a pouch-like structure having a back surface (which faces opposite, or away from, the treatment area) constructed from shielding material, such as metallized polyethylene. At least a portion of the cover which faces the treatment area is constructed solely from non-shielding material. Adhesive strips, ZIP-LOCK®, or other interlocking edges, secure the applicator inside the cover and close off any leaks. The electromagnetic properties of the cover are integrated into the circuitry for the treatment applicator, such that the applicator is not functional in the absence of the cover. In use, an electromagnetic treatment applicator is inserted into the cover and positioned over the area to be treated, with the non-shielding, or “window”, portion of the cover overlying the treatment area. Once assembled, the applicator/cover combination forms a closely matched and tuned network for effecting a highly efficient RF output. When activated, the generated electromagnetic energy only exits the cover through the opening or “window”, thereby preventing exposure of the patient or caregiver to potentially harmful radiation.",REGENESIS BIOMEDICAL INC,GEORGE FRANK R;;BRYANT ROBERT T;;DALY MICHAEL F;;LOYA ARTHUR A;;RITZ MARY C,REGENESIS BIOMEDICAL INC (2000-07-10),https://lens.org/045-934-138-757-690,Granted Patent,yes,9,11,7,20,0,A61N1/16;;A61N1/326;;A61N1/40;;G21H1/00;;A61N1/16;;G21H1/00;;A61N1/326;;A61N1/40,A61N1/16;;G21H1/00;;H05K9/00,250/516.1;;250/519.1,0,0,,,,EXPIRED
955,DE,T2,DE 69526550 T2,070-725-948-749-612,2002-10-31,2002,DE 69526550 T,1995-09-18,US 30930194 A,1994-09-20,"2-(4-Hydroxyphenyl)-benzothiophen-Derivate, Zubereitungen und Methoden zur Milderung der Symptome des post-menopausalen Syndroms",,LILLY CO ELI,BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH;;DODGE JEFFREY ALAN;;FAHEY KENNAN JOSEPH;;JONES CHARLES DAVID,,https://lens.org/070-725-948-749-612,Granted Patent,no,0,0,12,12,0,A61K31/381;;A61K31/4025;;A61K31/4535;;A61K31/5377;;A61K31/55;;C07D333/56;;Y02P20/55;;A61P13/02;;A61P15/00;;A61P3/02;;A61P35/00;;A61P3/06;;A61P43/00;;A61P9/00;;C07D333/56;;A61K31/4025;;A61K31/4535;;A61K31/5377;;A61K31/381;;A61K31/55;;Y02P20/55,C07D333/54;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4535;;A61K31/535;;A61K31/5377;;A61K31/55;;A61P3/02;;A61P3/06;;A61P9/00;;A61P13/02;;A61P15/00;;A61P35/00;;A61P43/00;;C07D333/56,,0,0,,,,EXPIRED
956,CA,A1,CA 2200204 A1,098-157-007-127-268,1996-03-28,1996,CA 2200204 A,1995-09-18,US 30930194 A,1994-09-20,"BENZOTHIOPHENE COMPOUNDS, COMPOSITIONS, AND METHODS","The present invention provides novel benzothiophene compounds, pharmaceutical formulations, and processes for preparation thereof, and methods of using such compounds for alleviating the symptoms of post-menopausal syndrome and inhibiting endometriosis, uterine fibrosis, and smooth muscle cell proliferation.",LILLY CO ELI,DODGE JEFFREY ALAN;;BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH;;FAHEY KENNAN JOSEPH;;JONES CHARLES DAVID,,https://lens.org/098-157-007-127-268,Patent Application,no,0,0,12,12,0,A61K31/381;;A61K31/4025;;A61K31/4535;;A61K31/5377;;A61K31/55;;C07D333/56;;Y02P20/55;;A61P13/02;;A61P15/00;;A61P3/02;;A61P35/00;;A61P3/06;;A61P43/00;;A61P9/00;;C07D333/56;;A61K31/4025;;A61K31/4535;;A61K31/5377;;A61K31/381;;A61K31/55;;Y02P20/55,C07D333/54;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4535;;A61K31/535;;A61K31/5377;;A61K31/55;;A61P3/02;;A61P3/06;;A61P9/00;;A61P13/02;;A61P15/00;;A61P35/00;;A61P43/00;;C07D333/56,,0,0,,,,DISCONTINUED
957,ID,A,ID 26625 A,004-243-746-203-616,2001-01-25,2001,ID 20001464 A,1999-02-01,US 1745798 A,1998-02-02,PROSES PEMISAHAN YANG DISEMPURNAKAN,,UNION CARBIDE CHEM PLASTIC,ARGYROPOULOS JOHN N;;BRYANT DAVID ROBERT;;MORRISON DONALD LEE;;STOCKMAN KENNETH ELWOOD;;ABATJOGLOU ANTHONY GEORGE,,https://lens.org/004-243-746-203-616,Patent Application,no,0,0,24,24,0,B01J31/0259;;B01J31/0267;;B01J31/185;;B01J31/2208;;B01J31/24;;B01J31/2404;;B01J31/2457;;B01J31/2495;;B01J31/4015;;B01J31/4046;;B01J31/4053;;B01J2231/32;;B01J2231/321;;B01J2231/52;;B01J2231/641;;B01J2531/822;;C07C45/50;;C07C45/80;;C07C51/48;;C07F9/025;;Y02P20/584;;Y02P20/582;;C07C45/50;;B01J31/0267;;B01J31/0259;;B01J31/2457;;B01J31/2495;;B01J31/4015;;B01J31/4046;;B01J2231/32;;B01J31/2404;;C07C45/80;;B01J2231/321;;C07C45/50;;B01J31/185;;B01J2231/52;;B01J31/2208;;B01J2231/641;;B01J31/4053;;C07C51/48;;C07F9/025;;B01J31/24;;B01J2531/822;;Y02P20/584;;Y02P20/582,B01J31/40;;C07B63/00;;C07C45/50;;C07C45/80;;C07C49/92;;C07C51/373;;C07C51/48;;C07C59/147;;C07F9/02;;B01J31/18;;C07F9/50;;C07F9/655;;C07F9/6574,,0,0,,,,PENDING
958,CZ,A3,CZ 20002802 A3,071-161-759-447-338,2000-12-13,2000,CZ 20002802 A,1999-02-01,US 1745798 A,1998-02-02,Separation method of one or several products from a reaction liquid product,,UNION CARBIDE CHEM PLASTIC,ARGYROPOULOS JOHN N;;BRYANT DAVID ROBERT;;MORRISON DONALD LEE;;STOCKMAN KENNETH ELWOOD;;ABATJOGLOU ANTHONY GEORGE,,https://lens.org/071-161-759-447-338,Patent Application,no,0,0,24,24,0,B01J31/0259;;B01J31/0267;;B01J31/185;;B01J31/2208;;B01J31/24;;B01J31/2404;;B01J31/2457;;B01J31/2495;;B01J31/4015;;B01J31/4046;;B01J31/4053;;B01J2231/32;;B01J2231/321;;B01J2231/52;;B01J2231/641;;B01J2531/822;;C07C45/50;;C07C45/80;;C07C51/48;;C07F9/025;;Y02P20/584;;Y02P20/582;;C07C45/50;;B01J31/0267;;B01J31/0259;;B01J31/2457;;B01J31/2495;;B01J31/4015;;B01J31/4046;;B01J2231/32;;B01J31/2404;;C07C45/80;;B01J2231/321;;C07C45/50;;B01J31/185;;B01J2231/52;;B01J31/2208;;B01J2231/641;;B01J31/4053;;C07C51/48;;C07F9/025;;B01J31/24;;B01J2531/822;;Y02P20/584;;Y02P20/582,B01J31/18;;B01J31/40;;C07B63/00;;C07C45/50;;C07C45/80;;C07C49/92;;C07C51/373;;C07C51/48;;C07C59/147;;C07F9/02;;C07F9/50;;C07F9/655;;C07F9/6574,,0,0,,,,PENDING
959,AU,A,AU 1995/037277 A,118-958-495-535-669,1996-04-09,1996,AU 1995/037277 A,1995-09-18,US 30927194 A;;US 9512348 W,1994-09-20,"Benzofuran compounds, compositions, and methods","The present invention provides novel, reduced benzothiophenes of formula IwhereinR is -H, -OH, -O(C1-C4 alkyl), -O-CO-(C1-C6 alkyl), -O-CO-Ar in which Ar is optionally substituted phenyl, or -O-SO2-(C4-C6 alkyl);R<1 >is -H, -OH, -O(C1-C4 alkyl), -O-CO-(C1-C6 alkyl), -O-CO-Ar in which Ar is optionally substituted phenyl, -O-SO2-(C4-C6 alkyl) chloro or bromo;n is 2 or 3; andR<2 >and R<3 >each are independently C1-C4 alkyl, or combine to form 1-piperidinyl, 1-pyrrolidino, methyl-1-pyrrolidino, dimethyl-1-pyrrolidino, 4-morpholino or 1-hexamethyleneimino; or a pharmaceutically acceptable salt thereof. Further provided are methods for alleviating the symptoms of post-menopausal syndrome, and inhibiting endometriosis, uterine fibrosis, and aortal smooth muscle cell proliferation. Also provided are pharmaceutical formulations with formula I compounds, optionally including estrogen or progestin, and intermediate compounds.",LILLY CO ELI,BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH;;DODGE JEFFREY ALAN;;FAHEY KENNAN JOSEPH;;JONES CHARLES DAVID,,https://lens.org/118-958-495-535-669,Patent Application,no,0,0,11,11,0,C07D307/80;;C07D307/80,C07D307/80,,0,0,,,,PENDING
960,AT,T1,AT E289577 T1,165-375-748-471-545,2005-03-15,2005,AT 99905553 T,1999-02-01,US 1745798 A;;US 9901998 W,1998-02-02,TRENNUNGSVERFAHREN,,UNION CARBIDE CHEM PLASTIC,ARGYROPOULOS JOHN N;;BRYANT DAVID ROBERT;;MORRISON DONALD LEE;;STOCKMAN KENNETH ELWOOD;;ABATJOGLOU ANTHONY GEORGE,,https://lens.org/165-375-748-471-545,Granted Patent,no,0,0,24,24,0,B01J31/0259;;B01J31/0267;;B01J31/185;;B01J31/2208;;B01J31/24;;B01J31/2404;;B01J31/2457;;B01J31/2495;;B01J31/4015;;B01J31/4046;;B01J31/4053;;B01J2231/32;;B01J2231/321;;B01J2231/52;;B01J2231/641;;B01J2531/822;;C07C45/50;;C07C45/80;;C07C51/48;;C07F9/025;;Y02P20/584;;Y02P20/582;;C07C45/50;;B01J31/0267;;B01J31/0259;;B01J31/2457;;B01J31/2495;;B01J31/4015;;B01J31/4046;;B01J2231/32;;B01J31/2404;;C07C45/80;;B01J2231/321;;C07C45/50;;B01J31/185;;B01J2231/52;;B01J31/2208;;B01J2231/641;;B01J31/4053;;C07C51/48;;C07F9/025;;B01J31/24;;B01J2531/822;;Y02P20/584;;Y02P20/582,B01J31/18;;B01J31/40;;C07B63/00;;C07C45/50;;C07C45/80;;C07C49/92;;C07C51/373;;C07C51/48;;C07C59/147;;C07F9/02;;C07F9/50;;C07F9/655;;C07F9/6574,,0,0,,,,DISCONTINUED
961,US,A1,US 2008/0093119 A1,009-715-613-119-52X,2008-04-24,2008,US 27298305 A,2005-11-14,US 27298305 A;;US 20272805 A;;US 66160400 A;;US 15443599 P,1999-09-17,RF shielding cover for RF radiating applicator,"A disposable cover for electromagnetic treatment applicators prevents undesired exposure to potentially harmful radiation. The cover is a pouch-like structure having a back surface constructed from RF shielding material, such as metallized polyethylene, which back surface faces opposite, or away from, the treatment area. A portion of the cover which faces the treatment area is constructed from material transmissive to RF radiation from the applicator. Securing means, such as adhesive strips, or interlocking edges close an open end to secure the applicator inside the cover and to prevent RF radiation through the closed end. In use, an applicator is inserted within the cover and positioned over the area to be treated with the RF transmissive material overlying the treatment area. When the applicator is activated, the generated electromagnetic energy exits the cover only through the RF transmissive material to the treatment area and the RF shielding material prevents exposure of the caregiver to potentially harmful radiation.",REGENESIS BIOMEDICAL INC,GEORGE FRANK R;;BRYANT ROBERT T;;DALY MICHAEL F;;LOYA ARTHUR A;;RITZ MARY C,,https://lens.org/009-715-613-119-52X,Patent Application,yes,28,2,7,20,0,A61N1/16;;A61N1/326;;A61N1/40;;G21H1/00;;A61N1/16;;G21H1/00;;A61N1/326;;A61N1/40,A61N1/16;;H05K9/00;;G21H1/00,174/350,0,0,,,,EXPIRED
962,US,S,US D0671416 S,102-496-138-259-85X,2012-11-27,2012,US 201129406322 F,2011-11-11,US 201129406322 F,2011-11-11,Container,,NUKUTO GEORGE IKUYA;;BRYANT MICHAEL PATRICK;;MCMAHON MICHAEL DENNIS;;HOLM ERIK ALAN;;ZIMMER JONATHAN H;;HEINZ CO H J,NUKUTO GEORGE IKUYA;;BRYANT MICHAEL PATRICK;;MCMAHON MICHAEL DENNIS;;HOLM ERIK ALAN;;ZIMMER JONATHAN H,H.J. HEINZ COMPANY (2011-09-02);;H.J. HEINZ COMPANY BRANDS LLC (2015-06-30),https://lens.org/102-496-138-259-85X,Design Right,no,0,5,1,1,0,,,0901;;D 9542;;D9/574;;D9/520,0,0,,,,ACTIVE
963,EP,B1,EP 0774966 B1,132-303-666-957-509,2003-11-05,2003,EP 95935147 A,1995-09-18,US 9512348 W;;US 30927194 A,1994-09-20,"BENZOFURAN COMPOUNDS, COMPOSITIONS, AND METHODS","The present invention provides novel, reduced benzothiophenes of formula IwhereinR is -H, -OH, -O(C1-C4 alkyl), -O-CO-(C1-C6 alkyl), -O-CO-Ar in which Ar is optionally substituted phenyl, or -O-SO2-(C4-C6 alkyl);R<1 >is -H, -OH, -O(C1-C4 alkyl), -O-CO-(C1-C6 alkyl), -O-CO-Ar in which Ar is optionally substituted phenyl, -O-SO2-(C4-C6 alkyl) chloro or bromo;n is 2 or 3; andR<2 >and R<3 >each are independently C1-C4 alkyl, or combine to form 1-piperidinyl, 1-pyrrolidino, methyl-1-pyrrolidino, dimethyl-1-pyrrolidino, 4-morpholino or 1-hexamethyleneimino; or a pharmaceutically acceptable salt thereof. Further provided are methods for alleviating the symptoms of post-menopausal syndrome, and inhibiting endometriosis, uterine fibrosis, and aortal smooth muscle cell proliferation. Also provided are pharmaceutical formulations with formula I compounds, optionally including estrogen or progestin, and intermediate compounds.",LILLY CO ELI,BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH;;DODGE JEFFREY ALAN;;FAHEY KENNAN JOSEPH;;JONES CHARLES DAVID,,https://lens.org/132-303-666-957-509,Granted Patent,yes,6,0,11,11,0,C07D307/80;;C07D307/80,C07D307/80,,9,0,,,"DURANI N ET AL: ""STRUCTURE-ACTIVITY RELATIONSHIP OF ANTIESTROGENS: A STUDY USING TRIARYLBUTENONE, BENZOFURAN, AND TRIARYLFURAN ANALOGUES AS MODELS FOR TRIARYLETHYLENES AND TRIARYLPROPENONES"" JOURNAL OF MEDICINAL CHEMISTRY, vol. 32, no. 8, 1 August 1989, pages 1700-1707, XP000573924;;BIOLOGICAL ABSTRACTS, Volume 89, No. 5, issued 01 March 1990, LUMSDEN et al., ""Estrogenic Action of Tamoxifen in Women Treated with LHRH Agonists (Goserelin): Lack of Shrinkage of Uterine Fibroids"", Abstract No. 52267; & FERTIL. TERIL., 52(6), 924-929.;;CHEMICAL ABSTRACTS, Volume 82, No. 23, issued 09 June 1975, SUD et al., ""Histochemical Evaluation of Estrogenic and Antiestrogenic Properties of Some Nonsteroidal Postcoital Antifertility Agents"", Abstract No. 149708n; & INDIAN J. MED. RES., 62(10), 1437-42.;;ANTI-CANCER DRUG DESIGN, Volume 6, issued 1991, ERBER et al., ""2-Phe Nylbenzo[b]Furans : Relationship Between Structure, Estrogen Receptor Affinity and Cytostatic Activity Against Mammary Tumor Cells"", pages 417-426.;;AMERICAN J. OBSTETRICS AND GYNECOLOGY, Volume 156, Number 3, issued March 1987, HARBER et al., ""Preliminary Report on the Use of Tamoxifen in the Treatment of Endometriosis"", pages 582-586.;;SYNTHETIC ORGANIC CHEMISTRY, WAGNER et al., Published 1953, by JOHN WILEY & SONS, INC. (N.Y.), pages 148-149.;;DRUGS, Volume 39, Number 4, issued 1990, BARBIERI, ""Endometriosis 1990, Current Treatment Approaches"", pages 502-510.;;REAGENTS FOR ORGANIC SYNTHESIS, Volume 2, FIESER et al., Published 1969, by WILEY & SONS, INC. (NEW YORK), page 382.;;REAGENTS FOR ORGANIC SYSTHESIS, Volume 5, FIESER et al., Published 1975, by WILEY & SONS (NEW YORK), page 596.",EXPIRED
964,WO,A3,WO 2001/019275 A3,125-638-420-473-214,2001-11-01,2001,US 0040903 W,2000-09-14,US 15443599 P,1999-09-17,COVER FOR ELECTROMAGNETIC TREATMENT APPLICATOR,"A disposable cover for electromagnetic treatment applicators prevents undesired exposure to potentially harmful radiation. The cover is a pouch-like structure having a back surface (which faces opposite, or away from, the treatment area) constructed from shielding material, such as metallized polyethylene. At least a portion of the cover which faces the treatment area is constructed solely from non-shielding material. Securing means, such as adhesive strips, ZIP-LOCK®, or other interlocking edges, secure the applicator inside the cover and close off any leaks. The electromagnetic properties of the cover are integrated into the circuitry for the treatment applicator, such that the applicator is not functional in the absence of the cover. In use, an electromagnetic treatment applicator is inserted into the cover and positioned over the area to be treated, with the non-shielding, or 'window', portion of the cover overlying the treatment area. Once assembled, the applicator/cover combination forms a closely matched and tuned network for effecting a highly efficient RF output. When activated, the generated electromagnetic energy only exits the cover through the opening or 'window', thereby preventing exposure of the patient or caregiver to potentially harmful radiation.",REGENESIS BIOMEDICAL INC;;GEORGE FRANK R;;BRYANT ROBERT T;;DALY MICHAEL F;;LOYA ARTHUR A;;RITZ MARY C,GEORGE FRANK R;;BRYANT ROBERT T;;DALY MICHAEL F;;LOYA ARTHUR A;;RITZ MARY C,,https://lens.org/125-638-420-473-214,Search Report,yes,2,0,13,20,0,H05K9/0022;;H05K9/0043,A61B18/12;;A61B19/02;;A61N5/00;;H05K9/00,,0,0,,,,PATENTED
965,US,A,US 5544615 A,158-418-615-818-860,1996-08-13,1996,US 28286994 A,1994-07-29,US 28286994 A,1994-07-29,Synthesis and growth processes for zinc germanium diphosphide single crystals,"New single crystals of ZnGeP.sub.2 are grown by a chemical vapor transport process from bulk synthesized polycrystalline ZnGeP.sub.2 using the LEK process with a controlled injection of phosphorus. The synthesis of the bulk is based on direct injection of phosphorus through a B.sub.2 O.sub.3 encapsulant and reaction with the zinc germanium melt, resulting in synthesis of a large melt (350 g) of ZnGeP.sub.2. When crystallization is followed by cooling the congruent melt down through the .alpha.-.beta. transition temperature (952.degree. C.) as is typical for bulk growth processes, the result is the growth of partially disordered material. This material is placed in a two zone heated furnace where iodine is used to transport the intermediate product to the growth zone where the single crystals grow, at a temperature below the .alpha.-.beta. phase transition. The resulting crystals produced contained a second cubic phase, which has not been reported previously.",US ARMY,HARRIS MECKIE T;;BLISS DAVID F;;ARMINGTON ALTON F;;HIGGINS WILLIAM M;;BRYANT GEORGE G,AIR FORCE THE UNITED STATES OF AMERICA AS REPRESENTED BY THE (1994-07-29),https://lens.org/158-418-615-818-860,Granted Patent,yes,5,4,1,1,0,C30B25/00;;C30B29/10;;C30B25/00;;C30B29/10,C30B25/00,117/18;;117/77;;117/78;;423/299,2,1,016-491-145-631-664,10.1016/0022-0248(94)91263-7,"David F. Bliss et al, Synthesis and growth processes for zinc germanium diphosphide, Journal of Crystal Growth 137 (1994), pp. 145 149.;;H. M. Hobgood et al, ZnGeP 2 grown by the liquid encapsulated Czochralski method, J. Appl. Phys , 73(8), 15 Apr. 1993, pp. 4030 4037.",EXPIRED
966,US,B1,US 6399634 B1,168-006-848-730-837,2002-06-04,2002,US 42349895 A,1995-04-19,US 42349895 A;;US 30930194 A,1994-09-20,"Benzothiophene compounds, compositions, and methods","
    The present invention provides method of treating endometriosis using novel benzothiophene compounds of formula I 

    wherein 

    R is H, OH, O(C _{ 1 } -C _{ 4 } alkyl), OCO(C _{ 1 } -C _{ 6 } alkyl), OCOAr in which Ar is optionally substituted phenyl, or OSO _{ 2 } (C _{ 4 } -C _{ 6 } alkyl); 

    R ^{ 1 } is H, OH, O(C _{ 1 } -C _{ 4 } alkyl),, OCO(C _{ 1 } -C _{ 6 } alkyl), OCOAr in which Ar is optionally substituted phenyl, OSO _{ 2 } (C _{ 4 } -C _{ 6 } alkyl) chloro or bromo; 

    R ^{ 2 } is H or OH; 

    n is 2 or 3; and 

    R ^{ 3 } and R ^{ 4 } each are independently C _{ 1 } -C _{ 4 } alkyl, or combine to form 1-piperidinyl, 1-pyrrolidinyl, methyl-1-pyrrolidinyl, dimethyl-1-pyrrolidinyl, 4-morpholino, or 1-hexamethyleneimino; 

    or a pharmaceutically acceptable salt thereof. 
",LILLY CO ELI,BRYANT HENRY U;;CULLINAN GEORGE J;;DODGE JEFFREY A;;FAHEY KENNAN J;;JONES CHARLES D,,https://lens.org/168-006-848-730-837,Granted Patent,yes,18,2,12,12,0,A61K31/381;;A61K31/4025;;A61K31/4535;;A61K31/5377;;A61K31/55;;C07D333/56;;Y02P20/55;;A61P13/02;;A61P15/00;;A61P3/02;;A61P35/00;;A61P3/06;;A61P43/00;;A61P9/00;;C07D333/56;;A61K31/4025;;A61K31/4535;;A61K31/5377;;A61K31/381;;A61K31/55;;Y02P20/55,A61K31/38;;A61K31/381;;C07D333/54;;A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4535;;A61K31/535;;A61K31/5377;;A61K31/55;;A61P3/02;;A61P3/06;;A61P9/00;;A61P13/02;;A61P15/00;;A61P35/00;;A61P43/00;;C07D333/56,514/324;;540/596;;544/153;;546/202;;548/525;;549/49,8,6,030-054-907-377-079;;008-159-651-906-048;;105-610-128-085-169;;096-139-523-737-271;;065-946-033-703-470;;073-721-902-968-562,1764164;;10.1021/jm00294a011;;5116231;;1473726;;10.1139/g92-143;;10.1016/s0040-4039(01)84412-9;;14287267;;10.1021/jm00325a013;;10.1021/jm00313a016;;6031707,"Erber et al. ""2-Phenylbenzo[b]furans: relationship between structure, estrogen receptor affinity and cytostatic activity against mammary tumor cells"" CA 116:120397 (1991).;;Crenshaw, R.R., et al., J. Med. Chem., 14(12):1185-1190 (1971).;;Durani, N., et al., Indian J. Chem., 22B:489-490 (1983).;;Jones, C.D., et al., J. Med. Chem., 35:931-938 (1992).;;Cerny, et al., Tetrahedron Letters, 8:691-694 (1972).;;Lednicer, D., et al., J. Med. Chem., 8:52-57 (1964).;;Lednicer, D., et al., J. Med. Chem., 9:172-175 (1965).;;Lednicer, D., et al., J. Med. Chem., 10:78-84 (1967).",EXPIRED
967,EP,A4,EP 0774966 A4,084-334-607-287-720,1998-01-07,1998,EP 95935147 A,1995-09-18,US 9512348 W;;US 30927194 A,1994-09-20,"BENZOFURAN COMPOUNDS, COMPOSITIONS, AND METHODS","The present invention provides novel, reduced benzothiophenes of formula IwhereinR is -H, -OH, -O(C1-C4 alkyl), -O-CO-(C1-C6 alkyl), -O-CO-Ar in which Ar is optionally substituted phenyl, or -O-SO2-(C4-C6 alkyl);R<1 >is -H, -OH, -O(C1-C4 alkyl), -O-CO-(C1-C6 alkyl), -O-CO-Ar in which Ar is optionally substituted phenyl, -O-SO2-(C4-C6 alkyl) chloro or bromo;n is 2 or 3; andR<2 >and R<3 >each are independently C1-C4 alkyl, or combine to form 1-piperidinyl, 1-pyrrolidino, methyl-1-pyrrolidino, dimethyl-1-pyrrolidino, 4-morpholino or 1-hexamethyleneimino; or a pharmaceutically acceptable salt thereof. Further provided are methods for alleviating the symptoms of post-menopausal syndrome, and inhibiting endometriosis, uterine fibrosis, and aortal smooth muscle cell proliferation. Also provided are pharmaceutical formulations with formula I compounds, optionally including estrogen or progestin, and intermediate compounds.",LILLY CO ELI,BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH;;DODGE JEFFREY ALAN;;FAHEY KENNAN JOSEPH;;JONES CHARLES DAVID,,https://lens.org/084-334-607-287-720,Search Report,no,4,0,11,11,0,C07D307/80;;C07D307/80,C07D307/80,,1,1,095-072-552-800-903,2754694;;10.1021/jm00128a006,"DURANI N ET AL: ""STRUCTURE-ACTIVITY RELATIONSHIP OF ANTIESTROGENS: A STUDY USING TRIARYLBUTENONE, BENZOFURAN, AND TRIARYLFURAN ANALOGUES AS MODELS FOR TRIARYLETHYLENES AND TRIARYLPROPENONES"", JOURNAL OF MEDICINAL CHEMISTRY, vol. 32, no. 8, 1 August 1989 (1989-08-01), pages 1700 - 1707, XP000573924",EXPIRED
968,AU,A,AU 1999/025692 A,188-022-150-205-358,1999-08-16,1999,AU 1999/025692 A,1999-02-01,US 1745798 A;;US 9901998 W,1998-02-02,Improved separation processes,,UNION CARBIDE CHEM PLASTIC,ARGYROPOULOS JOHN N;;BRYANT DAVID ROBERT;;MORRISON DONALD LEE;;STOCKMAN KENNETH ELWOOD;;ABATJOGLOU ANTHONY GEORGE,,https://lens.org/188-022-150-205-358,Patent Application,no,0,0,24,24,0,B01J31/0259;;B01J31/0267;;B01J31/185;;B01J31/2208;;B01J31/24;;B01J31/2404;;B01J31/2457;;B01J31/2495;;B01J31/4015;;B01J31/4046;;B01J31/4053;;B01J2231/32;;B01J2231/321;;B01J2231/52;;B01J2231/641;;B01J2531/822;;C07C45/50;;C07C45/80;;C07C51/48;;C07F9/025;;Y02P20/584;;Y02P20/582;;C07C45/50;;B01J31/0267;;B01J31/0259;;B01J31/2457;;B01J31/2495;;B01J31/4015;;B01J31/4046;;B01J2231/32;;B01J31/2404;;C07C45/80;;B01J2231/321;;C07C45/50;;B01J31/185;;B01J2231/52;;B01J31/2208;;B01J2231/641;;B01J31/4053;;C07C51/48;;C07F9/025;;B01J31/24;;B01J2531/822;;Y02P20/584;;Y02P20/582,B01J31/18;;B01J31/40;;C07B63/00;;C07C45/50;;C07C45/80;;C07C49/92;;C07C51/373;;C07C51/48;;C07C59/147;;C07F9/02;;C07F9/50;;C07F9/655;;C07F9/6574,,0,0,,,,DISCONTINUED
969,WO,A1,WO 1999/038831 A1,161-483-649-511-727,1999-08-05,1999,US 9901998 W,1999-02-01,US 1745798 A,1998-02-02,IMPROVED SEPARATION PROCESSES,"This invention relates to a process for separating one or more products from a reaction product fluid comprising a metal-organophosphorus ligand complex catalyst, optionally free organophosphorus ligand, a polar solvent and said one or more products, wherein said process comprises (1) mixing said reaction product fluid with a nonpolar solvent to obtain by phase separation a polar phase comprising said metal-organophosphorus ligand complex catalyst, optionally free organophosphorus ligand and said polar solvent and nonpolar phase comprising said one or more products and nonpolar solvent, and (2) recovering said nonpolar phase from said polar phase; wherein said organophosphorus ligand has a partition coefficient between the polar solvent and the nonpolar solvent of greater than about 10, and said one or more products have a partition coefficient between the nonpolar solvent and the polar solvent of greater than about 0.5.",UNION CARBIDE CHEM PLASTIC,ARGYROPOULOS JOHN N;;BRYANT DAVID ROBERT;;MORRISON DONALD LEE;;STOCKMAN KENNETH ELWOOD;;ABATJOGLOU ANTHONY GEORGE,,https://lens.org/161-483-649-511-727,Patent Application,yes,6,2,24,24,0,B01J31/0259;;B01J31/0267;;B01J31/185;;B01J31/2208;;B01J31/24;;B01J31/2404;;B01J31/2457;;B01J31/2495;;B01J31/4015;;B01J31/4046;;B01J31/4053;;B01J2231/32;;B01J2231/321;;B01J2231/52;;B01J2231/641;;B01J2531/822;;C07C45/50;;C07C45/80;;C07C51/48;;C07F9/025;;Y02P20/584;;Y02P20/582;;C07C45/50;;B01J31/0267;;B01J31/0259;;B01J31/2457;;B01J31/2495;;B01J31/4015;;B01J31/4046;;B01J2231/32;;B01J31/2404;;C07C45/80;;B01J2231/321;;C07C45/50;;B01J31/185;;B01J2231/52;;B01J31/2208;;B01J2231/641;;B01J31/4053;;C07C51/48;;C07F9/025;;B01J31/24;;B01J2531/822;;Y02P20/584;;Y02P20/582,B01J31/40;;C07B63/00;;C07C45/50;;C07C45/80;;C07C49/92;;C07C51/373;;C07C51/48;;C07C59/147;;C07F9/02;;B01J31/18;;C07F9/50;;C07F9/655;;C07F9/6574,,0,0,,,,PATENTED
970,US,A,US 5484798 A,041-895-309-942-600,1996-01-16,1996,US 42498995 A,1995-04-19,US 42498995 A;;US 30930194 A,1994-09-20,"Benzothiophene compounds, compositions, and method of inhibiting restenosis","The present invention provides novel benzothiophene compounds of formula I ##STR1## wherein R is --H, --OH, --O(C.sub.1 -C.sub.4 alkyl), --O--CO--(C.sub.1 -C.sub.6 alkyl), --O--CO--Ar in which Ar is optionally substituted phenyl, or --O--SO.sub.2 --(C.sub.4 -C.sub.6 alkyl); R.sup.1 is --H, --OH, --O(C.sub.1 -C.sub.4 alkyl), --O--CO--(C.sub.1 -C.sub.6 alkyl), --O--CO--Ar in which Ar is optionally substituted phenyl, --O--SO.sub.2 --(C.sub.4 -C.sub.6 alkyl) chloro or bromo; R.sup.2 is --H or --OH; n is 2 or 3; and R.sup.3 and R.sup.4 each are independently C.sub.1 14 C.sub.4 alkyl, or combine to form 1-piperidinyl, 1-pyrrolidinyl, methyl-1-pyrrolidinyl, dimethyl-1-pyrrolidinyl, 4-morpholino, or 1-hexamethyleneimino; or a pharmaceutically acceptable salt thereof, for inhibiting restenosis.",LILLY CO ELI,BRYANT HENRY U;;CULLINAN GEORGE J;;DODGE JEFFREY A;;FAHEY KENNAN J;;JONES CHARLES D,,https://lens.org/041-895-309-942-600,Granted Patent,yes,19,59,12,12,0,A61K31/381;;A61K31/4025;;A61K31/4535;;A61K31/5377;;A61K31/55;;C07D333/56;;Y02P20/55;;A61P13/02;;A61P15/00;;A61P3/02;;A61P35/00;;A61P3/06;;A61P43/00;;A61P9/00;;C07D333/56;;A61K31/4025;;A61K31/4535;;A61K31/5377;;A61K31/381;;A61K31/55;;Y02P20/55,A61K31/38;;A61K31/381;;A61K31/40;;C07D333/54;;A61K31/4025;;A61K31/445;;A61K31/4535;;A61K31/535;;A61K31/5377;;A61K31/55;;A61P3/02;;A61P3/06;;A61P9/00;;A61P13/02;;A61P15/00;;A61P35/00;;A61P43/00;;C07D333/56,514/324;;514/212;;514/238.8;;514/422;;514/443;;560/609;;544/146;;546/202;;548/525;;548/527;;549/51;;549/58,9,5,008-159-651-906-048;;105-610-128-085-169;;096-139-523-737-271;;065-946-033-703-470;;073-721-902-968-562,10.1021/jm00294a011;;5116231;;1473726;;10.1139/g92-143;;10.1016/s0040-4039(01)84412-9;;14287267;;10.1021/jm00325a013;;10.1021/jm00313a016;;6031707,"Przewocki et al. Reaction of sulfur with organic compounds CA 113:23198 (1989).;;Przewock et al. Reaction of sulfur with benzyl halides CA 112:20863 (1989).;;Crenshaw, R. R., et al., J. Med. Chem., 14(12):1185 1190 (1971).;;Durani, N., et al., Indian J. Chem., 22B:489 490 (1983).;;Jones, C. D., et al., J. Med. Chem., 35:931 938 (1992).;;Cerny, et al., Tetrahedron Letters, 8:691 694 (1972).;;Lednicer, D., et al., J. Med. Chem., 8:52 57 (1964).;;Lednicer, D., et al., J. Med. Chem., 2:172 175 (1965).;;Lednicer, D., et al., J. Med. Chem., 10:78 84 (1967).",EXPIRED
971,AU,A,AU 1995/036864 A,060-302-762-483-759,1996-04-09,1996,AU 1995/036864 A,1995-09-18,US 30930194 A;;US 9512350 W,1994-09-20,"Benzothiophene compounds, compositions, and methods",,LILLY CO ELI,BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH;;DODGE JEFFREY ALAN;;FAHEY KENNAN JOSEPH;;JONES CHARLES DAVID,,https://lens.org/060-302-762-483-759,Patent Application,no,0,0,12,12,0,A61K31/381;;A61K31/4025;;A61K31/4535;;A61K31/5377;;A61K31/55;;C07D333/56;;Y02P20/55;;A61P13/02;;A61P15/00;;A61P3/02;;A61P35/00;;A61P3/06;;A61P43/00;;A61P9/00;;C07D333/56;;A61K31/4025;;A61K31/4535;;A61K31/5377;;A61K31/381;;A61K31/55;;Y02P20/55,C07D333/54;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4535;;A61K31/535;;A61K31/5377;;A61K31/55;;A61P3/02;;A61P3/06;;A61P9/00;;A61P13/02;;A61P15/00;;A61P35/00;;A61P43/00;;C07D333/56,,0,0,,,,PENDING
972,US,S,US D0704562 S,080-342-039-548-084,2014-05-13,2014,US 201129406329 F,2011-11-11,US 201129406329 F,2011-11-11,Container,,NUKUTO GEORGE IKUYA;;BRYANT MICHAEL PATRICK;;MCMAHON MICHAEL DENNIS;;HOLM ERIK ALAN;;ZIMMER JONATHAN H;;HEINZ CO H J,NUKUTO GEORGE IKUYA;;BRYANT MICHAEL PATRICK;;MCMAHON MICHAEL DENNIS;;HOLM ERIK ALAN;;ZIMMER JONATHAN H,H.J. HEINZ COMPANY (2011-09-02);;H.J. HEINZ COMPANY BRANDS LLC (2015-06-30),https://lens.org/080-342-039-548-084,Design Right,no,0,25,1,1,0,,,0901;;D 9542;;D9/574,0,0,,,,ACTIVE
973,DE,D1,DE 69532079 D1,096-097-622-698-498,2003-12-11,2003,DE 69532079 T,1995-09-18,US 30927194 A;;US 9512348 W,1994-09-20,"BENZOFURANVERBINDUNGEN, PRÄPARATE UND VERFAHREN","The present invention provides novel, reduced benzothiophenes of formula IwhereinR is -H, -OH, -O(C1-C4 alkyl), -O-CO-(C1-C6 alkyl), -O-CO-Ar in which Ar is optionally substituted phenyl, or -O-SO2-(C4-C6 alkyl);R<1 >is -H, -OH, -O(C1-C4 alkyl), -O-CO-(C1-C6 alkyl), -O-CO-Ar in which Ar is optionally substituted phenyl, -O-SO2-(C4-C6 alkyl) chloro or bromo;n is 2 or 3; andR<2 >and R<3 >each are independently C1-C4 alkyl, or combine to form 1-piperidinyl, 1-pyrrolidino, methyl-1-pyrrolidino, dimethyl-1-pyrrolidino, 4-morpholino or 1-hexamethyleneimino; or a pharmaceutically acceptable salt thereof. Further provided are methods for alleviating the symptoms of post-menopausal syndrome, and inhibiting endometriosis, uterine fibrosis, and aortal smooth muscle cell proliferation. Also provided are pharmaceutical formulations with formula I compounds, optionally including estrogen or progestin, and intermediate compounds.",LILLY CO ELI,BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH;;DODGE JEFFREY ALAN;;FAHEY KENNAN JOSEPH;;JONES CHARLES DAVID,,https://lens.org/096-097-622-698-498,Granted Patent,no,0,0,11,11,0,C07D307/80;;C07D307/80,C07D307/80,,0,0,,,,EXPIRED
974,US,S,US D0672248 S,119-062-129-917-995,2012-12-11,2012,US 201129406324 F,2011-11-11,US 201129406324 F,2011-11-11,Container,,NUKUTO GEORGE IKUYA;;BRYANT MICHAEL PATRICK;;MCMAHON MICHAEL DENNIS;;HOLM ERIK ALAN;;ZIMMER JONATHAN H;;HEINZ CO H J,NUKUTO GEORGE IKUYA;;BRYANT MICHAEL PATRICK;;MCMAHON MICHAEL DENNIS;;HOLM ERIK ALAN;;ZIMMER JONATHAN H,H.J. HEINZ COMPANY (2011-09-02);;H.J. HEINZ COMPANY BRANDS LLC (2015-06-30),https://lens.org/119-062-129-917-995,Design Right,no,0,9,1,1,0,,,0901;;D 9542;;D9/563;;D9/569;;D9/571;;D9/574,0,0,,,,ACTIVE
975,EP,A2,EP 1214871 A2,128-979-852-085-770,2002-06-19,2002,EP 00974103 A,2000-09-14,US 0040903 W;;US 15443599 P,1999-09-17,COVER FOR ELECTROMAGNETIC TREATMENT APPLICATOR,,REGENESIS BIOMEDICAL INC,GEORGE FRANK R;;BRYANT ROBERT T;;DALY MICHAEL F;;LOYA ARTHUR A;;RITZ MARY C,,https://lens.org/128-979-852-085-770,Patent Application,yes,0,0,13,20,0,H05K9/0022;;H05K9/0043,A61B18/12;;A61N5/00;;A61B19/02;;H05K9/00,,0,0,,,,DISCONTINUED
976,US,S,US D0672251 S,175-231-783-061-576,2012-12-11,2012,US 201129406326 F,2011-11-11,US 201129406326 F,2011-11-11,Container,,NUKUTO GEORGE IKUYA;;BRYANT MICHAEL PATRICK;;MCMAHON MICHAEL DENNIS;;HOLM ERIK ALAN;;ZIMMER JONATHAN H;;HEINZ CO H J,NUKUTO GEORGE IKUYA;;BRYANT MICHAEL PATRICK;;MCMAHON MICHAEL DENNIS;;HOLM ERIK ALAN;;ZIMMER JONATHAN H,H.J. HEINZ COMPANY (2011-09-02);;H.J. HEINZ COMPANY BRANDS LLC (2015-06-30),https://lens.org/175-231-783-061-576,Design Right,no,0,0,1,1,0,,,0901;;D 9562;;D9/573;;D9/574,0,0,,,,ACTIVE
977,CA,A1,CA 2381906 A1,181-451-124-456-066,2001-03-22,2001,CA 2381906 A,2000-09-14,US 15443599 P;;US 0040903 W,1999-09-17,COVER FOR ELECTROMAGNETIC TREATMENT APPLICATOR,"A disposable cover for electromagnetic treatment applicators prevents undesired exposure to potentially harmful radiation. The cover is a pouch-li ke structure having a back surface (which faces opposite, or away from, the treatment area) constructed from shielding material, such as metallized polyethylene. At least a portion of the cover which faces the treatment area is constructed solely from non-shielding material. Securing means, such as adhesive strips, ZIP-LOCK.RTM., or other interlocking edges, secure the applicator inside the cover and close off any leaks. The electromagnetic properties of the cover are integrated into the circuitry for the treatment applicator, such that the applicator is not functional in the absence of the cover. In use, an electromagnetic treatment applicator is inserted into the cover and positioned over the area to be treated, with the non-shielding, or ""window"", portion of the cover overlying the treatment area. Once assembled, the applicator/cover combination forms a closely matched and tuned network f or effecting a highly efficient RF output. When activated, the generated electromagnetic energy only exits the cover through the opening or ""window"", thereby preventing exposure of the patient or caregiver to potentially harmf ul radiation.",REGENESIS BIOMEDICAL INC,GEORGE FRANK R;;BRYANT ROBERT T;;DALY MICHAEL F;;RITZ MARY C;;LOYA ARTHUR A,,https://lens.org/181-451-124-456-066,Patent Application,no,0,0,13,20,0,H05K9/0022;;H05K9/0043,A61B18/12;;A61B19/02;;A61N5/00;;H05K9/00,,0,0,,,,EXPIRED
978,PL,A1,PL 342187 A1,187-231-081-838-462,2001-05-21,2001,PL 34218799 A,1999-02-01,US 1745798 A,1998-02-02,IMPROVED SEPARATING METHODS,,UNION CARBIDE CHEM PLASTIC,ARGYROPOULOS JOHN N;;BRYANT DAVID ROBERT;;MORRISON DONALD LEE;;STOCKMAN KENNETH ELWOOD;;ABATJOGLOU ANTHONY GEORGE,,https://lens.org/187-231-081-838-462,Patent Application,no,0,0,24,24,0,B01J31/0259;;B01J31/0267;;B01J31/185;;B01J31/2208;;B01J31/24;;B01J31/2404;;B01J31/2457;;B01J31/2495;;B01J31/4015;;B01J31/4046;;B01J31/4053;;B01J2231/32;;B01J2231/321;;B01J2231/52;;B01J2231/641;;B01J2531/822;;C07C45/50;;C07C45/80;;C07C51/48;;C07F9/025;;Y02P20/584;;Y02P20/582;;C07C45/50;;B01J31/0267;;B01J31/0259;;B01J31/2457;;B01J31/2495;;B01J31/4015;;B01J31/4046;;B01J2231/32;;B01J31/2404;;C07C45/80;;B01J2231/321;;C07C45/50;;B01J31/185;;B01J2231/52;;B01J31/2208;;B01J2231/641;;B01J31/4053;;C07C51/48;;C07F9/025;;B01J31/24;;B01J2531/822;;Y02P20/584;;Y02P20/582,B01J31/40;;C07B63/00;;C07C45/50;;B01J31/18;;C07C45/80;;C07C49/92;;C07C51/373;;C07C51/48;;C07C59/147;;C07F9/02;;C07F9/50;;C07F9/655;;C07F9/6574,,0,0,,,,PENDING
979,DE,T2,DE 69532079 T2,021-847-443-211-997,2004-08-26,2004,DE 69532079 T,1995-09-18,US 30927194 A;;US 9512348 W,1994-09-20,"BENZOFURANVERBINDUNGEN, PRÄPARATE UND VERFAHREN","The present invention provides novel, reduced benzothiophenes of formula IwhereinR is -H, -OH, -O(C1-C4 alkyl), -O-CO-(C1-C6 alkyl), -O-CO-Ar in which Ar is optionally substituted phenyl, or -O-SO2-(C4-C6 alkyl);R<1 >is -H, -OH, -O(C1-C4 alkyl), -O-CO-(C1-C6 alkyl), -O-CO-Ar in which Ar is optionally substituted phenyl, -O-SO2-(C4-C6 alkyl) chloro or bromo;n is 2 or 3; andR<2 >and R<3 >each are independently C1-C4 alkyl, or combine to form 1-piperidinyl, 1-pyrrolidino, methyl-1-pyrrolidino, dimethyl-1-pyrrolidino, 4-morpholino or 1-hexamethyleneimino; or a pharmaceutically acceptable salt thereof. Further provided are methods for alleviating the symptoms of post-menopausal syndrome, and inhibiting endometriosis, uterine fibrosis, and aortal smooth muscle cell proliferation. Also provided are pharmaceutical formulations with formula I compounds, optionally including estrogen or progestin, and intermediate compounds.",LILLY CO ELI,BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH;;DODGE JEFFREY ALAN;;FAHEY KENNAN JOSEPH;;JONES CHARLES DAVID,,https://lens.org/021-847-443-211-997,Granted Patent,no,0,0,11,11,0,C07D307/80;;C07D307/80,C07D307/80,,0,0,,,,EXPIRED
980,EP,A1,EP 0703231 A1,023-434-133-978-137,1996-03-27,1996,EP 95306540 A,1995-09-18,US 30930194 A,1994-09-20,"2-(4-Hydroxyphenyl)benzothiophene compounds, compositions and methods for alleviating the symptoms of post-menopause syndrome","The present invention provides novel benzothiophene compounds of formula I
  
 wherein 
   R is -H, -OH, -O(C₁-C₄ alkyl), -O-CO-(C₁-C₆ alkyl), -O-CO-Ar in which Ar is optionally substituted phenyl, or -O-SO₂-(C₄-C₆ alkyl); 
   R¹ is -H, -OH, -O(C₁-C₄ alkyl), -O-CO-(C₁-C₆ alkyl), -O-CO-Ar in which Ar is optionally substituted phenyl, -O-SO₂-(C₄-C₆ alkyl) chloro or bromo; 
   R is -H or -OH; 
   n is 2 or 3; and 
   R³ and R⁴ each are independently C₁-C₄ alkyl, or combine to form 1-piperidinyl, 1-pyrrolidinyl, methyl-1-pyrrolidinyl, dimethyl-l-pyrrolidinyl, 4-morpholino, or 1-hexamethyleneimino; 
or a pharmaceutically acceptable salt thereof. Further provided are methods for alleviating the symptoms of post-menopausal syndrome, and inhibiting endometriosis, uterine fibrosis, and aortal smooth muscle cell proliferation. Also provided are pharmaceutical formulations with formula I compounds, optionally including estrogen or progestin. The present invention further provides a process for preparing a compound of formula Ic
  
 wherein 
   R a  and R 1a  each are -OH or -OR⁵; 
   R³ and R⁴ each are independently C₁-C₄ alkyl, or combine to form 1-piperidinyl, 1-pyrrolidinyl, methoxy-1-pyrrolidinyl, dimethyl-l-pyrrolidinyl, 4-morpholino, or 1-hexamethyleneimino; and 
   R⁵ is a hydroxy protecting group capable of resisting reduction by a strong reducing agent; or a pharmaceutically acceptable salt thereof, which comprises
 a) optionally removing the R⁵ hydroxy protecting groups of a compound of formula II
   wherein 
   n, R³, R⁴, and R⁵ are as defined above, or a salt thereof; b) reacting said formula II compound with a reducing agent in the presence of a solvent having a boiling point in the range from about 150° C to about 200° C, and heating the mixture to reflux; and c) optionally salifying the reaction product from step b).",LILLY CO ELI,BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH;;DODGE JEFFREY ALLEN;;FAHEY KENNAN JOSEPH;;JONES CHARLES DAVID,,https://lens.org/023-434-133-978-137,Patent Application,yes,8,13,12,12,0,A61K31/381;;A61K31/4025;;A61K31/4535;;A61K31/5377;;A61K31/55;;C07D333/56;;Y02P20/55;;A61P13/02;;A61P15/00;;A61P3/02;;A61P35/00;;A61P3/06;;A61P43/00;;A61P9/00;;C07D333/56;;A61K31/4025;;A61K31/4535;;A61K31/5377;;A61K31/381;;A61K31/55;;Y02P20/55,C07D333/54;;A61K31/38;;A61K31/381;;A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4535;;A61K31/535;;A61K31/5377;;A61K31/55;;A61P3/02;;A61P3/06;;A61P9/00;;A61P13/02;;A61P15/00;;A61P35/00;;A61P43/00;;C07D333/56,,10,5,091-231-231-120-237;;035-906-980-629-155;;099-455-113-960-087;;059-203-066-003-361;;070-486-527-145-92X,10.1016/s0735-1097(85)80174-1;;3160756;;2063736;;10.1016/0002-8703(91)90775-d;;10.1016/0040-4020(80)80219-5;;10.1021/ja00842a057;;2784386;;10.1016/0014-4827(89)90104-3,"AUSTIN ET AL.: ""Intimal Proliferation of Smooth Muscle Cells as an Explanation for Recurrent Coronary Artery Stenosis after Percutaneous Transluminal Coronary Angioplasty"", JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, vol. 8, August 1985 (1985-08-01), pages 369 - 375;;HERMANS ET AL.: ""Prevention of Restenosis after Percutaneous Transluminal Coronary Angioplasty"", AMERICAN HEART JOURNAL, vol. 122, July 1991 (1991-07-01), pages 171 - 187, XP022949024, DOI: doi:10.1016/0002-8703(91)90775-D;;J.G.W. MCOMIE: ""Protective Groups in Organic Chemistry"", 1973, PLENUM PRESS, NEW YORK, article J.W. BARTON;;T.W. GREEN: ""Protective Groups in Organic Synthesis"", 1981, JOHN WILEY & SONS, NEW YORK;;HASLAM ET AL., TETRAHEDRON, vol. 36, 1980, pages 2409 - 2433;;BULL. CHEM. SOIC. JAPAN, vol. 38, 1965, pages 1979;;CHEM. BER., 1970, pages 788 AND - 2024;;KING, MONOIR, J. AM. CHEM. SOC., vol. 97, 1975, pages 2566 - 2567;;ROSS, J. OF CELL. BIO., vol. 50, 1971, pages 172;;BONIN ET AL., EXP. CELL. RES., vol. 181, 1989, pages 475 - 482",EXPIRED
981,MX,A,MX PA00007520 A,009-992-241-986-088,2001-02-28,2001,MX PA00007520 A,2000-08-01,US 1745798 A,1998-02-02,PROCESOS DE SEPARACION MEJORADOS,,UNION CARBIDE CHEM PLASTIC,ARGYROPOULOS JOHN N;;BRYANT DAVID ROBERT;;MORRISON DONALD LEE;;STOCKMAN KENNETH ELWOOD;;ABATJOGLOU ANTHONY GEORGE,,https://lens.org/009-992-241-986-088,Patent Application,no,0,0,24,24,0,B01J31/0259;;B01J31/0267;;B01J31/185;;B01J31/2208;;B01J31/24;;B01J31/2404;;B01J31/2457;;B01J31/2495;;B01J31/4015;;B01J31/4046;;B01J31/4053;;B01J2231/32;;B01J2231/321;;B01J2231/52;;B01J2231/641;;B01J2531/822;;C07C45/50;;C07C45/80;;C07C51/48;;C07F9/025;;Y02P20/584;;Y02P20/582;;C07C45/50;;B01J31/0267;;B01J31/0259;;B01J31/2457;;B01J31/2495;;B01J31/4015;;B01J31/4046;;B01J2231/32;;B01J31/2404;;C07C45/80;;B01J2231/321;;C07C45/50;;B01J31/185;;B01J2231/52;;B01J31/2208;;B01J2231/641;;B01J31/4053;;C07C51/48;;C07F9/025;;B01J31/24;;B01J2531/822;;Y02P20/584;;Y02P20/582,B01J31/18;;B01J31/40;;C07B63/00;;C07C45/50;;C07C45/80;;C07C49/92;;C07C51/373;;C07C51/48;;C07C59/147;;C07F9/02;;C07F9/50;;C07F9/655;;C07F9/6574,,0,0,,,,DISCONTINUED
982,TW,B,TW 399036 B,011-471-436-042-034,2000-07-21,2000,TW 84109782 A,1995-09-18,US 30952594 A,1994-09-20,"Naphthyl compounds, intermediates, pharmaceutical, compositions, and preparation process thereof","The present invention provides a compound of formula I wherein R1 is -H, -OH, -O(C1-C4 alkyl), -OCOC6H5, -OCO(C1-C6 alkyl), or -OSO2(C4-C6 alkyl); R2 is -H, -OH, -O(C1-C4 alkyl), -OCOC6H5, -OCO(C1-C6 alkyl) or -OSO2(C4-C6 alkyl); n is 2 or 3; and R3 is 1-piperidinyl, 1-pyrrolidinyl, methyl-1-pyrrolidinyl, dimethyl-1-pyrrolidinyl, 4-morpholino, dimethylamino, diethylamino, or 1-hexamethyleneimino; or a pharmaceutically acceptable salt thereof. Also provided are intermediate compounds of formula IV wherein R<1a> is -H, -OH, or -O(C1-C4 alkyl); R<2a> is -H, -OH, or -O(C1-C4 alkyl); R3 is 1-piperidinyl, 1-pyrrolidinyl, dimethylamino, diethylamino, or 1-hexamethyleneimino; and n is 2 or 3; or a pharmaceutically acceptable salt thereof. The present invention further provides pharmaceutical compositions containing compounds of formula I, optionally containing estrogen or progestin, and the use of such compounds alone, or in combination with estrogen or progestin, for alleviating the symptoms of post-menopausal syndrome, particularly osteoporosis, cardiovascular related pathological conditions, and estrogen-dependent cancer. As used herein, the term """"progestin"""" includes compounds having progestational activity such as, for example, progesterone, norethylnodrel, nongestrel, megestrol acetate, norethindrone, and the like. The compounds of the present invention also are useful for inhibiting uterine fibroid disease and endometriosis in women and aortal smooth muscle cell proliferation, particularly restenosis, in humans. Furthermore, the present invention provides a novel process for preparing compounds of formula Ia wherein R<1a> is -H, -OH, or -O(C1-C4 alkyl); R<2a> is -H, -OH, or -O(C1-C4 alkyl); R3 is 1-piperidinyl, 1-pyrrolidinyl, dimethylamino, diethylamino, or 1-hexamethyleneimino; and n is 2 or 3; or a pharmaceutically acceptable salt thereof, which comprises (a) reacting a compound of formula IIId wherein R<1b> is -H or -O(C1-C4 alkyl); R<2b> is -H or -O(C1-C4 alkyl); and R3 and n are as defined above, with a reducing agent in the presence of a solvent having a boiling point in the range from about 150 DEG C to about 200 DEG C, and heating the mixture to reflux; (b) when R<1b> and/or R<2b> is -O(C1-C4 alkyl), optionally removing the R<1b> and/or R<2b> hydroxy protecting groups; and (c) optionally salifying the reaction product from step (a) or (b).",LILLY CO ELI,BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH;;DODGE JEFFREY ALAN;;FAHEY KENNAN JOSEPH;;JONES CHARLES DAVID,,https://lens.org/011-471-436-042-034,Granted Patent,no,0,0,41,44,0,C07D295/088;;Y02P20/55;;A61P13/02;;A61P15/00;;A61P15/12;;A61P19/10;;A61P3/02;;A61P35/00;;A61P3/06;;A61P43/00;;C07D295/088;;C07D295/088;;Y02P20/55,C07D295/08;;A61K31/13;;A61K31/135;;A61K31/40;;A61K31/445;;A61K31/4453;;A61K31/535;;A61K31/5375;;A61K31/55;;A61P3/02;;A61P3/06;;A61P13/02;;A61P15/00;;A61P15/12;;A61P19/10;;A61P35/00;;A61P43/00;;C07C211/19;;C07C213/08;;C07C217/18;;C07C303/26;;C07C309/65;;C07D207/06;;C07D207/08;;C07D211/22;;C07D295/088;;C07D295/092,,0,0,,,,EXPIRED
983,EP,A1,EP 1053220 A1,022-793-215-329-235,2000-11-22,2000,EP 99905553 A,1999-02-01,US 9901998 W;;US 1745798 A,1998-02-02,IMPROVED SEPARATION PROCESSES,,UNION CARBIDE CHEM PLASTIC,ARGYROPOULOS JOHN N;;BRYANT DAVID ROBERT;;MORRISON DONALD LEE;;STOCKMAN KENNETH ELWOOD;;ABATJOGLOU ANTHONY GEORGE,UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY LLC (2009-01-05);;DOW TECHNOLOGY INVESTMENTS LLC (2008-10-22),https://lens.org/022-793-215-329-235,Patent Application,yes,0,0,24,24,0,B01J31/0259;;B01J31/0267;;B01J31/185;;B01J31/2208;;B01J31/24;;B01J31/2404;;B01J31/2457;;B01J31/2495;;B01J31/4015;;B01J31/4046;;B01J31/4053;;B01J2231/32;;B01J2231/321;;B01J2231/52;;B01J2231/641;;B01J2531/822;;C07C45/50;;C07C45/80;;C07C51/48;;C07F9/025;;Y02P20/584;;Y02P20/582;;C07C45/50;;B01J31/0267;;B01J31/0259;;B01J31/2457;;B01J31/2495;;B01J31/4015;;B01J31/4046;;B01J2231/32;;B01J31/2404;;C07C45/80;;B01J2231/321;;C07C45/50;;B01J31/185;;B01J2231/52;;B01J31/2208;;B01J2231/641;;B01J31/4053;;C07C51/48;;C07F9/025;;B01J31/24;;B01J2531/822;;Y02P20/584;;Y02P20/582,B01J31/18;;B01J31/40;;C07B63/00;;C07C45/50;;C07C45/80;;C07C49/92;;C07C51/373;;C07C51/48;;C07C59/147;;C07F9/02;;C07F9/50;;C07F9/655;;C07F9/6574,,0,0,,,,EXPIRED
984,AU,B2,AU 627569 B2,136-794-544-551-214,1992-08-27,1992,AU 1990/053759 A,1990-04-20,US 34203289 A,1989-04-24,INTRAMEDULLARY NAIL,,KYLE RICHARD F,KYLE RICHARD F;;MISER JOHN D;;BRYANT MARK A;;WINQUIST ROBERT A;;SIMPSON GEORGE E,,https://lens.org/136-794-544-551-214,Granted Patent,no,0,0,9,10,0,A61B17/72;;A61B17/7283;;A61B17/744,A61B17/58;;A61B17/72;;A61B17/78,,0,0,,,,EXPIRED
985,ZA,B,ZA 99775 B,102-712-478-568-740,1999-08-02,1999,ZA 99775 A,1999-02-01,US 1745798 A,1998-02-02,Separation process.,,UNION CARBIDE CHEM PLASTIC,ABATJOGLOU ANTHONY GEORGE;;BRYANT DAVID ROBERT;;STOCKMAN KENNETH ELWOOD;;ARGYROPOULOS JOHN N;;MORRISON DONALD LEE,,https://lens.org/102-712-478-568-740,Granted Patent,no,0,0,24,24,0,B01J31/0259;;B01J31/0267;;B01J31/185;;B01J31/2208;;B01J31/24;;B01J31/2404;;B01J31/2457;;B01J31/2495;;B01J31/4015;;B01J31/4046;;B01J31/4053;;B01J2231/32;;B01J2231/321;;B01J2231/52;;B01J2231/641;;B01J2531/822;;C07C45/50;;C07C45/80;;C07C51/48;;C07F9/025;;Y02P20/584;;Y02P20/582;;C07C45/50;;B01J31/0267;;B01J31/0259;;B01J31/2457;;B01J31/2495;;B01J31/4015;;B01J31/4046;;B01J2231/32;;B01J31/2404;;C07C45/80;;B01J2231/321;;C07C45/50;;B01J31/185;;B01J2231/52;;B01J31/2208;;B01J2231/641;;B01J31/4053;;C07C51/48;;C07F9/025;;B01J31/24;;B01J2531/822;;Y02P20/584;;Y02P20/582,B01J31/40;;C07B63/00;;B01J31/18;;C07C45/50;;C07C45/80;;C07C49/92;;C07C51/373;;C07C51/48;;C07C59/147;;C07F9/02;;C07F9/50;;C07F9/655;;C07F9/6574,,0,0,,,,EXPIRED
986,AU,A,AU 1990/053759 A,130-026-995-852-673,1990-10-25,1990,AU 1990/053759 A,1990-04-20,US 34203289 A,1989-04-24,INTRAMEDULLARY NAIL,,BRYANT MARK A;;KYLE RICHARD F;;MISER JOHN D;;SIMPSON GEORGE E;;WINQUIST ROBERT A,KYLE RICHARD F;;WINQUIST ROBERT A;;SIMPSON GEORGE E;;MISER JOHN D;;BRYANT MARK A,,https://lens.org/130-026-995-852-673,Patent Application,no,0,0,9,10,0,A61B17/72;;A61B17/7283;;A61B17/744,A61B17/58;;A61B17/72;;A61B17/78,,0,0,,,,EXPIRED
987,GB,B,GB 2232355 B,170-763-587-420-848,1992-08-19,1992,GB 9008855 A,1990-04-19,US 34203289 A,1989-04-24,INTRAMEDULLARY NAILS,,KYLE RICHARD F;;WINQUIST ROBERT A;;SIMPSON GEORGE E;;MISER JOHN D;;BRYANT MARK A,KYLE RICHARD F;;WINQUIST ROBERT A;;SIMPSON GEORGE E;;MISER JOHN D;;BRYANT MARK A,,https://lens.org/170-763-587-420-848,Granted Patent,no,0,0,9,10,0,A61B17/72;;A61B17/7283;;A61B17/744,A61B17/58;;A61B17/72;;A61B17/78,A5R RFB           RX4;;A5R RX4           RX4,0,0,,,,EXPIRED
988,US,S,US D0672245 S,178-782-310-494-62X,2012-12-11,2012,US 201129406328 F,2011-11-11,US 201129406328 F,2011-11-11,Container,,NUKUTO GEORGE IKUYA;;BRYANT MICHAEL PATRICK;;MCMAHON MICHAEL DENNIS;;HOLM ERIK ALAN;;ZIMMER JONATHAN H;;HEINZ CO H J,NUKUTO GEORGE IKUYA;;BRYANT MICHAEL PATRICK;;MCMAHON MICHAEL DENNIS;;HOLM ERIK ALAN;;ZIMMER JONATHAN H,H.J. HEINZ COMPANY (2011-09-02);;H.J. HEINZ COMPANY BRANDS LLC (2015-06-30),https://lens.org/178-782-310-494-62X,Design Right,no,0,1,1,1,0,,,0901;;D 9521;;D9/562;;D9/573;;D9/574,0,0,,,,ACTIVE
989,AU,B2,AU 779642 B2,193-094-190-008-432,2005-02-03,2005,AU 2001/012522 A,2000-09-14,US 15443599 P;;US 0040903 W,1999-09-17,Cover for electromagnetic treatment applicator,,REGENESIS BIOMEDICAL INC,GEORGE FRANK R;;BRYANT ROBERT T;;DALY MICHAEL F;;LOYA ARTHUR A;;RITZ MARY C,,https://lens.org/193-094-190-008-432,Granted Patent,no,0,0,13,20,0,H05K9/0022;;H05K9/0043,A61B19/02;;A61B18/12;;A61N5/00;;H05K9/00,,0,0,,,,EXPIRED
990,AU,A,AU 2001/012522 A,020-632-337-549-850,2001-04-17,2001,AU 2001/012522 A,2000-09-14,US 15443599 P;;US 0040903 W,1999-09-17,Cover for electromagnetic treatment applicator,,REGENESIS BIOMEDICAL INC,GEORGE FRANK R;;BRYANT ROBERT T;;DALY MICHAEL F;;LOYA ARTHUR A;;RITZ MARY C,,https://lens.org/020-632-337-549-850,Patent Application,no,0,0,13,20,0,H05K9/0022;;H05K9/0043,A61B19/02;;A61B18/12;;A61N5/00;;H05K9/00,,0,0,,,,EXPIRED
991,US,A1,US 2006/0113102 A1,044-008-839-913-976,2006-06-01,2006,US 20272805 A,2005-08-11,US 20272805 A;;US 66160400 A;;US 15443599 P,1999-09-17,Disposable protective cover for RF treatment apparatus,"A disposable cover for electromagnetic treatment applicators prevents undesired exposure to potentially harmful radiation. The cover is a pouch-like structure having a back surface constructed from shielding material, such as metallized polyethylene, which back surface faces opposite, or away from, the treatment area. At least a portion of the cover which faces the treatment area is constructed solely from RF non-shielding material. Securing means, such as adhesive strips, or interlocking edges, secure the applicator inside the cover and close off any leaks. The electromagnetic properties of the cover are integrated into the circuitry for the treatment applicator, such that the applicator is not functional in the absence of the cover. In use, an electromagnetic treatment applicator is inserted into the cover and positioned over the area to be treated with the non-shielding portion or window of the cover overlying the treatment area. Once assembled, the applicator/cover combination forms a closely matched and tuned network for effecting a highly efficient RF output. When activated, the generated electromagnetic energy only exits the cover through the RF non shielding portion or window, thereby preventing exposure of the patient or caregiver to potentially harmful radiation.",REGENESIS BIOMEDICAL INC,GEORGE FRANK R;;BRYANT ROBERT T;;DALY MICHAEL F;;LOYA ARTHUR A;;RITZ MARY C,REGENESIS BIOMEDICAL INC (2000-11-06),https://lens.org/044-008-839-913-976,Patent Application,yes,24,2,7,20,0,A61N1/16;;A61N1/326;;A61N1/40;;G21H1/00;;A61N1/16;;G21H1/00;;A61N1/326;;A61N1/40,A61N1/16;;H05K9/00;;G21H1/00,17403500R,0,0,,,,EXPIRED
992,WO,A1,WO 2004/102271 A1,071-803-230-501-244,2004-11-25,2004,US 2004/0013774 W,2004-05-03,US 43628803 A,2003-05-12,PHOTOGRAPHIC ELEMENTS WITH LOW DYE STAIN,"This invention provides a silver halide photographic element comprising at least one silver halide emulsion comprising silver halide grains which have associated therewith at least an inner dye layer and an outer dye layer wherein the outer dye layer comprises a dye having at least one substituent that has a positive charge, said photographic element further comprising a cyanine dye of formula (I) or (II) (as described in the specification) that is capable of spectrally sensitizing a silver halide emulsion.",EASTMAN KODAK CO;;LINK STEVEN GEORGE;;PARTON RICHARD LEE;;WILSON ROBERT DON;;BRYANT ROGER ANTHONY;;HARRISON WILLIAM JAMES,LINK STEVEN GEORGE;;PARTON RICHARD LEE;;WILSON ROBERT DON;;BRYANT ROGER ANTHONY;;HARRISON WILLIAM JAMES,,https://lens.org/071-803-230-501-244,Patent Application,yes,2,0,2,2,0,G03C1/29;;G03C1/29,G03C1/29,,1,1,007-204-099-352-136,10.1021/cr60274a001,"A. LEO, C. HANSCH. D. ELKINS: ""PARTITION COEFFICIENTS AND THEIR USES"", CHEMICAL REVIEWS, AMERICAN CHEMICAL SOCIETY, WASHINGTON, DC, US, vol. 71, no. 6, December 1971 (1971-12-01), pages 525 - 616, XP000853590",PENDING
993,ES,T3,ES 2176288 T3,090-246-401-346-796,2002-12-01,2002,ES 95306540 T,1995-09-18,US 30930194 A,1994-09-20,"COMPUESTOS DE 2-(4-HIDROXIFENIL)BENZOTIOFENO, COMPOSICIONES Y PROCEDIMIENTOS PARA ALIVIR EL SINDROME POSTMENOPAUSICO.","LA PRESENTE INVENCION PROPORCIONA NUEVOS COMPUESTOS DE BENZOTIOFENO DE FORMULA I EN DONDE R ES -H, -OH, -O(ALKILO C1-C4), -O-CO-(ALKILO C1-C6), -O-CO-AR EN EL QUE AR ES FENILO OPCIONALMENTE SUSTITUIDO, O -O-SO2-(ALKILO C4C6); R1 ES -H, -OH, -O(ALKILO C1-C4), -O-CO(ALKILO C1-C6), -O-CO-AR EN EL QUE AR ES FENILO OPCIONALMENTE SUSTITUIDO, -O-SO2-(ALKILO C4-C6) CLORO O BROMO; R2} ES -H O -OH; N ES 2 O 3; Y R3 Y R4 SON CADA UNO INDEPENDIENTEMENTE ALKILO C1-C4, O SE COMBINAN PARA FORMAR 1-PIPERIDINILO, 1PIRROLIDINO, METILO-1-PIRROLIDINILO, DIMETILO-L-PIRROLIDINILO, 4-MORFOLINO, O 1-HEXAMETILENEIMINO; O UNA SAL FARMACEUTICAMENTE ACEPTABLE DE LOS MISMOS. ADEMAS SE PROPORCIONAN METODOS PARA ALIVIAR LOS SINTOMAS DEL SINDROME POST-MENOPAUSIA, E INHIBICION DE ENDOMETRIOSIS, FIBROSIS UTERINA, Y PROLIFERACION CELULAR DEL MUSCULO BLANDO. ADEMAS SE PROPORCIONAN FORMULACIONES FARMACEUTICAS CON COMPUESTOS DE FORMULA I, QUE INCLUYEN OPCIONALMENTE ESTROGENO O PROGESTINA. LA PRESENTE INVENCION PROPORCIONA ADEMAS UN PROCESO PARA PREPARAR UN COMPUESTO DE FORMULA IC EN DONDE RA Y R1A SON -OH O -OR5; R3 Y R4 SON CADA UNO INDEPENDIENTEMENTE ALKILO C1-C4, O COMBINAN PARA FORMAR 1-PIPERIDINILO, 1PIRROLIDINO, METILO-1-PIRROLIDINILO, DIMETILO-L-PIRROLIDINILO, 4-MORFOLINO, O 1-HEXAMETILENEIMINO; Y R5 ES UN GRUPO DE PROTECCION HIDROXI CAPAZ DE RESISTIR LA REDUCCION MEDIANTE UN AGENTE DE REDUCCION FUERTE; O UNA SAL FARMACEUTICAMENTE ACEPTABLE DE LOS MISMOS, QUE COMPRENDE: A) LA ELIMINACION OPCIONALMENTE DE LOS GRUPOS DE PROTECCION HIDROXI R5 DE UN COMPUESTO DE FORMULA II EN DONDE N, R3, R4, Y R5 SON COMO SE HA DEFINIDO ANTERIORMENTE, O UNA SAL DE LOS MISMOS; B) LA REACCION DE DICHO COMPUESTO DE FORMULA II CON UN AGENTE DE REDUCCION EN LA PRESENCIA DE UN DISOLVENTE QUE TIENE UN PUNTO DE EBULLICION EN EL RANGO DE ALREDEDOR DE 150 (GRADOS) C A ALREDEDOR DE 200ºC, Y CALENTAMIENTO DE LA MEZCLA DE REFLUJO; Y C) SALIFICACION OPCIONALMENTE DEL PRODUCTO DE REACCION DEL PASO B).",LILLY CO ELI,BRYANT HENRY UHLMAN;;CULLINAN GEORGE JOSEPH;;DODGE JEFFREY ALAN;;FAHEY KENNAN JOSEPH;;JONES CHARLES DAVID,,https://lens.org/090-246-401-346-796,Granted Patent,no,0,0,12,12,0,A61K31/381;;A61K31/4025;;A61K31/4535;;A61K31/5377;;A61K31/55;;C07D333/56;;Y02P20/55;;A61P13/02;;A61P15/00;;A61P3/02;;A61P35/00;;A61P3/06;;A61P43/00;;A61P9/00;;C07D333/56;;A61K31/4025;;A61K31/4535;;A61K31/5377;;A61K31/381;;A61K31/55;;Y02P20/55,A61K31/38;;A61K31/381;;C07D333/54;;A61K31/40;;A61K31/4025;;A61K31/445;;A61K31/4535;;A61K31/535;;A61K31/5377;;A61K31/55;;A61P3/02;;A61P3/06;;A61P9/00;;A61P13/02;;A61P15/00;;A61P35/00;;A61P43/00;;C07D333/56,,0,0,,,,EXPIRED
994,EP,B1,EP 1053220 B1,136-138-377-287-86X,2005-02-23,2005,EP 99905553 A,1999-02-01,US 9901998 W;;US 1745798 A,1998-02-02,IMPROVED SEPARATION PROCESSES,,UNION CARBIDE CHEM PLASTIC,ARGYROPOULOS JOHN N;;BRYANT DAVID ROBERT;;MORRISON DONALD LEE;;STOCKMAN KENNETH ELWOOD;;ABATJOGLOU ANTHONY GEORGE,UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY LLC (2009-01-05);;DOW TECHNOLOGY INVESTMENTS LLC (2008-10-22),https://lens.org/136-138-377-287-86X,Granted Patent,yes,6,0,24,24,0,B01J31/0259;;B01J31/0267;;B01J31/185;;B01J31/2208;;B01J31/24;;B01J31/2404;;B01J31/2457;;B01J31/2495;;B01J31/4015;;B01J31/4046;;B01J31/4053;;B01J2231/32;;B01J2231/321;;B01J2231/52;;B01J2231/641;;B01J2531/822;;C07C45/50;;C07C45/80;;C07C51/48;;C07F9/025;;Y02P20/584;;Y02P20/582;;C07C45/50;;B01J31/0267;;B01J31/0259;;B01J31/2457;;B01J31/2495;;B01J31/4015;;B01J31/4046;;B01J2231/32;;B01J31/2404;;C07C45/80;;B01J2231/321;;C07C45/50;;B01J31/185;;B01J2231/52;;B01J31/2208;;B01J2231/641;;B01J31/4053;;C07C51/48;;C07F9/025;;B01J31/24;;B01J2531/822;;Y02P20/584;;Y02P20/582,B01J31/18;;B01J31/40;;C07B63/00;;C07C45/50;;C07C45/80;;C07C49/92;;C07C51/373;;C07C51/48;;C07C59/147;;C07F9/02;;C07F9/50;;C07F9/655;;C07F9/6574,,0,0,,,,EXPIRED
995,WO,A2,WO 2001/019275 A2,155-551-680-175-623,2001-03-22,2001,US 0040903 W,2000-09-14,US 15443599 P,1999-09-17,COVER FOR ELECTROMAGNETIC TREATMENT APPLICATOR,"A disposable cover for electromagnetic treatment applicators prevents undesired exposure to potentially harmful radiation. The cover is a pouch-like structure having a back surface (which faces opposite, or away from, the treatment area) constructed from shielding material, such as metallized polyethylene. At least a portion of the cover which faces the treatment area is constructed solely from non-shielding material. Securing means, such as adhesive strips, ZIP-LOCK®, or other interlocking edges, secure the applicator inside the cover and close off any leaks. The electromagnetic properties of the cover are integrated into the circuitry for the treatment applicator, such that the applicator is not functional in the absence of the cover. In use, an electromagnetic treatment applicator is inserted into the cover and positioned over the area to be treated, with the non-shielding, or 'window', portion of the cover overlying the treatment area. Once assembled, the applicator/cover combination forms a closely matched and tuned network for effecting a highly efficient RF output. When activated, the generated electromagnetic energy only exits the cover through the opening or 'window', thereby preventing exposure of the patient or caregiver to potentially harmful radiation.",REGENESIS BIOMEDICAL INC;;GEORGE FRANK R;;BRYANT ROBERT T;;DALY MICHAEL F;;LOYA ARTHUR A;;RITZ MARY C,GEORGE FRANK R;;BRYANT ROBERT T;;DALY MICHAEL F;;LOYA ARTHUR A;;RITZ MARY C,,https://lens.org/155-551-680-175-623,Patent Application,yes,5,0,13,20,0,H05K9/0022;;H05K9/0043,A61B18/12;;A61B19/02;;A61N5/00;;H05K9/00,,0,0,,,,PATENTED
996,BR,A,BR 9908360 A,162-125-527-126-931,2002-01-15,2002,BR 9908360 A,1999-02-01,US 1745798 A;;US 9901998 W,1998-02-02,Processos de separação aperfeiçoados,"""PROCESSOS DE SEPARAçãO APERFEIçOADOS"". A presente invenção refere-se a um processo para a separação de um ou mais produtos a partir do fluido de produto de reação que compreende catalisador de complexo de agente de ligação de metal-organofosforoso, opcionalmente um agente de ligação organofosforoso livre, um solvente polar e os referidos um ou mais produtos, onde o referido processo compreende (1) misturar o referido fluido de produto de reação com um solvente não polar para obter por separação de fase uma fase polar que compreende o referido catalisador de complexo de agente de ligação de metal-organofosforoso, opcionalmente um agente de ligação organofosforoso livre e o referido solvente polar e uma fase não polar que compreende os referidos um ou mais produtos e solvente não polar, e (2) recuperar a referida fase não polar a partir da referida fase polar; onde o referido agente de ligação organofosforoso é dotado de um coeficiente de divisão entre o solvente polar e o solvente não polar superior a cerca de 10, e o referido um ou mais produtos apresentam um coeficiente de divisão entre o solvente não polar e o solvente polar superior a cerca de 0,5.",UNION CARBIDE CHEM PLASTIC,ARGYROPOULOS JOHN N;;BRYANT DAVID ROBERT;;MORRISON DONALD LEE;;STOCKMAN KENNETH ELWOOD;;ABATJOGLOU ANTHONY GEORGE,UNION CARBIDE CHEMICALS AND PLASTICS TECHNOLOGY LL (2008-11-11);;DOW TECHNOLOGY INVESTMENTS LLC (US) (2008-11-25),https://lens.org/162-125-527-126-931,Patent Application,no,0,0,24,24,0,B01J31/0259;;B01J31/0267;;B01J31/185;;B01J31/2208;;B01J31/24;;B01J31/2404;;B01J31/2457;;B01J31/2495;;B01J31/4015;;B01J31/4046;;B01J31/4053;;B01J2231/32;;B01J2231/321;;B01J2231/52;;B01J2231/641;;B01J2531/822;;C07C45/50;;C07C45/80;;C07C51/48;;C07F9/025;;Y02P20/584;;Y02P20/582;;C07C45/50;;B01J31/0267;;B01J31/0259;;B01J31/2457;;B01J31/2495;;B01J31/4015;;B01J31/4046;;B01J2231/32;;B01J31/2404;;C07C45/80;;B01J2231/321;;C07C45/50;;B01J31/185;;B01J2231/52;;B01J31/2208;;B01J2231/641;;B01J31/4053;;C07C51/48;;C07F9/025;;B01J31/24;;B01J2531/822;;Y02P20/584;;Y02P20/582,B01J31/18;;B01J31/40;;C07B63/00;;C07C45/50;;C07C45/80;;C07C49/92;;C07C51/373;;C07C51/48;;C07C59/147;;C07F9/02;;C07F9/50;;C07F9/655;;C07F9/6574,,0,0,,,,DISCONTINUED
997,US,A,US 5034013 A,168-628-325-491-757,1991-07-23,1991,US 57704190 A,1990-08-31,US 57704190 A;;US 34203289 A,1989-04-24,Intramedullary nail,"An intramedullary nail is disclosed having a tubular elongated body that includes a proximal head portion, an intermediate portion and a distal end portion. The intermediate portion has a longitudinal slot along one side thereof, a groove coextensive with a portion of the slot, and three other grooves spaced about the circumference of the body. This construction provides more desirable flexibility and allows improved revascularization about the nail. The nail is formed of a rod material and the slot and grooves are machined therein to the desired depth and shape.",ZIMMER INC,KYLE RICHARD F;;WINQUIST ROBERT A;;SIMPSON GEORGE E;;MISER JOHN D;;BRYANT MARK A,ZIMMER INC. A CORP. OF DELAWARE (1989-04-25);;ZIMMER INC (2009-07-06);;ZIMMER TECHNOLOGY INC (2002-06-28),https://lens.org/168-628-325-491-757,Granted Patent,yes,19,155,1,10,0,A61B17/72;;A61B17/7233;;A61B17/7266;;A61B17/7283;;A61B17/74;;A61B17/744;;A61B17/7266;;A61B17/744;;A61B17/74;;A61B17/7283;;A61B17/7233;;A61B17/72,A61B17/72;;A61B17/74;;A61B17/78,606/62;;606/63,3,0,,,"Kempf et al., Closed Lock Intramedullary Nailing .;;Taylor et al., Russell Taylor Nail System .;;Grosse et al., The Grosse & Kempf Intramedullary Nailing System .",EXPIRED
998,US,A,US 5492921 A,186-842-905-977-489,1996-02-20,1996,US 42498895 A,1995-04-19,US 42498895 A;;US 30930194 A,1994-09-20,"Benzothiophene compounds, compositions, and methods for inhibiting aortal smooth muscle proliferation","The present invention provides novel benzothiophene compounds of formula I ##STR1## wherein R is --H, --OH, --O(C.sub.1 -C.sub.4 alkyl), --O--CO--(C.sub.1 -C.sub.6 alkyl), --O--CO--Ar in which Ar is optionally substituted phenyl, or --O--SO.sub.2 --(C.sub.4 -C.sub.6 alkyl); R.sup.1 is --H, --OH, --O(C.sub.1 -C.sub.4 alkyl), --O--CO--(C.sub.1 -C.sub.6 alkyl), --O--CO--Ar in which Ar is optionally substituted phenyl, --O--SO.sub.2 --(C.sub.4 -C.sub.6 alkyl) chloro or bromo; R.sup.2 is --H or --OH; n is 2 or 3; and R.sup.3 and R.sup.4 each are independently C.sub.1 -C.sub.4 alkyl, or combine to form 1-piperidinyl, 1-pyrrolidinyl, methyl-1-pyrrolidinyl, dimethyl-1-pyrrolidinyl, 4-morpholino, or 1-hexamethyleneimino; or a pharmaceutically acceptable salt thereof, for inhibiting aortal smooth muscle proliferation.",LILLY CO ELI,BRYANT HENRY U;;CULLINAN GEORGE J;;DODGE JEFFREY A;;FAHEY KENNAN J;;JONES CHARLES D,,https://lens.org/186-842-905-977-489,Granted Patent,yes,19,9,12,12,0,A61K31/381;;A61K31/4025;;A61K31/4535;;A61K31/5377;;A61K31/55;;C07D333/56;;Y02P20/55;;A61P13/02;;A61P15/00;;A61P3/02;;A61P35/00;;A61P3/06;;A61P43/00;;A61P9/00;;C07D333/56;;A61K31/4025;;A61K31/4535;;A61K31/5377;;A61K31/381;;A61K31/55;;Y02P20/55,A61K31/38;;A61K31/381;;A61K31/40;;A61K31/4025;;C07D333/54;;A61K31/445;;A61K31/4535;;A61K31/535;;A61K31/5377;;A61K31/55;;A61P3/02;;A61P3/06;;A61P9/00;;A61P13/02;;A61P15/00;;A61P35/00;;A61P43/00;;C07D333/56,514/324;;514/212;;514/233.5;;514/422;;514/443;;540/596;;544/146;;546/202;;548/525;;549/52,7,5,008-159-651-906-048;;105-610-128-085-169;;096-139-523-737-271;;065-946-033-703-470;;073-721-902-968-562,10.1021/jm00294a011;;5116231;;1473726;;10.1139/g92-143;;10.1016/s0040-4039(01)84412-9;;14287267;;10.1021/jm00325a013;;10.1021/jm00313a016;;6031707,"Crenshaw, R. R., et al., J. Med. Chem., 14(12):1185 1190 (1971).;;Durani, N., et al., Indian J. Chem., 22B:489 490 (1983).;;Jones, C. D., et al., J. Med. Chem., 35:931 938 (1992).;;Cerny, et al., Tetrahedron Letters, 8:691 694 (1972).;;Lednicer, D., et al., J. Med. Chem., 8:52 57 (1964).;;Lednicer, D., et al., J. Med. Chem., 9:172 175 (1965).;;Lednicer, D., et al., J. Med. Chem., 10:78 84 (1967).",EXPIRED
999,US,B2,US 7572985 B2,012-200-490-682-034,2009-08-11,2009,US 20272805 A,2005-08-11,US 20272805 A;;US 66160400 A;;US 15443599 P,1999-09-17,Disposable protective cover for RF treatment apparatus,"A disposable cover for electromagnetic treatment applicators prevents undesired exposure to potentially harmful radiation. The cover is a pouch-like structure having a back surface constructed from shielding material, such as metallized polyethylene, which back surface faces opposite, or away from, the treatment area. At least a portion of the cover which faces the treatment area is constructed solely from RF non-shielding material. Securing means, such as adhesive strips, or interlocking edges, secure the applicator inside the cover and close off any leaks. The electromagnetic properties of the cover are integrated into the circuitry for the treatment applicator, such that the applicator is not functional in the absence of the cover. In use, an electromagnetic treatment applicator is inserted into the cover and positioned over the area to be treated with the non-shielding portion or window of the cover overlying the treatment area. Once assembled, the applicator/cover combination forms a closely matched and tuned network for effecting a highly efficient RF output. When activated, the generated electromagnetic energy only exits the cover through the RF non shielding portion or window, thereby preventing exposure of the patient or caregiver to potentially harmful radiation.",REGENESIS BIOMEDICAL INC,GEORGE FRANK R;;BRYANT ROBERT T;;DALY MICHAEL F;;LOYA ARTHUR A;;RITZ MARY C,REGENESIS BIOMEDICAL INC (2000-11-06),https://lens.org/012-200-490-682-034,Granted Patent,yes,25,0,7,20,0,A61N1/16;;A61N1/326;;A61N1/40;;G21H1/00;;A61N1/16;;G21H1/00;;A61N1/326;;A61N1/40,H05K9/00;;A61N1/00;;A61N1/16;;G21H1/00,174/382;;174/378;;607/115,1,0,,,"International Search Report mailed Apr. 25, 2001, for PCT Application No. PCT/US00/40903 filed Sep. 14, 2000, 8 pages.",EXPIRED
1000,IN,B,IN 177719 B,023-645-066-741-139,1997-02-15,1997,IN 184DE1990 A,1990-02-27,IN 184DE1990 A,1990-02-27,Cutting insert,,KENNAMETAL INC,HUNT JAMES LYNN;;BRYANT WILLIAM ARTHUR;;GRAB GEORGE PAUL;;SANTHANAM ANAKKAVUR THATTAI;;QUINTO DENNIS TAMBAON,,https://lens.org/023-645-066-741-139,Granted Patent,no,0,0,1,1,0,,B25F1/00,,0,0,,,,EXPIRED
